A743 AUTHOR DISCLOSURE AUTHOR RELATIONSHIP/COMPANY AUTHOR RELATIONSHIP/COMPANY Aamidor, Sarah...................................... Disclosed no conflict of interest. Aanstoot, Henk-Jan .............................. Disclosed no conflict of interest. Abbas, Zulfiqarali G. ............................ Disclosed no conflict of interest. Abbasi, Fahim ....................................... Disclosed no conflict of interest. Abbasi, Munira S. ................................ Disclosed no conflict of interest. Abbott, Marcia ...................................... Disclosed no conflict of interest. Abbruzzese, Lorenza ............................. Disclosed no conflict of interest. Abdalla, Dulcineia................................. Disclosed no conflict of interest. Abd-Alrahman, Sherif ........................... Disclosed no conflict of interest. Abdella, Nabilla .................................... Disclosed no conflict of interest. Abdelmoneim, Ahmed .......................... Disclosed no conflict of interest. Abderrahmani, Amar............................. Disclosed no conflict of interest. Abdollahi, Maryam ............................... Disclosed no conflict of interest. Abdulatty, Mohamed ............................ Disclosed no conflict of interest. Abdul-Ghani, Muhammad..................... Disclosed no conflict of interest. Abdulhamid, Sarah ............................... Disclosed no conflict of interest. Abdul-Hay, Samer O. ........................... Disclosed no conflict of interest. Abdullah, Chowdhury S. ...................... Disclosed no conflict of interest. Abdulreda, Midhat H. .......................... Disclosed no conflict of interest. Abe, Takahiro ........................................ Disclosed no conflict of interest. Abel, E. Dale ......................................... Disclosed no conflict of interest. Aberer, Felix .......................................... Disclosed no conflict of interest. Abernethy, Gillian ................................. Disclosed no conflict of interest. Abiko, Atsuko ........................................ Disclosed no conflict of interest. Abood, Beth .......................................... Disclosed no conflict of interest. Abraham, Mary ..................................... Disclosed no conflict of interest. Abraham, Mona A. .............................. Disclosed no conflict of interest. Abraham, Tobin M. .............................. Disclosed no conflict of interest. Abrahamsson, Niclas ............................ Disclosed no conflict of interest. Abramson, Natalie W. ......................... Consultant: Daiichi-Sankyo, Inc. Abreu, Cristina ...................................... Research Support: Boehringer Ingelheim GmbH & Co. KG, Eli Lilly and Company, Novo Nordisk, Inc., Sanofi; Speaker’s Bureau: AstraZeneca/Bristol-Meyers Squibb, Eli Lilly and Company, Novo Nordisk, Inc., Sanofi. Abuaysheh, Sanaa ................................ Disclosed no conflict of interest. Abudukadier, Abulizi ............................. Disclosed no conflict of interest. Aburatani, Hiroyuki ............................... Disclosed no conflict of interest. Abu-Shamat, Layla................................ Disclosed no conflict of interest. Accili, Domenico ................................... Disclosed no conflict of interest. Acerini, Carlo L. .................................... Disclosed no conflict of interest. Acevado-Duncan, Mildred .................... Disclosed no conflict of interest. Achterath, Nicole .................................. Disclosed no conflict of interest. Ackermans, Mariette T. ....................... Disclosed no conflict of interest. Acker-Palmer, Amparo .......................... Disclosed no conflict of interest. Acord, Chelsea R. ................................. Disclosed no conflict of interest. Acum, Michelle ..................................... Disclosed no conflict of interest. Adaikalakoteswari, Antonysunil ........... Disclosed no conflict of interest. Adam, Klaus-Peter ................................ Employee: Metabolon, Inc.; Stock/Shareholder: Metabolon, Inc. Adams, Sara.......................................... Disclosed no conflict of interest. Adams, Sean H. ................................... Research Support: XOMA Corporation. Adamska, Agnieszka ............................. Disclosed no conflict of interest. Adamska, Edyta .................................... Disclosed no conflict of interest. Adeel, Saira .......................................... Disclosed no conflict of interest. Adkins, Deanna W. .............................. Disclosed no conflict of interest. Adkins, Laura ........................................ Disclosed no conflict of interest. Adler, Amanda I. .................................. Disclosed no conflict of interest. Admiraal, Wanda .................................. Disclosed no conflict of interest. Adrian, Charlotte L. .............................. Employee: Novo Nordisk A/S. Adzick, N. Scott..................................... Disclosed no conflict of interest. Affres, Helene ....................................... Disclosed no conflict of interest. Afik, Shaked .......................................... Disclosed no conflict of interest. Afkarian, Maryam ................................. Disclosed no conflict of interest. Agarwal, Chhavi.................................... Disclosed no conflict of interest. Agarwal, Neera..................................... Disclosed no conflict of interest. Agarwal, Ulka ....................................... Disclosed no conflict of interest. Agdauletova, Saule............................... Disclosed no conflict of interest. Agrawal, Madhur .................................. Disclosed no conflict of interest. Aguayo-Mazzucato, Cristina ................. Disclosed no conflict of interest. Aguilar, Linda ........................................ Disclosed no conflict of interest. Ahdal, Jaishid ....................................... Disclosed no conflict of interest. Ahlqvist, Emma ..................................... Disclosed no conflict of interest. Ahmad, Huma ....................................... Research Support: Merck. Ahmad, Shafqat .................................... Disclosed no conflict of interest. Ahmad, Tariq ......................................... Disclosed no conflict of interest. Ahmadian, Maryam .............................. Disclosed no conflict of interest. Ahmann, Andrew J. ............................. Advisory Panel: Novo Nordisk, Inc., Sanofi; Consultant: Dexcom, Inc., Horizon CME, Medtronic, Novo Nordisk, Inc.; Research Support: MannKind Corporation, Medtronic, Sanofi. Ahmed Khan, Balkhiwala...................... Disclosed no conflict of interest. Ahmed, Asma........................................ Disclosed no conflict of interest. Ahmed, Rania........................................ Disclosed no conflict of interest. Ahn, Chang Ho ...................................... Disclosed no conflict of interest. Ahn, Chul Woo ...................................... Disclosed no conflict of interest. Ahn, Jae Hee ........................................ Disclosed no conflict of interest. Ahn, Jin Hee ......................................... Disclosed no conflict of interest. Ahn, Kang Hee ...................................... Disclosed no conflict of interest. Ahn, Kyu Jeung ..................................... Disclosed no conflict of interest. Ahn, Song Voque................................... Disclosed no conflict of interest. Ahn, So-Yeon ........................................ Disclosed no conflict of interest. Ahn, Sylvie A. ....................................... Disclosed no conflict of interest. Ahn, You Hern ....................................... Disclosed no conflict of interest. Ahn, Yu-Bae .......................................... Disclosed no conflict of interest. Ahrén, Bo .............................................. Advisory Panel: AstraZeneca Pharmaceuticals LP, Bristol- Myers Squibb Company, Eli Lilly and Company, GlaxoSmithKline, Merck, Novartis Pharmaceuticals Corporation, Novo Nordisk, Inc., Sanofi, Takeda Pharmaceutical Company, Ltd.; Research Support: Boehringer Ingelheim GmbH & Co. KG.; Speaker’s Bureau: Merck, Novartis Pharmaceuticals Corporation, Novo Nordisk, Inc., Sanofi, Takeda Pharmaceutical Company, Ltd. Ahroni, Jessie H. .................................. Disclosed no conflict of interest. Ahter, Jaweed ....................................... Disclosed no conflict of interest. Ai, Heying.............................................. Disclosed no conflict of interest. Aiello, Lloyd P. ...................................... Board Member: Forseehome, Genzyme Corporation; Consultant: Eisai, Inc., KalVista Pharmaceuticals, Ltd., Thrombogenics, Vantia, Ltd.; Other Relationship: Optos. Aiello, Vito............................................. Disclosed no conflict of interest. Aihara, Ken-ichi .................................... Disclosed no conflict of interest. Ainai, Akira ........................................... Disclosed no conflict of interest. Aitkulov, Murat T. ................................. Disclosed no conflict of interest. Aizenstein, Howard J. ......................... Disclosed no conflict of interest. Aja, Susan ............................................. Disclosed no conflict of interest. Ajay, Vamadevan S. ............................. Disclosed no conflict of interest. Ajilore, Olusola ..................................... Disclosed no conflict of interest. Akana, Momi......................................... Disclosed no conflict of interest. Akanuma, Yasuo ................................... Disclosed no conflict of interest. Akbari, Omid ......................................... Disclosed no conflict of interest. Akhan, Muharrem ................................. Disclosed no conflict of interest. Aki, Nanako........................................... Disclosed no conflict of interest. Akil, Ammira ......................................... Disclosed no conflict of interest. Akiyama, Haruhiko ................................ Disclosed no conflict of interest. Akpunar, Dercan .................................... Disclosed no conflict of interest. Akturk, Mujde ....................................... Disclosed no conflict of interest. Al Arouj, Monira ................................... Advisory Panel: Novartis Pharma AG; Other Relationship: Novartis Pharma AG; Research Support: Novartis Pharma AG. Al Hayek, Ayman A. ............................. Disclosed no conflict of interest. Al Juhani, Amal .................................... Disclosed no conflict of interest. Al Khaldi, Rasha.................................... Disclosed no conflict of interest. Al Kharusi, Najma N. ........................... Disclosed no conflict of interest. Al Mehthel, Mohammed....................... Disclosed no conflict of interest. Al Mulla, Fahad..................................... Disclosed no conflict of interest. Al Sabaan, Fahad S. ............................ Disclosed no conflict of interest. Al Saeed, Abdulghani ........................... Disclosed no conflict of interest. Al Sayah, Fatima ................................... Disclosed no conflict of interest. Al Sinani, Sawsan S. ........................... Disclosed no conflict of interest. Al Tikriti, Alia ........................................ Disclosed no conflict of interest. Al Yahyaee, Said A. ............................. Disclosed no conflict of interest. Al Zadjali, Fahad ................................... Disclosed no conflict of interest. Al Zaid, Aus........................................... Disclosed no conflict of interest. Alahmar, Ahmed.................................... Disclosed no conflict of interest. Ala-Korpela, Mika ................................. Disclosed no conflict of interest. ABSTRACT AUTHOR DISCLOSURE INFORMATION All presenters/authors are required to disclose to the program audience any financial relationships related to the subject matter of this program. The intent of this disclosure is not to prevent a presenter or author from being involved in the activity, but rather to provide participants with information on which they may make their own judgments.
Aamidor, Sarah...................................... Disclosed no conflict of interest.Aanstoot, Henk-Jan .............................. Disclosed no conflict of interest.Abbas, Zulfiqarali G. ............................ Disclosed no conflict of interest.Abbasi, Fahim ....................................... Disclosed no conflict of interest.Abbasi, Munira S. ................................ Disclosed no conflict of interest.Abbott, Marcia ...................................... Disclosed no conflict of interest.Abbruzzese, Lorenza ............................. Disclosed no conflict of interest.Abdalla, Dulcineia ................................. Disclosed no conflict of interest.Abd-Alrahman, Sherif ........................... Disclosed no conflict of interest.Abdella, Nabilla .................................... Disclosed no conflict of interest.Abdelmoneim, Ahmed .......................... Disclosed no conflict of interest.Abderrahmani, Amar ............................. Disclosed no conflict of interest.Abdollahi, Maryam ............................... Disclosed no conflict of interest.Abdulatty, Mohamed ............................ Disclosed no conflict of interest.Abdul-Ghani, Muhammad ..................... Disclosed no conflict of interest.Abdulhamid, Sarah ............................... Disclosed no conflict of interest.Abdul-Hay, Samer O. ........................... Disclosed no conflict of interest.Abdullah, Chowdhury S. ...................... Disclosed no conflict of interest.Abdulreda, Midhat H. .......................... Disclosed no conflict of interest.Abe, Takahiro ........................................ Disclosed no conflict of interest.Abel, E. Dale ......................................... Disclosed no conflict of interest.Aberer, Felix .......................................... Disclosed no conflict of interest.Abernethy, Gillian ................................. Disclosed no conflict of interest.Abiko, Atsuko ........................................ Disclosed no conflict of interest.Abood, Beth .......................................... Disclosed no conflict of interest.Abraham, Mary ..................................... Disclosed no conflict of interest.Abraham, Mona A. .............................. Disclosed no conflict of interest.Abraham, Tobin M. .............................. Disclosed no conflict of interest.Abrahamsson, Niclas ............................ Disclosed no conflict of interest.Abramson, Natalie W. ......................... Consultant: Daiichi-Sankyo, Inc.Abreu, Cristina ...................................... Research Support: Boehringer Ingelheim GmbH & Co. KG, Eli
Lilly and Company, Novo Nordisk, Inc., Sanofi; Speaker’s Bureau: AstraZeneca/Bristol-Meyers Squibb, Eli Lilly and Company, Novo Nordisk, Inc., Sanofi.
Abuaysheh, Sanaa ................................ Disclosed no conflict of interest.Abudukadier, Abulizi ............................. Disclosed no conflict of interest.Aburatani, Hiroyuki ............................... Disclosed no conflict of interest.Abu-Shamat, Layla ................................ Disclosed no conflict of interest.Accili, Domenico ................................... Disclosed no conflict of interest.Acerini, Carlo L. .................................... Disclosed no conflict of interest.Acevado-Duncan, Mildred .................... Disclosed no conflict of interest.Achterath, Nicole .................................. Disclosed no conflict of interest.Ackermans, Mariette T. ....................... Disclosed no conflict of interest.Acker-Palmer, Amparo .......................... Disclosed no conflict of interest.Acord, Chelsea R. ................................. Disclosed no conflict of interest.Acum, Michelle ..................................... Disclosed no conflict of interest.Adaikalakoteswari, Antonysunil ........... Disclosed no conflict of interest.Adam, Klaus-Peter ................................ Employee: Metabolon, Inc.; Stock/Shareholder: Metabolon,
Inc.Adams, Sara .......................................... Disclosed no conflict of interest.Adams, Sean H. ................................... Research Support: XOMA Corporation.Adamska, Agnieszka ............................. Disclosed no conflict of interest.Adamska, Edyta .................................... Disclosed no conflict of interest.Adeel, Saira .......................................... Disclosed no conflict of interest.Adkins, Deanna W. .............................. Disclosed no conflict of interest.Adkins, Laura ........................................ Disclosed no conflict of interest.Adler, Amanda I. .................................. Disclosed no conflict of interest.Admiraal, Wanda .................................. Disclosed no conflict of interest.Adrian, Charlotte L. .............................. Employee: Novo Nordisk A/S.Adzick, N. Scott ..................................... Disclosed no conflict of interest.Affres, Helene ....................................... Disclosed no conflict of interest.Afik, Shaked .......................................... Disclosed no conflict of interest.Afkarian, Maryam ................................. Disclosed no conflict of interest.Agarwal, Chhavi .................................... Disclosed no conflict of interest.Agarwal, Neera ..................................... Disclosed no conflict of interest.Agarwal, Ulka ....................................... Disclosed no conflict of interest.Agdauletova, Saule ............................... Disclosed no conflict of interest.Agrawal, Madhur .................................. Disclosed no conflict of interest.Aguayo-Mazzucato, Cristina ................. Disclosed no conflict of interest.Aguilar, Linda ........................................ Disclosed no conflict of interest.Ahdal, Jaishid ....................................... Disclosed no conflict of interest.Ahlqvist, Emma ..................................... Disclosed no conflict of interest.
Ahmad, Huma ....................................... Research Support: Merck.Ahmad, Shafqat .................................... Disclosed no conflict of interest.Ahmad, Tariq ......................................... Disclosed no conflict of interest.Ahmadian, Maryam .............................. Disclosed no conflict of interest.Ahmann, Andrew J. ............................. Advisory Panel: Novo Nordisk, Inc., Sanofi; Consultant:
Dexcom, Inc., Horizon CME, Medtronic, Novo Nordisk, Inc.; Research Support: MannKind Corporation, Medtronic, Sanofi.
Ahmed Khan, Balkhiwala ...................... Disclosed no conflict of interest.Ahmed, Asma ........................................ Disclosed no conflict of interest.Ahmed, Rania ........................................ Disclosed no conflict of interest.Ahn, Chang Ho ...................................... Disclosed no conflict of interest.Ahn, Chul Woo ...................................... Disclosed no conflict of interest.Ahn, Jae Hee ........................................ Disclosed no conflict of interest.Ahn, Jin Hee ......................................... Disclosed no conflict of interest.Ahn, Kang Hee ...................................... Disclosed no conflict of interest.Ahn, Kyu Jeung ..................................... Disclosed no conflict of interest.Ahn, Song Voque................................... Disclosed no conflict of interest.Ahn, So-Yeon ........................................ Disclosed no conflict of interest.Ahn, Sylvie A. ....................................... Disclosed no conflict of interest.Ahn, You Hern ....................................... Disclosed no conflict of interest.Ahn, Yu-Bae .......................................... Disclosed no conflict of interest.Ahrén, Bo .............................................. Advisory Panel: AstraZeneca Pharmaceuticals LP, Bristol-
Myers Squibb Company, Eli Lilly and Company, GlaxoSmithKline, Merck, Novartis Pharmaceuticals Corporation, Novo Nordisk, Inc., Sanofi, Takeda Pharmaceutical Company, Ltd.; Research Support: Boehringer Ingelheim GmbH & Co. KG.; Speaker’s Bureau: Merck, Novartis Pharmaceuticals Corporation, Novo Nordisk, Inc., Sanofi, Takeda Pharmaceutical Company, Ltd.
Ahroni, Jessie H. .................................. Disclosed no conflict of interest.Ahter, Jaweed ....................................... Disclosed no conflict of interest.Ai, Heying .............................................. Disclosed no conflict of interest.Aiello, Lloyd P. ...................................... Board Member: Forseehome, Genzyme Corporation;
Aiello, Vito............................................. Disclosed no conflict of interest.Aihara, Ken-ichi .................................... Disclosed no conflict of interest.Ainai, Akira ........................................... Disclosed no conflict of interest.Aitkulov, Murat T. ................................. Disclosed no conflict of interest.Aizenstein, Howard J. ......................... Disclosed no conflict of interest.Aja, Susan ............................................. Disclosed no conflict of interest.Ajay, Vamadevan S. ............................. Disclosed no conflict of interest.Ajilore, Olusola ..................................... Disclosed no conflict of interest.Akana, Momi ......................................... Disclosed no conflict of interest.Akanuma, Yasuo ................................... Disclosed no conflict of interest.Akbari, Omid ......................................... Disclosed no conflict of interest.Akhan, Muharrem ................................. Disclosed no conflict of interest.Aki, Nanako ........................................... Disclosed no conflict of interest.Akil, Ammira ......................................... Disclosed no conflict of interest.Akiyama, Haruhiko ................................ Disclosed no conflict of interest.Akpunar, Dercan .................................... Disclosed no conflict of interest.Akturk, Mujde ....................................... Disclosed no conflict of interest.Al Arouj, Monira ................................... Advisory Panel: Novartis Pharma AG; Other Relationship: Novartis
Pharma AG; Research Support: Novartis Pharma AG.Al Hayek, Ayman A. ............................. Disclosed no conflict of interest.Al Juhani, Amal .................................... Disclosed no conflict of interest.Al Khaldi, Rasha .................................... Disclosed no conflict of interest.Al Kharusi, Najma N. ........................... Disclosed no conflict of interest.Al Mehthel, Mohammed ....................... Disclosed no conflict of interest.Al Mulla, Fahad ..................................... Disclosed no conflict of interest.Al Sabaan, Fahad S. ............................ Disclosed no conflict of interest.Al Saeed, Abdulghani ........................... Disclosed no conflict of interest.Al Sayah, Fatima ................................... Disclosed no conflict of interest.Al Sinani, Sawsan S. ........................... Disclosed no conflict of interest.Al Tikriti, Alia ........................................ Disclosed no conflict of interest.Al Yahyaee, Said A. ............................. Disclosed no conflict of interest.Al Zadjali, Fahad ................................... Disclosed no conflict of interest.Al Zaid, Aus ........................................... Disclosed no conflict of interest.Alahmar, Ahmed.................................... Disclosed no conflict of interest.Ala-Korpela, Mika ................................. Disclosed no conflict of interest.
ABSTRACT AUTHOR DISCLOSURE INFORMATION
All presenters/authors are required to disclose to the program audience any fi nancial relationships related to the subject matter of this program. The intent of this disclosure is not to prevent a presenter or author from being involved in the activity, but rather to provide participants with information on which they may make their own judgments.
Alam, Imran ........................................... Disclosed no conflict of interest.Alam, Uazman ....................................... Disclosed no conflict of interest.Alarcon, Cristina ................................... Disclosed no conflict of interest.Al-Attas, Omar ...................................... Disclosed no conflict of interest.Alba, Maria ........................................... Employee: Janssen Research & Development, LLC.Albai, Oana ........................................... Disclosed no conflict of interest.Al-Barazanji, Kamal A. ......................... Disclosed no conflict of interest.Albarwani, Sulayma A. ........................ Disclosed no conflict of interest.Alberico, Federica ................................. Disclosed no conflict of interest.Albers, Peter H. .................................... Employee: Novo Nordisk A/S; Stock/Shareholder: Novo
Nordisk A/S.Albertorio, Juan R. ............................... Disclosed no conflict of interest.Albrecht, Kellen .................................... Disclosed no conflict of interest.Albright, Ann L. .................................... Disclosed no conflict of interest.Albright, Cheryl L. ................................ Disclosed no conflict of interest.Al-Daghri, Nasser ................................. Disclosed no conflict of interest.Alderisio, Antonio ................................. Disclosed no conflict of interest.Aldini, Giancarlo ................................... Disclosed no conflict of interest.Al-Disi, Dara .......................................... Disclosed no conflict of interest.Alegre, Karen C. ................................... Disclosed no conflict of interest.Alejandro, Emilyn .................................. Disclosed no conflict of interest.Aleppo, Grazia ....................................... Disclosed no conflict of interest.Alexander, Michael ............................... Consultant: Islet Sciences.Alexanian, Sara M. .............................. Disclosed no conflict of interest.Alexiadou, Kleopatra ............................ Disclosed no conflict of interest.Alfadda, Assim ...................................... Disclosed no conflict of interest.Al-Fawaz, Hanan ................................... Disclosed no conflict of interest.Alharbi, Turki ......................................... Disclosed no conflict of interest.Alhenc-Gelas, Francois ......................... Disclosed no conflict of interest.Ali, Asif ................................................. Disclosed no conflict of interest.Ali, Mohammed K. ............................... Disclosed no conflict of interest.Ali, Tomader .......................................... Disclosed no conflict of interest.Al-janabi, Wissam ................................ Disclosed no conflict of interest.Aljohani, Naji ........................................ Disclosed no conflict of interest.Al-Kafaji, Ghada .................................... Disclosed no conflict of interest.Alkhalidy, Hana ..................................... Disclosed no conflict of interest.Alkharfy, Khalid ..................................... Disclosed no conflict of interest.Allayee, Hooman ................................... Disclosed no conflict of interest.Allen, Carrie .......................................... Research Support: Sanofi.Allen, Eric .............................................. Disclosed no conflict of interest.Allen, Janet M. .................................... Disclosed no conflict of interest.Aller, Rocio ............................................ Disclosed no conflict of interest.Allgrove, Jeremy ................................... Disclosed no conflict of interest.Allison, Beth A. .................................... Employee: viDa Therapeutics Inc.Allison, Matthew .................................. Disclosed no conflict of interest.Allister, Candice A. .............................. Disclosed no conflict of interest.Al-Lozi, Amal ......................................... Disclosed no conflict of interest.Al-Mahroos, Ghazi ................................ Disclosed no conflict of interest.Alman, Amy C. ..................................... Disclosed no conflict of interest.Almandoz, Jaime .................................. Disclosed no conflict of interest.Almario, Rogelio U. .............................. Disclosed no conflict of interest.Almond, Steve ....................................... Disclosed no conflict of interest.Alnaeeli, Mawadda .............................. Disclosed no conflict of interest.Aloi, Joseph .......................................... Disclosed no conflict of interest.Alokail, Majed ....................................... Disclosed no conflict of interest.Alonso, Laura C. ................................... Disclosed no conflict of interest.Alos, Victor A. ...................................... Disclosed no conflict of interest.Alsaheel, Abdulhameed ........................ Disclosed no conflict of interest.Alsaif, Mohammed ............................... Disclosed no conflict of interest.Al-Saleh, Yousef ................................... Disclosed no conflict of interest.Alsayed, Hany M. ................................ Disclosed no conflict of interest.Alsayed, Nasreen A. ............................ Disclosed no conflict of interest.Alssema, Marjan ................................... Employee: Unilever.Altinova, Alev ........................................ Disclosed no conflict of interest.Altman, Jean-Jacques A. .................... Disclosed no conflict of interest.Altomare, Maria .................................... Disclosed no conflict of interest.Altshuler, David M. .............................. Disclosed no conflict of interest.Altunbas, Hasan A. .............................. Disclosed no conflict of interest.Alvarado Martel, Dácil .......................... Disclosed no conflict of interest.Alvarez, Carmen .................................... Disclosed no conflict of interest.Alvarez, Jose M. .................................. Disclosed no conflict of interest.Alvarez-Perez, Juan C. ......................... Disclosed no conflict of interest.Alves, Claudia M. ................................. Disclosed no conflict of interest.Alves, Tiago C. ..................................... Disclosed no conflict of interest.Al-Yahyaee, Saeed ................................ Disclosed no conflict of interest.Al-Yousef, Mohammed ......................... Disclosed no conflict of interest.Amarasinghe, Sivarathy ........................ Disclosed no conflict of interest.Ambery, Philip D. ................................. Employee: GlaxoSmithKline; Stock/Shareholder:
GlaxoSmithKline.Ambler, Geoffrey ................................... Disclosed no conflict of interest.Ambos, Anu ........................................... Disclosed no conflict of interest.Amburgy, Sarah ..................................... Disclosed no conflict of interest.
Ameer, Barbara ..................................... Advisory Panel: CSL Behring, LLC; Consultant: Sanofi.Ameri, Mahmoud .................................. Employee: Zosano Pharma.Amiel, Stephanie A. ............................. Advisory Panel: Johnson & Johnson, Medtronic; Speaker’s
Aminuddin, Aminuddin ......................... Disclosed no conflict of interest.Amir Levy, Yifat ..................................... Disclosed no conflict of interest.Ammanath, Peethambaran ................... Disclosed no conflict of interest.Ammori, Basil ........................................ Disclosed no conflict of interest.Amols, Mark H. .................................... Disclosed no conflict of interest.Amor, Paul A. ....................................... Employee: Pfizer, Inc.Amorese, Gabriella ............................... Disclosed no conflict of interest.Amorosa, Louis F. ................................. Disclosed no conflict of interest.Amundson, Gerald H. ........................... Disclosed no conflict of interest.Amzalag, Gaël ....................................... Disclosed no conflict of interest.An, Hyun Ju ........................................... Disclosed no conflict of interest.An, Jee Hyun ......................................... Disclosed no conflict of interest.An, Jie ................................................... Research Support: Pfizer, Inc.An, Ping ................................................. Disclosed no conflict of interest.An, Yali .................................................. Disclosed no conflict of interest.An, Zhenmei .......................................... Disclosed no conflict of interest.Anand, Sonia S. ................................... Disclosed no conflict of interest.Anaruma, Chadi P. ................................ Disclosed no conflict of interest.Anders, Karlsson ................................... Disclosed no conflict of interest.Andersen, Camilla ................................. Disclosed no conflict of interest.Andersen, Emilie S. .............................. Disclosed no conflict of interest.Andersen, Gregers S. ........................... Other Relationship: Steno Diabetes Center A/S.Andersen, Henning ............................... Disclosed no conflict of interest.Andersen, Knut Robert .......................... Employee: Boehringer Ingelheim Norway KS.Andersen, Lars L. ................................. Disclosed no conflict of interest.Andersen, Steen ................................... Stock/Shareholder: Novo Nordisk A/S.Andersen, Stig E. ................................. Disclosed no conflict of interest.Anderson, Barbara J. ........................... Advisory Panel: Sanofi; Board Member: Sanofi; Consultant:
Sanofi; Research Support: Bayer Health Care LLC, National Institutes of Health.
Anderson, Cheryl A. ............................. Disclosed no conflict of interest.Anderson, Ethan J. ............................... Disclosed no conflict of interest.Anderson, Jeffrey L. ............................ Disclosed no conflict of interest.Anderson, Madeline ............................. Disclosed no conflict of interest.Anderson, Miranda J. .......................... Disclosed no conflict of interest.Anderson, Neil ...................................... Disclosed no conflict of interest.Anderson, Peter .................................... Disclosed no conflict of interest.Anderson, Richard A. ........................... Disclosed no conflict of interest.Anderson, Simon G. ............................. Disclosed no conflict of interest.Andjelkovic, Mirjana ............................. Employee: F. Hoffmann-La Roche, Ltd.Ando, Mitsu .......................................... Disclosed no conflict of interest.Andre, Anthony D. ............................... Consultant: GlaxoSmithKline, MannKind Corporation, Sanofi.Andreassen, Kim V. .............................. Employee: Nordic Bioscience A/S.Andreewa, Anne P. ............................... Disclosed no conflict of interest.Andrei, Adin-Christian .......................... Disclosed no conflict of interest.Andressdottir, Gudbjörg ........................ Disclosed no conflict of interest.Andrews, Christopher A. ..................... Disclosed no conflict of interest.Andrews, Rob ........................................ Speaker’s Bureau: Allergan, Inc., Bristol-Myers Squibb/
AstraZeneca, Eli Lilly and Company, Novo Nordisk, Inc., Sanofi.
Andriankaja, Oelisoa M. ...................... Disclosed no conflict of interest.Andrikopoulos, Sofianos ....................... Disclosed no conflict of interest.Andrulli Buccheri, Valentina ................. Disclosed no conflict of interest.Anene, Ayanna ...................................... Employee: Partnership for Health Analytic Research, LLC.Angela, Napoli ...................................... Disclosed no conflict of interest.Angeletti, Silvia .................................... Disclosed no conflict of interest.Angelopoulos, Theodoros ..................... Disclosed no conflict of interest.Angius, Maria Filippina ......................... Disclosed no conflict of interest.Anichini, Roberto .................................. Disclosed no conflict of interest.Anil, T.M. .............................................. Disclosed no conflict of interest.Anjana, Ranjit M. ................................. Disclosed no conflict of interest.Annamalai, Palam ................................. Disclosed no conflict of interest.Anne, Belton ......................................... Disclosed no conflict of interest.Anniballi, Gaia ...................................... Disclosed no conflict of interest.Annicotte, Jean-Sébastien ................... Disclosed no conflict of interest.Annuzzi, Giovanni .................................. Disclosed no conflict of interest.Ansarullah, A. ...................................... Disclosed no conflict of interest.Anson, Blake ......................................... Disclosed no conflict of interest.Antisdel-Lomaglio, Jeanne ................... Disclosed no conflict of interest.Antonioli, Luca ...................................... Disclosed no conflict of interest.Antoniolli, Luciana P. ............................ Disclosed no conflict of interest.Antosik, Karolina ................................... Disclosed no conflict of interest.Antsiferov, Mikhail B. .......................... Disclosed no conflict of interest.Antunes, Edson ..................................... Disclosed no conflict of interest.Anupunpisit, Vipavee ............................ Disclosed no conflict of interest.Anyfanti, Panagiota .............................. Disclosed no conflict of interest.Anzai, Keizo ........................................... Disclosed no conflict of interest.
Anzola, Isabel ........................................ Disclosed no conflict of interest.Ao, Ziliang ............................................. Disclosed no conflict of interest.Aoki, Michiko ........................................ Disclosed no conflict of interest.Aouizerat, Bradley ................................. Disclosed no conflict of interest.Aoyama, Tomohisa ................................ Disclosed no conflict of interest.Apanovitch, Anne Marie ....................... Employee: Bristol-Myers Squibb Company.Appana, Deepika ................................... Disclosed no conflict of interest.Arakawa, Hirokazu ................................ Disclosed no conflict of interest.Arakawa, Timothy ................................. Disclosed no conflict of interest.Araki, Atsushi ........................................ Disclosed no conflict of interest.Araki, Eiichi ........................................... Disclosed no conflict of interest.Araki, Hisazumi ..................................... Disclosed no conflict of interest.Araki, Shin-ichi ...................................... Disclosed no conflict of interest.Aram, Pedram ....................................... Disclosed no conflict of interest.Aramandla, Radhika .............................. Disclosed no conflict of interest.Arancio, Ottavio .................................... Disclosed no conflict of interest.Araneta, Maria Rosario ....................... Disclosed no conflict of interest.Arantes-Costa, Fernanda ...................... Disclosed no conflict of interest.Arasaratnam, Vasanthy ......................... Disclosed no conflict of interest.Araujo, Christina ................................... Disclosed no conflict of interest.Aravindalochanan, Vigneswari ............. Disclosed no conflict of interest.Araya-Ramirez, Felipe ........................... Disclosed no conflict of interest.Arbelaez, Ana Maria ............................. Disclosed no conflict of interest.Arbit, Ehud ............................................ Consultant: Oramed Pharmaceuticals.Arble, Deanna ....................................... Disclosed no conflict of interest.Archibald, Lennox K. ............................ Disclosed no conflict of interest.Arcidiacono, Biagio ............................... Disclosed no conflict of interest.Ardilouze, Jean-Luc .............................. Disclosed no conflict of interest.Arean, Patricia ...................................... Disclosed no conflict of interest.Arechavaleta Granell, Rosario .............. Advisory Panel: Merck; Research Support: Merck.Arena, Vincent C. ................................. Disclosed no conflict of interest.Arezzo, Joseph ...................................... Advisory Panel: Cebix, Inc.; Consultant: Cebix, Inc.Arias, Luis ............................................. Disclosed no conflict of interest.Ariel, Danit ............................................ Disclosed no conflict of interest.Aris, Izzuddin ......................................... Disclosed no conflict of interest.Ariyawansa, Shalika ............................. Disclosed no conflict of interest.Armian, Haleh ....................................... Disclosed no conflict of interest.Armitage, Ian M. .................................. Disclosed no conflict of interest.Armstrong, David G. ............................ Disclosed no conflict of interest.Armstrong, Debra A. ............................ Disclosed no conflict of interest.Armstrong, Loren L. ............................. Disclosed no conflict of interest.Armstrong, Taylor .................................. Disclosed no conflict of interest.Arnold, Suzanne V. ............................... Research Support: Genentech, Gilead Sciences, Inc., Sanofi.Arnolds, Sabine ..................................... Disclosed no conflict of interest.Aroda, Vanita ........................................ Disclosed no conflict of interest.Aronson, Ronnie .................................... Advisory Panel: AstraZeneca/Bristol-Meyers Squibb, Janssen
Pharmaceuticals, Medtronic, Novo Nordisk A/S, Sanofi, Takeda Pharmaceutical Company, Ltd.; Consultant: AstraZeneca/Bristol-Meyers Squibb, Janssen Pharmaceuticals, Medtronic, Novo Nordisk A/S, Sanofi, Takeda Pharmaceutical Company, Ltd.; Other Relationship: BD Medical Diabetes Care, GlaxoSmithKline, Sanofi, Takeda Pharmaceutical Company, Ltd.; Research Support: Abbott Laboratories, Inc., Andromeda Biotech, Ltd., AstraZeneca/Bristol-Meyers Squibb, BD Medical Diabetes Care, Boehringer Ingelheim Pharmaceuticals, Inc., ConjuChem, Eli Lilly and Company, Janssen Pharmaceuticals, Medtronic, Merck, Novartis Pharmaceuticals Corporation, Novo Nordisk A/S, Piramal, Regeneron Pharmaceuticals, Inc., Roche Pharmaceuticals, Sanofi, Takeda Pharmaceutical Company, Ltd., Tolerx, Inc.; Speaker’s Bureau: Bristol-Myers Squibb Company.
Aroor, Annayya ...................................... Disclosed no conflict of interest.Arora, Jagriti ......................................... Disclosed no conflict of interest.Arredouani, Abdelilah ........................... Disclosed no conflict of interest.Arrese, Marco ....................................... Disclosed no conflict of interest.Arriga, Roberto ...................................... Disclosed no conflict of interest.Arslan, Erol ............................................ Disclosed no conflict of interest.Arslan, Metin ........................................ Disclosed no conflict of interest.Arslanian, Silva A. ............................... Advisory Panel: Bristol-Myers Squibb Company, Novo
Arteaga, Juan M. ................................. Advisory Panel: AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Company, Novo Nordisk, Inc., Sanofi.
Arthur, Thais .......................................... Disclosed no conflict of interest.Arvan, Peter .......................................... Disclosed no conflict of interest.Asaad, Ghada A. .................................. Disclosed no conflict of interest.Asada, Yoshiko ...................................... Disclosed no conflict of interest.Asaka, Isao ............................................ Disclosed no conflict of interest.Asano, Mai ............................................ Disclosed no conflict of interest.
Asano, Tomoichiro................................. Disclosed no conflict of interest.Asante, Albert ....................................... Disclosed no conflict of interest.Asao, Keiko ........................................... Disclosed no conflict of interest.Asato, Tadashi....................................... Disclosed no conflict of interest.Asbjörnsdottir, Björg ............................. Disclosed no conflict of interest.Asche, Stephen E. ................................ Disclosed no conflict of interest.Aschemeier, Baerbel ............................. Disclosed no conflict of interest.Ascher-Svanum, Haya ........................... Employee: Eli Lilly and Company.Asghar, Omar......................................... Disclosed no conflict of interest.Ashida, Kenji ......................................... Disclosed no conflict of interest.Ashour, Amal ......................................... Disclosed no conflict of interest.A ık, Mehmet ........................................ Disclosed no conflict of interest.Asmar, Ali .............................................. Disclosed no conflict of interest.Asmar, Meena ....................................... Disclosed no conflict of interest.Aso, Yoshimasa ..................................... Disclosed no conflict of interest.Asrih, Mohamed ................................... Disclosed no conflict of interest.Aston, Christopher ................................ Disclosed no conflict of interest.Astor, Brad C. ....................................... Disclosed no conflict of interest.Hauge-Evans, Astrid C. ........................ Disclosed no conflict of interest.Astrup, Arne .......................................... Advisory Panel: Gerson Lehrman Group, Global Dairy
Platform, Jenny Craig, McCain Foods Limited, McDonald’s, the Dutch Beer Knowledge Institute.
Ata, Ashar ............................................. Disclosed no conflict of interest.Atageldiyeva, Kuralay K. ..................... Disclosed no conflict of interest.Atay, Ahmet E. ..................................... Disclosed no conflict of interest.Ateia, Simona ....................................... Disclosed no conflict of interest.Atkin, Stephen ...................................... Advisory Panel: Novo Nordisk A/S; Speaker’s Bureau: Novo
Nordisk A/S.Atkinson, Mark A. ................................ Disclosed no conflict of interest.Atlas, Eran ............................................. Disclosed no conflict of interest.Atlas, Steven J. .................................... Disclosed no conflict of interest.A-Troncoso, Isabel................................. Disclosed no conflict of interest.Atsumi, Tatsuya..................................... Disclosed no conflict of interest.Attané, Camille ..................................... Disclosed no conflict of interest.Attaoua, Redha ..................................... Disclosed no conflict of interest.Attia, John ............................................ Disclosed no conflict of interest.Attinger, Christopher E. ........................ Disclosed no conflict of interest.Aubert, Roberte ..................................... Disclosed no conflict of interest.Augustin, Thomas ................................. Disclosed no conflict of interest.Aukrust, Ingvild ..................................... Disclosed no conflict of interest.Aukrust, Pål ........................................... Disclosed no conflict of interest.Austad, Steven N. ................................ Disclosed no conflict of interest.Auster, Michael ..................................... Disclosed no conflict of interest.Austin, Erin ............................................ Disclosed no conflict of interest.Austin, Peter C. .................................... Disclosed no conflict of interest.Autier, Philippe ...................................... Disclosed no conflict of interest.Avery, Robert L. .................................... Consultant: Allergan, Inc., Genentech, Johnson & Johnson,
Avignon, Antoine................................... Consultant: Novo Nordisk, Inc.Aviles-Santa, Larissa ............................ Disclosed no conflict of interest.Avogaro, Angelo.................................... Disclosed no conflict of interest.Avorn, Jerry ........................................... Research Support: Eli Lilly and Company.Avotina, Gita ......................................... Disclosed no conflict of interest.Avram, Claudiu ...................................... Disclosed no conflict of interest.Avzaledinova, Diana K. ........................ Disclosed no conflict of interest.Aw, Andrew........................................... Disclosed no conflict of interest.Awan, Safia........................................... Disclosed no conflict of interest.Awata, Takuya ....................................... Disclosed no conflict of interest.Ayala, Jennifer E. ................................. Disclosed no conflict of interest.Ayala, Julio E. ...................................... Disclosed no conflict of interest.Ayano, Shiho T. .................................... Disclosed no conflict of interest.Aye, Tandy ............................................. Advisory Panel: Krikorjan.Ayepola, Omolola R. ............................ Disclosed no conflict of interest.Aylor, Kevin W. ..................................... Disclosed no conflict of interest.Ayre, Nia ............................................... Disclosed no conflict of interest.Ayvaz, Goksun ....................................... Disclosed no conflict of interest.Azar, Sami T. ........................................ Advisory Panel: Sanofi.Azevedo, Mirela J. ............................... Disclosed no conflict of interest.Azhar, Salman ....................................... Research Support: Artery Therapeutics.Azhdari, Sara ......................................... Disclosed no conflict of interest.Aziz, Amir .............................................. Disclosed no conflict of interest.Azmi, Shazli ........................................... Disclosed no conflict of interest.Azzarello, Jo .......................................... Disclosed no conflict of interest.Baack, Michelle L. ................................ Disclosed no conflict of interest.Baan, Mieke .......................................... Disclosed no conflict of interest.Baba, Masayaki .................................... Disclosed no conflict of interest.Baba, Mikako ........................................ Disclosed no conflict of interest.Babazono, Tetsuya ................................ Disclosed no conflict of interest.
Babourda, Maria ................................... Disclosed no conflict of interest.Babu, Sunanda ...................................... Disclosed no conflict of interest.Baccetti, Fabio ...................................... Disclosed no conflict of interest.Bacci, Simonetta ................................... Disclosed no conflict of interest.Bach, Ermina ......................................... Disclosed no conflict of interest.Bacha, Fida ............................................ Disclosed no conflict of interest.Bäck, Christer ........................................ Disclosed no conflict of interest.Backus, Carey ........................................ Disclosed no conflict of interest.Bacos, Karl ............................................ Disclosed no conflict of interest.Baculescu, Nicoleta .............................. Disclosed no conflict of interest.Badawi, Alaa ......................................... Disclosed no conflict of interest.Bader, Giovanni ..................................... Employee: Novartis Pharma AG.Bae, Jaehyun ........................................ Disclosed no conflict of interest.Bae, Ji Cheol ......................................... Disclosed no conflict of interest.Bae, Myung Ae ..................................... Disclosed no conflict of interest.Baek, Haeri ............................................ Disclosed no conflict of interest.Baek, Hong Sun ..................................... Disclosed no conflict of interest.Baek, Jongha ........................................ Disclosed no conflict of interest.Baez, Eileen ........................................... Disclosed no conflict of interest.Bagchi, Pramita ..................................... Disclosed no conflict of interest.Bagger, Jonatan I. ................................ Disclosed no conflict of interest.Bahceci, Mitat ....................................... Disclosed no conflict of interest.Bahler, Lonneke ..................................... Disclosed no conflict of interest.Bai, Peter ............................................... Disclosed no conflict of interest.Bai, Yang ............................................... Disclosed no conflict of interest.Bai, Yun ................................................. Disclosed no conflict of interest.Baier, Leslie J. ...................................... Disclosed no conflict of interest.Baig, Arshiya A. ................................... Research Support: NIDDK, Schweppe Foundation.Baik, Sei Hyun ....................................... Disclosed no conflict of interest.Bailes, Zelie .......................................... Employee: Boehringer Ingelheim Ltd.Bailetti, Diego ....................................... Disclosed no conflict of interest.Bailey, Clifford J. ................................. Advisory Panel: Abbott Laboratories, Inc., AstraZeneca/
Bristol-Meyers Squibb, Boehringer Ingelheim GmbH & Co. KG, Eli Lilly and Company, Janssen Biotech, Inc., Takeda Pharmaceutical Company, Ltd.; Other Relationship: Merck Sharp & Dohme Limited.
Bailey, Laura .......................................... Disclosed no conflict of interest.Bailey, Mark .......................................... Disclosed no conflict of interest.Bailey, Robert ........................................ Employee: Janssen Scientific Affairs, LLC; Stock/Shareholder:
Johnson & Johnson.Bailey, Timothy S. ................................ Consultant: Bayer Health Care LLC, BD Medical Diabetes
Care, Medtronic, Novo Nordisk, Sanofi; Research Support: Abbott Diabetes Care, ACON Laboratories, Inc., Alere, Animas Corporation, Bayer Health Care, LLC, BD Medical Diabetes Care, Bristol-Myers Squibb Company, Cebix, Inc., Dexcom, Inc., Eli Lilly and Company, GlaxoSmithKline, Halozyme Therapeutics, Insulet Corporation, Lifescan Animas, Inc., MannKind Corporation, Medtronic, Merck, Novo Nordisk A/S, Orexigen Therapeutics, Inc., Sanofi, Tandem Diabetes Care; Speaker’s Bureau: Novo Nordisk.
Baillargeon, Jean-Patrice ..................... Disclosed no conflict of interest.Baillot, Aurelie ...................................... Disclosed no conflict of interest.Bain, James R. ..................................... Disclosed no conflict of interest.Bain, Stephen C. .................................. Advisory Panel: AstraZeneca Pharmaceuticals LP, Boehringer
Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Janssen Pharmaceuticals, Merck Sharp & Dohme Limited, Novo Nordisk A/S, Omnia-Med, Sanofi; Board Member: Glycosmedia. Other Relationship: Cardiff University, Doctors.net, Onmedica, Omnia-Med, Medscape; Research Support: Abbott Laboratories, Inc., AstraZeneca/Bristol-Meyers Squibb, Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Diartis Pharmaceuticals, Eli Lilly and Company, GlaxoSmithKline, Merck Sharp & Dohme Limited, Novartis Pharmaceuticals Corporation, Novo Nordisk, Inc., Pfizer, Inc., Roche Pharmaceuticals, Sanofi, Schering-Plough, Servier, Takeda Pharmaceuticals U.S.A., Inc.; Stock/Shareholder: Glycosmedia.
Bair, Tami L. .......................................... Disclosed no conflict of interest.Bajaj, Harpreet S. ................................. Advisory Panel: AstraZeneca/Bristol-Meyers Squibb,
Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Janssen Pharmaceuticals, Merck, Novo Nordisk A/S, Sanofi; Research Support: Abbott Laboratories, Inc., AstraZeneca/Bristol-Meyers Squibb, Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Johnson & Johnson, Regeneron Pharmaceuticals, Inc., Sanofi, Takeda Pharmaceuticals U.S.A., Inc.; Speaker’s Bureau: AstraZeneca/Bristol-Meyers Squibb, Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Merck, Novo Nordisk A/S, Sanofi.
Bajpeyi, Sudip ....................................... Disclosed no conflict of interest.Bajwa, Ramey ....................................... Disclosed no conflict of interest.Bak, Ann M. ......................................... Disclosed no conflict of interest.Baker, Emma.......................................... Disclosed no conflict of interest.Baker, Rocky L. ..................................... Disclosed no conflict of interest.Baker, Takara ......................................... Disclosed no conflict of interest.Baker, William ....................................... Disclosed no conflict of interest.Bakhtiani, Parkash A. ........................... Disclosed no conflict of interest.Bakken, Inger J. ................................... Disclosed no conflict of interest.Bakker, Jessie P. ................................... Disclosed no conflict of interest.Bakker, Remko A. ................................. Employee: Boehringer Ingelheim GmbH & Co. KG.Balak, Jeetindra R. ............................... Disclosed no conflict of interest.Balakumar, Sandrasegarampillai .......... Disclosed no conflict of interest.Balamurugan, A.N. ............................... Disclosed no conflict of interest.Balasubramanyam, Ashok .................... Disclosed no conflict of interest.Balcezak, Thomas ................................. Disclosed no conflict of interest.Balci, Mustafa K. ................................. Disclosed no conflict of interest.Baldi, Simona ........................................ Disclosed no conflict of interest.Baldridge, Abigail ................................. Disclosed no conflict of interest.Baldwin, David ...................................... Research Support: Novo Nordisk, Inc.Balik, Oya .............................................. Disclosed no conflict of interest.Balkau, Beverley ................................... Advisory Panel: Boehringer Ingelheim Pharmaceuticals, Inc.
(Spouse/Partner), Bristol-Myers Squibb Company (Spouse/Partner), Eli Lilly and Company (Spouse/Partner), Novo Nordisk, Inc. (Spouse/Partner), Sanofi (Spouse/Partner); Research Support: Servier (Spouse/Partner).
Balkhiyarova, Zhanna R. ...................... Disclosed no conflict of interest.Ball, Randall .......................................... Disclosed no conflict of interest.Balla, Ioanna ......................................... Disclosed no conflict of interest.Ballantyne, Christie M. ........................ Research Support: Roche Pharmaceuticals.Balo, Andrew ........................................ Employee: Dexcom, Inc.Baltrukonis, Daniel ................................ Employee: Pfizer, Inc.; Stock/Shareholder: Pfizer, Inc.Baltzis, Dimitrios ................................... Disclosed no conflict of interest.Balusu, Sowmya ................................... Disclosed no conflict of interest.Bandier, Michala ................................... Employee: Novo Nordisk A/S.Bando, Yukiko ........................................ Disclosed no conflict of interest.Banerji, Mary Ann ................................. Disclosed no conflict of interest.Bangalore Krishna, Kanthi .................... Disclosed no conflict of interest.Bangdiwala, Shrikant ............................ Disclosed no conflict of interest.Banke, Natasha H. ............................... Disclosed no conflict of interest.Banks, Alexander .................................. Disclosed no conflict of interest.Banks, Jaminelli L. ............................... Disclosed no conflict of interest.Bansal, Alok S. ..................................... Disclosed no conflict of interest.Bansal, Nidhi ......................................... Disclosed no conflict of interest.Banton, Tom .......................................... Disclosed no conflict of interest.Banu, Isabela ........................................ Disclosed no conflict of interest.Bao, Wei................................................ Disclosed no conflict of interest.Bao, Yuqian ........................................... Disclosed no conflict of interest.Bapputty, Reena .................................... Disclosed no conflict of interest.Baquero, Arian F. .................................. Disclosed no conflict of interest.Barai, Varsha M. .................................. Disclosed no conflict of interest.Barajas, Rose Ann ................................. Disclosed no conflict of interest.Barakat, Maha T. .................................. Disclosed no conflict of interest.Barb, Diana ........................................... Disclosed no conflict of interest.Barbaresso, Rebecca ............................ Disclosed no conflict of interest.Barbaro, Maria ...................................... Disclosed no conflict of interest.Barbas, Coral ......................................... Disclosed no conflict of interest.Barber, Thomas ..................................... Advisory Panel: Boehringer Ingelheim Pharmaceuticals, Inc.,
Novo Nordisk A/S.Barberger-Gateau, Pascale ................... Disclosed no conflict of interest.Barbetti, Fabrizio ................................... Disclosed no conflict of interest.Bar-Dayan, Yosefa ................................. Disclosed no conflict of interest.Bardenheier, Barbara ............................ Disclosed no conflict of interest.Bargellini, Irene ..................................... Disclosed no conflict of interest.Bariohay, Bruno ..................................... Disclosed no conflict of interest.Barkai, Laszlo ........................................ Advisory Panel: 77 Electronics, Ltd.Barker, Adam ......................................... Disclosed no conflict of interest.Barker, Lawrence E. ............................. Disclosed no conflict of interest.Barkholt, Pernille ................................... Disclosed no conflict of interest.Barn, Vanessa ....................................... Disclosed no conflict of interest.Barnard, Katharine ................................ Advisory Panel: Animas Corporation, Novo Nordisk, Inc.,
Roche Pharmaceuticals; Consultant: Janssen Biotech, Inc., Lifescan Animas, Inc.
Barnard, Neal D. .................................. Disclosed no conflict of interest.Barnea, Maayan .................................... Disclosed no conflict of interest.Barnes, Catherine S. ............................ Disclosed no conflict of interest.Barnes, Jeffrey L. ................................. Disclosed no conflict of interest.Barnett, Anthony H. ............................. Advisory Panel: BMS, Boehringer-Ingelheim, Eli Lilly, Janssen
Barranco, Rafael J. .............................. Disclosed no conflict of interest.Barrera, Francisco ................................. Disclosed no conflict of interest.Barreto, Renata M. .............................. Disclosed no conflict of interest.Barrett, Dave ......................................... Disclosed no conflict of interest.Barrett, Eugene J. ................................ Disclosed no conflict of interest.Barrett-Connor, Elizabeth L. ................. Disclosed no conflict of interest.Barrias, Cláudia ..................................... Disclosed no conflict of interest.Barry, Jonathan D. ............................... Speaker’s Bureau: Baxter, Ethicon EndoSurgery, Inc.Barshes, Neal R. .................................. Disclosed no conflict of interest.Barsotti, Massimiliano .......................... Disclosed no conflict of interest.Barstow, Mariah M. ............................. Disclosed no conflict of interest.Bar-Tana, Jacob .................................... Disclosed no conflict of interest.Bartels, Thomas .................................... Employee: Sanofi.Barter, Philip J. ..................................... Advisory Panel: Amgen, Inc., AstraZeneca Pharmaceuticals LP,
Bartley, Adam ........................................ Disclosed no conflict of interest.Barton, Richard H. ................................ Disclosed no conflict of interest.Barton, Sheila ....................................... Disclosed no conflict of interest.Bartosch, Birke ...................................... Disclosed no conflict of interest.Baser, Onur ............................................ Employee: STATinMED ResearchBasile, Giorgio ....................................... Disclosed no conflict of interest.Basile, Kevin J. .................................... Disclosed no conflict of interest.Baskaran, Charu .................................... Disclosed no conflict of interest.Bass, Pat ............................................... Disclosed no conflict of interest.Bassi, Roberto ....................................... Disclosed no conflict of interest.Bastie, Claire C. ................................... Disclosed no conflict of interest.Bastyr, Edward J. III .............................. Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly
and Company.Basu, Ananda ........................................ Disclosed no conflict of interest.Basu, Arpita .......................................... Disclosed no conflict of interest.Basu, Rita .............................................. Disclosed no conflict of interest.Batch, Bryan .......................................... Research Support: Bristol Meyers Squib Foundation.Batchuluun, Baigalmaa ......................... Disclosed no conflict of interest.Batchuluun, Battsetseg ......................... Disclosed no conflict of interest.Bates, David W. ................................... Disclosed no conflict of interest.Batish, Sat Dev ..................................... Disclosed no conflict of interest.Batista, Márcia R. ................................ Disclosed no conflict of interest.Batra, Manav ........................................ Disclosed no conflict of interest.Battelino, Tadej ..................................... Advisory Panel: Bayer Health Care, LLC, Eli Lilly and Company,
Medtronics, Sanofi; Research Support: Ascendis Pharma, Novo Nordisk, Inc.; Speaker’s Bureau: Eli Lilly and Company, Medtronic, Menarini, Roche Pharmaceuticals, Sanofi.
Batterham, Rachel L. ........................... Disclosed no conflict of interest.Battezzati, Alberto ................................ Disclosed no conflict of interest.Bauduceau, Bernard .............................. Board Member: Merck Sharp & Dohme Limited, Novo Nordisk
A/S, Sanofi; Consultant: AstraZeneca/Bristol-Meyers Squibb, Bayer Health Care, LLC, BD Medical Diabetes Care, Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Merck, Novartis Pharmaceuticals Corporation, Roche Pharmaceuticals, Servier.
Bauer, Witold ........................................ Disclosed no conflict of interest.Baumann, Johannes ............................. Disclosed no conflict of interest.Baumstark, Annette .............................. Disclosed no conflict of interest.Baur, Joseph A. .................................... Disclosed no conflict of interest.Baverel, Gabriel .................................... Stock/Shareholder: Metabolys Inc.Baxi, Sunita ........................................... Disclosed no conflict of interest.Baxter, John N. .................................... Disclosed no conflict of interest.Baxter, Judy........................................... Disclosed no conflict of interest.Bayoumi, Riad A. .................................. Disclosed no conflict of interest.Bayram, Zeliha ...................................... Disclosed no conflict of interest.Baz, Baz R. ............................................ Disclosed no conflict of interest.Bazan, Hernan A. ................................. Disclosed no conflict of interest.Bazinet, Richard P. ................................ Disclosed no conflict of interest.Bazotte, Roberto B. .............................. Disclosed no conflict of interest.Beagley, Jessica ................................... Disclosed no conflict of interest.Beals, Janette ....................................... Disclosed no conflict of interest.Beam, Craig A. ..................................... Disclosed no conflict of interest.Beamish, Christine ................................ Disclosed no conflict of interest.Bean, Rachel ......................................... Disclosed no conflict of interest.Beato, Pilar ............................................ Disclosed no conflict of interest.Beatson, Christie ................................... Disclosed no conflict of interest.Beaucamps, Cedric ............................... Disclosed no conflict of interest.Beça, Helena ......................................... Disclosed no conflict of interest.Becher, Rune ......................................... Disclosed no conflict of interest.
Beck Jensen, Rikke ............................... Other Relationship: Novo Nordisk A/S.Beck, Joni K. ........................................ Disclosed no conflict of interest.Beck, Peter ............................................ Disclosed no conflict of interest.Beck, Roy ............................................... Advisory Panel: Sanofi; Consultant: Animas.Becker, Dorothy J. ................................ Disclosed no conflict of interest.Becker, Kevin G. ................................... Disclosed no conflict of interest.Becker, Reinhard H. .............................. Employee: Sanofi.Beck-Nielsen, Henning ......................... Research Support: Novo Nordisk A/S.Beckwith, Anita ..................................... Disclosed no conflict of interest.Bedi, Rumneek ...................................... Disclosed no conflict of interest.Bediako, Isaac Asare ............................ Disclosed no conflict of interest.Bedinger, Daniel H. .............................. Employee: XOMA Corporation.Bednarik, Petr ........................................ Disclosed no conflict of interest.Bee, Yong Mong .................................... Disclosed no conflict of interest.Beebe, David A. ................................... Employee: Pfizer, Inc.Beeney, Linda J. ................................... Speaker’s Bureau: Novo Nordisk, Inc.Beer, Mayara A. ................................... Disclosed no conflict of interest.Begg, Denovan P. ................................. Disclosed no conflict of interest.Begovatz, Paul ....................................... Disclosed no conflict of interest.Beguinot, Francesco .............................. Disclosed no conflict of interest.Begum, Piyara ....................................... Disclosed no conflict of interest.Behnke, Thomas .................................... Disclosed no conflict of interest.Beilman, Gregory J. ............................. Disclosed no conflict of interest.Belalcazar, Ligia M. .............................. Disclosed no conflict of interest.Belfort De Aguiar, Renata ..................... Disclosed no conflict of interest.Belinova, Lenka ..................................... Disclosed no conflict of interest.Beljic Zivkovic, Teodora ........................ Disclosed no conflict of interest.Bell, Callum ........................................... Disclosed no conflict of interest.Bell, Chaim ............................................ Disclosed no conflict of interest.Bell, Charles D. .................................... Disclosed no conflict of interest.Bell, Ewan ............................................. Disclosed no conflict of interest.Bell, Gordon J. ..................................... Disclosed no conflict of interest.Bell, Graeme I. ..................................... Disclosed no conflict of interest.Bell, Kelly F. .......................................... Employee: Bristol-Myers Squibb Company.Bell, Kirstine J. ..................................... Disclosed no conflict of interest.Bell, Marcia ........................................... Disclosed no conflict of interest.Bell, Ronny A. ....................................... Disclosed no conflict of interest.Bellante, Rosalia ................................... Disclosed no conflict of interest.Bellary, Srikanth .................................... Disclosed no conflict of interest.Bellia, Alfonso ....................................... Disclosed no conflict of interest.Bellido, Virginia ..................................... Disclosed no conflict of interest.Bellin, Melena D. ................................. Consultant: Viacyte; Research Support: Medtronic,
Merck. Bellini, Natalie ...................................... Disclosed no conflict of interest.Bello, Dilalat ......................................... Disclosed no conflict of interest.Below, Jennifer E. ................................ Disclosed no conflict of interest.Belt Davis, Dawn B. ............................. Disclosed no conflict of interest.Belton, Anne ......................................... Disclosed no conflict of interest.Ben Aharon, Adina ................................ Disclosed no conflict of interest.Ben Saad, Helmi ................................... Disclosed no conflict of interest.Bena, James ......................................... Disclosed no conflict of interest.Benamo, Eric ......................................... Disclosed no conflict of interest.Benbenek-Klupa, Teresa ....................... Employee: Bayer.Bender, Aaron........................................ Disclosed no conflict of interest.Bendre, Sachin ...................................... Disclosed no conflict of interest.Bendridi, Nadia ..................................... Disclosed no conflict of interest.Benedini, Stefano ................................. Disclosed no conflict of interest.Benesch, Carsten .................................. Disclosed no conflict of interest.Benhamou, Pierre-Yves ......................... Disclosed no conflict of interest.Benitez, Amanda ................................... Research Support: NIH.Benitez-Aguirre, Paul ............................ Disclosed no conflict of interest.Beniwal, Sanjay .................................... Disclosed no conflict of interest.Benkendorff, Charlotte .......................... Disclosed no conflict of interest.Bennett, Peter H. .................................. Disclosed no conflict of interest.Bennett, Robert G. ............................... Disclosed no conflict of interest.Benroubi, Maria .................................... Research Support: Boehringer Ingelheim Pharmaceuticals,
Inc., Eli Lilly and Company, Novo Nordisk, Inc.Benson, William G. .............................. Disclosed no conflict of interest.Bentley, Tanya G. ................................. Employee: Partnership for Health Analytic Research, LLC.Bentley-Lewis, Rhonda ......................... Consultant: Sanofi; Research Support: Amgen, Inc. (Spouse/
Beran, David H. .................................... Disclosed no conflict of interest.Berard, Lori ............................................ Disclosed no conflict of interest.Berencsi, Klára ...................................... Disclosed no conflict of interest.Berends, Frits J. ................................... Disclosed no conflict of interest.Berenguer, Marina ................................ Disclosed no conflict of interest.Berensci, Klara ...................................... Disclosed no conflict of interest.Berg, Chrystal ........................................ Disclosed no conflict of interest.Bergenstal, Richard ............................... Advisory Panel: Abbott Diabetes Care, Amylin
Pharmaceuticals, Inc., AstraZeneca/Bristol-Meyers Squibb, Bayer Health Care, LLC, Becton, Dickinson and
Company, Boehringer Ingelheim GmbH & Co. KG, Calibra Medical, Inc., Dexcom, Inc., Eli Lilly and Company, Halozyme Therapeutics, Hygieia, Inc., Johnson & Johnson, Medtronic, Merck, Novo Nordisk A/S, Roche Pharmaceuticals, Sanofi, Takeda Pharmaceutical Company, Ltd.; Research Support: Abbott Diabetes Care, Amylin Pharmaceuticals, Inc., AstraZeneca/Bristol-Meyers Squibb, Bayer Health Care, LLC, Becton, Dickinson and Company, Boehringer Ingelheim GmbH & Co. KG, Calibra Medical, Inc., Dexcom, Inc., Eli Lilly and Company, Halozyme Therapeutics, Hygieia, Inc., Johnson & Johnson, Medtronic, Merck, Novo Nordisk A/S, Roche Pharmaceuticals, Sanofi, Takeda Pharmaceutical Company, Ltd.
Bergeron, Valerie .................................. Disclosed no conflict of interest.Berggren, Per-Olof ................................. Disclosed no conflict of interest.Bergholdt, Helle Kirstine M. ................ Research Support: Danish Dairy Research Foundation.Berglund, Eric D. .................................. Disclosed no conflict of interest.Berglund, Lisa ....................................... Disclosed no conflict of interest.Bergman, Bryan C. ............................... Disclosed no conflict of interest.Bergman, Richard N. ............................ Consultant: Integrium, Novo Nordisk, Inc. (Spouse/Partner);
Research Support: GI Dynamics; Speaker’s Bureau: Merck (Spouse/Partner); Stock/Shareholder: Tethys (Spouse/Partner).
Bergmann, Karin ................................... Employee: Sanofi.Bergstrom, Colin P. ............................... Disclosed no conflict of interest.Berkowitz, Seth A. ............................... Disclosed no conflict of interest.Berlé, Clara ........................................... Disclosed no conflict of interest.Bernal-Mizrachi, Ernesto ...................... Disclosed no conflict of interest.Bernardo, Barbara L. ............................ Employee: Pfizer, Inc., Pfizer, Inc. (Spouse/Partner).Bernardo, Vincent.................................. Employee: Pfizer, Inc.Bernlohr, David A. ................................ Disclosed no conflict of interest.Berria, Rachele ...................................... Employee: Sanofi.Berry, K. Louise ..................................... Disclosed no conflict of interest.Berry, Rodney ........................................ Disclosed no conflict of interest.Berry, Shivani ........................................ Disclosed no conflict of interest.Bertola, Susana Carolina ...................... Disclosed no conflict of interest.Bertoli, Simona ..................................... Disclosed no conflict of interest.Bertoni, Alain G. ................................... Disclosed no conflict of interest.Bessho, Ryoichi ..................................... Disclosed no conflict of interest.Best, Jennie H. ..................................... Other Relationship: Bristol-Myers Squibb Company.Bethel, M. Angelyn ............................... Disclosed no conflict of interest.Beulens, Joline W. ............................... Disclosed no conflict of interest.Beveridge, Sue ...................................... Speaker’s Bureau: Eli Lilly and Company.Beverly, Elizabeth A. ............................ Disclosed no conflict of interest.Beysen, Carine ...................................... Employee: KineMed, Inc.Bezwada, Padma ................................... Disclosed no conflict of interest.Bhanot, Sanjay ...................................... Employee: Isis Pharmaceuticals.Bharara, Manish ................................... Disclosed no conflict of interest.Bhargava, Anuj ...................................... Research Support: Abbvie, Boehringer Ingelheim
Pharmaceuticals, Inc., Duke Clinical Research Institute, Eli Lilly and Company, Halozyme Therapeutics, Intarcia Therapeutics, Inc., Jaeb, Novo Nordisk, Inc., Orexigen Therapeutics, Inc., Sanofi, University of Oxford.
Bhat, Gowri ........................................... Employee: Merck Sharp & Dohme Limited.Bhat, Rama ............................................ Disclosed no conflict of interest.Bhatia, Loke .......................................... Disclosed no conflict of interest.Bhatnagar, Deepak ................................ Disclosed no conflict of interest.Bhatt, Deepak L. ................................... Research Support: Amarin, AstraZeneca/Bristol-Meyers
Bhattacharjee, Alpana .......................... Disclosed no conflict of interest.Bhattacharjee, Debamita ...................... Disclosed no conflict of interest.Bhattacharya, Palash ............................ Disclosed no conflict of interest.Bhattacharyya, Sumit ............................ Disclosed no conflict of interest.Bhatti, Tricia R. ..................................... Disclosed no conflict of interest.Bhavadharini, Balaji .............................. Disclosed no conflict of interest.Bhavaraju, Naresh ................................ Employee: Dexcom, Inc.Bhutta, Hina .......................................... Disclosed no conflict of interest.Bi, Lipeng .............................................. Disclosed no conflict of interest.Bi, Yan ................................................... Disclosed no conflict of interest.Bian, Hua ............................................... Disclosed no conflict of interest.Bian, Jing-Tan ....................................... Disclosed no conflict of interest.Bian, Xiaofang ....................................... Disclosed no conflict of interest.Bianchi, Loria ........................................ Disclosed no conflict of interest.Bianchi, Lucio ........................................ Disclosed no conflict of interest.Bielak, Lawrence F. .............................. Disclosed no conflict of interest.Bielicki, John ......................................... Research Support: Arerty Therapeutics.Biemans, Elke ........................................ Disclosed no conflict of interest.Biernacki, Diane .................................... Disclosed no conflict of interest.Bierwagen, Alessandra ......................... Disclosed no conflict of interest.Bieszk, Nella ......................................... Employee: Sanofi; Stock/Shareholder: Sanofi.
Bihan, Hélène ........................................ Consultant: Novo Nordisk.Bijos, Pawel .......................................... Disclosed no conflict of interest.Bikman, Benjamin T. ............................ Disclosed no conflict of interest.Billinger, Sandra .................................... Disclosed no conflict of interest.Billings, Liana K. .................................. Disclosed no conflict of interest.Bilo, Henk J. ......................................... Disclosed no conflict of interest.Bingley, Polly ......................................... Disclosed no conflict of interest.Binkley, Philip ........................................ Disclosed no conflict of interest.Binny, Monolina H. .............................. Disclosed no conflict of interest.Binz, Christiane ..................................... Employee: Bristol-Myers Squibb Company.Biondi, Giuseppina ................................ Disclosed no conflict of interest.Birch, Karen M. .................................... Disclosed no conflict of interest.Birk, Gurpreet ........................................ Disclosed no conflict of interest.Birk, Jesper ........................................... Disclosed no conflict of interest.Birkeland, Kåre I. .................................. Disclosed no conflict of interest.Birnbaum, Morris J. ............................. Advisory Panel: Pfizer, Inc.; Research Support: Eli Lilly and
Company.Birnie, Erwin .......................................... Disclosed no conflict of interest.Bischoff, Allison N. .............................. Disclosed no conflict of interest.Bishop, Franziska K. ............................. Disclosed no conflict of interest.Bisighini, Cinzia ..................................... Disclosed no conflict of interest.Bisschop, Peter H. ................................ Disclosed no conflict of interest.Bittencourt, Celia S. ............................. Disclosed no conflict of interest.Bittner, Stefanie .................................... Disclosed no conflict of interest.Bitton, Gabriel ....................................... Employee: Insuline Medical.Bjerregaard–Andersen, Morten ............ Disclosed no conflict of interest.Bjørkhaug, Lise ...................................... Disclosed no conflict of interest.Bjornstad, Petter ................................... Disclosed no conflict of interest.Blaak, Ellen E. ...................................... Disclosed no conflict of interest.Blaber, Sinead ....................................... Disclosed no conflict of interest.Blachnio-Zabielska, Agnieszka ............. Disclosed no conflict of interest.Black, Mary Helen ................................. Disclosed no conflict of interest.Blackburn, Brian K. ............................... Disclosed no conflict of interest.Black-Shinn, Jennifer ............................ Disclosed no conflict of interest.Blake, Rachel ........................................ Disclosed no conflict of interest.Bland, Devin .......................................... Disclosed no conflict of interest.Blandino-Rosano, Manuel .................... Disclosed no conflict of interest.Blangero, John ...................................... Disclosed no conflict of interest.Blasco, Gerard ....................................... Disclosed no conflict of interest.Blaslov, Kristina .................................... Disclosed no conflict of interest.Blaum, Caroline S. ............................... Disclosed no conflict of interest.Blauw, Helga ......................................... Employee: Inredadiabetic BV.Blevins, Thomas .................................... Advisory Panel: Sanofi; Research Support: Eli Lilly and
Company, Novo Nordisk, Inc., Sanofi; Other Relationship: Texas Diabetes & Endocrinology; Speaker’s Bureau: Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Novo Nordisk, Inc., Sanofi.
Blizanowska, Paulina ............................ Disclosed no conflict of interest.Block, Geoffrey A. ................................ Advisory Panel: ZS Pharma, Inc; Consultant: ZS Pharma, Inc.Block, Jennifer M. ................................ Disclosed no conflict of interest.Blocker-Adams, Helen ........................... Disclosed no conflict of interest.Blodgett, David M. ............................... Disclosed no conflict of interest.Blonde, Lawrence ................................. Consultant: Amylin Pharmaceuticals, Inc., Bristol-Myers
Squibb/AstraZeneca, Eisai, Inc., GlaxoSmithKline, Janssen Pharmaceuticals, Merck, Novo Nordisk, Inc., Pfizer, Inc., Sanofi, Santarus, Inc.; Other Relationship: Eli Lilly and Company, Novo Nordisk, Inc., Sanofi; Speaker’s Bureau: Amylin Pharmaceuticals, Inc., Bristol-Myers Squibb/AstraZeneca, Janssen Pharmaceuticals, Johnson & Johnson, Merck, Novo Nordisk, Inc., Sanofi, Santarus, Inc., Vivus, Inc.
Bloom, Kayla ......................................... Disclosed no conflict of interest.Bluestone, Jeffrey A. ........................... Disclosed no conflict of interest.Blüher, Matthias.................................... Disclosed no conflict of interest.Blumensatt, Marcel .............................. Disclosed no conflict of interest.Blumenthal, Jacob B. ........................... Disclosed no conflict of interest.Boaz, Mona ........................................... Disclosed no conflict of interest.Bobelu, Jeanette ................................... Disclosed no conflict of interest.Bodary, Peter F. .................................... Disclosed no conflict of interest.Bode, Bruce W. .................................... Consultant: Halozyme Therapeutics, Janssen
Pharmaceuticals, Medtronic, Novo Nordisk, Inc., Sanofi, Tandem Diabetes Care, Valeritas, LLC; Research Support: Abbott Diabetes Care, Biodel, Inc., Bristol-Myers Squibb Company, Dexcom, Inc., GlaxoSmithKline, Halozyme Therapeutics, Janssen Pharmaceuticals, Lilly-Boehringer Ingelheim, Macrogenics, Inc., MannKind Corporation, Medtronic, NIH, Novo Nordisk, Inc., Sanofi, Valeritas, LLC; Speaker’s Bureau: Bristol-Myers Squibb Company, Dexcom, Inc., Eli Lilly and Company, GlaxoSmithKline,
Bodenheimer, Thomas........................... Disclosed no conflict of interest.Bodin, Johanna ..................................... Disclosed no conflict of interest.Boehnke, Michael ................................. Disclosed no conflict of interest.Boerwinkle, Eric .................................... Disclosed no conflict of interest.Boesch, Chris ........................................ Disclosed no conflict of interest.Bogan, Jonathan S. .............................. Disclosed no conflict of interest.Bogardus, Clifton .................................. Disclosed no conflict of interest.Boggi, Ugo ............................................. Disclosed no conflict of interest.Boggio, Veronica ................................... Disclosed no conflict of interest.Bogie, Heather V. ................................. Employee: Data Sciences International; Stock/Shareholder:
Data Sciences International.Bogl, Leonie .......................................... Disclosed no conflict of interest.Bohren, Kurt M. .................................... Disclosed no conflict of interest.Boisseau, Lynelle .................................. Disclosed no conflict of interest.Boitard, Christian .................................. Disclosed no conflict of interest.Bojarska-Junak, Agnieszka ................... Disclosed no conflict of interest.Bojsen-Møller, Kirstine N. ................... Disclosed no conflict of interest.Boland, Brandon .................................... Disclosed no conflict of interest.Bolanz-Kopf, Katrin A. ......................... Disclosed no conflict of interest.Bollepalli, Sureka .................................. Disclosed no conflict of interest.Bolli, Geremia B. .................................. Advisory Panel: Sanofi; Consultant: Novartis Pharmaceuticals
Corporation, Sanofi; Speaker’s Bureau: AstraZeneca/Bristol-Meyers Squibb, Eli Lilly and Company, Novartis Pharma AG, Sanofi.
Bølling, Anette K. ................................. Disclosed no conflict of interest.Bolshakova, Maria V. ........................... Disclosed no conflict of interest.Bolte, Nancy .......................................... Disclosed no conflict of interest.Bolton, Thyra ......................................... Disclosed no conflict of interest.Bolze, Sebastien ................................... Employee: Poxel SA.Bomba-Opon, Dorota ............................ Disclosed no conflict of interest.Bombassaro, Bruna ............................... Disclosed no conflict of interest.Bonadonna, Riccardo C. ....................... Advisory Panel: Amgen, Inc., Eli Lilly and Company, Sanofi;
Speaker’s Bureau: AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Company, Eli Lilly and Company, Merck Sharp & Dohme Limited, Sanofi.
Bonaventura, Aldo ................................ Disclosed no conflict of interest.Bondor, Cosmina I. ............................... Disclosed no conflict of interest.Bone, Robert N. .................................... Disclosed no conflict of interest.Bonfanti, Riccardo ................................. Disclosed no conflict of interest.Bongaerts, Brenda ................................ Disclosed no conflict of interest.Boniol, Magali ....................................... Disclosed no conflict of interest.Boniol, Mathieu .................................... Disclosed no conflict of interest.Bonnefond, Amélie ............................... Disclosed no conflict of interest.Bonner, Caroline .................................... Disclosed no conflict of interest.Bonner-Weir, Susan .............................. Board Member: BetaO2 (Spouse/Partner); Consultant: Merck,
Novartis, Pfizer (Spouse/Partner); Research Support: Johnson & Johnson (Spouse/Partner); Speaker’s Bureau: Merck (Spouse/Partner).
Bonnet, Fabrice ..................................... Disclosed no conflict of interest.Bonnici, François ................................... Advisory Panel: AstraZeneca/Bristol-Meyers Squibb;
Consultant: AstraZeneca/Bristol-Meyers Squibb; Research Support: AstraZeneca/Bristol-Meyers Squibb, Novo Nordisk, Inc., Sanofi; Speaker’s Bureau: Eli Lilly and Company, Sanofi.
Bonsignore, Patricia .............................. Disclosed no conflict of interest.Bonventre, Joseph V. ........................... Advisory Panel: Janssen Research & Development, Pfizer,
Inc.; Research Support: Novo Nordisk, Inc.Boodhansingh, Kara E. ......................... Disclosed no conflict of interest.Booij, Jan .............................................. Disclosed no conflict of interest.Boopalan, Anand ................................... Employee: Novo Nordisk A/S.Booth, Gillian L. .................................... Disclosed no conflict of interest.Boqing, Ma ............................................ Disclosed no conflict of interest.Boraska, Vesna ...................................... Disclosed no conflict of interest.Bordiu, Elena ......................................... Disclosed no conflict of interest.Borecki, Ingrid B. .................................. Disclosed no conflict of interest.Borel, Anne-Laure ................................. Disclosed no conflict of interest.Borengasser, Sarah J. .......................... Disclosed no conflict of interest.Borg, Danielle J. .................................. Disclosed no conflict of interest.Borges-Yáñez, Socorro-Aida ................. Disclosed no conflict of interest.Boright, Andrew P. ............................... Disclosed no conflict of interest.Borkowska, Anna .................................. Disclosed no conflict of interest.Bornat, Yannick ..................................... Disclosed no conflict of interest.Bornstein, Stefan R. ............................. Disclosed no conflict of interest.Bornstein, Tobias D. ............................. Disclosed no conflict of interest.Borochowitz, Zvi .................................... Disclosed no conflict of interest.Borowiec, Maciej .................................. Disclosed no conflict of interest.Borsheim, Elisabet ................................ Disclosed no conflict of interest.Bos, Erik ................................................ Disclosed no conflict of interest.Boscari, Federico ................................... Disclosed no conflict of interest.
Bosch, Fatima ........................................ Disclosed no conflict of interest.Bosch, Jacqueline ................................. Disclosed no conflict of interest.Bosch-Traberg, Heidrun......................... Employee: Novo Nordisk A/S.Bosco, Chris .......................................... Disclosed no conflict of interest.Bosnjak, Ermina .................................... Disclosed no conflict of interest.Bostick, Brian P. .................................... Research Support: Merck.Bota, Maria ........................................... Disclosed no conflict of interest.Bottino, Rita .......................................... Disclosed no conflict of interest.Botton, Jeremie .................................... Disclosed no conflict of interest.Bottum, Kathy ....................................... Disclosed no conflict of interest.Bouby, Nadine ....................................... Disclosed no conflict of interest.Bouchard, Guy F. .................................. Disclosed no conflict of interest.Boucherie, Beatrix ................................. Disclosed no conflict of interest.Bouchonville, Matthew F. .................... Disclosed no conflict of interest.Boudaba, Nadia .................................... Disclosed no conflict of interest.Boudina, Sihem ..................................... Disclosed no conflict of interest.Boudou, Philippe ................................... Disclosed no conflict of interest.Boudoux, Jimmy .................................... Disclosed no conflict of interest.Boudreau, Robert M. ............................ Disclosed no conflict of interest.Bouffard, Alexis .................................... Disclosed no conflict of interest.Boulangé, Claire L. ............................... Disclosed no conflict of interest.Bouldin, Erin D. .................................... Disclosed no conflict of interest.Boulé, Normand G. ............................... Disclosed no conflict of interest.Boulet, Benoit ....................................... Disclosed no conflict of interest.Boulton, Andrew J.M. ......................... Disclosed no conflict of interest.Boulton, Michael E. .............................. Disclosed no conflict of interest.Boulware, David .................................... Disclosed no conflict of interest.Bound, Michelle .................................... Disclosed no conflict of interest.Bounthavong, Mark ............................... Disclosed no conflict of interest.Bouret, Sebastien G. ............................ Disclosed no conflict of interest.Bourgeois, Nancy .................................. Employee: GlaxoSmithKline; Stock/Shareholder:
GlaxoSmithKline.Bourron, Olivier ..................................... Disclosed no conflict of interest.Boursiquot, Ludovic ............................... Disclosed no conflict of interest.Bousboulas, Stavros ............................. Disclosed no conflict of interest.Bouziana, Stella .................................... Disclosed no conflict of interest.Bovenberg, Sarah .................................. Disclosed no conflict of interest.Bowden, Donald W. ............................. Disclosed no conflict of interest.Bowen, Ben ........................................... Disclosed no conflict of interest.Bowen, Michael E. ............................... Disclosed no conflict of interest.Bowering, Keith .................................... Advisory Panel: Boehringer Ingelheim Pharmaceuticals, Inc.,
Bristol-Myers Squibb/AstraZeneca, Eli Lilly and Company, Johnson & Johnson, Merck, Novartis Pharmaceuticals Corporation, Novo Nordisk, Inc., Pfizer, Inc., Takeda Pharmaceutical Company, Ltd.; Research Support: AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Merck, Novartis Pharmaceuticals Corporation, Novo Nordisk, Inc.; Speaker’s Bureau: AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Merck, Novartis Pharmaceuticals Corporation, Novo Nordisk, Inc.
Bowers, Daniel ...................................... Disclosed no conflict of interest.Bowers, Katherine ................................ Disclosed no conflict of interest.Bowers, Robert L. ................................ Disclosed no conflict of interest.Bowker, Weston .................................... Disclosed no conflict of interest.Bowler, Russell...................................... Disclosed no conflict of interest.Bowyer, Vicky ........................................ Disclosed no conflict of interest.Boye, Kristina S. ................................... Employee: Eli Lilly and Company.Boyer, James L. .................................... Disclosed no conflict of interest.Boyko, Edward J. ................................. Disclosed no conflict of interest.Boyle, Peter ........................................... Consultant: Sanofi, Takeda Pharmaceutical Company, Ltd.;
Research Support: Sanofi; Speaker’s Bureau: Sanofi.Bozadjieva, Nadejda ............................. Disclosed no conflict of interest.Bozzetto, Lutgarda ................................ Disclosed no conflict of interest.Bozzo, Janis E. ..................................... Disclosed no conflict of interest.Brabec, Marek ....................................... Disclosed no conflict of interest.Bracken, Richard M. ............................ Disclosed no conflict of interest.Bracy, Deanna P. ................................... Disclosed no conflict of interest.Bradley, Brenda ..................................... Disclosed no conflict of interest.Bradley, Helen ....................................... Disclosed no conflict of interest.Brady, Veronica ..................................... Disclosed no conflict of interest.Braffett, Barbara H. ............................. Disclosed no conflict of interest.Braham, Rim .......................................... Disclosed no conflict of interest.Bramlage, Peter .................................... Advisory Panel: Sanofi; Consultant: AstraZeneca/Bristol-
Meyers Squibb, Sanofi.Brammer, Michael J. ............................ Disclosed no conflict of interest.Brancato, Davide ................................... Disclosed no conflict of interest.Brand, Paul L. ....................................... Disclosed no conflict of interest.Brand-Miller, Jennie C. ........................ Board Member: Glycemic Index Foundation.Brandon, Amanda E. ............................ Disclosed no conflict of interest.Brandslund, Ivan ................................... Disclosed no conflict of interest.
Branigan, Deborah L. ........................... Disclosed no conflict of interest.Brath, Helmut ........................................ Disclosed no conflict of interest.Brathwaite, Collin ................................. Disclosed no conflict of interest.Bratina, Natasa ..................................... Speaker’s Bureau: Medtronics, Novo Nordisk, Inc., Sanofi.Braun, Kathryn ...................................... Disclosed no conflict of interest.Bravard, Amelie .................................... Disclosed no conflict of interest.Bravis, Vassilki ...................................... Disclosed no conflict of interest.Brawura-Biskupski-Samaha, Robert ..... Disclosed no conflict of interest.Bray, George A. .................................... Disclosed no conflict of interest.Brayman, Kenneth L. ............................ Disclosed no conflict of interest.Brazeau, Anne-Sophie .......................... Disclosed no conflict of interest.Br zert, Jacek ........................................ Disclosed no conflict of interest.Brazg, Ronald L. ................................... Other Relationship: Owner-Director Rainier Clinical Research
Center.Brazzale, Alessandra R. ....................... Disclosed no conflict of interest.Bregman, David B. ............................... Employee: MannKind Corporation; Stock/Shareholder:
MannKind Corporation.Bremer, Andrew A. ............................... Disclosed no conflict of interest.Brenner, Michael ................................... Disclosed no conflict of interest.Brentnall, Lee ........................................ Speaker’s Bureau: Merck Sharp & Dohme Limited.Breslin, Mary B. ................................... Disclosed no conflict of interest.Brethauer, Stacy A. .............................. Consultant: Ethicon EndoSurgery, Inc.; Speaker’s Bureau:
Covidien, Ethicon EndoSurgery, Inc.Breton, Marc D. ................................... Research Support: Animas Corporation.Bretzel, Reinhard G. ............................. Advisory Panel: AstraZeneca/Bristol-Meyers Squibb, Sanofi;
Brewer, Kelly ......................................... Disclosed no conflict of interest.Brewer, Paul D. .................................... Disclosed no conflict of interest.Brightwell-Conrad, Angela S. .............. Employee: Metabolic Solutions Development Co.Bril, Fernando ........................................ Disclosed no conflict of interest.Bril, Vera ................................................ Advisory Panel: Cebix, Inc., Eli Lilly and Company, Food and
Drug Administration, Grifols USA, LLC, Health Canada, Pfizer, Inc.
Brill, Gregory ......................................... Disclosed no conflict of interest.Brillon, David J. .................................... Disclosed no conflict of interest.Brinton, John T. .................................... Disclosed no conflict of interest.Briody, Julie .......................................... Disclosed no conflict of interest.Brissova, Marcela ................................. Disclosed no conflict of interest.Brito, Flavio D. ...................................... Disclosed no conflict of interest.Britton, Stephen .................................... Disclosed no conflict of interest.Britton-Colonnese, Jennifer .................. Disclosed no conflict of interest.Brix, Johanna M. .................................. Disclosed no conflict of interest.Brne, Tim S. .......................................... Employee: Walgreens; Stock/Shareholder: Walgreens.Broadbent, Keith ................................... Disclosed no conflict of interest.Brockway, Robert .................................. Employee: Data Sciences International; Stock/Shareholder:
Data Sciences International.Brod, Meryl ........................................... Consultant: Novo Nordisk A/S.Broderick, Tom L. .................................. Disclosed no conflict of interest.Brodie, Shannon .................................... Disclosed no conflict of interest.Brodovicz, Kimberly G. ......................... Employee: Merck; Stock/Shareholder: Merck.Broedl, Uli C. ........................................ Employee: Boehringer Ingelheim GmbH & Co. KG.Brogren, Carl-Henrik ............................. Disclosed no conflict of interest.Brokaw, Sarah ....................................... Disclosed no conflict of interest.Bron, Morgan ........................................ Employee: Takeda Pharmaceuticals U.S.A., Inc.; Stock/
Shareholder: Takeda Pharmaceuticals U.S.A., Inc.Brøndsted, Lise ..................................... Employee: Novo Nordisk A/S; Stock/Shareholder: Novo
Nordisk A/S.Broniowska, Katarzyna A. .................... Disclosed no conflict of interest.Brøns, Charlotte .................................... Stock/Shareholder: Novo Nordisk A/S.Brooks, Belinda A. ................................ Disclosed no conflict of interest.Brooks, Maria M. ................................. Disclosed no conflict of interest.Brooks, Nicole ....................................... Disclosed no conflict of interest.Brosnan, Mary J. .................................. Employee: Pfizer, Inc.Broussard, Josiane L. ........................... Disclosed no conflict of interest.Brown, Christine ................................... Disclosed no conflict of interest.Brown, David M. .................................. Consultant: Allergan, Inc., Bayer Health Care, LLC, Genentech,
Novartis Pharmaceuticals Corporation, Regeneron Pharmaceuticals, Inc., Roche Pharmaceuticals; Research Support: Allergan, Inc., Genentech, Novartis Pharmaceuticals Corporation, Regeneron Pharmaceuticals, Inc.
Brown, Florence M. ............................. Disclosed no conflict of interest.Brown, Hallie ........................................ Disclosed no conflict of interest.Brown, Heather ..................................... Disclosed no conflict of interest.Brown, James ....................................... Disclosed no conflict of interest.Brown, Julian D. .................................. Disclosed no conflict of interest.Brown, K. .............................................. Employee: GlaxoSmithKline.Brown, Larry D. .................................... Disclosed no conflict of interest.Brown, Laura D. ................................... Disclosed no conflict of interest.Brown, Marilyn ..................................... Disclosed no conflict of interest.
Brown, Rebecca J. ............................... Disclosed no conflict of interest.Brown, Susan D. .................................. Disclosed no conflict of interest.Brown, Zane A. .................................... Disclosed no conflict of interest.Brown-Augsburger, Patricia .................. Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly
and Company.Browne, Jessica L. ............................... Consultant: Roche Diagnostics Australia; Research Support:
Roche Diagnostics Australia.Browne, Shaynah .................................. Disclosed no conflict of interest.Broz, Jan ............................................... Disclosed no conflict of interest.Brubaker, Patricia .................................. Disclosed no conflict of interest.Bruce, David G. .................................... Disclosed no conflict of interest.Bruce, Sharon G. .................................. Disclosed no conflict of interest.Bruckbauer, Antje .................................. Employee: NuSirt Inc; Stock/Shareholder: NuSirt Inc.Bruder, Jan ............................................ Disclosed no conflict of interest.Brüggemann, Jutta ............................... Disclosed no conflict of interest.Brunel, Nicolas ...................................... Disclosed no conflict of interest.Brunel, Patrick ....................................... Employee: Novartis Pharma AG.Brunetti, Antonio ................................... Disclosed no conflict of interest.Brunk, Debra ......................................... Disclosed no conflict of interest.Brunton, Stephen A. ............................. Consultant: Abbott Laboratories, Inc., AstraZeneca
Pharmaceuticals LP, BMS, Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Janssen Pharmaceuticals, Novartis Pharma AG, Novo Nordisk, Inc., Sanofi, Teva Pharmaceuticals; Speaker’s Bureau: Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Janssen Pharmaceuticals, Novo Nordisk, Inc., Teva Pharmaceuticals.
Bruntz, Merribeth .................................. Disclosed no conflict of interest.Brusko, Todd M. ................................... Disclosed no conflict of interest.Bruttomesso, Daniela ........................... Disclosed no conflict of interest.Bryzinski, Brian ...................................... Employee: AstraZeneca Pharmaceuticals LP.Bu, Le .................................................... Disclosed no conflict of interest.Buanes, Trond........................................ Disclosed no conflict of interest.Bucca, Brian C. ..................................... Disclosed no conflict of interest.Buchanan, Thomas A. .......................... Disclosed no conflict of interest.Buchner, Klaus....................................... Employee: Noxxon.Buchwald, Peter .................................... Consultant: GlaxoSmithKline, Viacyte.Buckeridge, Clare .................................. Employee: Pfizer, Inc.Buckingham, Bruce A. .......................... Advisory Panel: BD Medical Diabetes Care, Medtronic
MiniMed, Inc., Novo Nordisk, Inc., Sanofi; Research Support: Medtronic MiniMed, Inc.
Buday, Barbara ...................................... Disclosed no conflict of interest.Buder, Brian ........................................... Disclosed no conflict of interest.Budiman-Mak, Elly ................................ Disclosed no conflict of interest.Bueno, Angeli ........................................ Disclosed no conflict of interest.Bue-Valleskey, Juliana .......................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly
and Company.Bugliani, Marco ..................................... Disclosed no conflict of interest.Buhl, Thora ............................................ Disclosed no conflict of interest.Bühligen, Ulf ......................................... Disclosed no conflict of interest.Bui, Helen .............................................. Disclosed no conflict of interest.Bujacz-Jedrzejczak, Urszula .................. Disclosed no conflict of interest.Bulcão, Caroline .................................... Disclosed no conflict of interest.Bull, Shelley B. ..................................... Disclosed no conflict of interest.Bullard, Kai M. ..................................... Disclosed no conflict of interest.Bülow, Jens ........................................... Disclosed no conflict of interest.Bulugahapitiya, Uditha ......................... Disclosed no conflict of interest.Bulum, Tomislav .................................... Disclosed no conflict of interest.Bunker, Clareann H. ............................. Disclosed no conflict of interest.Bunkers, Kari S. .................................... Disclosed no conflict of interest.Bunn, Janice Y. .................................... Disclosed no conflict of interest.Bunner, Anne E. .................................... Disclosed no conflict of interest.Burg, Ashley R. ..................................... Disclosed no conflict of interest.Burge, Mark .......................................... Disclosed no conflict of interest.Burgess, Shawn C. ............................... Disclosed no conflict of interest.Burkart, Alison ...................................... Disclosed no conflict of interest.Burke, Helen .......................................... Disclosed no conflict of interest.Burke, Susan J. .................................... Disclosed no conflict of interest.Burkhardt, Brant R. .............................. Disclosed no conflict of interest.Burmeister, Melissa A. ........................ Disclosed no conflict of interest.Burnet, Deborah L. ............................... Research Support: NIH.Burns, Kevin .......................................... Disclosed no conflict of interest.Burns, Stephen F. ................................. Disclosed no conflict of interest.Burrill, Joel S. ...................................... Disclosed no conflict of interest.Burrington, Christine M. ...................... Disclosed no conflict of interest.Burrows, Nilka R. ................................. Disclosed no conflict of interest.Bursac, Zoran ........................................ Disclosed no conflict of interest.Burstein, Aaron ..................................... Employee: TransTech Pharma.Burtt, Noël ............................................. Disclosed no conflict of interest.Buryk, Melissa A. ................................. Disclosed no conflict of interest.Busaidy, Naifa ....................................... Disclosed no conflict of interest.Buschard, Karsten ................................. Disclosed no conflict of interest.
Bushkofsky, Justin R. ........................... Disclosed no conflict of interest.Bushman, Lane ...................................... Disclosed no conflict of interest.Busik, Julia V. ....................................... Disclosed no conflict of interest.Busjahn, Andreas .................................. Disclosed no conflict of interest.Butcher, Marcene .................................. Disclosed no conflict of interest.Buti, Allison ........................................... Disclosed no conflict of interest.Butler, Amy R. ...................................... Disclosed no conflict of interest.Butler, Anne........................................... Disclosed no conflict of interest.Butler, Deborah A. ................................ Disclosed no conflict of interest.Butler, J.L. ............................................ Disclosed no conflict of interest.Butler, LaShanni .................................... Disclosed no conflict of interest.Butte, Atul J. ........................................ Disclosed no conflict of interest.Button, Eric ............................................ Employee: Metabolon, Inc.; Stock/Shareholder: Metabolon,
Inc.Buzzetti, Raffaella ................................. Disclosed no conflict of interest.Bygbjerg, Ib C. ...................................... Disclosed no conflict of interest.Byrd, MIchelle ....................................... Disclosed no conflict of interest.Byrne, Christopher D. ........................... Disclosed no conflict of interest.Bytoft, Birgitte ....................................... Disclosed no conflict of interest.Caan, Matthan W. ................................ Disclosed no conflict of interest.Caballero, A.E. ..................................... Advisory Panel: Boehringer Ingelheim GmbH & Co. KG.Caccioppoli, Cristina ............................. Disclosed no conflict of interest.Caceres, Elena ...................................... Disclosed no conflict of interest.Caceres, Maria ...................................... Stock/Shareholder: Merck.Cachia, E. ............................................. Disclosed no conflict of interest.Cadarso-Suarez, C. ............................... Disclosed no conflict of interest.Cadilhac, Dominique ............................. Disclosed no conflict of interest.Cahn, Avivit ........................................... Advisory Panel: Boehringer Ingelheim Pharmaceuticals, Inc.,
Cai, Huan ............................................... Disclosed no conflict of interest.Cai, Lu ................................................... Disclosed no conflict of interest.Cai, Weikang ......................................... Disclosed no conflict of interest.Cai, Xiaoling .......................................... Disclosed no conflict of interest.Cain, Sarah A. ...................................... Disclosed no conflict of interest.Cakar, Mustafa ...................................... Disclosed no conflict of interest.Calabrese, Mariella .............................. Disclosed no conflict of interest.Calabuig-Navarro, Virtu ........................ Disclosed no conflict of interest.Calder, Philip ......................................... Disclosed no conflict of interest.Calderari, Sophie .................................. Disclosed no conflict of interest.Calderon, Rosanna ................................ Disclosed no conflict of interest.Califf, Robert ......................................... Consultant: Bristol-Myers Squibb/AstraZeneca, Merck,
Calle, Roberto A. .................................. Employee: Pfizer, Inc.; Stock/Shareholder: Pfizer, Inc.Calle-Pascual, Alfonso L. ..................... Disclosed no conflict of interest.Calles, Jorge ......................................... Disclosed no conflict of interest.Calvi-Gries, Francoise ........................... Consultant: Sanofi.Camacho, Raul C. ................................. Employee: Merck Sharp & Dohme Limited.Camara, Soumaïla ................................. Disclosed no conflict of interest.Cameron, Fergus J. .............................. Disclosed no conflict of interest.Camilleri, Michael ................................. Research Support: Rhythm Pharmaceuticals.Caminiti, Maurizio ................................. Disclosed no conflict of interest.Camisasca, Riccardo ............................. Employee: Takeda Development Centre Europe Ltd.; Stock/
Shareholder: Takeda Development Centre Europe Ltd,.Cammacho, Jenny ................................. Disclosed no conflict of interest.Campagna, Shawn R. ........................... Disclosed no conflict of interest.Campagnol, Lisa .................................... Disclosed no conflict of interest.Campani, Daniela .................................. Disclosed no conflict of interest.Campbell, Amanda ................................ Disclosed no conflict of interest.Campbell, Latoya E. ............................. Disclosed no conflict of interest.Campbell, Matthew D. ........................ Disclosed no conflict of interest.Campbell, Sara C. ................................ Disclosed no conflict of interest.
Campesi, Ilaria ...................................... Disclosed no conflict of interest.Camporez, João Paulo G. ..................... Disclosed no conflict of interest.Campos, Carlos ..................................... Advisory Panel: Bristol-Myers Squibb/AstraZeneca, Eli Lilly
and Company, Janssen Pharmaceuticals, Novo Nordisk, Inc.
Canal, Fabio .......................................... Disclosed no conflict of interest.Canani, Luis H. ..................................... Disclosed no conflict of interest.Candelaria, Karla .................................. Disclosed no conflict of interest.Candelas, Christophe ............................ Employee: Sanofi.Candeloro, Paola ................................... Disclosed no conflict of interest.Canecki-Varžic, Silvija ........................... Advisory Panel: AstraZeneca Pharmaceuticals LP, Eli Lilly and
Company, Novo Nordisk A/S.Canfora, Emanuel E. ............................. Disclosed no conflict of interest.Cang, Zhen ............................................ Disclosed no conflict of interest.Canizalez, Dalia ..................................... Disclosed no conflict of interest.Canney, Lori ........................................... Employee: Biodel, Inc.; Stock/Shareholder: Biodel, Inc.Cannon, Adam E. .................................. Employee: Walgreens.Cannon, Anthony ................................... Speaker’s Bureau: Janssen Pharmaceuticals, Merck, Novo
Nordisk A/S, Valeritas, LLC.Cannon, Corey E. .................................. Disclosed no conflict of interest.Cantley, Jennifer L. .............................. Disclosed no conflict of interest.Cantwell, Martin ................................... Employee: Medtronic MiniMed, Inc.Canty, Angelo J. ................................... Disclosed no conflict of interest.Cao, Bingyan ......................................... Disclosed no conflict of interest.Cao, Julia X. ......................................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly
and Company.Cao, Liching ........................................... Disclosed no conflict of interest.Cao, Meng ............................................. Disclosed no conflict of interest.Cao, Qiang ............................................. Research Support: NuSirt Inc.Cao, Qing ............................................... Disclosed no conflict of interest.Cao, Yanan ............................................ Disclosed no conflict of interest.Caplin, Scott .......................................... Disclosed no conflict of interest.Cappell, Katherine ................................ Employee: Truven Health Analytics.Cappelleri, Joseph C. ........................... Employee: Pfizer, Inc.; Stock/Shareholder: Pfizer, Inc.Cappelletti, Chiara ................................ Disclosed no conflict of interest.Cappola, Anne ....................................... Disclosed no conflict of interest.Caprio, Sonia ......................................... Disclosed no conflict of interest.Caprioli, Richard .................................... Disclosed no conflict of interest.Capuani, Barbara .................................. Disclosed no conflict of interest.Capula, Carmelo .................................... Disclosed no conflict of interest.Caputo, Mariapaola .............................. Disclosed no conflict of interest.Caputo, Nicholas ................................... Disclosed no conflict of interest.Caputo, Salvatore ................................. Advisory Panel: Merck Sharp & Dohme Limited, Novo Nordisk
A/S; Speaker’s Bureau: Eli Lilly and Company, Merck, Merck Sharp & Dohme Limited, Novo Nordisk A/S, Sanofi, Takeda Pharmaceutical Company, Ltd.
Caratelli, Sara ....................................... Disclosed no conflict of interest.Caravajal-Gonzalez, Santos .................. Employee: Pfizer, Inc.Caraway Perkins, Jessica ..................... Disclosed no conflict of interest.Carbillon, Lionel .................................... Consultant: Novo Nordisk.Carcone, April ....................................... Disclosed no conflict of interest.Cardell, James ...................................... Disclosed no conflict of interest.Cardona, Saumeth ................................ Disclosed no conflict of interest.Carella, Massimo .................................. Disclosed no conflict of interest.Carey, Michelle ..................................... Disclosed no conflict of interest.Cariou, Bertrand .................................... Advisory Panel: Eli Lilly and Company, Genfit, Novo Nordisk,
Inc., Sanofi; Board Member: Novo Nordisk, Inc.; Research Support: Novo Nordisk, Inc., Sanofi.
Carle, Flavia .......................................... Disclosed no conflict of interest.Carless, Melanie ................................... Disclosed no conflict of interest.Carlotti, Françoise ................................. Disclosed no conflict of interest.Carlsen, David R. .................................. Disclosed no conflict of interest.Carlson, Coby ........................................ Disclosed no conflict of interest.Carlson, Edward .................................... Disclosed no conflict of interest.Carlson, Olga ......................................... Disclosed no conflict of interest.Carlsson, Lena ....................................... Consultant: AstraZeneca Pharmaceuticals LP; Stock/
Shareholder: Sahltech.Carlstrom, Mattias ................................ Disclosed no conflict of interest.Carmody, David ..................................... Disclosed no conflict of interest.Carmody, Louise .................................... Disclosed no conflict of interest.Carnethon, Mercedes R. ...................... Disclosed no conflict of interest.Carollo-Limeres, C. ............................... Disclosed no conflict of interest.Carpenedo, Dorota ................................ Disclosed no conflict of interest.Carpenter, Dee-Ann............................... Disclosed no conflict of interest.Carpentier, André C. ............................. Disclosed no conflict of interest.Carpino, Philip A. ................................. Employee: Pfizer, Inc.Carpio, Gandahari ................................. Disclosed no conflict of interest.Carr, Bernadette .................................... Employee: Vhi Healthcare.Carr, J. Jeffrey ...................................... Disclosed no conflict of interest.Carr, Molly C. ....................................... Employee: GlaxoSmithKline; Stock/Shareholder:
GlaxoSmithKline.Carrara, Marcia A. ............................... Disclosed no conflict of interest.
Carria, Lori R. ....................................... Disclosed no conflict of interest.Carrillo Domínguez, Armando ............... Disclosed no conflict of interest.Carrington, Paul E. ............................... Employee: Merck.Carroll, Julie M. ................................... Disclosed no conflict of interest.Carson, TreChelle .................................. Disclosed no conflict of interest.Carstensen, Bendix ............................... Employee: Novo Nordisk A/S; Stock/Shareholder: Novo
Nordisk A/S.Carstensen, Maren ............................... Disclosed no conflict of interest.Cartailler, Jean-Philippe........................ Disclosed no conflict of interest.Cartaya, Julia B. ................................... Disclosed no conflict of interest.Carter, Laura B. .................................... Disclosed no conflict of interest.Carter, Rickey ........................................ Disclosed no conflict of interest.Carter, Tonia .......................................... Employee: Marshfield Clinic Research Foundation.Cartwright, Brian M. ............................ Disclosed no conflict of interest.Caruso, Michael .................................... Disclosed no conflict of interest.Caruthers, Carrrie .................................. Disclosed no conflict of interest.Carvajal-Gonzalez, Santos .................... Employee: Pfizer, Inc.Carvalho, Bruno M. .............................. Disclosed no conflict of interest.Casal, Eileen ......................................... Employee: Dexcom, Inc.Casal, Florentino ................................... Disclosed no conflict of interest.Casellini, Carolina M. .......................... Disclosed no conflict of interest.Casey, John ........................................... Disclosed no conflict of interest.Cashy, John ........................................... Disclosed no conflict of interest.Caslake, Muriel J. ................................ Disclosed no conflict of interest.Cassel, Roméo ...................................... Disclosed no conflict of interest.Castel, Julien ........................................ Disclosed no conflict of interest.Castellino, Giuseppa ............................. Disclosed no conflict of interest.Casteràs, Ana ........................................ Disclosed no conflict of interest.Castle, Jessica R. ................................. Stock/Shareholder: Pacific Diabetes Technologies.Castorino, Kristin .................................. Research Support: Novo Nordisk, Inc., Sanofi.Castrejón-Pérez, Roberto C. ................. Disclosed no conflict of interest.Castro Cabezas, Manuel ....................... Disclosed no conflict of interest.Castro, Ana Valeria B. .......................... Disclosed no conflict of interest.Castro, Gisele ........................................ Disclosed no conflict of interest.Castro, João .......................................... Disclosed no conflict of interest.Catalano, Patrick M. ............................ Disclosed no conflict of interest.Catargi, Bogdan .................................... Disclosed no conflict of interest.Catharino, Rodrigo R. ........................... Disclosed no conflict of interest.Caton, Paul W. ..................................... Research Support: Eli Lilly and Company.Catrinacio, Cintia .................................. Disclosed no conflict of interest.Catteau, Jacki ....................................... Disclosed no conflict of interest.Catton, Edward ..................................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly
and Company.Caudle, Jane M. ................................... Disclosed no conflict of interest.Cauley, Jane A. .................................... Disclosed no conflict of interest.Caulfield, Thomas R. ............................ Disclosed no conflict of interest.Cavada, Manuel .................................... Disclosed no conflict of interest.Cavanagh, Peter R. ............................... Consultant: DIApedia, LLC; Stock/Shareholder: DIApedia,
LLC.Cavelti-Weder, Claudia ......................... Disclosed no conflict of interest.Cawthon, Peggy M. .............................. Disclosed no conflict of interest.Ceballos, Guillermo ............................... Stock/Shareholder: Cardero Therapeutics.Cechin, Sirlene R. ................................. Disclosed no conflict of interest.Cederberg, Henna ................................. Disclosed no conflict of interest.Cefalo, Chiara Maria Assunta .............. Disclosed no conflict of interest.Cefalu, William T. ................................ Consultant: Lexicon Pharmaceuticals, Inc., Novo Nordisk, Inc.,
Shire; Research Support: AstraZeneca/Bristol-Meyers Squibb, Aventis, GlaxoSmithKline, Johnson & Johnson, Lexicon Pharmaceuticals, Inc., MannKind Corporation, Sanofi.
Celeng, Csilla ........................................ Disclosed no conflict of interest.Celona-Jacobs, Nicole .......................... Disclosed no conflict of interest.Cengiz, Eda ............................................ Disclosed no conflict of interest.Cercone, Stefania ................................. Employee: Merck Sharp & Dohme Limited.Ceriello, Antonio ................................... Disclosed no conflict of interest.Cerit, Ethem T. ...................................... Disclosed no conflict of interest.Cernich, Joseph T. ................................ Disclosed no conflict of interest.Cersosimo, Eugenio .............................. Advisory Panel: Janssen Pharmaceuticals, Takeda
Pharmaceuticals U.S.A., Inc.; Speaker’s Bureau: Bristol-Myers Squibb Company, Eli Lilly and Company, Janssen Pharmaceuticals, Sanofi, Takeda Pharmaceuticals U.S.A., Inc.
Cerussi, Albert ...................................... Disclosed no conflict of interest.Cetin, Irene ............................................ Disclosed no conflict of interest.Cha, Bong Soo ....................................... Disclosed no conflict of interest.Cha, Bong-Yun ....................................... Disclosed no conflict of interest.Chadni, R. ............................................. Disclosed no conflict of interest.Chae, Kyung Sil ..................................... Disclosed no conflict of interest.Chae, Sehyun ........................................ Disclosed no conflict of interest.Chai, Jing .............................................. Disclosed no conflict of interest.Chai, Shangyu ....................................... Disclosed no conflict of interest.Chai, Weidong....................................... Disclosed no conflict of interest.
Chaieb, Larbi ......................................... Disclosed no conflict of interest.Chaillous, Lucy ...................................... Disclosed no conflict of interest.Chaisson, Candra .................................. Disclosed no conflict of interest.Chakkera, Harini .................................... Disclosed no conflict of interest.Chakrabarti, Subrata ............................. Disclosed no conflict of interest.Chalew, Stuart ...................................... Disclosed no conflict of interest.Chamberlain, Chester E. ...................... Disclosed no conflict of interest.Chambers, Christina M. ....................... Disclosed no conflict of interest.Chan, Catherine B. ............................... Disclosed no conflict of interest.Chan, Charles ........................................ Disclosed no conflict of interest.Chan, Christine L. ................................. Disclosed no conflict of interest.Chan, Jean L. ....................................... Employee: Bristol-Myers Squibb/AstraZeneca.Chan, Jeng Y. ....................................... Disclosed no conflict of interest.Chan, Jeremy H. ................................... Disclosed no conflict of interest.Chan, Juliana C. ................................... Consultant: AstraZeneca/Bristol-Meyers Squibb, Daiichi-
Sankyo, Inc., GlaxoSmithKline, Merck Sharp & Dohme Limited, Pfizer, Inc., Sanofi; Research Support: CUHK Focused Investment, Hong Kong Foundation for Research and Development in Diabetes, Merck Sharp & Dohme Limited, Sanofi; Speaker’s Bureau: AstraZeneca/Bristol-Meyers Squibb, Daiichi-Sankyo, Inc., Eli Lilly and Company, GlaxoSmithKline, Merck, Merck Sharp & Dohme Limited, Nestle, Inc., Novo Nordisk, Inc., Pfizer, Inc., Roche Pharmaceuticals, Sanofi, Takeda Pharmaceutical Company, Ltd.
Chan, Lawrence C. ............................... Disclosed no conflict of interest.Chan, Owen ........................................... Disclosed no conflict of interest.Chan, Paul K. ........................................ Disclosed no conflict of interest.Chan, Yuk C. ......................................... Disclosed no conflict of interest.Chandler, Lois A. .................................. Disclosed no conflict of interest.Chandra Sekran, Ambalam M. ............ Disclosed no conflict of interest.Chang, Anna .......................................... Disclosed no conflict of interest.Chang, Anne M. ................................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly
and Company.Chang, Chia-Hsuin ................................ Disclosed no conflict of interest.Chang, Chun-Jen ................................... Disclosed no conflict of interest.Chang, Chun-Ping H. ............................ Disclosed no conflict of interest.Chang, Eugene ...................................... Disclosed no conflict of interest.Chang, Healani K. ................................ Disclosed no conflict of interest.Chang, Julia J. ..................................... Disclosed no conflict of interest.Chang, Kiyuk ......................................... Disclosed no conflict of interest.Chang, Nancy ........................................ Disclosed no conflict of interest.Chang, Patricia P. ................................. Disclosed no conflict of interest.Chang, Ping-Chung ................................ Employee: MannKind Corporation; Stock/Shareholder:
MannKind Corporation.Chang, Xin-Xia ...................................... Disclosed no conflict of interest.Chang, Xusheng .................................... Disclosed no conflict of interest.Chang, Yi-Cheng.................................... Disclosed no conflict of interest.Chang, Yuefang ..................................... Disclosed no conflict of interest.Changizi, Arash ..................................... Disclosed no conflict of interest.Chanpoo, Malee .................................... Disclosed no conflict of interest.Chanu, Bernard ..................................... Disclosed no conflict of interest.Chao, Ariana M. ................................... Disclosed no conflict of interest.Chao, Tony ............................................. Disclosed no conflict of interest.Chao, Wang........................................... Disclosed no conflict of interest.Chao, Yu-Sheng ..................................... Disclosed no conflict of interest.Chapel, Sunny ....................................... Employee: A2PG.Chapman, Harry .................................... Disclosed no conflict of interest.Chapman, Julie C. ................................ Disclosed no conflict of interest.Charitanski, Didier ................................ Disclosed no conflict of interest.Charles, Andrew D. .............................. Employee: AstraZeneca Pharmaceuticals LP.Charles, Marie Aline ............................. Disclosed no conflict of interest.Charles, Matthew ................................. Employee: Diamedica, Inc.; Stock/Shareholder: Diamedica,
Inc.Charles, Morten .................................... Disclosed no conflict of interest.Charnaux, Nathalie ............................... Disclosed no conflict of interest.Charpentier, Guillaume ......................... Board Member: Novo Nordisk A/S.Charron, Maureen J. ............................ Disclosed no conflict of interest.Charron-Prochownik, Denise ................ Disclosed no conflict of interest.Chartoumpekis, Dionysios V. ............... Disclosed no conflict of interest.Chasan-Taber, Lisa ................................ Disclosed no conflict of interest.Chasapidou, Maria ................................ Disclosed no conflict of interest.Chase, Peter .......................................... Research Support: Dexcom, Inc.Chatterjee, Kaushik ............................... Disclosed no conflict of interest.Chattopadhyay, Munmun ...................... Disclosed no conflict of interest.Chaturvedi, Nishi .................................. Disclosed no conflict of interest.Chaudhuri, Ajay ..................................... Disclosed no conflict of interest.Chauvin, Marie-Agnès .......................... Disclosed no conflict of interest.Chava, Pavan ......................................... Consultant: Sanofi.Chavakis, Triantafyllos .......................... Disclosed no conflict of interest.Chavarro, Jorge E. ................................ Disclosed no conflict of interest.Chavez-Velazquez, Alberto .................... Disclosed no conflict of interest.
Chawla, Manoj S. ................................ Advisory Panel: Eli Lilly/ Boehringer-Ingelheim, Eris Life Sciences, Novartis Pharma AG; Employee: Piramal Life Sciences (Spouse/Partner); Other Relationship: Novartis Pharma AG; Research Support: Novartis Pharma AG; Speaker’s Bureau: Abbott Diabetes Care, Bristol-Myers Squibb Company, MSD, Novartis Pharma AG, Novo Nordisk, Inc.
Cheah, Yee S. ....................................... Disclosed no conflict of interest.Cheatham, Bentley ................................ Employee: BHV Pharma.Chechik, Tzila ........................................ Disclosed no conflict of interest.Chen, Ai-ling ......................................... Disclosed no conflict of interest.Chen, Angela ......................................... Disclosed no conflict of interest.Chen, Baoyuan ...................................... Disclosed no conflict of interest.Chen, Bill ............................................... Employee: Sanofi.Chen, Charlene ...................................... Disclosed no conflict of interest.Chen, Chih-Hung ................................... Disclosed no conflict of interest.Chen, Dapeng ........................................ Disclosed no conflict of interest.Chen, Ellen H. ....................................... Disclosed no conflict of interest.Chen, Gui-Lan ........................................ Disclosed no conflict of interest.Chen, Guofang ...................................... Disclosed no conflict of interest.Chen, Haibing ........................................ Disclosed no conflict of interest.Chen, Hainan ......................................... Disclosed no conflict of interest.Chen, Haiying ........................................ Disclosed no conflict of interest.Chen, Hao .............................................. Disclosed no conflict of interest.Chen, Hong ............................................ Disclosed no conflict of interest.Chen, Jian-Wen .................................... Employee: Novo Nordisk A/S.Chen, Jing ............................................. Disclosed no conflict of interest.Chen, Junqin ......................................... Disclosed no conflict of interest.Chen, Kuan-Yu Y. .................................. Disclosed no conflict of interest.Chen, Li ................................................. Disclosed no conflict of interest.Chen, Lihong Z. .................................... Disclosed no conflict of interest.Chen, Lihong ......................................... Employee: GlaxoSmithKline.Chen, Lili ............................................... Disclosed no conflict of interest.Chen, Liming ......................................... Disclosed no conflict of interest.Chen, Lin ............................................... Disclosed no conflict of interest.Chen, Ling ............................................. Disclosed no conflict of interest.Chen, Lisa .............................................. Employee: Novo Nordisk, Inc.Chen, Miao ............................................ Disclosed no conflict of interest.Chen, Pan .............................................. Disclosed no conflict of interest.Chen, Pei-Hsuan .................................... Disclosed no conflict of interest.Chen, Rui ............................................... Disclosed no conflict of interest.Chen, Ruihua ......................................... Disclosed no conflict of interest.Chen, Rusan .......................................... Disclosed no conflict of interest.Chen, Shali ............................................ Disclosed no conflict of interest.Chen, Shu-Cheng .................................. Employee: Merck.Chen, Shu-Ting ...................................... Disclosed no conflict of interest.Chen, Szu-Chi ........................................ Disclosed no conflict of interest.Chen, Timothy ....................................... Disclosed no conflict of interest.Chen, Wei-Min ...................................... Disclosed no conflict of interest.Chen, Xiang ........................................... Disclosed no conflict of interest.Chen, Xiao-Ping ..................................... Disclosed no conflict of interest.Chen, Xinhua ......................................... Disclosed no conflict of interest.Chen, Xinpu ........................................... Disclosed no conflict of interest.Chen, Xizhe ........................................... Disclosed no conflict of interest.Chen, Xuan ............................................ Employee: CrownBio.Chen, Xuequn ........................................ Disclosed no conflict of interest.Chen, Xuqing ......................................... Disclosed no conflict of interest.Chen, Y.S. ............................................. Disclosed no conflict of interest.Chen, Yan-ming ..................................... Disclosed no conflict of interest.Chen, Yanyan ........................................ Disclosed no conflict of interest.Chen, Yen-Ling ...................................... Disclosed no conflict of interest.Chen, Yen-Shun ..................................... Disclosed no conflict of interest.Chen, Yi-Chun........................................ Disclosed no conflict of interest.Chen, Yi-Guang ..................................... Disclosed no conflict of interest.Chen, Yii-Der I. ..................................... Disclosed no conflict of interest.Chen, Yong ............................................ Employee: Merck.Chen, Yu J. ........................................... Disclosed no conflict of interest.Chen, Yu-Han ........................................ Disclosed no conflict of interest.Chen, Yumay ......................................... Disclosed no conflict of interest.Chen, Yu-ming ....................................... Disclosed no conflict of interest.Chen, Yuning ......................................... Disclosed no conflict of interest.Chen, Zheng .......................................... Disclosed no conflict of interest.Chen, Zhuo ............................................ Disclosed no conflict of interest.Chen, Zijian ........................................... Disclosed no conflict of interest.Cheney, Michael C. .............................. Disclosed no conflict of interest.Cheng, Alex ........................................... Disclosed no conflict of interest.Cheng, Alfred S.L. ................................ Disclosed no conflict of interest.Cheng, Karen ......................................... Employee: Boehringer Ingelheim GmbH & Co. KG.Cheng, Peiyao ....................................... Disclosed no conflict of interest.Cheng, Sue-Yueh ................................... Disclosed no conflict of interest.Cheng, Susan ........................................ Disclosed no conflict of interest.Cheng, Yiling J. .................................... Disclosed no conflict of interest.
Cheon, Jaeyoung .................................. Disclosed no conflict of interest.Cherney, David Z. ................................. Consultant: Janssen Pharmaceuticals; Research Support:
Cherrington, Alan D. ............................ Advisory Panel: Biocon, Diamedica, Inc., Diasome Pharmaceuticals, Metavention, NuSirt, Thetis, VeroScience, Zafgen, Inc.; Consultant: Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Fractyl, Gilead Sciences, Inc., Merck, Novo Nordisk A/S, Profil Institute for Clinical Research, Inc., Sanofi, Thermalin Diabetes, LLC; Research Support: Diamedica, Inc., Metavention, Novo Nordisk A/S, Sensulin, VeroScience; Speaker’s Bureau: Merck; Stock/Shareholder: Diamedica, Inc., Fractyl, Metavention, Sensulin, Thetis, Zafgen, Inc.
Cherrington, Andrea M. ....................... Research Support: Sanofi.Cherubini, Valentino .............................. Disclosed no conflict of interest.Chessler, Steven D. .............................. Stock/Shareholder: Baxter, Johnson & Johnson.Cheta, Dan M. ...................................... Disclosed no conflict of interest.Cheung, Carol Y. ................................... Disclosed no conflict of interest.Cheung, N. Wah .................................... Disclosed no conflict of interest.Cheung, Roy K. ..................................... Disclosed no conflict of interest.Cheung, Susan S. ................................. Disclosed no conflict of interest.Cheung, Vanessa ................................... Disclosed no conflict of interest.Cheung, Wah......................................... Disclosed no conflict of interest.Cheyette, Chris ...................................... Disclosed no conflict of interest.Chhabra, Preeti ..................................... Disclosed no conflict of interest.Chheda, Himanshu ................................ Disclosed no conflict of interest.Chheda, T.K. ......................................... Disclosed no conflict of interest.Chhoun, Jennifer ................................... Disclosed no conflict of interest.Chi, Chengyuan ..................................... Disclosed no conflict of interest.Chi, Yuling ............................................. Disclosed no conflict of interest.Chia, Dennis .......................................... Disclosed no conflict of interest.Chiang, Janet M. ................................. Disclosed no conflict of interest.Chiari, Giovanni ..................................... Disclosed no conflict of interest.Chidester, Paul ...................................... Disclosed no conflict of interest.Chie, Kamiya ......................................... Disclosed no conflict of interest.Chiefari, Eusebio ................................... Disclosed no conflict of interest.Chien, Hung-Jen ................................... Disclosed no conflict of interest.Chien, Jenny Y. .................................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly
and Company.Chien, Ming-Nan ................................... Disclosed no conflict of interest.Chiheb, Sabrina ..................................... Disclosed no conflict of interest.Childers, Keri A. ................................... Disclosed no conflict of interest.Childress, Kristin ................................... Disclosed no conflict of interest.Chilloux, Julien ..................................... Disclosed no conflict of interest.Chilton, Robert J. ................................. Disclosed no conflict of interest.Chin, Eva R. .......................................... Disclosed no conflict of interest.Chin, LiKang .......................................... Disclosed no conflict of interest.Chin, Marshall H. ................................. Research Support: NIH.Chin, Sang Ouk ...................................... Disclosed no conflict of interest.Chines, Peter ......................................... Disclosed no conflict of interest.Ching, Jenny ......................................... Disclosed no conflict of interest.Chiou, Jeng Y. ...................................... Disclosed no conflict of interest.Chiriatti, Alberto ................................... Disclosed no conflict of interest.Chisari, Carmelo .................................... Disclosed no conflict of interest.Chitnis, Abhishek S. ............................. Employee: Evidera; Other Relationship: Evidera Chiu, Ching-Ju ....................................... Disclosed no conflict of interest.Chiu, Ken C. .......................................... Disclosed no conflict of interest.Chiu, Susannah ..................................... Disclosed no conflict of interest.Chmelik, Marek ..................................... Disclosed no conflict of interest.Chng, Keefe ........................................... Employee: CrownBio.Cho, Hee Yoon ....................................... Disclosed no conflict of interest.Cho, Jae Ho ........................................... Disclosed no conflict of interest.Cho, Jae Hyoung ................................... Disclosed no conflict of interest.Cho, Kae Won ....................................... Disclosed no conflict of interest.Cho, Nam H. ......................................... Disclosed no conflict of interest.Cho, Pyone ............................................ Disclosed no conflict of interest.Cho, Sung-Rae ...................................... Disclosed no conflict of interest.Cho, Theresa L. .................................... Advisory Panel: Sanofi.Cho, Yongin ........................................... Disclosed no conflict of interest.Cho, Young Min ..................................... Disclosed no conflict of interest.Chodik, Gabriel ...................................... Disclosed no conflict of interest.Choe, Eun Yeong ................................... Disclosed no conflict of interest.Choe, Sung Sik ...................................... Disclosed no conflict of interest.Choi, Dong Seop ................................... Disclosed no conflict of interest.Choi, Eun Hee ........................................ Disclosed no conflict of interest.Choi, Hae Yoon ...................................... Disclosed no conflict of interest.Choi, Haysook ....................................... Disclosed no conflict of interest.Choi, In Young ....................................... Disclosed no conflict of interest.Choi, Jeong-Hyeon ................................ Disclosed no conflict of interest.
Choi, Jessica ......................................... Disclosed no conflict of interest.Choi, Jin Myung .................................... Disclosed no conflict of interest.Choi, Jong Han ...................................... Disclosed no conflict of interest.Choi, Jung-Mook ................................... Disclosed no conflict of interest.Choi, Kyung Mook ................................. Disclosed no conflict of interest.Choi, Ok Kyong ...................................... Disclosed no conflict of interest.Choi, Sabina .......................................... Disclosed no conflict of interest.Choi, Seung Hee ................................... Disclosed no conflict of interest.Choi, Siak Leng ..................................... Employee: Eli Lilly and Company.Choi, So-Jin ........................................... Disclosed no conflict of interest.Choi, Soo Bong ...................................... Stock/Shareholder: Sooil Development Corporation.Choi, Soomin ......................................... Disclosed no conflict of interest.Choi, Steven .......................................... Disclosed no conflict of interest.Choi, Sung Hee ..................................... Disclosed no conflict of interest.Choi, Sung-E .......................................... Disclosed no conflict of interest.Choi, Woong Hwan ............................... Disclosed no conflict of interest.Choi, Yong Jun ...................................... Disclosed no conflict of interest.Choi, Youn-Hee ..................................... Disclosed no conflict of interest.Chollet, Catherine ................................. Disclosed no conflict of interest.Chon, Suk .............................................. Disclosed no conflict of interest.Chon, Young Eun ................................... Disclosed no conflict of interest.Chondronikola, Maria ........................... Disclosed no conflict of interest.Chong, Hui W. ...................................... Disclosed no conflict of interest.Chong, Yap-Seng ................................... Disclosed no conflict of interest.Chongjaroen, Nalinee ........................... Disclosed no conflict of interest.Chou, Cyril ............................................. Disclosed no conflict of interest.Chou, Engels ......................................... Disclosed no conflict of interest.Chou, Min-Yuan .................................... Disclosed no conflict of interest.Choudhary, Pratik .................................. Advisory Panel: Cellnovo, Lifescan, Animas, Inc., Johnson &
Johnson, Lilly, Medtronic; Research Support: Cellnovo, Medtronic; Speaker’s Bureau: Johnson & Johnson, Lilly, Medtronic, MSD, Novo Nordisk, Sanofi.
Choudhry, Niteesh ................................. Research Support: Eli Lilly and Company.Choukem, Siméon P. ............................. Disclosed no conflict of interest.Chow, Carson ........................................ Disclosed no conflict of interest.Chow, Francis C. .................................. Disclosed no conflict of interest.Chow, Lisa ............................................. Disclosed no conflict of interest.Chow, Rhuen C. .................................... Disclosed no conflict of interest.Chow, Wing ........................................... Employee: Janssen Pharmaceuticals; Stock/Shareholder:
Johnson & Johnson.Christensen, Cramer K. ........................ Disclosed no conflict of interest.Christensen, John ................................. Disclosed no conflict of interest.Christensen, Kaare ................................ Disclosed no conflict of interest.Christensen, Mikkel B. ......................... Disclosed no conflict of interest.Christensen, Ulla ................................... Disclosed no conflict of interest.Christian, Anna J. ................................ Disclosed no conflict of interest.Christiansen, Anita Vedel ..................... Employee: Boehringer Ingelheim Danmark A/S.Christiansen, Cindy L. .......................... Disclosed no conflict of interest.Christiansen, Jens S. ........................... Advisory Panel: Eli Lilly and Company, Novartis Pharma AG,
Novo Nordisk A/S, Pfizer, Inc.; Speaker’s Bureau: Eli Lilly and Company, Novartis Pharma AG, Novo Nordisk A/S, Pfizer, Inc.
Christiansen, Mark ................................ Disclosed no conflict of interest.Christie, Michael R. ............................. Disclosed no conflict of interest.Christopher, Solomon ............................ Disclosed no conflict of interest.Christophi, Costas A. ........................... Disclosed no conflict of interest.Chronley, Michael K. ............................ Disclosed no conflict of interest.Chrousos, George .................................. Disclosed no conflict of interest.Chrysostomou, Vicki .............................. Disclosed no conflict of interest.Chu, Audrey Y. ...................................... Disclosed no conflict of interest.Chu, Bong-Chul ..................................... Employee: Truven Health Analytics.Chu, Changan ........................................ Employee: Novartis Pharmaceticals Corporation; Stock/
Shareholder: Novartis.Chu, Connie K. ...................................... Disclosed no conflict of interest.Chu, Man Tak ........................................ Disclosed no conflict of interest.Chu, Qingwei ......................................... Disclosed no conflict of interest.Chu, Xuran ............................................. Disclosed no conflict of interest.Chu, Yanhui ........................................... Disclosed no conflict of interest.Chua, Laiyi ............................................. Employee: Eli Lilly and Company.Chua, Streamson C. ............................. Disclosed no conflict of interest.Chuah, Ling L. ....................................... Disclosed no conflict of interest.Chuan, Yang .......................................... Disclosed no conflict of interest.Chuang, Lee-Ming ................................. Disclosed no conflict of interest.Chulasiri, Pubudu .................................. Disclosed no conflict of interest.Chung, Cheng-Ho .................................. Disclosed no conflict of interest.Chung, Choon Hee ................................ Disclosed no conflict of interest.Chung, Harriet H. ................................. Disclosed no conflict of interest.Chung, Hsien Jui ................................... Disclosed no conflict of interest.Chung, Hsing-wen ................................. Disclosed no conflict of interest.Chung, Jae Bok ..................................... Disclosed no conflict of interest.Chung, Jin-ook ...................................... Disclosed no conflict of interest.Chung, Michelle .................................... Disclosed no conflict of interest.
Chung, Min-young ................................. Disclosed no conflict of interest.Chung, Stephanie T. ............................. Disclosed no conflict of interest.Chung, Sung Soo ................................... Disclosed no conflict of interest.Churilov, Leonid ..................................... Disclosed no conflict of interest.Chutkow, William A. ............................ Disclosed no conflict of interest.Ciano, Ornella ....................................... Disclosed no conflict of interest.Ciaraldi, Theodore P. ............................ Disclosed no conflict of interest.Ciavarella, Alessandro .......................... Disclosed no conflict of interest.Ciborowski, Michal ............................... Disclosed no conflict of interest.Cibula, Donald A. ................................. Research Support: NIDDK.Cicorelli, Antonello ............................... Disclosed no conflict of interest.Ciecko, Ashley E. .................................. Disclosed no conflict of interest.Cignarelli, Angelo ................................. Disclosed no conflict of interest.Cignarelli, Mauro .................................. Disclosed no conflict of interest.Cigolle, Christine ................................... Disclosed no conflict of interest.Cimino, Antonino .................................. Disclosed no conflict of interest.Cinar, Ali ................................................ Disclosed no conflict of interest.Cinar, Resat ........................................... Disclosed no conflict of interest.Cincotta, Anthony H. ............................ Employee: VeroScience.Cinkajzlova, Anna .................................. Disclosed no conflict of interest.Cintron, Miriam ..................................... Disclosed no conflict of interest.Ciociaro, Demetrio ................................ Disclosed no conflict of interest.Cioli, Patrizia ......................................... Disclosed no conflict of interest.Cioni, Roberto ....................................... Disclosed no conflict of interest.Cirkel, Deborah ..................................... Employee: GlaxoSmithKline; Stock/Shareholder:
GlaxoSmithKline.Citko, Anna ............................................ Disclosed no conflict of interest.Civantos Modino, Soralla ..................... Disclosed no conflict of interest.Cizmic, Amber ....................................... Disclosed no conflict of interest.Clark, Amy L. ........................................ Disclosed no conflict of interest.Clark, Anne ............................................ Disclosed no conflict of interest.Clark, Dawn ........................................... Disclosed no conflict of interest.Clark, Jeanne M. .................................. Disclosed no conflict of interest.Clark, Monique ...................................... Disclosed no conflict of interest.Clark, Shelley L. ................................... Disclosed no conflict of interest.Clarke, Geoffrey D. .............................. Disclosed no conflict of interest.Clarke, Hilda .......................................... Advisory Panel: Novo Nordisk, Inc.; Speaker’s Bureau: Novo
Nordisk, Inc., Sanofi.Clarke, Philip M. ................................... Disclosed no conflict of interest.Clarke, William L. ................................. Disclosed no conflict of interest.Clausen, Tine D. ................................... Disclosed no conflict of interest.Cleal, Bryan ........................................... Employee: Steno Diabetes Center A/S.Cleary, Patricia A. ................................ Disclosed no conflict of interest.Clee, Susanne M. ................................. Disclosed no conflict of interest.Clement, Stephen ................................. Disclosed no conflict of interest.Clements, Mark A. ............................... Consultant: Medtronic.Clements, Scott ..................................... Disclosed no conflict of interest.Clemmons, David .................................. Stock/Shareholder: Vascular Pharmaceuticals Inc.Clendenning, Megan ............................. Disclosed no conflict of interest.Clerici, Giacomo .................................... Advisory Panel: Integra Lifesciences, KCI; Research Support:
Molliter.Cline, Gary W. ...................................... Disclosed no conflict of interest.Clinton, Paula ........................................ Disclosed no conflict of interest.Clore, Gosia S. ..................................... Employee: Humana.Clough, Geraldine ................................. Disclosed no conflict of interest.Clough, Lynn .......................................... Disclosed no conflict of interest.Cobas, Roberta A. ................................ Disclosed no conflict of interest.Cobb, Jeff E. ......................................... Employee: Metabolon, Inc.; Stock/Shareholder: Metabolon,
Inc.Cobelli, Claudio ..................................... Consultant: Johnson & Johnson; Research Support: Dexcom,
Inc., Insulet Corporation, Roche Pharmaceuticals, Tandem Diabetes Care.
Coburn, Jeannine .................................. Disclosed no conflict of interest.Coccaro, Emil ........................................ Disclosed no conflict of interest.Cochran, Elaine K. ................................ Disclosed no conflict of interest.Cocozza, Sara ........................................ Disclosed no conflict of interest.Coculescu, Mihai .................................. Disclosed no conflict of interest.Coen, Paul M. ....................................... Disclosed no conflict of interest.Coester, Hans-Veit ................................ Disclosed no conflict of interest.Cogen, Fran R. ...................................... Other Relationship: healthcentral.com.Cogswell, Mary ..................................... Disclosed no conflict of interest.Cohen, Guy ............................................ Disclosed no conflict of interest.Cohen, Melana ...................................... Disclosed no conflict of interest.Cohen, Ohad .......................................... Disclosed no conflict of interest.Cohen, Ricardo V. ................................. Advisory Panel: GI Dynamics; Research Support: Imact
Medical Brasil, JJ Medical Brasil.Colagiuri, Stephen ................................ Disclosed no conflict of interest.Colca, Jerry R. ...................................... Board Member: Metabolic Solutions Development Co.;
Employee: Metabolic Solutions Development Co.; Stock/Shareholder: Metabolic Solutions Development Co.
Colclough, Kevin ................................... Disclosed no conflict of interest.Cole, David E. ....................................... Disclosed no conflict of interest.
Cole, Serena L. ..................................... Employee: Metabolic Solutions Development Co.; Stock/Shareholder: Metabolic Solutions Development Co.
Coleman, Karia ...................................... Disclosed no conflict of interest.Coleman-Pierron, Rachel ...................... Disclosed no conflict of interest.Coletta, Dawn K. .................................. Disclosed no conflict of interest.Colhoun, Helen M. ............................... Advisory Panel: Eli Lilly and Company, Merck Sharp & Dohme
Collado, Maria Carmen ......................... Disclosed no conflict of interest.Collard, Harold ...................................... Disclosed no conflict of interest.Colleran, Kathleen ................................ Disclosed no conflict of interest.Collier, Jason......................................... Disclosed no conflict of interest.Collins, Eileen ....................................... Disclosed no conflict of interest.Collins, Francis S. ................................. Disclosed no conflict of interest.Colmers, Isabelle N. ............................. Disclosed no conflict of interest.Colomo, Natalia .................................... Disclosed no conflict of interest.Colton, Clark .......................................... Disclosed no conflict of interest.Colvin, E. Scott ...................................... Disclosed no conflict of interest.Comuzzie, Anthony G. .......................... Disclosed no conflict of interest.Conarello, Stacey L. ............................. Employee: Merck Sharp & Dohme Limited.Concha, Jeannie B. .............................. Disclosed no conflict of interest.Condie, Ty .............................................. Disclosed no conflict of interest.Cong, Weina.......................................... Disclosed no conflict of interest.Conjard-Duplany, Agnès ....................... Stock/Shareholder: Metabolys Inc.Conley, Kevin ......................................... Disclosed no conflict of interest.Conneely, Mary M. .............................. Disclosed no conflict of interest.Connelly, Margery A. ........................... Employee: LipoScience.Connelly, Philip W. ............................... Disclosed no conflict of interest.Conner, Stephanie ................................. Disclosed no conflict of interest.Connor, Crystal ...................................... Disclosed no conflict of interest.Conradi, Alexandra ............................... Disclosed no conflict of interest.Consoli, Agostino .................................. Disclosed no conflict of interest.Constable, Todd..................................... Disclosed no conflict of interest.Constans, Thierry .................................. Disclosed no conflict of interest.Constantinescu, Cristina ....................... Disclosed no conflict of interest.Constantino, Maria I. ........................... Disclosed no conflict of interest.Conte, Caterina ..................................... Disclosed no conflict of interest.Conway, Baqiyyah N. ........................... Disclosed no conflict of interest.Conway, Mary Ellen .............................. Disclosed no conflict of interest.Cooney, Gregory J. ............................... Disclosed no conflict of interest.Coope dos Santos, Andressa ................ Disclosed no conflict of interest.Cooper, Mark ......................................... Disclosed no conflict of interest.Cooper, Matthew N. ............................ Disclosed no conflict of interest.Cooper, Paul .......................................... Disclosed no conflict of interest.Copetti, Massimiliano ........................... Disclosed no conflict of interest.Coppelli, Alberto ................................... Disclosed no conflict of interest.Coppola, Andrea ................................... Disclosed no conflict of interest.Corbelli, Alessandro .............................. Disclosed no conflict of interest.Corbett, John A. ................................... Disclosed no conflict of interest.Corbin, John A. .................................... Employee: XOMA Corporation.Cordell, Paul A. .................................... Disclosed no conflict of interest.Coresh, Josef ........................................ Disclosed no conflict of interest.Cormier, Jennifer................................... Employee: GI Dynamics; Stock/Shareholder: GI Dynamics.Correa, Adolfo ....................................... Disclosed no conflict of interest.Corrêa-Giannella, Maria Lucia .............. Disclosed no conflict of interest.Correa-Medina, Mayrin ........................ Disclosed no conflict of interest.Correia, Diana ....................................... Disclosed no conflict of interest.Corriere, Mark D. ................................. Disclosed no conflict of interest.Cortes, Tiffany M. ................................ Disclosed no conflict of interest.Cortez, Cory ........................................... Disclosed no conflict of interest.Corvo, Loic ............................................. Disclosed no conflict of interest.Cos, Xavier ............................................ Research Support: Eli Lilly and Company.Coskun, Tamer ....................................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly
and Company.Cosson, Emmanuel ................................ Board Member: Novo Nordisk; Consultant: Novo Nordisk.Costa, Carla ........................................... Disclosed no conflict of interest.Costa, Renata G. .................................. Disclosed no conflict of interest.Costabile, Giuseppina ........................... Disclosed no conflict of interest.Costacou, Tina ....................................... Disclosed no conflict of interest.Costagliola, Lucia .................................. Disclosed no conflict of interest.Coster, Adelle ........................................ Disclosed no conflict of interest.Cote, Clemence D. ............................... Disclosed no conflict of interest.Cotter, Thomas G. ................................ Disclosed no conflict of interest.Cottet-Rousselle, Cecile ....................... Disclosed no conflict of interest.Coudriet, Gina M. ................................. Disclosed no conflict of interest.Coughlan, Kimberly ............................... Disclosed no conflict of interest.
Coulter, Kristin R. ................................. Employee: Metabolic Solutions Development Co.Courcoulas, Anita P. ............................. Disclosed no conflict of interest.Courville, Amber B. .............................. Disclosed no conflict of interest.Coutant, David ...................................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly
and Company.Covarrubias, Alejandro ......................... Disclosed no conflict of interest.Cove, Matthew E. ................................ Disclosed no conflict of interest.Covington, Jeffrey D. ........................... Disclosed no conflict of interest.Cowie, Catherine C. ............................. Disclosed no conflict of interest.Cox, Alison ............................................ Disclosed no conflict of interest.Cox, Amy L. .......................................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly
and Company.Cox, Daniel ............................................ Research Support: Lifescan, Inc.Cox, Mark A. ........................................ Employee: GlaxoSmithKline; Stock/Shareholder:
GlaxoSmithKline.Cox, Nancy J. ....................................... Disclosed no conflict of interest.Craig, Colleen M. ................................. Disclosed no conflict of interest.Craig, Maria E. ..................................... Disclosed no conflict of interest.Crain, Karen I. ...................................... Disclosed no conflict of interest.Cramb, Robert ....................................... Disclosed no conflict of interest.Crandall, Jill .......................................... Disclosed no conflict of interest.Crandell, Jamie ..................................... Disclosed no conflict of interest.Crane, Dawn ......................................... Disclosed no conflict of interest.Crane, Sarah J. .................................... Disclosed no conflict of interest.Crapo, James ........................................ Disclosed no conflict of interest.Creatore, Maria I. ................................. Disclosed no conflict of interest.Cree-Green, Melanie ............................ Disclosed no conflict of interest.Crews, Ryan .......................................... Disclosed no conflict of interest.Crick, Michael ....................................... Employee: Biodel, Inc.; Stock/Shareholder: Biodel, Inc.Criscimanna, Angela ............................. Disclosed no conflict of interest.Crisostomo, Lindiane G. ....................... Disclosed no conflict of interest.Cristofaro, Maria Rosaria ..................... Disclosed no conflict of interest.Crites, Yvonne ....................................... Disclosed no conflict of interest.Croall, Stephanie E. ............................. Disclosed no conflict of interest.Croce, Kevin .......................................... Disclosed no conflict of interest.Croft, Richard P. .................................... Disclosed no conflict of interest.Cromer, Sara.......................................... Disclosed no conflict of interest.Cronejo-Pareja, Isabel M. .................... Disclosed no conflict of interest.Crossman, Richard ................................ Disclosed no conflict of interest.Crow, Micahel T. .................................. Disclosed no conflict of interest.Crowe, Susanne .................................... Employee: Boehringer Ingelheim GmbH & Co. KG.Crowley, Stephanie J. .......................... Disclosed no conflict of interest.Crowston, Jonathan .............................. Disclosed no conflict of interest.Cruciani-Guglielmacci, Celine ............... Disclosed no conflict of interest.Cruikshank, Greg ................................... Disclosed no conflict of interest.Crume, Tessa L. .................................... Disclosed no conflict of interest.Csapo, Bence ........................................ Disclosed no conflict of interest.Csoka, Balazs ........................................ Disclosed no conflict of interest.Cuadra, Silvia ........................................ Disclosed no conflict of interest.Cubbon, Richard .................................... Disclosed no conflict of interest.Cuddihy, Robert ..................................... Employee: Sanofi; Stock/Shareholder: Sanofi.Cudnik, Michelle ................................... Disclosed no conflict of interest.Cui, Jingqiu ........................................... Disclosed no conflict of interest.Cui, Jinhui ............................................. Disclosed no conflict of interest.Cui, Jisong ............................................ Disclosed no conflict of interest.Cui, Wenjie............................................ Disclosed no conflict of interest.Cui, Xin .................................................. Research Support: NuSirt Inc.Cui, Xuewei ........................................... Consultant: Eli Lilly and Company.Cumiskey, Anne-Marie .......................... Employee: Merck.Cummings, David .................................. Disclosed no conflict of interest.Cummings, Doyle M. ........................... Disclosed no conflict of interest.Cunningham, Solveig A. ....................... Disclosed no conflict of interest.Cura, Anthony J. .................................. Disclosed no conflict of interest.Curran, Ashley ....................................... Disclosed no conflict of interest.Curran, Debra M. ................................. Disclosed no conflict of interest.Curran, Joanne E. ................................. Disclosed no conflict of interest.Cursaru, Adrian ..................................... Disclosed no conflict of interest.Curtis, Bradley H. ................................. Employee: Eli Lilly and Company, Eli Lilly and Company
(Spouse/Partner); Stock/Shareholder: Eli Lilly and Company, Eli Lilly and Company (Spouse/Partner).
Curtis, Jeffrey M. ................................. Disclosed no conflict of interest.Curtis, Lesley ......................................... Research Support: Johnson & Johnson, Medtronic, Novartis
Pharma AG.Curtis, Sarah ......................................... Employee: Eli Lilly and Company.Cushman, Samuel W. .......................... Disclosed no conflict of interest.Cusi, Kenneth ........................................ Disclosed no conflict of interest.Cusihuallpa, Idalia ................................ Disclosed no conflict of interest.Cussac-Pillegand, Camille .................... Disclosed no conflict of interest.Cvitic, Silvija ......................................... Disclosed no conflict of interest.Cyganek, Katarzyna ............................... Disclosed no conflict of interest.Cypess, Aaron M. ................................ Consultant: Pfizer, Inc.; Research Support: Chugai
Czupryniak, Leszek ................................ Disclosed no conflict of interest.Da Costa, Anabela ................................ Disclosed no conflict of interest.Da Silva, Maria Elizabeth R. ................ Disclosed no conflict of interest.Dabelea, Dana ...................................... Disclosed no conflict of interest.DaCosta, Deborah ................................. Disclosed no conflict of interest.D’Addio, Francesca ............................... Disclosed no conflict of interest.Daddona, Peter E. ................................ Employee: Zosano Pharma.Daffu, Gurdip ......................................... Disclosed no conflict of interest.D’Agati, Vivette D. ............................... Disclosed no conflict of interest.Dagdeviren, Sezin ................................. Disclosed no conflict of interest.Dagogo-Jack, Samuel ........................... Disclosed no conflict of interest.D’Agostino, Ralph B. ............................ Disclosed no conflict of interest.Dahl, Dominik ........................................ Disclosed no conflict of interest.Dahl-Jørgensen, Knut ........................... Disclosed no conflict of interest.Dai, Chunhua ......................................... Disclosed no conflict of interest.Dai, Feihan ............................................ Disclosed no conflict of interest.Dai, Houbei ........................................... Disclosed no conflict of interest.Daiber, Andreas..................................... Disclosed no conflict of interest.Daikoku, Harumi .................................... Disclosed no conflict of interest.Daimon, Makoto ................................... Disclosed no conflict of interest.Dain, Marie-Paule ................................. Employee: Sanofi.Dalal, Mehul ......................................... Employee: Sanofi; Stock/Shareholder: Sanofi.Dalbøge, Louise S. ............................... Disclosed no conflict of interest.Dale, Simeon ......................................... Disclosed no conflict of interest.Dalenbäck, Jan ..................................... Disclosed no conflict of interest.Dalenberg, Angela K. ........................... Disclosed no conflict of interest.D’Alessio, David A. .............................. Disclosed no conflict of interest.Dall, Timothy M. .................................. Consultant: Novo Nordisk, Inc.Dallabrida, Susan M. ........................... Disclosed no conflict of interest.DallaMan, Chiara .................................. Disclosed no conflict of interest.Dallaporta, Michel ................................ Disclosed no conflict of interest.Dam, Tien .............................................. Disclosed no conflict of interest.Damacharla, Divyasri ............................ Disclosed no conflict of interest.Damaraju, C.V. ...................................... Employee: Janssen Research & Development, LLC.Damato, Erika M. ................................. Disclosed no conflict of interest.Damian, Vincent .................................... Disclosed no conflict of interest.Damiano, Edward R. ............................ Other Relationship: Tandem Diabetes Care.Damiao, Elaine B. ................................. Disclosed no conflict of interest.Damm, Peter ......................................... Advisory Panel: Novo Nordisk A/S; Consultant: Novo Nordisk
A/S; Other Relationship: Novo Nordisk A/S; Speaker’s Bureau: Novo Nordisk A/S
Dan, Liu ................................................. Disclosed no conflict of interest.Dan, Naoki ............................................ Disclosed no conflict of interest.Danalache, Bogdan A. ......................... Disclosed no conflict of interest.Danchin, Nicolas ................................... Consultant: AstraZeneca Pharmaceuticals LP, Boehringer
Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, GlaxoSmithKline, Menarini, Merck, Novartis Pharmaceuticals Corporation, Novo Nordisk A/S, Pfizer, Inc., Sanofi, The Medicines Company; Research Support: AstraZeneca Pharmaceuticals LP, Eli Lilly and Company, GlaxoSmithKline, Merck, Novartis Pharmaceuticals Corporation, Pfizer, Inc., Sanofi, Servier, The Medicines Company; Speaker’s Bureau: AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, GlaxoSmithKline, Menarini, Novartis Pharmaceuticals Corporation, Novo Nordisk A/S, Pfizer, Inc., Sanofi, The Medicines Company.
Dandona, Paresh ................................... Research Support: Novo Nordisk, Inc.D’Angelo, Angela .................................. Disclosed no conflict of interest.Dangwal, Seema ................................... Disclosed no conflict of interest.Daniel, Bareket ..................................... Disclosed no conflict of interest.Daniele, Giuseppe ................................. Disclosed no conflict of interest.Daniels, Mark ........................................ Employee: Cebix, Inc.; Stock/Shareholder: Cebix, Inc.Daniels, Pamela .................................... Disclosed no conflict of interest.Danielson, Kirstie K. ............................ Disclosed no conflict of interest.Dann, Stephen G. ................................. Employee: Pfizer, Inc.Danne, Thomas ..................................... Advisory Panel: Sanofi; Consultant: Boehringer Ingelheim
Pharmaceuticals, Inc., Eli Lilly and Company, Medtronic, Novo Nordisk, Inc., Roche Pharmaceuticals, Sanofi; Speaker’s Bureau: Eli Lilly and Company, Medtronics, Novo Nordisk, Inc., Roche Pharmaceuticals, Sanofi.
Dantas, Joana R. .................................. Disclosed no conflict of interest.Danyliv, Andriy ...................................... Disclosed no conflict of interest.Daoudi, Ahmed ..................................... Disclosed no conflict of interest.Daphna-Iken, Dorit ................................ Disclosed no conflict of interest.Dardari, Dured ....................................... Disclosed no conflict of interest.Daros, Roberto ...................................... Disclosed no conflict of interest.Dart, Julie ............................................. Disclosed no conflict of interest.Das, Sadhan .......................................... Disclosed no conflict of interest.Das, Samarjit ........................................ Disclosed no conflict of interest.
Dasari, Paul S. ...................................... Disclosed no conflict of interest.Dasari, Surendra ................................... Disclosed no conflict of interest.Dasgupta, Kaberi .................................. Disclosed no conflict of interest.Dash, Satya ........................................... Disclosed no conflict of interest.Daskoulidou, Nikoleta ........................... Disclosed no conflict of interest.Dassau, Eyal .......................................... Advisory Panel: Animas Corporation; Consultant: Animas
Corporation; Research Support: Animas Corporation.Daub, Steffen ........................................ Disclosed no conflict of interest.Dauch, Jacqueline R. ........................... Disclosed no conflict of interest.Daunis-i-Estadella, Josep ..................... Disclosed no conflict of interest.Dauphin, Hélène ................................... Disclosed no conflict of interest.Dauriz, Marco ........................................ Disclosed no conflict of interest.Davey, Adam ......................................... Disclosed no conflict of interest.David, Larry L. ...................................... Disclosed no conflict of interest.Davidson, Jaime A. .............................. Advisory Panel: Aspire Bariatrics, AstraZeneca
Pharmaceuticals LP, Bristol-Myers Squibb Company, Eli Lilly and Company, GlaxoSmithKline, Janssen Biotech, Inc., Johnson & Johnson, Merck Sharp & Dohme Limited, Novo Nordisk, Inc., Valeritas, LLC; Speaker’s Bureau: Janssen Biotech, Inc., Novo Nordisk, Inc.
Davidson, Mayer B. ............................. Disclosed no conflict of interest.Davies, J. ............................................. Disclosed no conflict of interest.Davies, Melanie .................................... Advisory Panel: Eli Lilly and Company, Merck Sharp &
Dohme Limited, Novartis Pharmaceuticals Corporation, Novo Nordisk A/S, Sanofi; Consultant: Eli Lilly and Company, Merck Sharp & Dohme Limited, Novartis Pharmaceuticals Corporation, Novo Nordisk A/S, Sanofi; Research Support: Eli Lilly and Company, GlaxoSmithKline, Merck Sharp & Dohme Limited, Novartis Pharmaceuticals Corporation, Novo Nordisk A/S, Servier; Speaker’s Bureau: Eli Lilly and Company, Merck Sharp & Dohme Limited, Novartis Pharmaceuticals Corporation, Novo Nordisk A/S, Sanofi, Servier; Stock/Shareholder: Sanofi.
Davies, Michael .................................... Employee: Janssen Scientific Affairs, LLC; Stock/Shareholder: Johnson & Johnson, Merck.
Daviglus, Martha .................................. Disclosed no conflict of interest.Davis, Elizabeth A. ............................... Disclosed no conflict of interest.Davis, James ......................................... Disclosed no conflict of interest.Davis, Keith L. ...................................... Employee: RTI.Davis, Melissa ...................................... Disclosed no conflict of interest.Davis, Roger .......................................... Disclosed no conflict of interest.Davis, Ryan ........................................... Disclosed no conflict of interest.Davis, Shain .......................................... Disclosed no conflict of interest.Davis, Stephen N. ................................ Disclosed no conflict of interest.Davis, Timothy M. ................................ Advisory Panel: AstraZeneca/Bristol-Meyers Squibb, Merck
Sharp & Dohme Limited, Novo Nordisk A/S, Sanofi, Takeda Pharmaceutical Company, Ltd.; Research Support: Merck Sharp & Dohme Limited, Novartis Pharma AG, Novo Nordisk A/S, Sanofi; Speaker’s Bureau: Abbott Laboratories, Inc., AstraZeneca/Bristol-Meyers Squibb, Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Merck Sharp & Dohme Limited, Novartis Pharma AG, Novo Nordisk A/S, Takeda Pharmaceutical Company, Ltd.
Davis, Wendy A. .................................. Advisory Panel: Novo Nordisk A/S.Dayan, Colin .......................................... Disclosed no conflict of interest.Dayeh, Tasnim ....................................... Disclosed no conflict of interest.De Almeida, Jussara ............................. Disclosed no conflict of interest.De Amicis, Ramona ............................... Disclosed no conflict of interest.De Azevedo, Mirela J. ......................... Disclosed no conflict of interest.De Beaufort, Carine .............................. Disclosed no conflict of interest.De Bellis, Alessandra ............................ Disclosed no conflict of interest.De Bettignies, Carine ............................ Disclosed no conflict of interest.De Bock, Martin I. ................................ Disclosed no conflict of interest.De Boer, Ian H. ..................................... Disclosed no conflict of interest.De Boer, Michiel P. ............................... Disclosed no conflict of interest.De Boer, Stefanie A. ............................ Disclosed no conflict of interest.De Bruin, Tjerk W. ................................ Employee: AstraZeneca/Bristol-Meyers Squibb.De Carlo, Giulia ..................................... Disclosed no conflict of interest.De Cosmo, Salvatore ............................ Disclosed no conflict of interest.De Courten, Barbora ............................. Disclosed no conflict of interest.De Courten, Maximilian ........................ Disclosed no conflict of interest.De Filippis, Elena A. ............................. Disclosed no conflict of interest.De Galan, Bastiaan E. .......................... Disclosed no conflict of interest.De Graaf, Robbert ................................. Disclosed no conflict of interest.De Grauw, Wim J. ............................... Disclosed no conflict of interest.De Groot, Mary K. ................................ Speaker’s Bureau: Johnson & Johnson.De Haan, Bart J. .................................. Disclosed no conflict of interest.De Jesus Oliveira, Karen ...................... Disclosed no conflict of interest.De Jesus, Daniel ................................... Disclosed no conflict of interest.De Koning, Eelco J. .............................. Disclosed no conflict of interest.
De La Cal, Manuel A. ........................... Disclosed no conflict of interest.De la Mata, Manuel.............................. Disclosed no conflict of interest.De la Peña, Amparo .............................. Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly
and Company.De la Torre, Alejandro J. ...................... Disclosed no conflict of interest.De Leon, Diva D. .................................. Disclosed no conflict of interest.De Loredo, Luis ..................................... Consultant: Novo Nordisk A/S.De los Campos, Gustavo ....................... Disclosed no conflict of interest.De Luca, Maria ...................................... Disclosed no conflict of interest.De Luis, Daniel ...................................... Disclosed no conflict of interest.De Lurgio, Steve .................................... Disclosed no conflict of interest.De Marinis, Yang .................................. Disclosed no conflict of interest.De Moura, Eduardo G. ......................... Disclosed no conflict of interest.De Moura, Rodrigo F. ........................... Disclosed no conflict of interest.De Pablos-Velasco, Pedro ..................... Advisory Panel: AstraZeneca Pharmaceuticals LP, Boehringer
Ingelheim Pharmaceuticals, Inc., Medtronic, Sanofi; Speaker’s Bureau: Bristol-Myers Squibb Company, Eli Lilly and Company, Novartis Pharma AG, Sanofi.
De Paula, Tatiana P. ............................. Disclosed no conflict of interest.De Souza, Errol ...................................... Board Member: Biodel, Inc.; Employee: Biodel, Inc.; Stock/
Shareholder: Biodel, Inc.De Tata, Vincenzo.................................. Disclosed no conflict of interest.De Vore, Joanna D. .............................. Disclosed no conflict of interest.De Vos, Paul .......................................... Disclosed no conflict of interest.De Weijer, Barbara A. .......................... Disclosed no conflict of interest.De Wit, Helena ..................................... Disclosed no conflict of interest.Deacon, Carolyn F. ............................... Disclosed no conflict of interest.DeAlmeida, Dilhari ................................ Disclosed no conflict of interest.Dean, Heather J. .................................. Disclosed no conflict of interest.Debacker, Guy ....................................... Disclosed no conflict of interest.Debong, Fredrik ..................................... Stock/Shareholder: mySugr GmbH.Dedio, Jürgen ........................................ Employee: Sanofi; Stock/Shareholder: Sanofi.Dedousis, Nikolaos ............................... Disclosed no conflict of interest.Dedoussis, George ................................ Disclosed no conflict of interest.Deeg, Mark ........................................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly
and Company.Deepa, Mohan ...................................... Disclosed no conflict of interest.Deepak, Doddabele S. ......................... Disclosed no conflict of interest.Defeudis, Giuseppe ............................... Disclosed no conflict of interest.DeFronzo, Ralph A. ............................... Advisory Panel: Amylin Pharmaceuticals, Inc., Boehringer
Degertekin, Ceyla K. ............................ Disclosed no conflict of interest.DeGoffau, Marcus ................................. Disclosed no conflict of interest.Deharvengt, Cecile ................................ Disclosed no conflict of interest.DeHennis, Andrew ................................ Employee: Senseonics Incorporated.Dei Tos, Angelo Paolo ........................... Disclosed no conflict of interest.Deiriggi, Pamela .................................... Disclosed no conflict of interest.Deja, Grazyna ........................................ Disclosed no conflict of interest.Dejager, Sylvie ...................................... Employee: Novartis Pharma SAS.Dejong, Cornelis H. .............................. Disclosed no conflict of interest.Dekker, Jacqueline M. ......................... Research Support: Novo Nordisk A/S.Del Favero, Simone ............................... Disclosed no conflict of interest.Del Guerra, Silvia .................................. Disclosed no conflict of interest.Del Prato, Stefano ................................. Advisory Panel: Boehringer Ingelheim GmbH & Co. KG, Eli
Lilly and Company, Novo Nordisk, Inc., sanofi-aventis; Consultant: Takeda Global Research & Development Center, Inc.; Research Support: Boehringer Ingelheim GmbH & Co. KG, Eli Lilly and Company, Novo Nordisk, Inc., sanofi-aventis; Speaker’s Bureau: Boehringer Ingelheim GmbH & Co. KG, Eli Lilly and Company, Novo Nordisk, Inc., sanofi-aventis.
Del Re, Luigi .......................................... Consultant: Roche Diagnostics.Del Rincon, Juan Pablo ......................... Disclosed no conflict of interest.Del Valle, Laura ..................................... Disclosed no conflict of interest.Del Zotto, Héctor ................................... Disclosed no conflict of interest.Delahanty, Linda M. ............................. Advisory Panel: Eli Lilly and Company, Janssen Biotech, Inc.,
Nutrisystem, Inc., Omada Health; Consultant: Pfizer, Inc., UpToDate, Inc.
Delalleau, Nathalie ............................... Disclosed no conflict of interest.Delaney, Lauren .................................... Disclosed no conflict of interest.Delattre, Bénédicte ............................... Disclosed no conflict of interest.Delbin, Maria Andréa ........................... Disclosed no conflict of interest.Delfino von Frankenberg, Anize ............ Disclosed no conflict of interest.Delfolie, Astrid ...................................... Employee: Sanofi.Delgado, Elías ....................................... Disclosed no conflict of interest.
Delgado, Esther ..................................... Disclosed no conflict of interest.Delgado, Irene ....................................... Disclosed no conflict of interest.Delgado, Manuel .................................. Disclosed no conflict of interest.Delghingaro-Augusto, Viviane .............. Disclosed no conflict of interest.Deliard, Sandra ..................................... Disclosed no conflict of interest.Della Gatta, Paul A. ............................. Disclosed no conflict of interest.Della Morte, David ................................ Disclosed no conflict of interest.Della Pepa, Giuseppe ............................ Disclosed no conflict of interest.Dell’Agnello, Umberto .......................... Disclosed no conflict of interest.Dellweg, Sibylle .................................... Disclosed no conflict of interest.Delmastro-Greenwood, Meghan M. ... Disclosed no conflict of interest.DelProposto, Jennifer L. ...................... Disclosed no conflict of interest.DeMarco, Vincent ................................. Research Support: Boehringer Ingelheim Pharmaceuticals, Inc.Demarest, Keith .................................... Employee: Janssen Research & Development.Demirbas, Seref .................................... Disclosed no conflict of interest.Demircik, Filiz ........................................ Disclosed no conflict of interest.Demmer, Ryan T. .................................. Disclosed no conflict of interest.Demozay, Damien ................................. Disclosed no conflict of interest.Denburg, Michelle R. ........................... Disclosed no conflict of interest.Denechaud, Pierre-Damien ................... Disclosed no conflict of interest.Deng, Hao ............................................. Disclosed no conflict of interest.Deng, Hongrong .................................... Disclosed no conflict of interest.Deng, Lan .............................................. Disclosed no conflict of interest.Deng, Tuo .............................................. Disclosed no conflict of interest.Deng, Wanping ..................................... Disclosed no conflict of interest.Deng, Wei ............................................. Disclosed no conflict of interest.Deng, Yingfeng...................................... Disclosed no conflict of interest.Deng, Zhuo ............................................ Disclosed no conflict of interest.Dennedy, Michael C. ............................ Disclosed no conflict of interest.Dennick, Kathryn ................................... Disclosed no conflict of interest.Dennis, Mary Alice ............................... Disclosed no conflict of interest.Dennis, Michael D. .............................. Disclosed no conflict of interest.Denyer, Gareth ...................................... Disclosed no conflict of interest.DePinho, Ronald A. .............................. Disclosed no conflict of interest.Der, Ken ................................................. Disclosed no conflict of interest.Derave, Wim ......................................... Disclosed no conflict of interest.Derosa, Giuseppe .................................. Disclosed no conflict of interest.Desai, Akshata ...................................... Disclosed no conflict of interest.Desai, Akshay S. .................................. Consultant: Novartis Pharma AG.Desai, Ankit A. ..................................... Disclosed no conflict of interest.Desai, Jay R. ........................................ Disclosed no conflict of interest.DeSalvo, Daniel J. ............................... Disclosed no conflict of interest.Deshmukh, Harshal A. ......................... Disclosed no conflict of interest.Desousa, Marcia ................................... Disclosed no conflict of interest.Desouza, Cyrus V. ................................. Consultant: Novo Nordisk, Inc., Takeda Pharmaceuticals
U.S.A., Inc.; Research Support: Asahi Kasei.Desoye, Gernot ..................................... Disclosed no conflict of interest.Despa, Florin ......................................... Disclosed no conflict of interest.Despa, Sanda ........................................ Disclosed no conflict of interest.Desposito, Dorinne ............................... Disclosed no conflict of interest.D’Este, Catherine .................................. Disclosed no conflict of interest.Detaille, Dominique .............................. Disclosed no conflict of interest.Detournay, Bruno .................................. Board Member: Novartis Pharma SAS; Consultant: Novartis
Pharma SAS.Deutsch, Gail H. ................................... Disclosed no conflict of interest.Devaraj, Sridevi ..................................... Disclosed no conflict of interest.Devarajan, Raji ...................................... Disclosed no conflict of interest.Devlin, Heather ..................................... Disclosed no conflict of interest.DeVore, Denise ..................................... Disclosed no conflict of interest.DeVries, J. Hans ................................... Advisory Panel: Becton, Dickinson and Company, Johnson &
Johnson, Novo Nordisk A/S, Roche Diagnostic; Consultant: Sanofi; Research Support: Dexcom, Inc., Echo Therapeutics, Inc., GluMetrics, Inc., Medtronic, Novartis Pharmaceuticals Corporation, Novo Nordisk, Inc., Sanofi, Senseonics; Speaker’s Bureau: Dexcom, Inc., Eli Lilly and Company, Novo Nordisk, Inc., Roche Pharmaceuticals, Sanofi.
Dewey, Kathryn ..................................... Disclosed no conflict of interest.DeWitt, Peter ........................................ Disclosed no conflict of interest.Dex, Terry .............................................. Employee: Sanofi; Stock/Shareholder: Merck, Monsanto,
Pfizer, Inc., Sanofi, Teva Pharmaceuticals.Dhere, Archana ..................................... Disclosed no conflict of interest.Dhindsa, Sandeep ................................. Disclosed no conflict of interest.Dhurvas, Parvati .................................... Disclosed no conflict of interest.Di Bartolo, Paolo ................................... Disclosed no conflict of interest.Di Bartolo, Vittora ................................. Disclosed no conflict of interest.Di Candia, Stefania ............................... Disclosed no conflict of interest.Di Giacinto, Paola ................................. Disclosed no conflict of interest.Di Mauro, Lazzaro ................................. Disclosed no conflict of interest.Di Noto, Anna ....................................... Disclosed no conflict of interest.Di Palma, Federico ................................ Disclosed no conflict of interest.Di Paola, Rosa ....................................... Disclosed no conflict of interest.
Di Pietro, Natalia .................................. Disclosed no conflict of interest.Di Rosa, Claudia .................................... Disclosed no conflict of interest.Di Silvestre, Sara .................................. Disclosed no conflict of interest.Di Tomo, Pamela ................................... Disclosed no conflict of interest.Di Trani, Antonio ................................... Disclosed no conflict of interest.Diakoumopoulou, Evanthia ................... Disclosed no conflict of interest.Diamant, Michaela ............................... Consultant: Abbott Laboratories, Inc., AstraZeneca
Pharmaceuticals LP, Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, GI Dynamics, Merck Sharp & Dohme Limited, Novo Nordisk, Inc., Poxel Pharmaceutical Company, Sanofi; Research Support: Abbott Laboratories, Inc., Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb/AstraZeneca, Eli Lilly and Company, Medtronic, Merck Sharp & Dohme Limited, Novo Nordisk, Inc., Sanofi; Speaker’s Bureau: Bristol-Myers Squibb/AstraZeneca, Eli Lilly and Company, Novo Nordisk, Inc., Sanofi.
Diamantis, Theodoros ........................... Disclosed no conflict of interest.Diamond, Anne ..................................... Disclosed no conflict of interest.Diamond, Lucy ....................................... Disclosed no conflict of interest.Dias, James K. ..................................... Disclosed no conflict of interest.Diaz, Ana ............................................... Disclosed no conflict of interest.Diaz, Sylvia ............................................ Disclosed no conflict of interest.Dib, Sergio A. ....................................... Disclosed no conflict of interest.Dickens, Jazzmyne T. ........................... Disclosed no conflict of interest.Dicker, Dror............................................ Advisory Panel: AstraZeneca Pharmaceuticals LP, Boehringer
Didangelos, Triantafyllos ...................... Disclosed no conflict of interest.Diebold, Sebastian ................................ Disclosed no conflict of interest.Diedisheim, Marc .................................. Disclosed no conflict of interest.Dieguez, Marta ..................................... Disclosed no conflict of interest.Dietert, Gabriele ................................... Employee: Sanofi.Dietrich, Maren G. ............................... Disclosed no conflict of interest.Dieuzeide, Guillermo ............................. Advisory Panel: Bristol-Myers Squibb/AstraZeneca,
GlaxoSmithKline, Novo Nordisk A/S; Research Support: Bristol-Myers Squibb/AstraZeneca, Merck Sharp & Dohme Limited, Novo Nordisk A/S; Speaker’s Bureau: Bristol-Myers Squibb/AstraZeneca, GlaxoSmithKline, Montpellier, Novo Nordisk A/S.
Difazio, Diane ........................................ Disclosed no conflict of interest.DiGenio, Andres .................................... Employee: Sanofi; Stock/Shareholder: Sanofi.DiIeno, Amanda .................................... Disclosed no conflict of interest.Diker Cohen, Talia ................................. Disclosed no conflict of interest.Dilorio, Philip J. .................................... Disclosed no conflict of interest.Dimachkie, Mazen ................................ Speaker’s Bureau: Pfizer, Inc.DiMarchi, Richard ................................. Consultant: Roche Pharmaceuticals.DiMeglio, Linda A. ............................... Disclosed no conflict of interest.DiNapoli, Gina ....................................... Disclosed no conflict of interest.Dinatale, Emily ...................................... Disclosed no conflict of interest.Ding, Jingzhong .................................... Disclosed no conflict of interest.Ding, Kai ................................................ Disclosed no conflict of interest.Ding, Ying .............................................. Disclosed no conflict of interest.Ding, Yuyan ........................................... Disclosed no conflict of interest.Ding, Zhenyu ......................................... Disclosed no conflict of interest.Dinh, Tuan ............................................. Consultant: Novartis Pharma AG.Dinneen, Sean ....................................... Disclosed no conflict of interest.Dinu, Valentin ........................................ Disclosed no conflict of interest.Dinyari, Parastoo ................................... Disclosed no conflict of interest.Dione, Donald P. ................................... Disclosed no conflict of interest.Dippel, Franz-Werner ............................ Disclosed no conflict of interest.Dirksen, Carsten .................................... Disclosed no conflict of interest.Disbot, Maureen ................................... Disclosed no conflict of interest.Dissel, Stefan ........................................ Disclosed no conflict of interest.DiStefano, Johanna .............................. Disclosed no conflict of interest.Distelmaier, Klaus ................................. Disclosed no conflict of interest.Divers, Jasmin ...................................... Disclosed no conflict of interest.DiVincenzo, Richard .............................. Disclosed no conflict of interest.Divoux, Adeline ..................................... Disclosed no conflict of interest.Djaballah, Khier .................................... Employee: Sanofi.Dmitrieva, Renata M. .......................... Disclosed no conflict of interest.Do Nascimento, Filipe ........................... Disclosed no conflict of interest.Dobbins, Robert L. ................................ Disclosed no conflict of interest.Dobbs, Stuart ........................................ Disclosed no conflict of interest.Dobias, Milos ........................................ Disclosed no conflict of interest.
Docherty, Hilary M. .............................. Disclosed no conflict of interest.Docherty, Kevin ..................................... Disclosed no conflict of interest.Döcke, Stephanie .................................. Disclosed no conflict of interest.Dodd, Teresa ......................................... Disclosed no conflict of interest.Dogbey, Godwin .................................... Disclosed no conflict of interest.Dohm, G.L. ............................................ Disclosed no conflict of interest.Doi, Ayano ............................................. Disclosed no conflict of interest.Doktor, Mille.......................................... Employee: Steno Diabetes Center A/S.Dokuko, Kou .......................................... Disclosed no conflict of interest.Dolai, Subhankar ................................... Disclosed no conflict of interest.Dolan, Lawrence M. ............................ Disclosed no conflict of interest.Dolci, Wanda......................................... Disclosed no conflict of interest.Doliba, Nicolai M. ................................ Disclosed no conflict of interest.Doll, Werner .......................................... Disclosed no conflict of interest.Dolzan, Vita ........................................... Disclosed no conflict of interest.Domenger, Catherine ............................ Employee: Sanofi.Domingues, Andreia ............................. Disclosed no conflict of interest.Dominguez, James ................................ Disclosed no conflict of interest.Dominguez-Bendala, Juan .................... Disclosed no conflict of interest.Donadel, Giulia ..................................... Disclosed no conflict of interest.Donaghue, Kim C. ................................ Disclosed no conflict of interest.Donahue, Katrina .................................. Disclosed no conflict of interest.Donahue, Marina .................................. Disclosed no conflict of interest.Donahue, Patrick ................................... Disclosed no conflict of interest.Donaldson, Cynthia J. .......................... Disclosed no conflict of interest.Donaldson, Jill ...................................... Employee: GlaxoSmithKline; Stock/Shareholder:
GlaxoSmithKline.Donato Jr., José .................................... Disclosed no conflict of interest.Donato, Anthony ................................... Disclosed no conflict of interest.Dong, Feng ............................................ Disclosed no conflict of interest.Dong, Fran ............................................. Disclosed no conflict of interest.Dong, Henry .......................................... Disclosed no conflict of interest.Dong, Jennifer ...................................... Employee: Pfizer, Inc.; Stock/Shareholder: Pfizer, Inc.Dong, Kun .............................................. Disclosed no conflict of interest.Dong, XinYuan ....................................... Disclosed no conflict of interest.Dong, Yanjun ......................................... Disclosed no conflict of interest.Dong, Yanlan ......................................... Disclosed no conflict of interest.Donicova, Viera ..................................... Disclosed no conflict of interest.Donihi, Amy C. ..................................... Disclosed no conflict of interest.Donovan, Lois ........................................ Disclosed no conflict of interest.Donsa, Klaus ......................................... Disclosed no conflict of interest.Dooley, Steven ...................................... Disclosed no conflict of interest.Doree, Deon .......................................... Employee: Lexicon Pharmaceuticals, Inc.Dorey, David .......................................... Disclosed no conflict of interest.Dorfman, Mauricio D. .......................... Disclosed no conflict of interest.Doria, Alessandro ................................. Research Support: Sanofi.D’Oria, Rossella .................................... Disclosed no conflict of interest.Dorrestein, Pieter C. ............................ Disclosed no conflict of interest.Dos Santos, Andressa C. ..................... Disclosed no conflict of interest.Dosch, H. Michael ................................. Disclosed no conflict of interest.Dost, Axel .............................................. Disclosed no conflict of interest.Doty, Tasha D. ...................................... Disclosed no conflict of interest.Dou, Jianxin .......................................... Disclosed no conflict of interest.Doucet, Jean ......................................... Research Support: Merck, Novo Nordisk A/S; Speaker’s
Bureau: BD Medical Diabetes Care, Novo Nordisk A/S, Sanofi.
Dougher, Carly E. .................................. Disclosed no conflict of interest.Douma, Stella ....................................... Disclosed no conflict of interest.Doumas, Michael .................................. Disclosed no conflict of interest.Doupis, John ......................................... Disclosed no conflict of interest.Dourliou, Vasiliki ................................... Disclosed no conflict of interest.Dowd, Rory P. ....................................... Disclosed no conflict of interest.Doyle, Francis J. ................................... Advisory Panel: Animas Corporation; Research Support:
Animas Corporation.Doyle, Máire E. .................................... Disclosed no conflict of interest.Draghici, Sorin ...................................... Disclosed no conflict of interest.Dragomirescu, Liviu .............................. Disclosed no conflict of interest.Dragut, Ramona Maria ......................... Disclosed no conflict of interest.Drapalova, Jana .................................... Disclosed no conflict of interest.Drescher, Andrea................................... Disclosed no conflict of interest.Drexel, Heinz ......................................... Disclosed no conflict of interest.Drexler, Andrew .................................... Disclosed no conflict of interest.Driscoll, Henry ....................................... Disclosed no conflict of interest.Driver, John P. ...................................... Disclosed no conflict of interest.Drobni, Zsofia ........................................ Disclosed no conflict of interest.Dronova, Alexandra V. ......................... Disclosed no conflict of interest.Drossos, Tina ......................................... Disclosed no conflict of interest.Drozdowski, Wieslaw ........................... Disclosed no conflict of interest.Drozdz, Izabela ...................................... Disclosed no conflict of interest.Drury, Peta ............................................. Disclosed no conflict of interest.D’Silva, Linda J. ................................... Disclosed no conflict of interest.Du, Fuyong ............................................ Employee: Janssen Research & Development.
Du, Shichun ........................................... Disclosed no conflict of interest.Du, Xueping ........................................... Disclosed no conflict of interest.Dualib, Patricia ...................................... Disclosed no conflict of interest.Duan, Wei ............................................. Disclosed no conflict of interest.Duan, Wenlan ....................................... Disclosed no conflict of interest.Duarte, Joao ......................................... Disclosed no conflict of interest.Dubé, John ............................................ Disclosed no conflict of interest.Dubé, Kate ............................................ Disclosed no conflict of interest.Dube, Simmi .......................................... Disclosed no conflict of interest.Dubis, Gabriel S. .................................. Disclosed no conflict of interest.DuBose, Stephanie N. .......................... Disclosed no conflict of interest.Duc, Ha T. ............................................. Disclosed no conflict of interest.Duca, Frank A. ...................................... Disclosed no conflict of interest.Duca, Lindsey M. ................................. Disclosed no conflict of interest.Ducar, Dallas ......................................... Disclosed no conflict of interest.Ducreux, Sylvie ..................................... Disclosed no conflict of interest.Dudl, R.J. .............................................. Disclosed no conflict of interest.Duell, Anna ........................................... Disclosed no conflict of interest.Duggirala, Ravindranath ....................... Disclosed no conflict of interest.Dugo, Laura ........................................... Disclosed no conflict of interest.Duhamel, Todd ...................................... Disclosed no conflict of interest.Duke, Danny C. ..................................... Disclosed no conflict of interest.Dulak, Jozef .......................................... Disclosed no conflict of interest.Dumas, Marc E. ................................... Disclosed no conflict of interest.Dumser, Susan ...................................... Disclosed no conflict of interest.Dungan, Kathleen M. ........................... Advisory Panel: Eli Lilly and Company, Sanofi; Research
Support: Merck, Novo Nordisk, Inc.Dunger, David B. .................................. Disclosed no conflict of interest.Dunham, Ashley A. .............................. Disclosed no conflict of interest.Dunn, George ........................................ Disclosed no conflict of interest.Dunn, Jennifer ...................................... Disclosed no conflict of interest.Dunn, Joel ............................................. Disclosed no conflict of interest.Dunn, Rodney L. ................................... Disclosed no conflict of interest.Dunn, Ty................................................. Disclosed no conflict of interest.Dunne, Fidelma ..................................... Disclosed no conflict of interest.Dunseath, Gareth J. ............................. Disclosed no conflict of interest.Dupont, Olivia-Nezryn ........................... Disclosed no conflict of interest.Dupont, Philippe .................................... Disclosed no conflict of interest.Dupont-Versteegden, Esther E. ............ Disclosed no conflict of interest.Dupuis, Josée ....................................... Disclosed no conflict of interest.Dupuy, Olivier ........................................ Disclosed no conflict of interest.Durán Martínez, María ......................... Disclosed no conflict of interest.Duran, Ajejandra ................................... Disclosed no conflict of interest.Duran, Bonnie ....................................... Disclosed no conflict of interest.Duran, Elvira .......................................... Disclosed no conflict of interest.Durán-Garcia, Santiago ........................ Consultant: Boehringer Ingelheim GmbH & Co. KG.Durant, Nefertiti H. .............................. Disclosed no conflict of interest.Duranti, Emiliano .................................. Disclosed no conflict of interest.Duran-Valdez, Elizabeth ........................ Disclosed no conflict of interest.Durden, Emily ........................................ Consultant: DJO Global.Durgin, Jonathan M. ............................ Disclosed no conflict of interest.Durkan, Maeve C. ................................ Advisory Panel: Boehringer Ingelheim GmbH & Co. KG, Eli
Lilly and Company, Janssen Pharmaceuticals, Merck Sharp & Dohme Limited, Novartis Pharmaceuticals Corporation, Novo Nordisk, Inc., Sanofi; Speaker’s Bureau: AstraZeneca/Bristol-Meyers Squibb, Boehringer Ingelheim GmbH & Co. KG, Eli Lilly and Company, Menarini, Merck Sharp & Dohme Limited, Novartis Pharmaceuticals Corporation, Novo Nordisk, Inc., Sanofi.
Durrington, Paul N. .............................. Research Support: Pfizer, Inc.Durrwell, Laurence ................................ Employee: F. Hoffmann-La Roche, Ltd.Duru, O.K. ............................................. Disclosed no conflict of interest.Dutta, Tumpa ......................................... Disclosed no conflict of interest.Dutton, Heidi ......................................... Disclosed no conflict of interest.Duun-Henriksen, Jonas ......................... Employee: HypoSafe A/S.Duva, Ingrid M. .................................... Disclosed no conflict of interest.Duvnjak, Lea .......................................... Disclosed no conflict of interest.Dvorak, Justin D. ................................. Disclosed no conflict of interest.Dwyer, Peter M. ................................... Disclosed no conflict of interest.Dye, Amanda ......................................... Disclosed no conflict of interest.Dyer, Alan R. ........................................ Disclosed no conflict of interest.Dyer, Wendy T. ..................................... Disclosed no conflict of interest.Eaglehouse, Yvonne L. ......................... Disclosed no conflict of interest.Earley, Brian .......................................... Disclosed no conflict of interest.Easa, David ........................................... Disclosed no conflict of interest.Easter, Sarah Rae .................................. Disclosed no conflict of interest.Eaton, Charles B. .................................. Disclosed no conflict of interest.Ebenibo, Sotonte ................................... Disclosed no conflict of interest.Ebenstein, David B. .............................. Disclosed no conflict of interest.Eberly, Lynn E. ...................................... Disclosed no conflict of interest.Ebert, Thomas ....................................... Research Support: Merck Sharp & Dohme Limited.Ebihara, Emi .......................................... Disclosed no conflict of interest.
Ebihara, Ken .......................................... Disclosed no conflict of interest.Ebner, Karl M. ...................................... Disclosed no conflict of interest.Eckardt, Kristin ...................................... Disclosed no conflict of interest.Eckel, Jürgen ......................................... Disclosed no conflict of interest.Eckel, Robert H. .................................... Disclosed no conflict of interest.Ecker, Jeffrey......................................... Disclosed no conflict of interest.Eckfeldt, John H. .................................. Disclosed no conflict of interest.Eckhart, Andrea ..................................... Employee: Metabolon, Inc.; Stock/Shareholder: Metabolon,
Inc.Eddington, David ................................... Disclosed no conflict of interest.Eddy, Elena ............................................ Disclosed no conflict of interest.Edelman, Steven V. .............................. Advisory Panel: Abbott Diabetes Care, Insulet Corporation,
Edelstein, Sharon L. ............................. Disclosed no conflict of interest.Eden Engstrom, Britt ............................. Disclosed no conflict of interest.Edeoga, Chimaroke ............................... Disclosed no conflict of interest.Eder, Martina......................................... Disclosed no conflict of interest.Eder, Véronique ..................................... Disclosed no conflict of interest.Edgerton, Dale S. ................................. Disclosed no conflict of interest.Edmunds, Nicholas J. .......................... Employee: Pfizer, Inc.Edwards, Alun L. .................................. Disclosed no conflict of interest.Edwin, Bjorn .......................................... Disclosed no conflict of interest.Eeg-Olofsson, Katarina ......................... Disclosed no conflict of interest.Effoe, Valery S. .................................... Disclosed no conflict of interest.Efron, Nathan ........................................ Disclosed no conflict of interest.Egan, Aoife M. ..................................... Disclosed no conflict of interest.Egan, Josephine M. ............................. Disclosed no conflict of interest.Egede, Leonard E. ................................ Other Relationship: Novo Nordisk, Inc.Eggels, Leslie ........................................ Disclosed no conflict of interest.Egnatchik, Robert A. ............................ Disclosed no conflict of interest.Eguchi, Jun ............................................ Disclosed no conflict of interest.Eguchi, Yuichirou ................................... Disclosed no conflict of interest.Ehrhart-Bornstein, Monika .................... Disclosed no conflict of interest.Ehrlich, Jason S. .................................. Employee: Genentech.Ehrlich, Samantha F. ............................ Disclosed no conflict of interest.Ehrmann, David A. ............................... Disclosed no conflict of interest.Ehrmann, Dominic ................................. Speaker’s Bureau: Berlin Chemie AG, Sanofi.Eid, George M. ..................................... Disclosed no conflict of interest.Einhorn, Shannon .................................. Disclosed no conflict of interest.Eisele, Lewin ......................................... Disclosed no conflict of interest.Ejskjaer, Niels........................................ Disclosed no conflict of interest.Ekholm, Ola ........................................... Disclosed no conflict of interest.Ekinci, Elif I. .......................................... Disclosed no conflict of interest.Ekman, Maja J. .................................... Disclosed no conflict of interest.Eksi, Yunus E. ....................................... Disclosed no conflict of interest.Ekstrom, Heidi ....................................... Disclosed no conflict of interest.El Ghormli, Laure ................................... Disclosed no conflict of interest.El Hage, Maha ...................................... Employee: Metabolys Inc.El Ouaamari, Abdelfattah ..................... Disclosed no conflict of interest.El Youssef, Joseph ................................ Disclosed no conflict of interest.Elam, April ............................................. Disclosed no conflict of interest.Elavsky, Megan ..................................... Disclosed no conflict of interest.Elbers, Danne C. ................................... Disclosed no conflict of interest.Eleftheriadou, Ioanna ............................ Disclosed no conflict of interest.Elfekih, Zouhour .................................... Disclosed no conflict of interest.Elian, Viviana I. .................................... Disclosed no conflict of interest.Elias Fernandez, Amparo ...................... Disclosed no conflict of interest.Eliaschewitz, Freddy ............................. Advisory Panel: AstraZeneca/Bristol-Meyers Squibb, Merck
Sharp & Dohme Limited, Sanofi; Board Member: Bristol-Myers Squibb Company, Novo Nordisk, Inc.; Consultant: Novo Nordisk, Inc.; Research Support: Sanofi; Speaker’s Bureau: AstraZeneca/Bristol-Meyers Squibb, Eli Lilly and Company, Novo Nordisk, Inc., Sanofi.
Eliashar Iron, Hila .................................. Disclosed no conflict of interest.Eliasson, Björn ...................................... Disclosed no conflict of interest.Eliasson, Lena ....................................... Disclosed no conflict of interest.El-Khairi, Ranna .................................... Disclosed no conflict of interest.El-Khatib, Firas H. ................................ Disclosed no conflict of interest.Elks, Carrie M. ...................................... Disclosed no conflict of interest.Ellard, Sian ............................................ Disclosed no conflict of interest.Ellenbroek, Johanne H. ........................ Disclosed no conflict of interest.Elleri, Daniela ........................................ Disclosed no conflict of interest.Ellervik, Christina .................................. Disclosed no conflict of interest.Elliman, Stephen J. .............................. Disclosed no conflict of interest.Elliott, Jackie ........................................ Speaker’s Bureau: Eli Lilly and Company, Merck Sharp &
Dohme Limited.Elliott, Mary .......................................... Employee: Amgen Limited.Ellis, Bernice B. .................................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly
and Company.Ellis, Deborah A. .................................. Disclosed no conflict of interest.
Ellis, Jeffrey J. ..................................... Employee: Humana.Ellis, Justine .......................................... Disclosed no conflict of interest.Ellis, Samuel L. ..................................... Disclosed no conflict of interest.Ellmerer, Martin .................................... Employee: B. Braun Melsungen AG.Elmquist, Joel K. .................................. Disclosed no conflict of interest.Elomaa, Viki-Veikko ............................... Disclosed no conflict of interest.El-Remessy, Azza B. ............................. Disclosed no conflict of interest.Elshaer, Sally L. .................................... Disclosed no conflict of interest.El-Shahawy, Mohamed A. ................... Advisory Panel: ZS Pharma, Inc.Elverson, Robert .................................... Employee: Metabolon, Inc.; Stock/Shareholder: Metabolon,
Inc.Emanuele, Nicholas .............................. Speaker’s Bureau: Merck.Emmert, Alison R. ................................ Disclosed no conflict of interest.Emoto, Masanori ................................... Disclosed no conflict of interest.Enache, Georgiana ................................ Disclosed no conflict of interest.Endo, Ginji ............................................. Disclosed no conflict of interest.Endo, Itsuro ........................................... Disclosed no conflict of interest.Endresen, Knut ...................................... Disclosed no conflict of interest.Engel, Lee .............................................. Disclosed no conflict of interest.Engel, Samuel S. .................................. Employee: Merck.Engelgau, Michael ................................ Disclosed no conflict of interest.Engelhard Nielsen, Kirsten ................... Disclosed no conflict of interest.Engelse, Marten A. .............................. Disclosed no conflict of interest.Engle, Sarah .......................................... Disclosed no conflict of interest.Eny, Karen M. ....................................... Disclosed no conflict of interest.Epstein, Noam ....................................... Disclosed no conflict of interest.Epstein, Paul ......................................... Disclosed no conflict of interest.Erdelyi, Katalin ...................................... Disclosed no conflict of interest.Erdos, Michael R. ................................. Disclosed no conflict of interest.Erichsen, Lars ........................................ Employee: Novo Nordisk A/S.Eriksson, Jan W. .................................. Employee: AstraZeneca Pharmaceuticals LP.Eriksson, Karl-Fredrik ............................ Disclosed no conflict of interest.Eringa, Etto C. ...................................... Disclosed no conflict of interest.Erion, Derek M. .................................... Employee: Pfizer, Inc.Ermel, Richard ....................................... Disclosed no conflict of interest.Ernst, Barbara ....................................... Disclosed no conflict of interest.Ernst, Stefanie ...................................... Disclosed no conflict of interest.Erqou, Sebhat ........................................ Disclosed no conflict of interest.Errazuriz, Isabel ..................................... Disclosed no conflict of interest.Escalona, Alex ....................................... Advisory Panel: GI Dynamics; Consultant: GI Dynamics;
Research Support: GI Dynamics.Eshel, Noa ............................................. Disclosed no conflict of interest.Eskelinen, Joonas J. ............................ Disclosed no conflict of interest.Esler, William P. ................................... Employee: Pfizer, Inc.Esni, Farzad ........................................... Disclosed no conflict of interest.Espeland, Mark ..................................... Disclosed no conflict of interest.Esposito, Fabrizio .................................. Disclosed no conflict of interest.Esser, Myrko .......................................... Disclosed no conflict of interest.Estevez, Emma ...................................... Disclosed no conflict of interest.Etoh, Rica .............................................. Disclosed no conflict of interest.Ettner, Susan L. .................................... Disclosed no conflict of interest.Eurich, Dean T. ..................................... Disclosed no conflict of interest.Evans, Gregory W. ............................... Disclosed no conflict of interest.Evans, Malcolm ..................................... Disclosed no conflict of interest.Evans, Marc .......................................... Advisory Panel: Merck Sharp & Dohme Limited, Novartis
Evans, Mark L. ...................................... Advisory Panel: Cellnovo, Medtronic, Roche, Sanofi; Speaker’s Bureau: Abbott Diabetes Care, Animas Corporation, Eli Lilly and Company.
Evans, Philip .......................................... Disclosed no conflict of interest.Evans, Stephanie .................................. Disclosed no conflict of interest.Evans-Behnke, Danita ........................... Disclosed no conflict of interest.Evans-Molina, Carmella ........................ Disclosed no conflict of interest.Everaert, Inge ........................................ Disclosed no conflict of interest.Ewing, Susan ........................................ Disclosed no conflict of interest.Ewins, David ......................................... Disclosed no conflict of interest.Eyre, Nia ................................................ Disclosed no conflict of interest.Ezeanolue, Echezona ............................. Disclosed no conflict of interest.Ezrokhi, Michael .................................... Employee: VeroScience.Faas, Marijke M. .................................. Disclosed no conflict of interest.Faber, Jens ............................................ Disclosed no conflict of interest.Faber, Thomas ....................................... Disclosed no conflict of interest.Fadavi, Hassan ...................................... Disclosed no conflict of interest.Fadia, Shruti .......................................... Disclosed no conflict of interest.Fadista, Joao ......................................... Disclosed no conflict of interest.Færch, Kristine ...................................... Board Member: Steno Diabetes Center A/S; Employee: Steno
Diabetes Center A/S; Stock/Shareholder: Novo Nordisk A/S.
Færch, Louise H. .................................. Employee: Novo Nordisk A/S.Fagan, Nora ........................................... Employee: Boehringer Ingelheim Pharmaceuticals, Inc.Fagerholm, Emma ................................. Disclosed no conflict of interest.Fagher, Katarina .................................... Speaker’s Bureau: Novo Nordisk A/S.Faglia, Ezio ............................................ Disclosed no conflict of interest.Fagour, Cedric........................................ Disclosed no conflict of interest.Fahlbusch, Pia ....................................... Disclosed no conflict of interest.Fahrleitner-Pammer, Astrid ................... Disclosed no conflict of interest.Fahrmann, Elke ...................................... Disclosed no conflict of interest.Fahy, Anna ............................................. Disclosed no conflict of interest.Fain, Randi ............................................ Employee: Eisai, Inc.Fairfield, Jane ....................................... Disclosed no conflict of interest.Falcone, Vito A. .................................... Disclosed no conflict of interest.Falk, Christine ....................................... Disclosed no conflict of interest.Fall, Tove ............................................... Disclosed no conflict of interest.Fallucca, Francesco ............................... Disclosed no conflict of interest.Fallucca, Sara ........................................ Disclosed no conflict of interest.Falzado, Jules ....................................... Consultant: Bristol-Myers Squibb/AstraZeneca.Fan, Chun-Po Steve ............................... Research Support: Merck.Fan, Jianhui ........................................... Disclosed no conflict of interest.Fan, Nengguang .................................... Disclosed no conflict of interest.Fan, Xiaoning ........................................ Disclosed no conflict of interest.Fanelli, Carmine G. ............................... Other Relationship: Menarini, Sanofi.Fang, Jingye .......................................... Disclosed no conflict of interest.Fang, Nancy N. ..................................... Disclosed no conflict of interest.Fang, Pingyan ........................................ Disclosed no conflict of interest.Fang, Qichen ......................................... Disclosed no conflict of interest.Fang, Shi ............................................... Disclosed no conflict of interest.Fang, Wei-Jin ........................................ Disclosed no conflict of interest.Farabi, Sarah S. .................................... Disclosed no conflict of interest.Farajzadegan, Ziba ................................ Disclosed no conflict of interest.Farchoukh, Lama ................................... Disclosed no conflict of interest.Farese, Robert ....................................... Disclosed no conflict of interest.Fargeix, Andi ......................................... Disclosed no conflict of interest.Farias, Javier M. .................................. Disclosed no conflict of interest.Fariello, Stefania ................................... Disclosed no conflict of interest.Farmer, Ben ........................................... Disclosed no conflict of interest.Farrell, Geoffrey C. ............................... Disclosed no conflict of interest.Farrell, Kristin ........................................ Employee: Janssen Research & Development, LLC.Farret, Anne .......................................... Disclosed no conflict of interest.Farrokhi, Farnoosh ................................. Research Support: Pfizer, Inc.Fasanmade, Olufemi A. ....................... Advisory Panel: AstraZeneca/Bristol-Meyers Squibb, Novartis
Pharmaceuticals Corporation, Novo Nordisk A/S, Sanofi.Faske, Jennifer ...................................... Disclosed no conflict of interest.Fasshauer, Mathias ............................... Disclosed no conflict of interest.Fatmi, Zafar ........................................... Disclosed no conflict of interest.Faulkner, Guy ......................................... Disclosed no conflict of interest.Fauman, Eric B. .................................... Employee: Pfizer, Inc.Faurschou, Annesofie ........................... Disclosed no conflict of interest.Fazli, Ghazal S. ..................................... Disclosed no conflict of interest.Fearnside, Jane F. ................................ Disclosed no conflict of interest.Featherstone, Travis .............................. Disclosed no conflict of interest.Febbraio, Mark A. ................................ Disclosed no conflict of interest.Fedak, Danuta ....................................... Disclosed no conflict of interest.Feder, Astrid .......................................... Disclosed no conflict of interest.Federici, Massimo ................................. Disclosed no conflict of interest.Feferman, Leo ....................................... Disclosed no conflict of interest.Feinberg, Meredith ............................... Disclosed no conflict of interest.Feins, Karen .......................................... Employee: Daiichi-Sankyo, Inc.Felber, Eugene ....................................... Employee: Bristol-Myers Squibb Company.Feldman, Eva L. .................................... Disclosed no conflict of interest.Feltbower, Richard G. ........................... Disclosed no conflict of interest.Fendler, Wojciech .................................. Disclosed no conflict of interest.Feng, Biao ............................................. Disclosed no conflict of interest.Feng, Bo ................................................ Disclosed no conflict of interest.Feng, Daorong ....................................... Disclosed no conflict of interest.Feng, Feng ............................................. Disclosed no conflict of interest.Feng, Jing .............................................. Disclosed no conflict of interest.Feng, Juanran ....................................... Disclosed no conflict of interest.Feng, Meijun ......................................... Disclosed no conflict of interest.Feng, Tao ............................................... Disclosed no conflict of interest.Feng, Wei .............................................. Disclosed no conflict of interest.Feng, Xiaocheng .................................... Disclosed no conflict of interest.Feng, Zhengping .................................... Disclosed no conflict of interest.Feng, Zhonggang ................................... Disclosed no conflict of interest.Fensom, Blake ....................................... Disclosed no conflict of interest.Fensterheim, Leonard E. ...................... Employee: Walgreens; Stock/Shareholder: Walgreens.Fentz, Joachim ...................................... Disclosed no conflict of interest.Ferdousi, Maryam ................................. Disclosed no conflict of interest.Ferguson, Rosalyn ................................. Disclosed no conflict of interest.Feriz, Karen ........................................... Advisory Panel: AstraZeneca/Bristol-Meyers Squibb,
Ferland, Annie ....................................... Disclosed no conflict of interest.Ferlita, Alessandra ................................ Disclosed no conflict of interest.Fernandes, Nicholas ............................. Disclosed no conflict of interest.Fernandes, Omar D. ............................. Disclosed no conflict of interest.Fernandez, Ernie .................................... Disclosed no conflict of interest.Fernandez, Juan .................................... Disclosed no conflict of interest.Fernandez, Llenalia ............................... Employee: Seplin Statistical Soultions.Fernandez, Marlene .............................. Disclosed no conflict of interest.Fernandez-Garcia, Diego J. ................. Disclosed no conflict of interest.Fernández-Real, José Manuel .............. Disclosed no conflict of interest.Ferrannini, Ele ....................................... Advisory Panel: AstraZeneca/Bristol-Meyers Squibb,
Ferrara, Assiamira ................................. Research Support: Takeda Pharmaceutical Company, Ltd.Ferrara, Lidia ......................................... Disclosed no conflict of interest.Ferré, Pascal .......................................... Disclosed no conflict of interest.Ferreira, Ana ......................................... Disclosed no conflict of interest.Ferreira, Teresa ..................................... Disclosed no conflict of interest.Ferrell, Robert E. .................................. Disclosed no conflict of interest.Ferrelli, Francesca ................................. Disclosed no conflict of interest.Ferrier, Bernard...................................... Stock/Shareholder: Metabolys Inc.Ferris, Heather A. ................................. Disclosed no conflict of interest.Ferrucci, Luigi ........................................ Disclosed no conflict of interest.Festa, Andreas ...................................... Employee: Eli Lilly and Company.Fetia, Lila-Sabrina ................................. Disclosed no conflict of interest.Fhärm, Eva ............................................. Disclosed no conflict of interest.Ficarella, Romina .................................. Disclosed no conflict of interest.Fickley, Catherine E. ............................. Disclosed no conflict of interest.Fidler, Trevor P. ..................................... Disclosed no conflict of interest.Fields, James B. ................................... Disclosed no conflict of interest.Fielitz, Jens ........................................... Disclosed no conflict of interest.Figarola, James ..................................... Disclosed no conflict of interest.Filion, Julianne ...................................... Disclosed no conflict of interest.Filios, Stephen ...................................... Disclosed no conflict of interest.Filippi, Beatrice M. ............................... Disclosed no conflict of interest.Filipponi, Franco .................................... Disclosed no conflict of interest.Finan, Daniel A. .................................... Employee: Animas Corporation; Stock/Shareholder: Johnson
& Johnson.Finch, Joan ............................................ Disclosed no conflict of interest.Finck, Brian N. ...................................... Disclosed no conflict of interest.Fincke, Benjamin G. ............................. Disclosed no conflict of interest.Findeisen, Hannes M ............................ Disclosed no conflict of interest.Findlay, Steven B. ................................ Employee: Eli Lilly and Company.Finer, Sarah ........................................... Disclosed no conflict of interest.Fingerlin, Tasha E. ................................ Disclosed no conflict of interest.Finkelstein, Jonathan A. ...................... Disclosed no conflict of interest.Finlin, Brian S. ...................................... Disclosed no conflict of interest.Finn, Peter V. ........................................ Disclosed no conflict of interest.Finucane, Francis M. ............................ Advisory Panel: Merck Sharp & Dohme Limited, Novo Nordisk
A/S, Sanofi; Speaker’s Bureau: Bristol-Myers Squibb/AstraZeneca, Daiichi-Sankyo, Inc., Eli Lilly and Company, Merck Sharp & Dohme Limited, Novo Nordisk A/S.
Fiordaliso, Fabio .................................... Disclosed no conflict of interest.Fioretto, Paola ....................................... Advisory Panel: AstraZeneca-BMS, Boehringer Ingelheim, Eli
Fiori, Jennifer L. ................................... Disclosed no conflict of interest.Fiorina, Paolo ........................................ Disclosed no conflict of interest.Fiory, Francesca ..................................... Disclosed no conflict of interest.Fiquet, Béatrice ..................................... Employee: Novartis Pharma SAS.Fischer, Annelie ..................................... Employee: Profil Institute for Clinical Research, Inc.Fischer, Hadas ....................................... Disclosed no conflict of interest.Fischer, Michael A. .............................. Disclosed no conflict of interest.Fischl, Andrea F. ................................... Disclosed no conflict of interest.Fisher, Edwin B. .................................... Research Support: Bristol-Myers Squibb Company, Eli Lilly
and Company, Sanofi.Fisher, Ffolliott Martin .......................... Disclosed no conflict of interest.Fisher, Keyt E. ....................................... Disclosed no conflict of interest.Fisher, Lawrence ................................... Disclosed no conflict of interest.Fisher, Simon J. .................................... Speaker’s Bureau: Merck.Fitzgerald, Nora ..................................... Disclosed no conflict of interest.Fitzgerald, Shane .................................. Disclosed no conflict of interest.Flacke, Frank ......................................... Employee: Sanofi.Flández González, Beatriz ..................... Disclosed no conflict of interest.Flannick, Jason A. ................................ Disclosed no conflict of interest.
Flatt, Peter R. ....................................... Research Support: Amylin Pharmaceuticals, Inc., Sanofi; Stock/Shareholder: Diabetica Limited.
Fleck, Penny .......................................... Employee: Takeda Global Research & Development Center, Inc.; Stock/Shareholder: Takeda Global Research & Development Center, Inc.
Fleischer, Jesper ................................... Stock/Shareholder: Medicus Engineering.Fleming, Thomas H. ............................. Disclosed no conflict of interest.Fleres, Mattia ........................................ Disclosed no conflict of interest.Flier, Jeffery S. ..................................... Disclosed no conflict of interest.Fliers, Eric .............................................. Disclosed no conflict of interest.Fligner, Corinne L. ................................ Disclosed no conflict of interest.Flint, Anne ............................................. Employee: Novo Nordisk A/S; Stock/Shareholder: Novo
Nordisk A/S.Floderer, Jean-Baptiste ......................... Disclosed no conflict of interest.Floegel, Uli ............................................ Disclosed no conflict of interest.Flores, Georgina .................................... Disclosed no conflict of interest.Flores, Luis E. ....................................... Disclosed no conflict of interest.Flores-Luna, Lourdes ............................. Disclosed no conflict of interest.Florez, Hermes ...................................... Disclosed no conflict of interest.Florez, Jose C. ...................................... Disclosed no conflict of interest.Flowers, Elena ....................................... Disclosed no conflict of interest.Flowers, Frank N. ................................. Disclosed no conflict of interest.Floyd, Baraka D. ................................... Disclosed no conflict of interest.Fluiters, Enrique .................................... Disclosed no conflict of interest.Flum, David R. ...................................... Disclosed no conflict of interest.Flynn, Angela ........................................ Disclosed no conflict of interest.F-Mariño, Alexis .................................... Disclosed no conflict of interest.Fog, Jacob U. ....................................... Disclosed no conflict of interest.Fogari, Elena ......................................... Disclosed no conflict of interest.Fogel, Aviel............................................ Disclosed no conflict of interest.Foghsgaard, Signe ................................ Research Support: Novo Nordisk A/S; Speaker’s Bureau:
Merck Sharp & Dohme Limited.Fogliame, Giuseppe .............................. Disclosed no conflict of interest.Foley, Mike ............................................ Disclosed no conflict of interest.Folsom, Aaron R. .................................. Disclosed no conflict of interest.Fonda, Stephanie J. ............................. Disclosed no conflict of interest.Fong, Carol H. ....................................... Disclosed no conflict of interest.Fonseca, Vivian ..................................... Consultant: Abbott Laboratories, Inc., AstraZeneca
Pharmaceuticals LP, Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Daiichi-Sankyo, Inc., Eli Lilly and Company, GlaxoSmithKline, Novo Nordisk, Inc., Pamlab, LLC, Sanofi, Takeda Pharmaceutical Company, Ltd.; Other Relationship: Abbott Laboratories, Inc., Eli Lilly and Company, GI Dynamics, Novo Nordisk A/S, Pan American Laboratories, LLC, Reata Pharmaceuticals, Sanofi; Research Support: Abbott Laboratories, Inc., Eli Lilly and Company, GI Dynamics, Novo Nordisk, Inc., Pan American Laboratories, LLC, Reata Pharmaceuticals, Sanofi.
Fontaine, Eric ........................................ Research Support: Poxel SA.Fontana, Andrea .................................... Disclosed no conflict of interest.Fontana, Lucia ....................................... Disclosed no conflict of interest.Fontanillas, Pierre ................................. Disclosed no conflict of interest.Foo, Lin .................................................. Disclosed no conflict of interest.Foos, Volker ........................................... Research Support: AstraZeneca Pharmaceuticals LP, Bristol-
Myers Squibb Company, Eli Lilly and Company, GlaxoSmithKline, Novo Nordisk, Inc., Sanofi, Takeda Pharmaceuticals U.S.A., Inc.
Forbes, Josephine M. .......................... Disclosed no conflict of interest.Forbes, Peter W. ................................... Disclosed no conflict of interest.Forbes, Shareen .................................... Disclosed no conflict of interest.Forbes, Stuart J. ................................... Disclosed no conflict of interest.Ford, Derek ............................................ Disclosed no conflict of interest.Forde, Melika ........................................ Disclosed no conflict of interest.Foretz, Marc .......................................... Disclosed no conflict of interest.Foreyt, John P. ...................................... Disclosed no conflict of interest.Formisano, Pietro .................................. Disclosed no conflict of interest.Formoso, Gloria ..................................... Disclosed no conflict of interest.Fornoni, Alessia .................................... Consultant: Hoffman-La Roche, Mesoblast.Forsander, Gun ...................................... Disclosed no conflict of interest.Forsberg, Matthew H. .......................... Disclosed no conflict of interest.Forsblom, Carol ..................................... Disclosed no conflict of interest.Forst, Thomas ........................................ Advisory Panel: Boehringer Ingelheim Pharmaceuticals, Inc.,
Bristol-Myers Squibb Company, Eli Lilly and Company, Consultant: Boehringer Ingelheim GmbH & Co. KG, Sanofi; Employee: Profil Institute for Clinical Research, Inc.; Research Support: Boehringer Ingelheim Pharmaceuticals, Inc., Novartis Pharma AG, Sanofi; Speaker’s Bureau: Berlin Chemie AG, Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Novartis Pharma AG, Novo Nordisk, Inc., Sanofi.
Fortier, Marielle V. ................................ Disclosed no conflict of interest.Fortmann, Addie L. ............................... Disclosed no conflict of interest.Fosgerau, Keld ...................................... Disclosed no conflict of interest.Foss, Milton C. ..................................... Disclosed no conflict of interest.Foss-Freitas, Maria Cristina .................. Disclosed no conflict of interest.Foster III, Clarence ................................ Disclosed no conflict of interest.Foster, Erin R. ....................................... Disclosed no conflict of interest.Foster, Nicole C. ................................... Disclosed no conflict of interest.Foster-Schubert, Karen ......................... Disclosed no conflict of interest.Fotheringham, Amelia K. ..................... Disclosed no conflict of interest.Foti, Daniela .......................................... Disclosed no conflict of interest.Foufelle, Fabienne ................................. Disclosed no conflict of interest.Fouqueray, Pascale ............................... Employee: Poxel SA.Fourcaudot, Marcel ............................... Disclosed no conflict of interest.Fouts, Alexandra R. .............................. Disclosed no conflict of interest.Foutz, Julia ............................................ Disclosed no conflict of interest.Fowler, Dale E. ..................................... Disclosed no conflict of interest.Fowler, Samantha ................................. Disclosed no conflict of interest.Fox, Caroline S. .................................... Disclosed no conflict of interest.Fox, Kathleen M. .................................. Research Support: AstraZeneca Pharmaceuticals LP.Fox, Larry A. ......................................... Disclosed no conflict of interest.Fox, Peter .............................................. Disclosed no conflict of interest.Foyt, Howard ......................................... Consultant: Cebix, Inc.; Employee: Viacyte; Stock/Shareholder:
Viacyte.Fragasso, Gabriele ................................ Disclosed no conflict of interest.Frahnow, Turid ....................................... Disclosed no conflict of interest.Franberg, Mattias ................................. Disclosed no conflict of interest.Franc, Sylvia .......................................... Disclosed no conflict of interest.Francia, Piergiorgio ............................... Disclosed no conflict of interest.Franco, Denise ...................................... Advisory Panel: Bristol-Myers Squibb Company, Sanofi; Board
Member: Eli Lilly and Company, Roche Pharmaceuticals, Sanofi; Consultant: Medtronic; Research Support: Eli Lilly and Company, MannKind Corporation, Sanofi; Speaker’s Bureau: AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Company, Eli Lilly and Company, Medtronic, Roche Pharmaceuticals, Sanofi.
Franconi, Flavia ..................................... Disclosed no conflict of interest.Frandsen, Erik ........................................ Disclosed no conflict of interest.Franek, Edward ..................................... Advisory Panel: AstraZeneca/Bristol-Meyers Squibb, Bioton,
Boehringer Ingelheim Pharmaceuticals, Inc., Johnson & Johnson, Novartis Pharma AG, Novo Nordisk A/S; Speaker’s Bureau: AstraZeneca/Bristol-Meyers Squibb, Bioton, Boehringer Ingelheim Pharmaceuticals, Inc., Merck, Novo Nordisk A/S, Servier.
Franklin, Brian ....................................... Disclosed no conflict of interest.Franklin, Mallory P. ............................... Disclosed no conflict of interest.Franks, Paul W. .................................... Disclosed no conflict of interest.Frappin, Guillaume ................................ Employee: Boehringer Ingelheim GmbH & Co. KG.Fraterrigo, Gemma ................................ Disclosed no conflict of interest.Fraty, Mathilde ...................................... Disclosed no conflict of interest.Fraunberger, Peter ................................. Disclosed no conflict of interest.Frayling, Timothy M. ............................ Disclosed no conflict of interest.Frazzatto, Eliana .................................... Disclosed no conflict of interest.Freckmann, Guido ................................. Advisory Panel: Abbott Diabetes Care, Sanofi; Consultant:
Becton, Dickinson and Company, Novo Nordisk A/S; Speaker’s Bureau: Abbott Diabetes Care, Bayer Health Care, LLC, Berlin Chemie AG/Menarini, Hoffman La Roche, Menarini, Sanofi, Ypsomed.
Frederick, David W. .............................. Disclosed no conflict of interest.Frederiksen, Brittni ................................ Disclosed no conflict of interest.Fredholm, Bertil ..................................... Disclosed no conflict of interest.Freeby, Matthew ................................... Disclosed no conflict of interest.Freedman, Laurence .............................. Disclosed no conflict of interest.Freeman, Kurt A. .................................. Disclosed no conflict of interest.Freeman, Melissa ................................. Disclosed no conflict of interest.Freemantle, Nick ................................... Consultant: Eli Lilly and Company, Medtronic, Novo Nordisk
A/S, Pfizer, Inc., Sanofi; Research Support: Eli Lilly and Company, Medtronic, Novo Nordisk A/S, Pfizer, Inc., Sanofi; Speaker’s Bureau: Novo Nordisk A/S, Sanofi.
Freisinger, Oana .................................... Disclosed no conflict of interest.French, Anna ......................................... Disclosed no conflict of interest.Freudenberg, Johannes ........................ Employee: GlaxoSmithKline.Friborg, Søren ........................................ Disclosed no conflict of interest.Friday, Karen ......................................... Disclosed no conflict of interest.Fried, Linda ............................................ Research Support: Reata Pharmaceuticals.Fried, Martin ......................................... Disclosed no conflict of interest.Fried, Susan K. ..................................... Disclosed no conflict of interest.Friedline, Randall H. ............................. Disclosed no conflict of interest.Friedman, Jacob E. ............................... Disclosed no conflict of interest.Friedman, Theodore C. ......................... Disclosed no conflict of interest.
Friedrichs, Carl ...................................... Disclosed no conflict of interest.Friedrichsen, Martin .............................. Disclosed no conflict of interest.Frigè, Francesca .................................... Disclosed no conflict of interest.Friis, Steffen U. .................................... Disclosed no conflict of interest.Frimpter, Jeffrey .................................... Employee: Sanofi; Stock/Shareholder: Sanofi.Fritsche, Andreas .................................. Disclosed no conflict of interest.Fritsche, Louise ..................................... Disclosed no conflict of interest.Fritschi, Cynthia .................................... Disclosed no conflict of interest.Frittitta, Lucia ........................................ Disclosed no conflict of interest.Froguel, Philippe ................................... Disclosed no conflict of interest.Frølich, Anne ......................................... Disclosed no conflict of interest.Frontoni, Simona ................................... Disclosed no conflict of interest.Froy, Oren .............................................. Disclosed no conflict of interest.Frykberg, Robert .................................... Disclosed no conflict of interest.Frystyk, Jan ........................................... Disclosed no conflict of interest.Fu, Alex Z. ............................................ Research Support: Merck.Fu, Arthur .............................................. Research Support: Genentech.Fu, Chia-Po ............................................ Disclosed no conflict of interest.Fu, Hanjing ............................................ Disclosed no conflict of interest.Fu, Haoda .............................................. Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly
and Company.Fu, Lizhi ................................................. Research Support: NuSirt Inc.Fu, Xiaorong .......................................... Disclosed no conflict of interest.Fu, Yiling................................................ Disclosed no conflict of interest.Fu, Yongji ............................................... Stock/Shareholder: Becton, Dickinson and Company.Fu, Yuchang ........................................... Disclosed no conflict of interest.Fu, Zhuo ................................................. Disclosed no conflict of interest.Fuchs, Holger ........................................ Employee: Boehringer Ingelheim GmbH & Co. KG.Fuchsberger, Christian........................... Disclosed no conflict of interest.Fueger, Patrick T. .................................. Disclosed no conflict of interest.Fuhrman, Christopher A. ...................... Disclosed no conflict of interest.Fujihara, Kazuya .................................... Disclosed no conflict of interest.Fujii, Hitomi ........................................... Disclosed no conflict of interest.Fujii, Nobuharu L. ................................. Disclosed no conflict of interest.Fujii, Takayoshi ...................................... Employee: Ajinomoto Group.Fujikura, Junji ........................................ Disclosed no conflict of interest.Fujimoto, Kanta ..................................... Disclosed no conflict of interest.Fujimoto, Shimpei ................................. Disclosed no conflict of interest.Fujimoto, Simpei ................................... Disclosed no conflict of interest.Fujimoto, Wilfred Y. ............................. Disclosed no conflict of interest.Fujimura, Takanori ................................. Disclosed no conflict of interest.Fujioka, Kenneth ................................... Advisory Panel: Eisai, Inc., Novo Nordisk, Inc., Vivus, Inc.,
Zafgen, Inc.; Speaker’s Bureau: Eisai, Inc.Fujioka, Youhei ...................................... Disclosed no conflict of interest.Fujisaka, Shiho ...................................... Disclosed no conflict of interest.Fujishiro, Midori .................................... Disclosed no conflict of interest.Fujita, Naotaka ...................................... Disclosed no conflict of interest.Fujita, Yoshihito .................................... Disclosed no conflict of interest.Fujita, Yukihiro ...................................... Disclosed no conflict of interest.Fujitani, Yoshio ...................................... Research Support: Boehringer Ingelheim Pharmaceuticals,
Fujiwara, Kazuya ................................... Disclosed no conflict of interest.Fukagawa, Naomi K. ............................ Disclosed no conflict of interest.Fukatsu, Atsushi .................................... Consultant: Taisho.Fukuda, Kanji ......................................... Disclosed no conflict of interest.Fukuda, Shuichi ..................................... Disclosed no conflict of interest.Fukuda, Takashi ..................................... Disclosed no conflict of interest.Fukuda, Takuya ...................................... Disclosed no conflict of interest.Fukui, Masaki ........................................ Disclosed no conflict of interest.Fukui, Michiaki ...................................... Disclosed no conflict of interest.Fukui, Rosa ............................................ Disclosed no conflict of interest.Fukui, Tomoyasu .................................... Disclosed no conflict of interest.Fukumoto, Shinya .................................. Disclosed no conflict of interest.Fukushima, Arata .................................. Disclosed no conflict of interest.Fukushima, Toru .................................... Disclosed no conflict of interest.Fukushima, Toshiaki .............................. Disclosed no conflict of interest.Fulcher, Gregory .................................... Advisory Panel: Amgen, Inc., Boehringer Ingelheim GmbH &
Co. KG, Janssen Pharmaceuticals, Merck Sharp & Dohme Limited, Novo Nordisk A/S, Sanofi; Research Support: Novo Nordisk A/S; Speaker’s Bureau: Boehringer Ingelheim GmbH & Co. KG, Merck Sharp & Dohme Limited, Novo Nordisk A/S.
Fumeron, Frédéric ................................. Disclosed no conflict of interest.Funai, Katsuhiko .................................... Disclosed no conflict of interest.Funaki, Makoto ..................................... Research Support: Otsuka Pharmaceutical Group.Funakoshi, Satoshi ................................ Disclosed no conflict of interest.Funato, Michinori .................................. Disclosed no conflict of interest.
Funel, Niccola ....................................... Disclosed no conflict of interest.Fung, Albert ........................................... Employee: Janssen Research & Development, LLC.Fung, Anne ............................................ Consultant: Alcon, Genentech, Santen, Sequenom,
Thrombogenics; Research Support: Genentech.Funk, Kristine L. .................................... Disclosed no conflict of interest.Funnell, Martha M. .............................. Advisory Panel: Bayer Health Care, LLC, Bristol-Myers
Squibb/AstraZeneca, Eli Lilly and Company, GlaxoSmithKline, Halozyme Therapeutics, Hygieia, Inc., Johnson & Johnson, Lifescan Animas, Inc., Omada Health.
Fuqua, Jack ........................................... Disclosed no conflict of interest.Furie, Karen L. ...................................... Disclosed no conflict of interest.Furihata, Takaaki ................................... Disclosed no conflict of interest.Furlan, Anna .......................................... Disclosed no conflict of interest.Furman, Elise ......................................... Disclosed no conflict of interest.Furman, Roy .......................................... Disclosed no conflict of interest.Furnary, Anthony ................................... Consultant: Echo Therapeutics, Inc.; Research Support: Echo
Therapeutics, Inc.; Stock/Shareholder: Echo Therapeutics, Inc.
Furshong, Ginny .................................... Disclosed no conflict of interest.Furuichi, Kengo ..................................... Disclosed no conflict of interest.Furukawa, Asami .................................. Disclosed no conflict of interest.Furukawa, Kazuo ................................... Disclosed no conflict of interest.Furusawa, Yuki ...................................... Employee: Mochida Pharmaceutical Co., Ltd.Furuta, Kazue ........................................ Disclosed no conflict of interest.Fushiki, Tohru ........................................ Disclosed no conflict of interest.Fyalka, Robert ....................................... Disclosed no conflict of interest.Fysekidis, Marinos ................................ Disclosed no conflict of interest.Gaba, Ruchi ........................................... Disclosed no conflict of interest.Gabbay, Robert A. ................................ Research Support: Becton, Dickinson and Company.Gabrielsson, Johan ............................... Consultant: AstraZeneca Pharmaceuticals LP.Gabriely, Ilan ......................................... Disclosed no conflict of interest.Gadgil, Meghana D. ............................. Disclosed no conflict of interest.Gadir, Noga ........................................... Employee: Merck Sharp & Dohme Limited.Gaffar, Iljana.......................................... Disclosed no conflict of interest.Gaffney, Kaitlin C. ................................ Disclosed no conflict of interest.Gage, Matthew ..................................... Disclosed no conflict of interest.Gagliardino, Juan J. ............................. Advisory Panel: Merck; Research Support: Merck.Gagnon, Jeffrey .................................... Disclosed no conflict of interest.Gai, Ying ................................................ Disclosed no conflict of interest.Gaigé, Stéphanie .................................. Disclosed no conflict of interest.Gaillard, Trudy R. .................................. Disclosed no conflict of interest.Gaisano, Herbert Y. .............................. Disclosed no conflict of interest.Gaita, Dan ............................................. Disclosed no conflict of interest.Gaitan, Julien ........................................ Disclosed no conflict of interest.Gaksch, Martin ...................................... Disclosed no conflict of interest.Gal, Avner.............................................. Employee: Integrity Applications, Ltd.Galagudza, Mikle M. ............................ Disclosed no conflict of interest.Galassetti, Pietro R. ............................. Disclosed no conflict of interest.Galasso, Silvia ...................................... Disclosed no conflict of interest.Galbo, Thomas ...................................... Disclosed no conflict of interest.Galderisi, Alfonso ................................. Disclosed no conflict of interest.Galindo, Cynthia .................................... Disclosed no conflict of interest.Galindo, Mercedes ................................ Disclosed no conflict of interest.Gallagher, Emily J. ............................... Disclosed no conflict of interest.Gallego, Consuelo ................................. Disclosed no conflict of interest.Gallen, Geraldine .................................. Disclosed no conflict of interest.Gallen, Ian W. ...................................... Disclosed no conflict of interest.Galli, Angelica ....................................... Disclosed no conflict of interest.Gallo, Andrea ........................................ Disclosed no conflict of interest.Gallo, Linda A. ...................................... Disclosed no conflict of interest.Gallo, Linda C. ...................................... Disclosed no conflict of interest.Galloway, Stacey .................................. Disclosed no conflict of interest.Gallwitz, Baptist .................................... Advisory Panel: AstraZeneca Pharmaceuticals LP, Boehringer
Ingelheim GmbH & Co. KG, Bristol-Myers Squibb Company, Eli Lilly and Company, Merck, Novartis Pharmaceuticals Corporation, Novo Nordisk, Inc., Roche Pharmaceuticals, Sanofi, Takeda Pharmaceutical Company, Ltd.; Speaker’s Bureau: AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim GmbH & Co. KG, Bristol-Myers Squibb Company, Eli Lilly and Company, Merck, Novartis Pharmaceuticals Corporation, Novo Nordisk, Inc., Roche Pharmaceuticals, Sanofi, Takeda Pharmaceutical Company, Ltd.
Galvan, Beatriz ...................................... Disclosed no conflict of interest.Gambhire, Dhiraj ................................... Disclosed no conflict of interest.Gamboa, Ceciia ..................................... Disclosed no conflict of interest.Gan, Minglu .......................................... Disclosed no conflict of interest.Gan, Siew Hua ...................................... Disclosed no conflict of interest.
Gancheva, Sofiya .................................. Disclosed no conflict of interest.Gand, Elise ............................................ Disclosed no conflict of interest.Gandhi, Rajiv ......................................... Disclosed no conflict of interest.Gandhi, Shruti M. ................................. Disclosed no conflict of interest.Gandica, Rachelle ................................. Disclosed no conflict of interest.Ganesan, Goutham ............................... Disclosed no conflict of interest.Ganguli, Rohan ...................................... Disclosed no conflict of interest.Gannon, Maureen A. ............................ Disclosed no conflict of interest.Gans, Asaf ............................................. Disclosed no conflict of interest.Gans, Richard ........................................ Disclosed no conflict of interest.Gantz, Ira ............................................... Employee: Merck Sharp & Dohme Limited.Ganz, Michael L. .................................. Employee: Evidera; Other Relationship: Evidera receives
research funds from Novo Nordisk Inc.Ganz, Tali ............................................... Disclosed no conflict of interest.Gao, Dan ............................................... Disclosed no conflict of interest.Gao, Feng .............................................. Disclosed no conflict of interest.Gao, Jing ............................................... Disclosed no conflict of interest.Gao, Jingying ........................................ Disclosed no conflict of interest.Gao, Junhong ........................................ Disclosed no conflict of interest.Gao, Leili ............................................... Disclosed no conflict of interest.Gao, Ling ............................................... Consultant: Sanofi.Gao, Meifang ........................................ Disclosed no conflict of interest.Gao, Mingyan ........................................ Disclosed no conflict of interest.Gao, Rufei ............................................. Disclosed no conflict of interest.Gao, Shan .............................................. Disclosed no conflict of interest.Gao, Xiang ............................................. Disclosed no conflict of interest.Gao, Xiaoyi ............................................ Disclosed no conflict of interest.Gao, Xin ................................................. Disclosed no conflict of interest.Gao, Xiuying .......................................... Disclosed no conflict of interest.Gappmayer, Brigitta .............................. Disclosed no conflict of interest.Garau, Valentina ................................... Disclosed no conflict of interest.Garay-Nontal, Barbara .......................... Disclosed no conflict of interest.Garber, Manuel ..................................... Disclosed no conflict of interest.Garbis, Spiros ........................................ Disclosed no conflict of interest.Garcia de la Torre, Nuria ...................... Disclosed no conflict of interest.Garcia, Erika .......................................... Disclosed no conflict of interest.Garcia, Isabel ........................................ Disclosed no conflict of interest.Garcia, Joel ........................................... Disclosed no conflict of interest.Garcia, Jose J. ..................................... Disclosed no conflict of interest.Garcia, Maria Isabel ............................. Disclosed no conflict of interest.Garcia-Alcala, Hector ............................ Disclosed no conflict of interest.Garcia-Aleman, Jorge ........................... Disclosed no conflict of interest.Garcia-Mayor, Ricardo V. ..................... Disclosed no conflict of interest.Garcia-Ocana, Adolfo ............................ Disclosed no conflict of interest.Garcia-Soidan, Francisco J. ................. Disclosed no conflict of interest.Gardiner, Phillip ..................................... Disclosed no conflict of interest.Garduno Garcia, Jose de Jesus ............ Disclosed no conflict of interest.Garg, Manisha ...................................... Disclosed no conflict of interest.Garg, Rajesh .......................................... Research Support: Bristol-Myers Squibb/AstraZeneca.Garg, Satish K. ..................................... Advisory Panel: Medtronic, Novo Nordisk, Roche, Sanofi;
Other Relationship: Sanofi; Research Support: Eli Lilly, Halozyme, JDRF, Lexicon, Medtronic, NIH, Novo Nordisk, Sanofi.
Garg, Trit................................................ Disclosed no conflict of interest.Garhyan, Parag ...................................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly
and Company.Gariani, Joanna ..................................... Disclosed no conflict of interest.Gariani, Karim ....................................... Disclosed no conflict of interest.Garibotto, Valentina .............................. Disclosed no conflict of interest.Garnett, E. Dessa .................................. Disclosed no conflict of interest.Garnett, Sarah ....................................... Disclosed no conflict of interest.Garnham, Andrew ................................. Disclosed no conflict of interest.Garofolo, Monia .................................... Disclosed no conflict of interest.Garrett, Timothy J. ............................... Disclosed no conflict of interest.Garrison, Etoi A. ................................... Disclosed no conflict of interest.Gärtner, Babette .................................... Research Support: Almased Wellness GmbH.Garvey, Katharine C. ............................ Disclosed no conflict of interest.Garvey, W. Timothy ............................... Disclosed no conflict of interest.Garvey, W. John .................................... Disclosed no conflict of interest.Garvin, Maria Cristina ........................... Disclosed no conflict of interest.Gary, Sarah T. ....................................... Disclosed no conflict of interest.Gaspar, Joana M. ................................. Disclosed no conflict of interest.Gastaldelli, Amalia ............................... Consultant: Eli Lilly and Company, Roche Pharmaceuticals;
Research Support: Amylin Pharmaceuticals, Inc.Gastol, Joanna ...................................... Disclosed no conflict of interest.Gatelli, Lucas ........................................ Disclosed no conflict of interest.Gatenby, Victoria K. ............................. Disclosed no conflict of interest.Gates, Simon ......................................... Disclosed no conflict of interest.Gaudreau, Pierrette ............................... Disclosed no conflict of interest.Gauguier, Dominique............................. Disclosed no conflict of interest.Gaul, Micheal ........................................ Employee: Janssen Research & Development.Gault, Victor A. ..................................... Stock/Shareholder: Diabetica Ltd.
Gaulton, Kyle J. .................................... Disclosed no conflict of interest.Gause-Nilsson, Ingrid A. ...................... Employee: AstraZeneca/Bristol-Meyers Squibb.Gauthier, Benoit R. ............................... Disclosed no conflict of interest.Gautier, Jean-Francois .......................... Advisory Panel: AstraZeneca Pharmaceuticals LP, Eli Lilly and
Company; Board Member: Novartis Pharmaceuticals Corporation, Novo Nordisk A/S, Sanofi; Research Support: Novo Nordisk, Inc.
Gavan, Norina A. .................................. Employee: Worwag Pharma.Gavin, James R. ................................... Consultant: Abbott Diabetes Care, Vivus Pharmaceuticals,
Gavriilaki, Eleni ..................................... Disclosed no conflict of interest.Ge, Jiapu ............................................... Disclosed no conflict of interest.Geary, Kate ............................................ Disclosed no conflict of interest.Gebo, Wen ............................................ Disclosed no conflict of interest.Gee, Jodie ............................................. Disclosed no conflict of interest.Geelhoed-Duijvestijn, Petronella .......... Advisory Panel: Abbott Diabetes Care, Medtronic, Sanofi.Gehr, Berhard ........................................ Advisory Panel: Roche Diagnostics GmbH; Research Support:
Geiger, Kathrin ...................................... Disclosed no conflict of interest.Geiser, Jeanne S. ................................. Employee: Eli Lilly and Company; Stock/Shareholder: Eli
Lilly and Company, Eli Lilly and Company (Spouse/Partner).
Geiss, Linda S. ..................................... Disclosed no conflict of interest.Gejl, Michael ......................................... Disclosed no conflict of interest.Gelchsheimer, Ulrich ............................. Employee: Roche Diagnostics GmbH.Geletka, Lynn......................................... Disclosed no conflict of interest.Gene, Brittany ....................................... Disclosed no conflict of interest.Genest, Jacques ................................... Disclosed no conflict of interest.Gensini, Gianfranco .............................. Disclosed no conflict of interest.Gentile, Sandro ..................................... Disclosed no conflict of interest.Genuth, Saul ......................................... Disclosed no conflict of interest.George, Biju .......................................... Disclosed no conflict of interest.George, Carly E. ................................... Disclosed no conflict of interest.George, Minu ........................................ Disclosed no conflict of interest.George, Victoria .................................... Disclosed no conflict of interest.Geransar, Parnia .................................... Employee: Novartis Pharmaceuticals UK Limited.Gerasimidou-Vazeou, Adriani ............... Disclosed no conflict of interest.Gerasimova, Maria ............................... Disclosed no conflict of interest.Gerber, Linda M. .................................. Disclosed no conflict of interest.Gerchman, Fernando ............................. Disclosed no conflict of interest.Gerling, Ivan C. ..................................... Disclosed no conflict of interest.German, Michael S. ............................. Research Support: NIDDK, Sanofi; Stock/Shareholder:
Viacyte.Gerst, Felicia ......................................... Disclosed no conflict of interest.Gerstein, Hertzel C. .............................. Consultant: AstraZeneca Pharmaceuticals LP, Bayer Health
Care, LLC, Bristol-Myers Squibb Company, GlaxoSmithKline, Lilly, Novo Nordisk, Inc., Roche Pharmaceuticals, Sanofi; Other Relationship: Bayer Health Care, LLC, Sanofi; Research Support: AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Lilly, Merck, Novo Nordisk, Inc., Sanofi.
Gerszten, Robert E. .............................. Disclosed no conflict of interest.Gesing, Julia ......................................... Disclosed no conflict of interest.Gesuita, Rosaria .................................... Disclosed no conflict of interest.Gettys, Thomas ..................................... Disclosed no conflict of interest.Gewelber, Civon .................................... Disclosed no conflict of interest.Ghaffari-Tabrizzi, Nassim ...................... Disclosed no conflict of interest.Ghahate, Donica ................................... Disclosed no conflict of interest.Ghanim, Husam A. ............................... Disclosed no conflict of interest.Ghannam, Nadia ................................... Advisory Panel: Novo Nordisk A/S.Ghazalli, Nadiah .................................... Disclosed no conflict of interest.Gheorghiu, Monica ............................... Disclosed no conflict of interest.Gherlinzoni, Filippo ............................... Disclosed no conflict of interest.Ghislain, Julien ..................................... Disclosed no conflict of interest.Ghosh, Rajarshi ..................................... Disclosed no conflict of interest.Ghosh, Sandip ....................................... Disclosed no conflict of interest.Ghosh, Sangeeta ................................... Disclosed no conflict of interest.Ghosh, Sujoy ......................................... Disclosed no conflict of interest.Giacca, Adria ......................................... Disclosed no conflict of interest.Giaccari, Andrea ................................... Disclosed no conflict of interest.Giacco, Angela ...................................... Disclosed no conflict of interest.Giampatzis, Vasilios .............................. Disclosed no conflict of interest.Giani, Guido .......................................... Disclosed no conflict of interest.Giannarelli, Rosa ................................... Disclosed no conflict of interest.Giannini, Cosimo ................................... Disclosed no conflict of interest.Gibbs, Richard ....................................... Disclosed no conflict of interest.Gibson, Alice ......................................... Disclosed no conflict of interest.Gibson, Ronald L. ................................. Disclosed no conflict of interest.
Gidaya, Nicole ....................................... Other Relationship: Sanofi US, Inc.Gidding, Samuel S. .............................. Disclosed no conflict of interest.Gidlund, Peter ....................................... Disclosed no conflict of interest.Giedraitis, Vilmantas............................. Disclosed no conflict of interest.Giehm, Lise ........................................... Disclosed no conflict of interest.Giepmans, Ben N. ................................ Disclosed no conflict of interest.Giesler, Paula D. ................................... Disclosed no conflict of interest.Gil, So Young ......................................... Disclosed no conflict of interest.Gilbert, Deana ....................................... Disclosed no conflict of interest.Gilbert, Richard E. ................................ Advisory Panel: AstraZeneca/Bristol-Meyers Squibb, Eli Lilly
and Company, Merck; Research Support: Boehringer Ingelheim, NovoNordisk, Merck, Eli Lilly, Janssen, BMS, AstraZeneca.
Gilden, Janice L. .................................. Research Support: Boehringer Ingelheim Pharmaceuticals, Inc.; Speaker’s Bureau: Novo Nordisk, Inc.
Gildengorin, Ginny ................................ Disclosed no conflict of interest.Gilder, Kye M. ...................................... Employee: Orexigen Therapeutics, Inc.; Stock/Shareholder:
Orexigen Therapeutics, Inc.Gilet, Catherine ..................................... Disclosed no conflict of interest.Gilijamse, P.W. ..................................... Disclosed no conflict of interest.Gill, Dawn ............................................. Disclosed no conflict of interest.Gill, G. .................................................. Disclosed no conflict of interest.Gill, Jasvinder K. .................................. Employee: Sanofi; Stock/Shareholder: Sanofi.Gillberg, Linn ......................................... Disclosed no conflict of interest.Gillespie, Karin B. ................................ Employee: Novo Nordisk, Inc.Gillespie, Paddy .................................... Disclosed no conflict of interest.Gil-Lozano, Manuel ............................... Disclosed no conflict of interest.Giltelman, Stephen E. .......................... Other Relationship: Novo Nordisk, Inc.Gimble, Jeffrey M. ............................... Employee: LaCell, LLC; Stock/Shareholder: LaCell, LLC.Gin, Henri .............................................. Disclosed no conflict of interest.Gingras, Marie-Claude .......................... Disclosed no conflict of interest.Gingras, Véronique ............................... Disclosed no conflict of interest.Ginsberg, Barry ..................................... Consultant: Facet Technologies, LLC.Giorda, Carlo B. .................................... Disclosed no conflict of interest.Giordani, Ilaria ...................................... Disclosed no conflict of interest.Giorgini, Marisa .................................... Disclosed no conflict of interest.Giorgino, Francesco .............................. Advisory Panel: AstraZeneca Pharmaceuticals LP, Bristol-
Myers Squibb Company, Eli Lilly and Company, Janssen Pharmaceuticals, Roche Diagnostics, Takeda Pharmaceutical Company, Ltd.; Consultant: AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Lifescan Animas, Inc., Merck Sharp & Dohme Limited, Novo Nordisk, Inc., Sanofi; Research Support: AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Company, Eli Lilly and Company, Lifescan Animas, Inc., Sanofi; Speaker’s Bureau: AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Lifescan Animas, Inc., Merck Sharp & Dohme Limited, Novartis Pharmaceuticals Corporation, Novo Nordisk, Inc., Sanofi.
Giroux, Isabelle ..................................... Disclosed no conflict of interest.Gitelman, Stephen E. ........................... Disclosed no conflict of interest.Gitt, Anselm K. ..................................... Advisory Panel: Sanofi; Consultant: AstraZeneca/Bristol-
Meyers Squibb; Research Support: Sanofi; Speaker’s Bureau: Sanofi.
Gittes, George K. ................................. Disclosed no conflict of interest.Giuffrida, Fernando M. ........................ Disclosed no conflict of interest.Giugliano, Robert P. .............................. Consultant: Amgen, Inc., Beckman Coulter, Daiichi-Sankyo,
Inc., Janssen Pharmaceuticals, Lexicon Pharmaceuticals, Inc., Merck, Sanofi; Other Relationship: Daiichi-Sankyo, Inc., Merck; Research Support: Amgen, Inc., Daiichi-Sankyo, Inc., Merck.
Gius, David R. ....................................... Disclosed no conflict of interest.Giusti, Laura .......................................... Disclosed no conflict of interest.Giustizieri, Valentina ............................. Disclosed no conflict of interest.Giveon, Shmuel ..................................... Disclosed no conflict of interest.Gjelsvik, Annie ...................................... Disclosed no conflict of interest.Gkaliagkousi, Eugenia ........................... Disclosed no conflict of interest.Glavin, Maria ........................................ Disclosed no conflict of interest.Glazier, Rick ........................................... Disclosed no conflict of interest.Glick, Henry A. ..................................... Disclosed no conflict of interest.Glindorf, Mette ..................................... Disclosed no conflict of interest.Gloyn, Anna L. ...................................... Disclosed no conflict of interest.Gluckman, Peter D. .............................. Disclosed no conflict of interest.Glueck, Deborah H. .............................. Disclosed no conflict of interest.Glümer, Charlotte .................................. Disclosed no conflict of interest.Gluud, Lise L. ........................................ Other Relationship: Merck.Glynn, Liam ........................................... Disclosed no conflict of interest.Gmyr, Valery .......................................... Disclosed no conflict of interest.Gnudi, Luigi ........................................... Disclosed no conflict of interest.Gnys, Piotr ............................................. Disclosed no conflict of interest.
Go, Min Jin ........................................... Disclosed no conflict of interest.Go, Younghoon ...................................... Disclosed no conflict of interest.Gobbo, Raffaella ................................... Disclosed no conflict of interest.Godfrey, Keith M. ................................. Disclosed no conflict of interest.Godfrey, Lisa ......................................... Disclosed no conflict of interest.Godin, Jean-Philippe ............................. Employee: Nestec SA.Godin, Matthew .................................... Disclosed no conflict of interest.Godlewski, Grzegorz ............................. Disclosed no conflict of interest.Godsland, Ian ........................................ Disclosed no conflict of interest.Godzien, Joanna ................................... Disclosed no conflict of interest.Goebel-Fabbri, Ann ............................... Disclosed no conflict of interest.Goergen, Laura G. ................................ Disclosed no conflict of interest.Goff, David C. ....................................... Disclosed no conflict of interest.Gögebakan, Özlem ................................ Disclosed no conflict of interest.Gökler, Michaela ................................... Disclosed no conflict of interest.Gola, Joanna ......................................... Disclosed no conflict of interest.Goland, Robin S. .................................. Disclosed no conflict of interest.Goldberg Eliaschewitz, Freddy .............. Advisory Panel: AstraZeneca Pharmaceuticals LP, Merck
Sharp & Dohme Limited, Sanofi; Board Member: Bristol-Myers Squibb Company, Novo Nordisk, Inc.; Consultant: Novo Nordisk, Inc.; Research Support: Sanofi; Speaker’s Bureau: AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Company, Eli Lilly and Company, Novo Nordisk, Inc., Sanofi.
Goldberg, Andrew P. ............................ Disclosed no conflict of interest.Goldberg, Ronald B. ............................. Disclosed no conflict of interest.Golden, Lauren ...................................... Disclosed no conflict of interest.Golden, Sherita H. ................................ Disclosed no conflict of interest.Goldenberg, Ronald .............................. Advisory Panel: AstraZeneca Pharmaceuticals LP, Boehringer
Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Janssen Pharmaceuticals, Merck, Novo Nordisk, Inc., Roche Pharmaceuticals, Sanofi, Takeda Pharmaceutical Company, Ltd.; Consultant: AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Janssen Pharmaceuticals, Novo Nordisk, Inc., Takeda Pharmaceutical Company, Ltd.; Research Support: Abbott, AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, GlaxoSmithKline, Janssen Pharmaceuticals, Medtronic, Merck, Novartis Pharmaceuticals Corporation, Novo Nordisk, Inc., Roche Pharmaceuticals, Sanofi, Takeda Pharmaceutical Company, Ltd.; Speaker’s Bureau: Abbott, AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Merck, Novo Nordisk, Inc., Sanofi, Servier.
Goldfine, Allison B. .............................. Disclosed no conflict of interest.Goldfine, Ira D. ..................................... Employee: XOMA Corporation.Goldis, Marina ...................................... Disclosed no conflict of interest.Goldstein, Inbal ..................................... Disclosed no conflict of interest.Goldstein, Neta ..................................... Employee: Integrity Applications, Ltd.Goletzke, Janina ................................... Disclosed no conflict of interest.Golics, Rebecca ..................................... Disclosed no conflict of interest.Gollahon, Katherine .............................. Employee: Vascular Pharmaceuticals Inc.Golonko, Anna ....................................... Disclosed no conflict of interest.Golor, Georg .......................................... Employee: PAREXEL GmbH.Gomes, Marilia B. ................................ Disclosed no conflict of interest.Gomes, Patricia M. .............................. Disclosed no conflict of interest.Gomez, Jose .......................................... Disclosed no conflict of interest.Gomez, Maria F. ................................... Disclosed no conflict of interest.Gómez-Huelgas, Ricardo ....................... Disclosed no conflict of interest.Gomez-Peralta, Fernando ...................... Advisory Panel: Novo Nordisk, Inc., Sanofi; Research Support:
Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim Pharmaceuticals, Inc. (Spouse/Partner), Eli Lilly and Company (Spouse/Partner), Eli Lilly and Company, Novo Nordisk, Inc., Novo Nordisk, Inc. (Spouse/Partner), Sanofi, Sanofi (Spouse/Partner); Speaker’s Bureau: AstraZeneca Pharmaceuticals LP, AstraZeneca Pharmaceuticals LP (Spouse/Partner), Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Bristol-Myers Squibb Company (Spouse/Partner), Eli Lilly and Company (Spouse/Partner), Eli Lilly and Company, Novo Nordisk, Inc., Novo Nordisk, Inc. (Spouse/Partner), Sanofi (Spouse/Partner), Sanofi.
Gomez-Perez, Ana M. .......................... Disclosed no conflict of interest.Gonai, Megumi ..................................... Disclosed no conflict of interest.Goncalves, Natalia B. .......................... Disclosed no conflict of interest.Gonder-Frederick, Linda ........................ Consultant: Novo Nordisk, Inc.Gong, Chunxiu ....................................... Disclosed no conflict of interest.
Gong, Fangchao .................................... Disclosed no conflict of interest.Gong, Fengying ..................................... Disclosed no conflict of interest.Gong, Li T. ............................................ Disclosed no conflict of interest.Gong, Qi ................................................ Disclosed no conflict of interest.Gong, Qiuhong ...................................... Disclosed no conflict of interest.Gong, Zhenwei ...................................... Disclosed no conflict of interest.Gonzalez Mariscal, Isabel ..................... Disclosed no conflict of interest.Gonzalez, Adriana ................................. Disclosed no conflict of interest.Gonzalez, Claudio D. ............................ Employee: Merck.Gonzalez, Concepcion ........................... Disclosed no conflict of interest.Gonzalez, Erica V. ................................. Disclosed no conflict of interest.González, Frank ..................................... Disclosed no conflict of interest.Gonzalez, Jeffrey S. ............................. Disclosed no conflict of interest.Gonzalez, Joseph .................................. Disclosed no conflict of interest.Gonzalez, Manuel ................................. Disclosed no conflict of interest.González-Gálvez, Guillermo .................. Advisory Panel: AstraZeneca Pharmaceuticals LP, Boehringer
Goodarzi, Mark O. ................................ Disclosed no conflict of interest.Gooderham, Nigel ................................. Disclosed no conflict of interest.Goodman, Andrew ................................ Disclosed no conflict of interest.Goodpaster, Bret H. .............................. Disclosed no conflict of interest.Goodyear, Laurie J. .............................. Disclosed no conflict of interest.Gopal, Jayashree .................................. Speaker’s Bureau: Eli Lilly and Company, Novo Nordisk, Inc.,
USV.Gopalakrishnan, Gopikakrishnan .......... Disclosed no conflict of interest.Goran, Michael I. ................................. Disclosed no conflict of interest.Gorczynski, Paul .................................... Disclosed no conflict of interest.Gorden, Phillip ....................................... Disclosed no conflict of interest.Gordon, Jason ....................................... Research Support: AstraZeneca Pharmaceuticals LP, Bristol-
Myers Squibb Company, Eli Lilly and Company, GSK, Novo Nordisk, Inc., Sanofi, Takeda Pharmaceuticals U.S.A., Inc.
Gordon, Valerie ..................................... Disclosed no conflict of interest.Görgens, Sven W. ................................ Disclosed no conflict of interest.Gorgoglione, Matthew F. ..................... Employee: Pfizer, Inc.Goricar, Katja......................................... Disclosed no conflict of interest.Gorman, Mark ....................................... Disclosed no conflict of interest.Gorman, Tracy ....................................... Disclosed no conflict of interest.Gormsen, Lars C. .................................. Disclosed no conflict of interest.Gorska, Maria ....................................... Disclosed no conflict of interest.Goscik, Joanna ...................................... Disclosed no conflict of interest.Goto, Moritaka ...................................... Employee: Sanwa Kagaku Kenkyusho Co.,Ltd.Goto, Rieko ............................................ Disclosed no conflict of interest.Gottlieb, Peter A. ................................. Advisory Panel: Viacyte; Research Support: Omni
Biopharmaceuticals.Gotzamani-Psarrakou, Anna ................. Disclosed no conflict of interest.Gougeon, Claire .................................... Disclosed no conflict of interest.Gough, Stephen C. ............................... Board Member: Eli Lilly and Company, Novo Nordisk A/S;
Research Support: Novo Nordisk A/S, Takeda Pharmaceutical Company, Ltd.
Gougourelas, Dimitrios M. .................. Disclosed no conflict of interest.Goulden, Peter A. ................................. Disclosed no conflict of interest.Gourdy, Pierre ........................................ Board Member: Novo Nordisk A/S. Consultant: AstraZeneca
Pharmaceuticals LP, Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Merck Sharp & Dohme Limited, Novo Nordisk, Inc., Sanofi; Research Support: Sanofi.
Govind, M.K. ........................................ Disclosed no conflict of interest.Goyal, Abhinav ...................................... Disclosed no conflict of interest.Goyal, Akankasha ................................. Disclosed no conflict of interest.Goyeau, Harmonie ................................ Consultant: Sanofi.Gozdyra, Peter ....................................... Disclosed no conflict of interest.Graaff, Reindert .................................... Employee: Diagnoptics.Graber, Evan .......................................... Disclosed no conflict of interest.Grabman, Jesse H. .............................. Disclosed no conflict of interest.Grabner, Michael................................... Other Relationship: Sanofi US, Inc.Grace, Edward ....................................... Disclosed no conflict of interest.Grace, Mundu B. .................................. Disclosed no conflict of interest.Grady, Kathleen ..................................... Disclosed no conflict of interest.Grady, Mike ........................................... Employee: Lifescan Animas, Inc.Graessler, Juergen ................................ Disclosed no conflict of interest.Graf, Scott ............................................. Disclosed no conflict of interest.Graff, Emily C. ...................................... Disclosed no conflict of interest.Graham, Felicia ..................................... Disclosed no conflict of interest.Grallert, Harald ..................................... Disclosed no conflict of interest.Grande, Joseph P. ................................ Disclosed no conflict of interest.Grandinetti, Andrew ............................. Disclosed no conflict of interest.Grandjean, Peter W. ............................. Disclosed no conflict of interest.Grandy, Susan ....................................... Employee: AstraZeneca Pharmaceuticals LP; Stock/
Grant, David M. ................................... Research Support: AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Company, Eli Lilly and Company, GSK, Novo Nordisk, Inc., Sanofi, Takeda Pharmaceuticals U.S.A., Inc.
Grant, Denis M. ................................... Disclosed no conflict of interest.Grant, Eugene ....................................... Employee: Janssen Research & Development.Grant, Maria B. .................................... Disclosed no conflict of interest.Grant, Richard W. ................................ Disclosed no conflict of interest.Grant, Ryan W. ..................................... Disclosed no conflict of interest.Grant, Struan F.A. ................................. Disclosed no conflict of interest.Granville, David ..................................... Consultant: viDA Therapeutics Inc.Grarup, Niels ......................................... Disclosed no conflict of interest.Grasso, Daniel ....................................... Disclosed no conflict of interest.Graue-Hernandez, Enrique O. .............. Disclosed no conflict of interest.Gravholt, Claus H. ................................ Disclosed no conflict of interest.Gray, Benjamin J. ................................. Disclosed no conflict of interest.Gray, Nora ............................................. Disclosed no conflict of interest.Gray, Robyn ........................................... Disclosed no conflict of interest.Gray, Terry ............................................. Disclosed no conflict of interest.Greally, John M. .................................. Disclosed no conflict of interest.Greeley, Siri Atma W. .......................... Disclosed no conflict of interest.Green, Andrew J. ................................. Advisory Panel: AstraZeneca Pharmaceuticals LP.Green, Charlotte J. ............................... Disclosed no conflict of interest.Green, Christopher D. .......................... Disclosed no conflict of interest.Green, James ........................................ Employee: BHV Pharma; Stock/Shareholder: BHV Pharma.Green, Jennifer B. ................................ Consultant: Merck Sharp & Dohme Limited; Other
Green, Karin .......................................... Disclosed no conflict of interest.Green, Kelly ........................................... Disclosed no conflict of interest.Green, Tiffany ........................................ Disclosed no conflict of interest.Green, Todd ........................................... Disclosed no conflict of interest.Greenbaum, Carla J. ............................ Disclosed no conflict of interest.Greene, Michael W. ............................. Disclosed no conflict of interest.Greene, Shane ...................................... Disclosed no conflict of interest.Gregersen, Søren .................................. Disclosed no conflict of interest.Gregg, Brigid ......................................... Disclosed no conflict of interest.Gregg, Edward W. ................................ Disclosed no conflict of interest.Gregoire, Francine M. .......................... Employee: CrownBio.Gregori , Nadan ..................................... Disclosed no conflict of interest.Gregory, Justin M. ............................... Disclosed no conflict of interest.Gregory, Rob .......................................... Disclosed no conflict of interest.Greig, Marni .......................................... Research Support: NeuroMetrix.Greiner, Dale ......................................... Disclosed no conflict of interest.Greiner, Melissa .................................... Disclosed no conflict of interest.Greulich, Sabrina .................................. Disclosed no conflict of interest.Greve, Jan William ............................... Advisory Panel: GI Dynamics; Consultant: GI Dynamics.Grevstad, Ulrik ...................................... Disclosed no conflict of interest.Grewal, Gurtej ....................................... Disclosed no conflict of interest.Grey, Margaret ...................................... Disclosed no conflict of interest.Gribble, Fiona M. ................................. Disclosed no conflict of interest.Grice, Brian A. ...................................... Employee: NIDDK.Griffin, Peter S. .................................... Employee: Bristol-Myers Squibb Company.Griffin, Simon J. ................................... Disclosed no conflict of interest.Griffith, David A. .................................. Employee: Pfizer, Inc.Griffiths, Jane ....................................... Disclosed no conflict of interest.Griffiths, Lyn .......................................... Disclosed no conflict of interest.Griffiths, Rhonda ................................... Disclosed no conflict of interest.Griffo, Ettore ......................................... Disclosed no conflict of interest.Grigorescu, Florin .................................. Disclosed no conflict of interest.Grigoropoulou, Pinelopi ........................ Disclosed no conflict of interest.Grimes, Imogene ................................... Employee: TransTech Pharma.Grimsby, Joseph .................................... Employee: MedImmune.Grimshaw, Jeremy M. ......................... Disclosed no conflict of interest.Grinder-Hansen, Laura .......................... Disclosed no conflict of interest.Grineva, Elena N. ................................. Disclosed no conflict of interest.Griva, Theodora ..................................... Disclosed no conflict of interest.Groenier, Klaas H. ................................ Disclosed no conflict of interest.Groff, David N. ..................................... Disclosed no conflict of interest.Grogorenz, Jana .................................... Disclosed no conflict of interest.Grohl, Anke ........................................... Other Relationship: AstraZeneca Pharmaceuticals LP.Grønbæk, Henning ................................ Disclosed no conflict of interest.Grøndahl, Magnus ................................ Disclosed no conflict of interest.Grondin, Carine ..................................... Other Relationship: Novo Nordisk, Inc.Gronowski, Pawel ................................. Employee: Catermed.Groop, Leif ............................................. Disclosed no conflict of interest.Groop, Per-Henrik .................................. Board Member: Boehringer Ingelheim GmbH & Co. KG,
Novartis Pharmaceuticals Corporation; Research Support: Eli Lilly and Company, Roche Pharmaceuticals; Speaker’s Bureau: Boehringer Ingelheim GmbH & Co. KG, Cebix,
Inc., Eli Lilly and Company, Genzyme Corporation, Merck Sharp & Dohme Limited, Novartis Pharmaceuticals Corporation.
Bristol-Myers Squibb Company, Eli Lilly and Company, Novo Nordisk, Inc.; Research Support: Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, GlaxoSmithKline, Novo Nordisk, Inc.
Gross, Myron ......................................... Disclosed no conflict of interest.Grouthier, Virginie ................................. Disclosed no conflict of interest.Grove, Kaylene ...................................... Disclosed no conflict of interest.Grove, Kevin L. ..................................... Disclosed no conflict of interest.Grover, Nisha B. ................................... Disclosed no conflict of interest.Grübler, Martin ...................................... Disclosed no conflict of interest.Grunberger, George ............................... Consultant: Valeritas, LLC; Research Support: Valeritas, LLC;
Speaker’s Bureau: Valeritas, LLC.Grunnet, Louise G. ............................... Stock/Shareholder: Novo Nordisk A/S.Gruss, Stephanie ................................... Disclosed no conflict of interest.Grzanka, Malgorzata ............................. Research Support: Bioton.Grzeszczak, Wladyslaw ......................... Advisory Panel: Astra zeneca, Bms, Lilly, Novo nordisk,
Servier; Board Member: Astra zeneca, Bms, Lilly, Novo nordisk, Servier; Consultant: Astra zeneca, Bms, Lilly, Novo Nordisk, Servier; Speaker’s Bureau: Astra Zeneca, Bms, Lilly, Novo Nordisk, Servier.
Gu, Hui .................................................. Disclosed no conflict of interest.Gu, Quan ............................................... Disclosed no conflict of interest.Gu, Yi ..................................................... Disclosed no conflict of interest.Guadagnini, Dioze ................................. Disclosed no conflict of interest.Guan, Hongyu ........................................ Disclosed no conflict of interest.Guangyao, Song .................................... Disclosed no conflict of interest.Guariguata, Leonor ............................... Disclosed no conflict of interest.Guazzelli, Isabel C. ............................... Disclosed no conflict of interest.Gubitosi-Klug, Rose .............................. Disclosed no conflict of interest.Gudbjörnsdottir, Soffia .......................... Disclosed no conflict of interest.Gudiksen, Anders .................................. Disclosed no conflict of interest.Guebre-Egziabher, Fitsum ..................... Disclosed no conflict of interest.Guerci, Bruno ........................................ Disclosed no conflict of interest.Guérin, Brigitte ...................................... Disclosed no conflict of interest.Guerra, Yannis ....................................... Disclosed no conflict of interest.Guglielmi, Chiara .................................. Disclosed no conflict of interest.Guidotti, Stefnao ................................... Disclosed no conflict of interest.Guigard, Emmanuel ............................... Disclosed no conflict of interest.Guigni, Blas A. ..................................... Disclosed no conflict of interest.Guijarro de Armas, Guadalupe ............. Disclosed no conflict of interest.Guillaume, Charpentier ......................... Disclosed no conflict of interest.Guimarães, Alessandra ......................... Research Support: Sanofi.Gujral, Unjali P. ..................................... Disclosed no conflict of interest.Gulisano, Massimo ............................... Disclosed no conflict of interest.Gullestad, Lars ...................................... Disclosed no conflict of interest.Gulliford, Martin ................................... Disclosed no conflict of interest.Gumprecht, Janusz ............................... Consultant: Kowa, Lilly, Merck, Polpharma, Sharp&Dome;
Gumus Balikcioglu, Pinar ...................... Disclosed no conflict of interest.Gunasekaran, Uma ................................ Disclosed no conflict of interest.Gunawardana, Subhadra C. ................. Disclosed no conflict of interest.Gunderson, Erica P. .............................. Disclosed no conflict of interest.Gundu Rao, Nagashree ......................... Disclosed no conflict of interest.Gunnet, Joseph ..................................... Employee: Janssen Research & Development.Gunstad, John ....................................... Disclosed no conflict of interest.Guo, Deng-Fu ........................................ Disclosed no conflict of interest.Guo, Fangjian ........................................ Disclosed no conflict of interest.Guo, Huan ............................................. Disclosed no conflict of interest.Guo, Jianjin ........................................... Disclosed no conflict of interest.Guo, Lian ............................................... Disclosed no conflict of interest.Guo, Lixin .............................................. Research Support: Bayer Health Care, LLC.Guo, Peng .............................................. Disclosed no conflict of interest.Guo, Ping ............................................... Disclosed no conflict of interest.Guo, Qing .............................................. Disclosed no conflict of interest.Guo, Xiaohui .......................................... Disclosed no conflict of interest.Guo, Xingyi ............................................ Disclosed no conflict of interest.Guo, Xiuqing .......................................... Disclosed no conflict of interest.Guo, Yan ................................................ Disclosed no conflict of interest.Guo, Vivian ............................................ Disclosed no conflict of interest.Guo, Yichen ........................................... Disclosed no conflict of interest.Guo, Zhiguang ....................................... Disclosed no conflict of interest.Guo, Zhuyu ............................................ Disclosed no conflict of interest.Gupta, Aditi ........................................... Disclosed no conflict of interest.Gupta, Dhananjay ................................. Disclosed no conflict of interest.Gupta, Olga T. ...................................... Disclosed no conflict of interest.
Gur, Serap.............................................. Disclosed no conflict of interest.Gure, Tanya ........................................... Disclosed no conflict of interest.Gusdorf, Lisette ..................................... Disclosed no conflict of interest.Gustafson, Birgit ................................... Disclosed no conflict of interest.Gustafsson, Stefan ............................... Disclosed no conflict of interest.Gustavson, Stephanie ........................... Employee: TransTech Pharma.Gusto, Gaelle ........................................ Disclosed no conflict of interest.Gutaj, Paweł .......................................... Disclosed no conflict of interest.Guthikonda, Anu ................................... Disclosed no conflict of interest.Gutkowska, Jolanta .............................. Disclosed no conflict of interest.Gutteridge, Alex .................................... Employee: Pfizer, Inc.Guy, Vanessa ......................................... Disclosed no conflict of interest.Guyenet, Stephan J. ............................ Disclosed no conflict of interest.Guyton, Robert ...................................... Disclosed no conflict of interest.Guzzetta, Russell C. ............................. Disclosed no conflict of interest.Gydesen, Sofie ...................................... Employee: Nordic Bioscience A/S.Gyldenløve, Mette ................................ Disclosed no conflict of interest.Gyllenhammer, Lauren E. ..................... Disclosed no conflict of interest.Ha, Chae-Myeong ................................. Disclosed no conflict of interest.Ha, Eun Suk ........................................... Disclosed no conflict of interest.Ha, Hyekyung ........................................ Disclosed no conflict of interest.Ha, Jinkyung ......................................... Disclosed no conflict of interest.Haahr, Hanne L. .................................... Employee: Novo Nordisk A/S; Stock/Shareholder: Novo
Nordisk A/S.Haak, Thomas ....................................... Advisory Panel: Abbott Diabetes Care, AstraZeneca/Bristol-
Meyers Squibb, Insuline Medical, Roche Diagnostics Germany; Speaker’s Bureau: Abbott Diabetes Care, AstraZeneca/Bristol-Meyers Squibb, Boehringer Ingelheim GmbH & Co. KG, Eli Lilly and Company, Insuline Medical, Novo Nordisk A/S, Roche Diagnostics Germany.
Haas, Jutta ............................................ Disclosed no conflict of interest.Haas, Michael K. .................................. Disclosed no conflict of interest.Haataja, Leena ...................................... Disclosed no conflict of interest.Habegger, Kirk M. ................................ Disclosed no conflict of interest.Habener, Joel F. .................................... Disclosed no conflict of interest.Habibi, Javad ........................................ Disclosed no conflict of interest.Habtemichael, Estifanos N. ................. Disclosed no conflict of interest.Habu, Masako ....................................... Disclosed no conflict of interest.Hach, Thomas ....................................... Employee: Boehringer Ingelheim GmbH & Co. KG.Hackett, Andy P. ................................... Employee: PHT Corporation.Haczeyni, Fahrettin ............................... Disclosed no conflict of interest.Haddad, Christine ................................. Disclosed no conflict of interest.Hadi, Salah ............................................ Employee: PRA International; Research Support: Diamedica,
Inc.Hadjadj, Samy ....................................... Board Member: AstraZeneca Pharmaceuticals LP, Eli Lilly and
Company, Novo Nordisk A/S, Takeda Pharmaceutical Company, Ltd.; Consultant: Merck Sharp & Dohme Limited; Speaker’s Bureau: Merck Sharp & Dohme Limited, Novo Nordisk A/S, Novo Nordisk, Inc., Sanofi, Servier.
Haensler, Judith .................................... Disclosed no conflict of interest.Haering, Hans-Ulrich ............................. Disclosed no conflict of interest.Haering, Max-Felix ................................ Disclosed no conflict of interest.Haffner, Steven M. ............................... Disclosed no conflict of interest.Hafiane, Anouar .................................... Disclosed no conflict of interest.Hage Hassan, Rima ............................... Disclosed no conflict of interest.Haggar, Michelle ................................... Disclosed no conflict of interest.Haghiac, Maricela ................................. Disclosed no conflict of interest.Hagstedt, Therese ................................. Employee: AstraZeneca Pharmaceuticals LP.Hahn, Rebecca M. ................................ Research Support: GlaxoSmithKline.Hahn, Tom ............................................. Disclosed no conflict of interest.Haidar, Ahmad....................................... Disclosed no conflict of interest.Haidich, Betina ...................................... Disclosed no conflict of interest.Haigh, Geoffrey ..................................... Disclosed no conflict of interest.Haim, Alon ............................................ Disclosed no conflict of interest.Hainault, Isabelle .................................. Disclosed no conflict of interest.Hainer, Vojtech ...................................... Disclosed no conflict of interest.Hajduch, Eric ......................................... Disclosed no conflict of interest.Hajjaji, Issam M. .................................. Advisory Panel: Boehringer Ingelheim GmbH & Co. KG;
Speaker’s Bureau: Merck Sharp & Dohme Limited.Hajnsek, Martin .................................... Disclosed no conflict of interest.Hakami, Al Hussain M. ........................ Disclosed no conflict of interest.Halkos, Michael .................................... Disclosed no conflict of interest.Hall, Becky ............................................ Disclosed no conflict of interest.Hall, Ben A. .......................................... Disclosed no conflict of interest.Hall, Elin ................................................ Disclosed no conflict of interest.Hall, Keneth .......................................... Disclosed no conflict of interest.Hall, Michael N. ................................... Disclosed no conflict of interest.Hallakou-Bozec, Sophie ........................ Employee: Poxel.Haller, Michael J. ................................. Disclosed no conflict of interest.Halliday, Jennifer .................................. Disclosed no conflict of interest.Halm, Ethan A. ..................................... Disclosed no conflict of interest.
Halpern, Elise M. ................................. Disclosed no conflict of interest.Halseth, Amy E. ................................... Employee: Orexigen Therapeutics, Inc.; Stock/Shareholder:
Orexigen Therapeutics, Inc.Halushka, Marc H. ............................... Disclosed no conflict of interest.Haluzík, Martin ...................................... Advisory Panel: Boehringer Ingelheim Pharmaceuticals, Inc.,
Bristol-Myers Squibb Company, Eli Lilly and Company, Novo Nordisk A/S, Sanofi; Research Support: AstraZeneca/Bristol-Meyers Squibb, Eli Lilly and Company; Speaker’s Bureau: Eli Lilly and Company, Novo Nordisk A/S.
Ham, Dong-Sik ...................................... Disclosed no conflict of interest.Hamada, Yoji ......................................... Disclosed no conflict of interest.Hamaguchi, Masahide .......................... Disclosed no conflict of interest.Hamaguchi, Yuriko ................................ Disclosed no conflict of interest.Hamamoto, Yoshiyuki ........................... Research Support: Eli Lilly and Company.Hamano, Kumiko ................................... Disclosed no conflict of interest.Hamano, Kunihisa ................................. Disclosed no conflict of interest.Hamaty, Marwan .................................. Disclosed no conflict of interest.Hambidge, Bertha ................................. Disclosed no conflict of interest.Hamel, Frederick G. ............................. Disclosed no conflict of interest.Hamilton, Gavin .................................... Disclosed no conflict of interest.Hamilton, Marianthe ............................. Employee: Novo Nordisk, Inc.Hamilton, Marilyn ................................. Disclosed no conflict of interest.Hamilton, Robert T. .............................. Employee: Eli Lilly and Company, Eli Lilly and Company
(Spouse/Partner); Stock/Shareholder: Eli Lilly and Company, Eli Lilly and Company (Spouse/Partner).
Hamm, Megan E. ................................. Research Support: Becton, Dickinson and Company.Hammad, Samar ................................... Disclosed no conflict of interest.Hamman, Richard F. ............................. Disclosed no conflict of interest.Hammar, Mårten ................................... Employee: AstraZeneca Pharmaceuticals LP.Hammarstedt, Ann ................................ Disclosed no conflict of interest.Hammer, Marilyn J. ............................. Disclosed no conflict of interest.Hammer, Mette ..................................... Employee: Novo Nordisk, Inc.; Stock/Shareholder: Novo
Nordisk, Inc.Hammes, Hans Peter ............................ Disclosed no conflict of interest.Hamo-Tchatchouang, Eliane ................. Disclosed no conflict of interest.Hampe, Christiane S. ........................... Disclosed no conflict of interest.Han, Bok-Ghee ...................................... Disclosed no conflict of interest.Han, Christina ....................................... Disclosed no conflict of interest.Han, Je-ho ............................................. Disclosed no conflict of interest.Han, Jenny ............................................ Employee: Bristol-Myers Squibb Company.Han, Jing-Dong J. ................................ Disclosed no conflict of interest.Han, Ju-Young ....................................... Disclosed no conflict of interest.Han, Kwang-Hyub ................................. Disclosed no conflict of interest.Han, Kyung Ah ...................................... Disclosed no conflict of interest.Han, Ping ............................................... Disclosed no conflict of interest.Han, Seung Jin ...................................... Disclosed no conflict of interest.Han, Weiping ........................................ Disclosed no conflict of interest.Han, Xueyao .......................................... Disclosed no conflict of interest.Han, Yong Hwan ................................... Disclosed no conflict of interest.Hanai, Ko ............................................... Disclosed no conflict of interest.Hanas, Ragnar ....................................... Advisory Panel: Abbott Diabetes Care, Eli Lilly and Company,
NovoNordisk; Consultant: Medtronic; Speaker’s Bureau: Abbott Diabetes Care, Eli Lilly and Company, Medtronic, Sanofi.
Hancock, Tamara ................................... Disclosed no conflict of interest.Handa, Keiko ......................................... Disclosed no conflict of interest.Haneda, Masakazu ............................... Consultant: Taisho; Research Support: Boehringer Ingelheim
Pharmaceuticals, Inc., Eli Lilly and Company, Mitsubishi Tanabe Pharmaceutical Corporation, MSD, Novartis Pharmaceuticals Corporation, Novo Nordisk, Inc., Ono Pharmaceutical Co., Ltd., Sanofi, Sanwa Kagaku Kenkyusho Co, Ltd., Takeda Pharmaceutical Company, Ltd.
Hanefeld, Markolf ................................. Advisory Panel: Bristol-Myers Squibb Company, GlaxoSmithKline, Sanofi, Takeda Pharmaceuticals U.S.A., Inc.; Speaker’s Bureau: Bayer Health Care, LLC, Eli Lilly and Company, GlaxoSmithKline, Roche Pharmaceuticals, Sanofi, Takeda Pharmaceuticals U.S.A., Inc.
Hanif, Wasim ........................................ Disclosed no conflict of interest.Hanis, Craig L. ...................................... Disclosed no conflict of interest.Hanks, Chris .......................................... Disclosed no conflict of interest.Hanley, Anthony J. ............................... Disclosed no conflict of interest.Hanley, David A. .................................. Research Support: Pure North S’Energy Foundation.Hanley, Stephanie ................................. Disclosed no conflict of interest.Hannan, Karen ...................................... Disclosed no conflict of interest.Hannerz, Harald .................................... Disclosed no conflict of interest.Hannon, Tamara S. ............................... Disclosed no conflict of interest.Hannoun, Zara ....................................... Disclosed no conflict of interest.Hannukainen, Jarna C. ......................... Disclosed no conflict of interest.Hansen, Barbara C. .............................. Consultant: Merck, XOMA, Ltd.; Research Support: XOMA, Ltd.Hansen, Carsten P. ............................... Disclosed no conflict of interest.
Hansen, Christian S. ............................ Employee: Steno Diabetes Center A/S; Other Relationship: Steno Diabetes Center A/S.
Hansen, Henrik B. ................................ Disclosed no conflict of interest.Hansen, Jeffrey ..................................... Disclosed no conflict of interest.Hansen, Katrine B. ............................... Disclosed no conflict of interest.Hansen, Michael K. .............................. Employee: Janssen Research & Development.Hansen, Morten .................................... Disclosed no conflict of interest.Hansen, Søren B. ................................. Disclosed no conflict of interest.Hansen, Tine W. ................................... Employee: Steno Diabetes Center.Hansen, Torben ..................................... Other Relationship: Steno Diabetes Center A/S.Hanson, Robert L. ................................. Employee: NIDDK.Hanssen, Kristian F. ............................. Disclosed no conflict of interest.Hantel, Stefan ....................................... Employee: Boehringer Ingelheim GmbH & Co. KG.Hanusek, Ryan J. ................................. Employee: NIDDK.Hanyu, Osamu ....................................... Disclosed no conflict of interest.Hao, Jianqiang ...................................... Disclosed no conflict of interest.Hao, Jie ................................................. Disclosed no conflict of interest.Hao, Yaping ........................................... Disclosed no conflict of interest.Hara, Kanako ......................................... Disclosed no conflict of interest.Hara, Kenji ............................................ Disclosed no conflict of interest.Hara, Manami ....................................... Disclosed no conflict of interest.Harada, Mikiko ...................................... Disclosed no conflict of interest.Harada, Norio ........................................ Disclosed no conflict of interest.Harada, Takashi..................................... Disclosed no conflict of interest.Harada, Yoshifumi ................................. Employee: Teijin Pharma Limited.Harashima, Shin-ichi ............................. Disclosed no conflict of interest.Harcourt, Brooke E. .............................. Disclosed no conflict of interest.Hardy, Dale S. ...................................... Disclosed no conflict of interest.Hardy, Elise ........................................... Employee: AstraZeneca Pharmaceuticals LP; Stock/
Shareholder: AstraZeneca Pharmaceuticals LP.Hardy, Thomas A. ................................. Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly
and Company.Hare, David L. ....................................... Disclosed no conflict of interest.Häring, Hans-Ulrich ............................... Advisory Panel: Boehringer Ingelheim GmbH & Co. KG,
Harish, C. .............................................. Disclosed no conflict of interest.Harish, Ranjani ...................................... Disclosed no conflict of interest.Haritunians, Talin .................................. Disclosed no conflict of interest.Harlan, David M. .................................. Disclosed no conflict of interest.Harman-Boehm, Ilana ........................... Advisory Panel: Integrity Applications, Ltd.Harmsen, Hermie .................................. Disclosed no conflict of interest.Haro, Heidi ............................................ Disclosed no conflict of interest.Harrington, Daniel ................................. Disclosed no conflict of interest.Harrington, Kara R. .............................. Disclosed no conflict of interest.Harrington, T. Michael .......................... Research Support: Sanofi.Harris, Emma ......................................... Disclosed no conflict of interest.Harris, Michael A. ................................ Disclosed no conflict of interest.Harris, Robert A. .................................. Disclosed no conflict of interest.Harris, Ronald I. ................................... Disclosed no conflict of interest.Harris, Stewart B. ................................ Advisory Panel: Abbott Diabetes Care, Bristol-Myers Squibb/
AstraZeneca, Eli Lilly and Company, Janssen Pharmaceuticals, Merck, Novo Nordisk, Inc., Sanofi, Takeda Pharmaceutical Company, Ltd.; Research Support: Bristol-Myers Squibb/AstraZeneca, Janssen Pharmaceuticals, Merck, Novartis Pharmaceuticals Corporation, Novo Nordisk, Inc., Sanofi.
Harris, Tabitha ....................................... Disclosed no conflict of interest.Harrisberg, Brian ................................... Disclosed no conflict of interest.Harrison, Leonard C. ............................ Disclosed no conflict of interest.Harrod, Curtis S. .................................. Disclosed no conflict of interest.Hart, Graeme ......................................... Disclosed no conflict of interest.Hart, Huberta E. ................................... Disclosed no conflict of interest.Hart, Nathaniel J. ................................ Disclosed no conflict of interest.Hartline, Lee M. ................................... Disclosed no conflict of interest.Hartmann, Bolette ................................. Disclosed no conflict of interest.Hartnell, Sara ........................................ Disclosed no conflict of interest.Hartono, Stella P. ................................. Disclosed no conflict of interest.Hartvig, Helle ........................................ Employee: Novo Nordisk A/S; Stock/Shareholder: Novo
Nordisk A/S.Harwell, Todd S. ................................... Disclosed no conflict of interest.Hasan, Sana .......................................... Disclosed no conflict of interest.Hasan, Zuheir A. .................................. Disclosed no conflict of interest.Hasebe, Makiko .................................... Employee: Teijin Pharma Limited.Hasegawa, Goji ..................................... Disclosed no conflict of interest.Hasegawa, Hideki ................................. Disclosed no conflict of interest.Hasegawa, Makoto ............................... Disclosed no conflict of interest.Hasegawa, Noriko ................................ Disclosed no conflict of interest.Hasenour, Clinton M. ........................... Disclosed no conflict of interest.Hashiguchi, Jyunichiro .......................... Disclosed no conflict of interest.Hashimoto, Hiroyuki .............................. Employee: Sanwa Kagaku Kenkyusho Co.,Ltd.Hashimoto, Motomu ............................. Disclosed no conflict of interest.
Hashimoto, Shinichi .............................. Disclosed no conflict of interest.Hashimoto, Shinji .................................. Employee: Sanwa Kagaku Kenkyusho Co.,Ltd.Hashimoto, Takuya ................................ Disclosed no conflict of interest.Hashimoto, Tomomi .............................. Disclosed no conflict of interest.Hashimura, Kayako ............................... Disclosed no conflict of interest.Haskins, Kathryn ................................... Disclosed no conflict of interest.Hasko, Gyorgy ....................................... Disclosed no conflict of interest.Hasman, David ...................................... Disclosed no conflict of interest.Hassan, Hazem ..................................... Disclosed no conflict of interest.Hassan, Khan M. .................................. Disclosed no conflict of interest.Hassan, Mohammed O. ....................... Disclosed no conflict of interest.Hassoun, Ahmed A. ............................. Advisory Panel: AstraZeneca/Bristol-Meyers Squibb,
Boehringer Ingelheim/Eli Lilly, MerckSerono, MSD, Novartis Pharma AG, Novo-Nordisk, Sanofi Aventis; Other Relationship: MerckSerono, Novartis Pharma AG; Research Support: Eli Lilly and Company, Novartis Pharma AG.
Hastings, Jon ........................................ Disclosed no conflict of interest.Hastings, Stephanie M. ....................... Disclosed no conflict of interest.Hastings, Timothy ................................. Disclosed no conflict of interest.Hata, Akiko ............................................ Disclosed no conflict of interest.Hata, Masaki ......................................... Disclosed no conflict of interest.Hatakeyama, Hiroyasu .......................... Disclosed no conflict of interest.Hatanaka, Takashi ................................. Disclosed no conflict of interest.Hathway, Joanne .................................. Disclosed no conflict of interest.Hattersley, Andrew T. .......................... Disclosed no conflict of interest.Hattori, Yutaka ...................................... Disclosed no conflict of interest.Hatunic, Mensud ................................... Disclosed no conflict of interest.Hatzis, George ....................................... Disclosed no conflict of interest.Hatzitolios, Apostolos I. ....................... Disclosed no conflict of interest.Haug, Cornelia ...................................... Disclosed no conflict of interest.Hauguel-de Mouzon, Sylvie .................. Disclosed no conflict of interest.Haukka, Jari .......................................... Disclosed no conflict of interest.Hauksson, Jón ....................................... Disclosed no conflict of interest.Haumea, Stacy ...................................... Disclosed no conflict of interest.Haumschild, Mark J. ............................ Employee: Sanofi; Stock/Shareholder: Sanofi.Haus, Jacob M. .................................... Disclosed no conflict of interest.Hausding, Michael ................................ Disclosed no conflict of interest.Hauser, Robert....................................... Employee: Biodel, Inc.; Stock/Shareholder: Biodel, Inc.Hausmann, Leslie .................................. Disclosed no conflict of interest.Havel, Peter J. ...................................... Disclosed no conflict of interest.Hawkins, Meredith ............................... Disclosed no conflict of interest.Hay, Jacqueline ..................................... Disclosed no conflict of interest.Hay, William W. ................................... Disclosed no conflict of interest.Hayashi, Reiko D. ................................. Disclosed no conflict of interest.Hayashi, Tomoshige .............................. Disclosed no conflict of interest.Hayashi, Toshio ..................................... Disclosed no conflict of interest.Hayashizaki, Yuka ................................. Disclosed no conflict of interest.Hayden, Christine .................................. Disclosed no conflict of interest.Hayden, Melvin R. ................................ Disclosed no conflict of interest.Hayes, Clarice ....................................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly
and Company.Hayes, Geoff ......................................... Disclosed no conflict of interest.Hayes, John M. .................................... Disclosed no conflict of interest.Hayes, Risa P. ....................................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly
and Company.Hayes, Stella ......................................... Disclosed no conflict of interest.Haymond, Morey W. ............................ Disclosed no conflict of interest.Haynes, Kevin ....................................... Disclosed no conflict of interest.Hay-Schmidt, Anders ............................ Disclosed no conflict of interest.Haywood, Natalie J. ............................ Disclosed no conflict of interest.Hazan, Shir ............................................ Disclosed no conflict of interest.Hazlett, Linda J. ................................... Disclosed no conflict of interest.Hazuda, Helen ....................................... Disclosed no conflict of interest.He, Guang ............................................. Disclosed no conflict of interest.He, Jian Hua ......................................... Disclosed no conflict of interest.He, Lan .................................................. Research Support: CUHK Focused Investment, Hong Kong
Foundation for Research and Development in Diabetes, Sanofi.
He, Ping ................................................. Disclosed no conflict of interest.He, Qing ................................................ Disclosed no conflict of interest.He, Rui ................................................... Disclosed no conflict of interest.He, Sheng-qing ..................................... Disclosed no conflict of interest.He, Xiaoming ......................................... Disclosed no conflict of interest.He, Xiaoying .......................................... Disclosed no conflict of interest.He, Zhiheng ........................................... Disclosed no conflict of interest.He, Zhi-Min ........................................... Disclosed no conflict of interest.Heald, Adrian H. ................................... Disclosed no conflict of interest.Healy, Sara J. ....................................... Disclosed no conflict of interest.Hebert, Catherine .................................. Disclosed no conflict of interest.Hecht, Joan ........................................... Disclosed no conflict of interest.Hedderson, Monique M. ...................... Research Support: Takeda Pharmaceutical Company, Ltd.Hedrington, Maka S. ............................ Disclosed no conflict of interest.
Heer, Martina ........................................ Advisory Panel: Bayer Health Care, LLC; Consultant: Bayer Health Care, LLC, Wyle Labs Gmbh; Employee: Profil.
Hehnke, Uwe ......................................... Employee: Boehringer Ingelheim GmbH & Co. KG.Heianza, Yoriko ..................................... Disclosed no conflict of interest.Heier, Margit ......................................... Disclosed no conflict of interest.Heinemann, Lutz ................................... Advisory Panel: Abbott Diabetes Care, Biodel, Inc., Roche
Diagnostics, Sanofi; Research Support: Adocia, Becton, Biocon, Boehringer Ingelheim GmbH & Co. KG, Bristol-Myers Squibb Company, Dance Pharmaceuticals, Dickinson and Company, Eli Lilly and Company, Evolva, Hoffman La Roche, Johnson & Johnson, Marvel, Novartis Pharmaceuticals Corporation, Novo Nordisk A/S, Sanofi, Servier; Speaker’s Bureau: Roche Diagnostics, Sanofi.
Heinrich, Joachim ................................. Disclosed no conflict of interest.Heise, Tim ............................................. Advisory Panel: Novo Nordisk, Inc.; Other Relationship: Novo
Nordisk; Research Support: Adocia, Becton, Dickinson and Company, Biocon, Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Dance Pharmaceuticals, Eli Lilly and Company, Evolva, Hoffman La Roche, Johnson & Johnson, Marvel Pharmaceuticals, Novartis Pharma AG, Novo Nordisk, Inc., Sanofi, Servier; Speaker’s Bureau: Eli Lilly and Company, Novo Nordisk, Inc.
Heisel, Olaf ........................................... Research Support: Merck.Heisler, Michele .................................... Disclosed no conflict of interest.Heitmeier, Monique .............................. Disclosed no conflict of interest.Hejna, Jeanne ....................................... Disclosed no conflict of interest.Helbling, Nikki L. .................................. Disclosed no conflict of interest.Helgerson, Steven D. ........................... Disclosed no conflict of interest.Helgeson, Vicki...................................... Disclosed no conflict of interest.Heller, Simon R. ................................... Advisory Panel: Eli Lilly and Company, Novo Nordisk A/S,
Takeda Pharmaceutical Company, Ltd.; Consultant: Eli Lilly and Company, Lifescan Animas, Inc., Novo Nordisk, Inc., Sanofi. Research Support: Medtronic; Speaker’s Bureau: Eli Lilly and Company, Novo Nordisk A/S, Takeda Pharmaceutical Company, Ltd.
Hellerstein, Marc .................................. Employee: KineMed, Inc.; Stock/Shareholder: KineMed, Inc.Hellmann, Jason ................................... Disclosed no conflict of interest.Hempe, James M. ............................... Disclosed no conflict of interest.Hemphill, Kafi ....................................... Disclosed no conflict of interest.Hempler, Nana F. .................................. Other Relationship: Novo Nordisk A/S.Hendel, Jakob W. ................................. Disclosed no conflict of interest.Henderson, Celia ................................... Disclosed no conflict of interest.Henderson, Gregory C. ......................... Disclosed no conflict of interest.Hendrickson, Karrie ............................... Disclosed no conflict of interest.Hendrickson-Nelson, Mary ................... Disclosed no conflict of interest.Hendry, Diana ........................................ Disclosed no conflict of interest.Heni, Martin .......................................... Disclosed no conflict of interest.Henk, Henry J. ...................................... Consultant: Janssen Pharmaceuticals; Employee:
OptumInsight.Henkin, Leora F. .................................... Disclosed no conflict of interest.Hennenlotter, Jörg ................................ Disclosed no conflict of interest.Hennige, Anita M. ................................ Disclosed no conflict of interest.Hennild, Ditte E. ................................... Disclosed no conflict of interest.Henninger, Josefin A. .......................... Disclosed no conflict of interest.Henriksen, Jan Erik ............................... Disclosed no conflict of interest.Henriksen, Kim ...................................... Employee: Nordic Bioscience A/S.Henriksen, Tore ..................................... Disclosed no conflict of interest.Henry, Robert R. ................................... Advisory Panel: Amgen, Inc., AstraZeneca Pharmaceuticals LP,
Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Daiichi-Sankyo, Inc., Elcelyx Therapeutics, Inc., Eli Lilly and Company, Genentech, Gilead Sciences, Inc., Intarcia Therapeutics, Inc., Janssen Pharmaceuticals, Johnson & Johnson, Merck, Novartis Pharmaceuticals Corporation, Roche Pharmaceuticals, Sanofi-Aventis, Vivus, Inc.; Consultant: Alere, Boehringer Ingelheim Pharmaceuticals, Inc., Clin Met, Eisai, Inc., Eli Lilly and Company, Genentech, Gilead Sciences, Inc., Hitachi Chemical Research Center, Inc., Intarcia Therapeutics, Inc., Isis Pharmaceuticals, Novo Nordisk, Inc., Roche Pharmaceuticals, Sanofi-Aventis, Vivus, Inc.; Research Support: AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Company, Eli Lilly and Company, Sanofi-Aventis.
Henshaw, Frances R. ........................... Disclosed no conflict of interest.Heppelmann, Carrie-Jo ......................... Disclosed no conflict of interest.Heptulla, Rubina A. .............................. Research Support: Lexicon Pharmaceuticals, Inc., NIH; Stock/
Shareholder: Thermalin Diabetes, LLC.Herbelin, Laura ...................................... Disclosed no conflict of interest.Herbert, Ben .......................................... Disclosed no conflict of interest.Herbert, Linda J. .................................. Disclosed no conflict of interest.
Herder, Christian ................................... Disclosed no conflict of interest.Herebian, Diran ..................................... Disclosed no conflict of interest.Hering, Berhnard J. .............................. Consultant: Novartis Pharmaceuticals Corporation, Novo
Nordisk, Inc., Otsuka Pharmaceutical Group, Sanofi.Herman, Mark A. ................................. Disclosed no conflict of interest.Herman, William H. ............................. Disclosed no conflict of interest.Hermann, Julia M. ............................... Disclosed no conflict of interest.Hermanns, Iris ....................................... Disclosed no conflict of interest.Hermanns, Norbert ............................... Advisory Panel: Abbott Diabetes Care, Eli Lilly and Company;
Research Support: Berlin Chemie AG, Roche Diagnostics Germany; Speaker’s Bureau: Berlin Chemie AG, Eli Lilly and Company, Insuline Medical, Novo Nordisk A/S.
Hermans, Michel P. .............................. Disclosed no conflict of interest.Hernandez, Adrian ................................ Research Support: AstraZeneca Pharmaceuticals LP, Bristol-
Myers Squibb Company.Hernandez, Chihiro ................................ Disclosed no conflict of interest.Hernández, Cristina ............................... Disclosed no conflict of interest.Hernández, Virginia ............................... Disclosed no conflict of interest.Hernandez-Triana, Eric .......................... Advisory Panel: AstraZeneca Pharmaceuticals LP, Boehringer
Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Merck, Sanofi; Research Support: AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Janssen Pharmaceuticals, Novartis Pharmaceuticals Corporation, Novo Nordisk, Inc., Roche Pharmaceuticals, Sanofi; Speaker’s Bureau: AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Merck, Novo Nordisk, Inc., Sanofi.
Hero, Christel ........................................ Disclosed no conflict of interest.Herold, Kevan ........................................ Research Support: Macrogenics, Inc.Herraiz, Miguel A. ................................ Disclosed no conflict of interest.Herrero, Ignacio .................................... Disclosed no conflict of interest.Hershey, Tamara.................................... Disclosed no conflict of interest.Hershkop, Karen J. ............................... Disclosed no conflict of interest.Hershkovitz, Eli ...................................... Disclosed no conflict of interest.Hershon, Ken ......................................... Disclosed no conflict of interest.Hertel, Jens K. ..................................... Disclosed no conflict of interest.Herz, Matthias ...................................... Employee: F. Hoffmann-La Roche, Ltd.; Stock/Shareholder: F.
Hoffmann-La Roche, Ltd.Herzfeld de Wiza, Daniella ................... Disclosed no conflict of interest.Hess, Katharina ..................................... Disclosed no conflict of interest.Hessler, Danielle M. ............................ Disclosed no conflict of interest.Heuer, Loretta J. .................................. Disclosed no conflict of interest.Heusser, Karsten ................................... Disclosed no conflict of interest.Hewitt, Holly ......................................... Disclosed no conflict of interest.Heyden, Josine ..................................... Disclosed no conflict of interest.Heymans, Martijn W. ........................... Research Support: Novo Nordisk A/S.Hhou, Hongying ..................................... Disclosed no conflict of interest.Hiatt, William R. .................................. Disclosed no conflict of interest.Hickner, Robert C. ................................ Disclosed no conflict of interest.Hidalgo, Bertha ..................................... Disclosed no conflict of interest.Hiden, Ursula ........................................ Disclosed no conflict of interest.Hidvegi, Tibor ........................................ Advisory Panel: 77 Electronics, Ltd.Hieshima, Kunio .................................... Disclosed no conflict of interest.Higa, Mariko ......................................... Disclosed no conflict of interest.Higashide, Takashi ................................ Disclosed no conflict of interest.Highland, Heather M. .......................... Disclosed no conflict of interest.Hildago, Bertha ..................................... Disclosed no conflict of interest.Hill Golden, Sherita ............................... Disclosed no conflict of interest.Hill, Bradford ......................................... Disclosed no conflict of interest.Hill, David J. ......................................... Disclosed no conflict of interest.Hill, Jessica L. ...................................... Disclosed no conflict of interest.Hill, Martin ............................................ Disclosed no conflict of interest.Hillard, Mallory A. ............................... Disclosed no conflict of interest.Hilliard, Marisa E. ................................ Disclosed no conflict of interest.Hillman, Sara ........................................ Disclosed no conflict of interest.Hilsted, Linda ........................................ Disclosed no conflict of interest.Himeno, Tatsuhito ................................. Disclosed no conflict of interest.Himmerick, Katherine A. ...................... Disclosed no conflict of interest.Hincelin-Méry, Agnès ........................... Employee: Sanofi.Hinder, Lucy M. .................................... Disclosed no conflict of interest.Hines, Adriane K. ................................. Disclosed no conflict of interest.Hines, Harrison ..................................... Disclosed no conflict of interest.Hingst, Janne R. ................................... Disclosed no conflict of interest.Hinshaw, Ling ........................................ Disclosed no conflict of interest.Hirai, Aizan ............................................ Disclosed no conflict of interest.Hirai, Keiji ............................................. Disclosed no conflict of interest.Hiraki, Linda T. ..................................... Disclosed no conflict of interest.Hirano, Hisato ....................................... Disclosed no conflict of interest.Hirano, Seiki .......................................... Disclosed no conflict of interest.
Hirano, Tsutomu .................................... Research Support: Sanwa Kagaku Kenkyusho Co.,Ltd.Hirao, Rieko A. ..................................... Disclosed no conflict of interest.Hirate, Mitsuru ...................................... Disclosed no conflict of interest.Hire, Don ............................................... Disclosed no conflict of interest.Hirose, Ayumi ........................................ Disclosed no conflict of interest.Hirose, Jun ............................................ Disclosed no conflict of interest.Hirose, Masakazu ................................. Disclosed no conflict of interest.Hirsch, Irl B. .......................................... Consultant: Abbott Diabetes Care, Roche Pharmaceuticals;
Research Support: Halozyme Therapeutics, Sanofi.Hirsch, Jan D. ....................................... Disclosed no conflict of interest.Hirschhorn, Joel N. .............................. Disclosed no conflict of interest.Hirshberg, Boaz ..................................... Employee: AstraZeneca/Bristol-Meyers Squibb.Hirshman, Michael F. ........................... Disclosed no conflict of interest.Hirukawa, Hidenori ............................... Disclosed no conflict of interest.Hishida, Ai ............................................. Disclosed no conflict of interest.Hitchcock, Christine .............................. Disclosed no conflict of interest.Hitman, Graham .................................... Advisory Panel: Eli Lilly and Company; Consultant:
GlaxoSmithKline; Other Relationship: Pfizer, Inc.; Research Support: Eli Lilly and Company; Speaker’s Bureau: Eli Lilly and Company.
Hivert, Marie-France ............................. Disclosed no conflict of interest.Hjelmesæth, Jøran ............................... Disclosed no conflict of interest.Hjort, Line .............................................. Stock/Shareholder: Novo Nordisk A/S.Hjuler, Sara T. ....................................... Employee: Nordic Bioscience A/S.Ho, Cheng .............................................. Disclosed no conflict of interest.Ho, Kai Fai ............................................. Consultant: Janssen Research & Development, LLC.Ho, Kevin ............................................... Consultant: ZS Pharma Inc.; Other Relationship: Partners
Healthcare.Ho, Sam ................................................. Disclosed no conflict of interest.Hoagland-Fuchs, Nancy ........................ Disclosed no conflict of interest.Hobizal, Kimberlee B. ........................... Disclosed no conflict of interest.Hocher, Berthold.................................... Disclosed no conflict of interest.Hocking, Samantha L. .......................... Disclosed no conflict of interest.Hoda, Mohamed N. .............................. Disclosed no conflict of interest.Hodson, Leanne .................................... Disclosed no conflict of interest.Hoebaus, Clemens ................................ Disclosed no conflict of interest.Hoekstra, Joost ..................................... Advisory Panel: AstraZeneca/Bristol-Meyers Squibb.Hoel Andersen, Rune ............................ Employee: Lilly pharmaceutical.Hoell, Bernhard ..................................... Disclosed no conflict of interest.Hoene, Miriam ...................................... Disclosed no conflict of interest.Hofer, Sabine E. ................................... Disclosed no conflict of interest.Hoffman, Amnon ................................... Disclosed no conflict of interest.Hoffman, Duncan .................................. Disclosed no conflict of interest.Hoffman, Rachel S. .............................. Disclosed no conflict of interest.Hoffmann, Daniela ................................ Disclosed no conflict of interest.Hoffmann, Udo ...................................... Disclosed no conflict of interest.Hofmann, Karin ..................................... Disclosed no conflict of interest.Hogan, Andrew E. ................................ Disclosed no conflict of interest.Hoitsma, Andries J. ............................. Disclosed no conflict of interest.Højlund, Kurt ......................................... Disclosed no conflict of interest.Hokanson, John E. ............................... Disclosed no conflict of interest.Holden, Candice .................................... Disclosed no conflict of interest.Holewa, Danielle D. ............................. Employee: Metabolic Solutions Development Co.Holl, Jane .............................................. Disclosed no conflict of interest.Holl, Reinhard W. ................................. Disclosed no conflict of interest.Holland, Jenna ...................................... Disclosed no conflict of interest.Holland, M. Claire ................................. Employee: GlaxoSmithKline; Stock/Shareholder:
GlaxoSmithKline.Holland, Melissa ................................... Disclosed no conflict of interest.Hollander, Kenneth................................ Disclosed no conflict of interest.Hollander, Priscilla ................................ Advisory Panel: Johnson & Johnson, Merck, Novo Nordisk,
Inc., Roche Pharmaceuticals.Holleman, Frits ...................................... Advisory Panel: Johnson & Johnson, Sanofi.Hollenbeak, Christopher S. .................. Consultant: Amgen, Inc., Sanofi, Thermo Fisher Scientific,
United BioSource Corporation; Research Support: CDC, NIH.
Hollenberg, Anthony ............................. Disclosed no conflict of interest.Höller, Vera ............................................ Disclosed no conflict of interest.Hollingsworth, Kieren G. ..................... Disclosed no conflict of interest.Hollister-Lock, Jennifer ......................... Disclosed no conflict of interest.Holloway, John ..................................... Disclosed no conflict of interest.Holman, Rury R. ................................... Advisory Panel: Amylin/Eli Lilly, Merck, Novartis Pharma AG,
Novo Nordisk A/S; Research Support: Amylin Pharmaceuticals, Inc., Bayer Health Care, LLC, Merck Sharp & Dohme Limited, Novartis Pharmaceuticals Corporation; Speaker’s Bureau: Amylin/Eli Lilly, Bayer Health Care, LLC, Merck.
Holst, Birgitte ........................................ Disclosed no conflict of interest.Holst, Jens J. ....................................... Advisory Panel: GlaxoSmithKline, Merck Sharp & Dohme
Limited, Novartis Pharmaceuticals Corporation, Novo Nordisk A/S; Research Support: Merck Sharp & Dohme Limited, Novo Nordisk A/S; Speaker’s Bureau:
GlaxoSmithKline, Merck Sharp & Dohme Limited, Novo Nordisk A/S.
Holub, Zachary ...................................... Disclosed no conflict of interest.Homann, Joanna ................................... Disclosed no conflict of interest.Home, Philip .......................................... Advisory Panel: AstraZeneca/Bristol-Meyers Squibb,
GlaxoSmithKline, Janssen Pharmaceuticals, Johnson & Johnson, Merck Sharp & Dohme Limited, Novo Nordisk A/S, Roche Diagnostics, Roche Pharmaceuticals, Sanofi, SkyePharma, Takeda Pharmaceutical Company, Ltd.; Research Support: Eli Lilly and Company, GlaxoSmithKline, Sanofi; Speaker’s Bureau: AstraZeneca/Bristol-Meyers Squibb, Eli Lilly and Company, GlaxoSmithKline, Merck Sharp & Dohme Limited, Novo Nordisk A/S, Sanofi.
Homma, Tsuneaki .................................. Disclosed no conflict of interest.Hompesch, Marcus ............................... Employee: Profil Institute for Clinical Research, Inc.; Research
Support: Novo Nordisk A/S; Stock/Shareholder: Profil Institute for Clinical Research, Inc.
Honarpour, Narimon .............................. Employee: Amgen, Inc.Hong, Eun Shil ....................................... Disclosed no conflict of interest.Hong, Ho Cheol ..................................... Disclosed no conflict of interest.Hong, Jun-Hwa ..................................... Disclosed no conflict of interest.Hong, KyungHee ................................... Disclosed no conflict of interest.Hong, Sang Mo ..................................... Disclosed no conflict of interest.Hong, Sangmo ....................................... Disclosed no conflict of interest.Hong, Seong BIn ................................... Disclosed no conflict of interest.Hong, Soo Min ...................................... Disclosed no conflict of interest.Hongwu, Zhang ..................................... Disclosed no conflict of interest.Honjo, Jun ............................................. Disclosed no conflict of interest.Honjo, Sachiko ...................................... Disclosed no conflict of interest.Honka, Henri ......................................... Disclosed no conflict of interest.Hoo, Ruby L. ......................................... Disclosed no conflict of interest.Hood, Anita ........................................... Disclosed no conflict of interest.Hood, Korey K. ..................................... Disclosed no conflict of interest.Hood, Megan M. .................................. Disclosed no conflict of interest.Hoogenberg, Klaas ................................ Disclosed no conflict of interest.Hopkins, David ...................................... Advisory Panel: Novo Nordisk A/S, Roche, Sanofi; Research
Support: Novo Nordisk A/S; Speaker’s Bureau: Bristol-Myers Squibb/AstraZeneca, Eli Lilly and Company, Novo Nordisk A/S.
Hopper-Borge, Elizabeth A. .................. Disclosed no conflict of interest.Hora, Israel ............................................ Disclosed no conflict of interest.Horcsik, Dorottya .................................. Disclosed no conflict of interest.Horenstein, Richard B. ......................... Disclosed no conflict of interest.Horii, Takeshi......................................... Disclosed no conflict of interest.Horikawa, Chika .................................... Disclosed no conflict of interest.Horikawa, Yukio .................................... Disclosed no conflict of interest.Horman, Keren ...................................... Employee: Integrity Applications, Ltd.Horne, Benjamin D. .............................. Research Support: Intermountain Research and Medical
Foundation.Hornemann, Silke .................................. Disclosed no conflict of interest.Horowitz, Jeffrey F. .............................. Disclosed no conflict of interest.Horowitz, Michael ................................. Advisory Panel: AstraZeneca Pharmaceuticals LP, Novartis
Pharmaceuticals Corporation; Research Support: Eli Lilly and Company, Novartis Pharmaceuticals Corporation, Sanofi; Speaker’s Bureau: Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Merck Sharp & Dohme Limited, Sanofi; Stock/Shareholder: Satiogen Pharmaceuticals, Inc.
Horton, Claire ........................................ Disclosed no conflict of interest.Horton, Edward S. ................................ Disclosed no conflict of interest.Horvath, Tamas ..................................... Disclosed no conflict of interest.Hoskin, Mary ......................................... Disclosed no conflict of interest.Hosking, Joanne ................................... Disclosed no conflict of interest.Hosoda, Kiminori ................................... Disclosed no conflict of interest.Hosokawa, Masaya .............................. Disclosed no conflict of interest.Hosokawa, Saho ................................... Disclosed no conflict of interest.Hosokawa, Yoshiya ............................... Disclosed no conflict of interest.Hotaling, James .................................... Disclosed no conflict of interest.Hothersall, Eleanor ............................... Disclosed no conflict of interest.Hoti, Fabian ........................................... Disclosed no conflict of interest.Hotta, Nigishi ........................................ Disclosed no conflict of interest.Hou, Hongying ....................................... Disclosed no conflict of interest.Hou, Wolin ............................................ Disclosed no conflict of interest.Hou, Xuhong .......................................... Disclosed no conflict of interest.Houde, Ghislaine ................................... Disclosed no conflict of interest.Houin, Satya .......................................... Disclosed no conflict of interest.Houlbert, Dominique ............................. Disclosed no conflict of interest.Houlihan, Christine A. .......................... Disclosed no conflict of interest.Houmard, Joseph A. ............................ Disclosed no conflict of interest.Houweling, Sebastiaan ......................... Disclosed no conflict of interest.Hövelmann, Ulrike ................................. Disclosed no conflict of interest.
Hovorka, Roman .................................... Advisory Panel: Animas Corporation, Eli Lilly and Company, Medtronic MiniMed, Inc.; Consultant: B. Braun Melsungen AG, Becton, Dickinson and Company, Profil Institute for Clinical Research, Inc., Sanofi; Other Relationship: B. Braun Melsungen AG, Becton, Dickinson and Company; Speaker’s Bureau: B. Braun Melsungen AG, Eli Lilly and Company, Lifescan Animas, Inc., Medtronic MiniMed, Inc., Novo Nordisk, Inc.
Howard, Gabrielle ................................. Disclosed no conflict of interest.Howard, Neville .................................... Disclosed no conflict of interest.Howell, Mary E. ................................... Disclosed no conflict of interest.Howman-Giles, Robert .......................... Disclosed no conflict of interest.Hoyles, Lesley ....................................... Disclosed no conflict of interest.Hruz, Paul W. ........................................ Disclosed no conflict of interest.Hryniewicka, Justyna ............................ Disclosed no conflict of interest.Hsiao, Hui W. ....................................... Disclosed no conflict of interest.Hsiao, Wen-Chi ..................................... Disclosed no conflict of interest.Hsieh, Yueh-Chun .................................. Disclosed no conflict of interest.Hsu, Ching ............................................. Employee: Daiichi-Sankyo, Inc.Hsu, Ivy .................................................. Disclosed no conflict of interest.Hsu, Jasper ........................................... Disclosed no conflict of interest.Hsu, Jean W. ........................................ Disclosed no conflict of interest.Hsu, Kevin ............................................. Disclosed no conflict of interest.Hsu, Stephen I. ..................................... Board Member: Prometheon Pharma, LLC; Employee:
Hsu, William C. .................................... Advisory Panel: Novo Nordisk A/S.Hsueh, Wen-Chi .................................... Disclosed no conflict of interest.Hsueh, Willa A. .................................... Disclosed no conflict of interest.Hu, Cheng .............................................. Disclosed no conflict of interest.Hu, Frank B. .......................................... Research Support: Merck & Co., Inc.Hu, Hai-rong .......................................... Disclosed no conflict of interest.Hu, Ji ..................................................... Disclosed no conflict of interest.Hu, Jiang ............................................... Disclosed no conflict of interest.Hu, Li ..................................................... Disclosed no conflict of interest.Hu, Reming ............................................ Disclosed no conflict of interest.Hu, Wenxiu............................................ Disclosed no conflict of interest.Hu, Xiaodi .............................................. Disclosed no conflict of interest.Hu, Yang ................................................ Disclosed no conflict of interest.Hu, Yanyun ............................................ Disclosed no conflict of interest.Hu, Yi-Han ............................................. Disclosed no conflict of interest.Hu, Yinghua ........................................... Disclosed no conflict of interest.Hu, Zhimin ............................................. Disclosed no conflict of interest.Hua, Cyue-Huei ..................................... Disclosed no conflict of interest.Hua, Tzu-En ........................................... Disclosed no conflict of interest.Huang, April .......................................... Employee: Bayer.Huang, Chien N. ................................... Disclosed no conflict of interest.Huang, Chuan-Chuan ............................ Disclosed no conflict of interest.Huang, Elbert ........................................ Disclosed no conflict of interest.Huang, Guofeng .................................... Disclosed no conflict of interest.Huang, Hui ............................................ Disclosed no conflict of interest.Huang, Jean .......................................... Disclosed no conflict of interest.Huang, Jin E. ........................................ Disclosed no conflict of interest.Huang, Jun-Yuan ................................... Disclosed no conflict of interest.Huang, Ke .............................................. Disclosed no conflict of interest.Huang, Paul L. ...................................... Disclosed no conflict of interest.Huang, Qianfang ................................... Disclosed no conflict of interest.Huang, Shuyue ...................................... Disclosed no conflict of interest.Huang, Suiying ...................................... Employee: Medtronic.Huang, TianLian .................................... Disclosed no conflict of interest.Huang, Tianyi ........................................ Disclosed no conflict of interest.Huang, Tze-Pao ..................................... Disclosed no conflict of interest.Huang, Xiaofei ...................................... Disclosed no conflict of interest.Huang, Yan ............................................ Disclosed no conflict of interest.Huang, Yi ............................................... Disclosed no conflict of interest.Huang, Yihe ........................................... Disclosed no conflict of interest.Huang, Ying ........................................... Disclosed no conflict of interest.Huang, Yu .............................................. Disclosed no conflict of interest.Huang, Yueye ........................................ Disclosed no conflict of interest.Huang, Yun ............................................ Disclosed no conflict of interest.Huang, Zhen Ru ..................................... Disclosed no conflict of interest.Huang, Zhimin ....................................... Disclosed no conflict of interest.Hubal, Monica J. .................................. Disclosed no conflict of interest.Hudson, Krischan .................................. Employee: Pfizer, Inc.; Stock/Shareholder: Pfizer, Inc.Hudson, Margo S. ................................ Disclosed no conflict of interest.Hudson, Megan ..................................... Disclosed no conflict of interest.Hue, Christophe .................................... Disclosed no conflict of interest.Huebert, Norman .................................. Employee: Janssen Research & Development.Huerta-Saenz, Lina ................................ Disclosed no conflict of interest.Huet, Beverley ....................................... Disclosed no conflict of interest.Huete, Alvaro ........................................ Disclosed no conflict of interest.
Huffman, Jennifer E. ............................ Disclosed no conflict of interest.Huggins, Gordon ................................... Disclosed no conflict of interest.Hughes, Katelyn J. ............................... Disclosed no conflict of interest.Hughes, Thomas A. .............................. Disclosed no conflict of interest.Hui, Elaine ............................................. Disclosed no conflict of interest.Huikari, Ville .......................................... Disclosed no conflict of interest.Huising, Mark O. .................................. Disclosed no conflict of interest.Hull, Rebecca L. ................................... Research Support: Eli Lilly and Company.Hulme, Maigan A. ................................ Disclosed no conflict of interest.Hung, Ming-Shiu ................................... Disclosed no conflict of interest.Hung, Peter ........................................... Disclosed no conflict of interest.Hung, Wei Ting ..................................... Disclosed no conflict of interest.Hung, Yi-Jen.......................................... Disclosed no conflict of interest.Hunt, Sharon ......................................... Research Support: Sanofi.Huo, Jenny ............................................ Disclosed no conflict of interest.Hur, Junguk ........................................... Disclosed no conflict of interest.Hur, Kyu Yeon ........................................ Disclosed no conflict of interest.Hurley, Timothy ..................................... Employee: DIApedia, LLC; Stock/Shareholder: DIApedia, LLC,
Pfizer, Inc.Hurren, Nicholas M. ............................ Disclosed no conflict of interest.Hurwitz, Barry ....................................... Disclosed no conflict of interest.Huse, Daniel M. ................................... Consultant: DJO Global.Hussey, Sophie E. ................................ Disclosed no conflict of interest.Huster, William J. ................................ Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly
and Company.Hutchens, Troy J. ................................. Disclosed no conflict of interest.Huyghe, Jeroen R. ................................ Disclosed no conflict of interest.Huynh, Jennifer ..................................... Disclosed no conflict of interest.Hvas Mortensen, Laust ......................... Disclosed no conflict of interest.Hwang, Byung-Hee ............................... Disclosed no conflict of interest.Hwang, Daehee .................................... Disclosed no conflict of interest.Hwang, Eun Sook .................................. Disclosed no conflict of interest.Hwang, Janice J. ................................. Disclosed no conflict of interest.Hwang, Jessica L. ................................ Disclosed no conflict of interest.Hwang, Joo-Yeon .................................. Disclosed no conflict of interest.Hwang, Misun ....................................... Disclosed no conflict of interest.Hyland, Kristen ...................................... Research Support: Sanofi.Hysing, Mari .......................................... Disclosed no conflict of interest.Iacopi, Elisabetta .................................. Disclosed no conflict of interest.Iannilli, Antonio ..................................... Disclosed no conflict of interest.Ibdah, Jamal A. .................................... Disclosed no conflict of interest.Ichihara, Takako .................................... Disclosed no conflict of interest.Ichii, Hirohito ......................................... Disclosed no conflict of interest.Ichijo, Takamasa.................................... Disclosed no conflict of interest.Iciek, Rafał ............................................ Disclosed no conflict of interest.Idzior-Walus, Barbara ........................... Disclosed no conflict of interest.Igase, Michiya ....................................... Disclosed no conflict of interest.Iglay, Kristy ............................................ Employee: Merck.Ignácio de Souza, Letícia M. ............... Disclosed no conflict of interest.Ignaut, Debra A. ................................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly
and Company.Iida, Hitoshi ........................................... Disclosed no conflict of interest.Iijima, Toshie ......................................... Disclosed no conflict of interest.Iizuka, Katsumi ...................................... Disclosed no conflict of interest.Ikeda, Fuki ............................................. Speaker’s Bureau: Abbott Diabetes Care, Boehringer
Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Medtronic, Novartis Pharmaceuticals Corporation, Sanofi.
Ikeda, Hiroki .......................................... Disclosed no conflict of interest.Ikeda, Kaori ........................................... Disclosed no conflict of interest.Ikeda, Shinichiro ................................... Disclosed no conflict of interest.Ikeda, Takahide ..................................... Disclosed no conflict of interest.Ikeda, Yukio ........................................... Disclosed no conflict of interest.Ikeno, Yu ................................................ Disclosed no conflict of interest.Ikezoe, Seriko ........................................ Disclosed no conflict of interest.Ikura, Kazuki .......................................... Disclosed no conflict of interest.Ikuta, Atsuko ......................................... Disclosed no conflict of interest.Ilag, Liza ................................................ Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly
and Company.Iliadis, Fotios ......................................... Disclosed no conflict of interest.Ilkavets, Iryna ........................................ Disclosed no conflict of interest.Ilkayeva, Olga ........................................ Research Support: Pfizer, Inc.Ilonen, Jorma ........................................ Disclosed no conflict of interest.Im, Hae K. ............................................. Disclosed no conflict of interest.Imai, Hirohisa ........................................ Disclosed no conflict of interest.Imai, Junta ............................................ Disclosed no conflict of interest.Imamine, Rui ......................................... Disclosed no conflict of interest.Imamura, Minako .................................. Disclosed no conflict of interest.Imamura, Satoshi .................................. Disclosed no conflict of interest.Imamura, Shigeki .................................. Disclosed no conflict of interest.Imamura, Tomohiro ............................... Disclosed no conflict of interest.Imani Nejad, Maryam ........................... Disclosed no conflict of interest.Imes, Sharleeen .................................... Disclosed no conflict of interest.
Immonen, Heidi ..................................... Disclosed no conflict of interest.Imperatore, Giuseppina ........................ Disclosed no conflict of interest.Improta, Maria Rosaria ......................... Disclosed no conflict of interest.Imran, Naeem ....................................... Disclosed no conflict of interest.Imrie, Helen ........................................... Disclosed no conflict of interest.Ina, Koichiro .......................................... Disclosed no conflict of interest.Inaba, Masaaki ..................................... Disclosed no conflict of interest.Inaba, Wataru ....................................... Disclosed no conflict of interest.Inagaki, Katsunori ................................. Disclosed no conflict of interest.Inagaki, Nobuya .................................... Consultant: GSK, Mitsubishi Tanabe Pharmaceutical
Inagaki, Noriko ...................................... Disclosed no conflict of interest.Inashima, Kunikazu ............................... Disclosed no conflict of interest.Inata, Kento ........................................... Disclosed no conflict of interest.Incalza, Maria Angela ........................... Disclosed no conflict of interest.Ingelsson, Erik ....................................... Disclosed no conflict of interest.Ingersoll, Karen ..................................... Disclosed no conflict of interest.Ingerson, Alyssa .................................... Disclosed no conflict of interest.Ingvast, Sofie ........................................ Disclosed no conflict of interest.Inoguchi, Toyoshi................................... Disclosed no conflict of interest.Inoue, Tsuyoshi ...................................... Disclosed no conflict of interest.Inoue, Yuichiro ...................................... Disclosed no conflict of interest.Inskip, Hazel M. ................................... Disclosed no conflict of interest.Inui, Yoshiaki ......................................... Disclosed no conflict of interest.Inukai, Kouichi ....................................... Disclosed no conflict of interest.Inukai, Toshihiko.................................... Disclosed no conflict of interest.Inverardi, Luca ....................................... Disclosed no conflict of interest.Inzucchi, Silvio E. ................................. Disclosed no conflict of interest.Ionut, Viorica ......................................... Disclosed no conflict of interest.Iovane, Brunella .................................... Disclosed no conflict of interest.Iovino, Salvatore ................................... Disclosed no conflict of interest.Iozzo, Patricia ........................................ Disclosed no conflict of interest.Ip, Wilfred ............................................. Disclosed no conflict of interest.Iqbal, Ahmed ......................................... Disclosed no conflict of interest.Iqbal, Nayyar ......................................... Employee: Bristol-Myers Squibb Company; Stock/Shareholder:
Bristol-Myers Squibb Company.Iqbal, Romaina ...................................... Disclosed no conflict of interest.Irarrazabal, Pablo .................................. Disclosed no conflict of interest.Irie, Junichiro ........................................ Disclosed no conflict of interest.Irribarra, V. ............................................ Disclosed no conflict of interest.Irshad, Zehra ......................................... Disclosed no conflict of interest.Irving, Brian A. ..................................... Disclosed no conflict of interest.Irwin, Nigel ........................................... Stock/Shareholder: Diabetica Ltd.Isaacs, Charles J. ................................. Disclosed no conflict of interest.Isasi, Carmen ........................................ Disclosed no conflict of interest.Ishfaq, Tasneem .................................... Disclosed no conflict of interest.Ishida, Hitoshi ....................................... Disclosed no conflict of interest.Ishida, Kanae ........................................ Disclosed no conflict of interest.Ishigaki, Yasushi ................................... Disclosed no conflict of interest.Ishiguro, Hajime .................................... Disclosed no conflict of interest.Ishihara, Hisamitsu ............................... Disclosed no conflict of interest.Ishii, Katsuhisa ...................................... Disclosed no conflict of interest.Ishii, Yoko .............................................. Disclosed no conflict of interest.Ishikado, Atsushi ................................... Disclosed no conflict of interest.Ishiki, Manabu ...................................... Disclosed no conflict of interest.Ishimatsu, Masaru ................................ Disclosed no conflict of interest.Ishizaki, Akemi ...................................... Disclosed no conflict of interest.Ishizawa, Sho ........................................ Disclosed no conflict of interest.Ishizu, Tamiko ........................................ Disclosed no conflict of interest.Ishizuka, Naoki ...................................... Disclosed no conflict of interest.Ishizuka, Tatsuo ..................................... Disclosed no conflict of interest.Islam, Ashequl ...................................... Disclosed no conflict of interest.Islam, Sadia .......................................... Disclosed no conflict of interest.Isobe, Ken-ichi ...................................... Disclosed no conflict of interest.Isom, Scott ............................................ Disclosed no conflict of interest.Isshiki, Keiji ........................................... Disclosed no conflict of interest.Itagaki, Eiji ............................................ Disclosed no conflict of interest.Itani, Mohamed B. ............................... Disclosed no conflict of interest.Itaya-Hironaka, Asako ........................... Disclosed no conflict of interest.
Ito, Hideki .............................................. Disclosed no conflict of interest.Ito, Sachiko ........................................... Disclosed no conflict of interest.Ito, Yuma ............................................... Disclosed no conflict of interest.Itoh, Hiroshi ........................................... Disclosed no conflict of interest.Itoh, Nobuyuki ....................................... Disclosed no conflict of interest.Itoh, Takeshi .......................................... Disclosed no conflict of interest.Iurciuc, Mircea ...................................... Disclosed no conflict of interest.Iurciuc, Stela ......................................... Disclosed no conflict of interest.Ivey, Robert ........................................... Disclosed no conflict of interest.Ivovic, Alexander ................................... Disclosed no conflict of interest.Iwabu, Masato ...................................... Disclosed no conflict of interest.Iwabu, Miki O. ...................................... Disclosed no conflict of interest.Iwamoto, Taku ....................................... Disclosed no conflict of interest.Iwamoto, Yasuhiko ................................ Research Support: Merck Sharp & Dohme Limited, Novartis
Iwase, Hiroya ........................................ Disclosed no conflict of interest.Iwashita, Misaki ................................... Disclosed no conflict of interest.Iwata, Minoru ....................................... Disclosed no conflict of interest.Iwata, Shinpei ....................................... Disclosed no conflict of interest.Iwata, Takanori...................................... Disclosed no conflict of interest.Iwata, Yasunori ..................................... Disclosed no conflict of interest.Iyer, Dinakar V. ..................................... Disclosed no conflict of interest.Iyer, Malini ............................................ Disclosed no conflict of interest.Izaola, Olatz ........................................... Disclosed no conflict of interest.Izawa, Shoichiro .................................... Disclosed no conflict of interest.Izquierdo, Nuria ..................................... Disclosed no conflict of interest.Izumi, Kazuo .......................................... Disclosed no conflict of interest.Izuora, Kenneth ..................................... Research Support: Sanofi.Jaacks, Lindsay M. .............................. Research Support: Sanofi.Jaber, Yaya ............................................ Disclosed no conflict of interest.Jablonski, Kathleen A. ......................... Disclosed no conflict of interest.Jackson, Anne U. ................................. Disclosed no conflict of interest.Jackson, Josephine .............................. Disclosed no conflict of interest.Jackson, Richard A. ............................. Disclosed no conflict of interest.Jackson, Sabrina N. ............................. Disclosed no conflict of interest.Jackson, Sandra L. ............................... Research Support: Amylin/Eli Lilly.Jackuliak, Peter ..................................... Disclosed no conflict of interest.Jacober, Scott J. .................................. Employee: Eli Lilly and Company.Jacobs, Joely ........................................ Disclosed no conflict of interest.Jacobs, Peter ........................................ Disclosed no conflict of interest.Jacobs, Sol ............................................ Disclosed no conflict of interest.Jacobsen, Elizabeth A. ......................... Disclosed no conflict of interest.Jacobsen, Judith L. .............................. Consultant: Novo Nordisk A/S.Jacobsen, Siv H. .................................. Disclosed no conflict of interest.Jacobson, David A. .............................. Disclosed no conflict of interest.Jacome, Jose Antonio .......................... Disclosed no conflict of interest.Jacovetti, Cécile ................................... Disclosed no conflict of interest.Jaddoe, Vincent .................................... Disclosed no conflict of interest.Jaeger, Cassie ....................................... Disclosed no conflict of interest.Jaekel, Karsten ..................................... Employee: F. Hoffmann-La Roche, Ltd.Jafari, Najmeh ...................................... Disclosed no conflict of interest.Jafari, Noushin ..................................... Disclosed no conflict of interest.Jaffe, Anat ............................................ Disclosed no conflict of interest.Jagannath, M.R. .................................. Disclosed no conflict of interest.Jagasia, Shubhada M. ......................... Disclosed no conflict of interest.Jager, Kitty ............................................ Disclosed no conflict of interest.Jaghab, Justin J. ................................. Disclosed no conflict of interest.Jagienicki, Maciej ................................. Disclosed no conflict of interest.Jahn, Linda ............................................ Disclosed no conflict of interest.Jahnsen, Frode ...................................... Disclosed no conflict of interest.Jahoor, Farook ....................................... Disclosed no conflict of interest.Jaideep, Singh ...................................... Disclosed no conflict of interest.Jain, Nibha N. ...................................... Disclosed no conflict of interest.Jain, Sushil K. ...................................... Disclosed no conflict of interest.Jaishy, Bharat P. ................................... Disclosed no conflict of interest.Jaiswal, Mamta .................................... Disclosed no conflict of interest.Jaju, Deepali S. .................................... Disclosed no conflict of interest.Jakaitis, Daniel ..................................... Disclosed no conflict of interest.Jakosdottir, Johanna............................. Disclosed no conflict of interest.Jakubowicz, Daniela ............................. Disclosed no conflict of interest.Jalali, Seyed A. .................................... Disclosed no conflict of interest.James, Cathryn ..................................... Disclosed no conflict of interest.James, Freyja D. .................................. Disclosed no conflict of interest.James, June R. .................................... Advisory Panel: Sanofi; Speaker’s Bureau: Bristol-Myers
James, Lisa K. ...................................... Disclosed no conflict of interest.James-Todd, Tamarra ............................ Disclosed no conflict of interest.Jan, Junfeng ......................................... Disclosed no conflict of interest.Janas, Izabela ....................................... Disclosed no conflict of interest.Janez, Andrej ........................................ Disclosed no conflict of interest.Jang, Hak Chul ...................................... Disclosed no conflict of interest.Jang, Hyun-Ju ....................................... Disclosed no conflict of interest.Janí ková Ž árská, Denisa ..................... Disclosed no conflict of interest.Jankovec, Zdenek ................................. Disclosed no conflict of interest.Jankowiak, Frank .................................. Disclosed no conflict of interest.Jankowski, Marek ................................. Disclosed no conflict of interest.Janmey, Paul A. ................................... Disclosed no conflict of interest.Jansen, Henry J. .................................. Disclosed no conflict of interest.Jansen, Ignace ...................................... Disclosed no conflict of interest.Jansky, Gerhard .................................... Disclosed no conflict of interest.Jansson, Leif ......................................... Disclosed no conflict of interest.Jansson, Per-Anders ............................. Disclosed no conflict of interest.Januszewski, Andrzej S. ...................... Disclosed no conflict of interest.Jaremko, Malgorzata ............................ Disclosed no conflict of interest.Jariwala, Ravi H. .................................. Disclosed no conflict of interest.Jasien, Christine L. .............................. Disclosed no conflict of interest.Jastreboff, Ania M. ............................. Other Relationship: Pfizer, Inc.Jax, Thomas .......................................... Disclosed no conflict of interest.Jayagopal, Ashwath ............................. Disclosed no conflict of interest.Jayatillake, Harsha ............................... Disclosed no conflict of interest.Jazbec, Anamarija ................................ Disclosed no conflict of interest.Jean, Moise-Denis K. .......................... Disclosed no conflict of interest.Jeandidier, Nathalie.............................. Board Member: Novo Nordisk, Inc.Jefferson, Leonard S. ........................... Disclosed no conflict of interest.Jeffery, Alison N. ................................. Disclosed no conflict of interest.Jeffries, Sue .......................................... Disclosed no conflict of interest.Jeganathan, Ramesh ............................ Disclosed no conflict of interest.Jelaska, Ante ........................................ Employee: Boehringer Ingelheim Pharmaceuticals, Inc.Jelenik, Tomas ...................................... Disclosed no conflict of interest.Jelodar, Gholamali ................................ Disclosed no conflict of interest.Jelodar, Sina ......................................... Disclosed no conflict of interest.Jelsing, Jacob ....................................... Employee: Gubra ApS.Jena, Bhanu P. ...................................... Disclosed no conflict of interest.Jendle, Johan ....................................... Advisory Panel: Boehringer Ingelheim Pharmaceuticals, Inc.,
Bristol-Myers Squibb Company, Eli Lilly and Company, Janssen Pharmaceuticals, Medtronic, Novo Nordisk, Inc., Roche Diagnostics; Research Support: Novo Nordisk, Inc.; Speaker’s Bureau: AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Novo Nordisk, Inc., Pfizer, Inc.
Jenkins, Alicia J. .................................. Advisory Panel: Medtronic; Research Support: Aventis, Eli Lilly and Company, Medtronic, Novo Nordisk, Inc., Sanofi; Speaker’s Bureau: Abbott Laboratories, Inc., Animas Corporation, Medtronic.
Jennings, Paul ....................................... Disclosed no conflict of interest.Jennings, Richard ................................. Disclosed no conflict of interest.Jensen, Christine B. ............................. Employee: Novo Nordisk, Inc.; Stock/Shareholder: Novo
Nordisk A/S.Jensen, Dorte M. ................................. Research Support: Novo Nordisk A/S.Jensen, Henrik Holm ............................. Consultant: Novo Nordisk A/S.Jensen, Jens E. .................................... Disclosed no conflict of interest.Jensen, Lene ......................................... Employee: Novo Nordisk A/S; Stock/Shareholder: Novo
Nordisk A/S.Jensen, Magnus T. ............................... Disclosed no conflict of interest.Jensen, Marie Markert ......................... Employee: Novo Nordisk A/S; Stock/Shareholder: Novo
Nordisk A/S.Jensen, Richard A. ............................... Disclosed no conflict of interest.Jensen, Troels M. ................................ Employee: Steno Diabetes Center A/S; Stock/Shareholder:
Novo Nordisk A/S.Jensterle Sever, Mojca ......................... Disclosed no conflict of interest.Jenum, Anne K. .................................... Disclosed no conflict of interest.Jeon, Eun Kyong ................................... Disclosed no conflict of interest.Jeon, Ja Young ..................................... Disclosed no conflict of interest.Jeon, Ja Youong ................................... Disclosed no conflict of interest.Jeon, Tae Joo ........................................ Disclosed no conflict of interest.Jeon, Yun Kyung ................................... Disclosed no conflict of interest.Jeong, Hana .......................................... Disclosed no conflict of interest.Jeong, Jong-Gab ................................... Disclosed no conflict of interest.Jeong-taek, Woo................................... Research Support: Sanofi.Jeoung, Nam Ho ................................... Disclosed no conflict of interest.Jeppesen, Jacob ................................... Disclosed no conflict of interest.Jepsen, Sara L. .................................... Disclosed no conflict of interest.Jermendy, Adam L. .............................. Disclosed no conflict of interest.Jermendy, György ................................. Advisory Panel: 77 Electronics, Ltd.Jerry, Joseph ......................................... Disclosed no conflict of interest.Jerums, George ..................................... Disclosed no conflict of interest.Jessen, Niels ........................................ Disclosed no conflict of interest.
Jetton, Thomas L. ................................ Disclosed no conflict of interest.Jeyaraman, Kirthika .............................. Disclosed no conflict of interest.Jeziorska, Maria ................................... Disclosed no conflict of interest.Jhund, Pardeep S. ................................ Disclosed no conflict of interest.Ji, Lele ................................................... Disclosed no conflict of interest.Ji, Linong ............................................... Advisory Panel: Bristol-Myers Squibb Company, Eli Lilly and
Company, Novo Nordisk, Inc., Sanofi.Ji, Qiuhe ................................................ Disclosed no conflict of interest.Jia, Weiping .......................................... Research Support: Bristol-Myers Squibb/AstraZeneca.Jialal, Ishwarlal .................................... Disclosed no conflict of interest.Jiaming, Li ............................................. Disclosed no conflict of interest.Jiang, Boyi ............................................ Disclosed no conflict of interest.Jiang, Fei ............................................... Disclosed no conflict of interest.Jiang, Honghua ..................................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly
and Company.Jiang, Hualiang ..................................... Disclosed no conflict of interest.Jiang, Jiahui ......................................... Disclosed no conflict of interest.Jiang, Luohua ........................................ Disclosed no conflict of interest.Jiang, Zhen Y. ...................................... Disclosed no conflict of interest.Jianghua, Liu ......................................... Disclosed no conflict of interest.Jianwen, Cai ......................................... Disclosed no conflict of interest.Ji-Cao, Jingwei ..................................... Disclosed no conflict of interest.Jiménez Ortega, Angelines ................... Disclosed no conflict of interest.Jimenez, James J. ............................... Disclosed no conflict of interest.Jimenez, Sandra ................................... Disclosed no conflict of interest.Jimenez-Corona, Aida ........................... Disclosed no conflict of interest.Jimenez-Corona, Leonardo ................... Disclosed no conflict of interest.Jimenez-Corona, Maria-Eugenia .......... Disclosed no conflict of interest.Jiménez-Moreno, Carmen M. .............. Disclosed no conflict of interest.Jimenez-Palomares, Margarita ............ Disclosed no conflict of interest.Jin, Heung Yong .................................... Disclosed no conflict of interest.Jin, Liang ............................................... Disclosed no conflict of interest.Jin, Mengshi ......................................... Disclosed no conflict of interest.Jin, Sang-Man ...................................... Disclosed no conflict of interest.Jin, Tianrong ......................................... Disclosed no conflict of interest.Jin, Tianru ............................................. Disclosed no conflict of interest.Jin, Wen ................................................ Disclosed no conflict of interest.Jin, Zhuqiu ............................................ Disclosed no conflict of interest.Jing, Enxuan .......................................... Disclosed no conflict of interest.Jing, Gu ................................................. Disclosed no conflict of interest.Jing, Li ................................................... Disclosed no conflict of interest.Jing, Ya-li .............................................. Disclosed no conflict of interest.Jing, Zhong ........................................... Disclosed no conflict of interest.Jinga, Mariana ...................................... Disclosed no conflict of interest.JingLu, Zhang ........................................ Disclosed no conflict of interest.Jinnouchi, Hideaki ................................ Disclosed no conflict of interest.Jinnouchi, Tomio ................................... Disclosed no conflict of interest.Jirkovska, Jarmila ................................. Disclosed no conflict of interest.Jiroutek, Michael R. ............................. Disclosed no conflict of interest.Jo, Kwan Hoon ...................................... Disclosed no conflict of interest.Jo, Sehee .............................................. Disclosed no conflict of interest.Jodar, Esteban....................................... Consultant: BMS/AZ, FAES, MSD, Novartis, NovoNordisk;
Joensen, Lene E. .................................. Other Relationship: Novo Nordisk A/S.Jofre-Bonet, Mireia .............................. Disclosed no conflict of interest.Joh, Takashi .......................................... Disclosed no conflict of interest.Johannsen, Darcy L. ............................. Disclosed no conflict of interest.Johansen, Nanna B. ............................. Employee: Steno Diabetes Center A/S; Stock/Shareholder:
Novo Nordisk A/S.Johansen, Odd Erik ............................... Employee: Boehringer Ingelheim GmbH & Co. KG.Johansen, Pierre ................................... Disclosed no conflict of interest.Johansen, Thue ..................................... Employee: Novo Nordisk A/S; Stock/Shareholder: Novo
Nordisk A/S.Johansson, Ingegerd ............................. Disclosed no conflict of interest.Johansson, Jan ..................................... Other Relationship: CEO, Artery Therapeutics.Johansson, Stefan ................................ Disclosed no conflict of interest.John, Reggie ......................................... Disclosed no conflict of interest.Johns, Michael ..................................... Disclosed no conflict of interest.Johnson II, Theodore M. ...................... Disclosed no conflict of interest.Johnson Oakes, Diana .......................... Disclosed no conflict of interest.Johnson, Andrea ................................... Disclosed no conflict of interest.Johnson, C. Michael ............................. Disclosed no conflict of interest.Johnson, Carolyn C. ............................. Disclosed no conflict of interest.Johnson, Cathryn .................................. Disclosed no conflict of interest.Johnson, Geoffrey S. ........................... Disclosed no conflict of interest.Johnson, Ian .......................................... Disclosed no conflict of interest.Johnson, James D. .............................. Disclosed no conflict of interest.Johnson, Jeffrey A. .............................. Disclosed no conflict of interest.
Johnson, Justin ..................................... Disclosed no conflict of interest.Johnson, Lonnie .................................... Disclosed no conflict of interest.Johnson, Matthew E. ........................... Disclosed no conflict of interest.Johnson, Matthew L. ........................... Disclosed no conflict of interest.Johnson, Nicole .................................... Disclosed no conflict of interest.Johnson, Paul E. ................................... Disclosed no conflict of interest.Johnson, Richard J. ............................. Disclosed no conflict of interest.Johnson, Steven T. ............................... Disclosed no conflict of interest.Johnson, Susan ..................................... Employee: GlaxoSmithKline; Stock/Shareholder:
GlaxoSmithKline.Johnson, Suzanne B. ............................ Disclosed no conflict of interest.Johnson-Newell, Doreen ...................... Disclosed no conflict of interest.Johnsson, Eva ....................................... Employee: AstraZeneca Pharmaceuticals LP, AstraZeneca
Pharmaceuticals LP (Spouse/Partner).Johnsson, Kristina M. .......................... Employee: AstraZeneca Pharmaceuticals LP.Johnston, Desmond G. ........................ Disclosed no conflict of interest.Johnston, Luke W. ............................... Disclosed no conflict of interest.Johnston, Stephen ................................ Employee: Truven Health Analytics.Johnstone, Bryan .................................. Employee: Sanofi; Stock/Shareholder: Eli Lilly and Company,
Sanofi.Jojima, Teruo......................................... Disclosed no conflict of interest.Joly, Erik ................................................ Disclosed no conflict of interest.Jomori, Takahito.................................... Employee: Sanwa Kagaku Kenkyusho Co.,Ltd.Joner, Geir ............................................. Disclosed no conflict of interest.Jones, Barton ........................................ Disclosed no conflict of interest.Jones, Deborah ..................................... Disclosed no conflict of interest.Jones, Gregory C. ................................. Disclosed no conflict of interest.Jones, Jocelyn ...................................... Disclosed no conflict of interest.Jones, John G. ..................................... Disclosed no conflict of interest.Jones, Karen L. .................................... Disclosed no conflict of interest.Jones, Lisa ............................................ Disclosed no conflict of interest.Jones, M. Danielle ................................ Disclosed no conflict of interest.Jones, Peter M. .................................... Disclosed no conflict of interest.Jones, Terry E. ...................................... Disclosed no conflict of interest.Jones, Timothy W. ............................... Disclosed no conflict of interest.Jones, Wendy ....................................... Disclosed no conflict of interest.Jones-Leone, Angela ............................ Employee: GlaxoSmithKline; Stock/Shareholder:
GlaxoSmithKline.Jonscher, Karen R. ............................... Disclosed no conflict of interest.Jonsson, Anna E. ................................. Disclosed no conflict of interest.Joo, Erina .............................................. Disclosed no conflict of interest.Jordan, Jens ......................................... Consultant: Novartis Pharma AG, Sanofi Aventis, Vivus, Inc.;
Jordy, Andreas B. ................................. Disclosed no conflict of interest.Jørgensen, Jens O. .............................. Disclosed no conflict of interest.Jørgensen, Marit E. ............................. Employee: Steno Diabetes Center A/S; Stock/Shareholder:
Novo Nordisk A/S.Jorgensen, Nils B. ................................ Disclosed no conflict of interest.Jørgensen, Peter G. ............................. Disclosed no conflict of interest.Jørgensen, Sine W. .............................. Disclosed no conflict of interest.Jornayvaz, François R. ......................... Disclosed no conflict of interest.Jornsay, Donna L. ................................ Other Relationship: Eli Lilly and Company; Stock/Shareholder:
Medtronic MiniMed, Inc.Jorsal, Tina ............................................ Disclosed no conflict of interest.Joseph, Franklin .................................... Disclosed no conflict of interest.Joseph, Jalaja ....................................... Disclosed no conflict of interest.Joseph, Jeffrey ..................................... Advisory Panel: Becton, Dickinson and Company, Echo
Joseph, Lawrence ................................. Disclosed no conflict of interest.Joshi, Shashank .................................... Disclosed no conflict of interest.Joshi, Shilpa S. .................................... Disclosed no conflict of interest.Joshipura, Kaumudi .............................. Disclosed no conflict of interest.Joshua, Thomas .................................... Disclosed no conflict of interest.Josiah Willock, Robina ......................... Disclosed no conflict of interest.Jothydev, Sunitha ................................. Disclosed no conflict of interest.Joubert, Michael ................................... Disclosed no conflict of interest.Jourdan, Tony ........................................ Disclosed no conflict of interest.Jovanovic, Lois ...................................... Research Support: Dexcom, Inc., Insulet Corporation, Lifescan
Animas, Inc., Novo Nordisk, Inc., Sanofi.Joy, Nino G. ......................................... Disclosed no conflict of interest.Joy, Tisha .............................................. Disclosed no conflict of interest.Jozkowicz, Alicja ................................... Disclosed no conflict of interest.Ju, Alana ............................................... Disclosed no conflict of interest.Ju, Cythia .............................................. Disclosed no conflict of interest.Juang, Charity ....................................... Disclosed no conflict of interest.Juang, Jyuhn-Huarng ............................ Disclosed no conflict of interest.Jubrias, Sharon ..................................... Disclosed no conflict of interest.
Judd, Robert L. ..................................... Disclosed no conflict of interest.Juhl, Claus B. ....................................... Employee: HypoSafe A/S.Juliusdottir, Thorhildur .......................... Disclosed no conflict of interest.Jun, Lucy S. .......................................... Employee: Eli Lilly and Company; Research Support: Eli Lilly
and Company; Stock/Shareholder: Eli Lilly and Company.Jung, Chang Hee ................................... Disclosed no conflict of interest.Jung, Chan-Hee .................................... Disclosed no conflict of interest.Jung, Christian ...................................... Employee: Sanofi.Jung, Dae Young ................................... Disclosed no conflict of interest.Jung, Dong Ho ...................................... Disclosed no conflict of interest.Jung, Hye Seung ................................... Disclosed no conflict of interest.Jung, Jin Hyuk ...................................... Disclosed no conflict of interest.Jung, Kyong Yeon ................................. Disclosed no conflict of interest.Jung, KyongYeun .................................. Disclosed no conflict of interest.Jung, Kyu Sik ........................................ Disclosed no conflict of interest.Jungtrakoon, Prapaporn ........................ Disclosed no conflict of interest.Junior, Dorival M. ................................ Disclosed no conflict of interest.Junker, Anders E. ................................. Disclosed no conflict of interest.Jurczak, Michael J. .............................. Disclosed no conflict of interest.Just, Rasmus ......................................... Disclosed no conflict of interest.Juul, Svend ........................................... Disclosed no conflict of interest.Juy, Odile .............................................. Disclosed no conflict of interest.Ka, Sojeong ........................................... Disclosed no conflict of interest.Kabeya, Yusuke ..................................... Disclosed no conflict of interest.Kabeya, Yuusuke ................................... Disclosed no conflict of interest.Kabir, Morvarid...................................... Disclosed no conflict of interest.Kaburagi, Yasushi ................................. Disclosed no conflict of interest.Kachamakova-Trojanowska, Neli.......... Disclosed no conflict of interest.Kachoria, Rashmi .................................. Disclosed no conflict of interest.Kachroo, Sumesh .................................. Employee: Bristol-Myers Squibb Company.Kaczmarek, Przemyslaw ........................ Research Support: Noxxon.Kadir, Muhammad M. .......................... Disclosed no conflict of interest.Kadoguchi, Tomoyasu ........................... Disclosed no conflict of interest.Kadowaki, Takashi ................................ Advisory Panel: AstraZeneca Pharmaceuticals LP, Chugai
Kaestner, Klaus H. ................................ Disclosed no conflict of interest.Kagaya, Hiroki ....................................... Disclosed no conflict of interest.Kageyama, Takahiro .............................. Disclosed no conflict of interest.Kahil Binenfeld, Nurit ........................... Disclosed no conflict of interest.Kahleova, Hana ..................................... Disclosed no conflict of interest.Kahlert, Johnny A. ............................... Disclosed no conflict of interest.Kahles, Florian ...................................... Disclosed no conflict of interest.Kahlon, Gunjan ...................................... Disclosed no conflict of interest.Kahn, Barbara B. .................................. Disclosed no conflict of interest.Kahn, C. Ronald ..................................... Advisory Panel: Catabasis, CohBar, Dicerna, Ember
Therapeutics, FivePrime; Research Support: Sanofi.Kahn, Matthew T. ................................ Disclosed no conflict of interest.Kahn, Steven E. .................................... Disclosed no conflict of interest.Kaholokula, Joseph K. ......................... Disclosed no conflict of interest.Kai, Hirofumi ......................................... Disclosed no conflict of interest.Kain, Kirti .............................................. Disclosed no conflict of interest.Kain, Nakul ............................................ Disclosed no conflict of interest.Kaisen, Anne ......................................... Disclosed no conflict of interest.Kaiser, Gabriele ..................................... Disclosed no conflict of interest.Kaiser, Nurit .......................................... Disclosed no conflict of interest.Kaiyala, Karl .......................................... Disclosed no conflict of interest.Kajimoto, Tadafumi ............................... Disclosed no conflict of interest.Kajita, Kazuo ......................................... Disclosed no conflict of interest.Kajiura, Takayuki ................................... Employee: Ajinomoto Group.Kajiwara, Keizo ..................................... Disclosed no conflict of interest.Kakoola, Dorothy N. ............................. Disclosed no conflict of interest.Kaku, Kohei ........................................... Advisory Panel: AstraZeneca Pharmaceuticals LP, Chugai
Kalaiyarasi, Gunasekaran ..................... Disclosed no conflict of interest.Kalavalapalli, Srilaxmi .......................... Disclosed no conflict of interest.Kalgutkar, Amit S. ................................ Employee: Pfizer, Inc.
Kallinikou, Chrysoyla ............................. Disclosed no conflict of interest.Kalliokoski, Kari K. ............................... Disclosed no conflict of interest.Kalousova, Marta .................................. Disclosed no conflict of interest.Kalra, Sanjay ......................................... Advisory Panel: Bayer Health Care, LLC, Novo Nordisk, Inc.;
Consultant: Bayer Health Care, LLC, Novo Nordisk, Inc.; Speaker’s Bureau: Bayer Health Care, LLC.
Kalsbeek, Andries ................................. Disclosed no conflict of interest.Kalsekar, Iftekar .................................... Employee: Bristol-Myers Squibb Company.Kaltheuner, Matthias ............................ Disclosed no conflict of interest.Kalu, Gregory ........................................ Disclosed no conflict of interest.Kalyani, Rita R. ..................................... Disclosed no conflict of interest.Kamada, Chiemi .................................... Disclosed no conflict of interest.Kamadulski, Andrew ............................. Disclosed no conflict of interest.Kamalden, Tengku A. ........................... Disclosed no conflict of interest.Kamara, Eli ............................................ Disclosed no conflict of interest.Kamata, Kohsuke .................................. Disclosed no conflict of interest.Kamatani, Naoyuki ................................ Disclosed no conflict of interest.Kambe, Hiroshi ...................................... Disclosed no conflict of interest.Kameo, Junko ....................................... Disclosed no conflict of interest.Kameyama, Keishi ................................ Employee: Ajinomoto Group.Kami ska-Tru , Bo ena ........................... Disclosed no conflict of interest.Kamiya, Hideki ...................................... Disclosed no conflict of interest.Kamiya, Takayuki................................... Disclosed no conflict of interest.Kamper-Jørgensen, Zaza ...................... Disclosed no conflict of interest.Kampmann, Ulla .................................... Disclosed no conflict of interest.Kamvissi, Virginia.................................. Disclosed no conflict of interest.Kanai, Akio ............................................ Disclosed no conflict of interest.Kanamaluru, Deepthi ............................ Disclosed no conflict of interest.Kanasaki, Keizo ..................................... Research Support: Boehringer Ingelheim GmbH & Co. KG, Eli
Lilly and Company; Speaker’s Bureau: Boehringer Ingelheim GmbH & Co. KG, Daiichi-Sankyo, Inc., Eli Lilly and Company, Mitsubishi Tanabe Pharmaceutical Corporation, Novartis Pharmaceuticals Corporation, Sanofi.
Kanasaki, Megumi ................................ Disclosed no conflict of interest.Kanaya, Alka M. ................................... Research Support: NIH.Kanazawa, Akio .................................... Speaker’s Bureau: Boehringer Ingelheim Pharmaceuticals,
Inc., Eli Lilly and Company, Kissei Pharmaceutical Co., Ltd., Novo Nordisk, Inc., Sanofi, Takeda Pharmaceutical Company, Ltd.
Kanazawa, Ken ..................................... Disclosed no conflict of interest.Kanazawa, Yasushi ............................... Disclosed no conflict of interest.Kanda, Shoichi ...................................... Disclosed no conflict of interest.Kandeel, Fouad ..................................... Disclosed no conflict of interest.Kanderian, Sami .................................... Stock/Shareholder: Becton, Dickinson and Company.Kandula, Namratha R. .......................... Disclosed no conflict of interest.Kane, John ............................................ Disclosed no conflict of interest.Kaneki, Masao ...................................... Disclosed no conflict of interest.Kaneko, Shizuka .................................... Advisory Panel: Novo Nordisk A/S; Consultant: Novo Nordisk
A/S. Speaker’s Bureau: Novartis Pharma AG, Novo Nordisk, Inc.
Kaneko, Shuhei ..................................... Disclosed no conflict of interest.Kaneko, Shuichi .................................... Disclosed no conflict of interest.Kaneko, Sunao ...................................... Disclosed no conflict of interest.Kanematsu, Takayuki ............................ Disclosed no conflict of interest.Kaneto, Hideaki ..................................... Disclosed no conflict of interest.Kaneto, Leia A. ..................................... Disclosed no conflict of interest.Kang, Ah-Rhem ..................................... Disclosed no conflict of interest.Kang, Borami ......................................... Disclosed no conflict of interest.Kang, Eun Seok ..................................... Disclosed no conflict of interest.Kang, Hyeon-Ji ...................................... Disclosed no conflict of interest.Kang, Hyun Min .................................... Disclosed no conflict of interest.Kang, Jahoon ........................................ Employee: Hanmi Pharmaceutical Co.Kang, Jun Goo ....................................... Disclosed no conflict of interest.Kang, Kai ............................................... Disclosed no conflict of interest.Kang, Li ................................................. Disclosed no conflict of interest.Kang, Min Jueng ................................... Disclosed no conflict of interest.Kang, Naven .......................................... Disclosed no conflict of interest.Kang, Ping ............................................. Disclosed no conflict of interest.Kang, Shinae ......................................... Disclosed no conflict of interest.Kang, Sung-Koo .................................... Disclosed no conflict of interest.Kang, Youhou ........................................ Disclosed no conflict of interest.Kang, Yu Mi ........................................... Disclosed no conflict of interest.Kang, Yup Kang ..................................... Disclosed no conflict of interest.Kang, Yup .............................................. Disclosed no conflict of interest.Kangas, Antti J. ................................... Disclosed no conflict of interest.Kankova, Katerina ................................. Disclosed no conflict of interest.Kanlic, Dobrila ....................................... Disclosed no conflict of interest.Kannan, Subramanian ........................... Disclosed no conflict of interest.Kanno, Kazuo ........................................ Disclosed no conflict of interest.Kanou, Masanobu ................................. Employee: Teijin Pharma Limited.Kant, Ravi .............................................. Disclosed no conflict of interest.
Kantartzis, Konstantinos ....................... Disclosed no conflict of interest.Kanter, Justin ........................................ Disclosed no conflict of interest.Kanzaki, Makoto ................................... Disclosed no conflict of interest.Kao, Shih Ling ....................................... Disclosed no conflict of interest.Kao, Wen Hong L. ................................ Disclosed no conflict of interest.Kapanen, Jukka ..................................... Disclosed no conflict of interest.Kapitza, Christoph ................................. Other Relationship: Sanofi; Research Support: Boehringer
Ingelheim GmbH & Co. KG, Danse Pharmaceuticals, Eli Lilly and Company, Hoffman La Roche, Johnson & Johnson, Novartis Pharma AG, Novo Nordisk A/S, Noxxon, Sanofi, Servier.
Kaplan, David L. ................................... Disclosed no conflict of interest.Kaplan, L.M. ......................................... Advisory Panel: Ethicon Surgical Care, Fractyl, GI Dynamics,
Novo Nordisk, Inc.; Consultant: Ethicon Surgical Care, Fractyl, GI Dynamics, Novo Nordisk, Inc.; Research Support: Ethicon Surgical Care; Stock/Shareholder: Fractyl, GI Dynamics.
Kaplan, Robert ...................................... Disclosed no conflict of interest.Kapoor, Ekta .......................................... Disclosed no conflict of interest.Kaprio, Jaakko ...................................... Disclosed no conflict of interest.Kapur, Rahul .......................................... Employee: Novo Nordisk A/S; Stock/Shareholder: Novo
Nordisk A/S.Kapustin, Jane ...................................... Advisory Panel: Janssen Pharmaceuticals; Speaker’s Bureau:
Janssen Pharmaceuticals.Karajic, Aleksandar ............................... Disclosed no conflict of interest.Karakas, Sidika E. ................................ Disclosed no conflict of interest.Karalliedde, Janaka .............................. Disclosed no conflict of interest.Karamitos, Theodoros ........................... Disclosed no conflict of interest.Karasik, Avraham .................................. Advisory Panel: Boehringer Ingelheim Pharmaceuticals, Inc.,
Merck, Novo Nordisk A/S; Consultant: Merck, Novo Nordisk A/S; Speaker’s Bureau: Merck, Novartis Pharma AG, Novo Nordisk A/S.
Karastergiou, Kalypso ........................... Disclosed no conflict of interest.Karczewska-Kupczewska, Monika ........ Disclosed no conflict of interest.Kardara, Marina .................................... Disclosed no conflict of interest.Karimian, Negar .................................... Disclosed no conflict of interest.Karlstad, Michael D. ............................ Disclosed no conflict of interest.Karnchanasorn, Rudruidee .................... Disclosed no conflict of interest.Karnes, Jeffery M. ............................... Disclosed no conflict of interest.Karolicki, Boris ...................................... Employee: Novo Nordisk, Inc.Karpe, Fredrik ........................................ Disclosed no conflict of interest.Karsdal, Morten A. .............................. Employee: Nordic Bioscience A/S; Stock/Shareholder: Nordic
Bioscience A/S.Karstoft, Kristian ................................... Disclosed no conflict of interest.Karunasena, Nayananjani ..................... Disclosed no conflict of interest.Karvounis, Haralampos ......................... Disclosed no conflict of interest.Kasahara, Yoshinori .............................. Employee: Teijin Pharma Limited.Kasai, Kikuo .......................................... Disclosed no conflict of interest.Kashihara, Yoneo .................................. Disclosed no conflict of interest.Kashima, Koji ........................................ Disclosed no conflict of interest.Kashiwagi, Atsunori .............................. Disclosed no conflict of interest.Kashyap, Sangeeta R. .......................... Disclosed no conflict of interest.Kaspers, Stefan ..................................... Employee: Boehringer Ingelheim GmbH & Co. KG.Kassanos, Dimitrios .............................. Disclosed no conflict of interest.Katagiri, Hideki ..................................... Disclosed no conflict of interest.Katagiri, Sayaka .................................... Disclosed no conflict of interest.Katalenich, Bonnie L. ........................... Disclosed no conflict of interest.Katayama, Shigehiro ............................. Disclosed no conflict of interest.Katic, Bozena J. ................................... Disclosed no conflict of interest.Katkar, Rujuta ........................................ Disclosed no conflict of interest.Katkhouda, Namir ................................. Disclosed no conflict of interest.Kato, Hirotsugu ..................................... Employee: Teijin Pharma Limited.Kato, Kiminori ....................................... Disclosed no conflict of interest.Kato, Masahiko ..................................... Disclosed no conflict of interest.Kato, Masayuki ..................................... Disclosed no conflict of interest.Kato, Mitsutoshi ................................... Disclosed no conflict of interest.Kato, Naoka .......................................... Disclosed no conflict of interest.Kato, Norihiro ........................................ Disclosed no conflict of interest.Kato, Noriko .......................................... Disclosed no conflict of interest.Kato, Takao............................................ Disclosed no conflict of interest.Kato, Yuka ............................................. Disclosed no conflict of interest.Katra, Barbara ....................................... Disclosed no conflict of interest.Katsilambros, Nicholas ......................... Disclosed no conflict of interest.Katsuki, Takeshi .................................... Disclosed no conflict of interest.Katsuta, Hidenori .................................. Disclosed no conflict of interest.Katsuyama, Ryoichi ............................... Disclosed no conflict of interest.Katuki, Takeshi ...................................... Disclosed no conflict of interest.Katunga, Lalage A. ............................... Disclosed no conflict of interest.Katz, Arie ............................................... Employee: AstraZeneca Pharmaceuticals LP.Katz, Laurence B. ................................. Employee: Lifescan Animas, Inc.Katz, Michelle L. .................................. Disclosed no conflict of interest.Katzeff, Harvey ...................................... Employee: Merck.
Katzman, Per ......................................... Disclosed no conflict of interest.Kaufman, Francine R. ........................... Employee: Medtronic.Kaufman, Keith D. ................................ Employee: Merck.Kaufman-Shriqui, Vered ........................ Disclosed no conflict of interest.Kauh, Anya ............................................ Employee: Merck.Kauh, Eunkyung ..................................... Employee: Merck Sharp & Dohme Limited.Kauka, Iris ............................................. Disclosed no conflict of interest.Kaul, Kirti .............................................. Disclosed no conflict of interest.Kaur, Akaal ............................................ Disclosed no conflict of interest.Kaur, Gagandeep ................................... Disclosed no conflict of interest.Kaushal, Rashimi .................................. Disclosed no conflict of interest.Kautzky-Willer, Alexandra..................... Disclosed no conflict of interest.Kavalkova, Petra ................................... Disclosed no conflict of interest.Kawagoe, Nobuaki ................................ Disclosed no conflict of interest.Kawagoe, Yoshiaki ................................ Disclosed no conflict of interest.Kawaguchi, Minako .............................. Disclosed no conflict of interest.Kawaguchi, Yoshiya .............................. Disclosed no conflict of interest.Kawai, Mariko ....................................... Disclosed no conflict of interest.Kawakami, Soshi .................................. Disclosed no conflict of interest.Kawamoto, Ryuichi ............................... Disclosed no conflict of interest.Kawamura, Ryoichi ............................... Disclosed no conflict of interest.Kawamura, Takahiko ............................. Disclosed no conflict of interest.Kawamura, Tomoyuki ............................ Disclosed no conflict of interest.Kawanami, Daiji .................................... Disclosed no conflict of interest.Kawanami, Takako ................................ Disclosed no conflict of interest.Kawasaki, Maki .................................... Disclosed no conflict of interest.Kawasaki, Michiko ................................ Disclosed no conflict of interest.Kawase, Ryota ...................................... Disclosed no conflict of interest.Kawashima, Junji ................................. Disclosed no conflict of interest.Kawata, Sumio ...................................... Disclosed no conflict of interest.Kawazu, Shoji ....................................... Disclosed no conflict of interest.Kaya, Ecem ............................................ Disclosed no conflict of interest.Kayal, Arivudainambi ............................ Disclosed no conflict of interest.Kayaniyil, Sheena ................................. Disclosed no conflict of interest.Kayano, Kouko ...................................... Disclosed no conflict of interest.Kaye, Sanna .......................................... Disclosed no conflict of interest.Kaye, Simon .......................................... Disclosed no conflict of interest.Kayser, Brandon D. ............................... Disclosed no conflict of interest.Kazantzidou, Pavlina ............................. Disclosed no conflict of interest.Kazda, Christof M. ............................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly
and Company.Kazdova, Ludmila .................................. Disclosed no conflict of interest.Kazma, Carim ........................................ Disclosed no conflict of interest.Kazunori, Sango .................................... Disclosed no conflict of interest.Ke, Weijian............................................ Disclosed no conflict of interest.Kearney, Mark T. .................................. Disclosed no conflict of interest.Keech, Anthony C. ................................ Advisory Panel: Abbott Laboratories, Inc., AstraZeneca/
Bristol-Meyers Squibb, Eli Lilly and Company, Merck, Novartis Pharmaceuticals Corporation, Pfizer, Inc., Roche Pharmaceuticals, Solvay; Research Support: Solvay; Speaker’s Bureau: Abbott Laboratories, Inc., Solvay.
Keely, Erin ............................................. Advisory Panel: Pfizer, Inc.Keenan, Barry ........................................ Employee: Medtronic.Keenan, Hillary A. ................................ Disclosed no conflict of interest.Keene, Catherine .................................. Research Support: Merck.Kehlenbrink, Sylvia ............................... Disclosed no conflict of interest.Kei, Teramoto ........................................ Disclosed no conflict of interest.Keil, Rudolf ............................................ Consultant: Almased Wellness GmbH.Keim, Kathryn S. .................................. Disclosed no conflict of interest.Keith-Hynes, Patrick .............................. Disclosed no conflict of interest.Kellerher-Yassen, Donna ....................... Disclosed no conflict of interest.Keller, Amy ............................................ Disclosed no conflict of interest.Kelley, Carly .......................................... Research Support: Sanofi.Kelley, David E. .................................... Employee: Merck.Kelly, Darren .......................................... Disclosed no conflict of interest.Kelly, Ronan P. ...................................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly
and Company.Kelsey, Megan M. ................................ Disclosed no conflict of interest.Kemp, Gail ............................................. Disclosed no conflict of interest.Kempegowda, Punith ............................ Disclosed no conflict of interest.Kempf, Kerstin ...................................... Consultant: HMM Holding AG, Sanofi; Research Support:
Kennedy, Amy ....................................... Disclosed no conflict of interest.Kennedy, Laurence ................................ Disclosed no conflict of interest.Kennedy, Norman .................................. Disclosed no conflict of interest.Kensler, Thomas W. ............................. Disclosed no conflict of interest.Kent, Denise A. .................................... Disclosed no conflict of interest.Keown, Paul .......................................... Research Support: Merck.Kerem, Eitan .......................................... Disclosed no conflict of interest.Kern, Philip A. ...................................... Disclosed no conflict of interest.
Kern, Werner ......................................... Advisory Panel: Novo Nordisk A/S; Board Member: Merck Sharp & Dohme Limited, Novo Nordisk A/S, Sanofi; Speaker’s Bureau: AstraZeneca Pharmaceuticals LP, Berlin Chemie AG, Bristol-Myers Squibb Company, Eli Lilly and Company, Merck Sharp & Dohme Limited, Novo Nordisk A/S, Sanofi.
Kernan, Walter N. ................................ Disclosed no conflict of interest.Kerr, Becky............................................. Disclosed no conflict of interest.Kerr-Conte, Julie ................................... Disclosed no conflict of interest.Kesavadev, Jothydev ............................ Disclosed no conflict of interest.Keske, Michelle A. ............................... Disclosed no conflict of interest.Kestler, Hans ......................................... Disclosed no conflict of interest.Ketterer, Caroline .................................. Disclosed no conflict of interest.Kevin, Aylor ........................................... Disclosed no conflict of interest.Kfuri, Antoine ........................................ Disclosed no conflict of interest.Khaja, Shamim ...................................... Disclosed no conflict of interest.Khalaf, Ferdaws .................................... Disclosed no conflict of interest.Khalid, Luma ......................................... Disclosed no conflict of interest.Khaliddin, Nurliza .................................. Disclosed no conflict of interest.Khamaisi, Mogher ................................. Disclosed no conflict of interest.Khamseh, Mohamed E. ........................ Advisory Panel: Novartis Pharma AG, Novo Nordisk A/S,
Sanofi; Research Support: Novartis Pharma AG, Novo Nordisk A/S, Sanofi.
Khan, Ainy ............................................. Disclosed no conflict of interest.Khan, Asif .............................................. Disclosed no conflict of interest.Khan, Muhammad ................................. Disclosed no conflict of interest.Khan, Nasiruddin .................................. Disclosed no conflict of interest.Khan, Zia A. .......................................... Disclosed no conflict of interest.Khang, Ah Reum ................................... Disclosed no conflict of interest.Khanh, Tran Q. ...................................... Research Support: Bayer Health Care, LLC, Merck, Novo
Nordisk A/S.Khattab, Mohammed ............................ Advisory Panel: AstraZeneca/Bristol-Meyers Squibb, Eli Lilly
and Company, Merck, Merck Sharp & Dohme Limited, Novartis Pharma AG, Novo Nordisk A/S, Sanofi, Servier; Board Member: AstraZeneca/Bristol-Meyers Squibb, Eli Lilly and Company, Merck, Merck Sharp & Dohme Limited, Novartis Pharma AG, Novo Nordisk A/S, Sanofi, Servier; Speaker’s Bureau: AstraZeneca/Bristol-Meyers Squibb, Eli Lilly and Company, Merck, Merck Sharp & Dohme Limited, Novartis Pharma AG, Novo Nordisk A/S, Sanofi, Servier.
Khazrai, Yeganeh Manon ...................... Disclosed no conflict of interest.Kheyami, Ahmad ................................... Disclosed no conflict of interest.Khichar, Satyendra ................................ Disclosed no conflict of interest.Khin, May Oo ........................................ Disclosed no conflict of interest.Khochtali, Ines ...................................... Disclosed no conflict of interest.Khodaghalian, Bernadette .................... Disclosed no conflict of interest.Khoo, Chin Meng .................................. Disclosed no conflict of interest.Khoo, Eric Y. ......................................... Disclosed no conflict of interest.Khoo, Yin Hao E. .................................. Disclosed no conflict of interest.Khosroheidari, Mahdieh ....................... Disclosed no conflict of interest.Khot, Rajashree S. ............................... Disclosed no conflict of interest.Khowaja, Ameer A. .............................. Disclosed no conflict of interest.Khunti, Kamlesh .................................... Advisory Panel: Eli Lilly and Company, Merck Sharp & Dohme
Limited, Novo Nordisk, Inc., Sanofi; Consultant: Eli Lilly and Company, Merck Sharp & Dohme Limited, Novartis Pharmaceuticals Corporation, Novo Nordisk, Inc., Sanofi; Research Support: Boehringer Ingelheim GmbH & Co. KG, Eli Lilly and Company, Merck Sharp & Dohme Limited, Novartis Pharmaceuticals Corporation, Novo Nordisk, Inc., Pfizer, Inc., Sanofi.
Khurana, Rahul N. ................................ Consultant: Genentech, Regeneron Pharmaceuticals, Inc.; Research Support: Allergan, Inc., Regeneron Pharmaceuticals, Inc.; Speaker’s Bureau: Genentech, Regeneron Pharmaceuticals, Inc.
Kiat, Clifford .......................................... Disclosed no conflict of interest.Kibbe, Carly ........................................... Disclosed no conflict of interest.Kibbey, Richard G. ................................ Disclosed no conflict of interest.Kidron, Miriam ...................................... Employee: Oramed Pharmaceuticals.Kiec-Wilk, Beata ................................... Disclosed no conflict of interest.Kiefer-Schmidt, Isabelle ........................ Disclosed no conflict of interest.Kieffer, Timothy J. ................................ Disclosed no conflict of interest.Kiefte-de Jong, Jessica ........................ Disclosed no conflict of interest.Kiehling, Claus ...................................... Advisory Panel: Roche Diagnostics GmbH; Research Support:
Roche Diagnostics GmbH.Kiely, Michele ....................................... Disclosed no conflict of interest.Kien, C.L. .............................................. Disclosed no conflict of interest.Kienreich, Katharina ............................. Disclosed no conflict of interest.Kiens, Bente .......................................... Disclosed no conflict of interest.Kiess, Wieland ...................................... Disclosed no conflict of interest.Kieswich, Julius .................................... Disclosed no conflict of interest.Kikimbaeva, Ausulu A. ......................... Disclosed no conflict of interest.
Kikuchi, Takako...................................... Disclosed no conflict of interest.Kildentoft, Christina .............................. Other Relationship: Novo Nordisk A/S.Kilduff, Liam P. ..................................... Disclosed no conflict of interest.Kilic, Dilek ............................................. Disclosed no conflict of interest.Kilicarslan, Murat ................................. Disclosed no conflict of interest.Kilkenny, Dawn M. ............................... Disclosed no conflict of interest.Kilkuskie, Peter M. ............................... Employee: Metabolic Solutions Development Co.Kim, Bhumsoo ....................................... Disclosed no conflict of interest.Kim, Bo Hyun ......................................... Disclosed no conflict of interest.Kim, Bong-Jo ......................................... Disclosed no conflict of interest.Kim, Bo-Yeon ......................................... Disclosed no conflict of interest.Kim, Catherine ...................................... Research Support: NIDDKKim, Chul Hoon ..................................... Disclosed no conflict of interest.Kim, Chul Sik ......................................... Disclosed no conflict of interest.Kim, Chul-Hee ....................................... Disclosed no conflict of interest.Kim, Dae Hyun ...................................... Disclosed no conflict of interest.Kim, Dae Jung ....................................... Disclosed no conflict of interest.Kim, Dennis D. ..................................... Advisory Panel: Alkermes, Plc., Cebix, Inc., Diamedica, Inc., GI
Dynamics; Consultant: Cebix, Inc., Diamedica, Inc., GI Dynamics; Stock/Shareholder: Zafgen, Inc.
Kim, Dong Sun ...................................... Disclosed no conflict of interest.Kim, Dongjoon ....................................... Disclosed no conflict of interest.Kim, Dong-Jun ...................................... Disclosed no conflict of interest.Kim, Doo-Man ....................................... Disclosed no conflict of interest.Kim, Doo-Mon ....................................... Disclosed no conflict of interest.Kim, Eun Sook ....................................... Disclosed no conflict of interest.Kim, Eunhee G. ..................................... Disclosed no conflict of interest.Kim, Gabriel .......................................... Employee: Boehringer Ingelheim GmbH & Co. KG.Kim, Gyuri .............................................. Disclosed no conflict of interest.Kim, Hae Jin .......................................... Disclosed no conflict of interest.Kim, Hae-Suk ........................................ Disclosed no conflict of interest.Kim, Hail ................................................ Disclosed no conflict of interest.Kim, Hee Young ..................................... Disclosed no conflict of interest.Kim, Hong-Min ...................................... Disclosed no conflict of interest.Kim, Hye Kyoung ................................... Disclosed no conflict of interest.Kim, Hye-Soo Kim ................................. Disclosed no conflict of interest.Kim, Hyun Kyung ................................... Disclosed no conflict of interest.Kim, Hyun-Jin ........................................ Disclosed no conflict of interest.Kim, Hyunok .......................................... Disclosed no conflict of interest.Kim, In Joo ............................................ Disclosed no conflict of interest.Kim, In Ju .............................................. Disclosed no conflict of interest.Kim, Jae Bum ........................................ Disclosed no conflict of interest.Kim, Jae Hyeon ..................................... Disclosed no conflict of interest.Kim, Jang Young ................................... Disclosed no conflict of interest.Kim, Jason K. ....................................... Disclosed no conflict of interest.Kim, Jennifer ......................................... Disclosed no conflict of interest.Kim, Jeong-a ......................................... Disclosed no conflict of interest.Kim, Jin Sook ........................................ Disclosed no conflict of interest.Kim, Ji-Won .......................................... Disclosed no conflict of interest.Kim, Jiwoon .......................................... Disclosed no conflict of interest.Kim, Jong Ho ......................................... Disclosed no conflict of interest.Kim, Jong Hun ....................................... Disclosed no conflict of interest.Kim, Jong-Il ........................................... Disclosed no conflict of interest.Kim, Joo Young ..................................... Disclosed no conflict of interest.Kim, Jung Min ....................................... Disclosed no conflict of interest.Kim, Jung-Guk ....................................... Disclosed no conflict of interest.Kim, Ki Woong ...................................... Disclosed no conflict of interest.Kim, Kristine M. ................................... Disclosed no conflict of interest.Kim, Kwang Joon .................................. Disclosed no conflict of interest.Kim, Kwang-Won .................................. Disclosed no conflict of interest.Kim, Kyeong Jin .................................... Disclosed no conflict of interest.Kim, Kyoung Min ................................... Disclosed no conflict of interest.Kim, Kyoung-Ah .................................... Disclosed no conflict of interest.Kim, Kyuho ............................................ Disclosed no conflict of interest.Kim, Kyu-Jin .......................................... Disclosed no conflict of interest.Kim, Kyung Rae ..................................... Disclosed no conflict of interest.Kim, Kyunga .......................................... Disclosed no conflict of interest.Kim, Kyung-Jin ...................................... Disclosed no conflict of interest.Kim, Lisa ................................................ Disclosed no conflict of interest.Kim, Mi Kyoung ..................................... Disclosed no conflict of interest.Kim, Min Jae ......................................... Disclosed no conflict of interest.Kim, Min Joo ......................................... Disclosed no conflict of interest.Kim, Min Kyeong ................................... Disclosed no conflict of interest.Kim, Min Kyung ..................................... Disclosed no conflict of interest.Kim, Mina .............................................. Disclosed no conflict of interest.Kim, Min-Seon ...................................... Disclosed no conflict of interest.Kim, Mi-Sun .......................................... Disclosed no conflict of interest.Kim, Nam Hoon ..................................... Disclosed no conflict of interest.Kim, Nan Hee ........................................ Disclosed no conflict of interest.Kim, Paul ............................................... Consultant: KCI.Kim, Sang Soo ....................................... Disclosed no conflict of interest.Kim, Sarah ............................................. Disclosed no conflict of interest.
Kim, Seung K. ....................................... Disclosed no conflict of interest.Kim, Shin ............................................... Disclosed no conflict of interest.Kim, Sin Gon ......................................... Disclosed no conflict of interest.Kim, So Hun .......................................... Disclosed no conflict of interest.Kim, Sohee ............................................ Disclosed no conflict of interest.Kim, Soo Hyun ....................................... Disclosed no conflict of interest.Kim, Soojin ............................................ Disclosed no conflict of interest.Kim, Stella P. ........................................ Disclosed no conflict of interest.Kim, Sum Hwa ...................................... Disclosed no conflict of interest.Kim, Sun H. .......................................... Disclosed no conflict of interest.Kim, Sun Hwa ....................................... Disclosed no conflict of interest.Kim, Sun ................................................ Disclosed no conflict of interest.Kim, Sung Rae ....................................... Disclosed no conflict of interest.Kim, Sung-Hoon .................................... Disclosed no conflict of interest.Kim, Sunhee .......................................... Disclosed no conflict of interest.Kim, Sun-Yee ......................................... Disclosed no conflict of interest.Kim, Tae Ho ........................................... Disclosed no conflict of interest.Kim, Tae Hwa ........................................ Disclosed no conflict of interest.Kim, Tae-Hun ......................................... Disclosed no conflict of interest.Kim, Teayoun ......................................... Disclosed no conflict of interest.Kim, Won Jin ........................................ Disclosed no conflict of interest.Kim, Wook ............................................. Disclosed no conflict of interest.Kim, Ye An ............................................. Disclosed no conflict of interest.Kim, Yong Ki .......................................... Disclosed no conflict of interest.Kim, Yong Seong ................................... Disclosed no conflict of interest.Kim, Yoon Ji .......................................... Disclosed no conflict of interest.Kim, Yoon Jung ..................................... Disclosed no conflict of interest.Kim, Young Bum .................................... Disclosed no conflict of interest.Kim, Young Heui .................................... Disclosed no conflict of interest.Kim, Young Hoon ................................... Disclosed no conflict of interest.Kim, Young Il ......................................... Disclosed no conflict of interest.Kim, Young Seol .................................... Disclosed no conflict of interest.Kim, Young Sook ................................... Disclosed no conflict of interest.Kim, Young-Bum .................................... Disclosed no conflict of interest.Kim, Yuji ................................................ Disclosed no conflict of interest.Kimball, Scot R. .................................... Disclosed no conflict of interest.Kimbrell, Matthew R. .......................... Disclosed no conflict of interest.Kimchi, Ofer .......................................... Disclosed no conflict of interest.Kimura, Chizuko .................................... Disclosed no conflict of interest.Kimura, Tomohiko.................................. Disclosed no conflict of interest.Kincade, John R. .................................. Disclosed no conflict of interest.King, Allen B. ....................................... Advisory Panel: Novo Nordisk, Inc., Sanofi; Consultant: Novo
Nordisk, Inc.; Research Support: Amylin Pharmaceuticals, Inc., Animas Corporation, Medtronics, Novo Nordisk, Inc., Sanofi; Speaker’s Bureau: Novo Nordisk, Inc.
King, Bruce ............................................ Disclosed no conflict of interest.King, Elaine B. ...................................... Disclosed no conflict of interest.King, George L. ..................................... Consultant: Janssen Pharmaceuticals; Research Support:
Sanofi.King, Martina ........................................ Disclosed no conflict of interest.Kingkaew, Pritaporn .............................. Disclosed no conflict of interest.Kinney, Gregory L. ................................ Disclosed no conflict of interest.Kinoshita, Jun ....................................... Disclosed no conflict of interest.Kinra, Sanjay ......................................... Disclosed no conflict of interest.Kinugawa, Shintaro .............................. Disclosed no conflict of interest.Kinuhata, Shigeki .................................. Disclosed no conflict of interest.Kinz, Elena ............................................. Disclosed no conflict of interest.Kircher, Robert....................................... Employee: Dose Safety Company; Stock/Shareholder: Dose
Safety Company.Kirchhoff, Brenda A. ............................ Disclosed no conflict of interest.Kirchner, Thomas................................... Employee: Janssen Research & Development.Kirchsteiger, Harald............................... Disclosed no conflict of interest.Kirigiti, Melissa ..................................... Disclosed no conflict of interest.Kirkpatrick, Clare ................................... Disclosed no conflict of interest.Kirvan, Anya .......................................... Disclosed no conflict of interest.Kirwan, Breda ....................................... Disclosed no conflict of interest.Kirwan, John P. .................................... Disclosed no conflict of interest.Kiselyov, Vladislav ................................ Employee: Eli Lilly and Company.Kishimoto, Ichiro ................................... Disclosed no conflict of interest.Kishimoto, Junji .................................... Disclosed no conflict of interest.Kishore, Preeti ....................................... Disclosed no conflict of interest.Kiss, Endre ............................................ Disclosed no conflict of interest.Kissner, Thomas .................................... Employee: Sanofi.Kitabchi, Abbas E. ................................ Disclosed no conflict of interest.Kitada, Yoshihiko .................................. Disclosed no conflict of interest.Kitahara, Atsuko ................................... Disclosed no conflict of interest.Kitahara, Yoshiro ................................... Employee: Ajinomoto Group.Kitajima, Yoichirou ................................ Disclosed no conflict of interest.Kitamoto, Eiko ....................................... Disclosed no conflict of interest.Kitamoto, Hideko .................................. Disclosed no conflict of interest.Kitamoto, Takumi .................................. Disclosed no conflict of interest.Kitamura, Kumiko .................................. Disclosed no conflict of interest.
Kitamura, Tadahiro ................................ Disclosed no conflict of interest.Kitano, Sayaka ...................................... Disclosed no conflict of interest.Kitao, Tatsuya........................................ Disclosed no conflict of interest.Kitaoka, Masafumi ................................ Disclosed no conflict of interest.Kitazato, Hiroji ...................................... Speaker’s Bureau: Astellas Pharma US, Inc., AstraZeneca
Kitazawa, Masaru ................................. Disclosed no conflict of interest.Kitsis, Richard N. ................................. Disclosed no conflict of interest.Kitsunai, Hiroya ..................................... Disclosed no conflict of interest.Kiyosue, Arihiro ..................................... Disclosed no conflict of interest.Kizirian, Nathalie .................................. Disclosed no conflict of interest.Kjær, Troels W. ..................................... Disclosed no conflict of interest.Kjellstedt, Ann ...................................... Employee: AstraZeneca Pharmaceuticals LP.Kjøbsted, Rasmus ................................. Disclosed no conflict of interest.Klater-Leibovici, Ofra ............................ Disclosed no conflict of interest.Klaus, Katherine .................................... Disclosed no conflict of interest.Klee, Katharina ..................................... Disclosed no conflict of interest.Kleefstra, Nanne ................................... Disclosed no conflict of interest.Klein, Barbara E. .................................. Disclosed no conflict of interest.Klein, Ben .............................................. Disclosed no conflict of interest.Klein, Eric J. ......................................... Speaker’s Bureau: AstraZeneca Pharmaceuticals LP, Bristol-
Myers Squibb Company.Klein, Kerenaftali .................................. Disclosed no conflict of interest.Klein, Michelle ...................................... Disclosed no conflict of interest.Klein, Oana L. ....................................... Disclosed no conflict of interest.Klein, Oliver ........................................... Disclosed no conflict of interest.Klein, Richard L. ................................... Disclosed no conflict of interest.Klein, Ronald ......................................... Disclosed no conflict of interest.Klein, Samuel ........................................ Advisory Panel: Aspire Bariatrics, Egg Nutrition Council;
Consultant: Bristol-Myers Squibb/AstraZeneca, Danone-Yakult, Egg Nutrition Council, Merck, Santarus, Inc., Takeda Pharmaceuticals U.S.A., Inc.; Research Support: Dairy Research Institute, Egg Nutrition Council; Speaker’s Bureau: Merck; Stock/Shareholder: Aspire Bariatrics.
Klein, Thomas ....................................... Employee: Boehringer Ingelheim GmbH & Co. KG.Kleine, Kere ........................................... Disclosed no conflict of interest.Kleinridders, Andre ............................... Disclosed no conflict of interest.Klen, Jasna ........................................... Disclosed no conflict of interest.Kler, Lata ............................................... Disclosed no conflict of interest.Kletzien, Rolf F. .................................... Board Member: Metabolic Solutions Development Co.;
Employee: Metabolic Solutions Development Co.; Stock/Shareholder: Metabolic Solutions Development Co.
Klimentidis, Yann C. ............................. Disclosed no conflict of interest.Klingensmith, Georgeanna J. .............. Consultant: Novo Nordisk, Inc.Klintenberg, Maria ................................ Disclosed no conflict of interest.Klonoff, David C. .................................. Research Support: Medtronic.Klopfer, Stephanie................................. Employee: Merck Sharp & Dohme Limited.Klopfleisch, Robert ................................ Disclosed no conflict of interest.Klöting, Nora ......................................... Disclosed no conflict of interest.Kluding, Patricia M. ............................. Disclosed no conflict of interest.Klupa, Tomasz ....................................... Advisory Panel: Bioton, Eli Lilly, Medtronic; Research Support:
Bioton.Klussmann, Sven ................................... Employee: Noxxon.Knadler, Mary P. ................................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly
and Company.Knap, Ditte ............................................ Employee: Novartis Pharma AG.Knaub, Leslie A. ................................... Disclosed no conflict of interest.Knebel, Birgit ........................................ Disclosed no conflict of interest.Knecht, Nicole ....................................... Disclosed no conflict of interest.Knezevic Cuca, Jadranka ...................... Disclosed no conflict of interest.Knight, Stacey ....................................... Disclosed no conflict of interest.Knight, William ..................................... Disclosed no conflict of interest.Knip, Mikael .......................................... Disclosed no conflict of interest.Knobf, M. Tish ....................................... Disclosed no conflict of interest.Knoefel, Wolfram T. ............................. Disclosed no conflict of interest.Knop, Filip K. ........................................ Advisory Panel: Bristol-Myers Squibb/AstraZeneca, Eli Lilly
and Company, Sanofi, Zealand Pharma A/S; Consultant: AstraZeneca/Bristol-Meyers Squibb, Gilead Sciences, Inc., Ono Pharmaceutical Co., Ltd., Zealand Pharma A/S; Research Support: Sanofi; Speaker’s Bureau: AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb/AstraZeneca, Eli Lilly and Company, Gilead Sciences, Inc., Merck Sharp & Dohme Limited, Novo Nordisk, Inc., Ono Pharmaceutical Co., Ltd., Sanofi, Zealand Pharma A/S.
Knorr, Sine ............................................. Disclosed no conflict of interest.Knowler, William C. ............................. Employee: NIDDK.Knudsen, Bruce E. ................................ Disclosed no conflict of interest.Knudsen, Sine H. .................................. Disclosed no conflict of interest.
Knuuti, Juhani ....................................... Disclosed no conflict of interest.Ko, Kyung Soo ....................................... Disclosed no conflict of interest.Ko, Seung-Hyun .................................... Disclosed no conflict of interest.Ko, Yoo Mi ............................................. Disclosed no conflict of interest.Kobayashi, Hiroya ................................. Disclosed no conflict of interest.Kobayashi, Junji .................................... Disclosed no conflict of interest.Kobayashi, Takuya................................. Disclosed no conflict of interest.Kobayashi, Tsunefumi ........................... Employee: Teijin Pharma Limited.Kobayashi, Yasuko ................................ Disclosed no conflict of interest.Kobes, Sayuko ....................................... Disclosed no conflict of interest.Koch, Alexander .................................... Disclosed no conflict of interest.Koch, Armin ........................................... Disclosed no conflict of interest.Koch, Lauren ......................................... Disclosed no conflict of interest.Kochhar, Sunil ....................................... Employee: Nestec SA.Kodama, Keiichi .................................... Disclosed no conflict of interest.Kodama, Nobuhiro ................................ Disclosed no conflict of interest.Kodama, Satoru .................................... Disclosed no conflict of interest.Kodama, Shohta .................................... Disclosed no conflict of interest.Kodama, Tatsuhiko ................................ Disclosed no conflict of interest.Kodani, Eitaro ........................................ Disclosed no conflict of interest.Koechlin, Alice ...................................... Disclosed no conflict of interest.Koenigsrainer, Alfred ............................ Disclosed no conflict of interest.Koezuka, Ryo ......................................... Disclosed no conflict of interest.Koh, Gwanpyo ....................................... Disclosed no conflict of interest.Kohara, Katsuhiko ................................. Disclosed no conflict of interest.Kohara, Kenji ......................................... Disclosed no conflict of interest.Kohnert, Klaus-Dieter ........................... Disclosed no conflict of interest.Kojima, Daibo ........................................ Disclosed no conflict of interest.Kojima, Itaru .......................................... Disclosed no conflict of interest.Kojima, Motoyasu ................................. Disclosed no conflict of interest.Kojzar, Harald ........................................ Disclosed no conflict of interest.Kokai, Endre .......................................... Disclosed no conflict of interest.Kokkinos, Alexander ............................. Disclosed no conflict of interest.Kokolaki, Anthi ...................................... Disclosed no conflict of interest.Kokotos, George .................................... Disclosed no conflict of interest.Koliaki, Chrysi ....................................... Disclosed no conflict of interest.Kolka, Cathryn M. ................................ Disclosed no conflict of interest.Kollman, Craig ....................................... Disclosed no conflict of interest.Kolodny, Gerald M. .............................. Disclosed no conflict of interest.Kolodziejski, Pawel ............................... Research Support: Noxxon.Kolonics, Attila ...................................... Research Support: N-Gene.Komatsu, Masaaki ................................ Disclosed no conflict of interest.Komatsu, Takaaki .................................. Disclosed no conflict of interest.Komine, Maya ....................................... Disclosed no conflict of interest.Komiya, Hideaki .................................... Disclosed no conflict of interest.Komiya, Koji .......................................... Speaker’s Bureau: Boehringer Ingelheim Pharmaceuticals,
Inc., Eli Lilly and Company, Novartis Pharmaceuticals Corporation, Sanofi.
Komorowski, Jimes ............................... Disclosed no conflict of interest.Kondo, Hiroko ........................................ Disclosed no conflict of interest.Kondo, Kazuoki ...................................... Disclosed no conflict of interest.Kondo, Keiichi ....................................... Disclosed no conflict of interest.Kondo, Keiko ......................................... Disclosed no conflict of interest.Kondo, Masaki ...................................... Disclosed no conflict of interest.Kondo, Takuma ...................................... Disclosed no conflict of interest.Kondo, Tatsuya ...................................... Disclosed no conflict of interest.Kondo, Yasushi ...................................... Disclosed no conflict of interest.Kondo, Yoshinobu ................................. Disclosed no conflict of interest.Kong, Alice P.S. .................................... Disclosed no conflict of interest.Kong, Alice ............................................ Advisory Panel: Boehringer Ingelheim Pharmaceuticals, Inc.,
Eli Lilly and Company, Janssen Pharmaceuticals, Novartis Pharmaceuticals Corporation; Consultant: Novo Nordisk, Inc.; Speaker’s Bureau: Merck, Nestle, Inc., Novo Nordisk, Inc., Pfizer, Inc., Roche Pharmaceuticals, Servier.
Kong, Shengchun .................................. Disclosed no conflict of interest.Kong, XingXing ...................................... Disclosed no conflict of interest.Kongsø, Jens ......................................... Employee: Novo Nordisk A/S.Kono, Suminori ...................................... Disclosed no conflict of interest.Kono, Tatsuyoshi M. ............................ Disclosed no conflict of interest.Konopka, Adam R. ................................ Disclosed no conflict of interest.Konrad, Robert J. ................................. Employee: Eli Lilly and Company.Konvalina, Noa ...................................... Disclosed no conflict of interest.Konyashin, Alexander ........................... Disclosed no conflict of interest.Koo, Bokyung ........................................ Disclosed no conflict of interest.Kooijman-Buijting, Antoinette M. ....... Disclosed no conflict of interest.Koonce, Chad ........................................ Disclosed no conflict of interest.Koontz, Michaela B. ............................. Disclosed no conflict of interest.Koopman, Karin E. ................................ Disclosed no conflict of interest.Kooptiwut, Suwatttanee ....................... Disclosed no conflict of interest.Kooy, Adriaan ........................................ Disclosed no conflict of interest.Kopecky, Jan ......................................... Disclosed no conflict of interest.Kopecky, Petr ......................................... Disclosed no conflict of interest.
Kopp, Hans P. ....................................... Disclosed no conflict of interest.Korányi, László ...................................... Disclosed no conflict of interest.Kordonouri, Olga ................................... Disclosed no conflict of interest.Koren, Michael J. ................................. Employee: Jacksonville Center for Clinical Research; Research
Korgun, Emin ......................................... Disclosed no conflict of interest.Korhonen, Pasi ...................................... Disclosed no conflict of interest.Korkmaz, Ibrahim H. ............................. Disclosed no conflict of interest.Korn, Marcus ......................................... Employee: Sanofi; Stock/Shareholder: Sanofi.Kornelius, Edy ....................................... Disclosed no conflict of interest.Körner, Antje ......................................... Disclosed no conflict of interest.Koro, Carol E. ....................................... Employee: GlaxoSmithKline; Stock/Shareholder: GSK.Korsgren, Olle ....................................... Disclosed no conflict of interest.Korsholm, Lars ...................................... Employee: Novo Nordisk A/S.Korytkowski, Mary T. ........................... Research Support: Sanofi.Kosak, Mikulas ...................................... Disclosed no conflict of interest.Koscso, Balazs ...................................... Disclosed no conflict of interest.Koseki, Masahiro .................................. Disclosed no conflict of interest.Koshimizu, Yukiko ................................. Disclosed no conflict of interest.Koshitani, Rie ........................................ Disclosed no conflict of interest.Koshiyama, Hiroyuki ............................. Research Support: Boehringer Ingelheim Pharmaceuticals,
Inc., Mitsubishi Tanabe Pharmaceutical Corporation, Novo Nordisk, Inc.
Kosi, Lana .............................................. Disclosed no conflict of interest.Kosiborod, Mikhail ................................ Advisory Panel: Gilead Sciences, Inc.; Consultant: Abbvie,
Kostaki, Stavroula ................................. Disclosed no conflict of interest.Kostareva, Anna A. .............................. Disclosed no conflict of interest.Koster, Abraham J. .............................. Disclosed no conflict of interest.Kosugi, Chisato ..................................... Disclosed no conflict of interest.Kotani, Kazuhiko ................................... Disclosed no conflict of interest.Kothari, Vishal M. ................................ Disclosed no conflict of interest.Kothny, Wolfgang.................................. Employee: Novartis Pharma AG; Stock/Shareholder: Novartis.Kotova, Olga .......................................... Disclosed no conflict of interest.Kotzka, Jörg .......................................... Disclosed no conflict of interest.Kouchi, Yu ............................................. Disclosed no conflict of interest.Kougias, Panos ...................................... Disclosed no conflict of interest.Kouhara, Haruhiko ................................ Disclosed no conflict of interest.Kouichi, Inukai ....................................... Disclosed no conflict of interest.Koukoui, François .................................. Disclosed no conflict of interest.Kounaki, Stella ...................................... Disclosed no conflict of interest.Koutsovasilis, Anastasios G. ............... Disclosed no conflict of interest.Kovacs, Christopher S. ......................... Research Support: Boehringer Ingelheim GmbH & Co. KG.Kovalenko, Olga L. ............................... Disclosed no conflict of interest.Kovarova, Marketa ................................ Disclosed no conflict of interest.Kovatchev, Boris P. ............................... Consultant: Animas Corporation, Dexcom, Inc., Sanofi;
Research Support: Animas Corporation, Insulet Corporation, Lifescan Animas, Inc., Sanofi, Tandem Diabetes Care.
Kowalik, Edward ................................... Employee: Merck.Kowall, Bernd ........................................ Disclosed no conflict of interest.Kowalska, Irina ..................................... Disclosed no conflict of interest.Kown, Mi Hyang ................................... Disclosed no conflict of interest.Koya, Daisuke ....................................... Research Support: Banyu Pharmaceutical Co., Ltd., Eli Lilly
and Company, Kowa Pharmaceuticals, Mitsubishi Tanabe Pharmaceutical Corporation, Nippon Boehringer Ingelheim Co., Ltd., Novartis Pharmaceuticals Corporation, Sanofi, Takeda Pharmaceutical Company, Ltd.; Speaker’s Bureau: Banyu Pharmaceutical Co., Ltd., Eli Lilly and Company, Kowa Pharmaceuticals, Mitsubishi Tanabe Pharmaceutical Corporation, Nippon Boehringer Ingelheim Co., Ltd., Novartis Pharmaceuticals Corporation, Novo Nordisk, Inc., Sanofi.
Kraft, Guillaume .................................... Disclosed no conflict of interest.Kraft, Thomas E. ................................... Disclosed no conflict of interest.Krager, Stacey ....................................... Disclosed no conflict of interest.Kragh, Nana .......................................... Employee: Novo Nordisk A/S.Kralisch, Susan ..................................... Disclosed no conflict of interest.Krall, Jodi S. ......................................... Research Support: Becton, Dickinson and Company.Kramer, Anneke ..................................... Disclosed no conflict of interest.Kramer, Caroline K. .............................. Disclosed no conflict of interest.Kramer, M. Kaye ................................... Disclosed no conflict of interest.Kramer, Michael .................................... Disclosed no conflict of interest.Krasner, Alan ......................................... Employee: Biodel, Inc.; Stock/Shareholder: Biodel, Inc.Kratzsch, Jürgen ................................... Disclosed no conflict of interest.
Krausch, Markus ................................... Disclosed no conflict of interest.Kravchuk, Ekaterina N. ........................ Disclosed no conflict of interest.Kravos, Nika .......................................... Disclosed no conflict of interest.Krcma, Michal ....................................... Disclosed no conflict of interest.Krebs, Michael ...................................... Research Support: Sanofi; Speaker’s Bureau: Novartis
Pharmaceuticals Corporation, Novo Nordisk, Inc., Sanofi.Krekler, Michael .................................... Employee: Bristol-Myers Squibb Company.Krentz, Andrew ..................................... Employee: Profil Institute for Clinical Research, Inc.Kretowski, Adam ................................... Disclosed no conflict of interest.Kretzler, Matthias.................................. Disclosed no conflict of interest.Kriauciunas, Kristina ............................. Disclosed no conflict of interest.Kriellaars, Dean .................................... Disclosed no conflict of interest.Krischer, Jeffrey P. ............................... Disclosed no conflict of interest.Krishnamoorthy, Ezhilarasi .................... Disclosed no conflict of interest.Krishnamurthy, Mansa .......................... Disclosed no conflict of interest.Krishnan, Rahul ..................................... Consultant: Islet Sciences.Kriska, Andrea M. ................................ Disclosed no conflict of interest.Kristensen, Dorte E. ............................. Disclosed no conflict of interest.Kristensen, Jonas M. ........................... Disclosed no conflict of interest.Kristiansen, Viggo B. ............................ Disclosed no conflict of interest.Kritz-Sliverstein, Donna ........................ Disclosed no conflict of interest.Kroehl, Miranda .................................... Disclosed no conflict of interest.Krogvold, Lars ....................................... Disclosed no conflict of interest.Krol, Silke .............................................. Disclosed no conflict of interest.Krolewski, Andrzej S. ........................... Research Support: Eli Lilly and Company, Pfizer, Inc.Kröller-Schön, Swenja .......................... Disclosed no conflict of interest.Kroon, Tobias......................................... Employee: AstraZeneca Pharmaceuticals LP; Research
Support: AstraZeneca Pharmaceuticals LP.Kropff, Jort ............................................ Disclosed no conflict of interest.Krüger, Stefan ....................................... Disclosed no conflict of interest.Krull, Jordan E. ..................................... Disclosed no conflict of interest.Krum, Henry .......................................... Consultant: Novartis Pharmaceuticals Corporation.Krumholz, Harlan M. ............................ Board Member: UnitedHealthcare; Research Support:
Medtronic.Krupek, Tuane........................................ Disclosed no conflict of interest.Kruse, Michael ...................................... Disclosed no conflict of interest.Krzizek, Eva C. ...................................... Disclosed no conflict of interest.Krzysik-Walker, Susan M. .................... Disclosed no conflict of interest.Ku, Eu-jeong .......................................... Disclosed no conflict of interest.Ku, H. Teresa ......................................... Disclosed no conflict of interest.Kubat, Jessica ....................................... Disclosed no conflict of interest.Kublaoui, Bassil .................................... Disclosed no conflict of interest.Kubo, Fumiyo ......................................... Disclosed no conflict of interest.Kubo, Masahiro ..................................... Disclosed no conflict of interest.Kubo, Michiaki ...................................... Disclosed no conflict of interest.Kubota, Kiyoshi ..................................... Disclosed no conflict of interest.Kubota, Naoto ....................................... Disclosed no conflict of interest.Kubota, Tetsuya..................................... Disclosed no conflict of interest.Kudomi, Nobu ....................................... Disclosed no conflict of interest.Kudva, Yogish C. .................................. Disclosed no conflict of interest.Kuehl, Melanie N. ................................ Disclosed no conflict of interest.Kuhadiya, Nitesh D. ............................. Other Relationship: Endocrine Fellows Foundation Grant Kuhn, Alexander .................................... Disclosed no conflict of interest.Kuhre, Rune E. ...................................... Disclosed no conflict of interest.Kuijs, Ron .............................................. Disclosed no conflict of interest.Kuipers, Jeroen ..................................... Disclosed no conflict of interest.Kuki, Hideki ........................................... Disclosed no conflict of interest.Kukurova, Ivica ...................................... Disclosed no conflict of interest.Kulkarni, Rohit N. ................................. Disclosed no conflict of interest.Kullmann, Stephanie ............................. Disclosed no conflict of interest.Kullo, Iftikhar J. .................................... Disclosed no conflict of interest.Kulzer, Bernhard .................................... Advisory Panel: Berlin Chemie AG, Novo Nordisk A/S, Roche
Pharmaceuticals, Sanofi; Consultant: Berlin Chemie AG, Novo Nordisk A/S, Roche Pharmaceuticals, Sanofi; Research Support: Berlin Chemie AG, Roche Pharmaceuticals, Sanofi.
Kumah-Crystal, Yaa ............................... Disclosed no conflict of interest.Kumar, Anajli F. .................................... Disclosed no conflict of interest.Kumar, Anil ............................................ Disclosed no conflict of interest.Kumar, Ashish ....................................... Disclosed no conflict of interest.Kumar, Prasanna ................................... Advisory Panel: AstraZeneca/Bristol-Meyers Squibb, Biocon,
Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Merck Sharp & Dohme Limited, Novartis Pharma AG, Sanofi; Speaker’s Bureau: AstraZeneca/Bristol-Meyers Squibb, Biocon, Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Merck Sharp & Dohme Limited, Novartis Pharma AG, Sanofi.
Kumar, Sanjeev ..................................... Disclosed no conflict of interest.Kumar, Sudhesh .................................... Advisory Panel: Novo Nordisk A/S.Kumareswaran, Kavita .......................... Disclosed no conflict of interest.Kumasaiyai, Warunee ........................... Disclosed no conflict of interest.Kumashiro, Naoki .................................. Disclosed no conflict of interest.
Kumashiro, Yuki .................................... Disclosed no conflict of interest.Kume, Shinji .......................................... Disclosed no conflict of interest.Kümmel, Stefanie ................................. Disclosed no conflict of interest.Kumpatla, Satyavani ............................. Disclosed no conflict of interest.Kumsaiyai, Warunee ............................. Disclosed no conflict of interest.Kumusoglu, Doga .................................. Disclosed no conflict of interest.Kunach, Margaret ................................. Disclosed no conflict of interest.Kung, Ada .............................................. Disclosed no conflict of interest.Kunishita, Rieko .................................... Disclosed no conflict of interest.Kunos, George ....................................... Disclosed no conflict of interest.Kunutsor, Setor...................................... Disclosed no conflict of interest.Kunz, Jason ........................................... Disclosed no conflict of interest.Kuo, Charlotte ....................................... Disclosed no conflict of interest.Kuo, Chia-Yu .......................................... Disclosed no conflict of interest.Kuo, Chien-Hung ................................... Disclosed no conflict of interest.Kuo, Chun-Heng .................................... Disclosed no conflict of interest.Kuo, Gee-Hong ...................................... Employee: Janssen Research & Development.Kuo, Shihchen ....................................... Disclosed no conflict of interest.Kuper, Frieke.......................................... Disclosed no conflict of interest.Kuperman, Yael ..................................... Disclosed no conflict of interest.Kuppusamy, Selvan ............................... Disclosed no conflict of interest.Kurahashi, Kiyoe ................................... Disclosed no conflict of interest.Kurasaki, Kotaro .................................... Disclosed no conflict of interest.Kuricova, Katarina ................................. Disclosed no conflict of interest.Kurklinsky, Svetlana .............................. Disclosed no conflict of interest.Kuroda, Akio .......................................... Disclosed no conflict of interest.Kurt, Omer ............................................. Disclosed no conflict of interest.Kusakabe, Toru ...................................... Disclosed no conflict of interest.Kusama, Minoru .................................... Disclosed no conflict of interest.Kushida, Clete ....................................... Disclosed no conflict of interest.Kushiyama, Akifumi .............................. Disclosed no conflict of interest.Kushner, Jake A. .................................. Disclosed no conflict of interest.Kushner, Robert F. ................................ Advisory Panel: Novo Nordisk, Inc., Retrofit, Takeda
Kusova, Hana ........................................ Disclosed no conflict of interest.Kusunoki, Masataka ............................. Disclosed no conflict of interest.Kutoh, Eiji .............................................. Disclosed no conflict of interest.Kuusisto, Johanna ................................ Disclosed no conflict of interest.Kuwamura, Yumi ................................... Disclosed no conflict of interest.Kuwashiro, Takuya ................................ Disclosed no conflict of interest.Kuzik, Nicholas ...................................... Disclosed no conflict of interest.Kuzmiski, Joseph B. ............................. Employee: Pfizer, Inc.Kuzuya, Hideshi ..................................... Disclosed no conflict of interest.Kwak, Soo-Heon ................................... Disclosed no conflict of interest.Kwek, Kenneth ...................................... Disclosed no conflict of interest.Kwok, Kelvin H. .................................... Disclosed no conflict of interest.Kwon, Guim ........................................... Disclosed no conflict of interest.Kwon, Hee Sun ..................................... Disclosed no conflict of interest.Kwon, Hyuk-Sang .................................. Disclosed no conflict of interest.Kwon, Obin ............................................ Disclosed no conflict of interest.Kwon, Se Chang .................................... Employee: Hanmi Pharmaceutical Co.Kwon, Young Mi .................................... Disclosed no conflict of interest.Kyrou, Ioannis ....................................... Disclosed no conflict of interest.Kystaubaeva, Zaure T. .......................... Disclosed no conflict of interest.Kyung, Chanhee .................................... Disclosed no conflict of interest.La Fleur, Susanne .................................. Disclosed no conflict of interest.Laakso, Markku ..................................... Disclosed no conflict of interest.Laatiri, Imed .......................................... Disclosed no conflict of interest.LaBaer, Joshua ...................................... Disclosed no conflict of interest.Labarbuta, Rossella .............................. Disclosed no conflict of interest.Labbe, Pilar ........................................... Disclosed no conflict of interest.Labbe, Sebastien M. ............................ Disclosed no conflict of interest.Lacadie, Cheryl M. ............................... Disclosed no conflict of interest.Lacassie, Yves ....................................... Disclosed no conflict of interest.Lachin, John M. ................................... Disclosed no conflict of interest.Lacinova, Zdenka .................................. Disclosed no conflict of interest.Lacroix, Marlène Z. .............................. Disclosed no conflict of interest.LaCruz, Debby M. ................................. Research Support: Sanofi.Lacy, Mary E. ........................................ Disclosed no conflict of interest.Laederach, Kurt ..................................... Disclosed no conflict of interest.Laffel, Lori M. ....................................... Advisory Panel: Sanofi; Consultant: Boehringer Ingelheim,
Bristol-Myers Squibb Company, Dexcom, Inc., Eli Lilly and Company, Johnson & Johnson, Lifescan Animas, Inc., Menarini, NovoNordisk Inc., Oshadi Drug Administration, Roche Pharmaceuticals, Sanofi; Research Support: Bayer Health Care, LLC.
Lagana Lorber, Deborah ........................ Disclosed no conflict of interest.Lage, Maureen J. ................................. Consultant: Eli Lilly and Company, Eli Lilly and Company
(Spouse/Partner).Lahav, Maor .......................................... Disclosed no conflict of interest.
Lahtela, Jorma ...................................... Advisory Panel: Amgen, Inc., Medtronic, Merck Sharp & Dohme Limited, Novo Nordisk A/S; Speaker’s Bureau: Amgen, Inc., AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Company, Eli Lilly and Company, Merck Sharp & Dohme Limited, Novo Nordisk A/S, Sanofi.
Lai, Mei-Shu .......................................... Disclosed no conflict of interest.Lai, Ying-Chuen ..................................... Disclosed no conflict of interest.Lai, Yongqiang ....................................... Disclosed no conflict of interest.Laires, Pedro ......................................... Employee: Merck.Laitinen, Jaana ..................................... Disclosed no conflict of interest.Lajer, Maria ........................................... Disclosed no conflict of interest.Lakey, Jonathan .................................... Board Member: Islet Sciences; Research Support: Islet
Lakka, Timo ........................................... Disclosed no conflict of interest.Lakshmi, M.N. ...................................... Disclosed no conflict of interest.Lakshmipathi, Jayalakshmi ................... Disclosed no conflict of interest.Lally, Jayasree ...................................... Disclosed no conflict of interest.Lam, Augustine ..................................... Disclosed no conflict of interest.Lam, Eric Chen Quin .............................. Employee: Eli Lilly and Company.Lam, Jonathan ...................................... Disclosed no conflict of interest.Lam, Karen S. ....................................... Disclosed no conflict of interest.Lam, Tony K.T. ...................................... Disclosed no conflict of interest.Lam, Vincent K. .................................... Disclosed no conflict of interest.Lamacchia, Olga .................................... Disclosed no conflict of interest.Lamarche, Frederic ................................ Disclosed no conflict of interest.Lamb, Molly M. .................................... Disclosed no conflict of interest.Lambeth, Stacey ................................... Disclosed no conflict of interest.Lamendola, Cindy A. ............................ Disclosed no conflict of interest.Lammer, Jan .......................................... Disclosed no conflict of interest.Lammert, Eckhard ................................. Disclosed no conflict of interest.Lamola, Giuseppe ................................. Disclosed no conflict of interest.Lamont, Deanna J. ............................... Disclosed no conflict of interest.Lamonte, Michael J. ............................ Disclosed no conflict of interest.Lamounier-Zepter, Valeria ..................... Disclosed no conflict of interest.Lamprinou, Apostolia ............................ Disclosed no conflict of interest.Lan, Michael S. .................................... Disclosed no conflict of interest.Lan, Xu .................................................. Disclosed no conflict of interest.Lancaster, Jack...................................... Disclosed no conflict of interest.Lancaster, Victoria ................................. Disclosed no conflict of interest.Lancerotto, Luca .................................... Disclosed no conflict of interest.Landa-Rouben, Natalie ......................... Disclosed no conflict of interest.Landau, Zohar ....................................... Disclosed no conflict of interest.Landgraf, Kathrin .................................. Disclosed no conflict of interest.Landgraf, Wolfgang .............................. Employee: Sanofi; Stock/Shareholder: Sanofi.Landis, Margaret S. ............................. Employee: Pfizer, Inc.Landivar-Rocha, Adriana ....................... Disclosed no conflict of interest.Landman, Gijs W. ................................. Disclosed no conflict of interest.Lane, James T. ..................................... Research Support: Andromeda Biotech, Ltd., Boehringer
Lanford, Robert ..................................... Disclosed no conflict of interest.Lang, Alon ............................................. Disclosed no conflict of interest.Lang, Jochen ......................................... Disclosed no conflict of interest.Lang, Leonie .......................................... Disclosed no conflict of interest.Lang, Wei .............................................. Disclosed no conflict of interest.Lang, Wensheng ................................... Employee: Janssen Research & Development.Langbakke, Irene H. ............................. Employee: Novo Nordisk A/S; Stock/Shareholder: Novo
Nordisk A/S.Lange, Ethan ......................................... Disclosed no conflict of interest.Lange, Karin .......................................... Disclosed no conflict of interest.Lange, Leslie ......................................... Disclosed no conflict of interest.Langefeld, Carl D. ................................ Disclosed no conflict of interest.Langenberg, Claudia ............................. Disclosed no conflict of interest.Langer, Jakob ........................................ Employee: Novo Nordisk, Inc.; Stock/Shareholder: Novo
Nordisk, Inc.Langholz, Ebbe ...................................... Disclosed no conflict of interest.Langlais, Paul ........................................ Disclosed no conflict of interest.Langlois, Marie-France ......................... Disclosed no conflict of interest.Langman, Linda ..................................... Disclosed no conflict of interest.Lang-Olip, Ingrid .................................... Disclosed no conflict of interest.Langwell, Kathryn M. .......................... Research Support: Merck.Länne, Toste .......................................... Disclosed no conflict of interest.Lantier, Louise ....................................... Disclosed no conflict of interest.Lantieri, Olivier ...................................... Disclosed no conflict of interest.Lanting, Linda ........................................ Disclosed no conflict of interest.Lanza, Ian R. ......................................... Disclosed no conflict of interest.Lanzola, Giordano ................................. Disclosed no conflict of interest.Lanzoni, Giacomo .................................. Disclosed no conflict of interest.Lao, Guojuan ......................................... Disclosed no conflict of interest.
Lao, Julie Z. .......................................... Employee: Merck.LaPierre, Mary P. .................................. Disclosed no conflict of interest.Lappé, Donald L. .................................. Disclosed no conflict of interest.Lapworth, Amanda L. ........................... Research Support: Pfizer, Inc.Lares, Angela P. .................................... Disclosed no conflict of interest.Largay, Joseph ...................................... Advisory Panel: Dexcom, Inc., Takeda Pharmaceutical
Company, Ltd., Valeritas, LLC, Vivus, Inc.; Research Support: Abbott Diabetes Care, Andromeda Biotech, Ltd., AstraZeneca/Bristol-Meyers Squibb, Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, GI Dynamics, Halozyme Therapeutics, Hoffman La Roche, Johnson & Johnson, Lexicon Pharmaceuticals, Inc., Medtronic, Novo Nordisk, Inc., Orexigen Therapeutics, Inc., PhaseBio, Takeda Pharmaceutical Company, Ltd., Tolerx, Inc.
Larger, Etienne ...................................... Disclosed no conflict of interest.Larkin, Mary E. ..................................... Disclosed no conflict of interest.Larocque, Isabelle ................................. Disclosed no conflict of interest.Larrañaga, Alejandra ............................ Disclosed no conflict of interest.Larsen, Jennifer L. ............................... Disclosed no conflict of interest.Larsen, Steen ........................................ Disclosed no conflict of interest.Larsson, Christel ................................... Disclosed no conflict of interest.Lassance Gomes, Luciana ..................... Disclosed no conflict of interest.Lasseter, Kenneth C. ............................ Disclosed no conflict of interest.Latif, Zafar A. ....................................... Advisory Panel: Novo Nordisk A/S; Speaker’s Bureau: Eli Lilly
and Company, Novartis Pharmaceuticals Corporation, Novo Nordisk A/S, Sanofi, Servier.
Lattuada, Guido ..................................... Disclosed no conflict of interest.Laturnus, Donna .................................... Disclosed no conflict of interest.Lau, Karen ............................................. Disclosed no conflict of interest.Lau, May ............................................... Disclosed no conflict of interest.Lau, Raymond G. .................................. Disclosed no conflict of interest.Lau, Winnie W. .................................... Disclosed no conflict of interest.Laubner, Katharina ................................ Disclosed no conflict of interest.Lauer, Abigail ........................................ Disclosed no conflict of interest.Laughlin, Gail A. ................................... Disclosed no conflict of interest.Lauritzen, Torsten .................................. Research Support: Astra Denmark, GlaxoSmithKline Pharma,
Denmark, HemoCue Denmark A/S, Novo Nordisk A/S, Pzizer, Denmark, SERVIER Denmark A/S; Stock/Shareholder: Novo Nordisk A/S.
Lauro, Davide ........................................ Disclosed no conflict of interest.Laursen, Ditte H. .................................. Disclosed no conflict of interest.Laursen, Torben ..................................... Disclosed no conflict of interest.Lavallee, Barry ...................................... Disclosed no conflict of interest.Lavernia, Frank ...................................... Advisory Panel: Sanofi; Board Member: Eisai
Pharmaceuticals, Eli Lilly and Company, Janssen Pharmaceuticals, Sanofi.
Lavigne, Stéphane ................................ Other Relationship: Novo Nordisk, Inc.Lavin, Philip T. ...................................... Consultant: ZS Pharma, Inc; Employee: Boston Biostatistics
Research Foundation.Laviola, Luigi ......................................... Consultant: Bristol-Myers Squibb/AstraZeneca.Lavis, Victor ........................................... Disclosed no conflict of interest.Lavrador, Maria S. ................................ Disclosed no conflict of interest.Law, Gordon .......................................... Employee: Janssen Research & Development, LLC.Law, Jennifer R. ................................... Disclosed no conflict of interest.Lawrence, Jean M. .............................. Disclosed no conflict of interest.Lawson, Heather A. ............................. Disclosed no conflict of interest.Lawton, Kay .......................................... Employee: Metabolon, Inc.; Stock/Shareholder: Metabolon,
Inc.Laybutt, D.R. ......................................... Disclosed no conflict of interest.Laye, Matthew J. ................................. Disclosed no conflict of interest.Layton, Jill ............................................. Disclosed no conflict of interest.Lazo, Mariana ....................................... Disclosed no conflict of interest.Le Boeuf, Dominique ............................. Disclosed no conflict of interest.Le Floch, Jean-Pierre ............................ Consultant: Abbott Diabetes Care, Becton, Dickinson and
Company, Novo Nordisk, Inc.; Research Support: Merck, Novo Nordisk, Inc.
Le Roux, Carel W. ................................ Disclosed no conflict of interest.Le, Kha .................................................. Employee: Genentech.Le, N-Anh .............................................. Consultant: LipoScience, Inc; Research Support: Merck
Sharpe & Dohme.Le, Tima ................................................. Disclosed no conflict of interest.Le, Yun-Zheng ....................................... Disclosed no conflict of interest.Leahy, John L. ...................................... Disclosed no conflict of interest.Leak-Johnson, Tennille ......................... Disclosed no conflict of interest.Leamy, Alexandra K. ............................ Disclosed no conflict of interest.Lebherz, Corinna ................................... Disclosed no conflict of interest.LeBlanc, Erin ......................................... Research Support: Amgen, Inc., AstraZeneca/Bristol-Meyers
Squibb.LeBon, Jeanne ...................................... Disclosed no conflict of interest.Lebreton, Fanny ..................................... Disclosed no conflict of interest.Lebrun, Bruno ........................................ Disclosed no conflict of interest.
LeCaire, Tamara J. ............................... Disclosed no conflict of interest.Lecube, Albert ....................................... Advisory Panel: Novo Nordisk, Inc.; Speaker’s Bureau:
AstraZeneca/Bristol-Meyers Squibb, Bristol-Myers Squibb Company, Eli Lilly and Company, Novo Nordisk, Inc., Sanofi.
LeDoux, Susan ...................................... Disclosed no conflict of interest.Lee, Amy S. .......................................... Disclosed no conflict of interest.Lee, Anna .............................................. Disclosed no conflict of interest.Lee, Augustine M. ................................ Disclosed no conflict of interest.Lee, Biing Ming Simon.......................... Disclosed no conflict of interest.Lee, Byung-Wan .................................... Disclosed no conflict of interest.Lee, Chan Joo ....................................... Disclosed no conflict of interest.Lee, Chang Beom .................................. Disclosed no conflict of interest.Lee, Charlotte E. ................................... Disclosed no conflict of interest.Lee, Chia-lin .......................................... Disclosed no conflict of interest.Lee, Chien-Nan ..................................... Disclosed no conflict of interest.Lee, Christine ........................................ Disclosed no conflict of interest.Lee, Dong Hwa ...................................... Disclosed no conflict of interest.Lee, Eun Soo ......................................... Disclosed no conflict of interest.Lee, Eun Young ...................................... Disclosed no conflict of interest.Lee, Eunjung .......................................... Disclosed no conflict of interest.Lee, Heung Man .................................... Disclosed no conflict of interest.Lee, Hon-Chi .......................................... Disclosed no conflict of interest.Lee, Hyangkyu ....................................... Disclosed no conflict of interest.Lee, Hyoung Woo .................................. Disclosed no conflict of interest.Lee, Hyun Chul ...................................... Disclosed no conflict of interest.Lee, In-Kyu ............................................ Disclosed no conflict of interest.Lee, I-Te ................................................. Disclosed no conflict of interest.Lee, Jack ............................................... Disclosed no conflict of interest.Lee, Jae Hyuk ........................................ Disclosed no conflict of interest.Lee, Jae Min ......................................... Disclosed no conflict of interest.Lee, James J. ....................................... Disclosed no conflict of interest.Lee, Jayson ........................................... Disclosed no conflict of interest.Lee, Jeong Eun ...................................... Disclosed no conflict of interest.Lee, Jeongkyung ................................... Disclosed no conflict of interest.Lee, Jin-Hee .......................................... Disclosed no conflict of interest.Lee, Jin-sook ......................................... Disclosed no conflict of interest.Lee, Jisoo .............................................. Employee: Boehringer Ingelheim GmbH & Co. KG.Lee, Jong Woo ...................................... Disclosed no conflict of interest.Lee, Joseph H. ..................................... Disclosed no conflict of interest.Lee, Joyce M. ....................................... Disclosed no conflict of interest.Lee, Kevin Y. ......................................... Disclosed no conflict of interest.Lee, Ki Won ........................................... Disclosed no conflict of interest.Lee, Kim ................................................ Disclosed no conflict of interest.Lee, Kwan Woo ..................................... Disclosed no conflict of interest.Lee, Kyoung Min ................................... Disclosed no conflict of interest.Lee, Kyu Hwang .................................... Disclosed no conflict of interest.Lee, Kyung Ae ....................................... Disclosed no conflict of interest.Lee, Mackenzie ..................................... Disclosed no conflict of interest.Lee, Mi Young ....................................... Disclosed no conflict of interest.Lee, Michael ......................................... Disclosed no conflict of interest.Lee, Michelle L. .................................... Disclosed no conflict of interest.Lee, Min Jung ....................................... Disclosed no conflict of interest.Lee, Moon-Kyu ...................................... Disclosed no conflict of interest.Lee, Myung-Shik ................................... Disclosed no conflict of interest.Lee, Nancy A. ....................................... Disclosed no conflict of interest.Lee, Paul C. .......................................... Disclosed no conflict of interest.Lee, Pearl G. ......................................... Disclosed no conflict of interest.Lee, Sang-A ........................................... Disclosed no conflict of interest.Lee, Sarah ............................................. Disclosed no conflict of interest.Lee, Scott W. ........................................ Employee: Medtronic.Lee, Sean B. ......................................... Disclosed no conflict of interest.Lee, Seohui ........................................... Disclosed no conflict of interest.Lee, Seong-Su ....................................... Disclosed no conflict of interest.Lee, Seungbok ....................................... Disclosed no conflict of interest.Lee, Seung-Hoon ................................... Disclosed no conflict of interest.Lee, Seunghun P. .................................. Employee: Janssen Research & Development.Lee, Seung-Hwan .................................. Disclosed no conflict of interest.Lee, Seung-Pyo ..................................... Disclosed no conflict of interest.Lee, Shao Chin ...................................... Disclosed no conflict of interest.Lee, Simon B. ....................................... Disclosed no conflict of interest.Lee, Sojin .............................................. Disclosed no conflict of interest.Lee, SoJung .......................................... Disclosed no conflict of interest.Lee, Sun-Joo ......................................... Disclosed no conflict of interest.Lee, Syann ............................................. Disclosed no conflict of interest.Lee, Tae J. ............................................ Disclosed no conflict of interest.Lee, Wei An A. ..................................... Disclosed no conflict of interest.Lee, Yeji ................................................. Disclosed no conflict of interest.Lee, Yong Hee ....................................... Disclosed no conflict of interest.Lee, Yong-Ho ......................................... Disclosed no conflict of interest.Lee, You Jin ........................................... Disclosed no conflict of interest.Lee, Young-Kyun ................................... Disclosed no conflict of interest.
Lee, Youn-Kyoung ................................. Disclosed no conflict of interest.Lee, Yun Jeong ...................................... Disclosed no conflict of interest.Lee, Yun Kyung ...................................... Disclosed no conflict of interest.Lee, Yung Seng ..................................... Disclosed no conflict of interest.Leeds, William J. ................................. Disclosed no conflict of interest.Lee-Eng, Jacqueline .............................. Disclosed no conflict of interest.Leelarathna, Lalantha ........................... Disclosed no conflict of interest.Leey, Julio A. ....................................... Disclosed no conflict of interest.Leff, Jonathan ....................................... Disclosed no conflict of interest.Lefrandt, Joop D. ................................. Disclosed no conflict of interest.Lega, Iliana C. ...................................... Disclosed no conflict of interest.Legault, Laurent .................................... Advisory Panel: Pfizer, Inc.; Research Support: Medtronic,
Novo Nordisk, Inc.Lehert, Philippe ..................................... Disclosed no conflict of interest.Lehman, Donna M. ............................... Disclosed no conflict of interest.Lehmann, Roger .................................... Disclosed no conflict of interest.Lehrke, Michael .................................... Disclosed no conflict of interest.Lehtiniemi, Paula .................................. Disclosed no conflict of interest.Lei, Weiqi .............................................. Disclosed no conflict of interest.Lei, Xiaoyong ......................................... Disclosed no conflict of interest.Leibovitz, Eyal ....................................... Disclosed no conflict of interest.Leibowitz, Gil ........................................ Disclosed no conflict of interest.Leiherer, Andreas .................................. Disclosed no conflict of interest.Leiria, Luiz ............................................. Disclosed no conflict of interest.Leissring, Malcolm A. .......................... Disclosed no conflict of interest.Leitão, Cristiane B. ............................... Disclosed no conflict of interest.Leite, Silmara A. .................................. Board Member: Sanofi; Consultant: Novo Nordisk, Inc.;
Research Support: Merck Sharp & Dohme Limited, Novo Nordisk, Inc., Sanofi; Speaker’s Bureau: Eli Lilly and Company.
Leiter, Lawrence A. .............................. Advisory Panel: AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Janssen Pharmaceuticals, Merck, Novo Nordisk, Inc., Sanofi, Servier, Takeda Pharmaceutical Company, Ltd.; Research Support: AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Janssen Pharmaceuticals, Merck, Novo Nordisk, Inc., Sanofi, Servier, Takeda Pharmaceutical Company, Ltd.; Speaker’s Bureau: AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Janssen Pharmaceuticals, Merck, Novo Nordisk, Inc., Sanofi, Servier, Takeda Pharmaceutical Company, Ltd.
LeMaster, Joseph.................................. Disclosed no conflict of interest.Lenaerts, Kaatje .................................... Disclosed no conflict of interest.Lenchik, Nataliya I. .............................. Disclosed no conflict of interest.Leng, Yi-Ping ......................................... Disclosed no conflict of interest.Lenhard, M. James ............................... Speaker’s Bureau: Boehringer Ingelheim Pharmaceuticals,
Inc., Eli Lilly and Company, Janssen Pharmaceuticals.Leonard, Mary B. .................................. Disclosed no conflict of interest.Leonardini, Anna ................................... Research Support: Eli Lilly and Company.Leone, Alessandro ................................ Disclosed no conflict of interest.Leone, Alessia ....................................... Disclosed no conflict of interest.Leonetti, Donna L. ................................ Disclosed no conflict of interest.Leong, Aaron ......................................... Disclosed no conflict of interest.Leor, Yoni ............................................... Disclosed no conflict of interest.Leow, Khee Shing M. ........................... Disclosed no conflict of interest.Lepagnol, Astrid .................................... Disclosed no conflict of interest.Leporati, Elisabetta ............................... Disclosed no conflict of interest.Lerner, Kimberly .................................... Disclosed no conflict of interest.LeRoith, Derek ....................................... Consultant: Bristol-Myers Squibb/AstraZeneca, Janssen
Pharmaceuticals, Merck, Sanofi.Leroux, Catherine .................................. Disclosed no conflict of interest.Lertwattanarak, Raweewan ................. Disclosed no conflict of interest.Lesniewski, Scott J. ............................. Employee: Eli Lilly and Company, Eli Lilly and Company
(Spouse/Partner); Stock/Shareholder: Eli Lilly and Company, Eli Lilly and Company (Spouse/Partner).
Lessan, Nader ....................................... Disclosed no conflict of interest.Leszyk, John .......................................... Disclosed no conflict of interest.Leti, Fatjon ............................................ Disclosed no conflict of interest.Leung, Christopher ................................ Disclosed no conflict of interest.Leung, Po Sing ...................................... Disclosed no conflict of interest.Leung, Wilson C. .................................. Disclosed no conflict of interest.Levi, Chris .............................................. Disclosed no conflict of interest.Levin, Barry E. ...................................... Disclosed no conflict of interest.Levin, Philip ........................................... Advisory Panel: Novo Nordisk, Inc., Sanofi; Consultant: Novo
Nordisk, Inc., Sanofi; Research Support: Amylin Pharmaceuticals, Inc., Eli Lilly and Company, Novo Nordisk, Inc., Sanofi; Speaker’s Bureau: Aegerion Pharmaceuticals, Inc., Eli Lilly and Company, Novo Nordisk, Inc.
Levine, Steven N. ................................. Disclosed no conflict of interest.Levitan, Diane ....................................... Employee: Merck.Levy, Brian L. ........................................ Employee: Animas Corporation; Stock/Shareholder: Johnson
& Johnson.Lewandowski, E. Douglas ..................... Disclosed no conflict of interest.Lewi, Jack E. ........................................ Disclosed no conflict of interest.Lewin, Andrew J. ................................. Research Support: Akros Pharma, Inc., Amgen, Inc., Amylin
Pharmaceuticals, Inc., Bavarian Nordic, Bayer Health Care, LLC, Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Catabasis, Elcelyx Therapeutics, Inc., Eli Lilly and Company, Esperion, F. Hoffmann-La Roche, Ltd., Gilead Sciences, Inc., Isis Pharmaceuticals, Janssen Research & Development, Merck, Novartis Pharmaceuticals Corporation, Novo Nordisk, Inc., Pfizer, Inc., Phasebio Pharmaceuticals Inc, Pronova Biopharma Norge A/S, Sanofi, Theracos, TransTech Pharma.
Lewis, Basil S. ...................................... Research Support: Amgen, Inc., AstraZeneca Pharmaceuticals LP, GSK, Merck Sharp & Dohme Limited, Sanofi.
Lewis, Cora E. ...................................... Disclosed no conflict of interest.Lewis, Gary F. ....................................... Disclosed no conflict of interest.Lewis, Joshua P. ................................... Disclosed no conflict of interest.Lewis, Kevin .......................................... Disclosed no conflict of interest.Lewis, Monique .................................... Disclosed no conflict of interest.Lewis-D’Agostino, Diane ...................... Employee: Boehringer Ingelheim Pharmaceuticals Inc.Ley, Sylvia H. ........................................ Disclosed no conflict of interest.Li Calzi, Sergio ...................................... Disclosed no conflict of interest.Li Volsi, Patrizia ..................................... Disclosed no conflict of interest.Li, Can ................................................... Disclosed no conflict of interest.Li, Changhong ....................................... Disclosed no conflict of interest.Li, Chengjiang ....................................... Disclosed no conflict of interest.Li, Ching J. ........................................... Disclosed no conflict of interest.Li, Ching L. ............................................ Disclosed no conflict of interest.Li, ChunJun ........................................... Disclosed no conflict of interest.Li, Chunyan ............................................ Disclosed no conflict of interest.Li, Fei ..................................................... Disclosed no conflict of interest.Li, Fenfen ............................................... Research Support: NuSirt Inc.Li, Francois Y. ....................................... Disclosed no conflict of interest.Li, Guangwei ......................................... Disclosed no conflict of interest.Li, GuoDong ........................................... Disclosed no conflict of interest.Li, Guoyan ............................................. Disclosed no conflict of interest.Li, Hai .................................................... Disclosed no conflict of interest.Li, Han ................................................... Disclosed no conflict of interest.Li, Hechao ............................................. Disclosed no conflict of interest.Li, Hong ................................................. Disclosed no conflict of interest.Li, Huating ............................................. Disclosed no conflict of interest.Li, Hui .................................................... Disclosed no conflict of interest.Li, Hung-Yuan ........................................ Disclosed no conflict of interest.Li, Ji ....................................................... Disclosed no conflict of interest.Li, Jia ..................................................... Disclosed no conflict of interest.Li, Jianbo ............................................... Disclosed no conflict of interest.Li, Jian-Liang ......................................... Disclosed no conflict of interest.Li, Jibiao ................................................ Disclosed no conflict of interest.Li, Jin ..................................................... Disclosed no conflict of interest.Li, Jing ................................................... Disclosed no conflict of interest.Li, Ling ................................................... Disclosed no conflict of interest.Li, Ling-Jun ............................................ Disclosed no conflict of interest.Li, Lirong ................................................ Disclosed no conflict of interest.Li, Longfei .............................................. Disclosed no conflict of interest.Li, Man .................................................. Disclosed no conflict of interest.Li, Mengyao .......................................... Disclosed no conflict of interest.Li, Ming ................................................. Disclosed no conflict of interest.Li, Philip ................................................. Disclosed no conflict of interest.Li, Ping ................................................... Disclosed no conflict of interest.Li, Qian .................................................. Research Support: Janssen Pharmaceuticals.Li, Qiang ................................................ Disclosed no conflict of interest.Li, Qifu ................................................... Disclosed no conflict of interest.Li, Qin .................................................... Disclosed no conflict of interest.Li, Qing .................................................. Disclosed no conflict of interest.Li, Quanmin ........................................... Disclosed no conflict of interest.Li, Rong ................................................. Disclosed no conflict of interest.Li, Rui .................................................... Disclosed no conflict of interest.Li, Shaoqing .......................................... Disclosed no conflict of interest.Li, Shiri .................................................. Disclosed no conflict of interest.Li, Shuangqing ...................................... Disclosed no conflict of interest.Li, Tiangang ........................................... Disclosed no conflict of interest.Li, Wei ................................................... Disclosed no conflict of interest.Li, Weida ............................................... Disclosed no conflict of interest.Li, Wenhui ............................................. Disclosed no conflict of interest.Li, Wenjing ............................................ Disclosed no conflict of interest.Li, Wenya .............................................. Disclosed no conflict of interest.Li, Wenyu .............................................. Employee: Merck.
Li, X. ..................................................... Disclosed no conflict of interest.Li, Xia .................................................... Disclosed no conflict of interest.Li, Xian C. ............................................. Disclosed no conflict of interest.Li, Xiaodong .......................................... Disclosed no conflict of interest.Li, Xiaofeng ........................................... Disclosed no conflict of interest.Li, Xiaoming .......................................... Disclosed no conflict of interest.Li, Xiaowen ........................................... Disclosed no conflict of interest.Li, Xing .................................................. Disclosed no conflict of interest.Li, Xue ................................................... Disclosed no conflict of interest.Li, Ya-Lin ................................................ Disclosed no conflict of interest.Li, Yan Bing ........................................... Disclosed no conflict of interest.Li, Yan .................................................... Disclosed no conflict of interest.Li, Yanchun ............................................ Disclosed no conflict of interest.Li, Yanhong ............................................ Disclosed no conflict of interest.Li, Yanjun ............................................... Disclosed no conflict of interest.Li, Yanping ............................................. Disclosed no conflict of interest.Li, Yiming............................................... Disclosed no conflict of interest.Li, Yintao ............................................... Disclosed no conflict of interest.Li, Yong .................................................. Disclosed no conflict of interest.Li, Yong-Xi ............................................. Employee: Medpace, Inc.Li, Yu ...................................................... Disclosed no conflict of interest.Li, Yue .................................................... Disclosed no conflict of interest.LI, Yufeng .............................................. Disclosed no conflict of interest.Li, Yuhan ................................................ Employee: Eisai, Inc.Li, Yuling ................................................ Disclosed no conflict of interest.Li, Ze ...................................................... Disclosed no conflict of interest.Li, Zhao .................................................. Disclosed no conflict of interest.Li, Zhen .................................................. Employee: Metabolon, Inc.; Stock/Shareholder: Metabolon,
Inc.Li, Zhiyi .................................................. Research Support: Merck.Li, Zhu .................................................... Disclosed no conflict of interest.Lian, Jean .............................................. Employee: Novo Nordisk, Inc.Liang, Hanyu ......................................... Disclosed no conflict of interest.Liang, Qingning ..................................... Disclosed no conflict of interest.Liang, Tao .............................................. Disclosed no conflict of interest.Liang, Xiangyan ..................................... Disclosed no conflict of interest.Liang, Xiubin ......................................... Disclosed no conflict of interest.Liang, Yin............................................... Employee: Janssen Research & Development.Liang, Yuanjie ........................................ Employee: Novo Nordisk, Inc.Liang, Zhen ............................................ Disclosed no conflict of interest.Liao, Aurora ........................................... Employee: GI Dynamics; Stock/Shareholder: GI Dynamics.Liao, Bing Qing ...................................... Disclosed no conflict of interest.Liao, Chi-Ping ........................................ Disclosed no conflict of interest.Liao, Jane .............................................. Employee: Merck; Stock/Shareholder: Merck.Liao, Jiemin ........................................... Disclosed no conflict of interest.Liao, Ying-Jhu ....................................... Disclosed no conflict of interest.Liao, Yuan-Mei ...................................... Disclosed no conflict of interest.Liao, Zhi Hong ....................................... Disclosed no conflict of interest.Liaskos, Christos ................................... Disclosed no conflict of interest.Liberman, Ana ....................................... Disclosed no conflict of interest.Liberona, Jessica .................................. Disclosed no conflict of interest.Liberti, Lauren ....................................... Disclosed no conflict of interest.Libman, Ingrid M. ................................. Disclosed no conflict of interest.Licinio, Julio .......................................... Disclosed no conflict of interest.Lickliter, Jason ...................................... Other Relationship: Clinical Research Organization.Lidtke, Roy H. ....................................... Consultant: DJO Global.Lieberman, Nicky .................................. Disclosed no conflict of interest.Liebl, Andreas ....................................... Advisory Panel: Roche Diagnostics GmbH; Research Support:
Liese, Angela D. ................................... Disclosed no conflict of interest.Lieu, Cindy ............................................. Disclosed no conflict of interest.Lievre, Michel ....................................... Board Member: Novo Nordisk, Inc.Liew, Chong Wee .................................. Disclosed no conflict of interest.Light, Peter E. ....................................... Disclosed no conflict of interest.Lightell, Daniel J. ................................. Disclosed no conflict of interest.Liguori, Rossella .................................... Disclosed no conflict of interest.Liljenquist, David .................................. Disclosed no conflict of interest.Lilleøre, Søren ....................................... Stock/Shareholder: Novo Nordisk A/S.Lilly, Leslie C. ....................................... Employee: CeQur, Ltd.Lim, Chang Ki ........................................ Employee: Hanmi Pharmaceutical Co.Lim, Chang-gi ........................................ Employee: Hanmi Pharmaceutical Co.Lim, Gareth E. ....................................... Disclosed no conflict of interest.Lim, Jung Soo ....................................... Disclosed no conflict of interest.Lim, Soo ................................................ Disclosed no conflict of interest.Lim, Su Chi ............................................ Disclosed no conflict of interest.Lim, Suan T. .......................................... Disclosed no conflict of interest.Lima, Ines S. ......................................... Disclosed no conflict of interest.Lima, Maria J. ...................................... Disclosed no conflict of interest.Limbert, Catarina .................................. Disclosed no conflict of interest.Limesand, Sean W. .............................. Disclosed no conflict of interest.Lin, Ching-Ling ...................................... Disclosed no conflict of interest.
Lin, Edward ........................................... Disclosed no conflict of interest.Lin, Eric .................................................. Disclosed no conflict of interest.Lin, Huan-Dong ..................................... Disclosed no conflict of interest.Lin, James ............................................. Disclosed no conflict of interest.Lin, Jay .................................................. Research Support: Sanofi.Lin, Ji ..................................................... Disclosed no conflict of interest.Lin, Jihong ............................................. Disclosed no conflict of interest.Lin, Jou-Wei .......................................... Disclosed no conflict of interest.Lin, Lixiang ............................................ Disclosed no conflict of interest.Lin, Mao-Shin ........................................ Disclosed no conflict of interest.Lin, Shaoda ........................................... Disclosed no conflict of interest.Lin, Shih-Yi ............................................ Disclosed no conflict of interest.Lin, Shuo ............................................... Disclosed no conflict of interest.Lin, Wen-Yu ........................................... Disclosed no conflict of interest.Lin, Yi..................................................... Disclosed no conflict of interest.Lin, Yinchiu ............................................ Disclosed no conflict of interest.Lin, Yu T. ............................................... Disclosed no conflict of interest.Lin, Ziwei ............................................... Disclosed no conflict of interest.Linan, Margaret K. ............................... Disclosed no conflict of interest.Lind, Marcus ......................................... Disclosed no conflict of interest.Lindahl, Bernt ........................................ Disclosed no conflict of interest.Lindberg, Kristin .................................... Disclosed no conflict of interest.Lindegaard, Marie ................................. Employee: Novo Nordisk A/S; Stock/Shareholder: Novo
Nordisk A/S.Linden, Ellen H. .................................... Disclosed no conflict of interest.Linder, Barbara ...................................... Disclosed no conflict of interest.Linder, Katarzyna ................................... Disclosed no conflict of interest.Lindgren, Cecilia M. ............................. Disclosed no conflict of interest.Lindi, Virpi ............................................. Disclosed no conflict of interest.Lindner, Jaroslav ................................... Disclosed no conflict of interest.Lindström, Torbjörn ............................... Disclosed no conflict of interest.Linehan, Rose F. ................................... Disclosed no conflict of interest.Ling, Charlotte A. ................................. Disclosed no conflict of interest.Lingohr-Smith, Melissa ......................... Research Support: Sanofi.Lingvay, Ildiko ........................................ Disclosed no conflict of interest.Linjawi, Sultan ...................................... Advisory Panel: Novo Nordisk Australia.Link, Manuela ....................................... Disclosed no conflict of interest.Linnebjerg, Helle ................................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly
and Company.Linnenkamp, Ute ................................... Disclosed no conflict of interest.Lipinska, Danuta ................................... Disclosed no conflict of interest.Lipman, Terri H. .................................... Disclosed no conflict of interest.Lips, Michal ........................................... Disclosed no conflict of interest.Lipscombe, Lorraine L. ......................... Disclosed no conflict of interest.Lipska, Kasia ......................................... Disclosed no conflict of interest.Liptak, Gregory ...................................... Disclosed no conflict of interest.List, James F. ....................................... Employee: Bristol-Myers Squibb Company; Stock/Shareholder:
Bristol-Myers Squibb Company.Literáti-Nagy, Botond ............................ Disclosed no conflict of interest.Literati-Nagy, Zsuzsanna ...................... Research Support: N-Gene.Little, Tanya J. ...................................... Research Support: Novartis Pharmaceuticals Corporation.Littlefield, Laurel A. ............................. Disclosed no conflict of interest.Littlejohn, Elizabeth .............................. Disclosed no conflict of interest.Littlewood, Kerry ................................... Disclosed no conflict of interest.Littman, Alyson J. ................................ Disclosed no conflict of interest.Litwak, León .......................................... Speaker’s Bureau: AstraZeneca/Bristol-Meyers Squibb,
Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Novo Nordisk, Inc., Roche Pharmaceuticals, Sanofi.
Liu, Alice ............................................... Disclosed no conflict of interest.Liu, Amy W. .......................................... Disclosed no conflict of interest.Liu, Beijing ............................................ Employee: Bristol-Myers Squibb Company.Liu, Ben ................................................. Disclosed no conflict of interest.Liu, Bing ................................................ Disclosed no conflict of interest.Liu, Chang ............................................. Disclosed no conflict of interest.Liu, Chao ............................................... Disclosed no conflict of interest.Liu, Chen ............................................... Disclosed no conflict of interest.Liu, Chengyang ...................................... Disclosed no conflict of interest.Liu, Chune ............................................. Disclosed no conflict of interest.Liu, Dandan ........................................... Disclosed no conflict of interest.Liu, Dongmin ......................................... Disclosed no conflict of interest.Liu, Fang ................................................ Disclosed no conflict of interest.Liu, Feng ................................................ Disclosed no conflict of interest.Liu, Franklin ........................................... Employee: Merck.Liu, Haitao ............................................. Disclosed no conflict of interest.Liu, Haixia ............................................. Disclosed no conflict of interest.Liu, Hong ............................................... Disclosed no conflict of interest.Liu, Hongtao .......................................... Disclosed no conflict of interest.Liu, Hongxia .......................................... Disclosed no conflict of interest.Liu, Hongyan ......................................... Disclosed no conflict of interest.Liu, Jianghua ......................................... Disclosed no conflict of interest.Liu, Jianhui ............................................ Disclosed no conflict of interest.
Liu, Jianying .......................................... Disclosed no conflict of interest.Liu, Jie ................................................... Employee: Takeda Development Center Americas, Inc.Liu, Jiewu .............................................. Employee: Vascular Pharmaceuticals Inc.Liu, Joey Z. ........................................... Disclosed no conflict of interest.Liu, Juan ................................................ Disclosed no conflict of interest.Liu, Li ..................................................... Disclosed no conflict of interest.Liu, Liehua ............................................. Disclosed no conflict of interest.Liu, Li-Fen .............................................. Disclosed no conflict of interest.Liu, Limei ............................................... Disclosed no conflict of interest.Liu, Lin ................................................... Disclosed no conflict of interest.Liu, Miao ............................................... Disclosed no conflict of interest.Liu, Ming ............................................... Disclosed no conflict of interest.Liu, Qin .................................................. Disclosed no conflict of interest.Liu, Qing-Rong ....................................... Disclosed no conflict of interest.Liu, Shuqian .......................................... Disclosed no conflict of interest.Liu, Thomas ........................................... Employee: Amgen, Inc.Liu, Tianya ............................................. Disclosed no conflict of interest.Liu, Tiemin ............................................. Disclosed no conflict of interest.Liu, Wei ................................................. Research Support: Sanofi.Liu, Weihong ......................................... Disclosed no conflict of interest.Liu, Weiyi .............................................. Disclosed no conflict of interest.Liu, Xuan Y. .......................................... Disclosed no conflict of interest.Liu, Yanjun ............................................. Disclosed no conflict of interest.Liu, Yong ................................................ Disclosed no conflict of interest.Liu, Yongqiang ....................................... Employee: CrownBio.Liu, Yu .................................................... Disclosed no conflict of interest.Liu, Yunfeng .......................................... Disclosed no conflict of interest.Liu, Zhenqi ............................................. Disclosed no conflict of interest.Liu, Zhiwen ............................................ Employee: Merck; Stock/Shareholder: Merck.Liu, Zhongbo .......................................... Disclosed no conflict of interest.Livingstone, Shona J. ........................... Disclosed no conflict of interest.Livne, Ariela .......................................... Disclosed no conflict of interest.Ljubic, Spomenka .................................. Disclosed no conflict of interest.Llagostera, Roser .................................. Disclosed no conflict of interest.Llinas, Jose ........................................... Disclosed no conflict of interest.Llorca, Pierre-Michel ............................. Consultant: Novo Nordisk, Inc.Lloyd, Cathy E. ...................................... Disclosed no conflict of interest.Lo, Betty ................................................ Disclosed no conflict of interest.Loader, Cameron ................................... Disclosed no conflict of interest.Loba, Jerzy ............................................ Disclosed no conflict of interest.Lobelo, Roberto ..................................... Disclosed no conflict of interest.Lobo, Peter I. ........................................ Disclosed no conflict of interest.Lo-Ciganic, Wei-Hsuan ......................... Disclosed no conflict of interest.Locke, Adam E. ..................................... Disclosed no conflict of interest.Lockhart, Sam ....................................... Disclosed no conflict of interest.Lodh, Sukanya ....................................... Disclosed no conflict of interest.Lodhi, Irfan J. ....................................... Disclosed no conflict of interest.Lodwig, Volker ....................................... Employee: Roche Diagnostics.Loehr, Sarah .......................................... Disclosed no conflict of interest.Loeken, Mary R. ................................... Disclosed no conflict of interest.Loewenthal, Neta ................................. Disclosed no conflict of interest.Loftus, Paul ........................................... Disclosed no conflict of interest.Logan, Brent J. ..................................... Disclosed no conflict of interest.Logan, Douglas ..................................... Employee: MedPace, Inc.Loghin, Corina ....................................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly
and Company.Loghmani, Amir ..................................... Disclosed no conflict of interest.Logtenberg, Susan J. ........................... Disclosed no conflict of interest.Lohmann, Tobias ................................... Disclosed no conflict of interest.Lokurkar, Isha A. ................................... Disclosed no conflict of interest.Lombardero, Manuel ............................. Disclosed no conflict of interest.Lomonaco, Romina ................................ Disclosed no conflict of interest.Löndahl, Magnus .................................. Consultant: ReApplix AS; Speaker’s Bureau: AstraZeneca/
Long, Dustin .......................................... Disclosed no conflict of interest.Long, Eric K. ......................................... Disclosed no conflict of interest.Long, Gráinne H. .................................. Disclosed no conflict of interest.Long, Jonathan Z. ................................ Disclosed no conflict of interest.Long, Qi ................................................. Disclosed no conflict of interest.Long, S.A. ............................................. Disclosed no conflict of interest.Loo, Keat Wei ....................................... Disclosed no conflict of interest.Loomans, Cindy J. ................................ Disclosed no conflict of interest.Loos, Ruth ............................................. Disclosed no conflict of interest.Loots, Beth ............................................ Disclosed no conflict of interest.Loper, Alice E. ...................................... Employee: GlaxoSmithKline; Stock/Shareholder:
GlaxoSmithKline.Lopes da Mota, Carla............................ Disclosed no conflict of interest.Lopes, Ana ............................................ Disclosed no conflict of interest.Lopes, Luis ............................................ Disclosed no conflict of interest.Lopes-Virella, Maria F. ......................... Disclosed no conflict of interest.
López Plasencia, Yaiza .......................... Disclosed no conflict of interest.Lopez, Ana María .................................. Disclosed no conflict of interest.Lopez, Prudence .................................... Disclosed no conflict of interest.Lopez, Sandra ........................................ Disclosed no conflict of interest.López-Alvarenga, Juan C. .................... Disclosed no conflict of interest.Lopez-Guzman, Antonio ........................ Disclosed no conflict of interest.Lopez-Ocejo, Omar ................................ Disclosed no conflict of interest.Lopez-Pedrosa, Jose M. ....................... Employee: Abbott Nutrition.Lorber, Daniel L. ................................... Advisory Panel: BI-Lilly, Merck, Novo Nordisk, Inc., Roche
Pharmaceuticals; Board Member: Biodel, Inc.; Consultant: Merck, Novo Nordisk, Inc., Roche Pharmaceuticals; Research Support: Boehringer Ingelheim Pharmaceuticals, Inc., Janssen Pharmaceuticals, MannKind Corporation, Merck, Novo Nordisk, Inc.; Speaker’s Bureau: Janssen Pharmaceuticals, Novo Nordisk, Inc.; Stock/Shareholder: Biodel, Inc.
Lorentzen, Bjorg .................................... Disclosed no conflict of interest.Lorenzo, Carlos ...................................... Disclosed no conflict of interest.Lorenzo, Petra I. ................................... Disclosed no conflict of interest.Lorenzo, Rose ........................................ Disclosed no conflict of interest.Lorimer, Jamie....................................... Disclosed no conflict of interest.Lorrain, Simon ....................................... Disclosed no conflict of interest.Lorraine, Joanne ................................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly
and Company.Loskutova, Natalia ................................ Research Support: Sanofi, Shire.Lou, Jesse ............................................. Disclosed no conflict of interest.Lou, Qingqing ........................................ Disclosed no conflict of interest.Loucks, Eric ........................................... Disclosed no conflict of interest.Louis-Kullman, Emily ............................. Disclosed no conflict of interest.Lovblom, Leif E. .................................... Disclosed no conflict of interest.Lovejoy, Anne M. ................................. Disclosed no conflict of interest.Løvik, Martinus ..................................... Disclosed no conflict of interest.Lowe, Janae .......................................... Disclosed no conflict of interest.Lowe, Lynn P. ........................................ Disclosed no conflict of interest.Lowe, Rob ............................................. Disclosed no conflict of interest.Lowe, William L. .................................. Disclosed no conflict of interest.Lowery, Curtis ....................................... Disclosed no conflict of interest.Lowery, Jolene ...................................... Disclosed no conflict of interest.Loyd, Christine M. ................................ Disclosed no conflict of interest.Löyttyniemi, Eliisa ................................. Disclosed no conflict of interest.Lozier, Jay N. ........................................ Disclosed no conflict of interest.Lu, Chieh Hsiang ................................... Disclosed no conflict of interest.Lu, Danhong .......................................... Disclosed no conflict of interest.Lu, Feng-Hwa ........................................ Disclosed no conflict of interest.Lu, Huijuan ............................................ Disclosed no conflict of interest.Lu, Juming ............................................. Disclosed no conflict of interest.Lu, Min Y. ............................................. Disclosed no conflict of interest.Lu, Ming ................................................ Disclosed no conflict of interest.Lu, Qiu-Ju .............................................. Disclosed no conflict of interest.Lu, Tien-Hui ........................................... Disclosed no conflict of interest.Lu, Tong ................................................. Disclosed no conflict of interest.Lu, Wei .................................................. Disclosed no conflict of interest.Lu, Wen-Tsung ...................................... Disclosed no conflict of interest.Lu, Yi L. ................................................. Disclosed no conflict of interest.Lu, Yin L. ............................................... Disclosed no conflict of interest.Lu, Ying L. ............................................. Disclosed no conflict of interest.Lu, Yingchang ........................................ Disclosed no conflict of interest.Lu, Yingli................................................ Disclosed no conflict of interest.Lu, Zhigang ............................................ Disclosed no conflict of interest.Lu, Zhong X. ......................................... Disclosed no conflict of interest.Lu, Zhongyang ....................................... Disclosed no conflict of interest.Luan, Ju ................................................. Disclosed no conflict of interest.Lubina-Solomon, Alexandra .................. Disclosed no conflict of interest.Luca, Florina .......................................... Disclosed no conflict of interest.Lucchesi, Daniela .................................. Disclosed no conflict of interest.Luchs, Robert H. ................................... Disclosed no conflict of interest.Luchsinger, Jose A. .............................. Consultant: Danone, Inc.Lucidi, Paola .......................................... Disclosed no conflict of interest.Lucisano, Giuseppe ............................... Disclosed no conflict of interest.Ludlow, James P. .................................. Employee: GlaxoSmithKline; Stock/Shareholder:
GlaxoSmithKline.Ludovico, Ornella .................................. Disclosed no conflict of interest.Ludvigsen, Rebecca .............................. Disclosed no conflict of interest.Ludwig, Tonia ........................................ Disclosed no conflict of interest.Luercio, Marcella F. .............................. Disclosed no conflict of interest.Lugar, Heather M. ................................ Disclosed no conflict of interest.Luis, Henrique ....................................... Disclosed no conflict of interest.Luiz, Ronir R. ........................................ Disclosed no conflict of interest.Luk, Andrea O. ...................................... Disclosed no conflict of interest.Luk, Cynthia T. ...................................... Disclosed no conflict of interest.Lukashevich, Valentina ......................... Employee: Novartis Pharmaceuticals Corporation; Stock/
Lum, Helen ............................................ Disclosed no conflict of interest.Lumeng, Carey N. ................................. Disclosed no conflict of interest.Lunardi, Alessandro .............................. Disclosed no conflict of interest.Lund, Asger ........................................... Disclosed no conflict of interest.Lund, Søren S. ...................................... Employee: Boehringer Ingelheim GmbH & Co. KG.Lundbom, Jesper ................................... Disclosed no conflict of interest.Lundbom, Nina ...................................... Disclosed no conflict of interest.Lundquist, Rasmus ................................ Other Relationship: co-inventor Leucopatch, Reapplix Aps;
Stock/Shareholder: Reapplix Aps.Lundqvist, Kristin .................................. Disclosed no conflict of interest.Lung, Thomas ........................................ Disclosed no conflict of interest.Lungaro, Jenna ..................................... Disclosed no conflict of interest.Luo, Angela ........................................... Disclosed no conflict of interest.Luo, Deng .............................................. Disclosed no conflict of interest.Luo, Hengcong ...................................... Disclosed no conflict of interest.Luo, Jin .................................................. Disclosed no conflict of interest.Luo, Jing ................................................ Disclosed no conflict of interest.Luo, Nanlan ........................................... Disclosed no conflict of interest.Luo, Shuqin ........................................... Employee: VeroScience.Luo, Yingying ......................................... Disclosed no conflict of interest.Luo, Yuwen ............................................ Disclosed no conflict of interest.Luo, Zuojie ............................................. Disclosed no conflict of interest.Luopajärvi, Kristiina .............................. Disclosed no conflict of interest.Lupi, Roberto ......................................... Disclosed no conflict of interest.Luquet, Serge ........................................ Disclosed no conflict of interest.Luring, Christopher ................................ Disclosed no conflict of interest.Lussier, Roxane ..................................... Disclosed no conflict of interest.Lutale, Janet ......................................... Disclosed no conflict of interest.Lutes, Lesley ......................................... Disclosed no conflict of interest.Lutgers, Helen L. .................................. Disclosed no conflict of interest.Lutsey, Pamela L. ................................. Disclosed no conflict of interest.Lutz, Karen ............................................ Employee: Bristol-Myers Squibb/AstraZeneca.Lutz, Sharon .......................................... Disclosed no conflict of interest.Lutz, Stefan Z. ...................................... Disclosed no conflict of interest.Luzi, Livio ............................................... Advisory Panel: AstraZeneca/Bristol-Meyers
Luzio, Stephen D. ................................. Disclosed no conflict of interest.Lv, Wei................................................... Disclosed no conflict of interest.Lv, Xiao-Feng ......................................... Disclosed no conflict of interest.Lv, Yujie ................................................. Disclosed no conflict of interest.Ly, Socheata .......................................... Disclosed no conflict of interest.Ly, Trang T. ............................................ Disclosed no conflict of interest.Lyles, Shannon ...................................... Disclosed no conflict of interest.Lynch, Aisling M. ................................. Research Support: Sanofi.Lynch, Elizabeth B. ............................... Disclosed no conflict of interest.Lynch, Kristian ....................................... Disclosed no conflict of interest.Lynch, Lydia ........................................... Disclosed no conflict of interest.Lynes, Matthew D. ............................... Disclosed no conflict of interest.Lyon, Christopher J. ............................. Disclosed no conflict of interest.Lyon-Callo, Sarah .................................. Disclosed no conflict of interest.Lyons, Sarah K. .................................... Disclosed no conflict of interest.Lyons, Timothy J. ................................. Disclosed no conflict of interest.Lyubomirsky, Greg ................................. Employee: Merck Sharp & Dohme Limited.Ma, Ben ................................................. Disclosed no conflict of interest.Ma, Danjun ........................................... Disclosed no conflict of interest.Ma, Elizabeth ........................................ Disclosed no conflict of interest.Ma, Jianhua .......................................... Disclosed no conflict of interest.Ma, Jinhui ............................................. Disclosed no conflict of interest.Ma, Ke ................................................... Disclosed no conflict of interest.Ma, Qing B. .......................................... Disclosed no conflict of interest.Ma, Ronald C. ...................................... Research Support: AstraZeneca/Bristol-Meyers Squibb,
Ma, Wen-Ya .......................................... Disclosed no conflict of interest.Ma, Xiaojing .......................................... Disclosed no conflict of interest.Ma, Xiaoya ............................................ Disclosed no conflict of interest.Ma, Yina ................................................ Disclosed no conflict of interest.Ma, Yong ............................................... Disclosed no conflict of interest.Ma, Yuhui .............................................. Employee: MannKind Corporation; Stock/Shareholder:
MannKind Corporation.Ma, Zejun .............................................. Disclosed no conflict of interest.Ma, Zhulin ............................................. Disclosed no conflict of interest.Maahs, David M. ................................. Disclosed no conflict of interest.Maasch, Christian ................................. Employee: Noxxon.Mabrey, Melanie E. ............................. Consultant: Glytec, Sanofi; Research Support: Sanofi;
Speaker’s Bureau: Sanofi.Mabuchi, Hiroshi ................................... Disclosed no conflict of interest.Macauley, Mavin .................................. Disclosed no conflict of interest.Macchi, Francesca ................................ Disclosed no conflict of interest.
Macchiarini, Silvia ................................ Disclosed no conflict of interest.MacDonald, Catherine A. .................... Disclosed no conflict of interest.MacDonald, Patrick E. ......................... Disclosed no conflict of interest.Macdonald, Raymond J. ...................... Disclosed no conflict of interest.Macedo, Francisca A. .......................... Disclosed no conflict of interest.Macedo, Maria P. ................................. Disclosed no conflict of interest.Macha, Sreeraj ..................................... Employee: Boehringer Ingelheim Pharmaceuticals, Inc.Machann, Jürgen .................................. Disclosed no conflict of interest.Machicao, Fausto .................................. Disclosed no conflict of interest.Macias, Hector ...................................... Disclosed no conflict of interest.MacIntosh, Andrea ............................... Disclosed no conflict of interest.MacIsaac, Richard J. ........................... Disclosed no conflict of interest.Maciulewski, Rafal ............................... Disclosed no conflict of interest.Mackey, Eleanor .................................... Disclosed no conflict of interest.Macko, Antoni R. ................................. Disclosed no conflict of interest.MacLaren, Graeme ............................... Disclosed no conflict of interest.MacLeod, Colin ..................................... Disclosed no conflict of interest.Macura, Stanislava ............................... Employee: Novo Nordisk A/S.Madacsy, Lazlo ...................................... Disclosed no conflict of interest.Maddaloni, Ernesto ............................... Disclosed no conflict of interest.Madec, Anne-Marie .............................. Disclosed no conflict of interest.Mader, Julia K. ..................................... Speaker’s Bureau: Novo Nordisk, Inc.Mader, Michael ..................................... Disclosed no conflict of interest.Madhira, Ravi ........................................ Disclosed no conflict of interest.Madhusudhan, R. ................................. Disclosed no conflict of interest.Madiraju, Anila ..................................... Disclosed no conflict of interest.Madiraju, S.R. Murthy .......................... Disclosed no conflict of interest.Madley, Rachel ..................................... Disclosed no conflict of interest.Madsbad, Sten ...................................... Advisory Panel: AstraZeneca Pharmaceuticals LP, Boehringer
Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Intarcia Therapeutics, Inc., Johnson & Johnson, Merck Sharp & Dohme Limited, Novartis Pharma AG, Novo Nordisk A/S, Sanofi; Research Support: Novo Nordisk A/S; Speaker’s Bureau: AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Company, Eli Lilly and Company, Merck Sharp & Dohme Limited, Novartis Pharma AG, Novo Nordisk A/S, Sanofi.
Madsen, Ole .......................................... Disclosed no conflict of interest.Maeda, Hiromi ...................................... Disclosed no conflict of interest.Maeda, Manami ................................... Disclosed no conflict of interest.Maeda, Shiro ........................................ Disclosed no conflict of interest.Maeda, Yasutaka .................................. Disclosed no conflict of interest.Maegawa, Hiroshi ................................ Research Support: Nippon Boehringer Ingelheim Co., Ltd.Maemura, Koji ...................................... Research Support: Astellas Pharma US, Inc.,
Maffeis, Claudio ................................... Disclosed no conflict of interest.Maffettone, Ada ................................... Disclosed no conflict of interest.Maffioli, Pamela ................................... Disclosed no conflict of interest.Maggioni, Serena ................................. Disclosed no conflict of interest.Maggs, D. ............................................. Employee: GI Dynamics; Stock/Shareholder: GI Dynamics.Magi, Reedik ......................................... Disclosed no conflict of interest.Maginley, Roger .................................... Disclosed no conflict of interest.Maginley, Sylvan R. ............................. Disclosed no conflict of interest.Magliano, Dianna J. ............................ Disclosed no conflict of interest.Magnan, Christophe ............................. Disclosed no conflict of interest.Magni, Lalo ........................................... Disclosed no conflict of interest.Magni, Serena ...................................... Disclosed no conflict of interest.Magnus, Per .......................................... Disclosed no conflict of interest.Magnusson, Jessica ............................. Disclosed no conflict of interest.Magrioti, Victoria .................................. Disclosed no conflict of interest.Magrisso, Irwin J. ................................ Disclosed no conflict of interest.Magrisso, Jack ...................................... Disclosed no conflict of interest.Maguire, Jonathon ............................... Disclosed no conflict of interest.Magyar, Kendra L. ................................ Disclosed no conflict of interest.Mah, Jean K. ........................................ Disclosed no conflict of interest.Mahajan, Anubha ................................. Disclosed no conflict of interest.Mahalakshmi, Manni M. ..................... Disclosed no conflict of interest.Maheswari, Kumar ............................... Disclosed no conflict of interest.Mahfouz, Rana ...................................... Disclosed no conflict of interest.Mahmood, Arshad ................................ Disclosed no conflict of interest.Mahmoud, Abeer M. ........................... Disclosed no conflict of interest.Mahon, Jeffrey ..................................... Disclosed no conflict of interest.Mahroum, Muhammad ......................... Disclosed no conflict of interest.Mahurin, A. Jack ................................... Disclosed no conflict of interest.Mai, Hai-yan ......................................... Disclosed no conflict of interest.
Mai, Lifang ............................................ Disclosed no conflict of interest.Mai, Yifeng............................................ Disclosed no conflict of interest.Maia, Mauricio ..................................... Employee: Genentech.Maikuma, Rei ........................................ Disclosed no conflict of interest.Maile, Laura .......................................... Employee: Vascular Pharmaceuticals Inc; Stock/Shareholder:
Vascular Pharmaceuticals Inc.Maimaitiyiming, Hasiyeti ...................... Disclosed no conflict of interest.Mainali, Naba R. .................................. Disclosed no conflict of interest.Maisel, Alan .......................................... Board Member: Cardero Therapeutics; Stock/Shareholder:
Cardero Therapeutics.Maitland, Rahat A. ............................... Disclosed no conflict of interest.Maiztegui, Bárbara ............................... Disclosed no conflict of interest.Majeed, Azeem ..................................... Disclosed no conflict of interest.Majic Milotic, Dubravka ....................... Disclosed no conflict of interest.Majidi, Shideh ....................................... Disclosed no conflict of interest.Majima, Saori ....................................... Disclosed no conflict of interest.Majithia, Amit ....................................... Disclosed no conflict of interest.Majlesi, Mansoureh .............................. Disclosed no conflict of interest.Major, Melissa S. ................................. Disclosed no conflict of interest.Majumdar, Sumit R. ............................. Disclosed no conflict of interest.Makdissi, Antoine ................................. Disclosed no conflict of interest.Make, Barry ........................................... Disclosed no conflict of interest.Makimattila, Sari .................................. Employee: Novo Nordisk A/S; Stock/Shareholder: Novo
Nordisk A/S.Makino, Hideichi ................................... Disclosed no conflict of interest.Makino, Hirofumi .................................. Disclosed no conflict of interest.Makino, Hisashi .................................... Disclosed no conflict of interest.Makino, Taketoshi ................................. Disclosed no conflict of interest.Makino, Yuichi ...................................... Disclosed no conflict of interest.Makrilakis, Konstantinos ...................... Disclosed no conflict of interest.Maksymowicz, Anna ............................. Disclosed no conflict of interest.Malaisse, William J. ............................ Disclosed no conflict of interest.Malanda, Belma .................................... Disclosed no conflict of interest.Malandrucco, Ilaria ............................... Disclosed no conflict of interest.Malcolm, Andrew J. ............................ Disclosed no conflict of interest.Malcolm, Janine ................................... Disclosed no conflict of interest.Malecki, Maciej T. ............................... Advisory Panel: Bioton, Eli Lilly, NovoNordisk; Research
Support: Bioton.Malhotra, Atul ....................................... Disclosed no conflict of interest.Malik, Rayaz A. .................................... Disclosed no conflict of interest.Malik, Saima ......................................... Disclosed no conflict of interest.Malik, Shaista ....................................... Research Support: Novartis Pharmaceuticals Corporation.Malin, Cornelia ..................................... Disclosed no conflict of interest.Malin, Steven K. .................................. Disclosed no conflict of interest.Malinska, Hana ..................................... Disclosed no conflict of interest.Malipatil, Nagaraj S. ........................... Disclosed no conflict of interest.Maliszewska, Katarzyna ....................... Disclosed no conflict of interest.Mallad, Ashwini .................................... Disclosed no conflict of interest.Mallamaci, Francesca ........................... Disclosed no conflict of interest.Mallipedhi, Akhila ................................. Disclosed no conflict of interest.Mallory, Jason M. ................................ Employee: GlaxoSmithKline; Stock/Shareholder:
GlaxoSmithKline.Malloy, Jaret ......................................... Employee: Bristol-Myers Squibb Company.Malofeeva, Ekaterina ............................ Disclosed no conflict of interest.Malomo, Kenneth ................................. Employee: GI Dynamics; Stock/Shareholder: GI Dynamics.Maloni, Heidi W. .................................. Disclosed no conflict of interest.Mamakeesick, Mary ............................. Disclosed no conflict of interest.Manabe, Yasuko ................................... Disclosed no conflict of interest.Manchem, Vara Prasad ......................... Employee: Isis Pharmaceuticals.Manchester, Carol S. ........................... Disclosed no conflict of interest.Mandarino, Lawrence J. ...................... Disclosed no conflict of interest.Mandøe, Mette J. ................................ Disclosed no conflict of interest.Manfrini, Silvia ..................................... Disclosed no conflict of interest.Mangat, Simmanjeet ............................ Disclosed no conflict of interest.Mangia, Silvia ....................................... Disclosed no conflict of interest.Mangione, Anna ................................... Disclosed no conflict of interest.Mangione, Carol M. ............................. Disclosed no conflict of interest.Mangleburg, Carl G. ............................. Employee: Prometheon Pharma, LLC.Manicardi, Valeria ................................. Disclosed no conflict of interest.Manigrasso, Michaele B. .................... Disclosed no conflict of interest.Manley, Susan E. ................................. Disclosed no conflict of interest.Manly, Jennifer J. ................................ Disclosed no conflict of interest.Mann, David .......................................... Disclosed no conflict of interest.Mann, Johannes ................................... Advisory Panel: Abbott Diabetes Care, Amgen, Inc.,
Boehringer Ingelheim Pharmaceuticals, Inc., Novartis Pharma AG, Novo Nordisk A/S, Roche Pharmaceuticals; Research Support: Celgene Corporation, Roche Pharmaceuticals.
Manning, Alisa ...................................... Disclosed no conflict of interest.Manning, Peter W. ............................... Disclosed no conflict of interest.Manousopoulou, Antigoni .................... Disclosed no conflict of interest.Manroa, Pooja ....................................... Disclosed no conflict of interest.
Manson, JoAnn E. ................................ Disclosed no conflict of interest.Manson, Spero ...................................... Disclosed no conflict of interest.Mansuri, Sudaba ................................... Disclosed no conflict of interest.Mantegazza, Ermanno .......................... Disclosed no conflict of interest.Manzi, Clarissa S. ................................ Disclosed no conflict of interest.Manzoni, Giuseppina ............................ Disclosed no conflict of interest.Mao, Liqun ............................................ Disclosed no conflict of interest.Mao, Meng ........................................... Employee: Medtronic.Mao, Xiaodong ...................................... Disclosed no conflict of interest.Mao, Yushan ......................................... Disclosed no conflict of interest.Mar, Perry .............................................. Disclosed no conflict of interest.Maranda, Louise ................................... Disclosed no conflict of interest.Marathe, Chinmay ................................ Disclosed no conflict of interest.Maratos Flier, Eleftheria ....................... Disclosed no conflict of interest.Marbury, Thomas C. ............................. Employee: Orlando Clinical Research Center.Marcelino, Mafalda .............................. Disclosed no conflict of interest.Marchesini, Giulio ................................. Research Support: Merck Sharp & Dohme Limited; Speaker’s
Bureau: Eli Lilly and Company, Merck Sharp & Dohme Limited, Novartis Pharmaceuticals Corporation, Novo Nordisk, Inc., Sanofi.
Marchetti, Piero .................................... Research Support: Merck.Marcovina, Santica M. ........................ Disclosed no conflict of interest.Marelli, Giuseppe ................................. Disclosed no conflict of interest.Mares, Julie A. .................................... Disclosed no conflict of interest.Margonato, Alberto .............................. Disclosed no conflict of interest.Mari, Andrea ......................................... Research Support: Poxel SA.Marinelli Andreoli, Anna ...................... Disclosed no conflict of interest.Marion, Allison ..................................... Disclosed no conflict of interest.Marion, Lucy N. .................................... Disclosed no conflict of interest.Mariotti, Rita ......................................... Disclosed no conflict of interest.Marjanovic Petkovic, Milica ................. Disclosed no conflict of interest.Mark, Michael ....................................... Employee: Boehringer Ingelheim GmbH & Co. KG.Markley, Brandon .................................. Disclosed no conflict of interest.Marko, Limor ......................................... Disclosed no conflict of interest.Markovic, Tania ..................................... Disclosed no conflict of interest.Markowitz, Jessica T. .......................... Consultant: Children With Diabetes; Other Relationship:
Children With Diabetes.Marks, Jennifer B. ............................... Disclosed no conflict of interest.Marquard, Jan ...................................... Disclosed no conflict of interest.Marra, Giampiero .................................. Employee: Novo Nordisk A/S.Marrano, Nicola .................................... Disclosed no conflict of interest.Marre, Michel ....................................... Advisory Panel: Abbott Diabetes Care, Eli Lilly and
Company; Board Member: Abbott Diabetes Care, Merck, Novo Nordisk, Inc., Sanofi, Servier; Research Support: Novo Nordisk, Inc.; Speaker’s Bureau: Abbott Diabetes Care, Eli Lilly and Company, Novo Nordisk, Inc., Sanofi, Servier.
Marriage, Barbara ................................. Employee: Abbott Nutrition.Marriott, Paul ........................................ Disclosed no conflict of interest.Marschke, Keith B. .............................. Employee: Ligand Pharmaceuticals; Stock/Shareholder:
Ligand Pharmaceuticals.Marsden, Paul K. .................................. Disclosed no conflict of interest.Marselli, Lorella .................................... Disclosed no conflict of interest.Marshall, Andrew ................................. Disclosed no conflict of interest.Marshall, Helen .................................... Disclosed no conflict of interest.Martelli, Dario ....................................... Disclosed no conflict of interest.Martin, Alan A. .................................... Employee: GlaxoSmithKline; Stock/Shareholder:
GlaxoSmithKline.Martin, Bronwen ................................... Disclosed no conflict of interest.Martin, Catherine L. ............................. Disclosed no conflict of interest.Martin, Christine M. ............................ Disclosed no conflict of interest.Martin, Christopher ............................... Disclosed no conflict of interest.Martin, Guy ........................................... Stock/Shareholder: Metabolys Inc.Martin, Jennifer A. .............................. Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly
and Company.Martin, Joel .......................................... Employee: Cebix, Inc.; Stock/Shareholder: Cebix, Inc.Martin, Michael .................................... Disclosed no conflict of interest.Martin, Silas ......................................... Employee: Janssen Scientific Affairs, LLC; Stock/Shareholder:
Johnson & Johnson.Martin, Silke ......................................... Employee: Blutspendedienst des Bayerischen Roten Kreuzes
Martinez, Diana .................................... Disclosed no conflict of interest.Martinez, Jorge ..................................... Disclosed no conflict of interest.Martinez, Marina .................................. Disclosed no conflict of interest.Martinez, Mercedes .............................. Disclosed no conflict of interest.Martinez, Micaela ................................. Disclosed no conflict of interest.
Martinez, Sandra .................................. Disclosed no conflict of interest.Martinez-Sanchez, Aida ........................ Disclosed no conflict of interest.Martins, Milton A. ............................... Disclosed no conflict of interest.Martucci, Federico ................................ Disclosed no conflict of interest.Martyn-Nemeth, Pamela ...................... Disclosed no conflict of interest.Marucci, Antonella ............................... Disclosed no conflict of interest.Marui, Yuhji ........................................... Disclosed no conflict of interest.Maruthur, Nisa M. ............................... Disclosed no conflict of interest.Maruyama, Nobuko .............................. Disclosed no conflict of interest.Marx, Nikolaus ...................................... Disclosed no conflict of interest.Maryniuk, Melinda ................................ Disclosed no conflict of interest.Masaki, Yoshihiro ................................. Disclosed no conflict of interest.Masclee, Ad A. .................................... Disclosed no conflict of interest.Maser, Raelene E. ................................ Disclosed no conflict of interest.Masharani, Umesh ................................ Disclosed no conflict of interest.Mashek, Douglas G. ............................ Disclosed no conflict of interest.Mashek, Mara T. .................................. Disclosed no conflict of interest.Masiello, Lisa M. ................................. Disclosed no conflict of interest.Masiello, Pellegrino .............................. Disclosed no conflict of interest.Masierek, Malgorzata ........................... Employee: Bioton.Masini, Matilde .................................... Disclosed no conflict of interest.Maskati, Owais M. .............................. Disclosed no conflict of interest.Mason, Clinton C. ................................ Disclosed no conflict of interest.Mason, Colin L. .................................... Disclosed no conflict of interest.Mason, Graeme .................................... Disclosed no conflict of interest.Mason, Shaun ....................................... Disclosed no conflict of interest.Massaro, Joseph M. ............................ Disclosed no conflict of interest.Mastick, Cynthia ................................... Disclosed no conflict of interest.Masuda, Daisaku .................................. Research Support: Kowa Pharmaceuticals, Sanwa Kagaku
Kenkyusho Co., Ltd.Masuda, Takahiro.................................. Disclosed no conflict of interest.Matejko, Bartłomiej .............................. Research Support: Bioton.Mather, Kieren J. ................................. Consultant: Sanofi; Research Support: Merck, Novo Nordisk,
Inc., Roche Pharmaceuticals, Sanofi.Matheson, Della ................................... Disclosed no conflict of interest.Matheson, Don ..................................... Employee: Dose Safety Company; Stock/Shareholder: Dose
Safety Company.Matheson, Flora .................................... Disclosed no conflict of interest.Mathew, Justin T. ................................ Disclosed no conflict of interest.Mathews, Chris ..................................... Disclosed no conflict of interest.Mathews, Clayton E. ........................... Disclosed no conflict of interest.Mathews, Suresh T. ............................. Disclosed no conflict of interest.Mathiesen, Elisabeth R. ....................... Advisory Panel: Consultant: Novo Nordisk A/S; Speaker’s
Myers Squibb Company, Eli Lilly and Company, Johnson & Johnson, MannKind Corporation, Merck, Novartis Pharmaceuticals Corporation, Novo Nordisk, Inc., Pfizer, Inc., Sanofi; Research Support: Eli Lilly and Company, Merck, Novartis Pharmaceuticals Corporation, Novo Nordisk, Inc., Sanofi; Speaker’s Bureau: Eli Lilly and Company, Merck, Novartis Pharmaceuticals Corporation, Novo Nordisk, Inc., Sanofi.
Mathur, Ruchi ........................................ Disclosed no conflict of interest.Matlok, Maciej ...................................... Disclosed no conflict of interest.Matoba, Keiichiro ................................. Disclosed no conflict of interest.Matoulek, Martin .................................. Disclosed no conflict of interest.Matragoon, Suraporn ............................ Disclosed no conflict of interest.Matschinsky, Franz M. ......................... Disclosed no conflict of interest.Matsen, Miles E. .................................. Disclosed no conflict of interest.Matsuba, Ikiro ....................................... Research Support: Eli Lilly and Company.Matsuba, Ikuro ...................................... Research Support: Eli Lilly and Company.Matsubara, Tatsuaki ............................. Disclosed no conflict of interest.Matsubayashi, Sunao ........................... Disclosed no conflict of interest.Matsuda, Kazuyuki ................................ Disclosed no conflict of interest.Matsuda, Yayoi ..................................... Disclosed no conflict of interest.Matsuhisa, Munehide ........................... Disclosed no conflict of interest.Matsui, Jun ........................................... Disclosed no conflict of interest.Matsui, Mizue ....................................... Disclosed no conflict of interest.Matsui, Satoshi ..................................... Disclosed no conflict of interest.Matsumoto, Hitoshi .............................. Disclosed no conflict of interest.Matsumoto, Masahito .......................... Disclosed no conflict of interest.Matsumoto, Motonobu ......................... Disclosed no conflict of interest.Matsumoto, Shinobu ............................ Disclosed no conflict of interest.Matsumoto, Shuich ............................... Disclosed no conflict of interest.Matsumoto, Toshio ............................... Disclosed no conflict of interest.Matsumura, Takeshi.............................. Disclosed no conflict of interest.Matsunaga, Satoshi .............................. Disclosed no conflict of interest.Matsunaga, Yasuka .............................. Disclosed no conflict of interest.Matsuo, Yuko ........................................ Disclosed no conflict of interest.Matsuoka, Atsuko ................................. Disclosed no conflict of interest.Matsuoka, Taka-aki ............................... Disclosed no conflict of interest.
Matsuse, Yoko ...................................... Disclosed no conflict of interest.Matsushima, Shouji .............................. Disclosed no conflict of interest.Matsushita, Kanae ................................ Disclosed no conflict of interest.Matsuyama, Rina .................................. Disclosed no conflict of interest.Matsuzaka, Takashi............................... Disclosed no conflict of interest.Matsuzawa, Kazuhiko ........................... Disclosed no conflict of interest.Matsuzawa, Shu-ichi ............................ Disclosed no conflict of interest.Matsuzawa, Yoko .................................. Disclosed no conflict of interest.Mattaliano, Chiara ................................ Disclosed no conflict of interest.Matthaei, Stephan ................................ Advisory Panel: Bristol-Myers Squibb/AstraZeneca; Speaker’s
Consultant: Novo Nordisk, GlaxoSmithKline, Novartis, Eli Lilly, Sanofi Aventis, Johnson & Johnson, and Servier; Research Support: Johnson & Johnson and NIHR; Speaker’s Bureau: Novo Nordisk, Servier, Sanofi Aventis, Eli Lilly, Novartis, Janssen.
Matthews, Dwight E. ........................... Disclosed no conflict of interest.Matthews, Jessica E. .......................... Employee: GlaxoSmithKline; Stock/Shareholder:
GlaxoSmithKline.Mattos, Ligia O. ................................... Disclosed no conflict of interest.Matulewicz, Natalia ............................. Disclosed no conflict of interest.Maturu, Amita V. .................................. Disclosed no conflict of interest.Matzko, Michelle .................................. Disclosed no conflict of interest.Mau, Marjorie L. .................................. Disclosed no conflict of interest.Mau, Marjorie M. ................................ Stock/Shareholder: Merck, Shareholder.Maudsley, Stuart ................................... Disclosed no conflict of interest.Maulis, Matthew .................................. Disclosed no conflict of interest.Maurovich-Horvat, Pal .......................... Disclosed no conflict of interest.Maury, Elisa .......................................... Disclosed no conflict of interest.Mauseth, Richard .................................. Employee: Dose Safety Company; Stock/Shareholder: Dose
Safety Company.Maxhera, Bujar ..................................... Disclosed no conflict of interest.Maximos, Maryann ............................... Disclosed no conflict of interest.Maxon, Pamela ..................................... Research Support: Bristol Meyers Squib Foundation.Maxwell, Elizabeth ............................... Disclosed no conflict of interest.Maxwell, M. ......................................... Disclosed no conflict of interest.May, Amanda L. ................................... Disclosed no conflict of interest.May, Heidi T. ........................................ Disclosed no conflict of interest.May, Michael E. ................................... Disclosed no conflict of interest.Mayberry, Robert M. ............................ Disclosed no conflict of interest.Mayer-Davis, Elizabeth ......................... Disclosed no conflict of interest.Mayeux, Richard ................................... Disclosed no conflict of interest.Maynard, John D. ................................ Employee: VeraLight, Inc. Other Relationship: VeraLight, Inc.Mayor, Thibault ..................................... Disclosed no conflict of interest.Mayoux, Eric ......................................... Employee: Boehringer Ingelheim GmbH & Co. KG.Mayzel, Yulia ......................................... Employee: Integrity Applications, Ltd.Mazanderani, Adel B. .......................... Disclosed no conflict of interest.Mazurek, Urszula .................................. Disclosed no conflict of interest.Mazza, Carmen S. ................................ Advisory Panel: Sanofi.Mazza, Emilia ........................................ Disclosed no conflict of interest.Mazza, Tommaso................................... Disclosed no conflict of interest.Mazze, Roger S. ................................... Board Member: Prometheon Pharma, LLC; Research Support:
Abbott Diabetes Care, CeQur, Ltd.; Stock/Shareholder: Prometheon Pharma, LLC.
McAslan, Mary S. ................................ Disclosed no conflict of interest.McCaffery, Jeanne M. ......................... Disclosed no conflict of interest.McCall, Anthony L. .............................. Research Support: Lifescan, Inc.McCance, David R. .............................. Disclosed no conflict of interest.McCann, Thomas W. ........................... Employee: Animas Corporation; Stock/Shareholder: Johnson
& Johnson.McCargar, Linda J. ............................... Disclosed no conflict of interest.McCarter, Robert ................................... Disclosed no conflict of interest.McCarthy, Domenica A. ....................... Disclosed no conflict of interest.McCarthy, Mark I. ................................ Disclosed no conflict of interest.McClain, Donald A. .............................. Disclosed no conflict of interest.McClatchey, Martin .............................. Disclosed no conflict of interest.McClatchey, Penn ................................. Disclosed no conflict of interest.McClendon, Eric E. ............................... Disclosed no conflict of interest.McCloskey, Karen M. ........................... Disclosed no conflict of interest.McCommis, Kyle S. .............................. Disclosed no conflict of interest.McCormick, Keith .................................. Disclosed no conflict of interest.McCoy, Rozalina G. .............................. Disclosed no conflict of interest.McCrone, Susan .................................... Disclosed no conflict of interest.McDonald, Charlotte ............................. Disclosed no conflict of interest.McDonald, Thomas S. ......................... Employee: Pfizer, Inc.McDonald, William G. ......................... Employee: Metabolic Solutions Development Co.; Stock/
Shareholder: Metabolic Solutions Development Co.McDonnell, Kevin P. ............................. Disclosed no conflict of interest.McDonnell, Marie E. ............................ Disclosed no conflict of interest.
McDuffie, Roberta ................................ Advisory Panel: Novo Nordisk, Inc.; Board Member: Tulane University Institutional Review Board; Consultant: Novocell, Inc.
McElduff, Patrick ................................... Disclosed no conflict of interest.McEvoy, John W. ................................. Disclosed no conflict of interest.McEwan, Philip C. ................................ Research Support: AstraZeneca Pharmaceuticals LP, Bristol-
Myers Squibb Company, Eli Lilly and Company, GSK, Novo Nordisk, Inc., Sanofi, Takeda Pharmaceuticals U.S.A., Inc.
McEwen, Laura ..................................... Disclosed no conflict of interest.McFann, Kim ......................................... Disclosed no conflict of interest.McFarland, Raymie ............................... Employee: Glytec.McFedries, Amanda .............................. Disclosed no conflict of interest.McGavock, Jonathan ............................ Disclosed no conflict of interest.McGee, Edwin ....................................... Disclosed no conflict of interest.McGhee, Charles N. ............................ Disclosed no conflict of interest.McGhee, Theresa A. ............................ Disclosed no conflict of interest.McGill, Janet ........................................ Advisory Panel: Abbott Laboratories, Inc., Boehringer
Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Janssen Pharmaceuticals, McNeil Nutritionals, LLC, Merck, Novo Nordisk, Inc., Sanofi; Consultant: MannKind Corporation; Research Support: Andromeda Biotech, Ltd., MannKind Corporation, Novartis Pharmaceuticals Corporation, Sanofi, Takeda Pharmaceutical Company, Ltd.; Speaker’s Bureau: Janssen Pharmaceuticals, Merck.
McGill, Margaret .................................. Disclosed no conflict of interest.McGinnis, Patricia Q. ........................... Disclosed no conflict of interest.McGowan, Neil W. .............................. Disclosed no conflict of interest.McGrail, Kieran ..................................... Disclosed no conflict of interest.McGuigan, Paul ..................................... Disclosed no conflict of interest.McGuire, Alistair ................................... Research Support: GlaxoSmithKline.McGuire, Brian ...................................... Disclosed no conflict of interest.McGuire, Darren K. .............................. Consultant: AstraZeneca Pharmaceuticals LP, Boehringer
Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Daiichi-Sankyo, Inc., Eli Lilly and Company, F. Hoffmann-La Roche, Ltd., Genentech, Janssen Pharmaceuticals, Merck, Orexigen Therapeutics, Inc., Pfizer, Inc., Regeneron Pharmaceuticals, Inc., Tethys.
Mcintosh, Ian ........................................ Employee: Merck.McKay, Siripoom ................................... Research Support: Daiichi-Sankyo, Inc.McKeon, Katherine ............................... Disclosed no conflict of interest.McKew, Genevieve L. .......................... Disclosed no conflict of interest.McLaren, David ..................................... Employee: Merck.McLaughlin, John ................................. Disclosed no conflict of interest.McLaughlin, Kerry A. ........................... Disclosed no conflict of interest.McLaughlin, Tracey L. .......................... Disclosed no conflict of interest.McLean, Mark ....................................... Disclosed no conflict of interest.Mclean, Nellie ...................................... Disclosed no conflict of interest.McLease, Jane ...................................... Disclosed no conflict of interest.McLennan, Susan V. ............................ Disclosed no conflict of interest.McManus, Ruth M. .............................. Speaker’s Bureau: Novo Nordisk, Inc.McMillan, Ryan ..................................... Disclosed no conflict of interest.McMillin, Shawna ................................ Disclosed no conflict of interest.McMorrow, Donna ................................ Consultant: DJO Global; Research Support: Janssen Scientific
Affairs, LLC.McMurray, John J. .............................. Advisory Panel: GlaxoSmithKline; Other Relationship: Novartis
Pharma AG, PPD Development, LP.McNamara, Kaitie A. ........................... Disclosed no conflict of interest.McNamara, Sharon ............................... Disclosed no conflict of interest.McNamara-Cullinane, Mary ................. Employee: Echo Therapeutics, Inc.; Stock/Shareholder: Echo
Therapeutics, Inc.McNeely, Marguerite J. ...................... Disclosed no conflict of interest.McNeill, Calvin ..................................... Employee: Novartis Pharmaceticals Corporation; Stock/
Shareholder: Novartis.McPhee, Caroline .................................. Disclosed no conflict of interest.McPherson, R.K. ................................... Disclosed no conflict of interest.McPherson, Timothy ............................. Disclosed no conflict of interest.McQueen, Allison ................................. Disclosed no conflict of interest.McTernan, Philip G. .............................. Disclosed no conflict of interest.Mdingi, Colleen ..................................... Employee: Senseonics Incorporated.Meaney, Michael J. ............................. Disclosed no conflict of interest.Meany, Eduardo .................................... Disclosed no conflict of interest.Medina, Anya ........................................ Disclosed no conflict of interest.Medlej, Rita .......................................... Advisory Panel: Novartis Pharma AG; Other
Relationship: Teens Study Sanofi-Aventis, Novartis Pharma AG; Research Support: Novartis Pharma AG.
Medynskyj, Michael .............................. Disclosed no conflict of interest.Meehan, Rebecca J. ............................ Disclosed no conflict of interest.Meek, Thomas H. ................................. Disclosed no conflict of interest.Meena, Babu L. .................................... Disclosed no conflict of interest.
Meers, Grace M. .................................. Disclosed no conflict of interest.Meguro, Shu ......................................... Disclosed no conflict of interest.Mehana, Amir E. .................................. Disclosed no conflict of interest.Mehra, Kashish ..................................... Disclosed no conflict of interest.Mehta, Aditya ....................................... Disclosed no conflict of interest.Mehta, Munira G. ................................ Disclosed no conflict of interest.Mehta, Nivedita C. ............................... Disclosed no conflict of interest.Mehta, Sandhya .................................... Disclosed no conflict of interest.Meidtner, Karina ................................... Disclosed no conflict of interest.Meier, Daniel T. .................................... Disclosed no conflict of interest.Meier, Juris ........................................... Advisory Panel: AstraZeneca Pharmaceuticals LP, Bristol-
Myers Squibb Company, Eli Lilly and Company, Merck Sharp & Dohme Limited, Novo Nordisk, Inc., Sanofi; Board Member: AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Company, Eli Lilly and Company, Merck Sharp & Dohme Limited, Novo Nordisk, Inc., Sanofi; Research Support: Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Merck Sharp & Dohme Limited, Novartis Pharma AG, Novo Nordisk, Inc., Sanofi; Speaker’s Bureau: AstraZeneca Pharmaceuticals LP, Berlin Chemie AG, Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Merck Sharp & Dohme Limited, Novartis Pharma AG, Novo Nordisk, Inc., Roche Pharmaceuticals, Sanofi.
Meigs, James B. .................................. Disclosed no conflict of interest.Meijer, Rick I. ....................................... Disclosed no conflict of interest.Meinicke, Thomas ................................. Employee: Boehringer Ingelheim GmbH & Co. KG.Meininger, Gary..................................... Employee: Janssen Research & Development, LLC.Meira, Deyse M. .................................. Disclosed no conflict of interest.Meisinger, Christa ................................. Disclosed no conflict of interest.Meister, Daniel...................................... Disclosed no conflict of interest.Mejia, Roberto ...................................... Disclosed no conflict of interest.Melén, Erik ............................................ Disclosed no conflict of interest.Melendez, Lydia .................................... Disclosed no conflict of interest.Melkus, Gail D. .................................... Disclosed no conflict of interest.Mellalieu, Stephen D. .......................... Disclosed no conflict of interest.Mellberg, Caroline ................................ Disclosed no conflict of interest.Meloncelli, Illidio .................................. Disclosed no conflict of interest.Melton, Stephanie T. ........................... Disclosed no conflict of interest.Meltzer Cohen, Cheli ............................ Disclosed no conflict of interest.Meltzer, Sara J. .................................... Disclosed no conflict of interest.Menaged, Miriam ................................. Disclosed no conflict of interest.Menaouar, Ahmed................................. Disclosed no conflict of interest.Ménard, Julie ........................................ Disclosed no conflict of interest.Menard, Kathryn ................................... Disclosed no conflict of interest.Mendes, Eliana ..................................... Disclosed no conflict of interest.Mendes, João ....................................... Disclosed no conflict of interest.Mendez, Armando ................................. Disclosed no conflict of interest.Mendez, Carlos E. ................................ Disclosed no conflict of interest.Mendez, Michelle ................................. Disclosed no conflict of interest.Mendola, Pauline .................................. Disclosed no conflict of interest.Mendonca, Christine ............................. Disclosed no conflict of interest.Mendoza-Elias, Josua E. ...................... Disclosed no conflict of interest.Menendez, Edelmiro ............................. Disclosed no conflict of interest.Meng, Qingdong ................................... Disclosed no conflict of interest.Meng, Ran ............................................. Disclosed no conflict of interest.Meng, Ren ............................................. Disclosed no conflict of interest.Meng, Shu ............................................. Disclosed no conflict of interest.Meng, Xiuxiang ..................................... Disclosed no conflict of interest.Menke, Andy ......................................... Disclosed no conflict of interest.Menon, Renuka T. ................................ Disclosed no conflict of interest.Mensberg, Pernille ................................ Disclosed no conflict of interest.Menzaghi, Claudia ................................ Disclosed no conflict of interest.Menzies, Robert A. .............................. Disclosed no conflict of interest.Mera, Toshiyuki ..................................... Disclosed no conflict of interest.Merante`, Domenico ............................. Employee: Daiichi-Sankyo, Inc.Merchant, Anwar T. ............................. Disclosed no conflict of interest.Mercuri, Luana ...................................... Disclosed no conflict of interest.Meredith, Kate ...................................... Disclosed no conflict of interest.Merino Viveros, María .......................... Disclosed no conflict of interest.Merino-Torres, Juan Francisco ............. Disclosed no conflict of interest.Merkely, Bela ........................................ Disclosed no conflict of interest.Merker, Ludwig ..................................... Other Relationship: AstraZeneca Pharmaceuticals LP,
Boehringer Ingelheim GmbH & Co. KG, Bristol-Myers Squibb Company, Eli Lilly and Company, Hospira, Inc., Merck Sharp & Dohme Limited, Novo Nordisk, Inc.
Mermelstein, Robin .............................. Disclosed no conflict of interest.Merovci, Aurora .................................... Disclosed no conflict of interest.Merrins, Matthew J. ........................... Disclosed no conflict of interest.Merscher-Gomez, Sandra ..................... Disclosed no conflict of interest.
Mesa, Jordi ........................................... Disclosed no conflict of interest.Meskiri, Aisha ....................................... Disclosed no conflict of interest.Messier, Virginie ................................... Disclosed no conflict of interest.Messori, Mirko ...................................... Disclosed no conflict of interest.Mestres, Olga ....................................... Disclosed no conflict of interest.Metref, Salima ...................................... Disclosed no conflict of interest.Metzger, Boyd E. .................................. Disclosed no conflict of interest.Metzger, Daniel L. ................................ Disclosed no conflict of interest.Meulen, Noelle ..................................... Disclosed no conflict of interest.Meuth, Alex .......................................... Disclosed no conflict of interest.Mevi, Ashley A. ................................... Disclosed no conflict of interest.Mey, Jacob T. ....................................... Disclosed no conflict of interest.Meyer, Christian .................................... Employee: Boehringer Ingelheim GmbH & Co. KG.Meyer, Christina .................................... Disclosed no conflict of interest.Meyer, Laurent ...................................... Disclosed no conflict of interest.Meyers, Jennifer ................................... Disclosed no conflict of interest.Meyers, Juliana L. ............................... Other Relationship: RTIMeyers, Kristen J. ............................... Disclosed no conflict of interest.Meyramov, Gabit G. ............................. Disclosed no conflict of interest.Meyramova, Aizhan G. ........................ Disclosed no conflict of interest.Mezquita-Raya, Pedro ........................... Advisory Panel: FAES, Novo Nordisk A/S; Research Support:
Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Novo Nordisk A/S; Speaker’s Bureau: Bristol-Myers Squibb/AstraZeneca, Esteve, Merck Sharp & Dohme Limited, Novartis Pharmaceuticals Corporation, Novo Nordisk A/S.
Mezuk, Birana ....................................... Disclosed no conflict of interest.Mezza, Teresa ....................................... Disclosed no conflict of interest.Miao, Lining .......................................... Disclosed no conflict of interest.Miao, Raymond ..................................... Employee: Sanofi; Stock/Shareholder: Sanofi.Miccinilli, Elide ..................................... Disclosed no conflict of interest.Miccoli, Roberto .................................... Disclosed no conflict of interest.Michael, M.D. ...................................... Employee: Eli Lilly and Company, Eli Lilly and Company
(Spouse/Partner); Research Support: Eli Lilly and Company; Stock/Shareholder: Eli Lilly and Company, Eli Lilly and Company (Spouse/Partner).
Michalewski, Lucy ................................ Disclosed no conflict of interest.Michaliszyn, Sara .................................. Disclosed no conflict of interest.Michaud, Camille .................................. Disclosed no conflict of interest.Micheletti, Thayana .............................. Disclosed no conflict of interest.Micheletto, Giancarlo ........................... Disclosed no conflict of interest.Michels, Aaron ...................................... Disclosed no conflict of interest.Middleton, Michael .............................. Disclosed no conflict of interest.Middleton, Sandy .................................. Disclosed no conflict of interest.Miele, Claudia ....................................... Disclosed no conflict of interest.Migita, Mika ......................................... Disclosed no conflict of interest.Mihailescu, Dan .................................... Disclosed no conflict of interest.Mihic-Necic, Bojana ............................. Disclosed no conflict of interest.Miike, Tomohiro .................................... Disclosed no conflict of interest.Mikeladze, Maia ................................... Disclosed no conflict of interest.Mikhed, Yuliya ...................................... Disclosed no conflict of interest.Miki, Tetsuro ......................................... Disclosed no conflict of interest.Mikkelsen, Tarjei ................................... Disclosed no conflict of interest.Mikkola, Kirsi ........................................ Disclosed no conflict of interest.Mikołajczak, Przemysław ...................... Disclosed no conflict of interest.Mikova, Radka ...................................... Disclosed no conflict of interest.Milaszewski, Kerry M. ......................... Consultant: Medtronic MiniMed, Inc.Miles, John M. ..................................... Disclosed no conflict of interest.Milicevic, Zvonko .................................. Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly
and Company.Miliou, Antigoni .................................... Disclosed no conflict of interest.Miljkovic, Iva ......................................... Disclosed no conflict of interest.Millego, Raquel C. ............................... Disclosed no conflict of interest.Millego, Silvia H. ................................. Disclosed no conflict of interest.Millen, Amy E. ...................................... Research Support: Mushroom Council.Miller, Corey .......................................... Employee: Merck Sharp & Dohme Limited.Miller, Craig B. ..................................... Disclosed no conflict of interest.Miller, David .......................................... Disclosed no conflict of interest.Miller, Diane.......................................... Employee: GlaxoSmithKline; Stock/Shareholder:
GlaxoSmithKline.Miller, Donald R. .................................. Disclosed no conflict of interest.Miller, Edgar R. .................................... Disclosed no conflict of interest.Miller, Jamee ........................................ Disclosed no conflict of interest.Miller, Jutta........................................... Stock/Shareholder: Merck.Miller, Kellee M. .................................. Disclosed no conflict of interest.Miller, Michael E. ................................. Disclosed no conflict of interest.Miller, Rachel G. .................................. Disclosed no conflict of interest.Miller, Rehae C. ................................... Disclosed no conflict of interest.Miller, Sam ............................................ Disclosed no conflict of interest.Miller, Shahar........................................ Disclosed no conflict of interest.Millis, Michael ...................................... Disclosed no conflict of interest.Millot, Luc ............................................. Disclosed no conflict of interest.
Milton, Joanne ...................................... Disclosed no conflict of interest.Mima, Akira .......................................... Disclosed no conflict of interest.Min, Danqing ........................................ Disclosed no conflict of interest.Min, Kyung Wan ................................... Disclosed no conflict of interest.Min, Lillian ............................................ Disclosed no conflict of interest.Minagawa, Shinichi .............................. Disclosed no conflict of interest.Minagawa, Takako ................................ Disclosed no conflict of interest.Minamide, Toshiomi.............................. Employee: Ono Pharmaceutical Co., Ltd.Minatoguchi, Makiko ............................ Disclosed no conflict of interest.Minges, Karl E. ..................................... Disclosed no conflict of interest.Mingrino, Roberto ................................. Employee: F. Hoffmann-La Roche, Ltd.Minium, Judi ......................................... Disclosed no conflict of interest.Minnella, Daniela ................................. Disclosed no conflict of interest.Minnock, Pantea ................................... Disclosed no conflict of interest.Mino, Akihisa ........................................ Disclosed no conflict of interest.Minshall, Michael E. ............................ Employee: DJO Global.Minze, Laurie J. ................................... Disclosed no conflict of interest.Miquel, J.F. ........................................... Disclosed no conflict of interest.Miranda, Marie Lynn ............................ Research Support: BMSF.Mirante, Alice ....................................... Disclosed no conflict of interest.Miras, Alex D. ...................................... Disclosed no conflict of interest.Mirbolooki, M. Reza .............................. Disclosed no conflict of interest.Mirra, Paola .......................................... Disclosed no conflict of interest.Mirza, Bahram ....................................... Disclosed no conflict of interest.Mirza, Raihan ........................................ Disclosed no conflict of interest.Misfeldt, Amanda A. ........................... Disclosed no conflict of interest.Mishima, Takashi .................................. Disclosed no conflict of interest.Misiasz, Meaghan R. ........................... Disclosed no conflict of interest.Mita, Tomoya ........................................ Research Support: Eli Lilly and Company, Merck Sharp &
Dohme Limited, Takeda Pharmaceutical Company, Ltd.; Speaker’s Bureau: Eli Lilly and Company, Kowa Pharmaceuticals, Merck Sharp & Dohme Limited, Mochida Pharmaceutical Co., Ltd., Ono Pharmaceutical Co., Ltd.
Mitch, William E. ................................. Disclosed no conflict of interest.Mitchell, Christina ................................ Disclosed no conflict of interest.Mitchell, Grant ...................................... Disclosed no conflict of interest.Mitchell, Hannah E. ............................. Disclosed no conflict of interest.Mitchell, Madeline ............................... Disclosed no conflict of interest.Mitchell, Matthew ................................ Employee: Metabolon, Inc.; Stock/Shareholder: Metabolon,
Inc.Mitre, Naim ........................................... Disclosed no conflict of interest.Mitre, Tina ............................................. Disclosed no conflict of interest.Mitrea, Adina ........................................ Disclosed no conflict of interest.Mitri, Joanna ........................................ Disclosed no conflict of interest.Mitsuhashi, Kazuteru ............................ Disclosed no conflict of interest.Mitsumatsu, Takako .............................. Disclosed no conflict of interest.Mitsuoka, Keisuke ................................ Disclosed no conflict of interest.Mittelman, Steven ................................ Disclosed no conflict of interest.Miura, Junnosuke ................................. Disclosed no conflict of interest.Miura, Kyoko ......................................... Employee: Ajinomoto Group.Miura, Naoko ........................................ Disclosed no conflict of interest.Miyakawa, Takaichi .............................. Disclosed no conflict of interest.Miyake, Masato .................................... Disclosed no conflict of interest.Miyamoto, Chinobu ............................... Disclosed no conflict of interest.Miyamoto, Robin ................................... Disclosed no conflict of interest.Miyamoto, Satoshi ................................ Disclosed no conflict of interest.Miyashita, Kazuyuki .............................. Disclosed no conflict of interest.Miyatsuka, Takeshi ............................... Disclosed no conflict of interest.Miyazaki, Yuko ...................................... Disclosed no conflict of interest.Miyoshi, Hideaki ................................... Disclosed no conflict of interest.Miyoshi, Masashi ................................. Disclosed no conflict of interest.Miyoshi, Sousuke .................................. Disclosed no conflict of interest.Mizoguchi, Asako .................................. Disclosed no conflict of interest.Mizukami, Hiroki ................................... Disclosed no conflict of interest.Mizumoto, Katsutoshi ........................... Disclosed no conflict of interest.Mjalli, Adnan ........................................ Board Member: TransTech Pharma; Employee: TransTech
Pharma.Mladenovic, Ana ................................... Disclosed no conflict of interest.Mlynarski, Wojciech ............................. Disclosed no conflict of interest.Mo, Eun Young ...................................... Disclosed no conflict of interest.Moaddel, Ruin ....................................... Disclosed no conflict of interest.Modi, Honey .......................................... Disclosed no conflict of interest.Modzelewski, Katherine ....................... Disclosed no conflict of interest.Moeller, Niels........................................ Disclosed no conflict of interest.Moerman, Ericka ................................... Disclosed no conflict of interest.Moffa, Simona ...................................... Disclosed no conflict of interest.Mogami, Hideo ..................................... Disclosed no conflict of interest.Moghaddam, Shirin .............................. Disclosed no conflict of interest.Moh, Mei Chung ................................... Disclosed no conflict of interest.Mohamed, Islam N. ............................. Disclosed no conflict of interest.Mohammad Taghvaei, Narges .............. Disclosed no conflict of interest.
Mohammed, Ali .................................... Disclosed no conflict of interest.Mohammedi, Kamel .............................. Disclosed no conflict of interest.Mohan, Anjana R. ................................ Disclosed no conflict of interest.Mohan, Rahul ........................................ Disclosed no conflict of interest.Mohan, Viswanathan ............................ Research Support: Eli Lilly and Company, Johnson & Johnson,
Merck, Novo Nordisk, Inc., Sanofi, USV.Moheet, Amir A. .................................. Disclosed no conflict of interest.Moin, Abu S. ........................................ Disclosed no conflict of interest.Moin, Tannaz ......................................... Disclosed no conflict of interest.Moineddin, Rahim ................................. Disclosed no conflict of interest.Moinet, Gérard ...................................... Stock/Shareholder: Metabolys Inc.Mojaddidi, Hafasa ................................ Disclosed no conflict of interest.Mojiminiyi, Olusegun ............................ Disclosed no conflict of interest.Mok, Ji-Oh ............................................ Disclosed no conflict of interest.Mok, Shao Feng .................................... Disclosed no conflict of interest.Mokshagundam, Shilpa ........................ Disclosed no conflict of interest.Mokta, Jitender .................................... Disclosed no conflict of interest.Mokta, Kiran ......................................... Disclosed no conflict of interest.Moleta, Chace ....................................... Disclosed no conflict of interest.Molina, Xavier ....................................... Disclosed no conflict of interest.Molina-Vega, Maria .............................. Disclosed no conflict of interest.Molina-Wilkins, Marjorie ..................... Disclosed no conflict of interest.Molitch, Mark E. .................................. Advisory Panel: Bristol-Myers Squibb/AstraZeneca, Janssen
Pharmaceuticals, Novartis Pharmaceuticals Corporation, Novo Nordisk, Inc.; Consultant: Abbott Laboratories, Inc., Eli Lilly and Company, Merck, Novo Nordisk, Inc.; Research Support: Bayer Health Care, LLC, Eli Lilly and Company, Novartis Pharmaceuticals Corporation, Novo Nordisk, Inc., Sanofi.
Møller, Andreas B. ............................... Disclosed no conflict of interest.Møller, Niels.......................................... Disclosed no conflict of interest.Möllmann, Julia .................................... Disclosed no conflict of interest.Molnes, Janne ...................................... Disclosed no conflict of interest.Moltz, Kathleen ..................................... Disclosed no conflict of interest.Molyneaux, Lynda ................................. Disclosed no conflict of interest.Momotsu, Takeshi ................................. Disclosed no conflict of interest.Mon, Sann Yu ........................................ Disclosed no conflict of interest.Monaghan, Maureen ............................ Disclosed no conflict of interest.Monaro, Marco ..................................... Disclosed no conflict of interest.Monciotti, Carlamaria ........................... Disclosed no conflict of interest.Mondon, Philippe .................................. Disclosed no conflict of interest.Monks, Bobby R. .................................. Disclosed no conflict of interest.Monnier, Vincent M. ............................ Disclosed no conflict of interest.Monson, Rebecca S. ............................ Disclosed no conflict of interest.Montalto, Giuseppe .............................. Disclosed no conflict of interest.Montañez, Carmen ................................ Disclosed no conflict of interest.Monteiro, Gabriela S. .......................... Disclosed no conflict of interest.Monteiro, Pedro .................................... Disclosed no conflict of interest.Montejano, Leslie ................................. Research Support: Janssen Scientific Affairs, LLC.Montesano, Anna ................................. Disclosed no conflict of interest.Montez, Maria G. ................................. Disclosed no conflict of interest.Montminy, Marc .................................... Disclosed no conflict of interest.Montori, Victor M. ............................... Disclosed no conflict of interest.Monyak, John ....................................... Employee: AstraZeneca Pharmaceuticals LP.Monzavi, Roshanak ............................... Disclosed no conflict of interest.Moolemath, Y. ...................................... Disclosed no conflict of interest.Moon, Jae Hoon ................................... Disclosed no conflict of interest.Moon, Junsung ..................................... Disclosed no conflict of interest.Moon, Min Kyong ................................. Disclosed no conflict of interest.Moon, Seong Su ................................... Disclosed no conflict of interest.Moon, Sung Dae ................................... Disclosed no conflict of interest.Moore, Jared ........................................ Disclosed no conflict of interest.Moore, Thomas R. ................................ Disclosed no conflict of interest.Moore, William ..................................... Disclosed no conflict of interest.Mora Becerra, Nancy ............................ Disclosed no conflict of interest.Moraes, Juliana C. ............................... Disclosed no conflict of interest.Morais, José A. .................................... Disclosed no conflict of interest.Morales, Francisco Miguel ................... Disclosed no conflict of interest.Moralidis, Efstratios ............................. Disclosed no conflict of interest.Moran, Antoinette ................................ Research Support: Pfizer, Inc.Morari, Joseane .................................... Disclosed no conflict of interest.Morbey, Claire ....................................... Disclosed no conflict of interest.Morcos, Mary ........................................ Disclosed no conflict of interest.Morcos, Michael ................................... Disclosed no conflict of interest.Moreira, Camilo .................................... Disclosed no conflict of interest.Moreira, Daisy C. ................................. Disclosed no conflict of interest.Morello, Candis M. .............................. Disclosed no conflict of interest.Moreno, Marina .................................... Disclosed no conflict of interest.Moreno-Ulloa, Aldo .............................. Disclosed no conflict of interest.Moret, Vittoria....................................... Disclosed no conflict of interest.Morgan, Diana ...................................... Disclosed no conflict of interest.Morgan, James ..................................... Disclosed no conflict of interest.
Morgan, Kerry ....................................... Disclosed no conflict of interest.Morgan, Michael .................................. Employee: Arena Pharmaceuticals, Inc.Morgantini, Cecilia ............................... Disclosed no conflict of interest.Mori, Eisaku .......................................... Disclosed no conflict of interest.Mori, Ichiro ............................................ Disclosed no conflict of interest.Mori, Katsuhito ..................................... Disclosed no conflict of interest.Mori, Shunske ....................................... Disclosed no conflict of interest.Mori, Takayuki ....................................... Disclosed no conflict of interest.Mori, Tomoko ........................................ Disclosed no conflict of interest.Mori, Yasumichi .................................... Disclosed no conflict of interest.Mori, Yukiko .......................................... Disclosed no conflict of interest.Mori, Yutaka .......................................... Disclosed no conflict of interest.Moriarty, Mary Sha ............................... Disclosed no conflict of interest.Morigami, Hirokazu ............................... Disclosed no conflict of interest.Morinaga, Shojiro ................................. Disclosed no conflict of interest.Morinaga, Yuta ..................................... Disclosed no conflict of interest.Morinaga, Yuuta ................................... Disclosed no conflict of interest.Morini, Eleonora ................................... Disclosed no conflict of interest.Morino, Katsutaro ................................. Disclosed no conflict of interest.Morioka, Tetsu ...................................... Disclosed no conflict of interest.Morioka, Tomoaki.................................. Disclosed no conflict of interest.Morita, Hiroshi ...................................... Disclosed no conflict of interest.Morita, Keiko ........................................ Disclosed no conflict of interest.Morita, Michiko .................................... Disclosed no conflict of interest.Morita, Miwa ........................................ Disclosed no conflict of interest.Morita, Satoshi ..................................... Disclosed no conflict of interest.Moriuchi, Akie ....................................... Disclosed no conflict of interest.Moriya, Junji ......................................... Disclosed no conflict of interest.Moriya, Rie ............................................ Disclosed no conflict of interest.Morken, Mario A. ................................ Disclosed no conflict of interest.Mørkrid, Kjersti ..................................... Disclosed no conflict of interest.Moro, Cedric ......................................... Disclosed no conflict of interest.Morrato, Elaine ..................................... Disclosed no conflict of interest.Morris, Andrew P. ................................ Disclosed no conflict of interest.Morris, E. Matthew ............................... Disclosed no conflict of interest.Morris, Mike ......................................... Disclosed no conflict of interest.Morrison, Fritha .................................... Disclosed no conflict of interest.Morrow, Connie C. ............................... Disclosed no conflict of interest.Morrow, Linda ....................................... Employee: Profil Institute for Clinical Research, Inc.; Stock/
Shareholder: Profil Institute for Clinical Research, Inc.Morse, Dawn ........................................ Disclosed no conflict of interest.Mortensen, Brynjulf .............................. Disclosed no conflict of interest.Morton, Gregory J. .............................. Disclosed no conflict of interest.Morton, John ........................................ Disclosed no conflict of interest.Morton-Eggleston, Emma ..................... Disclosed no conflict of interest.Morugova, Tatiana V. ........................... Disclosed no conflict of interest.Mosenzon, Ofri ...................................... Advisory Panel: Eli Lilly and Company, Merck Sharp & Dohme
Limited, Novartis Pharma AG, Novo Nordisk, Inc., Sanofi; Research Support: AstraZeneca/Bristol-Meyers Squibb; Speaker’s Bureau: Eli Lilly and Company, Merck Sharp & Dohme Limited, Novartis Pharma AG, Novo Nordisk, Inc., Sanofi.
Moser, Emily G. .................................... Disclosed no conflict of interest.Moses, Robert ....................................... Disclosed no conflict of interest.Mosnier-Pudar, Helen ........................... Disclosed no conflict of interest.Mossavar-Rahmani, Yasmin ................. Disclosed no conflict of interest.Mosser, Rockann ................................... Disclosed no conflict of interest.Mota, Eugen .......................................... Disclosed no conflict of interest.Mota, Maria .......................................... Disclosed no conflict of interest.Mota, Vanessa ...................................... Disclosed no conflict of interest.Motala, Ayesha ..................................... Disclosed no conflict of interest.Motiani, Kumail K. ............................... Disclosed no conflict of interest.Motoshima, Hiroyuki ............................. Disclosed no conflict of interest.Motoyama, Koka ................................... Disclosed no conflict of interest.Mottl, Amy K. ....................................... Disclosed no conflict of interest.Mottola, Michelle ................................. Disclosed no conflict of interest.Mou, Jiani ............................................. Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly
and Company.Moulik, Mousumi .................................. Disclosed no conflict of interest.Moura, Rodrigo F. ................................. Disclosed no conflict of interest.Mouratoglou, Sofia ............................... Disclosed no conflict of interest.Mourouzis, Iordanis .............................. Disclosed no conflict of interest.Mous, Jan ............................................. Employee: Midatech Ltd; Stock/Shareholder: Midatech Ltd.Moutquin, Jean-Marie .......................... Disclosed no conflict of interest.Moutsianas, Loukas .............................. Disclosed no conflict of interest.Moyers, Julie S. ................................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly
and Company, Eli Lilly and Company (Spouse/Partner).Moyssakis, Ioannis ............................... Disclosed no conflict of interest.Mozzi, Enrico ......................................... Disclosed no conflict of interest.Mraz, Milos ........................................... Disclosed no conflict of interest.Mridha, Auvro ....................................... Disclosed no conflict of interest.Mrozikiewicz, Przemysław .................... Disclosed no conflict of interest.
Mrozinska, Sandra ................................ Disclosed no conflict of interest.Msallaty, Zaher ..................................... Disclosed no conflict of interest.Mu, Pan-wei .......................................... Disclosed no conflict of interest.Mudaliar, Sunder R. ............................. Consultant: Bristol-Myers Squibb/AstraZeneca, Roche
Pharmaceuticals; Research Support: Amgen, Inc., Amylin Pharmaceuticals, Inc., Sanofi.
Mudaliar, Uma....................................... Disclosed no conflict of interest.Mudumby, Pallavi .................................. Employee: Humana.Muehlbauer, Michael J. ....................... Disclosed no conflict of interest.Muehlen-Bartmer, Isabel ...................... Employee: Sanofi.Mueller, Claudia .................................... Disclosed no conflict of interest.Mueller, Heidi........................................ Disclosed no conflict of interest.Muendlein, Axel .................................... Disclosed no conflict of interest.Mughal, Romana S. ............................. Research Support: Novo Nordisk, Inc.Muhamedagic, Cynthia A. ................... Disclosed no conflict of interest.Muhlestein, Joseph B. ......................... Disclosed no conflict of interest.Muir, Kenneth R. .................................. Disclosed no conflict of interest.Muirhead, Roslyn .................................. Disclosed no conflict of interest.Mukai, Eri .............................................. Disclosed no conflict of interest.Mukheef, Farah ..................................... Disclosed no conflict of interest.Mukherjee, Bhramar ............................. Disclosed no conflict of interest.Mukherjee, Jayanti ............................... Employee: Bristol-Myers Squibb Company.Mul, Joram D. ...................................... Disclosed no conflict of interest.Mulas, Maria Franca ............................. Disclosed no conflict of interest.Mulder, Douwe J. ................................ Disclosed no conflict of interest.Mulla, Irena ........................................... Disclosed no conflict of interest.Muller, Ido ............................................. Disclosed no conflict of interest.Muller, Yunhua L. ................................. Disclosed no conflict of interest.Müller-Wieland, Dirk ............................ Advisory Panel: Boehringer Ingelheim GmbH & Co. KG,
Mullie, Patrick ....................................... Disclosed no conflict of interest.Mulvaney, Shelagh ............................... Disclosed no conflict of interest.Mundel, Peter ....................................... Disclosed no conflict of interest.Mune, Tomoatsu ................................... Disclosed no conflict of interest.Munir, Kashif M. .................................. Disclosed no conflict of interest.Munns, Craig F. .................................... Disclosed no conflict of interest.Munns, Diane ........................................ Disclosed no conflict of interest.Munoz Torres, Francisco J. .................. Disclosed no conflict of interest.Muñoz, R. ............................................. Disclosed no conflict of interest.Munoz-Bellili, Naima ............................ Disclosed no conflict of interest.Muñoz-Garach, Araceli ......................... Disclosed no conflict of interest.Munshi, Medha N. ............................... Advisory Panel: Amgen, Inc. (Spouse/Partner), Celgene
Corporation (Spouse/Partner), Janssen Pharmaceuticals (Spouse/Partner); Research Support: Sanofi.
Münzel, Thomas .................................... Disclosed no conflict of interest.Murahovschi, Veronica ......................... Disclosed no conflict of interest.Murakami, Hiroshi ................................ Disclosed no conflict of interest.Murakoshi, Michiaki ............................. Disclosed no conflict of interest.Muramatsu, Toshiya.............................. Disclosed no conflict of interest.Murdock, Margaret ............................... Disclosed no conflict of interest.Murji, Amyn .......................................... Employee: Vascular Pharmaceuticals Inc.Murphy, Anthony T. .............................. Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly
and Company.Murphy, Beth Ann ................................. Employee: Merck.Murphy, Elizabeth J. ............................ Disclosed no conflict of interest.Murphy, Helen ....................................... Disclosed no conflict of interest.Murphy, Kathryn M. ............................. Disclosed no conflict of interest.Murphy, Mary Beth ............................... Disclosed no conflict of interest.Murphy, Rinki ........................................ Disclosed no conflict of interest.Murphy, Sydney .................................... Research Support: Boehringer Ingelheim GmbH & Co. KG.Murray, Kori .......................................... Disclosed no conflict of interest.Murray, Neil .......................................... Disclosed no conflict of interest.Murray, Pamela J. ................................ Disclosed no conflict of interest.Murray, William .................................... Employee: Janssen Research & Development.Murzaku, Era C. .................................... Disclosed no conflict of interest.Musat, Madalina .................................. Disclosed no conflict of interest.Muscas, Fabrizio ................................... Disclosed no conflict of interest.Musi, Nicolas ........................................ Disclosed no conflict of interest.Mustafina, Olga E. ............................... Disclosed no conflict of interest.Muto, Tetsuya ....................................... Disclosed no conflict of interest.Muzny, Donna M. ................................. Disclosed no conflict of interest.Myers, Leann ........................................ Disclosed no conflict of interest.Mysliwiec, Malgorzata ......................... Disclosed no conflict of interest.Mysona, Barbara A. ............................. Disclosed no conflict of interest.Naar-King, Sylvie .................................. Disclosed no conflict of interest.Nabrdalik, Katarzyna ............................. Disclosed no conflict of interest.Nachman, Rachel .................................. Disclosed no conflict of interest.
Nacitarhan, Cahit .................................. Disclosed no conflict of interest.Nadeau, Kristen J. ............................... Disclosed no conflict of interest.Naderali, E. .......................................... Disclosed no conflict of interest.Naderi, Ramin ....................................... Disclosed no conflict of interest.Nadler, Evan P. ..................................... Disclosed no conflict of interest.Nadler, Jerry L. ..................................... Disclosed no conflict of interest.Naessens, James M. ........................... Disclosed no conflict of interest.Nagai, Takashi....................................... Disclosed no conflict of interest.Nagakura, Joe ....................................... Disclosed no conflict of interest.Nagamatsu, Shinya ............................... Disclosed no conflict of interest.Nagaoka, Taiji ....................................... Disclosed no conflict of interest.Nagar, Ron............................................. Employee: Insuline Medical.Nagasawa, Masahiro ........................... Disclosed no conflict of interest.Nagasawa, Shin-Ya .............................. Disclosed no conflict of interest.Nagashima, Kazuaki ............................. Disclosed no conflict of interest.Nagashimada, Mayumi ......................... Disclosed no conflict of interest.Nagata, Naoto ...................................... Disclosed no conflict of interest.Nagel, Andrea ....................................... Disclosed no conflict of interest.Nagy, Eszter .......................................... Disclosed no conflict of interest.Nahhas, Georges J. ............................. Disclosed no conflict of interest.Naidis, Eugene ...................................... Employee: Integrity Applications, Ltd.Naik, Sarita ........................................... Disclosed no conflict of interest.Nair, Anup K. ........................................ Disclosed no conflict of interest.Nair, K. Sreekumaran ............................ Disclosed no conflict of interest.Nair, Viji ................................................. Disclosed no conflict of interest.Najafi, Bijan .......................................... Disclosed no conflict of interest.Naji, Ali ................................................. Disclosed no conflict of interest.Najmabadi, Adriana .............................. Disclosed no conflict of interest.Najmi, Laeya A. .................................... Disclosed no conflict of interest.Nakadaira, Ikue ..................................... Disclosed no conflict of interest.Nakagami, Tomoko................................ Disclosed no conflict of interest.Nakagawa, Kei ...................................... Disclosed no conflict of interest.Nakagawa, Takashi ............................... Disclosed no conflict of interest.Nakagawa, Yoshimi .............................. Disclosed no conflict of interest.Nakagawa, Yuko ................................... Disclosed no conflict of interest.Nakagawa-Toyama, Yumiko.................. Disclosed no conflict of interest.Nakamachi, Takafumi............................ Disclosed no conflict of interest.Nakamura, Akinobu .............................. Speaker’s Bureau: AstraZeneca Pharmaceuticals LP, Daiichi-
Nakamura, Eiji ....................................... Employee: Ajinomoto Group.Nakamura, Jiro ..................................... Disclosed no conflict of interest.Nakamura, Katherine ............................ Employee: Dexcom, Inc.Nakamura, Masahiro ............................ Disclosed no conflict of interest.Nakamura, Masato ............................... Disclosed no conflict of interest.Nakamura, Naoto .................................. Disclosed no conflict of interest.Nakamura, Nobuhisa ............................ Disclosed no conflict of interest.Nakamura, Nobumi ............................... Disclosed no conflict of interest.Nakamura, Takao .................................. Disclosed no conflict of interest.Nakanishi, Mahito ................................ Disclosed no conflict of interest.Nakanishi, Risa ..................................... Disclosed no conflict of interest.Nakano, Kaoru ...................................... Disclosed no conflict of interest.Nakano, Yasuko .................................... Disclosed no conflict of interest.Nakao, Hiroyuki ..................................... Disclosed no conflict of interest.Nakao, Honami ..................................... Disclosed no conflict of interest.Nakao, Kazuhiro .................................... Disclosed no conflict of interest.Nakao, Kazuwa ..................................... Disclosed no conflict of interest.Nakao, Keiko ......................................... Disclosed no conflict of interest.Nakao, Takayuki .................................... Disclosed no conflict of interest.Nakaoka, Hajime ................................... Disclosed no conflict of interest.Nakashima, Eitaro ................................. Disclosed no conflict of interest.Nakatani, Kazuhiro ................................ Disclosed no conflict of interest.Nakatsu, Yusuke ................................... Disclosed no conflict of interest.Nakatsuka, Atsuko ................................ Disclosed no conflict of interest.Nakaya, Keizo ....................................... Employee: Sanwa Kagaku Kenkyusho Co.,Ltd.Nakayama, Hidetaka ............................. Disclosed no conflict of interest.Nakayama, Hitomi ................................ Disclosed no conflict of interest.Nakazato, Masamitsu ........................... Disclosed no conflict of interest.Nakhla, Meranda .................................. Disclosed no conflict of interest.Nalls, Michael A. ................................. Disclosed no conflict of interest.Nam, Ji Sun .......................................... Disclosed no conflict of interest.Nam, Moon Suk .................................... Disclosed no conflict of interest.Nam, Soo Min ....................................... Disclosed no conflict of interest.Nam, Soohyun ....................................... Disclosed no conflict of interest.Nam, Yoon Jeong .................................. Disclosed no conflict of interest.Nam-Goong, Il Sung .............................. Disclosed no conflict of interest.Namkoong, Churl .................................. Disclosed no conflict of interest.Nan, Bin ................................................ Disclosed no conflict of interest.
Nan, Raluca S. ..................................... Disclosed no conflict of interest.Nandagopalan, S. ................................ Consultant: Dexcom, Inc.Nandi-Munshi, Debika .......................... Disclosed no conflict of interest.Nankervis, Alison .................................. Disclosed no conflict of interest.Nanto, Shinsuke .................................... Disclosed no conflict of interest.Naowaboot, Jarinyaporn ...................... Disclosed no conflict of interest.Napoli, Zaleida ...................................... Disclosed no conflict of interest.Napolitano, Antonella ........................... Disclosed no conflict of interest.Nar, Herbert........................................... Employee: Boehringer Ingelheim GmbH & Co. KG.Nara, Eriko ............................................ Disclosed no conflict of interest.Narain, Niven R. ................................... Disclosed no conflict of interest.Naratani, Shun ...................................... Disclosed no conflict of interest.Narayan, K.M. Venkat ........................... Disclosed no conflict of interest.Narayanan, Ram P. ............................... Disclosed no conflict of interest.Narendran, Parth ................................... Disclosed no conflict of interest.Narisu, Narisu ....................................... Disclosed no conflict of interest.Narita, Hirohisa ..................................... Employee: MSD K.K.Narively, Doria ...................................... Disclosed no conflict of interest.Naruse, Keiko ........................................ Disclosed no conflict of interest.Narvaez, Luis ......................................... Disclosed no conflict of interest.Nascimento, Filipe V. ........................... Disclosed no conflict of interest.Nash, Kate ............................................ Disclosed no conflict of interest.Nasraway, Stanley ................................ Advisory Panel: Echo Therapeutics, Inc.; Research Support:
Echo Therapeutics, Inc.; Stock/Shareholder: Echo Therapeutics, Inc.
Nata, Koji .............................................. Disclosed no conflict of interest.Natali, Andrea ....................................... Disclosed no conflict of interest.Natalicchio, Annalisa ............................ Disclosed no conflict of interest.Natarajan, Jansi R. .............................. Disclosed no conflict of interest.Natarajan, Jaya .................................... Employee: Janssen Research & Development, LLC.Natarajan, Rama ................................... Disclosed no conflict of interest.Nathan, David M. ................................. Disclosed no conflict of interest.Nauck, Michael A. ..........................Advisory Panel: Amylin Pharmaceuticals, Inc., Berlin
Chemie AG, Boehringer Ingelheim GmbH & Co. KG, Eli Lilly and Company, F. Hoffmann-La Roche, Ltd., Intarcia Therapeutics, Inc., Janssen Global Services, LLC, Merck, Merck Sharp & Dohme Limited, Novo Nordisk A/S, Sanofi, Sanofi-Aventis Pharma, Versartis, Inc.; Consultant: Amylin Pharmaceuticals, Inc., AstraZeneca Pharmaceuticals LP, Berlin Chemie AG/Menarini, Boehringer Ingelheim GmbH & Co. KG, Bristol-Myers Squibb Company, Diartis Pharmaceuticals, Eli Lilly and Company, F. Hoffmann-La Roche, Ltd., GlaxoSmithKline, Lilly Deutschland GmbH, MannKind Corporation, Merck Sharp & Dohme Limited, Novartis Pharma AG, Novo Nordisk A/S, Novo Nordisk Pharma GmbH, Novo Nordisk Pharmaceuticals Pty Ltd, Sanofi Australia & New Zealand, Sanofi-Aventis Pharma, Takeda Pharmaceuticals U.S.A., Inc., Wyeth; Research Support: AstraZeneca Pharmaceuticals LP, Berlin Chemie AG/Menarini, Boehringer Ingelheim GmbH & Co. KG, Eli Lilly and Company, GlaxoSmithKline, Lilly Deutschland GmbH, Merck Sharp & Dohme Limited, Metacure, Novartis Pharma AG, Novo Nordisk Pharma GmbH, Roche Pharmaceuticals, Tolerx, Inc.
Navea Aguilera, Cristina ....................... Disclosed no conflict of interest.Naveen Kumar, B.S. ............................. Disclosed no conflict of interest.Nawrocki, Andrea ................................. Employee: Merck.Nawroth, Peter P. ................................. Disclosed no conflict of interest.Nayak, Ananth U. ................................. Disclosed no conflict of interest.Nayar, Rahul .......................................... Disclosed no conflict of interest.Nayar, Sunita......................................... Disclosed no conflict of interest.Naylor, Rochelle N. .............................. Disclosed no conflict of interest.Nazaret, Rémi ....................................... Employee: Metabolys Inc.Nazarian, Arbi ....................................... Disclosed no conflict of interest.Nazim, Joanna ...................................... Disclosed no conflict of interest.Ndehi, Lilian .......................................... Employee: Humana.Ndumele, Chiadi ................................... Disclosed no conflict of interest.Neal, Adam S. ...................................... Disclosed no conflict of interest.Neal, Doss W. ...................................... Disclosed no conflict of interest.Nebioglu, Serpil .................................... Disclosed no conflict of interest.Nedel, Bárbara L. ................................. Disclosed no conflict of interest.Nederveen, A.J. ................................... Disclosed no conflict of interest.Needham, Belinda ................................ Disclosed no conflict of interest.Neef, Madlen ........................................ Disclosed no conflict of interest.Neglia, Danilo ....................................... Disclosed no conflict of interest.Negrato, Carlos A. ............................... Disclosed no conflict of interest.Negrin, Kimberly A. ............................. Disclosed no conflict of interest.Neiderhäuser, Guy................................. Disclosed no conflict of interest.Neinstein, Aaron B. .............................. Disclosed no conflict of interest.Nellemann, Birgitte ............................... Disclosed no conflict of interest.
Nelson, Deborah B. .............................. Disclosed no conflict of interest.Nelson, James K. ................................. Employee: Truven Health Analytics.Nelson, Michael .................................... Disclosed no conflict of interest.Nelson, Patric ........................................ Employee: Amgen, Inc.Nelson, Robert G. ................................. Disclosed no conflict of interest.Nelson, Robert H. ................................. Disclosed no conflict of interest.Nemeth, Zoltan H. ................................ Disclosed no conflict of interest.Nemoto, Ken-ichi .................................. Disclosed no conflict of interest.Neo, Ye Bin ........................................... Disclosed no conflict of interest.Nery, Márcia ......................................... Disclosed no conflict of interest.Nesbit, Chloe ........................................ Disclosed no conflict of interest.Neslusan, Cheryl ................................... Employee: Janssen Global Services, LLC.Nesto, Richard W. ................................ Consultant: Merck, Novartis Pharmaceuticals
Corporation.Nettel-Aguirre, Alberto ......................... Disclosed no conflict of interest.Neubacher, Dietmar .............................. Employee: Boehringer Ingelheim GmbH & Co. KG.Neubauer, Katharina M. ...................... Disclosed no conflict of interest.Neubauer, Michael................................ Disclosed no conflict of interest.Neugebauer, Romain............................. Disclosed no conflict of interest.Neuhaus, Peter ..................................... Disclosed no conflict of interest.Neumann, William L. ........................... Disclosed no conflict of interest.Neves, Francisco ................................... Disclosed no conflict of interest.Newby, Brittney N. .............................. Disclosed no conflict of interest.Newcomb, Jennifer D. ......................... Disclosed no conflict of interest.Newcomer, Bradley R. ......................... Disclosed no conflict of interest.Newell, John ......................................... Disclosed no conflict of interest.Newell-Johnson, Doreen ...................... Disclosed no conflict of interest.Newgard, Christopher B. ..................... Research Support: Pfizer, Inc.Newman, Anne B. ................................ Disclosed no conflict of interest.Newman, Julie ...................................... Employee: Bristol-Myers Squibb Company.Newnes, Lindsey ................................... Disclosed no conflict of interest.Newsom, Sean A. ................................ Disclosed no conflict of interest.Newton, Christopher A. ....................... Advisory Panel: Sanofi.Newton, Katherine M. ......................... Disclosed no conflict of interest.Newton, Tabitha.................................... Disclosed no conflict of interest.Nezu, Uru .............................................. Disclosed no conflict of interest.Ng, Hui Jin ............................................ Disclosed no conflict of interest.Ng, Ming T. .......................................... Disclosed no conflict of interest.Ng, Taria ................................................ Disclosed no conflict of interest.Ng, Xiao Wei ......................................... Disclosed no conflict of interest.Nguewa, Jean-Louis ............................. Disclosed no conflict of interest.Nguyen, Dung ....................................... Disclosed no conflict of interest.Nguyen, Hiep ........................................ Employee: Bristol-Myers Squibb/AstraZeneca.Nguyen, Minh Tuan ............................... Disclosed no conflict of interest.Nguyen, Nhung ..................................... Disclosed no conflict of interest.Nguyen, Phoung .................................... Disclosed no conflict of interest.Nguyen, Thu .......................................... Disclosed no conflict of interest.Nguyen, Van T. ..................................... Disclosed no conflict of interest.Ngwenyama, Njabulo ........................... Disclosed no conflict of interest.Ni, Yinhua.............................................. Disclosed no conflict of interest.Nichols, Colin G. .................................. Disclosed no conflict of interest.Nichols, Gregory ................................... Research Support: AstraZeneca Pharmaceuticals LP, Bristol-
Nicholson, Jeremy K. ........................... Disclosed no conflict of interest.Nicolas, Anthony ................................... Disclosed no conflict of interest.Nicolau, Christiane ............................... Disclosed no conflict of interest.Nicolucci, Antonio ................................. Advisory Panel: Bristol-Myers Squibb/AstraZeneca, Merck
Sharp & Dohme Limited, Novartis Pharmaceuticals Corporation, Novo Nordisk A/S; Research Support: Merck Sharp & Dohme Limited, Novo Nordisk A/S, Sanofi.
Nicotra, Cassandra M. ......................... Disclosed no conflict of interest.Nie, Jing ................................................ Disclosed no conflict of interest.Nie, Meiyun .......................................... Disclosed no conflict of interest.Nielsen, Aneta A. ................................. Disclosed no conflict of interest.Nielsen, Jens S. ................................... Disclosed no conflict of interest.Nielsen, Søren ...................................... Disclosed no conflict of interest.Nielsen, Thomas S. .............................. Disclosed no conflict of interest.Nien, Feng-Jung .................................... Disclosed no conflict of interest.Niessen, Hans W. ................................ Disclosed no conflict of interest.Niessen, Markus ................................... Disclosed no conflict of interest.Nieuwdorp, M. ..................................... Disclosed no conflict of interest.Niewczas, Monika A. ........................... Disclosed no conflict of interest.Nightingale, Peter G. ........................... Disclosed no conflict of interest.Nigro, Cecilia ........................................ Disclosed no conflict of interest.Nigro, Pasquale ..................................... Disclosed no conflict of interest.Niiimi, Lance ......................................... Disclosed no conflict of interest.Nijpels, Giel .......................................... Disclosed no conflict of interest.Nikami, Fumio ....................................... Disclosed no conflict of interest.Nikhil, Tandon ....................................... Disclosed no conflict of interest.Nikolaidou, Barbara .............................. Disclosed no conflict of interest.
Nikolajuk, Agnieszka ............................. Disclosed no conflict of interest.Nikolic, Dragana ................................... Disclosed no conflict of interest.Nikonova, Elena .................................... Employee: Sanofi.Nikrad, Malti ......................................... Employee: SomaLogic, Inc.Nilsson, Anders L. ................................ Speaker’s Bureau: Novo Nordisk A/S, Sanofi.Nilsson, Emma A. ................................ Disclosed no conflict of interest.Nimalasuriya, Ananda .......................... Disclosed no conflict of interest.Nimri, Revital ........................................ Speaker’s Bureau: Novo Nordisk, Inc.Ning, Guan ............................................ Disclosed no conflict of interest.Ning, Guang .......................................... Disclosed no conflict of interest.Ning, Xian ............................................. Disclosed no conflict of interest.Nino, Antonio J. ................................... Employee: GlaxoSmithKline; Stock/Shareholder:
GlaxoSmithKline.Ninomiya, Yuzo ..................................... Disclosed no conflict of interest.Nisbet, Chloe ........................................ Disclosed no conflict of interest.Nishi, Yuichi .......................................... Disclosed no conflict of interest.Nishida, Makoto ................................... Disclosed no conflict of interest.Nishida, Susumu ................................... Disclosed no conflict of interest.Nishida, Wataru Nishida ...................... Disclosed no conflict of interest.Nishida, Yasuhiro .................................. Disclosed no conflict of interest.Nishihara, Harumi ................................. Disclosed no conflict of interest.Nishii, Naoko ........................................ Disclosed no conflict of interest.Nishijima, Keiji ...................................... Employee: Novo Nordisk Pharma Ltd.; Stock/Shareholder:
Novo Nordisk Pharma Ltd.Nishikawa, Sachiko .............................. Employee: Ajinomoto Group, Ajinomoto Group (Spouse/
Partner).Nishikawa, Tetsuo................................. Disclosed no conflict of interest.Nishimura, Fusanori .............................. Disclosed no conflict of interest.Nishimura, Miho ................................... Disclosed no conflict of interest.Nishina, Atsuyoshi ................................ Disclosed no conflict of interest.Nishinakamura, Hitomi ......................... Disclosed no conflict of interest.Nishio, Naoko ....................................... Disclosed no conflict of interest.Niskanen, Leo ....................................... Disclosed no conflict of interest.Nissen, Steven E. ................................. Disclosed no conflict of interest.Nistala, Ravi .......................................... Research Support: Merck.Niu, WenYan ......................................... Disclosed no conflict of interest.Niwa, Hiroyuki ...................................... Disclosed no conflict of interest.Njølstad, Pål .......................................... Disclosed no conflict of interest.Noctor, Eoin ........................................... Other Relationship: Novo Nordisk, Inc.Noda, Mitsuhiko ................................... Research Support: Daiichi-Sankyo, Inc.; Speaker’s Bureau:
Nodale, Marianna ................................. Disclosed no conflict of interest.Noe, Dawn ............................................ Disclosed no conflict of interest.Noerregaard, Pia ................................... Disclosed no conflict of interest.Nogawa, Miyuki .................................... Disclosed no conflict of interest.Noguchi, Constance Tom ...................... Employee: NIDDK.Noguchi, Michio .................................... Disclosed no conflict of interest.Noh, Junghyun ...................................... Disclosed no conflict of interest.Noh, Yun H. .......................................... Disclosed no conflict of interest.Nohara, Atsushi .................................... Disclosed no conflict of interest.Nohara, Ryuji ........................................ Disclosed no conflict of interest.Nolan, Christopher J. ........................... Disclosed no conflict of interest.Noland, Robert C. ................................. Disclosed no conflict of interest.Noll, Christophe .................................... Disclosed no conflict of interest.Nolven, Anders ..................................... Disclosed no conflict of interest.Nomiyama, Takashi ............................... Disclosed no conflict of interest.Nomoto, Hiroshi .................................... Disclosed no conflict of interest.Nomura, Akitoshi .................................. Disclosed no conflict of interest.Nomura, Hideki ..................................... Disclosed no conflict of interest.Nomura, Mitsuru ................................... Disclosed no conflict of interest.Nonaka, Akihito .................................... Disclosed no conflict of interest.Norberg, Margareta .............................. Disclosed no conflict of interest.Norby, Barbara ...................................... Disclosed no conflict of interest.Nordestgaard, Boerge G. ..................... Disclosed no conflict of interest.Norman-Burgdolf, Heather L. .............. Disclosed no conflict of interest.Normand, Christophe ............................ Disclosed no conflict of interest.Nørredam, Marie L. ............................. Disclosed no conflict of interest.Norris, Andrew W. ............................... Disclosed no conflict of interest.Norris, Jill M. ....................................... Disclosed no conflict of interest.Norris, Keri ............................................ Disclosed no conflict of interest.Norris, Olga C. ...................................... Disclosed no conflict of interest.Norström, Fredrik .................................. Disclosed no conflict of interest.Norton, Luke .......................................... Disclosed no conflict of interest.Nosek, Leszek ....................................... Disclosed no conflict of interest.Noto, Hiroshi ......................................... Disclosed no conflict of interest.Nour, Nawal .......................................... Disclosed no conflict of interest.Nourmohammedzadeh, Mohammed .... Disclosed no conflict of interest.Novelli, Deborah ................................... Disclosed no conflict of interest.Novelli, Michela .................................... Disclosed no conflict of interest.Nóvoa Mogollón, F. Javier .................... Disclosed no conflict of interest.Nowak, Felicia V. ................................. Disclosed no conflict of interest.
Nowak, Krzysztof W. ............................ Disclosed no conflict of interest.Nowak, Natalia ..................................... Disclosed no conflict of interest.Nowotny, Bettina .................................. Disclosed no conflict of interest.Nowotny, Irene ...................................... Employee: Sanofi.Nowotny, Peter ..................................... Disclosed no conflict of interest.Ntabadde, Catherine ............................. Other Relationship: Merck.Ntalla, Ioanna ....................................... Disclosed no conflict of interest.Nube, Vanessa L. ................................. Disclosed no conflict of interest.Nukada, Hitoshi .................................... Disclosed no conflict of interest.Numaguchi, Ryutaro ............................. Disclosed no conflict of interest.Nunez, Derek J. .................................... Disclosed no conflict of interest.Nunley, Karen A. .................................. Disclosed no conflict of interest.Nuutila, Pirjo ......................................... Disclosed no conflict of interest.Nybo Andersen, Anne-Marie ................ Disclosed no conflict of interest.Nyby, Signe ........................................... Disclosed no conflict of interest.Nye, Ann M. ......................................... Disclosed no conflict of interest.Nygaard, Unni C. .................................. Disclosed no conflict of interest.Nylen, Eric S. ........................................ Disclosed no conflict of interest.Nystrom, Fredrik H. .............................. Disclosed no conflict of interest.O’Connor, Michelle Y. ........................... Disclosed no conflict of interest.O’ Flynn, Lisa ......................................... Disclosed no conflict of interest.O’Brien, Timothy .................................... Disclosed no conflict of interest.O’Connell, Brendon ............................... Disclosed no conflict of interest.O’Malley, Cheryl W. ............................. Disclosed no conflict of interest.Oakes, Nicholas D. .............................. Employee: AstraZeneca Pharmaceuticals LP.Obanda, Diana ...................................... Disclosed no conflict of interest.Obara, Akio ........................................... Disclosed no conflict of interest.Obatake, Azusa ..................................... Disclosed no conflict of interest.Obayashi, Hiroshi .................................. Disclosed no conflict of interest.Oberholzer, Jose.................................... Disclosed no conflict of interest.Obermaier, Karin ................................... Employee: Roche Diagnostics GmbH.Oberman, Bernice ................................. Disclosed no conflict of interest.Obermayer-Pietsch, Barbara ................. Disclosed no conflict of interest.Obici, Silvana ........................................ Disclosed no conflict of interest.O’Brien, Kyle ......................................... Employee: Biodel, Inc.O’Brien, Matthew J. ............................ Disclosed no conflict of interest.O’Brien, Phillipe D. ............................... Disclosed no conflict of interest.O’Brien, Richard M. ............................. Disclosed no conflict of interest.O’Brien, Timothy .................................... Advisory Panel: Merck Sharp & Dohme Limited, Novo Nordisk
A/S, Sanofi; Speaker’s Bureau: Daiichi-Sankyo, Inc., Novo Nordisk A/S.
Obuchowicz, Ewa .................................. Disclosed no conflict of interest.Occhipinti, Margherita .......................... Disclosed no conflict of interest.Ochoa, Hector ....................................... Disclosed no conflict of interest.Ock, So Young ....................................... Disclosed no conflict of interest.O’Connell, Rachel .................................. Disclosed no conflict of interest.O’Connor, Michelle Y. ........................... Disclosed no conflict of interest.O’Connor, Patrick J. .............................. Disclosed no conflict of interest.O’Connor-Semmes, Robin ..................... Disclosed no conflict of interest.Oda, Kanako .......................................... Disclosed no conflict of interest.Oda, Tomoyasu ...................................... Disclosed no conflict of interest.Odawara, Masato ................................. Research Support: Astellas Pharma US, Inc., AstraZeneca
O’Dea, Angela ....................................... Disclosed no conflict of interest.O’Dell, Laura E. .................................... Disclosed no conflict of interest.Oden, Jon D. ........................................ Disclosed no conflict of interest.O’Doherty, Robert M. ........................... Disclosed no conflict of interest.O’Donnell, Amy C. ................................ Disclosed no conflict of interest.O’Donnell, Christopher P. ..................... Disclosed no conflict of interest.Odori, Shinji .......................................... Disclosed no conflict of interest.Odriozola, Ariel A. ................................ Disclosed no conflict of interest.Oelze, Matthias ..................................... Disclosed no conflict of interest.O’Farrell, Libbey .................................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly
and Company.Ofstad, Anne Pernille ............................ Disclosed no conflict of interest.Ogasawara, Saori ................................. Disclosed no conflict of interest.Ogata, Emi ............................................. Disclosed no conflict of interest.Ogawa, Daisuke .................................... Disclosed no conflict of interest.Ogihara, Takeshi.................................... Speaker’s Bureau: Eli Lilly and Company, Kissei
O’Grady, Michael J. ............................. Consultant: Novo Nordisk, Inc.Ogrocki, Dagmar ................................... Disclosed no conflict of interest.Ogu, Linda ............................................. Research Support: Merck.
Oguntibeju, Oluwafemi ......................... Disclosed no conflict of interest.Ogura, Kasane ....................................... Disclosed no conflict of interest.Ogura, Masahito ................................... Disclosed no conflict of interest.Oguri, Yasuo .......................................... Disclosed no conflict of interest.Oguro, Yukari ......................................... Disclosed no conflict of interest.Oguz, Aytekin ........................................ Disclosed no conflict of interest.Oh, Bae Jun ........................................... Disclosed no conflict of interest.Oh, Chang-Myung ................................. Disclosed no conflict of interest.Oh, Elissa H. ......................................... Disclosed no conflict of interest.Oh, Henpiru ........................................... Disclosed no conflict of interest.Oh, Richard ............................................ Employee: Takeda Development Center Americas, Inc.Oh, SangSu ........................................... Disclosed no conflict of interest.OH, Seung-Hoon ................................... Disclosed no conflict of interest.Oh, Sewon ............................................. Disclosed no conflict of interest.Oh, Sohee .............................................. Disclosed no conflict of interest.Oh, Su Jin .............................................. Disclosed no conflict of interest.Oh, Tae Keun ......................................... Disclosed no conflict of interest.Oh, Young Taek ..................................... Disclosed no conflict of interest.Ohama, Tohru ........................................ Disclosed no conflict of interest.Ohara, Nobumasa ................................. Disclosed no conflict of interest.Ohara-Imaizumi, Mica ........................... Disclosed no conflict of interest.O’Hare, Elizabeth A. ............................. Disclosed no conflict of interest.O’Harte, Finbarr P. ................................ Consultant: Eli Lilly and Company, Novo Nordisk, Inc., Sanofi;
Research Support: Amylin Pharmaceuticals, Inc.; Stock/Shareholder: Diabetica Limited.
Ohashi, Yasuo ....................................... Disclosed no conflict of interest.Ohata, Yoko ........................................... Disclosed no conflict of interest.Ohki, Tsuyoshi ....................................... Disclosed no conflict of interest.Ohkura, Hiroko ...................................... Disclosed no conflict of interest.Ohkura, Tsuyoshi ................................... Disclosed no conflict of interest.Ohmi, Satoko ......................................... Disclosed no conflict of interest.Ohta, Akira ............................................ Disclosed no conflict of interest.Ohtaka, Manami ................................... Disclosed no conflict of interest.Ohtsu, Kyoshiaki ................................... Disclosed no conflict of interest.Ohtsu, Yoshiaki ..................................... Disclosed no conflict of interest.Ohtsuka, Yoshie .................................... Disclosed no conflict of interest.Oikawa, Shinichi ................................... Disclosed no conflict of interest.Oikawa, Yoichi ...................................... Disclosed no conflict of interest.Oikawa, Youichi .................................... Disclosed no conflict of interest.Oikonen, Vesa ....................................... Disclosed no conflict of interest.Oiso, Yutaka .......................................... Disclosed no conflict of interest.Oka, Kazumasa ...................................... Disclosed no conflict of interest.Okada, Hideyuki .................................... Disclosed no conflict of interest.Okada, Hiroshi ....................................... Disclosed no conflict of interest.Okada, Michiaki .................................... Disclosed no conflict of interest.Okada, Shuichi ...................................... Disclosed no conflict of interest.Okada, Takashi ...................................... Disclosed no conflict of interest.Okada, Takeshi ...................................... Disclosed no conflict of interest.Okada-Iwabu, Miki ................................ Disclosed no conflict of interest.Okahata, Sumie ..................................... Disclosed no conflict of interest.Okamoto, Hiroshi .................................. Disclosed no conflict of interest.Okamoto, Takuya ................................... Disclosed no conflict of interest.Okamura, Emi ........................................ Disclosed no conflict of interest.Okamura, Tadashi.................................. Disclosed no conflict of interest.Okano, Teruo ......................................... Disclosed no conflict of interest.Okauchi, Syouzou .................................. Disclosed no conflict of interest.Okawa, Tetsuji....................................... Disclosed no conflict of interest.Okayama, Naotsuka .............................. Disclosed no conflict of interest.Okazaki, Kentaro ................................... Disclosed no conflict of interest.Okazaki, Satoko ..................................... Disclosed no conflict of interest.Okerberg, Carl K. .................................. Disclosed no conflict of interest.Oki, Kaori ............................................... Employee: Ono Pharmaceutical Co., Ltd.Oki, Yutaka ............................................ Disclosed no conflict of interest.Okihiro, May M. ................................... Disclosed no conflict of interest.Okita, Koichi .......................................... Disclosed no conflict of interest.Okosieme, Onyebuchi E. ...................... Disclosed no conflict of interest.Okouchi, Masahiro ................................ Disclosed no conflict of interest.Okrainec, Karen ..................................... Disclosed no conflict of interest.Okubo, Hirofumi .................................... Disclosed no conflict of interest.Okuda, Masayuki .................................. Disclosed no conflict of interest.Okumura, Akinori .................................. Disclosed no conflict of interest.Okumura, Ryota ..................................... Disclosed no conflict of interest.Okuno, Misako ...................................... Disclosed no conflict of interest.Olavarría, Luis ....................................... Disclosed no conflict of interest.Olbers, Torsten ...................................... Disclosed no conflict of interest.O’Leary, Kevin ....................................... Disclosed no conflict of interest.Oleksiewicz, Luiza ................................. Disclosed no conflict of interest.Olenina, Lyubov ..................................... Disclosed no conflict of interest.Olesen, Thomas B. ............................... Disclosed no conflict of interest.Oleson, Bryndon J. ............................... Disclosed no conflict of interest.Olimpico, Francesco .............................. Disclosed no conflict of interest.Oliveira, Carolina S. ............................. Disclosed no conflict of interest.
Oliveira, José E. ................................... Disclosed no conflict of interest.Oliveira, Milena F. ................................ Disclosed no conflict of interest.Oliver, Nick ............................................ Disclosed no conflict of interest.Oliver, Noah G. ..................................... Disclosed no conflict of interest.Oliverio, Rosa ........................................ Disclosed no conflict of interest.Olivier, Alicia K. .................................... Disclosed no conflict of interest.Olivier, Alina .......................................... Disclosed no conflict of interest.Oliyarnyk, Olena .................................... Disclosed no conflict of interest.Olsen, Adriane ...................................... Research Support: Sanofi.Olsén, Arne ........................................... Employee: AstraZeneca Pharmaceuticals LP.Olsen, Michael H. ................................ Disclosed no conflict of interest.Olsen, Sjurdur F. ................................... Disclosed no conflict of interest.Olson, Darin E. ..................................... Research Support: Amylin Pharmaceuticals, Inc., Novo
Nordisk, Inc.Olson, David .......................................... Employee: Echo Therapeutics, Inc.; Stock/Shareholder: Echo
Therapeutics, Inc.Olson, Eric N. ....................................... Disclosed no conflict of interest.Olsson, Anders H. ................................ Disclosed no conflict of interest.Olsson, Tommy ...................................... Disclosed no conflict of interest.Oltolini, Alice ........................................ Disclosed no conflict of interest.Omae, Tsuneaki ..................................... Disclosed no conflict of interest.Omi, Maiko ............................................ Disclosed no conflict of interest.Omkaramurthy, M. ............................... Disclosed no conflict of interest.Omura, Masao ...................................... Disclosed no conflict of interest.O’Neal, David ........................................ Other Relationship: Bristol-Myers Squibb Company,
Medtronic, Merck, Honoraria, Merck, Novo Nordisk, Inc., Roche Pharmaceuticals, Sanofi; Research Support: Bristol-Myers Squibb Company, Medtronic, Merck, Novo Nordisk, Inc., Roche Pharmaceuticals, Sanofi.
O’Neil, Adrienne ................................... Disclosed no conflict of interest.O’Neill, Brian T. .................................... Disclosed no conflict of interest.O’Neill, Ciaran ....................................... Disclosed no conflict of interest.Onengut-Gumuscu, Suna ...................... Disclosed no conflict of interest.Ong, Kwok Leung .................................. Advisory Panel: Pfizer, Inc.Ong, Lizhen ............................................ Disclosed no conflict of interest.Onishi, Tetsuro ...................................... Disclosed no conflict of interest.Ono, Hiraku ........................................... Disclosed no conflict of interest.Ono, Junko ............................................ Disclosed no conflict of interest.Ono, Kaoru ............................................ Disclosed no conflict of interest.Ono, Masafumi ..................................... Disclosed no conflict of interest.Ono, Shinji ............................................. Disclosed no conflict of interest.Ono, Tomoji ........................................... Disclosed no conflict of interest.Ono, Yuri ................................................ Disclosed no conflict of interest.Onogi, Yasuhiro ..................................... Disclosed no conflict of interest.Onuma, Hirohisa ................................... Disclosed no conflict of interest.Onuma, Hiroshi ..................................... Disclosed no conflict of interest.Onuma, Tomio ....................................... Disclosed no conflict of interest.Oommen, A.M. ..................................... Disclosed no conflict of interest.Oravec, Michael .................................... Disclosed no conflict of interest.Orchard, Trevor J. ................................. Consultant: Aegerion Pharmaceuticals, Inc., Gilead Sciences,
Inc.; Research Support: VeraLight, Inc; Stock/Shareholder: Bristol-Myers Squibb Company.
Orciga, Michael-Angelo P. ................... Disclosed no conflict of interest.Ordelheide, Anna-Maria ....................... Disclosed no conflict of interest.Orgill, Dennis P. .................................... Disclosed no conflict of interest.Orii, Noemia .......................................... Disclosed no conflict of interest.Orivuori, Laura ....................................... Disclosed no conflict of interest.Orlandi, Augusto ................................... Disclosed no conflict of interest.Orlando, Maura R. ................................ Disclosed no conflict of interest.Orozco-Beltran, Domingo ...................... Advisory Panel: Eli Lilly and Company, Novo Nordisk A/S,
Orsak, Beverly ....................................... Disclosed no conflict of interest.Orsi, Emanuela ...................................... Disclosed no conflict of interest.Orszag, Andrej ....................................... Disclosed no conflict of interest.Orta, Israel ............................................ Disclosed no conflict of interest.Ortmeyer, Heidi K. ................................ Disclosed no conflict of interest.Oruk, Guzide Gonca ............................... Disclosed no conflict of interest.Orvik, Elsa ............................................. Disclosed no conflict of interest.Orwoll, Eric S. ...................................... Disclosed no conflict of interest.Osafune, Kenji ....................................... Disclosed no conflict of interest.Osaki, Aya ............................................. Disclosed no conflict of interest.Osawa, Haruhiko ................................... Disclosed no conflict of interest.Osei, Kwame ......................................... Disclosed no conflict of interest.O’Shea, Donal ....................................... Advisory Panel: Menarini, Merck Sharp & Dohme Limited,
Novo Nordisk, Inc., Takeda Pharmaceuticals U.S.A., Inc.; Research Support: Novo Nordisk, Inc., Sanofi; Speaker’s Bureau: Merck Sharp & Dohme Limited, Novo Nordisk, Inc.
O’Shea, Terry ......................................... Research Support: Sanofi.
Oshige, Tamami..................................... Disclosed no conflict of interest.Oshima, Yoshitake ................................ Disclosed no conflict of interest.Osmundson, Sarah ................................ Disclosed no conflict of interest.Osonoi, Takeshi ..................................... Disclosed no conflict of interest.Osterhoff, Martin .................................. Disclosed no conflict of interest.Östgren, Carl Johan .............................. Disclosed no conflict of interest.Ostrov, David ......................................... Disclosed no conflict of interest.Ostrovsky, Yana ..................................... Disclosed no conflict of interest.O’Sullivan, Esther S. ............................ Disclosed no conflict of interest.Ota, Hiroyo ............................................ Disclosed no conflict of interest.Ota, Kazuki ............................................ Disclosed no conflict of interest.Ota, Tomoki ........................................... Disclosed no conflict of interest.Ota, Tsuguhito ....................................... Disclosed no conflict of interest.Otabe, Shuichi ....................................... Disclosed no conflict of interest.Otani, Shinichi ....................................... Disclosed no conflict of interest.Otekeiwebia, Anthony .......................... Disclosed no conflict of interest.Otfried Schwab, Karl ............................. Disclosed no conflict of interest.Otlivanchik, Oleg ................................... Disclosed no conflict of interest.Otsuka, Fumiko ...................................... Disclosed no conflict of interest.Otsuka, Yuichiro .................................... Disclosed no conflict of interest.Otsuki, Shingo ....................................... Disclosed no conflict of interest.Ottaway, Nickki ..................................... Disclosed no conflict of interest.Ottemann, Brendan M. ........................ Disclosed no conflict of interest.Otten, Julia ........................................... Disclosed no conflict of interest.Otvos, James D. ................................... Employee: LipoScience.Otziomek, Elzbieta ................................. Disclosed no conflict of interest.Ou, Dawei ............................................. Disclosed no conflict of interest.Ou, Horng-Yih ........................................ Disclosed no conflict of interest.Ouchi, Hiromi ........................................ Disclosed no conflict of interest.Oue, Keiko ............................................. Disclosed no conflict of interest.Ouwens, D. Margriet ............................ Disclosed no conflict of interest.Ovize, Michel ........................................ Disclosed no conflict of interest.Owczarek, Aleksander .......................... Disclosed no conflict of interest.Owen-Jones, Elizabeth ......................... Disclosed no conflict of interest.Owens, Lisa A. ..................................... Disclosed no conflict of interest.Oya, Junko ............................................ Disclosed no conflict of interest.Oya, Takeshi .......................................... Disclosed no conflict of interest.Oyadomari, Miho .................................. Disclosed no conflict of interest.Oyadomari, Seiichi ................................ Disclosed no conflict of interest.Oyama, Akiko ........................................ Disclosed no conflict of interest.Oyedokun, Festus .................................. Disclosed no conflict of interest.Oz, Gulin ................................................ Disclosed no conflict of interest.Oza-Frank, Reena .................................. Disclosed no conflict of interest.Ozaki, Iwata .......................................... Disclosed no conflict of interest.Ozaki, Risa ............................................. Disclosed no conflict of interest.Ozawa, Sachihiko .................................. Disclosed no conflict of interest.Ozawa, Shogo ....................................... Disclosed no conflict of interest.Ozdem, Sadi S. ..................................... Disclosed no conflict of interest.Ozdem, Sebahat .................................... Disclosed no conflict of interest.Ozel Demiralp, Duygu ........................... Disclosed no conflict of interest.Özgül, Özgür .......................................... Disclosed no conflict of interest.Pacal, Lukas .......................................... Disclosed no conflict of interest.Pacaud, Danièle .................................... Disclosed no conflict of interest.Paccagnella, Agostino .......................... Disclosed no conflict of interest.Pace, Wilson D. .................................... Research Support: Sanofi, Shire; Stock/Shareholder: Merck,
Novartis Pharmaceuticals Corporation, Pfizer, Inc.Pacher, Pál ............................................. Disclosed no conflict of interest.Pacifici, Francesca ................................ Disclosed no conflict of interest.Pacilli, Antonio ...................................... Disclosed no conflict of interest.Pacini, Giovanni .................................... Research Support: Poxel SA.Packham, David K. ............................... Disclosed no conflict of interest.Paczkowski, Rosirene ............................ Employee: Eli Lilly and Company.Padgett, Lindsey E. ............................... Disclosed no conflict of interest.Padmalayam, Indira .............................. Disclosed no conflict of interest.Padmanabhan, Suja .............................. Disclosed no conflict of interest.Paeth, Guenter ...................................... Disclosed no conflict of interest.Page, Kathleen A. ................................ Disclosed no conflict of interest.Pagkalos, Ioannis .................................. Disclosed no conflict of interest.Paithankar, Madhuri M. ....................... Disclosed no conflict of interest.Pajewski, Nicholas M. ......................... Disclosed no conflict of interest.Palacios Martinez, Margarita ............... Disclosed no conflict of interest.Palakiko, Donna-Marie ......................... Disclosed no conflict of interest.Palakodeti, Sandeep ............................. Disclosed no conflict of interest.Palaniappan, Latha P. ........................... Disclosed no conflict of interest.Paldánius, Päivi M. .............................. Employee: Novartis Pharma AG; Stock/Shareholder: Novartis.Palermo, Nadine ................................... Disclosed no conflict of interest.Palla, Jyothsna ...................................... Disclosed no conflict of interest.Palladino, Andrew A. ........................... Disclosed no conflict of interest.Palmer, Andrew J. ................................ Disclosed no conflict of interest.Palmer, Colin N. ................................... Disclosed no conflict of interest.Palmer, Jerry ......................................... Disclosed no conflict of interest.Palmer, Nicholette D. ........................... Disclosed no conflict of interest.
Palming, Jenny ...................................... Disclosed no conflict of interest.Palnati, Madhuri ................................... Disclosed no conflict of interest.Paloma, Diane ....................................... Disclosed no conflict of interest.Pambianco, Georgia .............................. Disclosed no conflict of interest.Pan, An .................................................. Disclosed no conflict of interest.Pan, Chang Yu ....................................... Advisory Panel: Novo Nordisk A/S.Pan, Chunshen ...................................... Employee: Sanofi.Pan, Fong C. ......................................... Disclosed no conflict of interest.Pan, Qianqian ........................................ Disclosed no conflict of interest.Pan, Qing ............................................... Disclosed no conflict of interest.Pan, Sufang ........................................... Disclosed no conflict of interest.Pan, Xiaoping ........................................ Disclosed no conflict of interest.Pan, Xiaoyu ........................................... Disclosed no conflict of interest.Panda, Prashant .................................... Disclosed no conflict of interest.Pandey, Shivam ..................................... Disclosed no conflict of interest.Pandit, Keta ........................................... Disclosed no conflict of interest.Pandolfi, Assunta .................................. Disclosed no conflict of interest.Pang, Chi ............................................... Disclosed no conflict of interest.Pang, Nyuk Vun ..................................... Disclosed no conflict of interest.Pankow, James ..................................... Disclosed no conflict of interest.Pa kowska, Ewa .................................... Disclosed no conflict of interest.Pannangpetch, Patchareewan .............. Disclosed no conflict of interest.Pantea Stoian, Anca ............................. Disclosed no conflict of interest.Pantoja-Melendez, Carlos ..................... Disclosed no conflict of interest.Panton, Michelle C. .............................. Disclosed no conflict of interest.Panyarachun, Busaba ............................ Disclosed no conflict of interest.Papa, Feroz R. ....................................... Disclosed no conflict of interest.Papadimitriou, Konstantina .................. Disclosed no conflict of interest.Papadogiannis, Dimitris ........................ Disclosed no conflict of interest.Papadopoulou, Maria ............................ Disclosed no conflict of interest.Papageorgiou, Nikolaos ........................ Disclosed no conflict of interest.Papamargaritis, Dimitris ....................... Disclosed no conflict of interest.Papandonatos, George D. .................... Disclosed no conflict of interest.Papandreopoulou, Vaso ........................ Disclosed no conflict of interest.Papaoikonomou, Stavroula ................... Disclosed no conflict of interest.Papasavvas, Diamanto M. ................... Disclosed no conflict of interest.Papazafiropoulou, Athanasia K. ........... Disclosed no conflict of interest.Papizan, James ..................................... Disclosed no conflict of interest.Pappan, Kirk .......................................... Employee: Metabolon, Inc.; Stock/Shareholder: Metabolon,
Inc.Pappas, Stavros .................................... Disclosed no conflict of interest.Paramalingam, Nirubasini .................... Disclosed no conflict of interest.Paranjape, Sachin A. ............................ Disclosed no conflict of interest.Parast, Mana ......................................... Disclosed no conflict of interest.Pardo, Scott ........................................... Employee: Bayer.Pardo, Virginia ....................................... Disclosed no conflict of interest.Parellada, Clara B. ............................... Disclosed no conflict of interest.Parikh, Shamik J. ................................. Employee: AstraZeneca Pharmaceuticals LP; Stock/
Shareholder: AstraZeneca Pharmaceuticals LP.Parisi, Maria C. .................................... Disclosed no conflict of interest.Park Kim, Soohyun ................................ Disclosed no conflict of interest.Park, Bo-Yoon ........................................ Disclosed no conflict of interest.Park, Chang ........................................... Disclosed no conflict of interest.Park, Cheol-Young ................................. Disclosed no conflict of interest.Park, Ha Neul ........................................ Disclosed no conflict of interest.Park, Hanjong ........................................ Disclosed no conflict of interest.Park, Heon-Seok .................................... Disclosed no conflict of interest.Park, Ie Byung ....................................... Disclosed no conflict of interest.Park, Jae Yeo ........................................ Disclosed no conflict of interest.Park, Jin ................................................ Disclosed no conflict of interest.Park, Jong Suk ...................................... Disclosed no conflict of interest.Park, Joong-Yeol ................................... Disclosed no conflict of interest.Park, Jun H. .......................................... Disclosed no conflict of interest.Park, Jun Yong ...................................... Disclosed no conflict of interest.Park, Jung Hwan ................................... Disclosed no conflict of interest.Park, Juri ............................................... Disclosed no conflict of interest.Park, Kang Seo ...................................... Disclosed no conflict of interest.Park, Keun-Gyu ...................................... Disclosed no conflict of interest.Park, Kyong Han .................................... Disclosed no conflict of interest.Park, Kyong Soo .................................... Disclosed no conflict of interest.Park, Kyoung Soo .................................. Disclosed no conflict of interest.Park, Kyoungmin ................................... Research Support: Janssen Pharmaceuticals.Park, Sang Hyun .................................... Disclosed no conflict of interest.Park, Se Hee .......................................... Disclosed no conflict of interest.Park, So Young ...................................... Disclosed no conflict of interest.Park, Soon Hyun .................................... Disclosed no conflict of interest.Park, Su Bin ........................................... Disclosed no conflict of interest.Park, Sung Hee ...................................... Disclosed no conflict of interest.Park, Sung Woo .................................... Disclosed no conflict of interest.Park, Tae Sun ........................................ Disclosed no conflict of interest.Park, Tae-Joon....................................... Disclosed no conflict of interest.Park, Yong Soo ...................................... Disclosed no conflict of interest.
Park, Yong-Moon ................................... Disclosed no conflict of interest.Park, Yongsoo ........................................ Disclosed no conflict of interest.Park, Young Joo .................................... Disclosed no conflict of interest.Parker, Artist.......................................... Employee: AstraZeneca Pharmaceuticals LP.Parker, Richard ...................................... Disclosed no conflict of interest.Parker, Stephen ..................................... Disclosed no conflict of interest.Parkinson, Leigh .................................... Consultant: viDa Therapeutics Inc.Parkkinen, Mary P. ................................ Disclosed no conflict of interest.Parkkola, Riitta ...................................... Disclosed no conflict of interest.Parkner, Tina .......................................... Disclosed no conflict of interest.Parpala, Cristina .................................... Disclosed no conflict of interest.Parrinello, Christina M. ........................ Consultant: Genentech.Parson, Henri K. ................................... Disclosed no conflict of interest.Parsons, Bruce ...................................... Employee: Pfizer, Inc.; Stock/Shareholder: Pfizer, Inc.Parsons, Tamera .................................... Disclosed no conflict of interest.Partridge, Helen .................................... Disclosed no conflict of interest.Parvaneh, Saman .................................. Disclosed no conflict of interest.Pascoal, Livia Aparecida B. ................. Disclosed no conflict of interest.Pasko, Dorota ........................................ Disclosed no conflict of interest.Pasnoor, Mamatha ................................ Disclosed no conflict of interest.Pasquel, Francisco J. ........................... Disclosed no conflict of interest.Pasquel, Miguel .................................... Advisory Panel: Boehringer Ingelheim Pharmaceuticals, Inc.,
Pasquier, Jean-Charles ......................... Disclosed no conflict of interest.Passos, Dolores ..................................... Disclosed no conflict of interest.Paster, Ayana ........................................ Disclosed no conflict of interest.Pastore, Donatella ................................ Disclosed no conflict of interest.Pastukh, Viktor ...................................... Disclosed no conflict of interest.Paszkiewicz, Rebecca L. ...................... Disclosed no conflict of interest.Patao, Christopher ................................ Disclosed no conflict of interest.Patek, Stephen D. ................................ Research Support: Animas Corporation.Patel, Hetal G. ...................................... Disclosed no conflict of interest.Patel, Hiren ........................................... Disclosed no conflict of interest.Patel, Nashita R. .................................. Disclosed no conflict of interest.Patel, Payal R. ...................................... Disclosed no conflict of interest.Patel, Puja ............................................. Disclosed no conflict of interest.Patel, Rohini J. ..................................... Disclosed no conflict of interest.Patel, Sanjay ......................................... Employee: Boehringer Ingelheim GmbH & Co. KG.Paterson, Andrew D. ............................ Disclosed no conflict of interest.Paterson, Megan A. ............................. Disclosed no conflict of interest.Päth, Günter .......................................... Disclosed no conflict of interest.Pathak, Ram D. ..................................... Disclosed no conflict of interest.Pathan, Faruque .................................... Advisory Panel: Novartis Pharma AG, Novo-Nordisk, Sanofi-
Aventis; Board Member: Eli Lilly and Company;Consultant: IBRAHIM General Hospital and College; Employee: IBRAHIM General Hospital and College; Other Relationship: Writing support Novartis Pharma AG; Research Support: Boehringer-Ingelheim, Novartis Pharma AG, Novo-Nordisk, Sanofi-Aventis.
Patil, O. ................................................. Disclosed no conflict of interest.Patil, Shivajirao P. ................................ Disclosed no conflict of interest.Patil, Swapnil B. ................................... Disclosed no conflict of interest.Patrakeeva, Evgenya M. ...................... Disclosed no conflict of interest.Patrick, Alan L. ..................................... Disclosed no conflict of interest.Patrick, Amanda R. .............................. Disclosed no conflict of interest.Patterson, Bruce .................................... Disclosed no conflict of interest.Patterson, Christopher C. ..................... Disclosed no conflict of interest.Patti, Angelo Maria ............................... Disclosed no conflict of interest.Patti, Mary-Elizabeth ............................ Advisory Panel: Bristol-Myers Squibb/AstraZeneca, Janssen
Patton, Susana R. ................................. Disclosed no conflict of interest.Pattou, Francois .................................... Disclosed no conflict of interest.Pauff, Brandy R. ................................... Disclosed no conflict of interest.Paul, Sanjoy .......................................... Consultant: Amylin Pharmaceuticals, Inc., Bristol-Myers
Squibb Company; Research Support: Bristol-Myers Squibb Company, Novo Nordisk A/S.
Paulsen, Dag ......................................... Disclosed no conflict of interest.Paulsen, Sarah J. ................................. Employee: Gubra ApS.Paulweber, Bernhard ............................. Disclosed no conflict of interest.Paulynice, Martine ................................ Disclosed no conflict of interest.Pavlis, Bernadette ................................. Research Support: Sanofi.Pawlinski, Lukasz .................................. Disclosed no conflict of interest.Pawlowski, Maciej ................................ Disclosed no conflict of interest.Payer, Juraj............................................ Disclosed no conflict of interest.Payette, Hélène ..................................... Disclosed no conflict of interest.Paz-Filho, Gilberto ................................. Disclosed no conflict of interest.Pazinato, Tássia C. ............................... Disclosed no conflict of interest.
Peakman, Mark ..................................... Disclosed no conflict of interest.Pearce, Morgan M. .............................. Disclosed no conflict of interest.Pearson, Ewan R. ................................. Disclosed no conflict of interest.Pearson, Mackenzie .............................. Disclosed no conflict of interest.Pechhold, Susanne ................................ Disclosed no conflict of interest.Pechtner, Valeria ................................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly
and Company.Pecoraro, Giuseppina ............................ Disclosed no conflict of interest.Pedersen, Andreas J. ........................... Disclosed no conflict of interest.Pedersen, Bente K. ............................... Disclosed no conflict of interest.Pedersen, Jens ...................................... Disclosed no conflict of interest.Pedersen, Lars ....................................... Disclosed no conflict of interest.Pedersen, Oluf ....................................... Other Relationship: Steno Diabetes Center A/S.Pedersen, Philip J. ............................... Disclosed no conflict of interest.Pedersen, Søren L. ............................... Disclosed no conflict of interest.Pedersen, Steen B. ............................... Disclosed no conflict of interest.Pedersen-Bjergaard, Ulrik ..................... Advisory Panel: Merck Sharp & Dohme Limited, Novo Nordisk
A/S.Pedigo, Christopher ............................... Disclosed no conflict of interest.Pedley, Alison ........................................ Employee: Merck.Pedraza, Eileen ...................................... Disclosed no conflict of interest.Pedraza, Salvador ................................. Disclosed no conflict of interest.Pei, Dee ................................................. Disclosed no conflict of interest.Pei, Shaobo ........................................... Disclosed no conflict of interest.Peiró, Concepción ................................. Disclosed no conflict of interest.Pek, Li Ting ............................................ Disclosed no conflict of interest.Pelikanova, Terezie................................ Disclosed no conflict of interest.Pellegrini, Fabio .................................... Disclosed no conflict of interest.Pellissier, Franck.................................... Employee: Sanofi.Pena, Ana M. ....................................... Disclosed no conflict of interest.Penfold, Sally A. ................................... Disclosed no conflict of interest.Penfornis, Alfred ................................... Board Member: Novartis, Inc.; Research Support: Novartis, Inc.Peng, Danfeng ....................................... Disclosed no conflict of interest.Peng, Limin ............................................ Disclosed no conflict of interest.Peng, Shih-Jung .................................... Disclosed no conflict of interest.Peng, Yanhua ........................................ Disclosed no conflict of interest.Peng, Yongde ........................................ Disclosed no conflict of interest.Pennathur, Subramaniam ...................... Disclosed no conflict of interest.Penno, Giuseppe ................................... Disclosed no conflict of interest.Perakakis, Nikolaos ............................... Disclosed no conflict of interest.Pereira, Diana ....................................... Disclosed no conflict of interest.Pereira, Maria J. .................................. Disclosed no conflict of interest.Pereira, Renata O. ................................ Disclosed no conflict of interest.Perelman, Dalia ..................................... Disclosed no conflict of interest.Perera, Nayomi ..................................... Disclosed no conflict of interest.Perera, Ranjan J. .................................. Disclosed no conflict of interest.Perez, Cynthia M. ................................. Disclosed no conflict of interest.Perez, Everlyn ........................................ Disclosed no conflict of interest.Perez-Cadena, Zandra ........................... Disclosed no conflict of interest.Perez-Ferre, Natalia .............................. Disclosed no conflict of interest.Perez-Nieves, Magaly ........................... Employee: Eli Lilly and Company.Perez-Tilve, Diego ................................. Research Support: Roche Pharmaceuticals.Perfilyev, Alexander .............................. Disclosed no conflict of interest.Perichon, Regis ..................................... Employee: Metabolon, Inc.; Stock/Shareholder: Metabolon,
Inc.Perin, Juan C. ....................................... Disclosed no conflict of interest.Periwal, Vipul ........................................ Disclosed no conflict of interest.Perkins, Bruce A. .................................. Consultant: NeuroMetrix; Research Support: Boehringer
Ingelheim Pharmaceuticals, Inc., Medtronic; Speaker’s Bureau: Eli Lilly and Company, GSK, Johnson & Johnson, Medtronic, Novo Nordisk, Inc., Roche Pharmaceuticals, Sanofi.
Perkins, Christopher .............................. Employee: PPD Development, LP.Perkovic, Vlado ...................................... Disclosed no conflict of interest.Perls, Thomas T. ................................... Disclosed no conflict of interest.Pernet, Andrew ..................................... Disclosed no conflict of interest.Peroni, Odile D. .................................... Disclosed no conflict of interest.Perrea, Despoina ................................... Disclosed no conflict of interest.Perreault, Leigh ..................................... Advisory Panel: Merck; Speaker’s Bureau: Merck, Merck
(Spouse/Partner).Perrin, Paul ............................................ Disclosed no conflict of interest.Perrini, Sebastio .................................... Disclosed no conflict of interest.Perron, Patrice ....................................... Disclosed no conflict of interest.Perry, Brandon A. ................................. Disclosed no conflict of interest.Perry, Caroline ....................................... Employee: GlaxoSmithKline; Stock/Shareholder:
GlaxoSmithKline.Perry, Christina G. ................................ Disclosed no conflict of interest.Perry, Daniel J. ..................................... Disclosed no conflict of interest.Perry, Rachel J. .................................... Disclosed no conflict of interest.Persaud, Shanta J. ............................... Disclosed no conflict of interest.Perseghin, Gianluca .............................. Disclosed no conflict of interest.Persson, Erik .......................................... Disclosed no conflict of interest.
Pessin, Jeffrey E. ................................. Disclosed no conflict of interest.Pesta, Dominik ...................................... Disclosed no conflict of interest.Peter, Andreas ....................................... Disclosed no conflict of interest.Peter, Igna ............................................. Disclosed no conflict of interest.Peters, Anne L. ..................................... Disclosed no conflict of interest.Peters, Annette ..................................... Disclosed no conflict of interest.Petersen, Eva R. ................................... Disclosed no conflict of interest.Petersen, Kitt F. .................................... Disclosed no conflict of interest.Petersen, Max C. .................................. Disclosed no conflict of interest.Peterson, Charlotte A. ......................... Disclosed no conflict of interest.Peterson, Courtney M. ......................... Consultant: McKinsey & Company (Spouse/Partner).Peterson, Eric D. ................................... Disclosed no conflict of interest.Peterson, Leif ........................................ Disclosed no conflict of interest.Petidis, Konstantinos ............................ Disclosed no conflict of interest.Petit, Catherine ..................................... Disclosed no conflict of interest.Petit, Marie-Hélène .............................. Disclosed no conflict of interest.Petocz, Peter ......................................... Disclosed no conflict of interest.Petpiboonthai, Hattaya ......................... Disclosed no conflict of interest.Petrella, Robert ..................................... Speaker’s Bureau: Abbott Laboratories, Inc., Sanofi.Petrie, Dennis J. ................................... Disclosed no conflict of interest.Petrie, Keith J. ..................................... Disclosed no conflict of interest.Petropoulos, Ioannis N. ........................ Disclosed no conflict of interest.Petrovski, Goran .................................... Disclosed no conflict of interest.Petry, Nancy M. ................................... Disclosed no conflict of interest.Pettis, Ronald J. ................................... Stock/Shareholder: Becton, Dickinson and Company.Pettitt, David J. .................................... Disclosed no conflict of interest.Pettus, Jeremy ...................................... Consultant: Dexcom, Inc.Peyot, Marie-Line .................................. Disclosed no conflict of interest.Peyrot, Mark .......................................... Advisory Panel: Novo Nordisk A/S; Consultant: Eli Lilly and
Company, Novo Nordisk A/S, Tethys; Research Support: Bristol-Myers Squibb Company, Genentech, Novo Nordisk A/S; Speaker’s Bureau: Novo Nordisk A/S.
Peyser, Thomas ..................................... Disclosed no conflict of interest.Pezzolesi, Marcus G. ............................ Disclosed no conflict of interest.Pfeffer, Marc A. .................................... Consultant: Aastrom, Abbott Vascular, Amgen, Inc., Cerenis,
Concert, Fibrogen, GlaxoSmithKline, Hamilton Health Sciences, Medtronic, Merck, Roche Pharmaceuticals, Servier, Teva Pharmaceuticals, University of Oxford; Other Relationship: The BWH has patents for the use of inhibi-tors of the renin-angiotensin system in survivors of MI with Novartis, Dr Pfeffer is a co-inventor. His share is irrevocably transferred to charity; Research Support: Amgen, Inc., Celladon, Novartis Pharma AG, Sanofi.
Pfefferkorn, Jeffrey A. ......................... Employee: Pfizer, Inc.Pfeiffer, Andreas F. ............................... Disclosed no conflict of interest.Pfieffer, Kate ......................................... Consultant: Novo Nordisk A/S.Pfohl, Martin ......................................... Advisory Panel: Boehringer Ingelheim Pharmaceuticals, Inc.,
Eli Lilly and Company, Novo Nordisk A/S, Sanofi; Research Support: Eli Lilly and Company, Medtronic, Novo Nordisk A/S, Pfizer, Inc., Sanofi; Speaker’s Bureau: Novo Nordisk A/S, Sanofi.
Pfrunder, Louise..................................... Disclosed no conflict of interest.Pfuetzner, Andreas ................................ Consultant: Midatech Ltd; Stock/Shareholder: Midatech Ltd.Pfützner, Andreas .................................. Advisory Panel: Novo Nordisk A/S, Sanofi; Consultant:
Insuline Medical, Johnson & Johnson, Sanofi; Research Support: Eli Lilly and Company, Insuline Medical, Sanofi; Speaker’s Bureau: AstraZeneca/Bristol-Meyers Squibb, Insuline Medical, Novo Nordisk A/S, Sanofi.
Pfützner, Anke H. .................................. Disclosed no conflict of interest.Pham, Isabelle ....................................... Disclosed no conflict of interest.Pham, Vinh T. ....................................... Disclosed no conflict of interest.Pham-Short, Anna ................................. Disclosed no conflict of interest.Philips, Charlotte R. ............................. Disclosed no conflict of interest.Philipson, Louis H. ................................ Research Support: Novo Nordisk, Inc.; Speaker’s Bureau:
Merck.Philis-Tsimikas, Athena ......................... Advisory Panel: Novo Nordisk, Inc., Sanofi; Consultant:
Eli Lilly and Company, Medtronic, Sanofi (TEENS study steering committee); Board Member: CGM3 Ltd; Consultant: Andromeda, AstraZeneca, Bristol-Myers Squibb Company, D-Medical, Sanofi;Research Support: Andromeda, Eli Lilly and Company, Medtronic, Merck, Novo Nordisk A/S, Roche, Sanofi; Speaker’s Bureau: J&J Animas, Medtronic, Roche, Sanofi; Stock/Shareholder: CGM3 Ltd.
Phillips, James N. ................................ Board Member: MidaSol LLC, Midatech Ltd; Employee: Midatech Ltd; Stock/Shareholder: Midatech Ltd.
Phillips, Lawrence S. ............................ Advisory Panel: Janssen Pharmaceuticals; Research Support: Amylin Pharmaceuticals, Inc., Eli Lilly and Company, Novo Nordisk, Inc.
Phillips, Roxanne ................................... Disclosed no conflict of interest.
Phillips, Shane A. ................................. Disclosed no conflict of interest.Phillips, Susan A. ................................. Disclosed no conflict of interest.Phippard, Deborah ................................ Disclosed no conflict of interest.Phoenix, Serge ...................................... Disclosed no conflict of interest.Phung, Olivia J. .................................... Research Support: Merck.Phuong, Ho D. ...................................... Disclosed no conflict of interest.Piaggesi, Alberto ................................... Advisory Panel: Olympus Biotech, Urgo Laboratoires;
Research Support: Alfa Wassermann, KCI, Molliter.Piaggi, Paolo ......................................... Disclosed no conflict of interest.Pianesi, Mario ....................................... Disclosed no conflict of interest.Piatt, Gretchen ...................................... Disclosed no conflict of interest.Picard, Sylvie ......................................... Research Support: Sanofi.Piccinin, Meghan A. ............................. Disclosed no conflict of interest.Piccinini, Francesca ............................... Disclosed no conflict of interest.Piccirilli, Sara ........................................ Disclosed no conflict of interest.Piccoli, Vanessa .................................... Disclosed no conflict of interest.Picconi, Fabiana .................................... Disclosed no conflict of interest.Pichaipillai, Lakashminarayanan .......... Disclosed no conflict of interest.Pichotta, Philip ...................................... Employee: Biodel, Inc.; Stock/Shareholder: Biodel, Inc.Pieber, Thomas R. ................................ Advisory Panel: AstraZeneca/Bristol-Meyers Squibb, CeQur,
Ltd., Novo Nordisk, Inc., Roche Pharmaceuticals; Board Member: Novo Nordisk A/S (Spouse/Partner); Speaker’s Bureau: Novo Nordisk, Inc. (Spouse/Partner).
Piekarski, Robert ................................... Disclosed no conflict of interest.Pierpont, Bridget ................................... Disclosed no conflict of interest.Pierre, Clément ..................................... Disclosed no conflict of interest.Pierzynski, Piotr ..................................... Disclosed no conflict of interest.Pieske, Burkert ...................................... Disclosed no conflict of interest.Pietiläinen, Kirsi .................................... Disclosed no conflict of interest.Pietropaolo, Massimo ........................... Disclosed no conflict of interest.Piganelli, Jon D. ................................... Consultant: Biomimetix.Pihoker, Catherine ................................. Disclosed no conflict of interest.Pilegaard, Henriette .............................. Disclosed no conflict of interest.Piljac, Ante ............................................ Disclosed no conflict of interest.Pilorget, Valérie ..................................... Employee: Sanofi.Pilz, Stefan ............................................ Disclosed no conflict of interest.Pimazoni-Netto, Augusto ...................... Consultant: Becton Dickinson - Brazil.Pimentel, F. ........................................... Disclosed no conflict of interest.Pinaroc, Cherylene ................................ Disclosed no conflict of interest.Pineau, Mitchel ..................................... Employee: Facet Technologies, LLC.Pineda, Marco ....................................... Disclosed no conflict of interest.Pinnelli, Sabina ..................................... Disclosed no conflict of interest.Pinnetti, Sabine ..................................... Employee: Boehringer Ingelheim GmbH & Co. KG.Pintaudi, Basilio .................................... Disclosed no conflict of interest.Pipkin, J.D. ........................................... Employee: Ligand Pharmaceuticals; Stock/Shareholder:
Ligand Pharmaceuticals.Pipkin, Joseph A. ................................. Disclosed no conflict of interest.Pippa, Anna ........................................... Disclosed no conflict of interest.Pires, Karla M. ..................................... Disclosed no conflict of interest.Pirouzi Fard, Mir Nabi ........................... Disclosed no conflict of interest.Pirovano, Anna ...................................... Disclosed no conflict of interest.Piston, David W. ................................... Disclosed no conflict of interest.Pi-Sunyer, Xavier ................................... Disclosed no conflict of interest.Pitsiladis, Yannis ................................... Disclosed no conflict of interest.Pitta, Ivan .............................................. Disclosed no conflict of interest.Pittas, Anastassios G. .......................... Disclosed no conflict of interest.Pitukcheewanont, Pisit ......................... Disclosed no conflict of interest.Piveta, Valdecira M. ............................. Disclosed no conflict of interest.Pivovarova, Olga ................................... Disclosed no conflict of interest.Piya, Milan K. ....................................... Disclosed no conflict of interest.Pizarro, P. .............................................. Disclosed no conflict of interest.Pizot, Cecile ........................................... Disclosed no conflict of interest.Place, Jerome ....................................... Disclosed no conflict of interest.Plamboeck, Astrid ................................. Disclosed no conflict of interest.Plank, Johannes .................................... Speaker’s Bureau: Novo Nordisk A/S (Spouse/Partner).Plante, Celine ........................................ Disclosed no conflict of interest.Plante, Eric ............................................ Disclosed no conflict of interest.Player, Mark .......................................... Employee: Janssen Research & Development.Plengvidhya, Nattachet ......................... Disclosed no conflict of interest.Pleus, Stefan ......................................... Disclosed no conflict of interest.Plotkin, Diane J. ................................... Consultant: Ligand Pharmaceuticals.Plotnikoff, Ronald .................................. Disclosed no conflict of interest.Plum-Mörschel, Leona .......................... Disclosed no conflict of interest.Plutzky, Jorge ........................................ Disclosed no conflict of interest.Pocai, Alessandro ................................. Employee: Merck.Pochat, Armelle ..................................... Disclosed no conflict of interest.Pogach, Leonard .................................... Disclosed no conflict of interest.Pohl, Roderike ....................................... Employee: Biodel, Inc.; Stock/Shareholder: Biodel, Inc.Poitout, Vincent ..................................... Advisory Panel: Takeda Global Research & Development
Center, Inc.; Consultant: Novartis Pharmaceuticals Corporation.
Policola, Caterina .................................. Disclosed no conflict of interest.
Polidori, David ....................................... Employee: Janssen Research & Development, LLC.Polinski, Jennifer M. ............................ Research Support: Eli Lilly and Company.Pollett, Jonathan B. ............................. Disclosed no conflict of interest.Pollin, Toni ............................................. Disclosed no conflict of interest.Pollom, Robyn K. .................................. Advisory Panel: Eli Lilly and Company (Spouse/Partner);
Consultant: Eli Lilly and Company (Spouse/Partner); Employee: Eli Lilly and Company, Eli Lilly and Company (Spouse/Partner); Speaker’s Bureau: Eli Lilly and Company (Spouse/Partner); Stock/Shareholder: Eli Lilly and Company.
Polonsky, Kenneth S. ........................... Disclosed no conflict of interest.Polonsky, William .................................. Advisory Panel: Eli Lilly and Company, Novo Nordisk, Inc.,
Sanofi; Consultant: Novo Nordisk, Inc., Sanofi.Polyzou, Electra ..................................... Disclosed no conflict of interest.Pomeroy, Jeremy ................................... Employee: VA Medical Center (Spouse/Partner); Research
Support: NIDDK.Pongrac, Drazenka B. ........................... Disclosed no conflict of interest.Pongratz, Rebecca L. ............................ Disclosed no conflict of interest.Ponikowski, Piotr ................................... Consultant: Novartis Pharma AG; Speaker’s Bureau: Novartis
Pharma AG.Ponirakis, Georgios ............................... Disclosed no conflict of interest.Ponnusamy, Saravanan ......................... Disclosed no conflict of interest.Ponsonby, Anne-Louise ......................... Disclosed no conflict of interest.Pontiroli, Antonio E. ............................. Disclosed no conflict of interest.Ponzani, Paola ....................................... Advisory Panel: Novo Nordisk, Inc.; Speaker’s Bureau:
Medtronic.Pooja, T.L. ............................................. Disclosed no conflict of interest.Poon, Aurora ......................................... Disclosed no conflict of interest.Popa, Simona Georgiana G. ................. Disclosed no conflict of interest.Pop-Busui, Rodica ................................. Consultant: Acorda Therapeutics, AstraZeneca
Pharmaceuticals LP, Janssen Pharmaceuticals; Research Support: Bristol-Myers Squibb Company.
Popescu, Iuliana .................................... Disclosed no conflict of interest.Popish, Amanda .................................... Disclosed no conflict of interest.Poplawska-Kita, Anna ........................... Disclosed no conflict of interest.Popov, Violeta B. .................................. Disclosed no conflict of interest.Popova, Polina V. .................................. Disclosed no conflict of interest.Porcellati, Francesca ............................. Other Relationship: Eli Lilly and Company, Sanofi.Pories, Walter J. .................................. Disclosed no conflict of interest.Porksen, Niels ....................................... Employee: Eli Lilly and Company.Porneala, Bianca C. .............................. Disclosed no conflict of interest.Port, John .............................................. Disclosed no conflict of interest.Porter, Craig........................................... Disclosed no conflict of interest.Porter, Karen.......................................... Disclosed no conflict of interest.Porter, Kristin......................................... Disclosed no conflict of interest.Portillo Sanchez, Paola ......................... Disclosed no conflict of interest.Poscia, Andrea ...................................... Disclosed no conflict of interest.Poston, Lucilla ....................................... Disclosed no conflict of interest.Potasso, Laura ....................................... Disclosed no conflict of interest.Pothier, Claire E. ................................... Disclosed no conflict of interest.Potier, Louis ........................................... Disclosed no conflict of interest.Potts, Oretha ......................................... Disclosed no conflict of interest.Poucheret, Patrick ................................. Disclosed no conflict of interest.Poudel, Ananta ...................................... Disclosed no conflict of interest.Poulsen, Kjeld ....................................... Other Relationship: Novo Nordisk A/S.Poulsen, Marianne K. ........................... Disclosed no conflict of interest.Poulsen, Pernille ................................... Employee: Novo Nordisk A/S; Stock/Shareholder: Novo
Nordisk A/S.Poulsen, Steen S. ................................. Disclosed no conflict of interest.Pouwer, Frans ........................................ Advisory Panel: Novo Nordisk A/S; Consultant: Novo Nordisk
A/S.Powell, A. Blair ..................................... Disclosed no conflict of interest.Powell, David R. ................................... Employee: Lexicon Pharmaceuticals, Inc.; Stock/Shareholder:
Lexicon Pharmaceuticals, Inc.Powell, Priscilla W. .............................. Disclosed no conflict of interest.Powell, Winter ...................................... Disclosed no conflict of interest.Powers, Alvin C. ................................... Advisory Panel: Boehringer Ingelheim GmbH & Co. KG, GNF
Novarits, JDRF, NIDDK, The Endocrine Society; Board Member: American Diabetes Association; Research Support: JDRF, NIDDK, VA Medical Center.
Poynter, Matthew E. ............................ Disclosed no conflict of interest.Pozzi, Ambra .......................................... Disclosed no conflict of interest.Pozzi, José Maria .................................. Disclosed no conflict of interest.Pozzilli, Paolo ........................................ Disclosed no conflict of interest.Prabhakar, Bellur ................................... Disclosed no conflict of interest.Prabhakaran, Dorairaj ........................... Disclosed no conflict of interest.Prada, Patricia O. ................................. Disclosed no conflict of interest.Pradeepa, Rajendra ............................... Disclosed no conflict of interest.Pradhan Shrestha, Deepika .................. Disclosed no conflict of interest.Pradignac, Alain .................................... Disclosed no conflict of interest.Prado, Camille R. .................................. Disclosed no conflict of interest.Prasad, Tanushree ................................. Disclosed no conflict of interest.
Prasadan, Krishna ................................. Disclosed no conflict of interest.Prashant, D. .......................................... Disclosed no conflict of interest.Pratt, Elizabeth ...................................... Disclosed no conflict of interest.Prazny, Martin ....................................... Advisory Panel: Eli Lilly and Company, Medtronic; Consultant:
Dexcom, Inc., Eli Lilly and Company, Medtronic, Novo Nordisk, Inc.; Speaker’s Bureau: Abbott Diabetes Care, Dexcom, Inc., Medtronic, Novo Nordisk, Inc., Roche Pharmaceuticals.
Preissl, Hubert ....................................... Disclosed no conflict of interest.Premilovac, Dino ................................... Disclosed no conflict of interest.Prentki, Marc ......................................... Disclosed no conflict of interest.Preske, Jeff ........................................... Disclosed no conflict of interest.Press, Eric .............................................. Disclosed no conflict of interest.Prevenzano, Immacolata ....................... Disclosed no conflict of interest.Price, Connie ......................................... Disclosed no conflict of interest.Price, David A. ...................................... Employee: Dexcom, Inc.; Stock/Shareholder: Dexcom, Inc.Prieto, Martín ........................................ Disclosed no conflict of interest.Prigeon, Ronald L. ................................ Disclosed no conflict of interest.Prince, John .......................................... Disclosed no conflict of interest.Prince, Melvin J. .................................. Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly
and Company.Princic, Nicole ....................................... Employee: Truven Health Analytics.Prior, Sarah ............................................ Disclosed no conflict of interest.Prior, Steven J. ..................................... Disclosed no conflict of interest.Pritchard, Eleanor .................................. Disclosed no conflict of interest.Prokopenko, Inga ................................... Disclosed no conflict of interest.Provenzano, Vincenzo............................ Disclosed no conflict of interest.Province, Michael A. ............................ Disclosed no conflict of interest.Prudente, Sabrina ................................. Disclosed no conflict of interest.Pruett, Timothy L. ................................. Disclosed no conflict of interest.Prusty, Vinay .......................................... Employee: Novo Nordisk A/S.Pruszynska-Oszmalek, Ewa ................... Research Support: Noxxon.Prutzman, Kelley ................................... Disclosed no conflict of interest.Psaros, Christina ................................... Disclosed no conflict of interest.Psihogios, Alexandra ............................ Disclosed no conflict of interest.Ptacek, Peggy ........................................ Disclosed no conflict of interest.Ptaszynska, Agata ................................. Employee: Bristol-Myers Squibb Company; Stock/Shareholder:
Bristol-Myers Squibb Company.Pu, Jia ................................................... Disclosed no conflict of interest.Pucci, Andrea ........................................ Disclosed no conflict of interest.Pucci, Laura ........................................... Disclosed no conflict of interest.Puccio, Luigi .......................................... Disclosed no conflict of interest.Pugliese, Alberto ................................... Disclosed no conflict of interest.Puhi, Desiree ......................................... Disclosed no conflict of interest.Puig Domingo, Manuel ......................... Advisory Panel: Eli Lilly and Company, Janssen
Pharmaceuticals, Novo Nordisk, Inc., Sanofi; Board Member: Eli Lilly and Company, Janssen Pharmaceuticals, Novo Nordisk, Inc., Sanofi; Research Support: Novo Nordisk, Inc., Sanofi; Speaker’s Bureau: Eli Lilly and Company, Janssen Biotech, Inc., Novo Nordisk, Inc., Sanofi.
Puig, Josep ............................................ Disclosed no conflict of interest.Puigdevall, Victor .................................. Disclosed no conflict of interest.Pujol, Anna ............................................ Disclosed no conflict of interest.Pullano, Vittorio..................................... Disclosed no conflict of interest.Pullen, Timothy J. ................................ Disclosed no conflict of interest.Pulliam, Lindsay .................................... Disclosed no conflict of interest.Puppala, Sobha ..................................... Disclosed no conflict of interest.Purnell, Jonathan Q. ............................ Disclosed no conflict of interest.Purschke, Werner G. ............................ Employee: Noxxon.Puskas, John D. .................................... Disclosed no conflict of interest.Putanko, Marina .................................... Disclosed no conflict of interest.Putarek, Natasa .................................... Disclosed no conflict of interest.Putnam, Amy L. .................................... Disclosed no conflict of interest.Pyatak, Elizabeth A. ............................. Disclosed no conflict of interest.Pyle, Laura ............................................. Disclosed no conflict of interest.Pynes, Mary Kate .................................. Employee: Facet Technologies, LLC.Pyun, Bo-Jeong ..................................... Disclosed no conflict of interest.Qi, Jenson ............................................. Employee: Janssen Research & Development.Qi, Lu ..................................................... Disclosed no conflict of interest.Qi, Meirigeng ........................................ Disclosed no conflict of interest.Qi, Qibin ................................................ Disclosed no conflict of interest.Qi, Tong ................................................. Disclosed no conflict of interest.Qi, Weier ............................................... Disclosed no conflict of interest.Qi, Yiqing ............................................... Disclosed no conflict of interest.Qi, Yong ................................................. Disclosed no conflict of interest.Qi, Yue ................................................... Disclosed no conflict of interest.Qian, Chunlin ......................................... Employee: Diaichi Sankyo.Qiang, Guifen ........................................ Disclosed no conflict of interest.Qiang, Li ................................................ Disclosed no conflict of interest.Qiao, Liping ........................................... Disclosed no conflict of interest.Qin, Bolin ............................................... Employee: IN Ingredients Inc.
Qin, Lang ............................................... Disclosed no conflict of interest.Qin, Qin-Feng ........................................ Disclosed no conflict of interest.Qin, Tairan ............................................. Disclosed no conflict of interest.Qin, Youw .............................................. Disclosed no conflict of interest.Qinghai, Zhang ...................................... Disclosed no conflict of interest.Qingrun, Li ............................................. Disclosed no conflict of interest.Qiu, Anqi ............................................... Disclosed no conflict of interest.Qiu, Ji .................................................... Disclosed no conflict of interest.Qiu, Liling .............................................. Disclosed no conflict of interest.Qiu, Lin .................................................. Disclosed no conflict of interest.Qiu, Ni ................................................... Disclosed no conflict of interest.Qiu, Weiyu............................................. Disclosed no conflict of interest.Qiu, Ying ................................................ Employee: Merck; Stock/Shareholder: Merck.Qu, Shen ................................................ Disclosed no conflict of interest.Qualls, Laura ......................................... Disclosed no conflict of interest.Quan, Joanne ........................................ Employee: Arena Pharmaceuticals, Inc.Quan, Judy ............................................ Disclosed no conflict of interest.Quaranta, Vitaliano ............................... Disclosed no conflict of interest.Quaresma, Paula Gabriele Fernandes .. Disclosed no conflict of interest.Queiroz, Márcia S. ............................... Disclosed no conflict of interest.Queniat, Gurvan .................................... Disclosed no conflict of interest.Quesenberry, Charles P. ....................... Research Support: Takeda Pharmaceuticals U.S.A., Inc.Quick, William W. ................................ Disclosed no conflict of interest.Quilici, Maria T. .................................... Disclosed no conflict of interest.Quilliam, Brian J. ................................. Disclosed no conflict of interest.Quinn III, William J. ............................. Disclosed no conflict of interest.Quinn, Clare .......................................... Disclosed no conflict of interest.Quinn, Lauretta T. ................................. Disclosed no conflict of interest.Quinn, Laurie ......................................... Disclosed no conflict of interest.Quinn, Michael T. ................................. Research Support: NIH.Quinones, Manuel J. ............................ Advisory Panel: Janssen Pharmaceuticals, Sanofi; Speaker’s
Bureau: AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Janssen Pharmaceuticals, Novo Nordisk, Inc.
Quiroga, Teresa ..................................... Disclosed no conflict of interest.Quotb, Adam ......................................... Disclosed no conflict of interest.Raal, Frederick J. ................................. Consultant: AstraZeneca Pharmaceuticals LP, Merck, Pfizer,
Inc.; Other Relationship: Amgen, Inc., AstraZeneca Pharmaceuticals LP, Merck, Pfizer, Inc., Sanofi; Research Support: Amgen, Inc., Sanofi; Speaker’s Bureau: Amgen, Inc., AstraZeneca Pharmaceuticals LP, Merck, Pfizer, Inc.
Rabasa-Lhoret, Remi ............................. Advisory Panel: AstraZeneca/Bristol-Meyers Squibb, BD Medical Diabetes Care, Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Janssen Pharmaceuticals, Merck, Neomed, Novartis Pharmaceuticals Corporation, Novo Nordisk, Inc., Roche Pharmaceuticals, Sanofi, Takeda Pharmaceutical Company, Ltd., Valeant; Other Relationship: Medtronic.
Rabbani, Naila ...................................... Disclosed no conflict of interest.Rabelink, Ton J. .................................... Disclosed no conflict of interest.Rabena, Melvin D. ............................... Disclosed no conflict of interest.Rabhi, Nabil .......................................... Disclosed no conflict of interest.Rabinovitz, Hadas ................................. Disclosed no conflict of interest.Racette, Susan ...................................... Disclosed no conflict of interest.Rachek, Lyudmila .................................. Disclosed no conflict of interest.Racine, Ariane ....................................... Disclosed no conflict of interest.Raciti, Gregory A. ................................. Disclosed no conflict of interest.Raddatz, Katy ........................................ Disclosed no conflict of interest.Rademacher, Emily ................................ Disclosed no conflict of interest.Rademacher, Thomas ............................ Board Member: Midatech Ltd; Employee: Midatech Ltd;
Stock/Shareholder: Midatech Ltd.Radian, Serban ...................................... Disclosed no conflict of interest.Radican, Larry ....................................... Employee: Merck; Stock/Shareholder: Merck.Radin, Michael S. ................................. Disclosed no conflict of interest.Radom-Aizik, Shlomit ............................ Disclosed no conflict of interest.Radulian, Gabriela ................................ Disclosed no conflict of interest.Raebel, Marsha A. ............................... Disclosed no conflict of interest.Raffa, Vittoria ........................................ Disclosed no conflict of interest.Raffeeq, Parakkal .................................. Disclosed no conflict of interest.Raffel, Leslie J. .................................... Disclosed no conflict of interest.Rafkin, Lisa ............................................ Disclosed no conflict of interest.Raghavan, Sridharan ............................. Disclosed no conflict of interest.Ragolia, Louis ........................................ Disclosed no conflict of interest.Ragot, Stéphanie .................................. Disclosed no conflict of interest.Rahbek, Iben ......................................... Disclosed no conflict of interest.Rahi, Berna ............................................ Disclosed no conflict of interest.Rahimi, Yasmeen .................................. Disclosed no conflict of interest.Rahmouni, Kamal .................................. Disclosed no conflict of interest.Räihä, Anne-Marie ................................ Disclosed no conflict of interest.Raitakari, Olli ........................................ Disclosed no conflict of interest.Rajadurai, Victor.................................... Disclosed no conflict of interest.
Rajan, Mangala ..................................... Disclosed no conflict of interest.Rajan, Rajeswari ................................... Disclosed no conflict of interest.Rajander, Johan .................................... Disclosed no conflict of interest.Rajaram, Rama ...................................... Disclosed no conflict of interest.Rajaratnam, Richard G. ........................ Disclosed no conflict of interest.Rajpal, Deepak ...................................... Employee: GlaxoSmithKline.Rajpal, Neetu ........................................ Employee: GlaxoSmithKline.Rajpathak, Swapnil ............................... Employee: Merck; Stock/Shareholder: Merck.Rakobowchuck, Mark ............................ Disclosed no conflict of interest.Rakyan, Vardhman ................................ Disclosed no conflict of interest.Ram, Nalini ........................................... Disclosed no conflict of interest.Ramados, Preeti .................................... Disclosed no conflict of interest.Ramakrishnan, Usha ............................. Disclosed no conflict of interest.Ramanadham, Sasanka ........................ Disclosed no conflict of interest.Ramaraj, Thiruvarangan ........................ Disclosed no conflict of interest.Ramasamy, Ravichandran ..................... Disclosed no conflict of interest.Ramchand, Sabashini K. ...................... Disclosed no conflict of interest.Ramchandani, Neesha .......................... Advisory Panel: Halozyme Therapeutics, Unomedical.Ramirez de Arellano, Antonio ............... Employee: Novo Nordisk A/S.Ramirez-Estrada, Daisy ......................... Disclosed no conflict of interest.Ramirez-Sanchez, Israel ........................ Disclosed no conflict of interest.Ramljak, Sanja ...................................... Disclosed no conflict of interest.Rämö, Joel ............................................ Disclosed no conflict of interest.Ramona, Dragut .................................... Disclosed no conflict of interest.Ramos-Prol, Agustín ............................. Disclosed no conflict of interest.Rampersaud, Evadnie ........................... Disclosed no conflict of interest.Ramsey, Bonnie W. .............................. Disclosed no conflict of interest.Ramsey, Michael W. ............................ Disclosed no conflict of interest.Rancière, Fanny ..................................... Disclosed no conflict of interest.Rangarajan, Janani ............................... Disclosed no conflict of interest.Rangel-Nieto, Ileana G. ....................... Disclosed no conflict of interest.Rao, Ganesh .......................................... Disclosed no conflict of interest.Rao, Rajesh R. ...................................... Disclosed no conflict of interest.Rao, Shengxiang ................................... Disclosed no conflict of interest.Raoux, Matthieu ................................... Disclosed no conflict of interest.Rapaport, Robert ................................... Disclosed no conflict of interest.Raposo, Joao-Felipe ............................. Disclosed no conflict of interest.Raquib, Aaishah .................................... Disclosed no conflict of interest.Rasa, Ingvars ......................................... Disclosed no conflict of interest.Rasbach, Lisa E. ................................... Disclosed no conflict of interest.Rasenack, Regina .................................. Disclosed no conflict of interest.Rask-Madsen, Christian ........................ Disclosed no conflict of interest.Rasmussen, Brittany A. ....................... Disclosed no conflict of interest.Rasmussen, Charlotte ........................... Disclosed no conflict of interest.Rasmussen, Henrik S. .......................... Employee: ZS Pharma, Inc.Rasmussen, Lars M. ............................ Disclosed no conflict of interest.Rasmussen, Søren ................................ Employee: Novo Nordisk A/S; Stock/Shareholder: Novo
Nordisk A/S.Rasmussen-Torvik, Laura J. ................. Disclosed no conflict of interest.Rasouli, Neda ........................................ Disclosed no conflict of interest.Rastogi, Ravi ......................................... Employee: Senseoics Incorporated.Ratcliffe, Sarah ..................................... Disclosed no conflict of interest.Rathmann, Wolfgang ............................ Disclosed no conflict of interest.Ratib, Osman ......................................... Disclosed no conflict of interest.Ratner, Robert E. .................................. Disclosed no conflict of interest.Rattigan, Stephen ................................. Disclosed no conflict of interest.Rauh, Simone P. ................................... Research Support: Novo Nordisk A/S.Rausaria, Smita ..................................... Disclosed no conflict of interest.Rausell-Palamos, Francisco .................. Disclosed no conflict of interest.Ravaine, Valérie .................................... Disclosed no conflict of interest.Raver, Christine ..................................... Disclosed no conflict of interest.Ravussin, Eric ........................................ Advisory Panel: Amylin Pharmaceuticals, Inc., Eli Lilly and
Rawlinson, William D. ......................... Disclosed no conflict of interest.Rawshani, Araz ..................................... Disclosed no conflict of interest.Rawson, Jeffery .................................... Disclosed no conflict of interest.Rayman, Gerry ....................................... Disclosed no conflict of interest.Raymond, Jennifer K. ........................... Disclosed no conflict of interest.Raymond, Stephen A. .......................... Employee: PHT Corporation.Rayner, Christopher K. ......................... Research Support: Eli Lilly and Company, Merck, Novartis
Pharmaceuticals Corporation.Rayner, Nigel W. .................................. Disclosed no conflict of interest.Rayner, William ..................................... Disclosed no conflict of interest.Raz, Itamar ............................................ Advisory Panel: AstraZeneca/Bristol-Meyers Squibb, Eli Lilly
and Company, Medscape, LLC, Merck Sharp & Dohme Limited, Novo Nordisk, Inc., Sanofi; Consultant: Andromeda Biotech, Ltd., AstraZeneca/Bristol-Meyers Squibb, Insuline Medical; Speaker’s Bureau: AstraZeneca/Bristol-Meyers Squibb, Eli Lilly and Company, Johnson & Johnson, Merck Sharp & Dohme
Razolli, Daniela S. ................................ Disclosed no conflict of interest.Re, Danila .............................................. Disclosed no conflict of interest.Reach, Gérard ....................................... Consultant: NovoNordisk.Ready, Elizabeth .................................... Disclosed no conflict of interest.Reaney, Matthew D. ............................ Employee: Eli Lilly and Company.Reaven, Gerald M. ............................... Disclosed no conflict of interest.Reaven, Peter D. .................................. Disclosed no conflict of interest.Rebrin, Kerstin ...................................... Stock/Shareholder: Becton, Dickinson and Company.Rector, R. Scott ..................................... Disclosed no conflict of interest.Reddy, K. Srinath ................................... Disclosed no conflict of interest.Reddy, Marpadga A. ............................ Disclosed no conflict of interest.Reddy, Narendra L. .............................. Disclosed no conflict of interest.Reddy, Pragati ....................................... Employee: Biodel, Inc.; Stock/Shareholder: Biodel, Inc.Redline, Susan ...................................... Disclosed no conflict of interest.Redondo, Maria J. ............................... Disclosed no conflict of interest.Reed, John C. ....................................... Disclosed no conflict of interest.Reed, Laurence J. ................................ Disclosed no conflict of interest.Reed, Melissa A. .................................. Disclosed no conflict of interest.Reed, Shelby D. .................................... Consultant: Genentech, Merck; Research Support: Amylin/Eli
Reencober, Nayara ................................ Disclosed no conflict of interest.Rees, Sandra ......................................... Disclosed no conflict of interest.Reeser, H.M. ........................................ Disclosed no conflict of interest.Reeves, Rebecca S. .............................. Disclosed no conflict of interest.Regan, Elizabeth ................................... Disclosed no conflict of interest.Regazzi, Romano ................................... Disclosed no conflict of interest.Rege, Saumitra V. ................................ Disclosed no conflict of interest.Rege, Shraddha D. ............................... Disclosed no conflict of interest.Regelmann, Molly ................................. Disclosed no conflict of interest.Rehfeld, Jens F. .................................... Disclosed no conflict of interest.Rehmer, Nathan .................................... Disclosed no conflict of interest.Reiber, Gayle E. .................................... Disclosed no conflict of interest.Reich, John ........................................... Research Support: Echo Therapeutics, Inc.Reichetzeder, Christoph ........................ Disclosed no conflict of interest.Reid, Timothy ........................................ Advisory Panel: Boehringer Ingelheim/Eli Lilly, Bristol-Myers
Squibb/AstraZeneca, Eli Lilly and Company, Janssen Pharmaceuticals, Novo Nordisk, Inc., Sanofi; Consultant: Boehringer Ingelheim/Eli Lilly, Bristol-Myers Squibb/AstraZeneca, Eli Lilly and Company, Janssen Pharmaceuticals, Novo Nordisk, Inc., Sanofi; Speaker’s Bureau: Boehringer Ingelheim/Eli Lilly, Bristol-Myers Squibb/AstraZeneca, Eli Lilly and Company, Janssen Pharmaceuticals, Novo Nordisk, Inc., Sanofi.
Reilly, Brian ........................................... Disclosed no conflict of interest.Reimann, Frank ..................................... Disclosed no conflict of interest.Reimer, André........................................ Disclosed no conflict of interest.Rein, Dietrich ........................................ Employee: Metanomics Health GmbH.Rein, Philipp .......................................... Disclosed no conflict of interest.Reinhardt, Rickey R. ............................. Employee: GlaxoSmithKline; Stock/Shareholder:
GlaxoSmithKline.Reis, André F. ....................................... Disclosed no conflict of interest.Reisetter, Anna C. ................................ Disclosed no conflict of interest.Reitz, Cheryl .......................................... Disclosed no conflict of interest.Remedi, Maria S. ................................. Disclosed no conflict of interest.Remington, Gary ................................... Disclosed no conflict of interest.Remonti, Luciana .................................. Disclosed no conflict of interest.Remvig, Line Sofie ................................ Employee: HypoSafe A/S.Ren, Decheng ........................................ Disclosed no conflict of interest.Ren, Guang ............................................ Disclosed no conflict of interest.Ren, Hongxia ......................................... Disclosed no conflict of interest.Ren, Meng ............................................. Disclosed no conflict of interest.Ren, Ping L. .......................................... Disclosed no conflict of interest.Ren, Qian ............................................... Disclosed no conflict of interest.Ren, Wei................................................ Disclosed no conflict of interest.Ren, Yuelan ........................................... Disclosed no conflict of interest.Renard, Eric ........................................... Consultant: A. Menarini Diagnostics, Abbott, Cellnovo,
Dexcom, Inc., Eli Lilly and Company, Johnson & Johnson, Lifescan Animas, Inc., Medtronic, Novo Nordisk, Inc., Roche Diagnostics, Sanofi; Research Support: Abbott, Dexcom, Inc., Insulet Corporation, Roche Pharmaceuticals.
Renaud, Sylvie ...................................... Disclosed no conflict of interest.Rendell, Marc ........................................ Research Support: GlaxoSmithKline.Rengarajan, Badri ................................. Disclosed no conflict of interest.Rengarajan, Manikandan ...................... Disclosed no conflict of interest.Renna, Sarah M. .................................. Disclosed no conflict of interest.Reno, Candace M. ................................ Disclosed no conflict of interest.
Renukuntla, Venkat S. .......................... Disclosed no conflict of interest.Renxian, Cao ......................................... Disclosed no conflict of interest.Resta, Onofrio ....................................... Disclosed no conflict of interest.Retnakaran, Ravi ................................... Consultant: Novo Nordisk, Inc.; Research Support: Novo
Nordisk, Inc.Reusch, Jane ......................................... Disclosed no conflict of interest.Reuter, Bradley ...................................... Disclosed no conflict of interest.Reutrakul, Sirimon ................................ Disclosed no conflict of interest.Rewers, Marian J. ............................... Disclosed no conflict of interest.Reyes, Maricela .................................... Disclosed no conflict of interest.Reynolds, James C. .............................. Disclosed no conflict of interest.Reynolds, Kristi ..................................... Disclosed no conflict of interest.Reynolds, Paul R. ................................. Disclosed no conflict of interest.Reynolds, Regina M. ............................ Disclosed no conflict of interest.Reyzer, Michelle .................................... Disclosed no conflict of interest.Rezaeizadeh, Alireza ............................. Disclosed no conflict of interest.Rezaie, Alireza ...................................... Disclosed no conflict of interest.Reznik, Yves .......................................... Disclosed no conflict of interest.Rezvani, Iraj ........................................... Disclosed no conflict of interest.Rhee, Byoung Doo ................................. Disclosed no conflict of interest.Rhee, Eugene P. .................................... Disclosed no conflict of interest.Rhee, Mary K. ...................................... Disclosed no conflict of interest.Rhee, Nicolai A. ................................... Employee: Novo Nordisk A/S; Stock/Shareholder: Novo
Nordisk A/S.Rhee, Sang Youl .................................... Disclosed no conflict of interest.Rhinehart, Andrew ................................ Advisory Panel: Amylin Pharmaceuticals, Inc., Boehringer
Rho, Eun ................................................ Disclosed no conflict of interest.Rhodes, Christopher J. ......................... Disclosed no conflict of interest.Rhydderch, Danielle C. ......................... Disclosed no conflict of interest.Ribel-Madsen, Rasmus ......................... Disclosed no conflict of interest.Riber, Ditte ............................................ Disclosed no conflict of interest.Ricardo, Giovanna T. ............................ Disclosed no conflict of interest.Ricart, Wifredo ...................................... Disclosed no conflict of interest.Riccardi, Gabriele .................................. Disclosed no conflict of interest.Rice, Kenneth M. ................................. Disclosed no conflict of interest.Rice, Kristen .......................................... Disclosed no conflict of interest.Rice, Sam .............................................. Advisory Panel: Merck Sharp & Dohme Limited, Novo
Rich, Stephen S. ................................... Disclosed no conflict of interest.Richards, Alice ...................................... Disclosed no conflict of interest.Richards, Paul ....................................... Disclosed no conflict of interest.Richards, Robert .................................... Disclosed no conflict of interest.Richards, Stephen M. .......................... Disclosed no conflict of interest.Richards, William .................................. Disclosed no conflict of interest.Richardson, Andrew .............................. Disclosed no conflict of interest.Richardson, Janell R. ........................... Disclosed no conflict of interest.Rich-Edwards, Janet ............................. Disclosed no conflict of interest.Richelsen, Bjørn .................................... Consultant: Eli Lilly and Company (Spouse/Partner).Richey, Joyce M. .................................. Disclosed no conflict of interest.Richmond, Rebecca ............................... Disclosed no conflict of interest.Richter, Erik A. ...................................... Stock/Shareholder: Novo Nordisk A/S.Ricks, Madia ......................................... Disclosed no conflict of interest.Ricordi, Camillo ..................................... Disclosed no conflict of interest.Ridderstråle, Martin .............................. Other Relationship: Head of the Patient Care Center at Steno
Diabetes Center A/S; Speaker’s Bureau: Boehringer Ingelheim GmbH & Co. KG, Eli Lilly and Company, GlaxoSmithKline, Johnson & Johnson, Medtronic, Merck & Co., Novartis Pharmaceuticals Corporation, Novo Nordisk A/S, Roche Pharmaceuticals, Sanofi-Aventis.
Riddle, Matthew C. .............................. Advisory Panel: Sanofi; Consultant: Amylin Pharmaceuticals, Inc., AstraZeneca/Bristol-Meyers Squibb, Elcelyx Therapeutics, Inc., Eli Lilly and Company, Sanofi, Valeritas, LLC; Research Support: Eli Lilly and Company, Sanofi.
Rideout, Drew ....................................... Disclosed no conflict of interest.Ridley, Derrick E. .................................. Disclosed no conflict of interest.Ried-Larsen, Mathias ............................ Disclosed no conflict of interest.Rieger, Cosima ...................................... Employee: Roche Diagnostics GmbH.Riestra, María ....................................... Disclosed no conflict of interest.Rieusset, Jennifer ................................. Research Support: Poxel.Rifkin, Samara ....................................... Disclosed no conflict of interest.Rifkin-Graboi, Anne ............................... Disclosed no conflict of interest.
Rigalleau, Vincent ................................. Disclosed no conflict of interest.Riggs, Arthur D. ................................... Disclosed no conflict of interest.Rijnsburger, Merel................................. Disclosed no conflict of interest.Riley, Andrew R. .................................. Disclosed no conflict of interest.Rimele, Thomas J. ............................... Disclosed no conflict of interest.Rinella, Sean P. .................................... Disclosed no conflict of interest.Ringel, Bernd ......................................... Disclosed no conflict of interest.Ringemann, Christian ............................ Employee: Roche Diagnostics GmbH.Ringgaard, Steffen ................................ Disclosed no conflict of interest.Ringholm, Lene ..................................... Disclosed no conflict of interest.Rink, Linda ............................................. Disclosed no conflict of interest.Rios-Prego, M. ..................................... Disclosed no conflict of interest.Rissanen, Aila ....................................... Disclosed no conflict of interest.Ritchey, Mary E. ................................... Employee: Merck.Ritholz, Marilyn D. ............................... Disclosed no conflict of interest.Ritter, Olesja.......................................... Disclosed no conflict of interest.Ritterband, Lee ...................................... Disclosed no conflict of interest.Rittig, Kilian .......................................... Disclosed no conflict of interest.Rittig, Nikolaj ........................................ Disclosed no conflict of interest.Rius, Ferran ........................................... Disclosed no conflict of interest.Rivas, Homero ....................................... Disclosed no conflict of interest.Rivas, Lourdes ....................................... Disclosed no conflict of interest.Rivas, Manuel A. .................................. Disclosed no conflict of interest.Riveline, Jean-Pierre ............................. Disclosed no conflict of interest.Rivellese, Angela A. ............................. Disclosed no conflict of interest.Rivera-Vega, Michelle ........................... Disclosed no conflict of interest.Rizell, Magnus ...................................... Disclosed no conflict of interest.Rizvi, Ali A. ........................................... Disclosed no conflict of interest.Rizvi, Syed ............................................. Disclosed no conflict of interest.Rizza, Robert A. .................................... Disclosed no conflict of interest.Rizza, Stefano ....................................... Disclosed no conflict of interest.Rizzo, Manfredi ..................................... Disclosed no conflict of interest.Roat, Regan E. ...................................... Disclosed no conflict of interest.Robbins, Mark S. .................................. Employee: Diamedica, Inc.; Stock/Shareholder: Diamedica,
Inc.Robert, Jean-Jacques ........................... Disclosed no conflict of interest.Robert, Julien ........................................ Research Support: Novartis Pharma SAS.Roberts, Charles T. ............................... Disclosed no conflict of interest.Roberts, Christian ................................. Disclosed no conflict of interest.Roberts, Hugh ....................................... Disclosed no conflict of interest.Robertson, Chris .................................... Disclosed no conflict of interest.Robertson, Neil ..................................... Disclosed no conflict of interest.Robinson, Austin T. .............................. Disclosed no conflict of interest.Robinson, Matthew M. ........................ Disclosed no conflict of interest.Robles, Lourdes ..................................... Disclosed no conflict of interest.Roche, Beatrice ..................................... Disclosed no conflict of interest.Rocheleau, Jonathan V. ....................... Disclosed no conflict of interest.Rockette-Wagner, Bonny ...................... Disclosed no conflict of interest.Rockstroh, Denise ................................. Disclosed no conflict of interest.Rodacki, Melanie .................................. Disclosed no conflict of interest.Rodbard, Helena W. ............................. Advisory Panel: Amylin Pharmaceuticals, Inc., AstraZeneca
Pharmaceuticals LP, Bayer Health Care, LLC, Biodel, Inc., Novo Nordisk A/S, Roche Pharmaceuticals, Sanofi; Consultant: Biodel, Inc., Roche Pharmaceuticals, Takeda Pharmaceuticals U.S.A., Inc.; Research Support: AstraZeneca Pharmaceuticals LP, Biodel, Inc., Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Merck, Novartis Pharmaceuticals Corporation, Novo Nordisk A/S, Roche Pharmaceuticals, Sanofi; Speaker’s Bureau: Amylin Pharmaceuticals, Inc., AstraZeneca Pharmaceuticals LP, BMS, Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Merck, Novo Nordisk A/S, Takeda Pharmaceuticals U.S.A., Inc.
Rodda, Christine .................................... Disclosed no conflict of interest.Roden, Michael ..................................... Advisory Panel: Eli Lilly and Company, Novo Nordisk, Inc.,
Takeda Pharmaceutical Company, Ltd.; Consultant: Sanofi; Research Support: Boehringer Ingelheim Pharmaceuticals, Inc., Novartis Pharmaceuticals Corporation; Speaker’s Bureau: Eli Lilly and Company, Novo Nordisk, Inc., Takeda Pharmaceutical Company, Ltd.
Rodenbeck, Dorothy .............................. Disclosed no conflict of interest.Rodeschini, Elena .................................. Disclosed no conflict of interest.Rodgers Fischl, Andrea ......................... Disclosed no conflict of interest.Rodier, Michel ....................................... Disclosed no conflict of interest.Rodnick, Kenneth J. ............................. Disclosed no conflict of interest.Rodríguez Cordero, Julia ....................... Disclosed no conflict of interest.Rodriguez, Abe ...................................... Disclosed no conflict of interest.Rodriguez, Angel ................................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly
and Company.Rodriguez, Carlos J. ............................. Disclosed no conflict of interest.Rodriguez, Henry ................................... Disclosed no conflict of interest.Rodriguez, Louisa .................................. Disclosed no conflict of interest.
Rodriguez, Luisa M. ............................. Disclosed no conflict of interest.Rodriguez, María Galiana ..................... Disclosed no conflict of interest.Rodriguez, Roser ................................... Disclosed no conflict of interest.Rodríguez-Medina, Beatriz ................... Disclosed no conflict of interest.Rodriguez-Ventura, Ana L. ................... Disclosed no conflict of interest.Rodriguez-Vigil, Efran............................ Research Support: Eli Lilly and Company.Roedlich, Marie Noëlle ......................... Disclosed no conflict of interest.Roefs, Anne ........................................... Disclosed no conflict of interest.Roefs, Maaike M. ................................ Disclosed no conflict of interest.Roehrig, Karin ....................................... Disclosed no conflict of interest.Roell, Marina K. ................................... Employee: XOMA Corporation.Roemmele, Emma ................................. Disclosed no conflict of interest.Rogan, Daniel ........................................ Disclosed no conflict of interest.Rogatsky, Eduard ................................... Disclosed no conflict of interest.Roger, Simon D. ................................... Disclosed no conflict of interest.Rogers, Heather M. ............................. Employee: NIDDK.Rogers, James R. ................................. Disclosed no conflict of interest.Rogers, Kendall M. .............................. Disclosed no conflict of interest.Roh, Eun ................................................ Disclosed no conflict of interest.Roh, Hyun C. ......................................... Disclosed no conflict of interest.Rohde, Ulrich ......................................... Disclosed no conflict of interest.Rohr, Serge ............................................ Disclosed no conflict of interest.Rohrs, Henry .......................................... Disclosed no conflict of interest.Rohwedder, Katja .................................. Employee: AstraZeneca Pharmaceuticals LP; Stock/
Shareholder: AstraZeneca Pharmaceuticals LP.Rojas, Anabel ........................................ Disclosed no conflict of interest.Rojas, Jose Alberto ............................... Disclosed no conflict of interest.Rokitta, Ilka ........................................... Disclosed no conflict of interest.Rolandsson, Olov .................................. Disclosed no conflict of interest.Rolka, Deborah B. ................................ Disclosed no conflict of interest.Rolph, Timothy P. .................................. Employee: Pfizer, Inc.Romacho, Tania ..................................... Disclosed no conflict of interest.Romagnoli, Fabio .................................. Research Support: Molliter.Román, Carolina L. ............................... Disclosed no conflict of interest.Roman, Richard ..................................... Research Support: Boehringer Ingelheim GmbH & Co. KG.Romanchuk, Kenneth ............................ Disclosed no conflict of interest.Romani, Marta ...................................... Disclosed no conflict of interest.Romano, Davide .................................... Disclosed no conflict of interest.Romano, Maria ..................................... Disclosed no conflict of interest.Romenskaia, Irina ................................. Disclosed no conflict of interest.Romero, Enrique .................................... Disclosed no conflict of interest.Romero, Francisco ................................. Disclosed no conflict of interest.Romero, Odile ....................................... Disclosed no conflict of interest.Rometo, David ....................................... Disclosed no conflict of interest.Romijn, J.A. .......................................... Disclosed no conflict of interest.Roncella, Elena ..................................... Disclosed no conflict of interest.Rondinini, Lorenzo ................................. Disclosed no conflict of interest.Rondinone, Cristina M. ........................ Employee: MedImmune.Rong, Zeng ............................................ Disclosed no conflict of interest.Rönn, Tina ............................................. Disclosed no conflict of interest.Rood, Jennifer ....................................... Disclosed no conflict of interest.Roopa, Shivashankar ............................ Disclosed no conflict of interest.Ropolo, Alejandro ................................. Disclosed no conflict of interest.Rosales, A.G. ........................................ Disclosed no conflict of interest.Rosamond, Wayne ................................ Disclosed no conflict of interest.Rosano, Caterina ................................... Disclosed no conflict of interest.Rosario, Rosa ........................................ Disclosed no conflict of interest.Rosas, Ulysses ...................................... Disclosed no conflict of interest.Rosas-Arellano, Patricia ....................... Disclosed no conflict of interest.Rose, Kyle J. ........................................ Consultant: Orange Healthcare; Employee: Delta Project
Management.Rose, Paulina ........................................ Disclosed no conflict of interest.Rosen, Evan D. ..................................... Disclosed no conflict of interest.Rosenfeld, Cheryl .................................. Consultant: Valeritas, LLC; Research Support: Valeritas, LLC;
Speaker’s Bureau: Valeritas, LLC.Rosengren, Annika ................................ Disclosed no conflict of interest.Rosenkilde, Mette M. .......................... Disclosed no conflict of interest.Rosenlund, Signe .................................. Employee: Steno Diabetes Center.Rosenstock, Julio .................................. Advisory Panel: Boehringer Ingelheim Pharmaceuticals, Inc.,
Daiichi-Sankyo, Inc., Eli Lilly and Company, GlaxoSmithKline, Halozyme Therapeutics, Intarcia Therapeutics, Inc., Janssen Pharmaceuticals, Lexicon Pharmaceuticals, Inc., MannKind Corporation, Merck, Novartis Pharmaceuticals Corporation, Novo Nordisk, Inc., Sanofi, Takeda Pharmaceutical Company, Ltd.; Consultant: Boehringer Ingelheim Pharmaceuticals, Inc., Diaichi Sankyo, Eli Lilly and Company, GlaxoSmithKline, Halozyme Therapeutics, Intarcia Therapeutics, Inc., Janssen Pharmaceuticals, Lexicon Pharmaceuticals, Inc., MannKind Corporation, Merck, Novartis Pharmaceuticals Corporation, Novo Nordisk, Inc., Sanofi, Takeda Pharmaceutical Company, Ltd.; Research Support: Amylin
Rosenthal, Emily ................................... Disclosed no conflict of interest.Rosenthal, Stephen ............................... Disclosed no conflict of interest.Rosenthal, Talma................................... Disclosed no conflict of interest.Ross, Alastair B. .................................. Advisory Panel: Nestec SA.Ross, Glynis ........................................... Disclosed no conflict of interest.Ross, Jane ............................................. Disclosed no conflict of interest.Ross, Joseph S. .................................... Board Member: Fair Health; Research Support: Medtronic.Ross, Stuart A. ..................................... Advisory Panel: Boehringer Ingelheim Pharmaceuticals, Inc.,
Eli Lilly and Company, Merck, Novo Nordisk, Inc., Sanofi-Aventis; Research Support: Boehringer Ingelheim GmbH & Co. KG, Eli Lilly and Company, Merck, Novo Nordisk, Inc., Sanofi-Aventis;Speaker’s Bureau: Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Merck, Novo Nordisk, Inc., Sanofi-Aventis.
Ross, Trenton T. .................................... Employee: Pfizer, Inc.Rosselot, Carolina ................................. Disclosed no conflict of interest.Rossetti, Paola ...................................... Disclosed no conflict of interest.Rossi, Maria Chiara .............................. Disclosed no conflict of interest.Rossing, Peter ....................................... Advisory Panel: Astellas Pharma US, Inc., AstraZeneca
Pharmaceuticals LP, Bristol-Myers Squibb Company, Eli Lilly and Company, Janssen Pharmaceuticals, Novo Nordisk A/S; Employee: Steno; Research Support: Abbvie, Novo Nordisk A/S; Stock/Shareholder: Novo Nordisk A/S.
Rossmeisl, Martin ................................. Disclosed no conflict of interest.Rossulek, Michelle I. ............................ Employee: Pfizer, Inc.; Stock/Shareholder: Pfizer, Inc.Rostoker, Ran ........................................ Disclosed no conflict of interest.Rotaru, Andreea .................................... Disclosed no conflict of interest.Rotberg, Britt ......................................... Research Support: Sanofi.Roteta, Leslie A. ................................... Disclosed no conflict of interest.Roth, Roswith ........................................ Disclosed no conflict of interest.Rothenberg, Paul ................................... Employee: Janssen Research & Development, LLC.Rothman, Douglas L. ............................ Disclosed no conflict of interest.Rothman, Russell L. ............................. Disclosed no conflict of interest.Rothwell, Alice R. ................................ Disclosed no conflict of interest.Rotter, Jerome I. .................................. Disclosed no conflict of interest.Roubideaux, Yvette ............................... Disclosed no conflict of interest.Roumeliotis, Theodoros ........................ Disclosed no conflict of interest.Round, Rachel A. .................................. Disclosed no conflict of interest.Rountree, Austin ................................... Disclosed no conflict of interest.Rouquet, Thaïs ...................................... Disclosed no conflict of interest.Rourke, Joanne ..................................... Disclosed no conflict of interest.Rouse, Michael ..................................... Disclosed no conflict of interest.Rousseau, Michel F. ............................. Disclosed no conflict of interest.Roussel, Ronan ..................................... Advisory Panel: Janssen Pharmaceuticals, Sanofi; Board
Roust, Lori R. ........................................ Disclosed no conflict of interest.Roux, Flavien ......................................... Employee: Boehringer Ingelheim France.Roux, Julien .......................................... Disclosed no conflict of interest.Roy, Anirban .......................................... Employee: Medtronic.Roy, Sani ............................................... Disclosed no conflict of interest.Roy, Sayon ............................................. Disclosed no conflict of interest.Roy-Duval, Christine ............................. Employee: Sanofi.Rozance, Paul J. ................................... Disclosed no conflict of interest.Rozo, Andrea V. .................................... Disclosed no conflict of interest.Rubanyi, Gabor M. ............................... Disclosed no conflict of interest.Ruberg, Melinda C. .............................. Disclosed no conflict of interest.Rubín, Angel .......................................... Disclosed no conflict of interest.Rubin, Daniel J. .................................... Disclosed no conflict of interest.Rubin, Paul ............................................ Disclosed no conflict of interest.Rubinstein, Debra ................................. Disclosed no conflict of interest.Rubio, Miguel A. .................................. Disclosed no conflict of interest.Ruchko, Mykhailo .................................. Disclosed no conflict of interest.Ruderman, Neil B. ................................ Disclosed no conflict of interest.Rudovich, Natalia N. ............................ Disclosed no conflict of interest.Rueda, Ricardo ...................................... Employee: Abbott Nutrition.Ruedy, Katrina ....................................... Disclosed no conflict of interest.Rüegg, Markus A. ................................ Disclosed no conflict of interest.Ruggiero, Laurie .................................... Other Relationship: Johnson & Johnson; Speaker’s Bureau:
Lifescan Animas, Inc.
Rui, Xuefei ............................................. Disclosed no conflict of interest.Rui, Yuanpeng ....................................... Disclosed no conflict of interest.Ruiz, Monica ......................................... Disclosed no conflict of interest.Ruiz-Barros, Viviana .............................. Disclosed no conflict of interest.Rumpler, Markus ................................... Disclosed no conflict of interest.Rungby, Jørgen ..................................... Disclosed no conflict of interest.Runkle, Isabelle ..................................... Disclosed no conflict of interest.Rupnow, Marcia .................................... Employee: Janssen Scientific Affairs, LLC; Stock/Shareholder:
Johnson & Johnson.Ruppert, Kristine ................................... Disclosed no conflict of interest.Rusak, Magdalena ................................ Disclosed no conflict of interest.Rusavy, Zdenek ..................................... Disclosed no conflict of interest.Rush, William ........................................ Disclosed no conflict of interest.Rushakoff, Robert J. ............................ Speaker’s Bureau: Merck, Novo Nordisk, Inc.Rusnak, James M. ............................... Employee: Pfizer, Inc.; Stock/Shareholder: Pfizer, Inc.Russell, Aaron P. .................................. Disclosed no conflict of interest.Russell, Ryan D. ................................... Disclosed no conflict of interest.Russell, Steven J. ................................ Other Relationship: Tandem Diabetes Care.Russell, Wayne S. ................................ Disclosed no conflict of interest.Russo, Carlo .......................................... Employee: GlaxoSmithKline; Stock/Shareholder:
GlaxoSmithKline.Russo, Eleonora .................................... Disclosed no conflict of interest.Russo, Giuseppina ................................ Disclosed no conflict of interest.Russo, Rossella ..................................... Disclosed no conflict of interest.Rusu, Emilia .......................................... Disclosed no conflict of interest.Rusu, Florin ........................................... Disclosed no conflict of interest.Rutten, Guy E. ...................................... Disclosed no conflict of interest.Rutter, Guy A. ....................................... Disclosed no conflict of interest.Rutters, Femke ...................................... Research Support: Novo Nordisk A/S.Ryan, Alexander J. ............................... Disclosed no conflict of interest.Ryan, Alice S. ....................................... Disclosed no conflict of interest.Ryan, Christopher .................................. Disclosed no conflict of interest.Ryan, Donna .......................................... Advisory Panel: Eisai, Inc., Janssen Pharmaceuticals,
Novo Nordisk, Inc., Takeda Pharmaceutical Company, Ltd., Vivus, Inc.; Consultant: Eisai, Inc.
Ryan, Patrick B. .................................... Employee: Janssen Research & Development.Ryberg, Mats ......................................... Disclosed no conflict of interest.Rybin, Denis .......................................... Disclosed no conflict of interest.Ryden, Anna .......................................... Employee: AstraZeneca Pharmaceuticals LP; Stock/
Shareholder: AstraZeneca Pharmaceuticals LP.Ryder, Robert E. .................................... Advisory Panel: Novo Nordisk A/S; Speaker’s Bureau: Novo
Inc.Rynders, Corey A. ................................ Disclosed no conflict of interest.Ryu, Ah Jeong ....................................... Disclosed no conflict of interest.Ryu, Ja Young ....................................... Disclosed no conflict of interest.Ryu, Kenki ............................................. Disclosed no conflict of interest.Saad, Mario J. ..................................... Disclosed no conflict of interest.Saaddine, Jinan .................................... Disclosed no conflict of interest.Sabico, Shaun ....................................... Disclosed no conflict of interest.Sabus, Carla H. .................................... Disclosed no conflict of interest.Sacks, David A. .................................... Disclosed no conflict of interest.Sacks, David B. .................................... Disclosed no conflict of interest.Sadananthan, Suresh Anand ................ Disclosed no conflict of interest.Saddi-Rosa, Pedro ................................. Disclosed no conflict of interest.Sadeghi-Yarandi, Shadi ........................ Disclosed no conflict of interest.Sadhu, Archana R. ............................... Disclosed no conflict of interest.Sadikova, Elsa R. .................................. Disclosed no conflict of interest.Sadiqi, Hamed ....................................... Disclosed no conflict of interest.Sadosky, Alesia ..................................... Employee: Pfizer, Inc.; Stock/Shareholder: Pfizer, Inc.Saedi, Samira ........................................ Disclosed no conflict of interest.Saely, Christoph H. .............................. Disclosed no conflict of interest.Saentaweesuk, Supakate ..................... Disclosed no conflict of interest.Saenz, Sofia .......................................... Disclosed no conflict of interest.Safren, Steven ...................................... Disclosed no conflict of interest.Saghatelian, Alan ................................. Disclosed no conflict of interest.Saha, Asish K. ...................................... Disclosed no conflict of interest.Sahli, Michelle W. ............................... Disclosed no conflict of interest.Saibara, Toshiji...................................... Disclosed no conflict of interest.Saibene, Alessandro ............................. Disclosed no conflict of interest.Said, Abduharan ................................... Disclosed no conflict of interest.Saiki, Yuko ............................................. Disclosed no conflict of interest.Saikumar Lakshmi, Priya ....................... Disclosed no conflict of interest.Sainsbury, Amanda ............................... Disclosed no conflict of interest.Sainsbury, Christopher A. .................... Disclosed no conflict of interest.Sainz, Jesus .......................................... Disclosed no conflict of interest.Saito, Isao ............................................. Disclosed no conflict of interest.Saito, Jun .............................................. Disclosed no conflict of interest.Saito, Rex .............................................. Disclosed no conflict of interest.Saito, Tsugumichi .................................. Disclosed no conflict of interest.
Sajan, Mini P. ....................................... Disclosed no conflict of interest.Sakagami, Hidemitsu ............................ Disclosed no conflict of interest.Sakaguchi, Kazuhiko ............................. Disclosed no conflict of interest.Sakai, Gota ............................................ Disclosed no conflict of interest.Sakai, Juro ............................................ Disclosed no conflict of interest.Sakai, Keiko .......................................... Disclosed no conflict of interest.Sakai, Soichi ......................................... Employee: Taisho.Sakai, Yoshihiko .................................... Disclosed no conflict of interest.Sakaki, Yuka .......................................... Disclosed no conflict of interest.Sakamoto, Kei ....................................... Disclosed no conflict of interest.Sakamoto, Kentaro ............................... Disclosed no conflict of interest.Sakamoto, Kumiko ................................ Disclosed no conflict of interest.Sakane, Naoki ....................................... Disclosed no conflict of interest.Sakata, Yasushi ..................................... Disclosed no conflict of interest.Sakoda, Hideyuki .................................. Disclosed no conflict of interest.Sakurai, Masaru .................................... Disclosed no conflict of interest.Sakuramoto-Tsuchida, Sumiyo .............. Disclosed no conflict of interest.Salamati, Sarah E. ............................... Disclosed no conflict of interest.Salari, Hamid ........................................ Employee: MedImmune.Salas, Elisabet ...................................... Disclosed no conflict of interest.Salazar, Tatiana ..................................... Disclosed no conflict of interest.Saleh Hassan, Lina ............................... Disclosed no conflict of interest.Salehi, Marzieh ..................................... Disclosed no conflict of interest.Salem, James ....................................... Disclosed no conflict of interest.Salem, Rany .......................................... Disclosed no conflict of interest.Salerno, Anna ....................................... Disclosed no conflict of interest.Salkind, Sara ......................................... Disclosed no conflict of interest.Sallum-Filho, Celso F. ........................... Disclosed no conflict of interest.Salmean, Gabriela ................................ Disclosed no conflict of interest.Salminen, Paulina ................................. Disclosed no conflict of interest.Salminen, Seppo ................................... Disclosed no conflict of interest.Salsali, Afshin ....................................... Employee: Boehringer Ingelheim GmbH & Co. KG.Salter, Rhys ........................................... Employee: Janssen Research & Development.Salvemini, Lucia .................................... Disclosed no conflict of interest.Samarasekera, Tanya ............................ Disclosed no conflict of interest.Sambataro, Maria ................................. Disclosed no conflict of interest.Samoa, Raynald .................................... Disclosed no conflict of interest.Sampanis, Christos ............................... Disclosed no conflict of interest.Sampene, Emmanuel ............................ Disclosed no conflict of interest.Sampol, Gabriel .................................... Disclosed no conflict of interest.Sampson Perrin, Alysa J. ..................... Disclosed no conflict of interest.Samson, Susan L. ................................. Disclosed no conflict of interest.Samuel, Stuart ...................................... Disclosed no conflict of interest.Samuel, Varman T. ............................... Disclosed no conflict of interest.Samukawa, Yoshishige ......................... Employee: Taisho.Sanal, Geethu ....................................... Disclosed no conflict of interest.Sánchez Hernández, Rosa María .......... Disclosed no conflict of interest.Sánchez, Cecilia .................................... Disclosed no conflict of interest.Sánchez-Ferrer, Carlos F. ...................... Disclosed no conflict of interest.Sanchez-Infantes, David ....................... Disclosed no conflict of interest.Sanchez-Sobrino, P. .............................. Disclosed no conflict of interest.Sancho Bornez, Veronica ...................... Disclosed no conflict of interest.Sanda, Srinath ...................................... Disclosed no conflict of interest.Sandahl Christiansen, Jens .................. Advisory Panel: Novo Nordisk A/S; Research Support: Novo
Nordisk A/S; Speaker’s Bureau: Eli Lilly and Company, Novo Nordisk A/S, Pfizer, Inc.
Sandbæk, Annelli .................................. Other Relationship: Novo Nordisk; Speaker’s Bureau: Novo Nordisk A/S, Pfizer, Inc.
Sandberg, Monica ................................. Disclosed no conflict of interest.Sandberg, Susanne ............................... Disclosed no conflict of interest.Sandholm, Niina ................................... Disclosed no conflict of interest.Sandhu, Narinder .................................. Disclosed no conflict of interest.Sandler, Victoria .................................... Disclosed no conflict of interest.Sandoval, Darleen A. ........................... Disclosed no conflict of interest.Sands, Arthur ........................................ Employee: Lexicon Pharmaceuticals, Inc.; Stock/Shareholder:
Lexicon Pharmaceuticals, Inc.Sandu, Oana .......................................... Disclosed no conflict of interest.Sandy, Philip .......................................... Disclosed no conflict of interest.Sankar, A. ............................................. Disclosed no conflict of interest.Sanke, Haruna ....................................... Disclosed no conflict of interest.Sanlioglu, Salih ..................................... Disclosed no conflict of interest.Sano, Yoshiko ........................................ Disclosed no conflict of interest.Sanpei, Kazuhiro ................................... Disclosed no conflict of interest.Santa-Cruz Calvo ................................... Disclosed no conflict of interest.Santana, Debora D. .............................. Disclosed no conflict of interest.Santaren, Ingrid D. ............................... Disclosed no conflict of interest.Santiago, Luis ....................................... Disclosed no conflict of interest.Santini, Eleonora ................................... Disclosed no conflict of interest.Santoro, Nicola ..................................... Disclosed no conflict of interest.Santos, Andressa C. ............................ Disclosed no conflict of interest.Santos, Estefania .................................. Disclosed no conflict of interest.Sanu, Olaleye ........................................ Disclosed no conflict of interest.
Sapsford, Andrew I. ............................. Employee: GlaxoSmithKline; Stock/Shareholder: GlaxoSmithKline.
Sarangarajan, Rangaprasad ................. Disclosed no conflict of interest.Saravanan, P. ........................................ Disclosed no conflict of interest.Saravanan, Ponnusamy ......................... Disclosed no conflict of interest.Sargin, Mehmet .................................... Disclosed no conflict of interest.Sarlak, Hakan ........................................ Disclosed no conflict of interest.Sarma, Aruna V. ................................... Disclosed no conflict of interest.Sarmady, Mahdi .................................... Disclosed no conflict of interest.Sartorius, Tina ....................................... Disclosed no conflict of interest.Saryusz-Wolska, Malgorzata ................ Disclosed no conflict of interest.Sasahara, Masakiyo ............................. Disclosed no conflict of interest.Sasaki, Satoshi ..................................... Disclosed no conflict of interest.Sasaki, Shigekazu ................................. Disclosed no conflict of interest.Sasaki, Shugo ....................................... Disclosed no conflict of interest.Sasaki, Shuji ......................................... Disclosed no conflict of interest.Sasaki, Takashi...................................... Consultant: Taisho.Sasaki, Tsutomu .................................... Disclosed no conflict of interest.Sasaki, Yuko .......................................... Disclosed no conflict of interest.Sasaoka, Toshiyasu ............................... Disclosed no conflict of interest.Sasson, Ariella ...................................... Disclosed no conflict of interest.Sasson, Shlomo .................................... Disclosed no conflict of interest.Sata, Fumihiro ....................................... Disclosed no conflict of interest.Satheesan, Sangeetha .......................... Disclosed no conflict of interest.Sathyanarayan, Aishwarya ................... Disclosed no conflict of interest.Satin, Leslie .......................................... Disclosed no conflict of interest.Sato, Daisuke ........................................ Disclosed no conflict of interest.Sato, Eiichi ............................................ Disclosed no conflict of interest.Sato, Hiroyuki ........................................ Employee: Sanwa Kagaku Kenkyusho Co.,Ltd.Sato, Juichi ........................................... Disclosed no conflict of interest.Sato, Junko ........................................... Other Relationship: Roche Pharmaceuticals.Sato, Koji ............................................... Disclosed no conflict of interest.Sato, Kyoko K. ...................................... Disclosed no conflict of interest.Sato, Ryosuke ....................................... Disclosed no conflict of interest.Sato, Ryuji ............................................. Disclosed no conflict of interest.Sato, Shinji ............................................ Disclosed no conflict of interest.Sato, Shotaro ........................................ Disclosed no conflict of interest.Sato, Takashi ......................................... Disclosed no conflict of interest.Sato, Yasutaka ...................................... Disclosed no conflict of interest.Sato, Yuichi ........................................... Disclosed no conflict of interest.Sato, Yuri ............................................... Employee: Taisho.Satoh, Aoi ............................................. Disclosed no conflict of interest.Satoh, Hiroaki ....................................... Disclosed no conflict of interest.Satoh, Hiroki ......................................... Disclosed no conflict of interest.Satoh, Jo ............................................... Disclosed no conflict of interest.Satoh, Kumi ........................................... Disclosed no conflict of interest.Satoh, Shinobu ...................................... Disclosed no conflict of interest.Satoh, Yuichi ......................................... Disclosed no conflict of interest.Sattin, Richard W. ................................ Disclosed no conflict of interest.Sauder, Matthew A. ............................. Disclosed no conflict of interest.Saukkonen, Tero .................................... Employee: Novo Nordisk A/S.Saul, Melissa ........................................ Disclosed no conflict of interest.Saulnier, Pierre-Jean............................. Disclosed no conflict of interest.Saunavaara, Virva ................................. Disclosed no conflict of interest.Saunders, Rhodri ................................... Consultant: Abbott Diabetes Care, Health Economics
Analysis, Novo Nordisk, Inc., Sanofi Pasteur.Saunders, William ................................ Consultant: Bristol-Myers Squibb Company.Sauque-Reyna, Leobardo ...................... Advisory Panel: Sanofi; Speaker’s Bureau: Boehringer
Ingelheim Pharmaceuticals, Inc. (Spouse/Partner), Sanofi.Saura, Gabriella .................................... Disclosed no conflict of interest.Savage, David B. .................................. Disclosed no conflict of interest.Savari, Omid .......................................... Disclosed no conflict of interest.Savel, Julia ........................................... Disclosed no conflict of interest.Savic, Gordana ...................................... Disclosed no conflict of interest.Savolainen, Anna A. ............................ Disclosed no conflict of interest.Savopoulos, Christos ............................ Disclosed no conflict of interest.Saw, Seang-Mei ................................... Disclosed no conflict of interest.Sawaguchi, Tatsuya .............................. Disclosed no conflict of interest.Sawai, Mizuki ....................................... Disclosed no conflict of interest.Sawamura, Mami S. ............................ Disclosed no conflict of interest.Sawyer, Nichola .................................... Disclosed no conflict of interest.Saxena, Aditi ......................................... Disclosed no conflict of interest.Saxton, Judith ....................................... Disclosed no conflict of interest.Saydah, Sharon H. ............................... Disclosed no conflict of interest.Sayre, Peter H. ..................................... Disclosed no conflict of interest.Sbraccia, Paolo ..................................... Disclosed no conflict of interest.Scanlan, Thomas ................................... Disclosed no conflict of interest.Scarabello, Chiara ................................. Disclosed no conflict of interest.Scardapane, Marco ............................... Disclosed no conflict of interest.Scardo, James ...................................... Disclosed no conflict of interest.Scarlett, Jarrad ..................................... Disclosed no conflict of interest.Scarpellini, Stefania ............................. Disclosed no conflict of interest.
Scarpitta, Antonietta Maria .................. Disclosed no conflict of interest.Scelsi, Amanda R. ................................ Disclosed no conflict of interest.Schaack, Jerome ................................... Disclosed no conflict of interest.Schade, David S. .................................. Disclosed no conflict of interest.Schaefer, Cynthia T. ............................. Disclosed no conflict of interest.Schaepelynck, Pauline .......................... Disclosed no conflict of interest.Schäffer, Lauge ..................................... Disclosed no conflict of interest.Schaller, Hans-Eberhard........................ Disclosed no conflict of interest.Schatz, Desmond A. ............................. Disclosed no conflict of interest.Schauer, Irene E. .................................. Disclosed no conflict of interest.Schauer, Philip R. ................................. Disclosed no conflict of interest.Schaupp, Lukas ..................................... Disclosed no conflict of interest.Scheel-Thomsen, Jan ........................... Disclosed no conflict of interest.Scheltema, Matthijs ............................. Disclosed no conflict of interest.Scherer, Philipp E. ................................ Disclosed no conflict of interest.Schernthaner, Gerit H. ......................... Disclosed no conflict of interest.Schernthaner, Guntram ......................... Board Member: AstraZeneca Pharmaceuticals LP, Boehringer
Ingelheim GmbH & Co. KG, Eli Lilly and Company, Janssen Pharmaceuticals, Takeda Pharmaceutical Company, Ltd.; Speaker’s Bureau: AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim GmbH & Co. KG, Eli Lilly and Company, Janssen Pharmaceuticals, Takeda Pharmaceutical Company, Ltd.
Scherrer-Crosbie, Marielle .................... Disclosed no conflict of interest.Scheuerman, Kathrin ............................ Disclosed no conflict of interest.Schiavon, Michele ................................ Disclosed no conflict of interest.Schick, Fritz ........................................... Disclosed no conflict of interest.Schigt, A. .............................................. Disclosed no conflict of interest.Schimke, Jill .......................................... Disclosed no conflict of interest.Schlauch, Karen .................................... Disclosed no conflict of interest.Schleger, Franziska................................ Disclosed no conflict of interest.Schleicher, Erwin................................... Disclosed no conflict of interest.Schlensak, Matthias ............................. Disclosed no conflict of interest.Schlessinger, Karni................................ Employee: Merck.Schliess, Freimut ................................... Disclosed no conflict of interest.Schlink, Sarah ....................................... Disclosed no conflict of interest.Schlotterer, Andreas ............................. Disclosed no conflict of interest.Schmelzeisen-Redeker, Guenther ......... Employee: Roche Diagnostics GmbH.Schmid, Johannes ................................. Disclosed no conflict of interest.Schmidt, Ann Marie .............................. Disclosed no conflict of interest.Schmidt, Karen ...................................... Disclosed no conflict of interest.Schmidt, Kathleen ................................. Disclosed no conflict of interest.Schmidt, Ronald .................................... Employee: Sanofi.Schmidt, Thorsten ................................. Employee: Sanofi.Schmidt, Ulrike ...................................... Disclosed no conflict of interest.Schmiege, Sarah ................................... Disclosed no conflict of interest.Schmitt, Andreas .................................. Disclosed no conflict of interest.Schmitt, Patricia .................................... Disclosed no conflict of interest.Schmittdiel, Julie A. ............................ Disclosed no conflict of interest.Schmitz-Peiffer, Carsten........................ Disclosed no conflict of interest.Schnapp, Gisela .................................... Employee: Boehringer Ingelheim GmbH & Co. KG.Schneeberger, Caroline ......................... Disclosed no conflict of interest.Schneider, Jennifer L. .......................... Disclosed no conflict of interest.Schneider, Steffen................................. Research Support: Sanofi.Schnell, Oliver ....................................... Advisory Panel: Bayer Health Care, LLC; Speaker’s Bureau:
Bayer Health Care, LLC.Schobel, Mark ....................................... Board Member: Monosol Rx; Employee: Monosol Rx; Stock/
Shareholder: Monosol Rx.Schober, Joseph .................................... Disclosed no conflict of interest.Schoemaker, Michael............................ Employee: Hoffman La Roche.Schoiswohl, Gabriele ............................ Disclosed no conflict of interest.Scholl, Theresa ..................................... Disclosed no conflict of interest.Scholtens, Denise M. .......................... Disclosed no conflict of interest.Scholz, Hanne ....................................... Disclosed no conflict of interest.Schrader, Donald ................................... Disclosed no conflict of interest.Schreiner, Birgit..................................... Disclosed no conflict of interest.Schreiner, George.................................. Board Member: Cardero Therapeutics.Schreuer, Mynda ................................... Disclosed no conflict of interest.Schriever, Susan.................................... Disclosed no conflict of interest.Schrodi, Steven ..................................... Employee: Marshfield Clinic Research Foundation.Schroeder, Emily B. .............................. Disclosed no conflict of interest.Schroeder, Jessica A. .......................... Disclosed no conflict of interest.Schroer, Stephanie ................................ Disclosed no conflict of interest.Schuemie, Martijn ................................ Employee: Janssen Research & Development.Schug, Jonathan ................................... Disclosed no conflict of interest.Schulman, Kathleen .............................. Disclosed no conflict of interest.Schultes, Bernd ..................................... Disclosed no conflict of interest.Schultz, Jim ........................................... Disclosed no conflict of interest.Schulz, Eberhard ................................... Disclosed no conflict of interest.Schulz, Tim J. ....................................... Disclosed no conflict of interest.Schumacher, Helmut ............................. Employee: Boehringer Ingelheim GmbH & Co. KG.
Schuster, Dara P. .................................. Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly and Company.
Schwab, Leendert ................................. Disclosed no conflict of interest.Schwahn, Uwe ...................................... Employee: Sanofi; Stock/Shareholder: Sanofi.Schwander, Flurina................................ Disclosed no conflict of interest.Schwartz, Frank L. ................................ Research Support: Medtronic.Schwartz, Heather ................................ Disclosed no conflict of interest.Schwartz, Mara ..................................... Disclosed no conflict of interest.Schwartz, Michael W. ......................... Disclosed no conflict of interest.Schwartz, Stanley ................................. Disclosed no conflict of interest.Schwartze, Julian T. ............................. Disclosed no conflict of interest.Schweitzer, George G. ......................... Disclosed no conflict of interest.Schwenke, Dawn C. ............................. Disclosed no conflict of interest.Schwentner, Christian ........................... Disclosed no conflict of interest.Scirica, Benjamin M. ........................... Consultant: Arena Pharmaceuticals, Inc., Boston Clinical
Research Institute, Bristol-Myers Squibb Company, Daiichi-Sankyo, Inc., Decision Research, Eisai, Inc., Forest Pharmaceuticals, Inc., Gilead Sciences, Inc., Lexicon Pharmaceuticals, Inc., St. Jude’s Medical; Research Support: AstraZeneca/Bristol-Meyers Squibb, Bayer Health Care, LLC, Daiichi-Sankyo, Inc., Gilead Sciences, Inc., GlaxoSmithKline, Johnson & Johnson, Merck.
Sconocchia, Giuseppe ........................... Disclosed no conflict of interest.Scorletti, Eleonora ................................ Disclosed no conflict of interest.Scorsone, Alessandro ........................... Disclosed no conflict of interest.Scott, Adrian R. .................................... Speaker’s Bureau: Eli Lilly and Company, Merck Sharp &
Dohme Limited, Novo Nordisk, Inc., Sanofi.Scott, D.J.A. ......................................... Disclosed no conflict of interest.Scott, David ........................................... Disclosed no conflict of interest.Scott, Donald ........................................ Disclosed no conflict of interest.Scott, James ......................................... Disclosed no conflict of interest.Scott, Melanie ...................................... Disclosed no conflict of interest.Scott, Peter ........................................... Disclosed no conflict of interest.Scott, Rhona A. .................................... Employee: GlaxoSmithKline; Stock/Shareholder:
GlaxoSmithKline.Scott, Robert A. ................................... Disclosed no conflict of interest.Scott, Robert ......................................... Disclosed no conflict of interest.Seaquist, Elizabeth R. .......................... Disclosed no conflict of interest.Seay, Howard R. .................................. Disclosed no conflict of interest.Sebastian, Gerard V. ............................ Disclosed no conflict of interest.Sebastian-Ochoa, Arantzazu ................. Disclosed no conflict of interest.Secchi, Chiara ....................................... Disclosed no conflict of interest.Secher, Anna L. .................................... Disclosed no conflict of interest.Sedar, Jon ............................................. Disclosed no conflict of interest.Seed, Paul T. ........................................ Disclosed no conflict of interest.Seeger, John D. .................................... Research Support: Eli Lilly and Company.Seeley, Randy J. .................................. Consultant: AngioChem, Inc., Boehringer Ingelheim
Pharmaceuticals, Inc., Eisai, Inc., Ethicon EndoSurgery, Inc., Forest Pharmaceuticals, Inc., Giuvadan, Novartis Pharma AG, Novo Nordisk, Inc., Takeda Global Research and Development, Inc.; Speaker’s Bureau: Ethicon EndoSurgery, Inc., Merck, Novo Nordisk, Inc.; Stock/Shareholder: Zafgen, Inc.
Seelig, Amber ....................................... Disclosed no conflict of interest.Seely, Ellen W. ..................................... Disclosed no conflict of interest.Segal, Alissa ......................................... Disclosed no conflict of interest.Segal-Lieberman, Gabriella .................. Disclosed no conflict of interest.Seganfreddo, Elena ............................... Disclosed no conflict of interest.Segata, Tateki ....................................... Disclosed no conflict of interest.Segel, Stine ........................................... Employee: Novo Nordisk A/S; Stock/Shareholder: Novo
Nordisk A/S.Seger, Mary E. ...................................... Stock/Shareholder: Eli Lilly and Company.Seghieri, Giuseppe ................................ Disclosed no conflict of interest.Segiet, Thomas ..................................... Disclosed no conflict of interest.Seida, Jennifer C. ................................ Disclosed no conflict of interest.Seifert, Jennifer .................................... Disclosed no conflict of interest.Seimon, Radhika ................................... Disclosed no conflict of interest.Seino, Yutaka ........................................ Advisory Panel: Astellas Pharma, Becton, Dickinson and
Company, Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb/AstraZeneca, Eli Lilly and Company, GlaxoSmithKline, Johnson & Johnson, KyowaKirin, Novo Nordisk A/S, Sanofi, Taisho, Takeda Pharmaceutical Company, Ltd.
Sejling, Anne-Sophie ............................ Research Support: HypoSafe A/S.Seki, Akiteru .......................................... Employee: Ono Pharmaceutical Co., Ltd.Seki, Yoshinori ...................................... Disclosed no conflict of interest.Sekine, Osamu ...................................... Disclosed no conflict of interest.Seley, Jane Jeffrie ................................ Disclosed no conflict of interest.Sell, David R. ........................................ Disclosed no conflict of interest.Sell, Henrike .......................................... Disclosed no conflict of interest.Sell, Simone .......................................... Employee: Noxxon.Sellers, Elizabeth A. ............................. Disclosed no conflict of interest.
Seltmann, Anne-Cathrin ....................... Disclosed no conflict of interest.Selvarajah, Dinesh ................................ Disclosed no conflict of interest.Selvin, Elizabeth .................................... Consultant: Genentech.Semenkovich, Clay F. ........................... Research Support: Merck; Speaker’s Bureau: Merck.Semenkovich, Katherine ....................... Disclosed no conflict of interest.Semilla, April P. .................................... Consultant: Novo Nordisk, Inc.Semple, Robert K. ................................ Disclosed no conflict of interest.Sen Gupta, Piya ..................................... Research Support: Novo Nordisk A/S.en, Hacer .............................................. Disclosed no conflict of interest.
Sen, Sabyasachi .................................... Disclosed no conflict of interest.Senda, Satoko ....................................... Disclosed no conflict of interest.Senderak, Michael ................................ Employee: Merck; Stock/Shareholder: Merck.Sener, Abdullah ..................................... Disclosed no conflict of interest.Senesi, Pamela ..................................... Disclosed no conflict of interest.Sengupta, Anshuman ............................ Disclosed no conflict of interest.Senicki, Sheri ........................................ Disclosed no conflict of interest.Senior, Peter A. .................................... Advisory Panel: Animas Corporation, Eli Lilly and Company,
Medtronic, Novo Nordisk A/S, Sanofi; Consultant: Medtronics; Research Support: Novo Nordisk A/S; Speaker’s Bureau: Eli Lilly and Company, Novo Nordisk A/S, Sanofi.
Senmaru, Takafumi ............................... Disclosed no conflict of interest.Sennblad, Bengt .................................... Disclosed no conflict of interest.Senthilselvan, Ambikaipakan ............... Disclosed no conflict of interest.Seo, Dongju ........................................... Disclosed no conflict of interest.Seo, Gi Hyeon ....................................... Disclosed no conflict of interest.Seo, Ji A ................................................ Disclosed no conflict of interest.Seo, Ji Won .......................................... Disclosed no conflict of interest.Seok, Hannah ........................................ Disclosed no conflict of interest.Serafinceanu, Cristian .......................... Disclosed no conflict of interest.Serban, Viorel........................................ Disclosed no conflict of interest.Sereika, Susan ...................................... Disclosed no conflict of interest.Sergyev, Elena ....................................... Disclosed no conflict of interest.Serlie, Mireille J. ................................. Disclosed no conflict of interest.Sermer, Mathew ................................... Disclosed no conflict of interest.Serné, Erik H. ....................................... Disclosed no conflict of interest.Serra, Monica C. .................................. Disclosed no conflict of interest.Serrano, Cristobal ................................. Disclosed no conflict of interest.Serrano, Trinidad ................................... Disclosed no conflict of interest.Serreze, Dave V. ................................... Disclosed no conflict of interest.Serusclat, Pierre .................................... Research Support: Sanofi.Seshiah, Veeraswamy ........................... Advisory Panel: Boehringer Ingelheim GmbH & Co. KG.Šeštakauskas, Kastytis ......................... Employee: Sanofi.Seto, Shirley .......................................... Disclosed no conflict of interest.Seufert, Jochen ..................................... Disclosed no conflict of interest.Seydoux, Gilles T. ................................. Employee: GlaxoSmithKline; Stock/Shareholder:
GlaxoSmithKline.Seyoum, Berhane .................................. Disclosed no conflict of interest.Sha, Sue ................................................ Employee: Janssen Research & Development, LLC.Shabbir, Asim ........................................ Disclosed no conflict of interest.Shadid, Husam ...................................... Disclosed no conflict of interest.Shaefer, Charles .................................... Advisory Panel: Bristol-Myers Squibb/AstraZeneca, Eli Lilly
Shaffer, Scott ........................................ Disclosed no conflict of interest.Shah, Amy S. ........................................ Disclosed no conflict of interest.Shah, Arti .............................................. Disclosed no conflict of interest.Shah, Avni C. ........................................ Disclosed no conflict of interest.Shah, Bimal ........................................... Disclosed no conflict of interest.Shah, Manan ......................................... Employee: Bristol-Myers Squibb Company.Shah, Meera ......................................... Disclosed no conflict of interest.Shah, Nilay D. ...................................... Disclosed no conflict of interest.Shah, Nina ............................................ Disclosed no conflict of interest.Shah, Sanjiv .......................................... Disclosed no conflict of interest.Shah, Shreepal ...................................... Disclosed no conflict of interest.Shah, Vallabh ........................................ Disclosed no conflict of interest.Shah, Viral ............................................. Disclosed no conflict of interest.Shah, Yatrik M. .................................... Disclosed no conflict of interest.Shahady, Edward J. ............................. Advisory Panel: Janssen Pharmaceuticals, Lilly/Boehringer
Ingelheim, Novo Nordisk, Inc.; Speaker’s Bureau: Merck.
Shaheen, Zachary R. ............................ Disclosed no conflict of interest.Shahid, Aamina ..................................... Disclosed no conflict of interest.Shaibi, Gabriel Q. ................................. Disclosed no conflict of interest.Shakher, Jaydave .................................. Disclosed no conflict of interest.Shalata, Adel ........................................ Disclosed no conflict of interest.Shalaurova, Irina ................................... Employee: LipoScience.Shalev, Anath ........................................ Disclosed no conflict of interest.Shalev, Varda ........................................ Disclosed no conflict of interest.
Shaltout, Inass ...................................... Advisory Panel: Novartis Pharma AG; Other Relationship: Novartis Pharma AG; Research Support: Novartis Pharma AG.
Shamanna, Paramesh ........................... Disclosed no conflict of interest.Shamkhalova, Minara ........................... Research Support: Novo Nordisk A/S.Shamoon, Harry .................................... Disclosed no conflict of interest.Shan, Nicole .......................................... Employee: Bristol-Myers Squibb Company.Shan, Zhongyan .................................... Disclosed no conflict of interest.Shanab, Ahmed Y. ................................ Disclosed no conflict of interest.Shanahan, William ............................... Employee: Arena Pharmaceuticals, Inc.Shankar, Arun ........................................ Disclosed no conflict of interest.Shankar, Kartik ...................................... Disclosed no conflict of interest.Shankar, R. Ravi .................................... Employee: Merck.Shankhdhar, Kshitij ............................... Disclosed no conflict of interest.Shankhdhar, Lakshmi K. ....................... Disclosed no conflict of interest.Shankhdhar, Smita ................................ Disclosed no conflict of interest.Shankhdhar, Uma .................................. Disclosed no conflict of interest.Shanmugham, Satya ............................. Disclosed no conflict of interest.Shao, Hui ............................................... Disclosed no conflict of interest.Shao, Jianhua ....................................... Disclosed no conflict of interest.Shao, Qing ............................................. Disclosed no conflict of interest.Shao, Weijuan....................................... Disclosed no conflict of interest.Shao, Xing-Hui ...................................... Disclosed no conflict of interest.Shapiro, James ..................................... Disclosed no conflict of interest.Sharkovska, Yuliya ................................ Disclosed no conflict of interest.Sharma, Arun ........................................ Disclosed no conflict of interest.Sharma, Kumar ..................................... Disclosed no conflict of interest.Sharma, Rohit B. .................................. Disclosed no conflict of interest.Sharma, Sanjeev ................................... Disclosed no conflict of interest.Sharma, Seema ..................................... Disclosed no conflict of interest.Sharma, Uma ........................................ Disclosed no conflict of interest.Sharoff, Carrie G. ................................. Disclosed no conflict of interest.Sharon, Ofer .......................................... Employee: Merck.Sharp, A. .............................................. Disclosed no conflict of interest.Sharp, Stephen J. ................................ Disclosed no conflict of interest.Sharrett, A. Richey ................................ Disclosed no conflict of interest.Shasha, Zang ........................................ Disclosed no conflict of interest.Shatenstein, Bryna ................................ Disclosed no conflict of interest.Shaw, Christopher S. ........................... Disclosed no conflict of interest.Shaw, James W. .................................. Employee: Bristol-Myers Squibb Company.Shaw, James ......................................... Disclosed no conflict of interest.Shaw, Jonathan .................................... Disclosed no conflict of interest.Shaw, Melissa ...................................... Disclosed no conflict of interest.Shawpurwala, Zainab ........................... Disclosed no conflict of interest.Shay, Christina M. ............................... Disclosed no conflict of interest.Shea, Jacqueline J. ............................. Disclosed no conflict of interest.Shea, Meghan ....................................... Employee: Vascular Pharmaceuticals Inc.Shearin, Abigail L. ................................ Disclosed no conflict of interest.Sheehan, Jack ....................................... Employee: Bristol-Myers Squibb/AstraZeneca.Sheetz, Matthew J. ............................. Employee: Eli Lilly and Company, Eli Lilly and Company
(Spouse/Partner); Stock/Shareholder: Eli Lilly and Company, Eli Lilly and Company (Spouse/Partner).
Sheffield, Val C. ................................... Disclosed no conflict of interest.Shen, Guiju ............................................ Disclosed no conflict of interest.Shen, Jing ............................................. Disclosed no conflict of interest.Shen, Joan Huaqiong ............................ Disclosed no conflict of interest.Shen, Shan-mei ..................................... Disclosed no conflict of interest.Shen, Tian ............................................. Disclosed no conflict of interest.Shen, Xiaoping ...................................... Disclosed no conflict of interest.Shen, Xiaoxia ........................................ Disclosed no conflict of interest.Shen, Yixie ............................................ Disclosed no conflict of interest.Shen, Yun .............................................. Disclosed no conflict of interest.Sheng, Hui ............................................. Disclosed no conflict of interest.Sheng, Quanhu ...................................... Disclosed no conflict of interest.Shepard, Jaclyn .................................... Disclosed no conflict of interest.Sherfan, Julie ........................................ Disclosed no conflict of interest.Sherman, Arthur .................................... Disclosed no conflict of interest.Sherry, Christina .................................... Employee: Abbott Nutrition.Sherwin, Robert S. ............................... Advisory Panel: MannKind Corporation, Merck, Novartis
Pharmaceuticals Corporation; Consultant: AstraZeneca Pharmaceuticals LP, BMS, Bristol-Myers Squibb Company, Eli Lilly and Company, Janssen Pharmaceuticals, McKinsey & Company, Pfizer, Inc.
Shestakova, Marina .............................. Advisory Panel: Novo Nordisk, Inc.; Research Support: Novartis Pharmaceuticals Corporation; Speaker’s Bureau: AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Merck Sharp & Dohme Limited, Novartis Pharmaceuticals Corporation, Novo Nordisk, Inc., Servier.
Sheu, Wayne H. ................................... Advisory Panel: AstraZeneca Pharmaceuticals LP, Bayer Health Care, LLC, Boehringer Ingelheim Pharmaceuticals,
Inc., Daiichi-Sankyo, Inc., Eli Lilly and Company, Merck Sharp & Dohme Limited, Mitsubishi Tanabe Pharmaceutical Corporation, Novartis Pharmaceuticals Corporation, Novo Nordisk, Inc., Pfizer, Inc., Sanofi, Takeda Pharmaceutical Company, Ltd.; Speaker’s Bureau: AstraZeneca Pharmaceuticals LP, Bayer Health Care, LLC, Boehringer Ingelheim Pharmaceuticals, Inc., Diaichi Sankyo, Eli Lilly and Company, Merck Sharp & Dohme Limited, Mitsubishi Tanabe Pharmaceutical Corporation, Novo Nordisk, Inc., Pfizer, Inc., Sanofi, Takeda Pharmaceutical Company, Ltd.
Sheu, Yahtyng ....................................... Disclosed no conflict of interest.Shi, Hang ............................................... Research Support: NuSirt Inc.Shi, Huan ............................................... Disclosed no conflict of interest.Shi, Huidong .......................................... Disclosed no conflict of interest.Shi, Jenny Y. ........................................ Disclosed no conflict of interest.Shi, Lixin ................................................ Disclosed no conflict of interest.Shi, Lizsheng ......................................... Consultant: Bristol-Myers Squibb Company; Research
Support: Bristol-Myers Squibb Company.Shi, Min ................................................. Disclosed no conflict of interest.Shi, Sally Y. .......................................... Disclosed no conflict of interest.Shi, Sen ................................................. Disclosed no conflict of interest.Shi, Tingqi ............................................. Disclosed no conflict of interest.Shi, Weibin............................................ Disclosed no conflict of interest.Shi, Xiaohui ........................................... Disclosed no conflict of interest.Shi, Xuhui .............................................. Disclosed no conflict of interest.Shia, Kak-Shan ...................................... Disclosed no conflict of interest.Shiba, Teruo .......................................... Research Support: Kowa Pharmaceuticals, Merck Sharp &
Shibata, Hiroe ....................................... Disclosed no conflict of interest.Shibayama, Yui ..................................... Disclosed no conflict of interest.Shibutani, Koko ..................................... Disclosed no conflict of interest.Shigematu, Erina ................................... Disclosed no conflict of interest.Shigihara, Nayumi ................................ Disclosed no conflict of interest.Shih, Erin M. ........................................ Disclosed no conflict of interest.Shih, Shyang-Rong ................................ Disclosed no conflict of interest.Shikama, Yosuke ................................... Disclosed no conflict of interest.Shillo, Pallai .......................................... Disclosed no conflict of interest.Shimada, Akira ...................................... Disclosed no conflict of interest.Shimada, Mariko ................................... Disclosed no conflict of interest.Shimano, Hitoshi ................................... Disclosed no conflict of interest.Shimauti, Eliana .................................... Disclosed no conflict of interest.Shimizu, HIroyuki .................................. Disclosed no conflict of interest.Shimizu, Jyunichi .................................. Disclosed no conflict of interest.Shimizu, Koichiro .................................. Disclosed no conflict of interest.Shimizu, Nobuyuki ............................... Disclosed no conflict of interest.Shimizu, Robert ..................................... Disclosed no conflict of interest.Shimizu, Tomoaki .................................. Research Support: Eli Lilly and Company, MSD, Novo Nordisk,
Shimizu, Yukiko ..................................... Disclosed no conflict of interest.Shimoda, Masashi ................................ Disclosed no conflict of interest.Shimoda, Yoko ...................................... Disclosed no conflict of interest.Shimomura, Iichiro ................................ Disclosed no conflict of interest.Shimomura, Kazuhiro ............................ Disclosed no conflict of interest.Shin, Chol .............................................. Disclosed no conflict of interest.Shin, Choong Ho ................................... Disclosed no conflict of interest.Shin, Dong Yeob .................................... Disclosed no conflict of interest.Shin, Hyunsook ..................................... Disclosed no conflict of interest.Shin, Jang Yel ....................................... Disclosed no conflict of interest.Shin, Ji Kyeong ..................................... Disclosed no conflict of interest.Shin, John ............................................. Employee: Medtronic.Shin, Kyung Cheul ................................. Disclosed no conflict of interest.Shin, Seon-Young .................................. Disclosed no conflict of interest.Shinjo, Takanori..................................... Disclosed no conflict of interest.Shiochi, Hideki ...................................... Disclosed no conflict of interest.Shioda, Yoshinobu ................................ Disclosed no conflict of interest.Shiota, Chiyo ......................................... Disclosed no conflict of interest.Shiota, Masakazu ................................. Consultant: AstraZeneca Pharmaceuticals LP.Shirahase, Hiroaki ................................. Disclosed no conflict of interest.Shiraiwa, Toshihiko ............................... Disclosed no conflict of interest.Shivashankar, Roopa ............................. Disclosed no conflict of interest.Shivaswamy, Vijay ................................ Disclosed no conflict of interest.
Shlyakhto, Evgeniy V. ........................... Disclosed no conflict of interest.Shnell, Santiago .................................... Disclosed no conflict of interest.Shoelson, Steven E. ............................. Disclosed no conflict of interest.Shoji, Tetsuo.......................................... Disclosed no conflict of interest.Shoji, Toshihiko ..................................... Disclosed no conflict of interest.Shomali, Mansur E. .............................. Employee: WellDoc.Shonkwiler, Cheryl ................................ Disclosed no conflict of interest.Short, Kevin ........................................... Disclosed no conflict of interest.Short, Megan M. .................................. Disclosed no conflict of interest.Shrank, William H. ............................... Research Support: Eli Lilly and Company.Shreck, Erica ......................................... Disclosed no conflict of interest.Shrestha, Deepika ................................. Disclosed no conflict of interest.Shrestha, Sundar S. ............................. Disclosed no conflict of interest.Shriver, John ......................................... Research Support: Bristol Meyers Squib Foundation.Shu, Jiong ............................................. Disclosed no conflict of interest.Shuai, Xuanyu ....................................... Disclosed no conflict of interest.Shubina, Maria ..................................... Disclosed no conflict of interest.Shubrook, Jay H. .................................. Advisory Panel: Eli Lilly and Company; Research Support:
Sanofi.Shuldiner, Alan R. ................................ Consultant: USDS, Inc.Shulman, Gerald I. ............................... Disclosed no conflict of interest.Shultz, Leonard D. ................................ Disclosed no conflict of interest.Shum, Kenny ......................................... Consultant: Eli Lilly and Company, Novartis Pharma AG.Shumel, Brad ......................................... Employee: MannKind Corporation; Stock/Shareholder:
MannKind Corporation.Shushlav, Yael ....................................... Consultant: Oramed Pharmaceuticals.Shuter, Borys ......................................... Disclosed no conflict of interest.Sia, Chang Ling ..................................... Disclosed no conflict of interest.Sibinga, Erica ........................................ Disclosed no conflict of interest.Sica, Domenic ....................................... Disclosed no conflict of interest.Sidibeh, Cherno O. ............................... Disclosed no conflict of interest.Sidossis, Labros S. ............................... Disclosed no conflict of interest.Sieber, Jochen....................................... Employee: Sanofi.Siega-Riz, AnnaMaria ........................... Disclosed no conflict of interest.Siegel-Axel, Dorothea I. ...................... Disclosed no conflict of interest.Siero, William ....................................... Disclosed no conflict of interest.Siewko, Katarzyna ................................ Disclosed no conflict of interest.Siford, Gerri L. ...................................... Disclosed no conflict of interest.Siitonen, Niina ...................................... Disclosed no conflict of interest.Sikaris, Ken ........................................... Disclosed no conflict of interest.Sikivou, Telatia Biu ............................... Disclosed no conflict of interest.Silva, Flavia M. .................................... Disclosed no conflict of interest.Silva, Joao ............................................ Disclosed no conflict of interest.Silva, Kleiton ......................................... Disclosed no conflict of interest.Silva, Nuno ............................................ Disclosed no conflict of interest.Silva, Pamuditha N. ............................. Disclosed no conflict of interest.Silva, Paolo S. ...................................... Research Support: Optos.Silver, Miriam ........................................ Disclosed no conflict of interest.Silverman, Edwin .................................. Disclosed no conflict of interest.Silverstein, Janet .................................. Disclosed no conflict of interest.Silvestre, Louise .................................... Employee: Sanofi; Stock/Shareholder: Sanofi.Silvestre, Marta .................................... Disclosed no conflict of interest.Silvia, Angeletti .................................... Disclosed no conflict of interest.Silviera, Stephanie L. ........................... Disclosed no conflict of interest.Sim, Xueling .......................................... Disclosed no conflict of interest.Sima, Alexandra .................................... Disclosed no conflict of interest.Simard, Marc ........................................ Disclosed no conflict of interest.Simell, Tuula.......................................... Disclosed no conflict of interest.Simin, Zhang ......................................... Disclosed no conflict of interest.Siminerio, Linda M. .............................. Research Support: Becton, Dickinson and Company.Simmons, Rebecca K. .......................... Disclosed no conflict of interest.Simms, Patrick ...................................... Employee: Biodel, Inc.; Stock/Shareholder: Biodel, Inc.Simó, Rafael .......................................... Disclosed no conflict of interest.Simonsen, Lene ..................................... Disclosed no conflict of interest.Simonson, Donald C. ............................ Disclosed no conflict of interest.Simpson, Ronda .................................... Disclosed no conflict of interest.Simpson, Scot H. ................................. Speaker’s Bureau: Eli Lilly and Company.Sims-Robinson, Catrina ........................ Disclosed no conflict of interest.Singh, Bhupinder ................................... Advisory Panel: ZS Pharma, Inc.Singh, Harsimran .................................. Disclosed no conflict of interest.Singh, Kavita ......................................... Disclosed no conflict of interest.Singh, Rishi P. ....................................... Consultant: Alcon Laboratories, Bausch and Lomb, Genentech;
Singh, Rupali ......................................... Disclosed no conflict of interest.Singh, Veer Bahadur ............................. Disclosed no conflict of interest.Singhal, Garima .................................... Disclosed no conflict of interest.Singhania, Akul ..................................... Disclosed no conflict of interest.Singhvi, Ajay ......................................... Disclosed no conflict of interest.Sinha, Manasi ....................................... Disclosed no conflict of interest.Sinha, Rajita .......................................... Disclosed no conflict of interest.Sinha, Sandeep ..................................... Disclosed no conflict of interest.
Sinha, Vikram P. ................................... Stock/Shareholder: Eli Lilly and Company.Sinha-Gregory, Naina ............................ Disclosed no conflict of interest.Sinner, Frank.......................................... Disclosed no conflict of interest.Sinnott, Margaret ................................. Employee: Vhi Healthcare.Sinusas, Albert J. ................................. Disclosed no conflict of interest.Sippl, Rachel M. ................................... Disclosed no conflict of interest.Sipula, Ian ............................................. Disclosed no conflict of interest.Siscovick, David S. ............................... Disclosed no conflict of interest.Sivertsen, Børge .................................... Disclosed no conflict of interest.Sivertsen, Jacob ................................... Disclosed no conflict of interest.Sjöholm, Kajsa ...................................... Stock/Shareholder: Pfizer, Inc.Sjöstrand, Annika .................................. Disclosed no conflict of interest.Sjöstrand, Mikaela ................................ Employee: AstraZeneca/Bristol-Meyers Squibb.Sjöström, David ..................................... Employee: AstraZeneca Pharmaceuticals LP; Stock/
Shareholder: AstraZeneca Pharmaceuticals LP.Sjostrom, Lars V. .................................. Board Member: Lenimen AB; Consultant: AstraZeneca
Pharmaceuticals LP; Speaker’s Bureau: AstraZeneca Pharmaceuticals LP, Johnson & Johnson.
Skentzos, Stephen ................................ Disclosed no conflict of interest.Skjøth, Trine V. ..................................... Employee: Novo Nordisk A/S; Stock/Shareholder: Novo
Nordisk A/S.Skog, Oskar ........................................... Disclosed no conflict of interest.Skoko, John J. ...................................... Disclosed no conflict of interest.Skøtt Pedersen, Grete ........................... Disclosed no conflict of interest.Skov, Lone ............................................. Advisory Panel: AbbVie, Janssen-Cilag A/S, Merck Sharp &
Skovlund, Soren E. ............................... Employee: Novo Nordisk A/S.Skrami, Edlira ........................................ Disclosed no conflict of interest.Skrha, Jan ............................................. Advisory Panel: Eli Lilly and Company, Novo Nordisk, Inc.;
Consultant: Eli Lilly and Company, Novo Nordisk, Inc.Skromna, Anna ...................................... Disclosed no conflict of interest.Skupien, Jan ......................................... Disclosed no conflict of interest.Skyler, Jay S. ........................................ Advisory Panel: Valeritas, LLC; Board Member: Danse
Slabaugh, Stephen L. ........................... Employee: Humana.Slagter, Sandra N. ................................ Disclosed no conflict of interest.Slama, Michael ..................................... Disclosed no conflict of interest.Slama, Rémy ......................................... Disclosed no conflict of interest.Slatcher, Richard ................................... Disclosed no conflict of interest.Slee, April ............................................. Disclosed no conflict of interest.Sletner, Line .......................................... Disclosed no conflict of interest.Slim, Ines .............................................. Advisory Panel: Novo Nordisk A/S.Slocum, Stephen L. .............................. Disclosed no conflict of interest.Sloop, Kyle W. ...................................... Employee: Eli Lilly and Company; Research Support: Eli Lilly
and Company; Stock/Shareholder: Eli Lilly and Company.Slover, Robert ........................................ Disclosed no conflict of interest.Slyne, Christine ..................................... Disclosed no conflict of interest.Slyvka, Yuriy .......................................... Disclosed no conflict of interest.Smahelova, Alena ................................. Disclosed no conflict of interest.Small, Peter K. ..................................... Disclosed no conflict of interest.Smart, Carmel ....................................... Disclosed no conflict of interest.Smart, Melissa ...................................... Disclosed no conflict of interest.Smiles, Adam M. ................................. Disclosed no conflict of interest.Smiley, Dawn ........................................ Advisory Panel: Boehringer Ingelheim Pharmaceuticals, Inc.,
Janssen Pharmaceuticals, Sanofi; Research Support: Abbott Nutrition, Merck, Sanofi.
Smink, Alexandra M. ........................... Disclosed no conflict of interest.Smir i -Duvnjak, Lea .............................. Advisory Panel: AstraZeneca Pharmaceuticals LP; Board
Member: Eli Lilly and Company, Novo Nordisk, Inc.;Consultant: Merck Sharp & Dohme Limited, Merck Sharp & Dohme Limited (Spouse/Partner), Novartis Pharma AG; Research Support: Merck Sharp & Dohme Limited; Speaker’s Bureau: AstraZeneca Pharmaceuticals LP, Novo Nordisk, Inc.
Smiris, Konstantinos ............................. Disclosed no conflict of interest.Smith, Albert ......................................... Disclosed no conflict of interest.Smith, Andrew ...................................... Disclosed no conflict of interest.Smith, Candice ...................................... Employee: Merck Sharp & Dohme Limited.Smith, Charles ....................................... Employee: Janssen Research & Development.Smith, David M. ................................... Employee: Truven Health Analytics.Smith, James F. .................................... Employee: Pfizer, Inc.Smith, Jessica ....................................... Disclosed no conflict of interest.Smith, Laura B. ..................................... Disclosed no conflict of interest.Smith, Lewis ......................................... Disclosed no conflict of interest.
Smith, Marta S. ................................... Disclosed no conflict of interest.Smith, Melissa ...................................... Disclosed no conflict of interest.Smith, Steven R. .................................. Disclosed no conflict of interest.Smith, Ulf .............................................. Disclosed no conflict of interest.Smouse, Hannah ................................... Disclosed no conflict of interest.Smulders, Yvo M. ................................. Disclosed no conflict of interest.Smyth, Graham ..................................... Disclosed no conflict of interest.Snarski, Emilian .................................... Disclosed no conflict of interest.Snegovskikh, Denis ............................... Disclosed no conflict of interest.Sneider, Michael B. .............................. Disclosed no conflict of interest.Snell-Bergeon, Janet K. ....................... Disclosed no conflict of interest.Snieder, Harold...................................... Disclosed no conflict of interest.Snikeris, Jaclyn ..................................... Disclosed no conflict of interest.Snitker, Soren ........................................ Disclosed no conflict of interest.Snow, Rodney J. .................................. Disclosed no conflict of interest.So, Wing-Yee ........................................ Disclosed no conflict of interest.Soare, Andreea ..................................... Disclosed no conflict of interest.Soares, Natasha ................................... Disclosed no conflict of interest.Sobki, Samia ......................................... Disclosed no conflict of interest.Sobngwi, Eugene .................................. Disclosed no conflict of interest.Socha, Luis A. ...................................... Disclosed no conflict of interest.Sodemann, Morten ............................... Disclosed no conflict of interest.Soedamah-Muthu, Sabita S. ............... Disclosed no conflict of interest.Soegondo, Sidartawan ......................... Advisory Panel: Bayer Health Care, LLC; Speaker’s Bureau:
Bayer Health Care, LLC.Soeters, Maarten R. ............................ Disclosed no conflict of interest.Soewondo, Pradana .............................. Advisory Panel: AstraZeneca/Bristol-Meyers Squibb, Novo
Nordisk A/S, Sanofi; Consultant: Merck Sharp & Dohme Limited; Speaker’s Bureau: AstraZeneca/Bristol-Meyers Squibb, Eli Lilly and Company, Merck Sharp & Dohme Limited, Novo Nordisk A/S, Sanofi.
Sogawa, Kenji ....................................... Disclosed no conflict of interest.Soh, Lip Min .......................................... Disclosed no conflict of interest.Soh, Shu E. ........................................... Disclosed no conflict of interest.Sohani, Zahra N. .................................. Disclosed no conflict of interest.Sohn, Min-Woong ................................. Disclosed no conflict of interest.Sohn, Tae Seo ....................................... Disclosed no conflict of interest.Soin, Avneet .......................................... Disclosed no conflict of interest.Soininen, Pasi ....................................... Disclosed no conflict of interest.Solano, Francis X. ................................ Stock/Shareholder: Johnson & Johnson.Solar, Chelsey........................................ Disclosed no conflict of interest.Solar, Svatopluk .................................... Disclosed no conflict of interest.Soldatovic, Ivan ..................................... Disclosed no conflict of interest.Soleymanlou, Nima ............................... Employee: Boehringer Ingelheim Pharmaceuticals, Inc.Soliman, William .................................. Employee: Eisai, Inc.Solin, Olof ............................................. Disclosed no conflict of interest.Solini, Anna ........................................... Advisory Panel: Boehringer Ingelheim Pharmaceuticals, Inc.;
Research Support: Bristol-Myers Squibb Company.Solis-Herrera, Carolina ......................... Disclosed no conflict of interest.Solomon, Scott D. ................................ Consultant: Amgen, Inc., Novartis Pharma AG; Research
Support: Abbott, Amgen, Inc., Boston Scientific, Daiichi-Sankyo, Inc., Lone Star Heart, NHLBI, Novartis Pharma AG, Sanofi, Theracos.
Solomon, Thomas P. ............................. Research Support: EFSD.Somal, Vikram S. .................................. Disclosed no conflict of interest.Somayaji, Veena ................................... Employee: Pfizer, Inc.; Stock/Shareholder: Pfizer, Inc.Somesh, B.P. ......................................... Disclosed no conflict of interest.Sommer, Christine ................................. Disclosed no conflict of interest.Somparn, Nuntiya ................................. Disclosed no conflict of interest.Son, Hyun Shik ...................................... Disclosed no conflict of interest.Son, Jang Won ..................................... Disclosed no conflict of interest.Son, JeeWoong..................................... Employee: Hanmi Pharmaceutical Co.Søndergaard, Esben .............................. Disclosed no conflict of interest.Sone, Hirohito ....................................... Disclosed no conflict of interest.Sone, Masakatsu .................................. Disclosed no conflict of interest.Sonenberg, Nahum ............................... Disclosed no conflict of interest.Song, An ................................................ Disclosed no conflict of interest.Song, Guangyao .................................... Disclosed no conflict of interest.Song, Haowei ........................................ Disclosed no conflict of interest.Song, Heein ........................................... Disclosed no conflict of interest.Song, Jen-Shin ...................................... Disclosed no conflict of interest.Song, Kee-Ho ........................................ Disclosed no conflict of interest.Song, Kexiu ........................................... Disclosed no conflict of interest.Song, Ki-Ho ........................................... Disclosed no conflict of interest.Song, Lige ............................................. Disclosed no conflict of interest.Song, Qianqian ...................................... Disclosed no conflict of interest.Song, Tammy ......................................... Disclosed no conflict of interest.Song, Yao G. ......................................... Disclosed no conflict of interest.Song, Yiqing .......................................... Disclosed no conflict of interest.Song, Young Mi ..................................... Disclosed no conflict of interest.Song, Youngshin ................................... Disclosed no conflict of interest.Song, Youngsup .................................... Disclosed no conflict of interest.
Song, Yuh-Min ...................................... Disclosed no conflict of interest.Song, Zhuolun E. .................................. Disclosed no conflict of interest.Sonne, David P. .................................... Disclosed no conflict of interest.Sonnenberg, Gabriele E. ...................... Employee: Pfizer, Inc.Sonnier, Tance ....................................... Disclosed no conflict of interest.Sonoda, Noriyuki ................................... Disclosed no conflict of interest.Sonstein, Lindsay K. ............................. Disclosed no conflict of interest.Soon, Danny .......................................... Employee: Eli Lilly and Company.Soprovich, Allison ................................. Disclosed no conflict of interest.Soran, Handrean ................................... Disclosed no conflict of interest.Sørensen, Henrik T. .............................. Disclosed no conflict of interest.Sørensen, Lars P. .................................. Disclosed no conflict of interest.Soria Contreras, Diana .......................... Disclosed no conflict of interest.Soria, Bernat ......................................... Disclosed no conflict of interest.Sorice, Gian Pio ..................................... Disclosed no conflict of interest.Soroka, Orysya ...................................... Disclosed no conflict of interest.Sosenko, Jay ......................................... Disclosed no conflict of interest.Sost, Mônica ......................................... Disclosed no conflict of interest.Sotiropoulos, lexis ............................... Disclosed no conflict of interest.Soto, Cristina L. .................................... Disclosed no conflict of interest.Souhami, Elisabeth ............................... Employee: Sanofi.Soupal, Jan ........................................... Consultant: Medtronic, Roche Pharmaceuticals, Sanofi.; Other
Relationship: Medtronic; Speaker’s Bureau: Sanofi.South, Mark A. ..................................... Disclosed no conflict of interest.Southam, Lorraine ................................. Disclosed no conflict of interest.Souza, Olivia F. ..................................... Disclosed no conflict of interest.Souza, Sandra C. .................................. Employee: Merck.Sowell, Margaret .................................. Employee: GlaxoSmithKline; Stock/Shareholder: GSK.Sowers, James R. ................................ Research Support: Merck.Spaans, Engelina A. ............................. Disclosed no conflict of interest.Spadafranca, Angela ............................ Disclosed no conflict of interest.Spadaro, Sara ....................................... Disclosed no conflict of interest.Spain, C. Victor ..................................... Employee: GlaxoSmithKline; Stock/Shareholder:
GlaxoSmithKline, Merck.Spano, Lucia .......................................... Disclosed no conflict of interest.Spanou, Marianna ................................ Disclosed no conflict of interest.Sparks, Avis E. ..................................... Disclosed no conflict of interest.Sparks, Lauren M. ................................ Disclosed no conflict of interest.Sparks, Steve M. ................................. Disclosed no conflict of interest.Sparre-Ulrich, Alexander H. ................. Disclosed no conflict of interest.Sparso, Thomas .................................... Disclosed no conflict of interest.Spat, Stephan ....................................... Disclosed no conflict of interest.Spears, Larry D. ................................... Disclosed no conflict of interest.Spector, Timothy D. .............................. Disclosed no conflict of interest.Speight, Jane ........................................ Advisory Panel: Roche Diagnostics Australia; Consultant:
Roche Diagnostics Australia; Other Relationship: Medtronic, MSD, Novo Nordisk A/S, Sanofi; Research Support: Roche Diagnostics Australia.
Spencer, Michael L. ............................. Disclosed no conflict of interest.Sperl-Hillen, JoAnn M. ........................ Disclosed no conflict of interest.Spertus, John A. .................................. Advisory Panel: United Healthcare; Consultant: Amgen, Inc.,
Genentech, Gilead Sciences, Inc.; Research Support: Eli Lilly and Company, Genentech, Gilead Sciences, Inc.
Spiegelman, Bruce M. ......................... Disclosed no conflict of interest.Spielman, Daniel ................................... Disclosed no conflict of interest.Spijker, Siebe ........................................ Disclosed no conflict of interest.Spinas, Giatgen ..................................... Consultant: AstraZeneca Pharmaceuticals LP, Eli Lilly and
Company, Merck, Novartis Pharmaceuticals Corporation, Novo Nordisk A/S, Sanofi, Servier; Research Support: Novo Nordisk A/S.
Spindler, Matthew ................................ Disclosed no conflict of interest.Spital, Glenn ......................................... Employee: Medtronic.Spite, Matthew ..................................... Disclosed no conflict of interest.Spivak, Aaron ........................................ Disclosed no conflict of interest.Spizzo, Tom............................................ Disclosed no conflict of interest.Sponton, Carlos H. ............................... Disclosed no conflict of interest.Spoto, Belinda ....................................... Disclosed no conflict of interest.Spraggins, Jeffrey ................................. Disclosed no conflict of interest.Spratt, Susan E. ................................... Research Support: Bristol Meyers Squibb Foundation, Sanofi.Springer, E. Joy ..................................... Disclosed no conflict of interest.Squires, Paul ......................................... Disclosed no conflict of interest.Sramkova, Petra .................................... Disclosed no conflict of interest.Sridhar, Sneha B. ................................. Disclosed no conflict of interest.Srinivasan, Gayathri .............................. Disclosed no conflict of interest.Srinivasan, Shubha ............................... Disclosed no conflict of interest.Srinonprasert, Varalak .......................... Disclosed no conflict of interest.Srivastava, Swayam P. ......................... Disclosed no conflict of interest.Sriwijitkamol, Apiradee ........................ Disclosed no conflict of interest.Srodulski, Sarah .................................... Disclosed no conflict of interest.Stacy, Mitchell ...................................... Disclosed no conflict of interest.Stadler, Marietta ................................... Disclosed no conflict of interest.Staecker, Hinrich ................................... Consultant: Novartis Pharmaceuticals Corporation.
Staels, Bart ........................................... Disclosed no conflict of interest.Stafford, Jeanette M. .......................... Disclosed no conflict of interest.Stager, William ..................................... Employee: Sanofi.Stahre, Christina ................................... Employee: AstraZeneca Pharmaceuticals LP.Staiger, Harald ...................................... Disclosed no conflict of interest.Staimez, Lisa R. .................................... Disclosed no conflict of interest.Stain, Steven C. ................................... Disclosed no conflict of interest.Stamateris, Rachel E. .......................... Disclosed no conflict of interest.Stamos, Michael J. .............................. Disclosed no conflict of interest.Stanczyk, Frank Z. ................................ Disclosed no conflict of interest.Standaert, Mary .................................... Disclosed no conflict of interest.Standfield, Scott ................................... Disclosed no conflict of interest.Standiford, Debra A. ............................ Disclosed no conflict of interest.Standl, Marie ........................................ Disclosed no conflict of interest.Standley, Robert A. .............................. Disclosed no conflict of interest.Stanford, Kristin I. ................................ Disclosed no conflict of interest.Stang, Paul E. ....................................... Employee: Janssen Research & Development.Stanley, Charles A. .............................. Disclosed no conflict of interest.Stanley, John ........................................ Disclosed no conflict of interest.Stanton, Robert C. ................................ Disclosed no conflict of interest.Stark Casagrande, Sarah ...................... Disclosed no conflict of interest.Starks, Rachel ....................................... Disclosed no conflict of interest.Starkstein, Sergio E. ............................ Disclosed no conflict of interest.Starnes, Angie ...................................... Disclosed no conflict of interest.Starup-Linde, Jakob .............................. Disclosed no conflict of interest.Stasinopoulos, Marilyn ......................... Disclosed no conflict of interest.Staten, Myrlene .................................... Disclosed no conflict of interest.Staup, Michael ...................................... Disclosed no conflict of interest.Stechemesser, Lars ............................... Consultant: Eli Lilly and Company, Roche Pharmaceuticals;
Stechl, Jens .......................................... Employee: Sanofi.Steck, Andrea K. .................................. Disclosed no conflict of interest.Steel, Jason .......................................... Disclosed no conflict of interest.Steele, Zachary D. ................................ Disclosed no conflict of interest.Steenkamp, Devin ................................. Disclosed no conflict of interest.Steers, W.N. ......................................... Disclosed no conflict of interest.Stefan, Norbert ..................................... Disclosed no conflict of interest.Stefanadis, Christodoulos ..................... Disclosed no conflict of interest.Stefanovic-Racic, Maja ......................... Disclosed no conflict of interest.Stefanovski, Darko ................................ Disclosed no conflict of interest.Stefanowicz, Magdalena ...................... Disclosed no conflict of interest.Steffen, Lyn ........................................... Disclosed no conflict of interest.Stehouwer, Coen D. ............................. Disclosed no conflict of interest.Steil, Garry M. ..................................... Advisory Panel: BD Medical Diabetes Care; Consultant: BD
Medical Diabetes Care.Stein, Daniel T. ..................................... Research Support: Merck; Speaker’s Bureau: Merck.Stein, Eden ............................................ Employee: LMC Diabetes & Endocrinology; Stock/
Shareholder: Novartis Pharmaceuticals Corporation.Stein, Joshua ........................................ Research Support: NIH.Steinberg, Helmut ................................. Employee: Merck.Steinberg, John S. ............................... Disclosed no conflict of interest.Steiner, Donald F. ................................. Disclosed no conflict of interest.Steiner, John F. ..................................... Disclosed no conflict of interest.Steinstraesser, Axel .............................. Consultant: Sanofi; Employee: Sanofi; Stock/Shareholder:
Sanofi.Stella, Peter .......................................... Employee: Boehringer Ingelheim GmbH & Co. KG.Stender, Monika .................................... Employee: GSK; Stock/Shareholder: GSK.Stender, Sarah R. ................................. Disclosed no conflict of interest.Stene, Lars C. ....................................... Disclosed no conflict of interest.Stengelin, Siegfried .............................. Employee: Sanofi.Stenlöf, Kaj ........................................... Disclosed no conflict of interest.Stentz, Frankie B. ................................. Disclosed no conflict of interest.Stenvers, Dirk Jan ................................. Disclosed no conflict of interest.Stenzl, Arnulf ........................................ Disclosed no conflict of interest.Stephens, Jacqueline M. ..................... Disclosed no conflict of interest.Stephens, Jeffrey .................................. Advisory Panel: Eli Lilly and Company, Novo Nordisk, Inc.,
Wales Advisory Board; Research Support: BUPA founda-tion; Speaker’s Bureau: AstraZeneca/Bristol-Meyers Squibb, Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Merck Sharp & Dohme Limited, Novo Nordisk, Inc.
Stephenson, Hannah ............................. Disclosed no conflict of interest.Stepniewski, Jacek ............................... Disclosed no conflict of interest.Sterling, Laura M. ................................ Disclosed no conflict of interest.Sternardi, Sara ...................................... Disclosed no conflict of interest.Sternlof, Steven .................................... Disclosed no conflict of interest.Sterrett, Andrew T. .............................. Disclosed no conflict of interest.Steven, Sarah ........................................ Disclosed no conflict of interest.Steven, Sebastian ................................. Disclosed no conflict of interest.
Stevens, Martin J. ............................... Disclosed no conflict of interest.Stevens, Robert D. ............................... Research Support: Pfizer, Inc.Stevenson, Victoria ............................... Disclosed no conflict of interest.Steverson, Dennis ................................. Disclosed no conflict of interest.Stewart, Andrew F. .............................. Disclosed no conflict of interest.Stewart, Andrew G. ............................. Disclosed no conflict of interest.Stewart, John ....................................... Employee: Sanofi; Stock/Shareholder: Sanofi.Stewart, Michael .................................. Disclosed no conflict of interest.Stewart, Murray W. ............................. Employee: GlaxoSmithKline, GlaxoSmithKline (Spouse/
Partner); Other Relationship: GlaxoSmithKline; Stock/Shareholder: GlaxoSmithKline, GlaxoSmithKline (Spouse/Partner).
Stewart, Rebecca L. ............................. Disclosed no conflict of interest.Stewart, Sunita M. .............................. Disclosed no conflict of interest.Stewart, Thomas ................................... Disclosed no conflict of interest.Stidsen, Jacob V. ................................. Disclosed no conflict of interest.Stier, Christine K. ................................. Disclosed no conflict of interest.Stirban, Alin O. ..................................... Advisory Panel: Diagnoptics, Wörwag Pharma; Other
Relationship: Abbott, Sanofi Aventis, Wörwag Pharma et Co KG; Research Support: Adocia, Becton, Dickinson and Company, Biocon, Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Dance Pharmaceuticals, Eli Lilly and Company, Evolva, F. Hoffmann-La Roche, Ltd., Johnson & Johnson, Marvel, Novartis Pharmaceuticals Corporation, Novo Nordisk, Inc., Sanofi, Servier; Speaker’s Bureau: Worwag Pharma.
Stitzel, Michael L. ................................ Disclosed no conflict of interest.Stochholm, Kirstine ............................... Disclosed no conflict of interest.Stockmann, Martin ............................... Disclosed no conflict of interest.Stoedkilde-Joergensen, Hans ............... Disclosed no conflict of interest.Stoey, Julie ........................................... Disclosed no conflict of interest.Stoffers, Doris A. ................................. Other Relationship: Amylin/Eli Lilly, Correlagen; Research
Support: Johnson & Johnson.Stolberg, Erhard .................................... Disclosed no conflict of interest.Stolte, Manuela .................................... Employee: Sanofi.Stone, Kirsten P. ................................... Disclosed no conflict of interest.Stone, Michael H. ................................ Disclosed no conflict of interest.Stoner, Julie A. .................................... Disclosed no conflict of interest.Størdal Lund, Randi ............................... Disclosed no conflict of interest.Størdal, Ketil ......................................... Disclosed no conflict of interest.Storgaard, Heidi .................................... Disclosed no conflict of interest.Storkholm, Jan ...................................... Disclosed no conflict of interest.Storm, Michael V. ................................ Consultant: Novo Nordisk, Inc.Storm, Petter ......................................... Disclosed no conflict of interest.Storti, Kristi L. ...................................... Disclosed no conflict of interest.Stout, Steven ........................................ Employee: Merck.Straczkowski, Marek ............................. Disclosed no conflict of interest.Strain, William D. ................................ Disclosed no conflict of interest.Strandberg, Charlotte ........................... Disclosed no conflict of interest.Strandjord, Sarah .................................. Disclosed no conflict of interest.Strange, Poul ......................................... Consultant: Valeritas, LLC.; Other Relationship: Medical
Director and President, Integrated Medical Development, LLC.
Stratmann, Bernd .................................. Disclosed no conflict of interest.Stratton, Irene M. ................................ Disclosed no conflict of interest.Strawbridge, Rona J. ........................... Disclosed no conflict of interest.Streeten, Elizabeth A. .......................... Disclosed no conflict of interest.Streisand, Randi .................................... Disclosed no conflict of interest.Stricker-Krongrad, Alain ........................ Disclosed no conflict of interest.Strickland, Lisa E. ................................. Disclosed no conflict of interest.Strock, Ellie ........................................... Consultant: CeQur, Ltd., Sanofi; Research Support: Sanofi.Stroebel, Robert J. ............................... Disclosed no conflict of interest.Strojek, Krzysztof .................................. Advisory Panel: Boehringer Ingelheim Pharmaceuticals, Inc.,
Eli Lilly and Company; Research Support: AstraZeneca/Bristol-Meyers Squibb; Speaker’s Bureau: Abbott Diabetes Care, Bayer Health Care, LLC, Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Novartis Pharma AG, Novo Nordisk, Inc., Sanofi, Serono, Servier.
Strom, Alexander .................................. Disclosed no conflict of interest.Strong, Jodi L. ...................................... Disclosed no conflict of interest.Strotmeyer, Elsa S. ............................... Disclosed no conflict of interest.Strowski, Mathias Z. ........................... Disclosed no conflict of interest.Struble, Geoffrey ................................... Employee: Janssen Research & Development.Strum, Matthew W. ............................. Consultant: Insulet Corporation, Medtronics, Tandem
Diabetes Care, Tandem Diabetes Care.Strzalka-Mrozik, Barbara ...................... Disclosed no conflict of interest.Stuart, Charles A. ................................ Disclosed no conflict of interest.Stuart, Ella ............................................ Disclosed no conflict of interest.Stuart, Jennifer ..................................... Disclosed no conflict of interest.Stubbe, Scott ........................................ Employee: Arena Pharmaceuticals, Inc.
Stuckey, Heather ................................... Disclosed no conflict of interest.Stuebe, Alison ....................................... Disclosed no conflict of interest.Stuhr, Andreas....................................... Employee: Sanofi; Stock/Shareholder: Roche Pharmaceuticals,
Sanofi.Stumvoll, Michael ................................. Disclosed no conflict of interest.Sturt, Jackie .......................................... Disclosed no conflict of interest.Su, Benli ................................................ Disclosed no conflict of interest.Su, Chang .............................................. Disclosed no conflict of interest.Su, Dongming ........................................ Disclosed no conflict of interest.Su, Junlei .............................................. Disclosed no conflict of interest.Su, Maxwell .......................................... Disclosed no conflict of interest.Su, Yee-Fun ........................................... Disclosed no conflict of interest.Suarez, Elizabeth ................................... Disclosed no conflict of interest.Suarez, Lorena ..................................... Disclosed no conflict of interest.Subaran, Sharmila C. ........................... Disclosed no conflict of interest.Subbarayan, Sreevidya ......................... Disclosed no conflict of interest.Subramaniam, Tavintharan ................... Disclosed no conflict of interest.Subramanian, Pushkala ........................ Disclosed no conflict of interest.Sudharsan, Bharath .............................. Disclosed no conflict of interest.Sudo, Tomomi........................................ Disclosed no conflict of interest.Suehs, Brandon ..................................... Employee: Humana; Stock/Shareholder: Humana.Suga, Tadashi ........................................ Disclosed no conflict of interest.Sugaya, Yoshiyuki ................................. Disclosed no conflict of interest.Sugg, Jennifer E. .................................. Employee: AstraZeneca Pharmaceuticals LP; Stock/
Shareholder: AstraZeneca Pharmaceuticals LP.Sugihara, Urara ..................................... Disclosed no conflict of interest.Sugimoto, Kazuhiro ............................... Disclosed no conflict of interest.Sugimoto, Toshitsugu............................ Disclosed no conflict of interest.Sugisawa, Chiho ................................... Disclosed no conflict of interest.Sugiyama, Seigo ................................... Disclosed no conflict of interest.Sugizaki, Kazu ....................................... Disclosed no conflict of interest.Suh, Kyung-Shin .................................... Disclosed no conflict of interest.Suhai, Ferenc I. .................................... Disclosed no conflict of interest.Sui, Chunhua ......................................... Disclosed no conflict of interest.Sujjitjoon, Jatuporn .............................. Disclosed no conflict of interest.Sukumar, N. .......................................... Disclosed no conflict of interest.Sukumar, Piruthivi ................................. Disclosed no conflict of interest.Sul, Hei Sook ......................................... Disclosed no conflict of interest.Suleiman, Mara .................................... Disclosed no conflict of interest.Sullivan, Brooke A. ............................... Disclosed no conflict of interest.Sullivan, Catherine A. .......................... Disclosed no conflict of interest.Sullivan, Christina L. ............................ Disclosed no conflict of interest.Sullivan, Daniel ..................................... Employee: Janssen Research & Development, LLC.Sullivan, David ...................................... Consultant: Abbott Laboratories, Inc., Amgen, Inc., Merck
Sharp & Dohme Limited; Other Relationship: Abbott Laboratories, Inc., Merck Sharp & Dohme Limited; Research Support: Amarin, Amgen, Inc., Eli Lilly & Company, Merck Sharp & Dohme Limited.
Sullivan, Mary M. ................................ Disclosed no conflict of interest.Sum, Chee Fang .................................... Disclosed no conflict of interest.Suman, Amitabh ................................... Disclosed no conflict of interest.Sumita, Takashi ..................................... Disclosed no conflict of interest.Sumitani, Yoshikazu .............................. Disclosed no conflict of interest.Sumner, Anne E. ................................... Disclosed no conflict of interest.Šumník, Zdenek ..................................... Disclosed no conflict of interest.Sun, Bei ................................................. Disclosed no conflict of interest.Sun, Gordon H. ..................................... Employee: Partnership for Health Analytic Research, LLC.Sun, Grace E. ........................................ Disclosed no conflict of interest.Sun, Haiyan ........................................... Disclosed no conflict of interest.Sun, Jennifer K. ................................... Advisory Panel: Eisai, Inc., Novartis Pharmaceuticals
Corporation; Consultant: Novartis Pharmaceuticals Corporation; Research Support: Boston Micromachines, Genentech, Optovue.
Sun, Jian ............................................... Disclosed no conflict of interest.Sun, Jinhong ......................................... Disclosed no conflict of interest.Sun, Juan .............................................. Disclosed no conflict of interest.Sun, Jui-Hung ....................................... Research Support: Astellas Pharma Taiwan, Inc., AstraZeneca
Taiwan Ltd., Eli Lilly and Company, Lotus Pharmaceutical Co., Ltd., Novartis Pharmaceuticals Corporation, Novo Nordisk, Inc.
Sun, Lei ................................................. Disclosed no conflict of interest.Sun, Li-ping ........................................... Employee: Merck.Sun, Peng .............................................. Disclosed no conflict of interest.Sun, Peter .............................................. Research Support: Eli Lilly and Company, Merck, Novartis
Pharmaceuticals Corporation, Novo Nordisk, Inc., Pfizer, Inc.
Sun, Vinsin A. ....................................... Disclosed no conflict of interest.Sun, Wanjie........................................... Disclosed no conflict of interest.Sun, Wanping........................................ Disclosed no conflict of interest.Sun, Wei................................................ Disclosed no conflict of interest.Sun, Xiu Qin .......................................... Disclosed no conflict of interest.Sun, Zilin ............................................... Disclosed no conflict of interest.
Sunagawa, Hiroshi ................................ Disclosed no conflict of interest.Sundararajan, Pragalath ....................... Disclosed no conflict of interest.Sundaresh, Vishnu ................................ Disclosed no conflict of interest.Sundbom, Magnus ................................ Disclosed no conflict of interest.Sung, Yeon Ah ....................................... Disclosed no conflict of interest.Suni, C. ................................................. Disclosed no conflict of interest.Sunkara, Manjula .................................. Disclosed no conflict of interest.Sunli, Yongjuan ..................................... Disclosed no conflict of interest.Sunny, Nishanth E. ............................... Disclosed no conflict of interest.Suraci, Concetta .................................... Disclosed no conflict of interest.Suryana, Eurwin .................................... Disclosed no conflict of interest.Susuta, Yutaka ...................................... Disclosed no conflict of interest.Sutanto, Surya ...................................... Disclosed no conflict of interest.Sutton, Angela ...................................... Disclosed no conflict of interest.Sutton, Beth S. ..................................... Disclosed no conflict of interest.Suzuki, Akiko ......................................... Disclosed no conflict of interest.Suzuki, Chieko ....................................... Disclosed no conflict of interest.Suzuki, Hiromi ....................................... Disclosed no conflict of interest.Suzuki, Hiroshi ...................................... Disclosed no conflict of interest.Suzuki, Jun ............................................ Disclosed no conflict of interest.Suzuki, Junichi ...................................... Disclosed no conflict of interest.Suzuki, Keisuke ..................................... Disclosed no conflict of interest.Suzuki, Kiyoshi ...................................... Disclosed no conflict of interest.Suzuki, Kunihiro .................................... Disclosed no conflict of interest.Suzuki, Masako ..................................... Disclosed no conflict of interest.Suzuki, Sadao ........................................ Disclosed no conflict of interest.Suzuki, Shuichi ...................................... Employee: Eli Lilly and Company.Suzuki, Tatsuro ...................................... Disclosed no conflict of interest.Suzuki, Tatsurou .................................... Disclosed no conflict of interest.Suzuki, Toru ........................................... Disclosed no conflict of interest.Suzuki, Yuka .......................................... Disclosed no conflict of interest.Svacina, Stepan .................................... Disclosed no conflict of interest.Svare, Jens A. ...................................... Disclosed no conflict of interest.Svehlikova, Eva ..................................... Disclosed no conflict of interest.Svendgaard, Mette ............................... Disclosed no conflict of interest.Svendsen, Anne Louise ......................... Employee: Novo Nordisk A/S; Stock/Shareholder: Novo
Nordisk A/S.Svendsen, Berit ..................................... Disclosed no conflict of interest.Svensson, Ann-Marie ........................... Disclosed no conflict of interest.Svensson, Jannet .................................. Disclosed no conflict of interest.Svensson, Katrin J. .............................. Disclosed no conflict of interest.Svensson, Maria K. .............................. Disclosed no conflict of interest.Svensson, Per-Arne ............................... Disclosed no conflict of interest.Swaminathan, Balakumar ..................... Disclosed no conflict of interest.Swaraj, Soji ........................................... Advisory Panel: Novo Nordisk A/S; Speaker’s Bureau:
Novartis Pharmaceuticals Corporation.Swarbrick, Michael M. ........................ Disclosed no conflict of interest.Swartling, Ulrica ................................... Disclosed no conflict of interest.Sweet, Ian ............................................. Disclosed no conflict of interest.Swensen, Adam .................................... Disclosed no conflict of interest.Swett, Katrina ....................................... Disclosed no conflict of interest.Swift, Larry L. ....................................... Disclosed no conflict of interest.Syed, Farooq ......................................... Disclosed no conflict of interest.Syeda, Mahrukh .................................... Disclosed no conflict of interest.Sykes, Andy ........................................... Disclosed no conflict of interest.Sykes, Kevin .......................................... Disclosed no conflict of interest.Sylvia, Victor L. .................................... Disclosed no conflict of interest.Syrén, Annika ........................................ Employee: Novo Nordisk A/S.Szabo, Antal .......................................... Advisory Panel: 77 Electronics, Ltd.Szadkowska, Agnieszka ........................ Disclosed no conflict of interest.Szanda, Gerg ........................................ Disclosed no conflict of interest.Szanton, Sarah ...................................... Disclosed no conflict of interest.Szczepaniak, Edward W. ...................... Disclosed no conflict of interest.Szczepaniak, Lidia S. ............................ Disclosed no conflict of interest.Szczurek, Mary R. ................................ Disclosed no conflict of interest.Szelachowska, Malgorzata ................... Disclosed no conflict of interest.Szendroedi, Julia .................................. Disclosed no conflict of interest.Szeto, Angela ........................................ Disclosed no conflict of interest.Szeto, Daphne ....................................... Employee: Merck.Szeto, Linda ........................................... Disclosed no conflict of interest.Szetu, John ........................................... Disclosed no conflict of interest.Szewczyk, Leszek .................................. Disclosed no conflict of interest.Szmitkowski, Maciej ............................. Disclosed no conflict of interest.Szopa, Magdalena ................................ Disclosed no conflict of interest.Szwergold, Benjamin S. ....................... Disclosed no conflict of interest.Szymanska-Garbacz, Elektra ................. Disclosed no conflict of interest.Szypowska, Agniesksa .......................... Disclosed no conflict of interest.Taa, H. Rob ............................................ Disclosed no conflict of interest.Tabara, Yasuharu................................... Disclosed no conflict of interest.Tabarkiewicz, Jacek .............................. Disclosed no conflict of interest.Tabassum, Juveria ................................ Disclosed no conflict of interest.Tachibana, Hiromi ................................. Disclosed no conflict of interest.
Tack, Cees J. ........................................ Disclosed no conflict of interest.Tacke, Frank........................................... Disclosed no conflict of interest.Taddei, Stefano ..................................... Disclosed no conflict of interest.Tadler, Friedrich ..................................... Disclosed no conflict of interest.Tagawa, Atsuko..................................... Disclosed no conflict of interest.Tagaya, Yuko ......................................... Disclosed no conflict of interest.Tagett, Rebecca..................................... Disclosed no conflict of interest.Taguchi, Koichiro ................................... Disclosed no conflict of interest.Tahara, Yumiko ...................................... Disclosed no conflict of interest.Tahrani, Abd A. .................................... Disclosed no conflict of interest.Tai, E. Shyong ........................................ Advisory Panel: AstraZeneca/Bristol-Meyers Squibb, Novo
Nordisk, Inc.Tai, Joseph ............................................ Disclosed no conflict of interest.Taila, Matthew ...................................... Disclosed no conflict of interest.Taitel, Michael S. ................................. Employee: Walgreens; Stock/Shareholder: Walgreens.Tajima, Naoko ....................................... Advisory Panel: Eli Lilly and Company, Novo Nordisk A/S,
Sanofi; Consultant: MSD K.K., Ono Pharmaceutical Co., Ltd.; Speaker’s Bureau: Astellas Pharma Inc., Daiichi-Sankyo, Inc., Dainippon Sumitomo Pharma Co., Ltd., Eli Lilly and Company, Kissei Pharmaceutical Co., Ltd., MSD K.K., Nippon Boehringer Ingelheim Co., Ltd., Novo Nordisk A/S, Ono Pharmaceutical Co., Ltd., Sanofi, Taisho, Takeda Pharmaceutical Company, Ltd.
Tajiri, Yuji............................................... Disclosed no conflict of interest.Takada, Shingo ...................................... Disclosed no conflict of interest.Takagi, Ayano ........................................ Disclosed no conflict of interest.Takaguri, Akira ...................................... Disclosed no conflict of interest.Takahara, Kazuna .................................. Disclosed no conflict of interest.Takahara, Mitsuyoshi ............................ Disclosed no conflict of interest.Takahashi, Atsushi ................................ Disclosed no conflict of interest.Takahashi, Eri ........................................ Disclosed no conflict of interest.Takahashi, Hirokazu .............................. Disclosed no conflict of interest.Takahashi, Kaoru ................................... Disclosed no conflict of interest.Takahashi, Kazuma................................ Disclosed no conflict of interest.Takahashi, Kazuto ................................. Disclosed no conflict of interest.Takahashi, Keisuke................................ Disclosed no conflict of interest.Takahashi, Masaki ................................ Employee: Sanwa Kagaku Kenkyusho Co., Ltd.Takahashi, Masashige .......................... Disclosed no conflict of interest.Takahashi, Nahoko ................................ Disclosed no conflict of interest.Takahashi, Noriko.................................. Disclosed no conflict of interest.Takahashi, Shin-iciro ............................. Disclosed no conflict of interest.Takahashi, Shori .................................... Disclosed no conflict of interest.Takahashi, Yoshihiko ............................. Disclosed no conflict of interest.Takaki, Ione ........................................... Disclosed no conflict of interest.Takakura, Shoji ...................................... Disclosed no conflict of interest.Takamoto, Iseki ..................................... Disclosed no conflict of interest.Takamura, Hiroshi ................................. Disclosed no conflict of interest.Takamura, Yusuke ................................. Disclosed no conflict of interest.Takane, Hiroshi...................................... Disclosed no conflict of interest.Takane, Karen K. .................................. Disclosed no conflict of interest.Takane, Karen........................................ Disclosed no conflict of interest.Takasawa, Shin ..................................... Disclosed no conflict of interest.Takasu, Chie .......................................... Disclosed no conflict of interest.Takasu, Mizuki....................................... Disclosed no conflict of interest.Takasu, Toshiyuki .................................. Disclosed no conflict of interest.Takata, Hiroshi ...................................... Disclosed no conflict of interest.Takata, Yasunori .................................... Disclosed no conflict of interest.Takayanagi, Kan .................................... Disclosed no conflict of interest.Takbou, Karim........................................ Disclosed no conflict of interest.Take, Kazumi ......................................... Disclosed no conflict of interest.Takebayashi, Kohzo ............................... Disclosed no conflict of interest.Takeda, Jun ........................................... Disclosed no conflict of interest.Takeda, Koji ........................................... Disclosed no conflict of interest.Takeda, Maiko ....................................... Disclosed no conflict of interest.Takeda, Yasuo ....................................... Disclosed no conflict of interest.Takeda, Yoshiyu..................................... Disclosed no conflict of interest.Takehiro, Takehiro ................................. Disclosed no conflict of interest.Takemoto, Minoru ................................. Disclosed no conflict of interest.Takeshi, Kondo ...................................... Disclosed no conflict of interest.Takihata, Masahiro ............................... Speaker’s Bureau: Boehringer Ingelheim GmbH & Co. KG, Eli
Takikawa, Akiko .................................... Disclosed no conflict of interest.Takiyama, Yumi ..................................... Disclosed no conflict of interest.Talal, Talal K. ........................................ Disclosed no conflict of interest.Talavera, Gregory A. ............................ Disclosed no conflict of interest.Talukdar, Saswata ................................. Employee: Pfizer, Inc.; Stock/Shareholder: Pfizer, Inc.Talwar, Nidhi ......................................... Disclosed no conflict of interest.Tam, Claudia H. .................................... Disclosed no conflict of interest.
Tam, Joseph .......................................... Disclosed no conflict of interest.Tamaki, Motoyuki .................................. Disclosed no conflict of interest.Tamanaha, Tamiko ................................ Disclosed no conflict of interest.Tamarina, Natalia A. ............................ Disclosed no conflict of interest.Tambascia, Marcos ............................... Advisory Panel: Eli Lilly and Company, Novo Nordisk, Inc.,
Sanofi; Board Member: Boehringer Ingelheim Pharmaceuticals, Inc., Takeda Pharmaceuticals U.S.A., Inc.; Speaker’s Bureau: Eli Lilly and Company, Novo Nordisk, Inc., Sanofi.
Tamborlane, William V. ........................ Consultant: Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Medtronic, Novo Nordisk A/S, Sanofi, Takeda Pharmaceuticals U.S.A., Inc.
Tamura, Ayako ....................................... Disclosed no conflict of interest.Tamura, Azusa ....................................... Employee: Teijin Pharma Limited.Tamura, Yoshiaki .................................. Disclosed no conflict of interest.Tamura, Yoshifumi................................. Speaker’s Bureau: AstraZeneca Pharmaceuticals LP,
Tan, Chuen Seng ................................... Disclosed no conflict of interest.Tan, Huiwen .......................................... Disclosed no conflict of interest.Tan, Kris................................................. Disclosed no conflict of interest.Tan, Lai Hock ......................................... Employee: Eli Lilly and Company.Tan, Yi .................................................... Disclosed no conflict of interest.Tanabe, Naohito .................................... Disclosed no conflict of interest.Tanaka, Daisuke .................................... Disclosed no conflict of interest.Tanaka, Keiji .......................................... Disclosed no conflict of interest.Tanaka, Muhei....................................... Disclosed no conflict of interest.Tanaka, Sachiko .................................... Disclosed no conflict of interest.Tanaka, Shiro......................................... Disclosed no conflict of interest.Tanaka, Takayuki ................................... Disclosed no conflict of interest.Tanaka, Tomoko ..................................... Disclosed no conflict of interest.Tanaka, Toshiaki .................................... Disclosed no conflict of interest.Tanaka, Yoshinobu ................................ Disclosed no conflict of interest.Tanaka, Yuki .......................................... Disclosed no conflict of interest.Tandon, Nikhil ....................................... Disclosed no conflict of interest.Taneichi, Haruhito ................................. Disclosed no conflict of interest.Tanenberg, Robert J. ............................ Disclosed no conflict of interest.Tang, Audrey ......................................... Disclosed no conflict of interest.Tang, Chin.............................................. Disclosed no conflict of interest.Tang, Jackson........................................ Research Support: Merck.Tang, Junling ......................................... Disclosed no conflict of interest.Tang, Shiue-Cheng ................................ Disclosed no conflict of interest.Tang, Tianyi ........................................... Disclosed no conflict of interest.Tang, Tricia S. ....................................... Disclosed no conflict of interest.Tang, Wern Ee ....................................... Disclosed no conflict of interest.Tang, Xixiang ......................................... Disclosed no conflict of interest.Tang, Xi-Xiang ....................................... Disclosed no conflict of interest.Tang, Yong ............................................. Disclosed no conflict of interest.Tang, Yunan ........................................... Disclosed no conflict of interest.Tangen, Samantha E. ........................... Disclosed no conflict of interest.Tangjittipokin, Watip ............................. Disclosed no conflict of interest.Tanigawa, Takeshi ................................. Disclosed no conflict of interest.Taniguchi, Akiko .................................... Disclosed no conflict of interest.Taniguchi, Shin-ichi ............................... Disclosed no conflict of interest.Taniguchi, Yukiko................................... Disclosed no conflict of interest.Tanioka, Toshihiro ................................ Disclosed no conflict of interest.Taniyama, Matsuo................................. Disclosed no conflict of interest.Tank, Jens ............................................. Disclosed no conflict of interest.Tanner, Charles J. ................................ Disclosed no conflict of interest.Tansey, Michael J. ............................... Disclosed no conflict of interest.Tanton, Damon ...................................... Consultant: Asante Solutions, Dexcom, Inc.; Speaker’s
Tanwir, Mansoor ................................... Disclosed no conflict of interest.Tao, Hong .............................................. Disclosed no conflict of interest.Taplin, Craig E. ..................................... Disclosed no conflict of interest.Tarabra, Elena ....................................... Disclosed no conflict of interest.Tarakanova, Vera L. .............................. Disclosed no conflict of interest.Tarasow, Eugeniusz ............................... Disclosed no conflict of interest.Tarnoki, Adam D. .................................. Disclosed no conflict of interest.Tarnoki, David L. ................................... Disclosed no conflict of interest.Tarnow, Lise .......................................... Disclosed no conflict of interest.Tarussio, David ...................................... Disclosed no conflict of interest.
Tasaki, Mai ............................................ Disclosed no conflict of interest.Tasyurek, Hale ....................................... Disclosed no conflict of interest.Tate, Donna B. ...................................... Disclosed no conflict of interest.Tateishi, Tetsunori ................................. Disclosed no conflict of interest.Tater, Priyanka ....................................... Disclosed no conflict of interest.Tatosian, Daniel .................................... Employee: Merck.Tatsuoka, Hisato.................................... Disclosed no conflict of interest.Taub, Pam .............................................. Stock/Shareholder: Cardero Therapeutics.Taura, Daisuke....................................... Disclosed no conflict of interest.Tauscher, Roy ........................................ Disclosed no conflict of interest.Tauschmann, Martin ............................. Disclosed no conflict of interest.Tavakkolizadeh, Ali................................ Disclosed no conflict of interest.Tavakoli, Mitra ...................................... Disclosed no conflict of interest.Taveau, Christopher .............................. Disclosed no conflict of interest.Tavintharan, Subramaniam ................... Disclosed no conflict of interest.Taxy, Jerome ......................................... Disclosed no conflict of interest.Tay, Jason.............................................. Disclosed no conflict of interest.Taylor, Ann G. ....................................... Disclosed no conflict of interest.Taylor, Kent D. ...................................... Disclosed no conflict of interest.Taylor, Leland ........................................ Disclosed no conflict of interest.Taylor, Roy ............................................. Disclosed no conflict of interest.Teare, Julian.......................................... Research Support: GI Dynamics.Tedeschi, Anna ...................................... Disclosed no conflict of interest.Teel, Cynthia.......................................... Disclosed no conflict of interest.Teerawattananon, Yot ........................... Disclosed no conflict of interest.Teh, Ming Ming ..................................... Disclosed no conflict of interest.Teichert, Lenore..................................... Employee: Sanofi.Teigland, Christie .................................. Disclosed no conflict of interest.Tejera, Cristina ...................................... Disclosed no conflict of interest.Tejos, Cristian........................................ Disclosed no conflict of interest.Telejko, Beata........................................ Disclosed no conflict of interest.Teles, Ricardo ........................................ Disclosed no conflict of interest.Tellechea, Ana....................................... Disclosed no conflict of interest.Teló, Gabriela H. .................................. Disclosed no conflict of interest.Temprosa, Ella ....................................... Disclosed no conflict of interest.Ten Eyck, Laura ..................................... Disclosed no conflict of interest.Teng, Ruifeng ........................................ Employee: NIDDK.Teng, Si-Yong ........................................ Disclosed no conflict of interest.Tennagels, Norbert................................ Employee: Sanofi.Tentolouris, Nicholas ............................ Disclosed no conflict of interest.Teodorescu, Cristina.............................. Disclosed no conflict of interest.Teoh, Henry ........................................... Disclosed no conflict of interest.Teoh, Kristine ........................................ Disclosed no conflict of interest.Teoh, Narci ............................................ Disclosed no conflict of interest.Terada, Tasuku ...................................... Research Support: Medtronic.Terada, Yoshio ....................................... Disclosed no conflict of interest.Terami, Naoto........................................ Disclosed no conflict of interest.Terauchi, Yasuo ..................................... Research Support: Astellas Pharmaceuticals, AstraZeneca
Terawaki, Yuichi .................................... Disclosed no conflict of interest.Terruzzi, Ileana ...................................... Disclosed no conflict of interest.Terry, James G. .................................... Disclosed no conflict of interest.Tesauro, Manfredi ................................. Disclosed no conflict of interest.Teschemaker, Anna ............................... Employee: Janssen Global Services, LLC.Tesfaye, Nola ........................................ Disclosed no conflict of interest.Tesfaye, Solomon .................................. Research Support: NeuroMetrix.Teslovich, Tanya M. ............................. Disclosed no conflict of interest.Tess, David A. ...................................... Employee: Pfizer, Inc.Testa, Alessandra.................................. Disclosed no conflict of interest.Testa, Marcia A. ................................... Disclosed no conflict of interest.Tesz, Gregory ......................................... Employee: Pfizer, Inc.Tfayli, Hala ............................................ Disclosed no conflict of interest.Thabit, Hood .......................................... Disclosed no conflict of interest.
Thadhani, Ravi ...................................... Disclosed no conflict of interest.Thai, Ngoc ............................................. Disclosed no conflict of interest.Thakur, Vikram ....................................... Disclosed no conflict of interest.Thalén, Pia ............................................ Employee: AstraZeneca Pharmaceuticals LP.Thaler, Joshua P. .................................. Disclosed no conflict of interest.Thambundit, Apisadaporn ..................... Disclosed no conflict of interest.Thangiah, Geetha .................................. Disclosed no conflict of interest.Thapar, Garima ...................................... Disclosed no conflict of interest.Thatcher, Mikayla.................................. Disclosed no conflict of interest.Thayer, Debra ........................................ Disclosed no conflict of interest.Thearle, Marie S. ................................. Disclosed no conflict of interest.Thein, Shermaine .................................. Disclosed no conflict of interest.Therasse, Ashley ................................... Disclosed no conflict of interest.Thethi, Tina ........................................... Consultant: Pamlab, LLC.Theurey, Pierre ...................................... Disclosed no conflict of interest.Thevenet, Julien ................................... Disclosed no conflict of interest.Thielen, Lance ....................................... Disclosed no conflict of interest.Thiemann, Sandra ................................. Employee: Boehringer Ingelheim GmbH & Co. KG.Thivolet, Charles ................................... Disclosed no conflict of interest.Thom, David H. ..................................... Disclosed no conflict of interest.Thomas, Abraham ................................. Disclosed no conflict of interest.Thomas, Anthony .................................. Disclosed no conflict of interest.Thomas, Cecil ........................................ Disclosed no conflict of interest.Thomas, David ...................................... Disclosed no conflict of interest.Thomas, Inas ......................................... Disclosed no conflict of interest.Thomas, J. ............................................ Disclosed no conflict of interest.Thomas, John F. ................................... Disclosed no conflict of interest.Thomas, Michael .................................. Disclosed no conflict of interest.Thomas, Prem ....................................... Disclosed no conflict of interest.Thomas, Sheikilya ................................. Disclosed no conflict of interest.Thomas, Stephen .................................. Disclosed no conflict of interest.Thomas, William ................................... Disclosed no conflict of interest.Thompson, David M. ............................ Disclosed no conflict of interest.Thompson, Joanice ............................... Research Support: Sanofi.Thompson, Sharon E. ........................... Disclosed no conflict of interest.Thompson, Sharon ................................ Disclosed no conflict of interest.Thompson, Ted ...................................... Disclosed no conflict of interest.Thompson, Theodore ............................ Disclosed no conflict of interest.Thomsen, Henrik H. ............................. Disclosed no conflict of interest.Thomsen, Reimar W. ........................... Disclosed no conflict of interest.Thong, Ken Y. ....................................... Speaker’s Bureau: Novo Nordisk A/S.Thorand, Barbara .................................. Disclosed no conflict of interest.Thorens, Bernard ................................... Disclosed no conflict of interest.Thoreson, Caroline K. ........................... Disclosed no conflict of interest.Thorn, Stephanie R. ............................. Disclosed no conflict of interest.Thornalley, Paul J. ............................... Disclosed no conflict of interest.Thorpe, Roland ...................................... Disclosed no conflict of interest.Thorpe, Suzanne ................................... Disclosed no conflict of interest.Thorsted, Brian L. ................................. Employee: Novo Nordisk A/S; Stock/Shareholder: Novo
Nordisk A/S.Thorsteinsson, Birger ............................ Advisory Panel: Eli Lilly and Company.Thosani, Sonali ..................................... Disclosed no conflict of interest.Thourani, Vinod ..................................... Disclosed no conflict of interest.Thrasher, James .................................... Advisory Panel: Medtronic; Consultant: Medtronic; Research
Support: Medtronic.Throop, Andrea ..................................... Disclosed no conflict of interest.Thuillier, Dorothee................................. Disclosed no conflict of interest.Thulaseedharan, N.K. .......................... Disclosed no conflict of interest.Thum, Thomas ....................................... Disclosed no conflict of interest.Thurheimer, Jennifer L. ........................ Disclosed no conflict of interest.Thurner, Matthias.................................. Disclosed no conflict of interest.Thurnheer, Martin ................................. Disclosed no conflict of interest.Thway Tint, Mya ................................... Disclosed no conflict of interest.Thyagarajan, Bharat .............................. Disclosed no conflict of interest.Thyfault, John P.P. ................................ Disclosed no conflict of interest.Thyssen, Jacob P. ................................. Disclosed no conflict of interest.Tian, Haoming ....................................... Disclosed no conflict of interest.Tian, Ling ............................................... Disclosed no conflict of interest.Tichy, Eileen M. .................................... Disclosed no conflict of interest.Tierney, Edward ..................................... Disclosed no conflict of interest.Tierney, Marie ....................................... Disclosed no conflict of interest.Tiesma, Scott ........................................ Employee: Data Sciences International; Stock/Shareholder:
Data Sciences International.Tildesley, Hamish G. ............................ Disclosed no conflict of interest.Tildesley, Hugh D. ................................ Disclosed no conflict of interest.Till, Holger ............................................. Disclosed no conflict of interest.Timar, Bogdan ....................................... Disclosed no conflict of interest.Timar, Romulus ...................................... Disclosed no conflict of interest.Timpson, Nic ......................................... Disclosed no conflict of interest.Tinahones, Francisco J. ....................... Disclosed no conflict of interest.Tinati, Tannaze ...................................... Disclosed no conflict of interest.Tinetti, Matias ....................................... Disclosed no conflict of interest.
Tinnes, Kai ............................................. Disclosed no conflict of interest.Tint, Mya-Thway ................................... Disclosed no conflict of interest.Tippetts, Trevor...................................... Disclosed no conflict of interest.Tirinato, Domenico ................................ Disclosed no conflict of interest.Tirrel, David A. ..................................... Disclosed no conflict of interest.Tischkau, Shelley .................................. Disclosed no conflict of interest.Titchenell, Paul M. ............................... Disclosed no conflict of interest.T’joen, Caroline L. ................................ Employee: Bristol-Myers Squibb Company.Tjosvold, Lisa ........................................ Disclosed no conflict of interest.Tobacman, Joanne K. ........................... Disclosed no conflict of interest.Tobe, Kazuyuki....................................... Research Support: Astellas Pharma US, Inc.; Speaker’s
Tobias, Deirdre K. ................................. Disclosed no conflict of interest.Tobias, Douglas J. ................................ Disclosed no conflict of interest.Tobin, Garry S. ...................................... Advisory Panel: Roche Pharmaceuticals; Speaker’s Bureau:
Dexcom, Inc., Janssen Pharmaceuticals, Medtronic, Novo Nordisk, Inc., Santarus, Inc.
Tobolski, Jared ...................................... Disclosed no conflict of interest.Tochiya, Mayu ....................................... Disclosed no conflict of interest.Toda, Hitoshi ......................................... Disclosed no conflict of interest.Toda, Kyoko ........................................... Disclosed no conflict of interest.Todd, Jennifer N. ................................. Disclosed no conflict of interest.Todenhöfer, Tilman ................................ Disclosed no conflict of interest.Toffanin, Chiara ..................................... Disclosed no conflict of interest.Toh, Sue-Anne Ee Shiow ...................... Disclosed no conflict of interest.Tohgi, Noriaki ........................................ Disclosed no conflict of interest.Tokai, Emi .............................................. Disclosed no conflict of interest.Tokarski, Kristin ..................................... Disclosed no conflict of interest.Tokubuchi, Ichiro ................................... Disclosed no conflict of interest.Tokumoto, Shinsuke .............................. Disclosed no conflict of interest.Tokuyama, Kumpei ................................ Disclosed no conflict of interest.Toledo, Frederico G. ............................. Disclosed no conflict of interest.Tom, Lisa ............................................... Disclosed no conflict of interest.Tomas, Eva ............................................ Disclosed no conflict of interest.Tomaschitz, Andreas ............................. Disclosed no conflict of interest.Tomasselli, Alfredo G. .......................... Consultant: Metabolic Solutions Development Co.Tomasso, Vanessa ................................. Disclosed no conflict of interest.Tomic, Martina ...................................... Disclosed no conflict of interest.Tomikawa, Shinji ................................... Disclosed no conflict of interest.Tomita, Masuomi .................................. Disclosed no conflict of interest.Tomita, Tsutomu .................................... Disclosed no conflict of interest.Tomky, Donna M. ................................. Advisory Panel: Medtronic, Perrigo Diabetes, Sanofi;
Tomolo, Anne M. .................................. Disclosed no conflict of interest.Tomotsune, Takanori ............................. Disclosed no conflict of interest.Tomuta, Nora......................................... Disclosed no conflict of interest.Tonarely, Niza A. .................................. Disclosed no conflict of interest.Tong, Cindy ............................................ Employee: Janssen Research & Development, LLC.Tong, Peter C. ....................................... Disclosed no conflict of interest.Tong, Xin................................................ Disclosed no conflict of interest.Tong, Yuzhen ......................................... Disclosed no conflict of interest.Top, Wiebe M. ..................................... Disclosed no conflict of interest.Topalov, Drina........................................ Disclosed no conflict of interest.Topolcan, Ondrej ................................... Disclosed no conflict of interest.Torekov, Signe S. .................................. Disclosed no conflict of interest.Torjman, Marc ....................................... Consultant: Echo Therapeutics, Inc.; Research Support: Echo
Therapeutics, Inc.Torlone, Elisabetta ................................ Disclosed no conflict of interest.Tornøe, Karen ........................................ Employee: Novo Nordisk A/S; Stock/Shareholder: Novo
Nordisk A/S.Toro, Gabor ............................................ Disclosed no conflict of interest.Torok, Christine ..................................... Disclosed no conflict of interest.Torrejon, Maria J. ................................ Disclosed no conflict of interest.Torres, Edwin A. ................................... Disclosed no conflict of interest.Tortosa, Federica ................................... Disclosed no conflict of interest.Tory, Kálmán .......................................... Research Support: N-Gene.Toscanella, Fabrizia ............................... Research Support: Molliter.Totiya, Mayu.......................................... Disclosed no conflict of interest.Toubal, Amine ....................................... Disclosed no conflict of interest.Toumadje, Arazdordi ............................. Disclosed no conflict of interest.Tousoulis, Dimitris................................. Disclosed no conflict of interest.Townsend, Claire K. ............................. Disclosed no conflict of interest.Townsend, Kristy L. .............................. Disclosed no conflict of interest.Townsend, Paul ..................................... Disclosed no conflict of interest.Toyoda, Kentaro .................................... Disclosed no conflict of interest.Toyoda, Taro .......................................... Disclosed no conflict of interest.Toyoshima, Marcos ............................... Disclosed no conflict of interest.
Tozzo, Effie ............................................ Employee: Merck Sharp & Dohme Limited.Tracey, Irene .......................................... Disclosed no conflict of interest.Trachta, Pavel ........................................ Disclosed no conflict of interest.Traina, Shana ........................................ Employee: Janssen Global Services, LLC.Tran, Duy A. .......................................... Disclosed no conflict of interest.Trast, Jeniece ........................................ Disclosed no conflict of interest.Trattnig, Siegfried ................................. Disclosed no conflict of interest.Traurig, Michael .................................... Disclosed no conflict of interest.Trautmann, Michael .............................. Advisory Panel: Merck; Consultant: AstraZeneca
Pharmaceuticals LP, Bristol-Myers Squibb Company, CeQur, Ltd., Hanmi Pharmaceuticals; Employee: Profil Institute for Clinical Research, Inc.; Stock/Shareholder: Eli Lilly and Company.
Traylor, Louise ....................................... Employee: Sanofi; Bristol-Myers Squibb Company (Spouse/Partner), Sanofi; Research Support: Sanofi; Stock/Shareholder: Sanofi.
Treglia, Michael .................................... Consultant: Eli Lilly and Company.Tremblay, Guy ........................................ Disclosed no conflict of interest.Tremblay, Jacob .................................... Disclosed no conflict of interest.Treuter, Eckardt ..................................... Disclosed no conflict of interest.Trevisan, Aline R. ................................. Disclosed no conflict of interest.Triantafyllou, Areti ................................ Disclosed no conflict of interest.Triantafyllou, George............................. Disclosed no conflict of interest.Trief, Paula M. ...................................... Research Support: NIDDK.Trigo, Enrique ........................................ Disclosed no conflict of interest.Tripathi, Gyanendra ............................... Disclosed no conflict of interest.Tripathi, Gyanenra ................................. Disclosed no conflict of interest.Tripathy, Devjit ...................................... Disclosed no conflict of interest.Tripepi, Giovanni ................................... Disclosed no conflict of interest.Triplitt, Curtis......................................... Disclosed no conflict of interest.Trischitta, Vincenzo ............................... Disclosed no conflict of interest.Tristao, Livia J. ..................................... Research Support: Sanofi.Troadec, Jean-Denis ............................. Disclosed no conflict of interest.Trojak, Aleksandra................................. Disclosed no conflict of interest.Troles, Tiago .......................................... Disclosed no conflict of interest.Tromberg, Bruce J. ............................... Disclosed no conflict of interest.Troost, Freddy J. ................................... Disclosed no conflict of interest.Trotta, Laura .......................................... Disclosed no conflict of interest.Trounce, Ian ........................................... Disclosed no conflict of interest.Trubitsyna, Yelena ................................. Employee: VeroScience.True, Mark W. ...................................... Research Support: Tethys Biosciences, Inc.Trujillo, Angelina ................................... Employee: Janssen Scientific Affairs, LLC.Tsai, Adam G. ....................................... Research Support: Nutrisystem, Inc., Sanofi.Tsai, Ai-Lin ............................................. Disclosed no conflict of interest.Tsai, Linus .............................................. Disclosed no conflict of interest.Tsai, Michael Y. .................................... Disclosed no conflict of interest.Tsai, Ming-Han ...................................... Disclosed no conflict of interest.Tsalikian, Eva ......................................... Disclosed no conflict of interest.Tschirhart, Holly .................................... Disclosed no conflict of interest.Tschöpe, Diethelm ................................. Advisory Panel: Sanofi; Consultant: Bristol-Myers Squibb/
AstraZeneca; Speaker’s Bureau: SanofiTschopp, Oliver ...................................... Disclosed no conflict of interest.Tse, Christina D. ................................... Disclosed no conflict of interest.Tse, Hubert M. ..................................... Disclosed no conflict of interest.Tse, Kai Wing ........................................ Disclosed no conflict of interest.Tseng, Chin-Lin ...................................... Disclosed no conflict of interest.Tseng, Wei-Kung ................................... Disclosed no conflict of interest.Tseng, Yu-Hua ....................................... Consultant: Ember Therapeutics.Tsitsilianos, Andrew V. ......................... Disclosed no conflict of interest.Tsitsilianos, Nicholas ............................ Disclosed no conflict of interest.Tsuboi, Kentaro ..................................... Disclosed no conflict of interest.Tsubouchi, Chikako ................................ Disclosed no conflict of interest.Tsuchida, Hiromi .................................... Disclosed no conflict of interest.Tsuchimochi, Wakaba ........................... Disclosed no conflict of interest.Tsuchiya, Takafumi ................................ Disclosed no conflict of interest.Tsugawa, Kazue .................................... Disclosed no conflict of interest.Tsugita, Makoto .................................... Disclosed no conflict of interest.Tsuji, Tomomi ........................................ Disclosed no conflict of interest.Tsujikawa, Muneo ................................. Disclosed no conflict of interest.Tsujinaka, Hiroki .................................... Disclosed no conflict of interest.Tsukagoshi, Chihiro ............................... Disclosed no conflict of interest.Tsukamoto, Masami .............................. Disclosed no conflict of interest.Tsumura, Yoshinori ................................ Employee: Teijin Pharma Limited.Tsunekawa, Shin ................................... Disclosed no conflict of interest.Tsuneki, Hiroshi ..................................... Disclosed no conflict of interest.Tsuriya, Daisuke .................................... Disclosed no conflict of interest.Tsuruo, Miho ......................................... Disclosed no conflict of interest.Tsuruta, Munehisa ................................ Disclosed no conflict of interest.Tsushima, Kensuke ................................ Disclosed no conflict of interest.Tsutsui, Hiroyuki .................................... Disclosed no conflict of interest.Tsutsumi, Shuichi .................................. Disclosed no conflict of interest.Tsuzaki, Kokoro ...................................... Disclosed no conflict of interest.
Tu, Lichuan ............................................ Disclosed no conflict of interest.Tu, Yinfang ............................................ Disclosed no conflict of interest.Tuazon, Marc A. ................................... Disclosed no conflict of interest.Tubbs, Emily .......................................... Disclosed no conflict of interest.Tulledge-Scheitel, Sidna M. ................ Disclosed no conflict of interest.Tulloch-Reid, Marshall K. ..................... Disclosed no conflict of interest.Tunceli, Kaan ......................................... Employee: Merck; Stock/Shareholder: Merck.Tuomala, Ruth ....................................... Disclosed no conflict of interest.Tuomi, Lisa ............................................ Employee: Genentech.Tura, Andrea .......................................... Disclosed no conflict of interest.Turchin, Alexander ................................ Research Support: Merck Sharp & Dohme Limited.Turcotte, Eric E. .................................... Disclosed no conflict of interest.Turgunova, Ludmila G. ......................... Disclosed no conflict of interest.Turiel, D. ............................................... Disclosed no conflict of interest.Turk, Norman ......................................... Disclosed no conflict of interest.Turkistani, Sarah ................................... Disclosed no conflict of interest.Turksoy, Kamuran .................................. Disclosed no conflict of interest.Turman, Janet P. ................................... Research Support: Sanofi.Turner, Daniel ........................................ Disclosed no conflict of interest.Turner, Scott .......................................... Employee: KineMed, Inc.Turner, Tamela J. .................................. Research Support: Sanofi.Tusón, Carmen....................................... Disclosed no conflict of interest.Tuthill, Theresa A. ................................ Employee: Pfizer, Inc.Tuulari, Jetro J. .................................... Disclosed no conflict of interest.Twersky, Jack ........................................ Disclosed no conflict of interest.Twigg, Stephen M. ............................... Advisory Panel: AstraZeneca/Bristol-Meyers Squibb, Aventis,
Novo Nordisk, Inc., Sanofi, Takeda Pharmaceutical Company, Ltd.; Consultant: Novo Nordisk, Inc.; Speaker’s Bureau: AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Merck, Merck Sharp & Dohme Limited, Novartis Pharmaceuticals Corporation, Novo Nordisk, Inc., Servier, Takeda Pharmaceutical Company, Ltd.
Tykesanova, Gulmira M. ...................... Disclosed no conflict of interest.Tym, Amy ............................................... Disclosed no conflict of interest.Tziomalos, Konstantinos ....................... Disclosed no conflict of interest.Tzotzas, Themistoklis ............................ Disclosed no conflict of interest.Ubukata, Michito .................................. Employee: Taisho.Uchida, Junichi ..................................... Disclosed no conflict of interest.Uchida, Takafumi................................... Disclosed no conflict of interest.Uchida, Toyoyoshi ................................. Speaker’s Bureau: Astellas, Aventis, Boehringer Ingelheim
Pharmaceuticals, Inc., Eli Lilly and Company, Fujifilm Pharma, Kissei Pharmaceutical Co., Ltd., Novartis Pharmaceuticals Corporation, Ono Pharmaceutical Co., Ltd., Takeda Pharmaceutical Company, Ltd., Tanabe Mitsubishi.
Uchigata, Yasuko .................................. Disclosed no conflict of interest.Ueda, Shinichiro .................................... Disclosed no conflict of interest.Uehara, Humiko .................................... Disclosed no conflict of interest.Uehara, Shinichiro ................................ Disclosed no conflict of interest.Ueki, Akio .............................................. Disclosed no conflict of interest.Ueki, Kohjiro .......................................... Disclosed no conflict of interest.Ueland, Thor .......................................... Disclosed no conflict of interest.Uemura, Yasuyuki ................................. Disclosed no conflict of interest.Ueno, Hiroaki ........................................ Disclosed no conflict of interest.Ugi, Satoshi ........................................... Disclosed no conflict of interest.Ujjwal, Vivek ......................................... Disclosed no conflict of interest.Ükinç, Kubilay ....................................... Disclosed no conflict of interest.Ukropcova, Barbara ............................... Disclosed no conflict of interest.Ukropec, Jozef ...................................... Disclosed no conflict of interest.Ulbrecht, Jan S. ................................... Consultant: DIApedia, LLC; Stock/Shareholder: DIApedia, LLC.Ulimoen, Geir R. ................................... Disclosed no conflict of interest.Ulisse, Gael ........................................... Disclosed no conflict of interest.Ullits Andersen, Henrik ......................... Advisory Panel: Abbott Diabetes Care.Ullmann, Silke ....................................... Consultant: Almased Wellness GmbH.Ullrich, Susanne .................................... Disclosed no conflict of interest.Ulrichsen, Sinna P. ............................... Disclosed no conflict of interest.Uma, Ram .............................................. Disclosed no conflict of interest.Umapathy, Dhamodharan ..................... Disclosed no conflict of interest.Umpierre, Daniel ................................... Disclosed no conflict of interest.Umpierrez, Guillermo E. ....................... Advisory Panel: Boehringer Ingelheim Pharmaceuticals, Inc.,
Merck, Sanofi; Other Relationship: Boehringer Ingelheim, Merck, Novo Nordisk, Sanofi.
Unett, David .......................................... Employee: Arena Pharmaceuticals, Inc.Unigwe, Michael ................................... Disclosed no conflict of interest.Unno, Michiaki ...................................... Disclosed no conflict of interest.Unoki-Kubota, Hiroyuki ......................... Disclosed no conflict of interest.Urakami, Tatsuhiko................................ Disclosed no conflict of interest.Urata, Hiromi ......................................... Disclosed no conflict of interest.Uratsu, Connie S. ................................. Disclosed no conflict of interest.Urbanová, Jana ..................................... Disclosed no conflict of interest.Urbina, Elaine M. ................................. Disclosed no conflict of interest.
Uribe, Sergio ......................................... Disclosed no conflict of interest.Ursini, Francesca ................................... Disclosed no conflict of interest.Uruno, Akira .......................................... Disclosed no conflict of interest.Ushigome, Emi ...................................... Disclosed no conflict of interest.Usiskin, Keith ........................................ Employee: Janssen Research & Development, LLC.Ussar, Siegfried ..................................... Disclosed no conflict of interest.Ussery, Donna ....................................... Disclosed no conflict of interest.Usui, Isao .............................................. Disclosed no conflict of interest.Usui, Taro .............................................. Disclosed no conflict of interest.Usuku, Koichiro ..................................... Disclosed no conflict of interest.Utsunomiya, Kazunori ........................... Disclosed no conflict of interest.Uy, Natalie ............................................ Disclosed no conflict of interest.Uzu, Takashi .......................................... Disclosed no conflict of interest.Uzun, Gulbahar ...................................... Disclosed no conflict of interest.Uzunlulu, Mehmet ................................. Disclosed no conflict of interest.Vaag, Allan A. ...................................... Advisory Panel: Novo Nordisk A/S; Board Member:
Novo Nordisk A/S; Research Support: Novo Nordisk A/S.
Vaarala, Outi ......................................... Disclosed no conflict of interest.Vaccaro, María I. .................................. Disclosed no conflict of interest.Vaeggemose, Michael .......................... Disclosed no conflict of interest.Vaidya, Dhanajay .................................. Disclosed no conflict of interest.Vajda, Eric G. ........................................ Employee: Ligand Pharmaceuticals; Stock/Shareholder:
Ligand Pharmaceuticals.Vakil, Zaineb .......................................... Disclosed no conflict of interest.Valcarce, Carmen .................................. Employee: TransTech Pharma.Valdecantos, M. Pilar ............................ Disclosed no conflict of interest.Valderas, Juan P. .................................. Disclosed no conflict of interest.Valderrama-Vasquez, Alessandro ......... Disclosed no conflict of interest.Valensi, Paul .......................................... Disclosed no conflict of interest.Valente, Francesca ................................ Disclosed no conflict of interest.Valente, Luciana .................................... Disclosed no conflict of interest.Valentine, Rudy J. ................................ Disclosed no conflict of interest.Valentine, William ................................ Consultant: Abbott Diabetes Care, Eli Lilly and Company,
Health Economics Consultancy, Novo Nordisk A/S, Novo Nordisk, Inc.
Valeur, Anders ....................................... Disclosed no conflict of interest.Valitsky, Michael ................................... Disclosed no conflict of interest.Vallejo, Susana ..................................... Disclosed no conflict of interest.Vallon, Volker ........................................ Research Support: Boehringer Ingelheim GmbH & Co. KG.Valverde, Angela M. ............................ Disclosed no conflict of interest.Vamadevan, Ajay S. ............................. Disclosed no conflict of interest.Van Apeldoorn, Aart A. ........................ Disclosed no conflict of interest.Van Brunt, Kate ..................................... Employee: Eli Lilly and Company.Van Coppenolle, Fabien ........................ Disclosed no conflict of interest.Van de Laar, Arnold ............................... Disclosed no conflict of interest.Van der Beek, Christina M. .................. Disclosed no conflict of interest.Van der Klauw, Melanie M. ................. Disclosed no conflict of interest.Van der Meulen, Talitha........................ Disclosed no conflict of interest.Van der Peet, Donald L. ....................... Disclosed no conflict of interest.Van der Zwaal, Esther M. .................... Disclosed no conflict of interest.Van Dijk, Peter R. ................................. Disclosed no conflict of interest.Van Everen, Sherri A. ........................... Employee: Genentech.Van Hall, Gerrit...................................... Disclosed no conflict of interest.Van Hateren, Kornelis ........................... Disclosed no conflict of interest.Van Hinsbergh, Victor W. ..................... Disclosed no conflict of interest.Van Houten, Holly K. ............................ Disclosed no conflict of interest.Van Name, Michelle A. ........................ Disclosed no conflict of interest.Van Poppel, Mireille.............................. Disclosed no conflict of interest.Van Remmen, Holly ............................... Disclosed no conflict of interest.Van Vliet, Andre .................................... Employee: PRA International; Research Support: Diamedica,
Inc.Van Vliet-Ostaptchouk, Jana V. ........... Disclosed no conflict of interest.Van Wagensveld, B.A. ......................... Disclosed no conflict of interest.Van Witteloostuijn, Søren B. ............... Disclosed no conflict of interest.Van Zuydam, Natalie R. ....................... Disclosed no conflict of interest.Van, Nancy ............................................ Disclosed no conflict of interest.Vander Heiden, Matthew...................... Disclosed no conflict of interest.Vandermeer, Ben ................................... Disclosed no conflict of interest.VanderWeele, Jennifer J. .................... Disclosed no conflict of interest.Vanderwood, Karl K. ............................ Disclosed no conflict of interest.Vargas, Hernando .................................. Advisory Panel: Sanofi; Speaker’s Bureau: Sanofi.Varma, Swarna ...................................... Speaker’s Bureau: Abbott Diabetes Care, AstraZeneca/Bristol-
Meyers Squibb, Aventis, Eli Lilly and Company, GlaxoSmithKline, Merck, Novartis Pharmaceuticals Corporation, Novo Nordisk, Inc., Pfizer, Inc., Takeda Pharmaceuticals U.S.A., Inc.; Stock/Shareholder: Amylin Pharmaceuticals, Inc.
Varughese, George I. ........................... Disclosed no conflict of interest.Vas, Prashanth R. ................................. Disclosed no conflict of interest.Vasantharajah, Laksha .......................... Disclosed no conflict of interest.Vasconcelos, Dewton ............................ Disclosed no conflict of interest.
Vasquez, Jan J. .................................... Disclosed no conflict of interest.Vassy, Jason .......................................... Disclosed no conflict of interest.Vater, Axel ............................................. Employee: Noxxon.Vatner, Daniel F. ................................... Disclosed no conflict of interest.Vaur, Laurent ......................................... Employee: Novo Nordisk, Inc.Vaz, Julius A. ....................................... Employee: Novartis Healthcare Pvt. Ltd., India; Stock/
Shareholder: Novartis Healthcare Pvt. Ltd., India.Vaziri, Nosratola D. .............................. Disclosed no conflict of interest.Vazquez Modroño, Ramon .................... Disclosed no conflict of interest.Vazquez, Ana ......................................... Disclosed no conflict of interest.Vecoli, Cecilia ........................................ Disclosed no conflict of interest.Vedartham, Veena V. ............................ Disclosed no conflict of interest.Vedralova, Lenka ................................... Disclosed no conflict of interest.Vedtofte, Louise .................................... Research Support: Novo Nordisk A/S.Veedfald, Simon .................................... Disclosed no conflict of interest.Veettil, Sona .......................................... Disclosed no conflict of interest.Veeze, Henk ........................................... Disclosed no conflict of interest.Veiga Vazquez, Ana ............................... Disclosed no conflict of interest.Veillon, François .................................... Disclosed no conflict of interest.Veit, Ralf ................................................ Disclosed no conflict of interest.Velan, S. Sendhil ................................... Disclosed no conflict of interest.Veldhoen, Danielle ................................ Disclosed no conflict of interest.Velho, Gilberto ...................................... Disclosed no conflict of interest.Vella, Adrian .......................................... Consultant: Sanofi (Spouse/Partner).Vellanki, Priya ........................................ Disclosed no conflict of interest.Velloso, Lício A. ................................... Disclosed no conflict of interest.Velusamy, Anand ................................... Disclosed no conflict of interest.Vendelbo, Mikkel H. ............................. Disclosed no conflict of interest.Venditti, Elizabeth M. .......................... Disclosed no conflict of interest.Venerova, Johana ................................. Disclosed no conflict of interest.Venkataraman, Hema ............................ Disclosed no conflict of interest.Venkataraman, Kavita ........................... Disclosed no conflict of interest.Venkataranganna, M.V. ........................ Disclosed no conflict of interest.Venn, Karri ............................................. Employee: LMC Diabetes & Endocrinology; Research
Support: Abbott Laboratories, Inc., Andromeda Biotech, Ltd., AstraZeneca/Bristol-Meyers Squibb, BD Medical Diabetes Care, Boehringer Ingelheim Pharmaceuticals, Inc., Diartis Pharmaceuticals, Eli Lilly and Company, Merck, Novartis Pharmaceuticals Corporation, Novo Nordisk A/S, Paraxel, Piramal, Regeneron Pharmaceuticals, Inc., Roche Pharmaceuticals, Sanofi, Takeda Pharmaceutical Company, Ltd.
Venteclef, Nicolas ................................. Disclosed no conflict of interest.Venturi, Martina .................................... Disclosed no conflict of interest.Venugopalan, Ramakrishna .................. Employee: Animas Corporation; Stock/Shareholder: Johnson
& Johnson.Vera, Nicholas B. ................................. Employee: Pfizer, Inc.Verberne, Hein J. ................................. Disclosed no conflict of interest.Verchere, C. Bruce................................. Disclosed no conflict of interest.Veresiu, Ioan A. .................................... Disclosed no conflict of interest.Vergani, Andrea .................................... Disclosed no conflict of interest.Vergara, Jose L. ................................... Disclosed no conflict of interest.Vergara-Bagby, Stella ........................... Disclosed no conflict of interest.Vergeres, Guy ........................................ Disclosed no conflict of interest.Vergidou, Paraskevi ............................... Disclosed no conflict of interest.Verheyen, Nicolas ................................. Disclosed no conflict of interest.Verma, M.K. ......................................... Disclosed no conflict of interest.Vermigli, Cristiana ................................. Research Support: Molliter.Vernier, Stephanie B. ........................... Disclosed no conflict of interest.Vernieri, Fabrizio ................................... Disclosed no conflict of interest.Vernon, Marlo ....................................... Disclosed no conflict of interest.Verny, Christiane ................................... Research Support: Merck, Novo Nordisk A/S.Vero, Ada ............................................... Disclosed no conflict of interest.Vero, Raffaella ...................................... Disclosed no conflict of interest.Veronelli, Annamaria ............................ Disclosed no conflict of interest.Versteeg, Ruth I. .................................. Disclosed no conflict of interest.Vervoort, Gerald M. ............................. Disclosed no conflict of interest.Vespasiani, Giacomo ............................. Disclosed no conflict of interest.Vestergaard, Peter ................................ Disclosed no conflict of interest.Vetrani, Claudia ..................................... Disclosed no conflict of interest.Veves, Aristidis ..................................... Advisory Panel: AOBiome, Biochemics, Kasiak Holdings AG,
Pluristem; Research Support: Boehringer Ingelheim Pharmaceuticals, Inc.
Vial, Guillaume ...................................... Research Support: PoxelViana, Luciana V. .................................. Disclosed no conflict of interest.Viberti, Giancarlo .................................. Disclosed no conflict of interest.Vickers, Kasey C. .................................. Disclosed no conflict of interest.Vidal, Hubert ......................................... Research Support: Poxel.Vieira, Alexandre E. ............................. Disclosed no conflict of interest.Vieira, Suelen ........................................ Research Support: Sanofi.Vietri, Jeffrey ........................................ Disclosed no conflict of interest.
Vigersky, Robert .................................... Advisory Panel: Bayer, Medtronic Diabetes, Merck, Sanofi-Aventis; Consultant: Abbott Diabetes Care; Research Support: DexCom.
Vignati, Laila ......................................... Disclosed no conflict of interest.Vigueira, Patrick A. .............................. Disclosed no conflict of interest.Vijapurkar, Ujjwala ................................ Employee: Janssen Research & Development; Stock/
Shareholder: Johnson & Johnson.Vijayakumar, Archana ........................... Disclosed no conflict of interest.Vilches-Flores, Alonso........................... Disclosed no conflict of interest.Vileikyte, Loretta ................................... Disclosed no conflict of interest.Villa, Simona ......................................... Disclosed no conflict of interest.Villalobos, Laura A. .............................. Disclosed no conflict of interest.Villares, Sandra Mara F. ...................... Disclosed no conflict of interest.Villarreal, Francisco............................... Stock/Shareholder: Cardero Therapeutics.Villar-Taibo, Rocio ................................. Speaker’s Bureau: AstraZeneca/Bristol-Meyers Squibb,
Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Sanofi.
Villena, Jaime E. .................................. Advisory Panel: Novo Nordisk, Inc., Sanofi; Research Support: AstraZeneca/Bristol-Meyers Squibb, Johnson & Johnson, Takeda Pharmaceutical Company, Ltd.; Speaker’s Bureau: Abbott Laboratories, Inc., Bristol-Myers Squibb Company, Merck Sharp & Dohme Limited, Novo Nordisk, Inc., Sanofi.
Vilmann, Peter ....................................... Disclosed no conflict of interest.Vilsbøll, Tina .......................................... Advisory Panel: AstraZeneca Pharmaceuticals LP,
Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, GI Dynamics, Merck Sharp & Dohme Limited, Novo Nordisk A/S, Sanofi, Takeda Pharmaceutical Company, Ltd.; Research Support: Novo Nordisk, Inc.; Speaker’s Bureau: AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Merck Sharp & Dohme Limited, Novartis Pharma AG, Novo Nordisk, Inc., Sanofi, Takeda Pharmaceutical Company, Ltd., Zealand Pharma A/S.
Vimalananda, Varsha ............................ Disclosed no conflict of interest.Vincent, Maya ....................................... Employee: Sanofi.Vinet, Laetitia ........................................ Consultant: Sanofi.Vinik, Aaron I. ....................................... Advisory Panel: AACE; Board Member: AACE; Consultant:
Vinik, Etta J. ......................................... Disclosed no conflict of interest.Vinolo, Marco A. .................................. Disclosed no conflict of interest.Vintila, Madalina................................... Disclosed no conflict of interest.Viollet, Benoit........................................ Disclosed no conflict of interest.Virdis, Agostino ..................................... Disclosed no conflict of interest.Virtanen, Kirsi A. .................................. Disclosed no conflict of interest.Viscoli, Catherine M. ........................... Disclosed no conflict of interest.Visentin, Roberto................................... Disclosed no conflict of interest.Vishnudas, Vivek ................................... Disclosed no conflict of interest.Visich, Jennifer E. ................................ Employee: Genentech.Vistisen, Dorte....................................... Employee: Steno Diabetes Center A/S; Stock/Shareholder:
Novo Nordisk A/S.Vistoli, Fabio.......................................... Disclosed no conflict of interest.Viswambharan, Hema ........................... Disclosed no conflict of interest.Viswanathan, Vijay ............................... Disclosed no conflict of interest.Vitai, Márta ........................................... Disclosed no conflict of interest.Vitolins, Mara Z. .................................. Disclosed no conflict of interest.Vittaz, Laurence..................................... Consultant: NovoNordisk.Vittinghoff, Eric ..................................... Disclosed no conflict of interest.Vivian, Eva M. ...................................... Disclosed no conflict of interest.Vivot, Kevin ........................................... Disclosed no conflict of interest.Vlachova, Zuzana .................................. Disclosed no conflict of interest.Vlad, Adrian .......................................... Disclosed no conflict of interest.Vlad, Mihaela ........................................ Disclosed no conflict of interest.Vlajnic, Aleksandra ............................... Employee: Sanofi; Stock/Shareholder: Sanofi.Vo, Kelly ................................................ Disclosed no conflict of interest.Vo, Lien .................................................. Employee: Janssen Scientific Affairs, LLC; Stock/Shareholder:
Janssen Scientific Affairs, LLC.Vogel, Mandy ........................................ Disclosed no conflict of interest.Volk, Catherine B. ................................ Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly
and Company.Volkening, Lisa K. ................................. Disclosed no conflict of interest.Volkov, Petr ............................................ Disclosed no conflict of interest.Volpi, Elena ........................................... Disclosed no conflict of interest.Von Eynatten, Maximilian ..................... Employee: Boehringer Ingelheim GmbH & Co. KG.Von Loeffelholz, Christian ..................... Disclosed no conflict of interest.Von Stein, Thorsten............................... Employee: Zosano Pharma.Vonbank, Alexander .............................. Disclosed no conflict of interest.
Vora, Jiten P. ........................................ Advisory Panel: Abbott Diabetes Care, AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim GmbH & Co. KG, Bristol-Myers Squibb Company, Eli Lilly and Company, MDS, Inc., Novartis Pharma AG, Novo Nordisk A/S, Sanofi, Takeda Pharmaceutical Company, Ltd.; Other Relationship: Eli Lilly and Company, MDS, Inc., Novo Nordisk, Inc., Sanofi; Speaker’s Bureau: Abbott Diabetes Care, AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim GmbH & Co. KG, Bristol-Myers Squibb Company, MDS, Inc., Novartis Pharma AG, Novo Nordisk A/S, Sanofi, Takeda Pharmaceutical Company, Ltd.
Voruganti, Saroja .................................. Disclosed no conflict of interest.Voss, Bernd ........................................... Employee: Merck; Stock/Shareholder: Merck Sharp & Dohme
Limited.Voss, Linda D. ...................................... Disclosed no conflict of interest.Voyias, Philip D. ................................... Disclosed no conflict of interest.Vracar, Sandra ....................................... Disclosed no conflict of interest.Vrang, Niels........................................... Employee: Gubra ApS.Vrbikova, Jana....................................... Disclosed no conflict of interest.Vrzalova, Jindra..................................... Disclosed no conflict of interest.Vucic Lovrencic, Marijana ..................... Disclosed no conflict of interest.Vuksanovic, Miljanka ............................ Disclosed no conflict of interest.Vusirikala, Amoolya .............................. Disclosed no conflict of interest.Wada, Jun ............................................. Disclosed no conflict of interest.Wada, Kengo......................................... Disclosed no conflict of interest.Wada, Nobuhiko ................................... Disclosed no conflict of interest.Wada, Takashi ....................................... Disclosed no conflict of interest.Wada, Tsutomu ..................................... Disclosed no conflict of interest.Wada, Yoshiharu ................................... Disclosed no conflict of interest.Wada, Youichiro .................................... Disclosed no conflict of interest.Wadley, Glenn D. ................................. Disclosed no conflict of interest.Wadsack, Christian ............................... Disclosed no conflict of interest.Wadwa, R. Paul .................................... Research Support: Novo Nordisk, Inc.Waeckel, Ludovic .................................. Disclosed no conflict of interest.Wagenknecht, Lynne E. ....................... Disclosed no conflict of interest.Wagenmakers, Anton J. ...................... Disclosed no conflict of interest.Wagie, Amy E. ..................................... Disclosed no conflict of interest.Wägner, Ana M. ................................... Disclosed no conflict of interest.Wagner, Isabel V. ................................. Disclosed no conflict of interest.Wagner, Julie A. .................................. Disclosed no conflict of interest.Wagner, Robert ..................................... Disclosed no conflict of interest.Wahed, Abdus....................................... Disclosed no conflict of interest.Wahl, Robert L. .................................... Disclosed no conflict of interest.Wahl, Simone........................................ Disclosed no conflict of interest.Wahlgren, Camilla D. ........................... Disclosed no conflict of interest.Wahlund, Göran .................................... Employee: AstraZeneca Pharmaceuticals LP.Wahren, John........................................ Board Member: Cebix, Inc.; Employee: Cebix, Inc.; Stock/
Shareholder: Cebix, Inc.Wai, Sandra .......................................... Disclosed no conflict of interest.Wainstein, Julio .................................... Disclosed no conflict of interest.Waitman, Jorge .................................... Speaker’s Bureau: Novartis Pharma AG, Novo Nordisk A/S.Wakabayashi, Ken-ichi ......................... Disclosed no conflict of interest.Wakabayashi, Nobunao ........................ Disclosed no conflict of interest.Wakamatsu, Sadako ............................. Disclosed no conflict of interest.Waki, Hironori ....................................... Disclosed no conflict of interest.Waldman, Lindsey................................. Disclosed no conflict of interest.Waldron, Sheridan ................................ Advisory Panel: Sanofi; Consultant: Eli Lilly and Company.Walford, Geoffrey A. ............................ Disclosed no conflict of interest.Walker, Ashby F. ................................... Disclosed no conflict of interest.Walker, Chris ......................................... Disclosed no conflict of interest.Walker, Mark ......................................... Disclosed no conflict of interest.Walker, Nykia ........................................ Employee: Merck.Walker, Stephanie ................................. Disclosed no conflict of interest.Walker, Susan M. ................................ Disclosed no conflict of interest.Walker, Susan ....................................... Disclosed no conflict of interest.Walkey, Helen ....................................... Disclosed no conflict of interest.Walkinshaw, Emma............................... Disclosed no conflict of interest.Wall, Martha L. .................................... Disclosed no conflict of interest.Wallach, Elizabeth ................................ Disclosed no conflict of interest.Wallen, Taylor ....................................... Disclosed no conflict of interest.Wallenius, Kristina................................ Employee: AstraZeneca Pharmaceuticals LP.Walley, John ......................................... Disclosed no conflict of interest.Wallia, Amisha...................................... Advisory Panel: Janssen Pharmaceuticals; Research Support:
Merck.Wallstrom, Garrick ................................ Disclosed no conflict of interest.Walmer, Rebecca .................................. Disclosed no conflict of interest.Walsh, Brandon..................................... Employee: Orexigen Therapeutics, Inc.; Stock/Shareholder:
Orexigen Therapeutics, Inc.Walsh, Katherine .................................. Disclosed no conflict of interest.Walton, Christopher .............................. Other Relationship: Novo Nordisk A/S.Walton, David ....................................... Employee: Echo Therapeutics, Inc.; Stock/Shareholder:
Walton, R. Grace ................................... Disclosed no conflict of interest.Walus-Miarka, Malgorzata ................... Disclosed no conflict of interest.Wan, Emily ............................................ Disclosed no conflict of interest.Wan, Gang ............................................ Disclosed no conflict of interest.Wan, Jim Y. .......................................... Disclosed no conflict of interest.Wan, Lili ................................................ Disclosed no conflict of interest.Wan, Xuesi ............................................ Disclosed no conflict of interest.Wan, Zhiqiang ....................................... Disclosed no conflict of interest.Wanapun, Debbie ................................. Employee: Pfizer, Inc.Wandall, Erik P. .................................... Disclosed no conflict of interest.Wanders, Desiree ................................. Disclosed no conflict of interest.Wang, Aihua ......................................... Disclosed no conflict of interest.Wang, Aileen ........................................ Disclosed no conflict of interest.Wang, Chen........................................... Disclosed no conflict of interest.Wang, Chuan......................................... Disclosed no conflict of interest.Wang, Chun........................................... Disclosed no conflict of interest.Wang, Congrong ................................... Disclosed no conflict of interest.Wang, Dong .......................................... Disclosed no conflict of interest.Wang, Elsie J. ...................................... Disclosed no conflict of interest.Wang, Heyao......................................... Disclosed no conflict of interest.Wang, Hong .......................................... Disclosed no conflict of interest.Wang, Hongwei .................................... Disclosed no conflict of interest.Wang, Hongyuan................................... Disclosed no conflict of interest.Wang, Hui ............................................. Disclosed no conflict of interest.Wang, Hye Jin ...................................... Disclosed no conflict of interest.Wang, Jen-Chywan............................... Disclosed no conflict of interest.Wang, Jichuan ...................................... Disclosed no conflict of interest.Wang, Jie .............................................. Disclosed no conflict of interest.Wang, Jijiao .......................................... Disclosed no conflict of interest.Wang, Jing ............................................ Disclosed no conflict of interest.Wang, Jinhua ........................................ Disclosed no conflict of interest.Wang, Jinli ............................................ Disclosed no conflict of interest.Wang, Jinping ....................................... Disclosed no conflict of interest.Wang, Jun-Che ..................................... Disclosed no conflict of interest.Wang, Jun-Sing .................................... Disclosed no conflict of interest.Wang, Kangjie....................................... Disclosed no conflict of interest.Wang, Li ................................................ Disclosed no conflict of interest.Wang, Lin .............................................. Disclosed no conflict of interest.Wang, Liping ......................................... Research Support: Pfizer, Inc.Wang, Man-man ................................... Disclosed no conflict of interest.Wang, Mei ............................................ Disclosed no conflict of interest.Wang, Na .............................................. Disclosed no conflict of interest.Wang, Nan ............................................ Disclosed no conflict of interest.Wang, Peili ............................................ Disclosed no conflict of interest.Wang, Peng ........................................... Disclosed no conflict of interest.Wang, Ping H. ...................................... Disclosed no conflict of interest.Wang, Pin-Wen ..................................... Employee: Genentech.Wang, Qian ........................................... Disclosed no conflict of interest.Wang, Qiang ......................................... Disclosed no conflict of interest.Wang, Qinghua ..................................... Advisory Panel: Diamyd Medical AB.Wang, Rui.............................................. Disclosed no conflict of interest.Wang, Shean Sheng ............................. Employee: Janssen Research & Development, LLC.Wang, Shu Pei ...................................... Disclosed no conflict of interest.Wang, Shuai.......................................... Disclosed no conflict of interest.Wang, Shuxia ........................................ Disclosed no conflict of interest.Wang, Shu-Yi ........................................ Disclosed no conflict of interest.Wang, Thomas J. ................................. Disclosed no conflict of interest.Wang, Ting ............................................ Disclosed no conflict of interest.Wang, Wang ......................................... Disclosed no conflict of interest.Wang, Wei ............................................ Employee: Beijing Novartis Pharma Co. Ltd.Wang, Weiqing ..................................... Disclosed no conflict of interest.Wang, Wenhui ...................................... Disclosed no conflict of interest.Wang, Xiao-Li........................................ Disclosed no conflict of interest.Wang, Xiaomeng................................... Disclosed no conflict of interest.Wang, Xuanchun ................................... Disclosed no conflict of interest.Wang, Xuerong ..................................... Disclosed no conflict of interest.Wang, Yan ............................................. Disclosed no conflict of interest.Wang, Yangwei ..................................... Disclosed no conflict of interest.Wang, Yanping ...................................... Disclosed no conflict of interest.Wang, Yi ................................................ Disclosed no conflict of interest.Wang, Yiting ......................................... Employee: Janssen Research & Development.Wang, Yi-Xin (Jim) ................................ Employee: CrownBio.Wang, Yong ........................................... Disclosed no conflict of interest.Wang, Yonggang ................................... Disclosed no conflict of interest.Wang, Youdong ..................................... Disclosed no conflict of interest.Wang, Yu ............................................... Disclosed no conflict of interest.Wang, YuanPing .................................... Employee: Janssen Research & Development.Wang, Yuehui ........................................ Disclosed no conflict of interest.Wang, Yufan.......................................... Disclosed no conflict of interest.Wang, Yuhui .......................................... Disclosed no conflict of interest.Wang, Zhenyuan X. .............................. Disclosed no conflict of interest.Wang, Zhenyuan ................................... Disclosed no conflict of interest.
Wang, Zhiyu .......................................... Disclosed no conflict of interest.Wang, Zhong Q. ................................... Disclosed no conflict of interest.Wanner, Christoph ................................ Advisory Panel: Abbott, Amgen, Inc., Sanofi-Genzyme; Board
Member: Boehringer Ingelheim GmbH & Co. KG; Consultant: Baxter, Keryx Biopharmaceuticals, Inc., Mitsubishi; Employee: University of Würzburg; Research Support: Genzyme Corporation.
Ward, Jeanette ..................................... Disclosed no conflict of interest.Ward, Micheal S. ................................. Disclosed no conflict of interest.Ward, Thomas ....................................... Research Support: AstraZeneca Pharmaceuticals LP, Bristol-
Myers Squibb Company, Eli Lilly and Company, GSK, Novo Nordisk, Inc., Sanofi, Takeda Pharmaceuticals U.S.A., Inc.
Ward, W. Kenneth ................................ Other Relationship: Filed Patent Application-Glucagon Chemistry.
Wardecki, Marek................................... Employee: Sanofi; Stock/Shareholder: Sanofi.Wareham, Kathie .................................. Disclosed no conflict of interest.Wareham, Nick J. ................................ Disclosed no conflict of interest.Warner, Noel ......................................... Disclosed no conflict of interest.Warnock, Garth L. ................................ Disclosed no conflict of interest.Warren, Jonathan L. ............................ Disclosed no conflict of interest.Warren, Laura ....................................... Disclosed no conflict of interest.Warren, Mark ........................................ Advisory Panel: Eli Lilly and Company, Novo Nordisk, Inc.,
Sanofi; Research Support: Amgen, Inc., Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, ESAI, MannKind Corporation, Merck, Novartis Pharmaceuticals Corporation, Novo Nordisk, Inc., NPS, Sanofi; Speaker’s Bureau: Amgen, Inc., Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Daiichi-Sankyo, Inc., Eli Lilly and Company, Janssen Pharmaceuticals, Merck, Novo Nordisk, Inc., Sanofi, Vivus, Inc.
Washio, Kaoru....................................... Disclosed no conflict of interest.Wasserfall, Clive ................................... Disclosed no conflict of interest.Wasserman, David H. .......................... Disclosed no conflict of interest.Wasserman, Scott M. .......................... Employee: Amgen, Inc.Waszczeniuk, Magdalena ..................... Disclosed no conflict of interest.Watada, Hirotaka .................................. Advisory Panel: Astellas Pharma US, Inc., Boehringer
Ingelheim Pharmaceuticals, Inc., Diaichi Sankyo, Mitsubishi Tanabe Pharmaceutical Corporation, Sanofi; Research Support: Astellas Pharma US, Inc., AstraZeneca Pharmaceuticals LP, Bayer Health Care, LLC, Boehringer Ingelheim Pharmaceuticals, Inc., Dainippon Sumitomo Pharma Co., Ltd., Diaichi Sankyo, Eli Lilly and Company, Merck Sharp & Dohme Limited, Novartis Pharmaceuticals Corporation, Novo Nordisk, Inc., Pfizer, Inc., Sanofi, Sanwa Kagaku Kenkyusho Co. Ltd., Shionogi, Inc., Takeda Pharmaceutical Company, Ltd.; Speaker’s Bureau: Bayer Health Care, LLC, Boehringer Ingelheim Pharmaceuticals, Inc., Diaichi Sankyo, Eli Lilly and Company, Merck Sharp & Dohme Limited, Novartis Pharmaceuticals Corporation, Novo Nordisk, Inc., Sanofi, Takeda Pharmaceutical Company, Ltd.
Watanabe, Chizuru................................ Disclosed no conflict of interest.Watanabe, Hirohumi ............................. Disclosed no conflict of interest.Watanabe, Jonathan H. ....................... Disclosed no conflict of interest.Watanabe, Richard M. ......................... Disclosed no conflict of interest.Watanabe, Takayuki .............................. Disclosed no conflict of interest.Watanabe, Tsuyoshi .............................. Disclosed no conflict of interest.Watanabe, Yuko .................................... Disclosed no conflict of interest.Watarai, Atsuko .................................... Disclosed no conflict of interest.Watkins, Steven M. ............................. Employee: Metabolon, Inc.Watson, Karol ....................................... Disclosed no conflict of interest.Watson, Luke ........................................ Disclosed no conflict of interest.Watts, Margaret ................................... Disclosed no conflict of interest.Waugh, Kathleen C. ............................. Disclosed no conflict of interest.Wawrusiewicz-Kurylonek, Natalia ....... Disclosed no conflict of interest.Way, James........................................... Employee: GlaxoSmithKline.Weaver, Jeff .......................................... Disclosed no conflict of interest.Webb, Amy............................................ Disclosed no conflict of interest.Webb, Paul ............................................ Disclosed no conflict of interest.Webber, Jonathan ................................. Disclosed no conflict of interest.Weber, David R. ................................... Disclosed no conflict of interest.Weber, Giovanna ................................... Disclosed no conflict of interest.Weber, Katelynn E. .............................. Disclosed no conflict of interest.Weber, Michael A. ............................... Consultant: AstraZeneca Pharmaceuticals LP, Boehringer
Weber, Michelle .................................... Disclosed no conflict of interest.Wedeken, Lena ..................................... Disclosed no conflict of interest.Wedrychowicz-Niedzwiecka, Anna ...... Disclosed no conflict of interest.Wei, Jung-Nan ...................................... Disclosed no conflict of interest.Wei, Wenhui ......................................... Employee: Sanofi; Stock/Shareholder: Sanofi.Weigensberg, Marc J. ......................... Disclosed no conflict of interest.Weigert, Cora ........................................ Disclosed no conflict of interest.Weil, Clara ............................................ Disclosed no conflict of interest.Weil, E.J. .............................................. Disclosed no conflict of interest.Weinberg, Janice .................................. Disclosed no conflict of interest.Weinehall, Lars ..................................... Disclosed no conflict of interest.Weiner, Lauren S. ................................ Disclosed no conflict of interest.Weinrauch, Larry A. ............................. Disclosed no conflict of interest.Weinstock, Ruth S. .............................. Research Support: AstraZeneca Pharmaceuticals LP, Biodel,
Inc., Eli Lilly and Company, Intarcia Therapeutics, Inc., Medtronic, NIDDK, Novo Nordisk, Inc., Sanofi.
Weinzimer, Stuart A. ............................ Consultant: BD Medical Diabetes Care, Medtronic; Speaker’s Bureau: Eli Lilly and Company.
Weir, Gordon C. .................................... Board Member: Beta O2; Consultant: Merck (Spouse/Partner), Novartis (Spouse/Partner), Pfizer; Research Support: Johnson & Johnson; Speaker’s Bureau: Merck.
Weir, Matthew R. ................................ Advisory Panel: Janssen, BMS.Weise, Sebastian .................................. Disclosed no conflict of interest.Weisman, Alanna.................................. Disclosed no conflict of interest.Weiss, Michael A. ............................... Disclosed no conflict of interest.Weiss, Ram ........................................... Consultant: Medtronic.Weissberg-Benchell, Jill ....................... Disclosed no conflict of interest.Weissman, Peter ................................... Other Relationship: GlaxoSmithKline; Research Support:
Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Janssen Pharmaceuticals, Merck Sharp & Dohme Limited, Novo Nordisk A/S, Sanofi, Takeda Pharmaceutical Company, Ltd.; Research Support: Novartis Pharma AG, Novo Nordisk A/S, Sanofi; Speaker’s Bureau: AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Janssen Pharmaceuticals, Medtronic, Nintamed, Novartis Pharma AG, Novo Nordisk A/S.
Welch, Ryan .......................................... Disclosed no conflict of interest.Wellenius, Gregory ............................... Disclosed no conflict of interest.Wells, Andrew D. ................................. Disclosed no conflict of interest.Welsh, John B. ..................................... Employee: Medtronic.Welte, Stefan ........................................ Employee: Sanofi.Weltman, Arthur ................................... Disclosed no conflict of interest.Weltman, Judy ...................................... Disclosed no conflict of interest.Wen, Gebo ............................................ Disclosed no conflict of interest.Wen, Xiao-Yan ...................................... Disclosed no conflict of interest.Wender-Ozegowska, Ewa ..................... Disclosed no conflict of interest.Wendrich, Thomas ................................ Employee: Sanofi.Wendt, Anna ......................................... Disclosed no conflict of interest.Wendtner, Christa ................................. Disclosed no conflict of interest.Weng, Jianping ..................................... Research Support: Bayer Health Care, LLC, Eli Lilly and
Company, Novo Nordisk, Inc.Weng, Pan ............................................. Disclosed no conflict of interest.Weng, Wayne ....................................... Employee: Novo Nordisk, Inc.Wenger, Julia ........................................ Disclosed no conflict of interest.Wennberg, Patrik .................................. Disclosed no conflict of interest.Wensman, Jeffrey................................. Disclosed no conflict of interest.Werner, Ulrich ....................................... Employee: Sanofi; Stock/Shareholder: Sanofi.Wertz, Marcia ....................................... Disclosed no conflict of interest.Wesch, Rebecca.................................... Disclosed no conflict of interest.Wessel, Jennifer ................................... Disclosed no conflict of interest.Wessells, Hunter................................... Disclosed no conflict of interest.West, Amy............................................. Disclosed no conflict of interest.West, Daniel J. .................................... Disclosed no conflict of interest.West, Donna S. .................................... Disclosed no conflict of interest.Westfall, Sally....................................... Disclosed no conflict of interest.Weston, Cynthia.................................... Employee: GlaxoSmithKline; Stock/Shareholder:
GlaxoSmithKline.Westphalen, Stefan .............................. Disclosed no conflict of interest.Westwell-Roper, Clara .......................... Disclosed no conflict of interest.Wever, Raiza ......................................... Disclosed no conflict of interest.Wexler, Deborah J. .............................. Disclosed no conflict of interest.Weyman, Kate....................................... Disclosed no conflict of interest.Whaley-Connell, Adam ......................... Disclosed no conflict of interest.Wheatcroft, Alison C. .......................... Disclosed no conflict of interest.Wheatcroft, Stephen B. ....................... Disclosed no conflict of interest.Wheeler, Jean S. ................................. Employee: Metabolic Solutions Development Co.
Wheeler, Michael.................................. Disclosed no conflict of interest.Whitaker, Robert C. .............................. Disclosed no conflict of interest.White, Adam S. .................................... Disclosed no conflict of interest.White, Heidi .......................................... Disclosed no conflict of interest.White, Kimberly V. ............................... Employee: Data Sciences International; Stock/Shareholder:
Data Sciences International.White, Michael G. ................................ Disclosed no conflict of interest.White, Morris F. ................................... Disclosed no conflict of interest.White, Neil H. ...................................... Advisory Panel: Daiichi-Sankyo, Inc., Novo Nordisk A/S;
Research Support: Bristol-Myers Squibb Company.White, Perrin C. .................................... Disclosed no conflict of interest.White, Phillip J. ................................... Research Support: Pfizer, Inc.White, Tiffani ........................................ Disclosed no conflict of interest.White, Ursula A. .................................. Disclosed no conflict of interest.Whiting, David R. ................................. Disclosed no conflict of interest.Whitlock, Kathryn ................................. Disclosed no conflict of interest.Whittemore, Robin ................................ Disclosed no conflict of interest.Wiberg, Anna ........................................ Disclosed no conflict of interest.Wicklow, Brandy ................................... Disclosed no conflict of interest.Wieland, Mark R. ................................. Advisory Panel: Genentech; Consultant: Genentech; Research
Support: Genentech.Wielgos, Miroslaw ............................... Disclosed no conflict of interest.Wiersch, John ....................................... Disclosed no conflict of interest.Wijesuriya, Mahen ............................... Disclosed no conflict of interest.Wijkman, Magnus ................................. Disclosed no conflict of interest.Wild, Sarah H. ...................................... Disclosed no conflict of interest.Wiley, Deanne ....................................... Disclosed no conflict of interest.Wilhelm, Joshua J. .............................. Disclosed no conflict of interest.Wilhelmsen-Langeland, Ane ................ Disclosed no conflict of interest.Wilinska, Malgorzata E. ....................... Consultant: Becton, Dickinson and Company.Wilk, Juliusz .......................................... Disclosed no conflict of interest.Wilken, Marlene K. .............................. Disclosed no conflict of interest.Wilkening, Randall B. .......................... Disclosed no conflict of interest.Wilkin, Terence J. ................................ Disclosed no conflict of interest.Wilkinson, Grahame ............................. Disclosed no conflict of interest.Wilkinson, I.D. ...................................... Disclosed no conflict of interest.Wilkinson, Iain ...................................... Disclosed no conflict of interest.Wilkison, William O. ............................ Employee: BHV Pharma; Stock/Shareholder: BHV Pharma.Wilks, Mike D. ..................................... Employee: GlaxoSmithKline; Stock/Shareholder:
GlaxoSmithKline.Willaing, Ingrid ..................................... Other Relationship: Novo Nordisk A/S.Willard-Grace, Rachel ........................... Disclosed no conflict of interest.Willems, Sara M. ................................. Disclosed no conflict of interest.Willett, Walter C. ................................. Disclosed no conflict of interest.Willi, Steven M. ................................... Disclosed no conflict of interest.Williams, Amy L. .................................. Disclosed no conflict of interest.Williams, Ashley S. ............................. Disclosed no conflict of interest.Williams, Desmond E. ......................... Disclosed no conflict of interest.Williams, Jan M. ................................. Disclosed no conflict of interest.Williams, Jonathan ............................... Disclosed no conflict of interest.Williams, Kelly ...................................... Disclosed no conflict of interest.Williams, Kevin Jon .............................. Stock/Shareholder: Hygieia, Inc.Williams, Kevin W. .............................. Disclosed no conflict of interest.Williams, Lovoria B. ............................. Disclosed no conflict of interest.Williams, Lyda....................................... Disclosed no conflict of interest.Williams, Meurig .................................. Disclosed no conflict of interest.Williams, Paul F. .................................. Disclosed no conflict of interest.Williams, Sally P. ................................. Disclosed no conflict of interest.Willis, Michael ...................................... Consultant: Novo Nordisk.Willmann, Irina ..................................... Employee: Sanofi.Wilms, Britta ......................................... Disclosed no conflict of interest.Wilson, Ben J. ...................................... Disclosed no conflict of interest.Wilson, Bryan R. .................................. Employee: Biodel, Inc.; Stock/Shareholder: Biodel, Inc.Wilson, Bula M. ................................... Disclosed no conflict of interest.Wilson, Craig ........................................ Employee: Takeda Global Research & Development Center,
Inc.; Stock/Shareholder: Takeda Global Research & Development Center, Inc.
Wilson, Donald ..................................... Advisory Panel: Aegerion Pharmaceuticals; Research Support: Merck Sharp & Dohme, Novo Nordisk Inc; Speaker’s Bureau: Osler Institute.
Wilson, Glenn ....................................... Disclosed no conflict of interest.Wilson, James ...................................... Disclosed no conflict of interest.Wilson, Kevin ........................................ Disclosed no conflict of interest.Wilson, Timothy H. .............................. Employee: GlaxoSmithKline; Stock/Shareholder:
GlaxoSmithKline.Wilton, Andrew ..................................... Disclosed no conflict of interest.Win, Khin .............................................. Employee: Profil Institute for Clinical Research, Inc.Windell, Lena ........................................ Disclosed no conflict of interest.Winden, Duane ..................................... Disclosed no conflict of interest.Windham MacMaster, Heidemarie ...... Disclosed no conflict of interest.Wineinger, Nathan ................................ Disclosed no conflict of interest.Wing, Rena R. ...................................... Disclosed no conflict of interest.
Winger, Mary E. ................................... Disclosed no conflict of interest.Wingert, Ashley .................................... Disclosed no conflict of interest.Winkler, Gabor ...................................... Advisory Panel: 77 Electronics, Ltd.Wintfeld, Neil ....................................... Employee: Novo Nordisk, Inc.Wirth, Mark ........................................... Employee: Merck.Wishart, Judith ..................................... Disclosed no conflict of interest.Witczak, Justyna K. ............................. Disclosed no conflict of interest.Witek, Przemyslaw ............................... Research Support: Bioton.Witkowska, Agnieszka .......................... Disclosed no conflict of interest.Witkowski, Piotr .................................... Disclosed no conflict of interest.Witkowski, Sarah .................................. Disclosed no conflict of interest.Witsch, Michael .................................... Disclosed no conflict of interest.Witte, Daniel R. ................................... Other Relationship: Novo Nordisk A/S; Stock/Shareholder:
Novo Nordisk A/S.Witte, Klaus K. ..................................... Disclosed no conflict of interest.Wittmeier, Kristy ................................... Disclosed no conflict of interest.Wlodarczyk, Catherine .......................... Other Relationship: Merck.Wnendt, Stephan .................................. Disclosed no conflict of interest.Woelk, Christopher ............................... Disclosed no conflict of interest.Woerle, Hans J. ................................... Employee: Boehringer Ingelheim GmbH & Co. KG.Wojan, Magdalena ............................... Disclosed no conflict of interest.Wojtaszewski, Jørgen F. ...................... Disclosed no conflict of interest.Wolczynski, Slawomir ........................... Disclosed no conflict of interest.Wolden, Michael L. .............................. Employee: Novo Nordisk A/S; Stock/Shareholder: Novo
Nordisk A/S.Wolf, Cassandra.................................... Disclosed no conflict of interest.Wolf, Tillmann ....................................... Disclosed no conflict of interest.Wolfe, Bruce ......................................... Disclosed no conflict of interest.Wolfe, Cindy L. ..................................... Employee: Metabolic Solutions Development Co.Wolfert, Robert ..................................... Employee: Metabolon, Inc.; Stock/Shareholder: Metabolon, Inc.Wolffenbuttel, Bruce H. ....................... Advisory Panel: Eli Lilly and Company, Novo Nordisk A/S;
Consultant: Eli Lilly and Company; Research Support: Eli Lilly and Company, Novo Nordisk A/S, Pfizer, Inc.
Wolford, Brooke .................................... Disclosed no conflict of interest.Wollheim, Claes B. .............................. Disclosed no conflict of interest.Wollitzer, Alison Okada ........................ Research Support: Dexcom, Inc., Insulet Corporation, Lifescan
Animas, Inc.Woloschak, Michael ............................. Employee: Novartis Pharmaceuticals Corporation.Wolski, Kathy ........................................ Disclosed no conflict of interest.Wolthers, Troels .................................... Employee: Merck Sharp & Dohme Limited.Won, Hee Kwan .................................... Disclosed no conflict of interest.Won, Jong Chul .................................... Disclosed no conflict of interest.Won, Kyu Chang ................................... Disclosed no conflict of interest.Wong, Chun Kwok ................................ Disclosed no conflict of interest.Wong, Craig .......................................... Disclosed no conflict of interest.Wong, Jencia ........................................ Disclosed no conflict of interest.Wong, Jenise C. ................................... Disclosed no conflict of interest.Wong, Kimberly..................................... Disclosed no conflict of interest.Wong, Ma-Li ......................................... Disclosed no conflict of interest.Wong, Nathan D. ................................. Research Support: Bristol-Myers Squibb Company.Wong, Rebecca Y. ................................ Disclosed no conflict of interest.Wong, Tien-Yin ...................................... Disclosed no conflict of interest.Wongchai, Kanyanat ............................. Disclosed no conflict of interest.Woo, Jeong-Taek .................................. Disclosed no conflict of interest.Woo, Minna .......................................... Disclosed no conflict of interest.Woo, Vincent C. ................................... Advisory Panel: Abbott Laboratories, Inc., AstraZeneca
Pharmaceuticals LP, Boehringer Ingelheim GmbH & Co. KG, Bristol-Myers Squibb Company, Eli Lilly and Company, Johnson & Johnson, Merck, Novo Nordisk A/S, Roche Pharmaceuticals, Sanofi; Speaker’s Bureau: Abbott Laboratories, Inc., AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim GmbH & Co. KG, Bristol-Myers Squibb Company, Eli Lilly and Company, Johnson & Johnson, Merck, Novo Nordisk A/S, Roche Pharmaceuticals, Sanofi.
Woo, Yu-Cho ......................................... Disclosed no conflict of interest.Wood III, William H. ............................ Disclosed no conflict of interest.Wood, Anna J. ..................................... Disclosed no conflict of interest.Wood, Colleen L. .................................. Disclosed no conflict of interest.Wood, Jamie ......................................... Disclosed no conflict of interest.Woodard, LeChauncy ............................ Disclosed no conflict of interest.Woodcock, Sean ................................... Disclosed no conflict of interest.Woods, Robert ...................................... Disclosed no conflict of interest.Woods, Stephen C. .............................. Disclosed no conflict of interest.Woods, Thomas C. ............................... Disclosed no conflict of interest.Woodward, Mark .................................. Disclosed no conflict of interest.Woolcott, Orison O. ............................. Disclosed no conflict of interest.Woolnough, Catherine .......................... Disclosed no conflict of interest.Wooten, Joshua S. .............................. Disclosed no conflict of interest.Wozniak, Lisa ........................................ Disclosed no conflict of interest.Wozniakiewicz, Ewa ............................. Disclosed no conflict of interest.Wrensford, Khalea ................................ Disclosed no conflict of interest.
Wright, Alice ......................................... Disclosed no conflict of interest.Wright, Christopher V. ......................... Disclosed no conflict of interest.Wright, Douglas E. ............................... Disclosed no conflict of interest.Wright, Jonathon J. ............................. Research Support: GlaxoSmithKline.Wright, Lorena A. ................................. Disclosed no conflict of interest.Wright, Robert ...................................... Disclosed no conflict of interest.Wrobel, James ...................................... Research Support: NIH, University of Michigan.Wroblewski, Victor J. .......................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly
and Company.Wronkowitz, Nina ................................. Disclosed no conflict of interest.Wu, Di ................................................... Disclosed no conflict of interest.Wu, Donghong ...................................... Disclosed no conflict of interest.Wu, En-Tzu ............................................ Disclosed no conflict of interest.Wu, Fengfeng ........................................ Disclosed no conflict of interest.Wu, Ge .................................................. Disclosed no conflict of interest.Wu, Ginger Y. ....................................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly
and Company.Wu, Haiyan............................................ Employee: F. Hoffmann-La Roche, Ltd.Wu, Hui ................................................. Disclosed no conflict of interest.Wu, I-Hsien ........................................... Disclosed no conflict of interest.Wu, Jiahua ............................................ Disclosed no conflict of interest.Wu, Jing ................................................ Disclosed no conflict of interest.Wu, Jun ................................................. Disclosed no conflict of interest.Wu, Li-Chiu............................................ Disclosed no conflict of interest.Wu, Mengrui ......................................... Disclosed no conflict of interest.Wu, Pei-Tzu ........................................... Disclosed no conflict of interest.Wu, Qiang ............................................. Disclosed no conflict of interest.Wu, Rui.................................................. Disclosed no conflict of interest.Wu, Rui.................................................. Research Support: NuSirt Inc.Wu, Ta-Jen ............................................ Disclosed no conflict of interest.Wu, Ted ................................................. Disclosed no conflict of interest.Wu, Tong ............................................... Disclosed no conflict of interest.Wu, W. Kelly ......................................... Disclosed no conflict of interest.Wu, Wan-Chen ...................................... Disclosed no conflict of interest.Wu, Wen-Chih ....................................... Disclosed no conflict of interest.Wu, Wenjie ........................................... Research Support: Boehringer Ingelheim GmbH & Co. KG.Wu, Wenxia .......................................... Disclosed no conflict of interest.Wu, Wudelehu ...................................... Disclosed no conflict of interest.Wu, Xiangdong...................................... Disclosed no conflict of interest.Wu, Yanqing .......................................... Disclosed no conflict of interest.Wu, Yong-Jian....................................... Disclosed no conflict of interest.Wu, Yueh C. ......................................... Disclosed no conflict of interest.Wukich, Dane K. .................................. Disclosed no conflict of interest.Wulff, Jacob.......................................... Employee: Metabolon, Inc.; Stock/Shareholder: Metabolon, Inc.Wulffhart, Liat ....................................... Disclosed no conflict of interest.Wurst, Ulrike ......................................... Disclosed no conflict of interest.Wylie-Rosett, Judith ............................. Disclosed no conflict of interest.Wysham, Carol H. ................................ Consultant: Boehringer Ingelheim Pharmaceuticals, Inc.,
Bristol-Myers Squibb Company, Eli Lilly and Company, Janssen Pharmaceuticals; Other Relationship: Amylin Pharmaceuticals, Inc., Eli Lilly and Company, Janssen Pharmaceuticals; Speaker’s Bureau: AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Janssen Pharmaceuticals, Novo Nordisk, Inc., Sangamo BioSciences, Inc.
Wysocki, Timothy T. ............................. Disclosed no conflict of interest.Wystrychowski, Antoni ......................... Research Support: Astellas Pharma U.S., Inc., Roche
Pharmaceuticals, Teva Pharmaceuticals.Wystrychowski, Grzegorz ...................... Research Support: Roche Pharmaceuticals, Teva
Pharmaceuticals.Xia, Fangzhen ........................................ Disclosed no conflict of interest.Xia, Juan ............................................... Disclosed no conflict of interest.Xia, Ming-Feng ...................................... Disclosed no conflict of interest.Xia, Qianghua ........................................ Disclosed no conflict of interest.Xiang, Anny H. ..................................... Disclosed no conflict of interest.Xiang, Kunsan ....................................... Disclosed no conflict of interest.Xiang, Yang K. ...................................... Disclosed no conflict of interest.Xiao, Changting ..................................... Disclosed no conflict of interest.Xiao, Fengxia ......................................... Disclosed no conflict of interest.Xiao, Guozhi .......................................... Disclosed no conflict of interest.Xiao, Huishen ........................................ Disclosed no conflict of interest.Xiao, Jianzhong ..................................... Disclosed no conflict of interest.Xiao, Xiang ............................................ Disclosed no conflict of interest.Xiao, Xiangwei ...................................... Disclosed no conflict of interest.Xiao, Xinhua .......................................... Disclosed no conflict of interest.Xiao, Yong-Fu ........................................ Employee: CrownBio.Xie, Hui .................................................. Disclosed no conflict of interest.Xie, Jing ................................................ Disclosed no conflict of interest.Xie, John ............................................... Employee: Janssen Research & Development, LLC.Xie, Li .................................................... Disclosed no conflict of interest.Xie, Lin .................................................. Other Relationship: Sanofi U.S., Inc.
Xie, Min ................................................. Disclosed no conflict of interest.Xie, Rongrong ........................................ Disclosed no conflict of interest.Xie, Xiangyang ...................................... Disclosed no conflict of interest.Xie, Xitao ............................................... Disclosed no conflict of interest.Xin, Jiang .............................................. Disclosed no conflict of interest.Xin, Ying ................................................ Disclosed no conflict of interest.Xing, Jin ................................................ Disclosed no conflict of interest.Xing, Wenjuan....................................... Disclosed no conflict of interest.Xing, Xiaoyan ........................................ Disclosed no conflict of interest.Xing, Yuan ............................................. Disclosed no conflict of interest.Xiong, Juan ........................................... Disclosed no conflict of interest.Xiong, Xiaoquan .................................... Disclosed no conflict of interest.Xiong, Yalin ........................................... Employee: Vascular Pharmaceuticals Inc.Xiong, Yan ............................................. Disclosed no conflict of interest.Xiong, Yi ................................................ Disclosed no conflict of interest.Xu, Aimin ............................................... Disclosed no conflict of interest.Xu, Am ................................................... Disclosed no conflict of interest.Xu, Bilin ................................................. Disclosed no conflict of interest.Xu, Canxin ............................................. Disclosed no conflict of interest.Xu, Fei ................................................... Disclosed no conflict of interest.Xu, Feng ................................................ Disclosed no conflict of interest.Xu, Fenghao .......................................... Disclosed no conflict of interest.Xu, Gang ................................................ Disclosed no conflict of interest.Xu, Guanlan ........................................... Disclosed no conflict of interest.Xu, Guozhang ........................................ Employee: Janssen Research & Development.Xu, Hong ................................................ Disclosed no conflict of interest.Xu, Hongyan .......................................... Disclosed no conflict of interest.Xu, Hui ................................................... Disclosed no conflict of interest.Xu, Jian ................................................. Disclosed no conflict of interest.xu, Jianping ........................................... Disclosed no conflict of interest.Xu, John ................................................ Employee: AstraZeneca Pharmaceuticals LP.Xu, June ................................................ Employee: Janssen Research & Development.Xu, Liang ............................................... Disclosed no conflict of interest.Xu, Lijuan .............................................. Disclosed no conflict of interest.Xu, Lu .................................................... Disclosed no conflict of interest.Xu, Michael M. .................................... Disclosed no conflict of interest.Xu, Shang-Zhong ................................... Disclosed no conflict of interest.Xu, Shiming ........................................... Disclosed no conflict of interest.Xu, Shiyao ............................................. Employee: Merck.Xu, Stanley ............................................ Disclosed no conflict of interest.Xu, Wen................................................. Disclosed no conflict of interest.Xu, Xiao ................................................. Disclosed no conflict of interest.Xu, XiaoJing .......................................... Disclosed no conflict of interest.Xu, Yuemei ............................................ Disclosed no conflict of interest.Xuan, Lei ............................................... Disclosed no conflict of interest.Xue, Bingzhong ..................................... Research Support: NuSirt, Inc.Xue, Lingshu .......................................... Disclosed no conflict of interest.Xue, Mingzhan ...................................... Disclosed no conflict of interest.Xue, Qian-Li ........................................... Disclosed no conflict of interest.Xue, Shenneng ...................................... Disclosed no conflict of interest.Xuyu, Zu ................................................ Disclosed no conflict of interest.Yabe, Daisuke ....................................... Advisory Panel: Novartis Pharma AG, Novo Nordisk, Inc.,
Sanofi; Speaker’s Bureau: Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Merck Sharp & Dohme Ltd., Novo Nordisk, Inc., Sanofi, Takeda Pharmaceuticals U.S.A., Inc.
Yachi, Yoko ............................................ Disclosed no conflict of interest.Yaghootkar, Hanieh ............................... Disclosed no conflict of interest.Yagi, Kunimasa ..................................... Disclosed no conflict of interest.Yagihashi, Soroku ................................. Disclosed no conflict of interest.Yagishita, Yoko ...................................... Disclosed no conflict of interest.Yahagi, Naoya ....................................... Disclosed no conflict of interest.Yakusevich, Vladimir ............................. Disclosed no conflict of interest.Yalcin, Mehmet M. .............................. Disclosed no conflict of interest.Yale, Jean-Francois ............................... Advisory Panel: Bristol-Myers Squibb/AstraZeneca, Eli Lilly
and Company, Janssen Pharmaceuticals, Merck, Novo Nordisk, Inc., Sanofi; Research Support: Bristol-Myers Squibb/AstraZeneca, Eli Lilly and Company, Janssen Pharmaceuticals, Medtronic, Merck, Novo Nordisk, Inc.; Speaker’s Bureau: Abbott Diabetes Care, Bayer Health Care, LLC, Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb/AstraZeneca, Eli Lilly and Company, Janssen Pharmaceuticals, Merck, Novo Nordisk, Inc., Sanofi.
Yamaaki, Naoto ..................................... Disclosed no conflict of interest.Yamada, Eijiro ....................................... Disclosed no conflict of interest.Yamada, Kentaro ................................... Disclosed no conflict of interest.Yamada, Masanobu .............................. Disclosed no conflict of interest.Yamada, Nobuhiro ................................ Disclosed no conflict of interest.Yamada, Satoru ..................................... Disclosed no conflict of interest.Yamada, Takaho .................................... Disclosed no conflict of interest.Yamada, Takatsugu ............................... Disclosed no conflict of interest.
Yamada, Tetsuya ................................... Disclosed no conflict of interest.Yamada, Yoshifumi ............................... Disclosed no conflict of interest.Yamada-Fowler, Naomi ......................... Disclosed no conflict of interest.Yamagishi, Masakazu ........................... Disclosed no conflict of interest.Yamaguchi, Eriko ................................... Disclosed no conflict of interest.Yamaguchi, Hideki ................................ Disclosed no conflict of interest.Yamaguchi, Rieko .................................. Disclosed no conflict of interest.Yamaguchi, Suguru ............................... Disclosed no conflict of interest.Yamahara, Kosuke ................................ Disclosed no conflict of interest.Yamakawa, Junichi ............................... Disclosed no conflict of interest.Yamakawa, Tadashi .............................. Disclosed no conflict of interest.Yamamoto, Kazuhiro ............................. Disclosed no conflict of interest.Yamamoto, Masahiko ........................... Disclosed no conflict of interest.Yamamoto, Masahiro ............................ Disclosed no conflict of interest.Yamamoto, Masayuki ........................... Disclosed no conflict of interest.Yamamoto, Noriyuki .............................. Employee: Bayer Health Care, LLC.Yamamoto, Wataru ............................... Disclosed no conflict of interest.Yamamoto, Yuichi ................................. Disclosed no conflict of interest.Yamamotoya, Takeshi ........................... Disclosed no conflict of interest.Yamanaka, Shinya ................................. Disclosed no conflict of interest.Yamano, Gen ......................................... Disclosed no conflict of interest.Yamasaki, Hironori ................................ Disclosed no conflict of interest.Yamasaki, Masahiro ............................. Disclosed no conflict of interest.Yamashiro, Keiko .................................. Disclosed no conflict of interest.Yamashita, Kaoru .................................. Disclosed no conflict of interest.Yamashita, Rie ...................................... Disclosed no conflict of interest.Yamashita, Satoko ................................ Employee: Sanwa Kagaku Kenkyusho Co., Ltd.Yamashita, Shizuya ............................... Research Support: Boehringer Ingelheim GmbH & Co. KG.Yamashita, Yukiko ................................. Disclosed no conflict of interest.Yamato, Masayuki ................................ Disclosed no conflict of interest.Yamauchi, Akiyo .................................... Disclosed no conflict of interest.Yamauchi, Jun ....................................... Disclosed no conflict of interest.Yamauchi, Toshimasa............................ Disclosed no conflict of interest.Yamaura, Shiori ..................................... Disclosed no conflict of interest.Yamazaki, Hiroki .................................... Disclosed no conflict of interest.Yamazaki, Masahiro .............................. Disclosed no conflict of interest.Yamazaki, Toru ...................................... Disclosed no conflict of interest.Yamazaki, Tsutomu ................................ Research Support: AstraZeneca Pharmaceuticals LP, Daiichi-
Yamazaki, Yuko ..................................... Disclosed no conflict of interest.Yan, Fei .................................................. Disclosed no conflict of interest.Yan, Hong-Mei ...................................... Disclosed no conflict of interest.Yan, Jimmy S. ...................................... Disclosed no conflict of interest.Yan, Jinhua ........................................... Disclosed no conflict of interest.Yan, Li .................................................... Disclosed no conflict of interest.Yan, Linfei ............................................. Disclosed no conflict of interest.Yan, Linling ............................................ Disclosed no conflict of interest.Yan, Shijun ............................................ Disclosed no conflict of interest.Yan, Xiaoqing ........................................ Disclosed no conflict of interest.Yan, Xin Tong ........................................ Disclosed no conflict of interest.Yan, Yuanqing ....................................... Disclosed no conflict of interest.Yanagimachi, Tsuyoshi .......................... Disclosed no conflict of interest.Yanase, Toshihiko.................................. Disclosed no conflict of interest.Yanase, Tosihiko.................................... Disclosed no conflict of interest.Yancheng, Xu ........................................ Disclosed no conflict of interest.Yancy, William S. ................................. Disclosed no conflict of interest.Yang, Alex ............................................. Consultant: ZS Pharma, Inc; Employee: Xelay Acumen, Inc.Yang, Chuan .......................................... Disclosed no conflict of interest.Yang, Daizhi .......................................... Disclosed no conflict of interest.Yang, Fred ............................................. Employee: GlaxoSmithKline; Other Relationship:
GlaxoSmithKline; Stock/Shareholder: GlaxoSmithKline.Yang, Gang-Yi........................................ Disclosed no conflict of interest.Yang, Guang-Ran .................................. Disclosed no conflict of interest.Yang, Hae Kyung ................................... Disclosed no conflict of interest.Yang, Hui ............................................... Disclosed no conflict of interest.Yang, Huijie ........................................... Disclosed no conflict of interest.Yang, Jiaojiao ....................................... Disclosed no conflict of interest.Yang, Jing ............................................. Disclosed no conflict of interest.Yang, Jin-Kui ......................................... Disclosed no conflict of interest.Yang, Kevin Kaiwen .............................. Disclosed no conflict of interest.Yang, Liu ................................................ Disclosed no conflict of interest.Yang, Lucy ............................................. Disclosed no conflict of interest.Yang, Mei .............................................. Employee: Diaichi Sankyo.Yang, Ming ............................................ Employee: Beijing Novartis Pharma Co. Ltd.Yang, Peixin ........................................... Disclosed no conflict of interest.Yang, Peng ............................................ Disclosed no conflict of interest.
Yang, Qingchan ..................................... Disclosed no conflict of interest.Yang, Qinglin ......................................... Disclosed no conflict of interest.Yang, Shumin ........................................ Disclosed no conflict of interest.Yang, Tao ............................................... Disclosed no conflict of interest.Yang, Wenjing ....................................... Disclosed no conflict of interest.Yang, Wen-Ying .................................... Disclosed no conflict of interest.Yang, Wulin ........................................... Disclosed no conflict of interest.Yang, Yanxiaoxiao ................................. Disclosed no conflict of interest.Yang, Yeo-Ree ....................................... Disclosed no conflict of interest.Yang, Yi S. ............................................ Disclosed no conflict of interest.Yang, Yihan ........................................... Disclosed no conflict of interest.Yang, Yisheng........................................ Disclosed no conflict of interest.Yang, Yu-Hui .......................................... Disclosed no conflict of interest.Yang, Zhao ............................................ Disclosed no conflict of interest.Yang, Zhaojun ....................................... Disclosed no conflict of interest.Yao, Bin ................................................. Disclosed no conflict of interest.Yao, Hua ................................................ Employee: Prometheon Pharma, LLC.Yao, Jing ............................................... Disclosed no conflict of interest.Yao, Wenliang ....................................... Disclosed no conflict of interest.Yao, Xiuzhong ........................................ Disclosed no conflict of interest.Yap, Fabian ............................................ Disclosed no conflict of interest.Yapa, Udeni ........................................... Employee: Pfizer, Inc.Yaqoob, Muhammad M. ...................... Disclosed no conflict of interest.Yarborough, Orlando ............................. Disclosed no conflict of interest.Yasuda, Haruka ..................................... Disclosed no conflict of interest.Yasuda, Mako ....................................... Disclosed no conflict of interest.Yasuda, Patrice ..................................... Disclosed no conflict of interest.Yasuda, Takao ....................................... Disclosed no conflict of interest.Yasuda, Tetsuyuki.................................. Disclosed no conflict of interest.Yasunaga, Yuichi ................................... Disclosed no conflict of interest.Yasunami, Yohichi ................................. Disclosed no conflict of interest.Yateesh, A.N. ....................................... Disclosed no conflict of interest.Yau, Michelle S. ................................... Disclosed no conflict of interest.Yavin, Yshai ........................................... Employee: Bristol-Myers Squibb Company; Stock/Shareholder:
Bristol-Myers Squibb Company.Yazib, Syatirah A. ................................. Disclosed no conflict of interest.Yderstraede, Knud ................................ Disclosed no conflict of interest.Ye, Chenglin .......................................... Consultant: LMC Diabetes & Endocrinology.Ye, Dewei .............................................. Disclosed no conflict of interest.Ye, Fen ................................................... Employee: Sanofi; Stock/Shareholder: Sanofi.Ye, Jianping .......................................... Disclosed no conflict of interest.Ye, June ................................................ Employee: GlaxoSmithKline; Stock/Shareholder:
GlaxoSmithKline.Ye, Kaitai ............................................... Disclosed no conflict of interest.Ye, Kuanping ......................................... Disclosed no conflict of interest.Ye, Xiaolei ............................................. Disclosed no conflict of interest.Ye, Yan-bin ............................................ Disclosed no conflict of interest.Yeager, Mark ......................................... Disclosed no conflict of interest.Yechoor, Vijay K. .................................. Disclosed no conflict of interest.Yee, Christine ........................................ Disclosed no conflict of interest.Yee, Jacqueline ..................................... Employee: Janssen Research & Development, LLC.Yeganeh Manon, Khazrai ...................... Disclosed no conflict of interest.Yeh, Helen ............................................. Employee: AstraZeneca Pharmaceuticals LP.Yeh, Hsin-Chieh ..................................... Disclosed no conflict of interest.Yeh, Matthew M. ................................. Disclosed no conflict of interest.Yeh, Teng-Kang H. ................................ Disclosed no conflict of interest.Yeh, Wen-I............................................. Disclosed no conflict of interest.Yenchitsomanus, Pa-thai ...................... Disclosed no conflict of interest.Yengo, Loic ............................................ Disclosed no conflict of interest.Yeo, Chia Rou ........................................ Disclosed no conflict of interest.Yeo, Kwee Poo ...................................... Employee: Eli Lilly and Company.Yeo, Sandy ............................................ Employee: Bayer.Yeoh, Lee Ying ...................................... Disclosed no conflict of interest.Yesilkaya, Sirzat .................................... Disclosed no conflict of interest.Yeung, Chun-Yip .................................... Disclosed no conflict of interest.Yeung, Edwina ...................................... Disclosed no conflict of interest.Yeung, Wing-Chi G. .............................. Disclosed no conflict of interest.Yfanti, Christina .................................... Disclosed no conflict of interest.Yi, Eugene C. ........................................ Disclosed no conflict of interest.Yi, Jiyoung............................................. Employee: Hanmi Pharmaceutical Co.Yi, Yong ................................................. Disclosed no conflict of interest.Yi, Zheng ............................................... Disclosed no conflict of interest.Yi, Zhengping ........................................ Disclosed no conflict of interest.Yildizhan, Hatice ................................... Disclosed no conflict of interest.Yilmaz, Didem ....................................... Disclosed no conflict of interest.Yim, Cheng-Bin...................................... Disclosed no conflict of interest.Yin, Dandan ........................................... Disclosed no conflict of interest.Yin, Jinhua ............................................ Disclosed no conflict of interest.Yin, Li..................................................... Disclosed no conflict of interest.Yin, Raynold V. ..................................... Disclosed no conflict of interest.Yin, Xueyao ........................................... Disclosed no conflict of interest.Ying, Wu ................................................ Disclosed no conflict of interest.
Yip, Denis .............................................. Disclosed no conflict of interest.Yixuan, Liu ............................................. Disclosed no conflict of interest.Yki-Järvinen, Hannele ........................... Consultant: AstraZeneca Pharmaceuticals LP, Bristol-Myers
Ylitalo, Kelly R. ..................................... Disclosed no conflict of interest.Ylli, Dorina ............................................ Disclosed no conflict of interest.Yogeshwari, S. ..................................... Disclosed no conflict of interest.Yogi-Morren, Divya ............................... Disclosed no conflict of interest.Yokoi, Hiroyoshi .................................... Disclosed no conflict of interest.Yokono, Masanori ................................. Disclosed no conflict of interest.Yokota, Ayako........................................ Disclosed no conflict of interest.Yokota, Harumasa ................................. Disclosed no conflict of interest.Yokota, Takashi ..................................... Disclosed no conflict of interest.Yokota, Tamotsu .................................... Disclosed no conflict of interest.Yokote, Koutaro ..................................... Disclosed no conflict of interest.Yonekawa, Tadato ................................. Disclosed no conflict of interest.Yong, Chun ............................................ Disclosed no conflict of interest.Yoo, Elsia ............................................... Disclosed no conflict of interest.Yoo, Hye Jin .......................................... Disclosed no conflict of interest.Yoo, Min ................................................ Disclosed no conflict of interest.Yoo, Soon Jib ........................................ Disclosed no conflict of interest.Yoon, HaeJee ........................................ Disclosed no conflict of interest.Yoon, Hye Jin ........................................ Disclosed no conflict of interest.Yoon, Ji Sung ........................................ Disclosed no conflict of interest.Yoon, Ji Won ......................................... Disclosed no conflict of interest.Yoon, Kun-Ho ........................................ Disclosed no conflict of interest.Yoon, Kyung-Jin .................................... Disclosed no conflict of interest.Yoon, Young-Sil ..................................... Disclosed no conflict of interest.York, Nathan ......................................... Disclosed no conflict of interest.Yorulmaz, Elif ........................................ Disclosed no conflict of interest.Yoshida, Akira ....................................... Disclosed no conflict of interest.Yoshida, Akitoshi .................................. Disclosed no conflict of interest.Yoshida, Nobuyuki ................................ Disclosed no conflict of interest.Yoshida, Toshihide ................................ Disclosed no conflict of interest.Yoshida, Toshiyuki ................................. Disclosed no conflict of interest.Yoshii, Hidenori ..................................... Disclosed no conflict of interest.Yoshikawa, Yuichiro .............................. Disclosed no conflict of interest.Yoshimoti, Chie ..................................... Disclosed no conflict of interest.Yoshimura, Kumiko ............................... Disclosed no conflict of interest.Yoshimura, Yukio ................................... Disclosed no conflict of interest.Yoshinari, Toru....................................... Disclosed no conflict of interest.Yoshino, Keiko ....................................... Disclosed no conflict of interest.Yoshizawa, Sakiko ................................ Disclosed no conflict of interest.You, Lianghui ......................................... Disclosed no conflict of interest.Youn, Jang H. ....................................... Disclosed no conflict of interest.Younès, Antoine .................................... Disclosed no conflict of interest.Younes, Areej K. ................................... Disclosed no conflict of interest.Young, Andrew A. ................................ Employee: GlaxoSmithKline.Young, Cheryl ........................................ Disclosed no conflict of interest.Young, Ian S. ........................................ Disclosed no conflict of interest.Young, Jamey D. .................................. Disclosed no conflict of interest.Young, Laura A. .................................... Research Support: Boehringer Ingelheim Pharmaceuticals,
Inc., Eli Lilly and Company, GI Dynamics, Halozyme Therapeutics, Johnson & Johnson, Lexicon Pharmaceuticals, Inc., Medtronic, Novo Nordisk, Inc., Orexigen Therapeutics, Inc., PhaseBio, Sanofi, Takeda Pharmaceuticals U.S.A., Inc., Tolerx, Inc.
Young, Laurie ........................................ Disclosed no conflict of interest.Young, Lawrence H. ............................. Disclosed no conflict of interest.Youngblood, Marston E. ....................... Disclosed no conflict of interest.Young-Hyman, Deborah ........................ Disclosed no conflict of interest.Younis, Firas M. ................................... Disclosed no conflict of interest.Younk, Lisa M. ...................................... Disclosed no conflict of interest.Yu, Bangwei .......................................... Disclosed no conflict of interest.Yu, Chengxia ......................................... Disclosed no conflict of interest.Yu, Dan .................................................. Disclosed no conflict of interest.Yu, Demin .............................................. Disclosed no conflict of interest.Yu, Haoyong .......................................... Disclosed no conflict of interest.Yu, Hea Min .......................................... Disclosed no conflict of interest.Yu, Hong ................................................ Disclosed no conflict of interest.Yu, Ji Hee .............................................. Disclosed no conflict of interest.Yu, Jiangyi ............................................. Disclosed no conflict of interest.Yu, Jing ................................................. Disclosed no conflict of interest.Yu, Lianbo .............................................. Disclosed no conflict of interest.Yu, Maria ............................................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly
and Company.Yu, Ming ................................................ Disclosed no conflict of interest.Yu, Pei ................................................... Disclosed no conflict of interest.
Yu, Richeng ........................................... Disclosed no conflict of interest.Yu, Shengsheng .................................... Employee: Merck.Yu, Shibing ............................................ Disclosed no conflict of interest.Yu, Shujie .............................................. Disclosed no conflict of interest.Yu, Wen Bo ........................................... Employee: Merck.Yu, Xuefeng ........................................... Disclosed no conflict of interest.Yu, Yerong ............................................. Disclosed no conflict of interest.Yu, Yongmei .......................................... Disclosed no conflict of interest.Yu, Yongxin ............................................ Disclosed no conflict of interest.Yu, Yu-Hsiang ........................................ Disclosed no conflict of interest.Yuan, Li .................................................. Disclosed no conflict of interest.Yuan, Mingxia ....................................... Disclosed no conflict of interest.Yuan, Qingxin ........................................ Disclosed no conflict of interest.Yuan, Shenyuan .................................... Disclosed no conflict of interest.Yuan, Xian Xian ..................................... Disclosed no conflict of interest.Yuan, Xiaolan ........................................ Disclosed no conflict of interest.Yuasa, Tomoyuki.................................... Disclosed no conflict of interest.Yudkin, John S. .................................... Disclosed no conflict of interest.Yue, Dennis K. ...................................... Disclosed no conflict of interest.Yue, Jessica T. ..................................... Disclosed no conflict of interest.Yue, Kevin K. ........................................ Disclosed no conflict of interest.Yuji, Hinoda ........................................... Disclosed no conflict of interest.Yuldasheva, Nadira Y. .......................... Disclosed no conflict of interest.Yun, Jae-Seung ..................................... Disclosed no conflict of interest.Yun, Kyung-Jin ...................................... Disclosed no conflict of interest.Yun, Mijin .............................................. Disclosed no conflict of interest.Yun, Nari ............................................... Employee: Hanmi Pharmaceutical Co.Yun, Yu Jung ......................................... Disclosed no conflict of interest.Yusuf, Salim .......................................... Consultant: Sanofi.Yuzefovych, Larysa ................................ Disclosed no conflict of interest.Yyan, Li .................................................. Disclosed no conflict of interest.Zachariae, Claus ................................... Advisory Panel: AbbVie, Eli Lilly and Company, Janssen-Cilag
Zacharias, Julie ..................................... Disclosed no conflict of interest.Zacho, Jeppe ......................................... Employee: Novo Nordisk A/S; Stock/Shareholder: Novo
Nordisk A/S.Zadeh Tahmasebi, Melika ..................... Disclosed no conflict of interest.Zafon, Carlos ......................................... Disclosed no conflict of interest.Zagar, Anthony ...................................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly
and Company.Zaghloul, Norann A. ............................. Disclosed no conflict of interest.Zahabian, Joshua .................................. Disclosed no conflict of interest.Zahn, Ralf .............................................. Disclosed no conflict of interest.Zajac, Jeffrey D. ................................... Disclosed no conflict of interest.Zajdenverg, Lenita ................................ Disclosed no conflict of interest.Zakaria, Ahmed S. ................................ Disclosed no conflict of interest.Zalevskaya, Alsu G. ............................. Disclosed no conflict of interest.Zamarron, Brian .................................... Disclosed no conflict of interest.Zambrowicz, Brian ................................ Employee: Lexicon Pharmaceuticals, Inc.; Stock/Shareholder:
Lexicon Pharmaceuticals, Inc.Zanella, Maria Teresa ........................... Research Support: AstraZeneca/Bristol-Meyers Squibb,
Novartis Pharmaceuticals Corporation, Novo Nordisk, Inc.
Zanesco, Angelina ................................ Disclosed no conflict of interest.Zang, Mengwei ..................................... Disclosed no conflict of interest.Zang, Sha S. ......................................... Disclosed no conflict of interest.Zanolin, Daniela .................................... Disclosed no conflict of interest.Zanotto, Tamires M. ............................. Disclosed no conflict of interest.Zantidis, Anestis ................................... Disclosed no conflict of interest.Zarowitz, Barbara J. ............................. Research Support: Sanofi.Zarrouki, Bader ...................................... Disclosed no conflict of interest.Zatterale, Federica ................................ Disclosed no conflict of interest.Zavoral, Miroslav .................................. Disclosed no conflict of interest.Zawiejska, Agnieszka ........................... Disclosed no conflict of interest.Zbucka-Kretowska, Monika .................. Disclosed no conflict of interest.Zecchini, Barbara .................................. Disclosed no conflict of interest.Zee, Benny ............................................ Disclosed no conflict of interest.Zeggin, Eleftheria .................................. Disclosed no conflict of interest.Zeitler, Philip S. .................................... Disclosed no conflict of interest.Zelaya, Fernando O. ............................. Disclosed no conflict of interest.Zelenko, Zara ........................................ Disclosed no conflict of interest.Zeller, Cordula ....................................... Employee: Boehringer Ingelheim GmbH & Co. KG.Zellner, Katie R. .................................... Disclosed no conflict of interest.Zemel, Michael B. ................................ Employee: NuSirt Inc; Stock/Shareholder: NuSirt Inc.Zeng, Bo ................................................ Disclosed no conflict of interest.Zeng, Hui ............................................... Disclosed no conflict of interest.Zeng, Jun .............................................. Disclosed no conflict of interest.Zeng, Liyi ............................................... Disclosed no conflict of interest.Zeng, Long-Yi ........................................ Disclosed no conflict of interest.Zeng, Mengsu ....................................... Disclosed no conflict of interest.Zeng, Wen ............................................. Disclosed no conflict of interest.
Zeng, Xing ............................................. Disclosed no conflict of interest.Zent, Roy ............................................... Disclosed no conflict of interest.Zera, Chloe ............................................ Disclosed no conflict of interest.Zgibor, Janice C. .................................. Disclosed no conflict of interest.Zhang, Audrey Mengqi ......................... Disclosed no conflict of interest.Zhang, Baifang ...................................... Disclosed no conflict of interest.Zhang, Ben ............................................ Disclosed no conflict of interest.Zhang, Bo Shao ..................................... Employee: Merck.Zhang, Bo .............................................. Disclosed no conflict of interest.Zhang, Charles ...................................... Disclosed no conflict of interest.Zhang, Chi ............................................. Disclosed no conflict of interest.Zhang, Chunfang ................................... Disclosed no conflict of interest.Zhang, Cuilin ......................................... Disclosed no conflict of interest.Zhang, Dan ............................................ Disclosed no conflict of interest.Zhang, Dandan ...................................... Disclosed no conflict of interest.Zhang, Dongyan .................................... Disclosed no conflict of interest.Zhang, Feifei ......................................... Disclosed no conflict of interest.Zhang, Feng ........................................... Disclosed no conflict of interest.Zhang, Fuzhuang ................................... Disclosed no conflict of interest.Zhang, Guangxiang ............................... Disclosed no conflict of interest.Zhang, Guochao .................................... Disclosed no conflict of interest.Zhang, Haifeng ...................................... Disclosed no conflict of interest.Zhang, Haihua ....................................... Disclosed no conflict of interest.Zhang, Hongman ................................... Disclosed no conflict of interest.Zhang, Huabing ..................................... Disclosed no conflict of interest.Zhang, Huiliang ..................................... Disclosed no conflict of interest.Zhang, Huixin ........................................ Disclosed no conflict of interest.Zhang, Jane .......................................... Disclosed no conflict of interest.Zhang, Jiajia ......................................... Disclosed no conflict of interest.Zhang, Jialiang ..................................... Disclosed no conflict of interest.Zhang, Jiameng .................................... Employee: Genentech.Zhang, Jian ........................................... Disclosed no conflict of interest.Zhang, Jingping .................................... Disclosed no conflict of interest.Zhang, Jinlu .......................................... Disclosed no conflict of interest.Zhang, Jiping ........................................ Disclosed no conflict of interest.Zhang, Kehao ........................................ Disclosed no conflict of interest.Zhang, Linshan ...................................... Disclosed no conflict of interest.Zhang, Liping ......................................... Disclosed no conflict of interest.Zhang, Manna ....................................... Disclosed no conflict of interest.Zhang, Mark .......................................... Disclosed no conflict of interest.Zhang, Mingliang .................................. Disclosed no conflict of interest.Zhang, Minxia ....................................... Disclosed no conflict of interest.Zhang, Ning ........................................... Disclosed no conflict of interest.Zhang, Pengyuan ................................... Disclosed no conflict of interest.Zhang, Pili ............................................. Disclosed no conflict of interest.Zhang, Ping ........................................... Disclosed no conflict of interest.Zhang, Puhong ...................................... Disclosed no conflict of interest.Zhang, Quan-Jiang ................................ Disclosed no conflict of interest.Zhang, Rong .......................................... Disclosed no conflict of interest.Zhang, Rui ............................................. Disclosed no conflict of interest.Zhang, Saifei ......................................... Disclosed no conflict of interest.Zhang, Shuyu ........................................ Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly
and Company.Zhang, Simin ......................................... Disclosed no conflict of interest.Zhang, Ting ............................................ Disclosed no conflict of interest.Zhang, Wan ........................................... Disclosed no conflict of interest.Zhang, Wei ............................................ Disclosed no conflict of interest.Zhang, Weibo ........................................ Disclosed no conflict of interest.Zhang, Wenlong .................................... Disclosed no conflict of interest.Zhang, Xian H. ...................................... Disclosed no conflict of interest.Zhang, Xiangmin ................................... Disclosed no conflict of interest.Zhang, Xian-Man .................................. Disclosed no conflict of interest.Zhang, Xiaoming ................................... Disclosed no conflict of interest.Zhang, Xin ............................................. Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly
and Company.Zhang, Xiuying ...................................... Disclosed no conflict of interest.Zhang, Xuanping ................................... Disclosed no conflict of interest.Zhang, Yahong ...................................... Employee: VeroScience.Zhang, Yan ............................................ Disclosed no conflict of interest.Zhang, Yi ............................................... Disclosed no conflict of interest.Zhang, Yinan ......................................... Disclosed no conflict of interest.Zhang, Ying ........................................... Disclosed no conflict of interest.Zhang, Yiqiang ...................................... Disclosed no conflict of interest.Zhang, Yizhu .......................................... Disclosed no conflict of interest.Zhang, Yong .......................................... Disclosed no conflict of interest.Zhang, Yong-jun .................................... Disclosed no conflict of interest.Zhang, Yuan .......................................... Disclosed no conflict of interest.Zhang, Yuying ........................................ Disclosed no conflict of interest.Zhang, Zefeng ....................................... Disclosed no conflict of interest.Zhang, Zhaoyun ..................................... Disclosed no conflict of interest.Zhang, Zhenwen ................................... Disclosed no conflict of interest.Zhang, Zhigguo ..................................... Disclosed no conflict of interest.
Zhang, Zhiguo ....................................... Disclosed no conflict of interest.Zhao, Aiping .......................................... Disclosed no conflict of interest.Zhao, Beinan ......................................... Disclosed no conflict of interest.Zhao, Chunhui ....................................... Disclosed no conflict of interest.Zhao, Hongyu ........................................ Disclosed no conflict of interest.Zhao, Huaqing ....................................... Disclosed no conflict of interest.Zhao, Jianhua ....................................... Disclosed no conflict of interest.Zhao, Jingsong ...................................... Disclosed no conflict of interest.Zhao, Lina .............................................. Disclosed no conflict of interest.Zhao, Liping ........................................... Disclosed no conflict of interest.Zhao, Mingming .................................... Disclosed no conflict of interest.Zhao, Peng ............................................ Disclosed no conflict of interest.Zhao, Weijing ........................................ Disclosed no conflict of interest.Zhao, Xiaojian ....................................... Disclosed no conflict of interest.Zhao, Yongcai ........................................ Disclosed no conflict of interest.Zhao, Yuguang ...................................... Disclosed no conflict of interest.Zhao, Zhigang ....................................... Disclosed no conflict of interest.Zhe, Dai ................................................. Disclosed no conflict of interest.Zhen, Wei .............................................. Disclosed no conflict of interest.Zheng, Deyou ........................................ Disclosed no conflict of interest.Zheng, Fenping ...................................... Disclosed no conflict of interest.Zheng, Pengfei ...................................... Disclosed no conflict of interest.Zheng, Quanxi ....................................... Disclosed no conflict of interest.Zheng, Shirong ...................................... Disclosed no conflict of interest.Zheng, Taishan ...................................... Disclosed no conflict of interest.Zheng, Xueying ..................................... Disclosed no conflict of interest.Zheng, Yang .......................................... Disclosed no conflict of interest.Zheng, Zhenyu ....................................... Disclosed no conflict of interest.Zhi, Hui .................................................. Employee: GlaxoSmithKline; Stock/Shareholder:
GlaxoSmithKline.Zhi, Lin ................................................... Employee: Ligand Pharmaceuticals; Stock/Shareholder:
Ligand Pharmaceuticals.Zhibo, Zhao ........................................... Disclosed no conflict of interest.Zhong, Huanzi ....................................... Disclosed no conflict of interest.Zhong, Ling ............................................ Disclosed no conflict of interest.Zhong, Ni ............................................... Disclosed no conflict of interest.Zhong, Ying ........................................... Disclosed no conflict of interest.Zhongming, Wu ..................................... Disclosed no conflict of interest.Zhou, Jian ............................................. Disclosed no conflict of interest.Zhou, Jiaojiao ....................................... Disclosed no conflict of interest.Zhou, Jiaqiang ...................................... Disclosed no conflict of interest.Zhou, Joe .............................................. Disclosed no conflict of interest.Zhou, Joey ............................................. Disclosed no conflict of interest.Zhou, Mi ................................................ Disclosed no conflict of interest.Zhou, Ming ............................................ Employee: Bristol-Myers Squibb Company.Zhou, Mingyan ...................................... Disclosed no conflict of interest.Zhou, Qiao ............................................. Disclosed no conflict of interest.Zhou, Qiong L. ...................................... Disclosed no conflict of interest.Zhou, Rong ............................................ Other Relationship: Sanofi US, Inc.Zhou, Saijun .......................................... Disclosed no conflict of interest.Zhou, Shanshan .................................... Disclosed no conflict of interest.Zhou, Shuisheng ................................... Disclosed no conflict of interest.Zhou, Steve ........................................... Employee: Sanofi.Zhou, Tianyue ........................................ Employee: Sanofi.Zhou, Wei .............................................. Employee: Sanofi.Zhou, Wen ............................................. Disclosed no conflict of interest.Zhou, Xianghai ...................................... Disclosed no conflict of interest.Zhou, Yuren ........................................... Disclosed no conflict of interest.Zhou, Zhiguang ..................................... Disclosed no conflict of interest.Zhu, Beibei ............................................ Disclosed no conflict of interest.Zhu, Bilian ............................................. Disclosed no conflict of interest.Zhu, Chaoxia ......................................... Disclosed no conflict of interest.
Zhu, Dalong ........................................... Disclosed no conflict of interest.Zhu, Dan ................................................ Disclosed no conflict of interest.Zhu, Jasmine J. .................................... Disclosed no conflict of interest.Zhu, Jinyue ............................................ Disclosed no conflict of interest.Zhu, Jun Y. ........................................... Disclosed no conflict of interest.Zhu, Jun ................................................ Disclosed no conflict of interest.Zhu, Liangxiang ..................................... Disclosed no conflict of interest.Zhu, Wanling ......................................... Disclosed no conflict of interest.Zhu, Weiliang ........................................ Disclosed no conflict of interest.Zhu, Yi ................................................... Disclosed no conflict of interest.Zhuang, Langen ..................................... Disclosed no conflict of interest.Zhuang, Ning ......................................... Disclosed no conflict of interest.Zhuang, Xiaotong .................................. Disclosed no conflict of interest.Zhuge, Fen ............................................. Disclosed no conflict of interest.Zhuo, Shu-yu ......................................... Disclosed no conflict of interest.Zhuo, Xiaohui ........................................ Disclosed no conflict of interest.Zhusbaeva, Gulmira O. ........................ Disclosed no conflict of interest.Zibar, Karin ............................................ Disclosed no conflict of interest.Zickmund, Susan L. .............................. Research Support: Becton, Dickinson and Company.Ziegler, Dan ........................................... Disclosed no conflict of interest.Ziegler, Iris............................................. Disclosed no conflict of interest.Zielinska, Anna ..................................... Disclosed no conflict of interest.Zielonka, Jason ..................................... Employee: Eli Lilly and Company.Ziemen, Monika .................................... Employee: Sanofi.Ziemer, David C. ................................... Disclosed no conflict of interest.Zimbalatti, Dario ................................... Disclosed no conflict of interest.Zimering, Mark ...................................... Disclosed no conflict of interest.Zimmerman, Andrew W. ...................... Disclosed no conflict of interest.Zimmerman, Robert S. ......................... Disclosed no conflict of interest.Zimmermann, Alan G. .......................... Employee: Eli Lilly and Company, Eli Lilly and Company
(Spouse/Partner); Stock/Shareholder: Eli Lilly and Company, Eli Lilly and Company (Spouse/Partner).
Zimpelmann, Joseph ............................. Disclosed no conflict of interest.Zinman, Bernard .................................... Advisory Panel: Amylin Pharmaceuticals, Inc., AstraZeneca
Pharmaceuticals LP, Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Merck, Novo Nordisk A/S, Sanofi, Takeda Pharmaceuticals U.S.A., Inc.; Research Support: AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim Pharmaceuticals, Inc., Merck, Novo Nordisk A/S.
Zirie, Mahmoud ..................................... Disclosed no conflict of interest.Zisser, Howard ...................................... Advisory Panel: Animas Corporation; Research Support:
Animas Corporation.Zitouni, Monther ................................... Disclosed no conflict of interest.Ziv, Arnona ............................................ Disclosed no conflict of interest.Zmuda, Joseph M. ............................... Disclosed no conflict of interest.Zmyslowska, Agnieszka ........................ Disclosed no conflict of interest.Zoccali, Carmine ................................... Disclosed no conflict of interest.Zografou, Ioanna ................................... Disclosed no conflict of interest.Zollars, Harry ......................................... Disclosed no conflict of interest.Zonszein, Joel ....................................... Disclosed no conflict of interest.Zontini, Alexis ....................................... Disclosed no conflict of interest.Zoulim, Fabien ....................................... Disclosed no conflict of interest.Zraika, Sakeneh .................................... Disclosed no conflict of interest.Zrebiec, John F. .................................... Disclosed no conflict of interest.Zschornack, Eva .................................... Disclosed no conflict of interest.Zu, Xuyu ................................................ Disclosed no conflict of interest.Zucatti, Alessandra T. .......................... Disclosed no conflict of interest.Zuellig, Richard A. ................................ Disclosed no conflict of interest.Zukowska-Szczechowska, Ewa ............. Research Support: Roche Pharmaceuticals.Zullo, Matthew M. ............................... Research Support: Merck.
